data_1y9x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1y9x _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 p30 . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.23 138.36 52.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.959 0.409 . . . . 0.0 110.824 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.51 151.03 33.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.0 tp -116.63 131.77 56.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.2 mm -84.41 121.98 37.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.18 -115.74 3.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.453 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.64 12.25 16.0 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.55 147.0 58.37 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.365 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.11 147.93 80.53 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.396 2.064 . . . . 0.0 110.781 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -58.64 -28.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 112.072 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.453 ' O ' HD13 ' A' ' 24' ' ' LEU . 27.1 ptt? -64.03 -24.0 67.55 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.19 0.519 . . . . 0.0 111.331 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.81 -30.49 51.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.021 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -82.82 -37.57 24.28 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.077 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.4 t -58.25 -51.06 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.021 0.439 . . . . 0.0 110.687 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 20' ' ' MET . 9.2 mp -67.37 -30.05 69.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.124 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.65 -44.96 80.53 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.826 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.28 -35.28 80.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.187 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.4 -36.8 79.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -67.74 -35.68 79.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.514 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.4 mt -63.97 -36.45 84.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.21 -46.87 85.01 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.7 -4.01 44.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.573 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.95 -22.94 17.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.7 -8.3 4.91 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.979 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.97 107.28 20.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.156 0.503 . . . . 0.0 110.624 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.6 p -85.6 -25.65 26.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -118.84 113.97 21.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.55 146.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 123.274 0.358 . . . . 0.0 110.701 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.44 118.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.2 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.8 mt -93.66 122.32 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.45 129.28 56.65 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.089 0.471 . . . . 0.0 109.785 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.12 169.59 17.37 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.496 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.401 ' HB3' HG22 ' A' ' 89' ' ' THR 0.309 0.0 OUTLIER -158.64 149.92 20.69 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.498 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.35 -120.02 8.98 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.223 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 ptm180 -87.0 -3.33 59.08 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.235 0.54 . . . . 0.0 110.96 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.63 -6.9 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.303 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.86 -36.13 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.991 0.516 . . . . 0.0 110.382 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -62.27 -35.88 80.34 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.179 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -75.08 -32.84 61.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.173 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.54 96.3 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 110.724 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.52 -39.87 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.51 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.418 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.2 t70 -57.9 -39.02 76.89 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.242 0.617 . . . . 0.0 110.006 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -66.68 -55.53 14.75 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.46 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.9 -31.15 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.635 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 31.0 tt0 -64.94 -44.48 89.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.3 mt -61.3 -49.01 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.95 0.405 . . . . 0.0 110.065 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.22 -36.59 58.34 Favored 'Isoleucine or valine' 0 C--O 1.259 1.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -87.4 -7.43 57.72 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.81 24.74 7.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.284 0.564 . . . . 0.0 111.583 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -137.1 -65.89 0.53 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -86.6 -51.25 6.27 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.687 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mp -132.16 112.84 12.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.19 -57.81 2.01 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.177 0.923 . . . . 0.0 112.096 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.14 -36.02 66.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.212 0.53 . . . . 0.0 111.631 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.04 -15.95 45.66 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -80.22 148.31 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.077 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -139.06 145.04 39.09 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -90.93 145.81 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -105.25 -52.59 2.81 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.114 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -169.39 152.2 4.78 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt -138.47 119.96 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.554 0.742 . . . . 0.0 110.32 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -133.5 133.99 42.91 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.715 -0.615 . . . . 0.0 110.874 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.24 136.79 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.42 162.85 29.87 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.611 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 12.0 p -82.13 125.54 30.99 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.577 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -104.62 146.3 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.767 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.31 -1.142 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.61 134.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -66.18 108.21 2.2 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.822 0.701 . . . . 0.0 111.362 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.401 HG22 ' HB3' ' A' ' 42' ' ' ARG . 35.1 p -105.83 150.15 25.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.092 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.53 131.34 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.08 115.99 27.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.9 mt -110.71 114.0 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.47 122.33 47.46 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 120.675 0.274 . . . . 0.0 110.577 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.9 pt -120.99 157.08 24.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.969 0.414 . . . . 0.0 110.421 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -119.56 118.54 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.336 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 C--N 1.286 -2.18 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.363 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p30 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.4 132.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.224 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.43 152.58 25.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.891 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -117.91 126.39 52.27 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -80.91 119.02 29.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.463 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.72 -116.75 3.72 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.018 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -114.63 15.47 17.67 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.769 0.319 . . . . 0.0 111.078 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -84.07 146.4 48.47 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.683 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.52 143.03 79.92 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.8 2.334 . . . . 0.0 110.858 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.6 -30.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.436 ' O ' HD13 ' B' ' 24' ' ' LEU . 27.0 ptt? -60.95 -28.48 69.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 111.135 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.61 -35.6 67.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.016 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -78.81 -37.37 40.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.19 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.37 -51.93 65.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.694 0.283 . . . . 0.0 110.649 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.436 HD13 ' O ' ' B' ' 20' ' ' MET . 8.1 mp -67.49 -28.63 68.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.908 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -66.23 -46.02 78.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.01 86.24 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 121.35 0.595 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 92.6 mt -65.48 -39.46 91.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.358 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.4 m -65.7 -37.05 85.36 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.394 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.5 mt -62.91 -37.17 85.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.709 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.86 -45.93 91.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -80.4 -2.3 45.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.825 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -93.48 -27.8 16.47 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.9 2.74 3.4 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.62 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.17 111.44 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 117.881 0.84 . . . . 0.0 110.087 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 p -87.79 -32.43 19.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.478 ' CD ' ' HZ2' ' B' ' 68' ' ' LYS . 47.2 mt-10 -112.39 117.95 33.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.19 147.61 29.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.452 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.62 119.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.425 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 55.2 mt -95.05 123.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -115.73 130.49 56.87 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 121.481 0.658 . . . . 0.0 110.11 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.31 169.12 18.35 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.493 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.433 ' HB3' HG22 ' B' ' 89' ' ' THR 0.288 0.0 OUTLIER -158.45 149.79 20.92 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.685 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.92 -117.48 7.51 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.404 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -88.96 -4.6 58.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.032 0.444 . . . . 0.0 110.757 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.79 -9.05 59.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.03 -36.23 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.567 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 33.5 t -62.36 -35.53 79.41 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.248 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -76.3 -34.51 59.06 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.684 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.69 88.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.12 0.486 . . . . 0.0 111.039 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -73.23 -40.38 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.828 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.415 ' O ' HG13 ' B' ' 55' ' ' ILE . 32.4 t70 -58.55 -41.53 85.8 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.064 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 73.0 m -63.44 -54.96 28.31 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.001 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.44 -30.36 49.54 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' A' ' 74' ' ' SER . 27.7 tt0 -66.3 -43.49 86.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 51' ' ' ASP . 76.2 mt -61.71 -47.79 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.184 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.1 -34.36 56.48 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -89.16 -6.49 56.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -123.61 18.56 9.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.961 0.41 . . . . 0.0 111.697 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -131.97 -68.01 0.65 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.426 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -85.56 -49.05 8.35 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.733 -171.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 mp -133.54 112.0 11.14 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.495 ' O ' HG23 ' B' ' 65' ' ' ILE . . . -100.21 -63.36 1.14 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 124.013 0.821 . . . . 0.0 111.472 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.49 -37.03 86.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.112 0.565 . . . . 0.0 112.503 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.06 -15.36 41.55 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.495 HG23 ' O ' ' B' ' 62' ' ' ALA . 16.2 tt -80.41 148.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.608 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.531 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 40.4 tt0 -138.75 147.3 42.49 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -93.71 143.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.478 ' HZ2' ' CD ' ' B' ' 36' ' ' GLU . 86.3 tttt -102.57 -52.46 3.09 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.294 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -169.87 150.97 4.01 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.98 118.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 123.575 0.547 . . . . 0.0 110.746 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.04 134.88 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.685 -0.634 . . . . 0.0 110.752 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.99 137.37 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.8 163.42 31.16 Favored Glycine 0 C--N 1.315 -0.619 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.635 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 17.5 p -83.38 124.27 30.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.361 0.601 . . . . 0.0 112.226 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . 0.57 ' HA ' HE21 ' B' ' 75' ' ' GLN . 0.0 OUTLIER -103.05 145.93 29.15 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 C--N 1.305 -1.35 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.813 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.17 134.95 50.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.2 p -66.29 108.66 2.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.472 0.653 . . . . 0.0 111.84 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.433 HG22 ' HB3' ' B' ' 42' ' ' ARG . 33.8 p -106.49 148.98 27.55 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.568 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.05 130.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.813 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -113.64 113.74 25.46 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.93 116.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.4 121.24 44.3 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.606 0.241 . . . . 0.0 110.59 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 pt -119.54 154.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.531 ' HD3' ' OE1' ' B' ' 66' ' ' GLU . 60.3 ttt180 -117.47 121.3 40.65 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -102.35 132.77 48.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.891 176.877 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 120.92 0.39 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.16 133.91 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.315 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.88 145.29 32.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.335 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 tp -107.18 124.32 49.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.36 117.23 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 118.685 -1.722 . . . . 0.0 115.171 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -155.07 -41.08 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.976 0.888 . . . . 0.0 110.695 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -101.43 158.06 32.49 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.967 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.3 157.11 55.98 Favored 'Trans proline' 0 C--O 1.248 0.995 0 C-N-CA 121.845 1.696 . . . . 0.0 110.129 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.505 HG21 ' OD1' ' A' ' 51' ' ' ASP . 14.7 p -56.9 -26.91 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.456 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.6 ptp -62.91 -28.57 70.14 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.77 -35.73 32.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.251 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.34 -34.63 72.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.278 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 19' ' ' VAL . 96.4 t -60.57 -48.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.653 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 20' ' ' MET . 88.4 mt -66.29 -31.56 72.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.468 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.493 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.99 -50.76 61.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.43 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.33 -38.89 92.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.65 -45.06 73.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.146 0.978 . . . . 0.0 109.604 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 m -71.57 -41.4 69.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.072 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.1 mt -60.66 -37.67 82.35 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.489 0.316 . . . . 0.0 111.786 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 93.6 mt -61.76 -36.74 81.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.746 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -95.37 0.77 53.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.99 0.424 . . . . 0.0 111.333 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -90.72 -31.35 16.6 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.86 -19.95 2.9 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.673 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -80.03 99.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 m -78.16 -37.34 46.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.388 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.505 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 9.9 pt-20 -120.26 118.66 31.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.8 pt -119.5 160.31 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.71 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.39 112.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.199 0.524 . . . . 0.0 110.745 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.54 126.63 44.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -114.29 112.82 23.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.51 133.87 54.34 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.557 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 89' ' ' THR . 87.4 mtt180 -129.76 143.61 50.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 45' ' ' ALA . . . 63.21 81.35 0.1 OUTLIER Glycine 0 C--O 1.211 -1.333 0 O-C-N 123.784 0.677 . . . . 0.0 114.49 175.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 58.66 -7.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 126.192 1.797 . . . . 0.0 115.083 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 43' ' ' GLY . . . -74.58 -3.12 29.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.7 mt -51.7 -39.33 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.188 1.395 . . . . 0.0 110.663 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -68.27 -24.46 64.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.562 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.86 -27.72 26.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.059 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.58 -44.61 81.79 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.812 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.01 -35.23 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.054 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.505 ' OD1' HG21 ' A' ' 19' ' ' VAL . 15.0 t70 -59.52 -47.87 83.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -54.75 -56.47 18.94 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.338 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 m -67.13 -30.76 50.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.29 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.549 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 27.1 tt0 -65.99 -38.69 89.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.42 0.45 . . . . 0.0 111.014 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.7 mt -66.26 -49.68 74.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.466 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.05 -50.47 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 35.0 ptt180 -68.56 -7.78 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -115.33 -12.07 11.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.716 0.769 . . . . 0.0 110.369 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -105.77 -53.5 2.63 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -82.22 -60.39 2.23 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.201 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.418 HD13 ' H ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -146.85 105.62 3.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -176.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 6.21 46.12 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.05 -65.0 1.01 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.484 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' H ' HD13 ' A' ' 61' ' ' LEU . 45.9 mttm -98.94 94.24 6.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tp -148.91 141.13 17.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -132.58 152.99 51.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.6 132.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -75.03 -53.75 8.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -173.71 156.84 2.98 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -129.96 115.69 34.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -139.46 147.55 41.51 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.414 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.23 146.76 20.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.29 -171.01 36.07 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.181 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.496 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 36.8 p -108.46 123.83 49.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -99.85 117.57 34.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 C--N 1.319 -0.729 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.102 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 . . . . . 0 CA--C 1.501 -0.913 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.3 t -127.77 125.94 65.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.162 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 p -67.03 121.57 15.85 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.467 HG22 ' HG2' ' A' ' 42' ' ' ARG . 64.6 p -117.47 153.91 32.32 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.6 tt -142.78 129.79 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -107.08 105.83 16.04 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.3 mm -102.26 110.77 29.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.31 128.91 54.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.612 0.244 . . . . 0.0 110.382 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.1 155.07 40.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.505 ' HD3' ' OE1' ' A' ' 36' ' ' GLU . 53.1 ttp180 -133.04 126.2 31.34 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.504 0.669 . . . . 0.0 111.592 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.495 ' HB3' ' HZ3' ' A' ' 96' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--O 1.239 0.513 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 20.9 m -120.37 138.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.428 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.36 145.48 35.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.032 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.17 126.45 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 46.4 mm -90.47 115.89 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.84 44.84 0.02 OUTLIER Glycine 0 CA--C 1.523 0.564 0 C-N-CA 118.849 -1.643 . . . . 0.0 114.855 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.89 -43.08 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 117.655 0.728 . . . . 0.0 110.875 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.431 ' HE2' ' HD2' ' B' ' 18' ' ' PRO . 13.5 mmmm -101.32 156.87 34.65 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.449 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.431 ' HD2' ' HE2' ' B' ' 17' ' ' LYS . 29.1 Cg_endo -64.64 157.77 53.78 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.293 1.996 . . . . 0.0 110.727 172.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.434 ' O ' HG21 ' B' ' 23' ' ' VAL . 13.9 p -56.12 -27.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.421 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.1 ptp -63.05 -29.24 70.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.065 0.459 . . . . 0.0 111.007 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.32 -37.88 36.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.201 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.62 -36.32 78.49 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.531 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.434 HG21 ' O ' ' B' ' 19' ' ' VAL . 66.2 t -61.2 -47.46 93.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 20' ' ' MET . 89.9 mt -67.66 -30.43 69.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.161 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.3 -51.38 53.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.487 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.85 -37.99 89.03 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.353 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 27.7 tp -55.02 -45.61 75.18 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.213 1.005 . . . . 0.0 109.194 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 48.7 m -70.47 -40.72 73.48 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.883 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.5 mt -61.32 -38.1 85.64 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.477 0.311 . . . . 0.0 111.499 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 98.3 mt -61.76 -38.48 88.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.101 0.56 . . . . 0.0 111.882 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.89 -5.37 51.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.424 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -84.13 -31.83 25.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.212 0.53 . . . . 0.0 109.788 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.06 -15.01 3.05 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.063 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.15 97.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -73.95 -39.14 63.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.32 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.535 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 10.2 pt-20 -121.14 118.56 30.0 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.41 0.624 . . . . 0.0 111.576 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.6 162.49 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.859 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 57.4 t -129.18 115.66 36.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.23 0.538 . . . . 0.0 110.369 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.8 mt -94.24 122.4 45.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.01 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -110.43 111.75 23.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.145 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.58 132.52 55.09 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.487 ' HG2' HG22 ' B' ' 89' ' ' THR . 87.8 mtt180 -129.06 144.06 51.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.44 80.98 0.12 Allowed Glycine 0 C--O 1.214 -1.11 0 O-C-N 123.879 0.737 . . . . 0.0 114.338 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 56.35 -3.81 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.998 1.719 . . . . 0.0 115.138 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.16 -3.07 34.24 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.271 0.557 . . . . 0.0 110.851 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 69.2 mt -51.67 -40.46 26.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.857 1.263 . . . . 0.0 110.365 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.6 t -66.12 -28.66 68.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.651 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.98 -28.39 29.76 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.508 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.8 86.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 120.945 0.402 . . . . 0.0 110.748 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.72 -36.69 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.545 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.482 ' O ' HG13 ' B' ' 55' ' ' ILE . 15.0 t70 -58.86 -46.85 86.79 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -54.45 -57.8 9.93 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.672 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.34 -29.3 45.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.871 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.507 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 24.0 tt0 -67.68 -36.93 81.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.968 0.413 . . . . 0.0 111.089 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.482 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.0 mt -66.56 -50.17 68.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.241 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.04 -50.45 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 34.5 ptt180 -67.83 -8.21 34.27 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -116.63 -12.51 10.91 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.759 0.79 . . . . 0.0 110.46 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -104.8 -53.51 2.67 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -82.64 -59.93 2.35 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.943 -172.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.471 HD13 ' H ' ' B' ' 64' ' ' LYS . 0.3 OUTLIER -146.72 106.31 3.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.39 6.32 44.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -94.81 -57.8 2.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.402 0.62 . . . . 0.0 110.924 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.471 ' H ' HD13 ' B' ' 61' ' ' LEU . 48.8 mttm -107.74 95.42 5.67 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.127 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tp -149.22 139.29 16.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.424 ' HB2' ' HE2' ' B' ' 97' ' ' LYS . 45.2 tt0 -130.33 148.39 52.15 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.91 123.94 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -67.45 -59.76 3.12 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.646 0.591 . . . . 0.0 109.847 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.38 154.69 8.72 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.1 mt -129.7 114.14 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 123.617 0.573 . . . . 0.0 109.66 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -138.07 146.68 43.24 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.308 -0.245 . . . . 0.0 111.177 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.6 144.69 23.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.82 -171.42 36.11 Favored Glycine 0 CA--C 1.5 -0.874 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.807 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.509 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 26.3 p -107.35 124.77 50.3 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 122.563 0.345 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -100.71 117.08 34.09 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.313 -1.01 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.8 179.636 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 . . . . . 0 CA--C 1.502 -0.901 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.37 126.07 68.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.084 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 73.8 p -67.32 122.99 19.1 Favored 'General case' 0 C--O 1.266 1.956 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.487 HG22 ' HG2' ' B' ' 42' ' ' ARG . 60.7 p -119.4 153.49 35.13 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 18.3 tt -142.46 131.28 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -109.02 105.5 15.04 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.588 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mm -102.6 110.72 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.87 129.85 55.89 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.874 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.597 0.236 . . . . 0.0 110.66 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.535 ' HD3' ' OE2' ' B' ' 36' ' ' GLU . 51.2 ttp180 -126.62 125.3 41.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.978 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.591 ' HZ2' ' C ' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -89.34 120.67 30.89 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.591 ' C ' ' HZ2' ' B' ' 96' ' ' LYS . 67.3 mttm . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.7 p30 . . . . . 0 CA--C 1.51 -0.568 0 CA-C-O 120.698 0.285 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.36 112.49 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -110.55 134.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.264 0.555 . . . . 0.0 110.74 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.59 129.5 43.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.8 mm -91.28 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.99 50.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.103 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -157.6 -65.05 0.09 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 117.22 0.51 . . . . 0.0 110.682 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -101.82 168.45 9.02 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.36 167.13 19.35 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.058 1.839 . . . . 0.0 112.253 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.468 HG12 ' OD2' ' A' ' 51' ' ' ASP . 93.1 t -50.32 -38.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.373 1.069 . . . . 0.0 112.602 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.3 ptp -52.02 -31.45 29.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.03 -32.87 63.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 121.507 0.67 . . . . 0.0 110.404 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -80.52 -34.64 35.47 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.285 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.01 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.291 0.567 . . . . 0.0 109.693 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.56 -35.95 81.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.032 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.47 96.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.288 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -9.19 57.69 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.11 0.481 . . . . 0.0 111.76 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.97 -43.99 7.56 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -60.3 -40.33 90.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.55 -36.07 81.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.396 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.436 HD22 ' HG3' ' A' ' 96' ' ' LYS . 3.4 tm? -64.86 -39.23 93.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -67.29 -17.82 64.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.17 0.51 . . . . 0.0 111.188 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -91.96 -4.56 54.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.4 -7.56 32.34 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.098 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.44 99.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -89.45 -29.64 18.87 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.095 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.32 115.99 30.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.782 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.81 156.14 39.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.555 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.0 t -124.95 124.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.807 0.692 . . . . 0.0 110.549 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.7 mt -105.65 130.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.419 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.39 122.99 41.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.189 0.519 . . . . 0.0 110.897 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.73 155.05 33.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -133.01 141.07 48.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.449 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.47 -118.58 7.91 Favored Glycine 0 CA--C 1.505 -0.574 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.304 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -94.65 8.08 43.58 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.84 -0.38 57.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.888 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.25 -38.3 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 p -62.72 -32.01 73.04 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.305 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -70.19 -37.27 75.06 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.1 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.93 91.22 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.546 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.89 -33.95 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.551 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.535 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 t70 -62.63 -45.24 93.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.7 m -57.0 -53.35 59.04 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.552 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.9 m -66.05 -36.05 76.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.27 -45.18 94.19 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 123.132 0.27 . . . . 0.0 111.563 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.4 mt -60.59 -43.03 93.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.49 -43.95 98.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.503 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -83.45 13.64 4.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.273 0.558 . . . . 0.0 111.41 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -119.99 -45.68 2.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.845 0.355 . . . . 0.0 110.277 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.4 ptp180 -81.8 -21.65 37.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 60.9 t80 -117.56 -70.12 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.391 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.537 ' HG ' ' CD2' ' A' ' 60' ' ' PHE . 90.0 mt -132.61 114.82 14.67 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.08 -33.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.245 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.33 -52.61 9.6 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.451 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -97.21 88.46 4.47 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.607 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -160.73 120.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.899 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.526 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 10.2 pt-20 -121.7 134.95 54.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 111.056 177.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.8 mt -88.81 139.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HZ3' ' NH2' ' A' ' 95' ' ' ARG . 31.1 mmmt -84.62 -54.92 4.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.074 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -170.69 152.62 3.83 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.1 mt -134.08 116.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 77.1 mtp180 -116.83 137.47 52.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.866 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.91 124.44 50.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 -168.37 24.71 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.537 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.6 p -118.04 124.34 47.87 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.128 0.489 . . . . 0.0 110.783 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -100.01 128.19 46.13 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--N 1.312 -1.038 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 CA--C 1.506 -0.733 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.25 126.43 73.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -67.64 128.45 36.5 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.473 0.483 . . . . 0.0 110.96 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.4 p -123.0 160.41 26.34 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 71' ' ' ARG . 13.0 tt -146.06 124.35 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -105.0 110.46 22.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.286 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -109.93 116.77 53.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.25 125.18 51.86 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.02 159.0 32.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.526 ' HD2' ' OE2' ' A' ' 66' ' ' GLU . 41.6 ttm180 -126.22 132.32 51.77 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 123.46 0.704 . . . . 0.0 111.18 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.436 ' HG3' HD22 ' A' ' 30' ' ' LEU . 34.2 mmtp . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.642 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p30 . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.88 0.371 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.1 115.17 47.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.14 134.57 53.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.086 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 tp -97.58 127.63 43.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.342 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mm -88.52 110.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.3 52.23 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.016 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -159.72 -65.4 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.219 0.509 . . . . 0.0 110.405 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -101.54 168.04 9.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.423 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.59 164.62 30.37 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.978 1.785 . . . . 0.0 112.393 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 95.2 t -46.77 -38.39 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.128 1.371 . . . . 0.0 113.22 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptp -52.31 -35.08 49.65 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -69.9 -35.39 74.57 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.19 0.519 . . . . 0.0 110.685 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -78.75 -35.49 44.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.16 -50.82 78.72 Favored 'Isoleucine or valine' 0 C--O 1.252 1.231 0 CA-C-O 121.601 0.715 . . . . 0.0 109.124 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.89 -32.53 74.28 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.158 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.85 94.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.021 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.16 68.38 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.168 0.509 . . . . 0.0 110.754 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.83 -44.19 42.22 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.468 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -63.21 -38.55 91.6 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.832 0.349 . . . . 0.0 111.152 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.24 -39.04 89.25 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 122.315 -0.241 . . . . 0.0 110.92 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.401 HD22 ' HG3' ' B' ' 96' ' ' LYS . 3.4 tm? -60.19 -40.13 88.96 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.709 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.87 -20.92 66.01 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.045 0.45 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -87.17 -9.28 55.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.11 -4.55 23.82 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.844 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.24 96.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 0.0 109.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -84.03 -28.24 27.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -114.84 120.42 39.93 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.98 154.56 40.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 O-C-N 123.16 0.288 . . . . 0.0 111.348 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.68 124.36 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.216 0.532 . . . . 0.0 110.56 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.64 130.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.343 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.26 123.95 44.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.173 0.511 . . . . 0.0 110.904 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 153.94 35.18 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -129.1 143.39 50.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.47 -122.76 15.35 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 116.312 -0.404 . . . . 0.0 113.533 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.17 11.64 24.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.905 0.383 . . . . 0.0 110.944 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.33 -1.04 57.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.509 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.49 -37.25 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.126 0.571 . . . . 0.0 110.36 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.5 p -66.12 -31.36 72.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.233 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -69.15 -39.96 78.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.31 91.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.606 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -72.4 -34.28 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.589 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.549 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.0 t70 -62.73 -45.18 93.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 90.4 m -56.23 -53.74 53.55 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.622 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.24 -34.23 67.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.959 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -60.99 -47.97 84.0 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.549 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.8 mt -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.883 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.01 -41.03 91.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -85.76 14.7 5.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.24 0.543 . . . . 0.0 111.043 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -121.33 -45.44 2.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.277 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.8 ptp180 -83.28 -19.28 36.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.462 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.535 ' CD2' ' HG ' ' B' ' 61' ' ' LEU . 57.8 t80 -118.66 -71.56 0.73 Allowed 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.64 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.535 ' HG ' ' CD2' ' B' ' 60' ' ' PHE . 94.0 mt -131.15 114.91 15.69 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.158 0.504 . . . . 0.0 111.71 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.26 -32.16 11.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.551 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.83 -49.48 11.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.0 87.35 3.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.413 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -160.71 119.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 11.0 pt-20 -122.04 136.16 54.89 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.131 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.42 143.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.677 ' HZ3' ' NH2' ' B' ' 95' ' ' ARG . 31.4 mmmt -87.76 -58.14 2.68 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.925 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -167.67 152.0 6.61 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 67.0 mt -133.35 115.56 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 90' ' ' ILE . 73.9 mtp180 -115.06 136.41 53.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.822 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.72 126.08 56.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.12 -168.45 26.19 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.156 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.2 p -116.27 121.14 41.12 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.359 0.6 . . . . 0.0 111.235 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -96.22 127.2 42.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.643 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.228 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.437 -1.111 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 72.7 t -115.7 125.24 72.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -67.26 127.08 31.31 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.969 0.414 . . . . 0.0 111.232 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 67.8 p -121.42 159.37 26.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.095 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' B' ' 71' ' ' ARG . 12.3 tt -146.21 124.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.933 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -103.59 113.16 26.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.31 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.9 mt -112.02 114.64 47.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.32 125.45 53.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 pt -126.07 158.54 35.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.677 ' NH2' ' HZ3' ' B' ' 68' ' ' LYS . 41.5 ttm180 -124.53 134.95 52.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.401 ' HG3' HD22 ' B' ' 30' ' ' LEU . 34.1 mmtp -97.66 148.52 23.24 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 123.849 0.86 . . . . 0.0 109.517 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.517 175.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.508 0.671 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 58.3 t -116.06 119.59 62.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.11 147.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.098 0.475 . . . . 0.0 111.284 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 tp -110.76 134.82 52.16 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.52 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.412 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.69 -138.06 4.59 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -101.68 18.3 20.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.86 154.67 38.23 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.152 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.44 148.15 53.81 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.187 2.591 . . . . 0.0 112.499 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.524 HG22 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -54.68 -36.15 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.762 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.415 ' O ' HD12 ' A' ' 24' ' ' LEU . 26.9 ptt? -59.31 -24.76 63.58 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -64.86 -38.59 91.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -85.33 -33.42 22.07 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.987 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.5 t -62.29 -55.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.169 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 20' ' ' MET . 9.3 mp -62.05 -26.45 68.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.692 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.68 -45.75 70.86 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.118 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -61.58 -42.45 98.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp -61.84 -38.26 87.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.1 m -68.2 -37.94 81.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.924 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 96.7 mt -63.18 -34.99 78.83 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.368 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.9 mt -57.52 -41.8 81.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.28 -16.89 62.49 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -91.63 2.05 56.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.51 0.672 . . . . 0.0 110.338 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.68 -3.81 59.31 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.56 91.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 t -90.24 -12.13 38.87 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.96 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -124.56 111.98 16.3 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.444 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.89 156.82 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.823 0.345 . . . . 0.0 111.698 -177.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -126.35 125.49 67.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.009 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.81 129.45 61.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.125 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -118.73 123.54 45.1 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.01 153.07 37.82 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -129.59 140.95 51.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.089 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.7 -135.04 18.6 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.292 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -83.05 2.63 34.1 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.5 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.5 30.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.579 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.35 -36.95 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.361 0.601 . . . . 0.0 109.705 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.1 p -61.55 -37.42 83.73 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.543 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HB2' ' NZ ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -67.64 -42.84 81.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.153 -178.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.27 89.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.466 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.8 -36.77 65.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.805 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.524 ' OD2' HG22 ' A' ' 19' ' ' VAL . 17.9 t70 -59.59 -47.63 84.83 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.2 m -53.36 -53.56 49.28 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.444 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -69.98 -31.18 46.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.493 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 25.3 tt0 -68.61 -32.17 71.87 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.947 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.3 mt -68.69 -42.83 83.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.119 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.19 -30.93 47.98 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 CA-C-O 121.25 0.548 . . . . 0.0 111.292 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 40.4 ptt180 -88.88 14.98 9.16 Favored 'General case' 0 C--O 1.211 -0.94 0 O-C-N 122.023 -0.423 . . . . 0.0 110.299 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -128.67 -56.02 1.22 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -73.27 -29.15 62.54 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -97.96 -63.21 1.15 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.023 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.48 110.55 5.69 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.798 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.41 -46.69 8.2 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.555 1.159 . . . . 0.0 110.777 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.91 -29.52 58.45 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.77 97.23 7.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -160.95 143.69 4.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.957 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.72 141.72 51.48 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.35 125.6 68.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -86.05 -62.48 1.51 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.28 149.29 5.91 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.014 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.2 mt -139.15 99.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.22 136.79 54.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.8 t -102.16 132.7 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.82 167.29 28.24 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.881 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 p -93.88 135.89 34.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.829 0.347 . . . . 0.0 110.825 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 36.0 tt0 -100.48 114.18 27.56 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.451 HG21 ' HG2' ' A' ' 86' ' ' ARG . 45.1 t . . . . . 0 C--N 1.321 -0.652 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.451 ' HG2' HG21 ' A' ' 76' ' ' VAL . 99.5 mtt180 . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.58 136.44 58.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.7 p -70.24 127.26 32.19 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.518 0.675 . . . . 0.0 111.956 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.0 p -133.11 160.15 38.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.774 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.67 139.53 48.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -118.13 110.76 18.0 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -111.5 119.74 60.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.41 120.26 30.56 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.723 0.297 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.34 168.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 ttt180 -136.85 133.7 36.12 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.22 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 70.7 mmtt . . . . . 0 C--N 1.289 -2.052 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.241 0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 62.2 t -113.03 114.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -111.29 143.46 21.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.01 138.28 43.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -86.18 125.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.792 0.329 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.56 -140.0 7.46 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.777 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -99.81 14.87 28.82 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -91.31 154.38 44.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.328 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.96 146.68 56.14 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.203 2.602 . . . . 0.0 112.391 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.425 HG22 ' OD1' ' B' ' 51' ' ' ASP . 7.1 p -51.66 -35.52 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.307 1.043 . . . . 0.0 113.516 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.09 -25.34 66.89 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.27 -36.96 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.495 0.664 . . . . 0.0 110.117 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -87.04 -33.66 19.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.205 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 65.6 t -61.31 -55.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.583 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.66 -26.16 68.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.761 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -68.34 -44.18 75.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.173 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -41.72 96.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.14 -36.81 80.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.958 0.408 . . . . 0.0 110.671 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 37.9 m -68.66 -38.36 80.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 95.6 mt -63.58 -35.18 79.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.254 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.2 mt -55.84 -42.81 76.32 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -71.61 -15.14 62.24 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -93.38 1.7 56.8 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.37 0.605 . . . . 0.0 110.382 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.42 -8.27 58.55 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.657 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.92 91.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.249 0.547 . . . . 0.0 109.605 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -90.16 -13.17 36.19 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.773 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -123.91 116.62 23.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.906 -0.496 . . . . 0.0 109.669 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 157.9 42.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-O 120.806 0.336 . . . . 0.0 111.633 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 58.9 t -127.0 124.7 65.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.218 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.9 mt -106.97 127.43 62.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.03 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . 0.411 ' NZ ' ' OE2' ' B' ' 91' ' ' GLU . 65.3 mttm -117.22 122.32 43.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.689 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.59 40.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -128.17 139.82 52.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.332 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.83 -136.14 20.25 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.239 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -80.52 0.53 33.36 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 122.439 -0.447 . . . . 0.0 111.53 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.43 -0.81 27.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.627 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 75.2 mt -55.91 -38.87 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.15 0.5 . . . . 0.0 110.021 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -61.71 -38.03 86.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.733 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.466 ' HZ1' ' HB2' ' B' ' 48' ' ' LYS . 0.0 OUTLIER -66.14 -41.56 90.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.28 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.89 81.23 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.209 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.11 -34.09 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.462 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.535 ' O ' HG13 ' B' ' 55' ' ' ILE . 12.3 t70 -60.9 -47.18 87.56 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -54.84 -55.08 34.21 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 18.0 m -68.14 -31.88 53.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.131 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 27.3 tt0 -68.6 -31.01 69.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.099 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.535 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.0 mt -69.54 -43.59 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.191 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.41 -31.36 52.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 CA-C-O 121.297 0.57 . . . . 0.0 111.335 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 40.0 ptt180 -88.66 17.27 5.64 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -131.56 -57.08 1.0 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.138 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -72.55 -26.68 61.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -101.65 -64.03 1.09 Allowed 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.975 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -141.93 112.33 7.07 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.7 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.9 -50.23 5.82 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 124.293 0.995 . . . . 0.0 110.875 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.49 -28.76 62.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -105.54 98.02 7.77 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.442 0.639 . . . . 0.0 110.755 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tp -161.15 145.12 4.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.869 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -126.17 138.48 53.66 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.24 126.72 63.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -86.63 -64.47 1.15 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -166.33 146.98 6.31 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.393 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.3 mt -139.43 100.82 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.19 143.46 50.49 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.59 123.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.56 168.64 24.1 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.761 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 35.1 p -92.96 133.34 36.22 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.659 0.384 . . . . 0.0 110.907 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 36.1 tt0 -99.61 114.49 27.57 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.438 HG21 ' HG2' ' B' ' 86' ' ' ARG . 46.7 t . . . . . 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.438 ' HG2' HG21 ' B' ' 76' ' ' VAL . 99.6 mtt180 . . . . . 0 N--CA 1.435 -1.199 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.62 137.4 56.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 7.2 p -72.31 127.47 32.67 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.464 0.649 . . . . 0.0 112.223 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.75 158.38 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.114 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.04 139.54 50.06 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . 0.411 ' OE2' ' NZ ' ' B' ' 40' ' ' LYS . 42.4 tt0 -119.16 112.38 19.44 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -112.39 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.01 35.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 pt -125.14 163.26 26.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 120.983 0.421 . . . . 0.0 110.482 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' B' ' 96' ' ' LYS . 76.4 ttt180 -132.44 134.21 44.81 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' B' ' 95' ' ' ARG . 69.4 mmtt -97.6 -170.36 1.99 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.318 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt . . . . . 0 C--O 1.256 1.4 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.195 176.773 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 121.547 0.689 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.65 120.37 60.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.156 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.53 139.69 42.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.991 0.424 . . . . 0.0 110.693 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.3 tp -104.21 136.73 43.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.313 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -84.09 123.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.4 -159.49 11.77 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.03 13.41 1.79 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -86.07 152.48 56.03 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 121.95 -0.469 . . . . 0.0 112.162 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.65 150.79 59.16 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.859 2.373 . . . . 0.0 112.213 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.532 HG22 ' OD2' ' A' ' 51' ' ' ASP . 7.4 p -56.23 -35.31 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.503 0.721 . . . . 0.0 112.388 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.1 ptp -57.89 -30.81 66.17 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.93 -34.08 74.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -79.09 -33.34 44.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.196 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 66.1 t -61.62 -48.52 88.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.84 -38.54 91.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.645 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.81 -44.64 96.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.2 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.38 96.61 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.19 0.519 . . . . 0.0 111.012 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 95.3 mt -64.92 -38.97 92.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.806 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.9 m -67.74 -31.79 71.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.2 mt -70.6 -40.37 73.25 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 122.088 -0.383 . . . . 0.0 110.245 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.56 -40.97 89.07 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.372 0.606 . . . . 0.0 109.406 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -59.13 -30.21 67.96 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.44 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -91.26 3.19 55.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.52 11.99 57.58 Favored Glycine 0 C--O 1.244 0.759 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.921 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.31 98.04 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 13.1 p -87.46 -13.87 42.01 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' OE1' ' HG3' ' A' ' 68' ' ' LYS . 36.6 tt0 -128.66 111.79 13.56 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.35 159.66 35.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.02 127.29 51.46 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-O 121.573 0.701 . . . . 0.0 110.86 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -101.88 124.29 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.52 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 81.8 mttt -115.46 114.27 24.81 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.32 0.581 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.07 158.49 17.7 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.848 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.503 ' HG2' HG23 ' A' ' 89' ' ' THR . 54.8 mtm180 -133.54 148.68 51.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.91 -121.58 19.57 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 123.559 0.537 . . . . 0.0 113.016 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -92.0 -0.28 57.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.63 -4.03 46.92 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -54.9 -36.07 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.7 0.8 . . . . 0.0 110.529 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -63.39 -35.49 80.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.616 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.23 -30.04 60.42 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.3 82.35 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.31 -37.19 64.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.184 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 19' ' ' VAL . 34.9 t70 -60.66 -43.39 97.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.875 0.369 . . . . 0.0 110.086 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -58.71 -51.25 70.77 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.279 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.96 -32.37 51.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.59 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.512 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 7.6 tp10 -63.66 -40.3 96.51 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.1 mt -64.21 -44.33 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.81 -39.59 82.34 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.831 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.512 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 2.6 ptm180 -80.66 1.33 30.43 Favored 'General case' 0 C--O 1.206 -1.199 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -128.17 11.35 6.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.081 0.467 . . . . 0.0 111.789 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -118.1 -66.71 1.05 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.709 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -75.9 -67.17 0.7 Allowed 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.827 0.346 . . . . 0.0 110.386 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.23 109.25 6.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -87.04 -44.9 11.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.429 1.08 . . . . 0.0 110.343 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.96 -28.71 67.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.619 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -121.02 106.84 11.96 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -159.26 120.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.291 0.567 . . . . 0.0 110.506 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 21.3 mm-40 -98.45 134.39 41.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.264 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.5 mt -101.2 122.64 53.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 1.9 tmtp? -83.58 -55.59 4.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.398 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -173.55 154.25 2.49 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -133.4 116.18 24.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -119.31 134.79 55.02 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.725 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.84 131.57 71.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.88 28.92 Favored Glycine 0 CA--C 1.493 -1.335 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -115.18 145.11 42.71 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 117.228 0.514 . . . . 0.0 111.238 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -114.48 134.81 54.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 C--N 1.311 -1.072 0 CA-C-O 121.408 0.623 . . . . 0.0 110.93 178.075 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.836 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.85 139.62 42.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.8 p -67.41 126.29 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 O-C-N 123.757 0.661 . . . . 0.0 110.828 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.503 HG23 ' HG2' ' A' ' 42' ' ' ARG . 46.6 p -132.03 151.19 51.89 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.2 tt -136.11 140.0 44.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.92 109.42 15.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.68 111.8 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.12 122.58 47.98 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.978 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.32 157.65 24.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.783 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.5 ttp180 -126.02 133.44 51.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? . . . . . 0 N--CA 1.413 -2.288 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.235 -174.261 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 C--O 1.246 0.87 0 CA-C-O 121.614 0.721 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.38 126.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.067 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.51 139.8 46.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.104 0.478 . . . . 0.0 110.495 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 tp -104.32 138.23 41.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.299 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -85.34 123.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.253 0.549 . . . . 0.0 111.295 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.9 -160.49 11.91 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.48 12.46 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -84.64 153.42 61.29 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.805 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.28 154.32 29.58 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.755 2.304 . . . . 0.0 111.772 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.428 HG22 ' OD2' ' B' ' 51' ' ' ASP . 7.1 p -61.58 -35.88 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.028 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.404 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.3 ptp -56.93 -28.74 62.44 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.179 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.18 -36.83 77.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -76.42 -32.92 58.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.422 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 70.2 t -60.94 -50.48 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 20' ' ' MET . 91.9 mt -64.1 -34.36 77.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.35 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.72 81.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.73 97.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.963 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 97.6 mt -63.8 -37.93 89.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.618 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -34.54 77.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.191 0.519 . . . . 0.0 110.251 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.38 -40.55 81.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.201 -0.312 . . . . 0.0 110.421 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.67 -39.35 80.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.096 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.25 -28.78 69.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.354 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -92.5 6.67 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.873 0.368 . . . . 0.0 111.909 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.73 60.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.433 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.82 97.57 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 31.7 p -83.8 -21.71 32.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -122.2 115.27 22.09 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.65 154.34 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.04 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.06 128.48 67.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 CA-C-O 121.775 0.798 . . . . 0.0 111.22 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -101.91 124.67 55.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.728 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.6 mttt -114.82 115.68 27.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.398 0.618 . . . . 0.0 110.744 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.41 158.54 18.36 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.458 ' HG2' HG23 ' B' ' 89' ' ' THR . 50.9 mtm180 -132.33 149.94 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.61 -117.08 9.84 Favored Glycine 0 N--CA 1.446 -0.643 0 O-C-N 123.604 0.565 . . . . 0.0 113.02 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -97.43 0.5 47.85 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.16 -2.96 43.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.686 0.279 . . . . 0.0 111.699 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.79 -36.21 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.887 0.875 . . . . 0.0 110.268 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.2 p -63.64 -35.4 80.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.37 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -76.29 -29.42 57.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.44 77.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -71.04 -34.91 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.518 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.0 t70 -60.87 -42.97 98.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.003 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.1 m -60.63 -53.17 60.7 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.512 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.35 -31.78 52.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 8.3 tp10 -64.92 -39.72 93.95 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 51' ' ' ASP . 81.7 mt -63.08 -45.65 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.6 t -60.52 -39.23 80.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.498 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 2.9 ptm180 -79.64 -2.87 44.68 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -127.21 20.75 6.81 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.041 0.448 . . . . 0.0 111.383 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -125.8 -66.58 0.93 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.547 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -77.61 -67.47 0.72 Allowed 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.21 110.0 7.6 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -86.59 -47.34 9.3 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 124.264 0.977 . . . . 0.0 110.71 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.56 -30.89 65.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.796 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -117.8 102.54 9.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.546 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -156.16 121.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.102 0.477 . . . . 0.0 110.647 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' B' ' 95' ' ' ARG . 23.5 mm-40 -99.98 133.79 43.85 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.061 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.45 123.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.21 -52.85 5.92 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.79 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -176.88 152.95 0.99 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.83 115.5 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -118.2 134.59 54.88 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.822 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.52 134.51 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.58 -167.44 37.9 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.9 p -109.66 149.28 29.94 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 117.59 0.695 . . . . 0.0 111.076 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.45 132.8 56.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.316 -0.849 0 CA-C-O 121.387 0.613 . . . . 0.0 111.318 177.312 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.41 138.99 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 13.1 p -66.24 128.02 34.47 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.216 0.532 . . . . 0.0 110.859 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.458 HG23 ' HG2' ' B' ' 42' ' ' ARG . 47.9 p -132.87 148.64 52.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.118 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 15.4 tt -133.62 139.37 48.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -118.09 108.9 15.78 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.72 111.8 37.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.0 123.24 49.88 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.815 0.341 . . . . 0.0 110.216 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -121.97 155.85 26.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' B' ' 35' ' ' SER . 60.7 ttp180 -126.06 128.5 47.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' B' ' 97' ' ' LYS . 2.7 tmtm? -104.94 143.34 33.3 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 -174.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.466 ' H ' ' HD3' ' B' ' 96' ' ' LYS . 74.4 mmtt . . . . . 0 C--O 1.263 1.8 0 CA-C-O 117.253 -1.356 . . . . 0.0 107.697 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.184 0.516 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -95.19 117.58 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 m -107.95 136.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.441 0.638 . . . . 0.0 111.57 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.26 104.74 14.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.819 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.89 107.7 12.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.375 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.53 36.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.921 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -160.21 -50.95 0.05 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.85 0.86 . . . . 0.0 110.611 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -97.97 154.88 37.6 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.777 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.78 156.37 62.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.914 2.409 . . . . 0.0 113.077 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.34 -41.73 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.811 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -62.85 -25.19 68.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.954 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.14 -21.83 56.13 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.294 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.0 -35.53 17.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.57 -50.65 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.143 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.09 -29.07 69.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.06 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -70.22 -48.15 58.31 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.621 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.86 91.03 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.516 0.51 . . . . 0.0 110.681 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.1 -30.6 71.56 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.305 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 93.7 m -78.89 -42.57 26.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 99.0 mt -62.78 -31.73 72.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.821 0.344 . . . . 0.0 110.732 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.96 -45.12 96.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.84 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.05 -25.64 64.57 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.421 0.629 . . . . 0.0 110.006 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 28' ' ' THR . 15.1 mm100 -80.01 -3.64 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.386 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 -7.93 36.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.447 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -85.44 97.18 5.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 m -98.38 0.01 44.58 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.796 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -135.38 115.15 12.89 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 155.35 41.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 O-C-N 123.306 0.379 . . . . 0.0 110.684 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.22 122.93 62.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.55 132.6 47.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.285 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -121.53 122.13 39.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.34 0.591 . . . . 0.0 111.359 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.68 147.73 50.77 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.158 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.401 ' HG3' HG21 ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.0 152.04 50.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 -124.25 9.12 Favored Glycine 0 C--N 1.309 -0.964 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.274 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -92.69 2.66 56.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.209 0.528 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.56 -7.68 55.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.967 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -55.83 -40.78 63.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.7 t -63.11 -33.38 75.33 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.959 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.79 -35.82 62.51 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.157 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.26 93.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.743 0.306 . . . . 0.0 111.508 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.88 -33.23 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 110.768 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.1 t70 -66.23 -40.82 90.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -57.46 -46.51 83.56 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.566 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -71.38 -36.74 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.07 -45.81 79.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.413 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 51' ' ' ASP . 74.1 mt -59.16 -50.35 80.1 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.788 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.83 -46.4 96.6 Favored 'Isoleucine or valine' 0 C--O 1.256 1.407 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -80.18 -5.48 56.15 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.119 0.485 . . . . 0.0 112.265 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -125.69 12.02 7.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -123.09 -41.49 2.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.772 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -123.71 -57.58 1.63 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.338 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.27 76.68 7.58 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.459 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 18.26 19.05 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.321 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -149.65 -59.7 0.21 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.515 0.674 . . . . 0.0 110.414 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -94.07 80.75 4.08 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.098 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.5 tp -159.2 145.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.291 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.41 167.93 21.0 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.036 0.446 . . . . 0.0 110.78 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.71 128.26 55.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.86 -57.45 3.75 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -177.03 146.9 0.53 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.4 pt -130.55 129.64 64.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.27 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -135.97 143.73 45.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.409 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 p -137.44 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.98 -145.42 5.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 m -138.38 134.47 34.21 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 65.2 tt0 -96.83 140.29 31.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.804 0.335 . . . . 0.0 110.276 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.705 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 94.3 mtt180 . . . . . 0 CA--C 1.491 -1.293 0 CA-C-O 120.893 0.378 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.55 136.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 m -62.81 123.99 19.89 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 123.566 0.541 . . . . 0.0 109.855 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.401 HG21 ' HG3' ' A' ' 42' ' ' ARG . 33.7 p -130.57 146.53 52.11 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.365 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -135.6 140.11 45.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.729 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.13 115.49 23.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.868 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.06 115.49 49.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.66 128.13 55.08 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -132.77 159.72 43.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -140.93 145.56 36.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.471 ' HD3' ' C ' ' A' ' 96' ' ' LYS . 12.7 tmtt? . . . . . 0 C--N 1.302 -1.473 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.976 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.5 p30 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.094 0.474 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 48.4 t -102.36 109.27 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.8 m -103.16 137.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.763 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.45 108.38 19.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.917 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.38 116.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.097 0.475 . . . . 0.0 109.927 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.38 35.46 0.02 OUTLIER Glycine 0 C--N 1.311 -0.823 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.829 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -161.92 -48.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.967 0.907 . . . . 0.0 111.212 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -99.88 155.48 36.41 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.391 -174.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.77 153.1 79.61 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.736 2.291 . . . . 0.0 112.374 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.439 ' O ' HG22 ' B' ' 23' ' ' VAL . 7.1 p -52.51 -39.47 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.616 0.767 . . . . 0.0 112.858 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -63.38 -26.78 68.91 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.76 -25.86 60.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.317 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.04 -37.85 21.61 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.439 HG22 ' O ' ' B' ' 19' ' ' VAL . 61.4 t -58.55 -49.56 81.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.426 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.3 -28.4 68.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.748 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.417 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -69.66 -47.9 61.71 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.447 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -45.62 87.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.606 0.566 . . . . 0.0 110.977 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.04 -31.49 72.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.157 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 90.6 m -77.12 -44.47 30.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.595 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 96.6 mt -61.57 -31.64 71.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.92 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.5 -45.29 94.32 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.128 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -69.57 -24.78 63.75 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.428 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -79.91 -8.56 59.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.153 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.48 2.83 33.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.231 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.86 96.19 5.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 41.4 m -100.08 2.81 43.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -137.48 111.35 8.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.23 157.2 40.62 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.063 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 60.4 t -127.13 122.23 59.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.268 0.556 . . . . 0.0 111.073 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.07 130.43 50.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -120.5 122.77 41.36 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.46 0.648 . . . . 0.0 111.291 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.98 151.85 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.97 -126.19 11.8 Favored Glycine 0 C--N 1.303 -1.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.177 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -89.79 1.21 56.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.07 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.82 -8.16 55.6 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.235 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.45 -39.96 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.407 0.683 . . . . 0.0 110.799 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 40.6 t -63.25 -33.48 75.58 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.065 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -75.31 -35.18 61.29 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.321 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.14 88.86 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.263 0.554 . . . . 0.0 111.381 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.72 -30.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.501 ' O ' HG13 ' B' ' 55' ' ' ILE . 22.9 t70 -66.4 -42.98 87.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 70.4 m -56.5 -47.5 79.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.786 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.6 m -70.1 -38.1 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.83 -46.45 78.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.15 0.281 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.1 mt -58.56 -51.1 75.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.017 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.18 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--O 1.254 1.341 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -79.98 -5.04 54.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -127.28 14.86 7.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -125.86 -38.69 2.18 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.818 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -126.69 -57.96 1.33 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.16 74.85 8.73 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.983 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.88 24.96 8.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.293 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -153.52 -59.77 0.13 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.772 0.796 . . . . 0.0 109.754 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.482 ' HB3' ' OXT' ' B' ' 97' ' ' LYS . 46.7 mttm -98.25 81.71 2.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.106 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.421 ' O ' ' HE3' ' B' ' 97' ' ' LYS . 8.9 tp -157.53 146.13 10.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.84 169.49 17.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.148 0.499 . . . . 0.0 110.854 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.47 128.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -79.9 -58.59 3.1 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . 0.415 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 43.5 tt0 -175.82 145.04 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.03 0.932 . . . . 0.0 108.913 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.91 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.415 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 53.5 mtt180 -135.79 139.67 43.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.09 144.07 36.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.41 -145.69 6.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -136.37 137.68 40.81 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -99.1 139.69 34.38 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.728 0.299 . . . . 0.0 110.197 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.315 -0.916 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.999 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.6 133.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 20.3 m -60.0 124.6 20.72 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.546 0.529 . . . . 0.0 109.904 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 33.5 p -132.22 144.69 50.81 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.249 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.8 tt -134.04 140.44 46.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.548 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -120.28 115.18 23.07 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.273 0.629 . . . . 0.0 109.611 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.37 115.98 51.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.15 128.26 54.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -132.75 159.98 42.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.418 ' O ' HD11 ' B' ' 65' ' ' ILE . 59.2 ttp180 -141.22 146.29 36.7 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.977 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 12.7 tmtt? -91.34 141.81 28.37 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.482 ' OXT' ' HB3' ' B' ' 64' ' ' LYS . 98.1 mttt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 121.304 0.573 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.25 122.24 68.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.6 156.55 14.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.073 0.463 . . . . 0.0 111.441 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.45 133.5 55.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.4 112.52 21.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.74 -155.71 13.24 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.68 26.27 0.18 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.92 150.56 36.96 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.75 150.58 81.97 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.939 2.426 . . . . 0.0 112.852 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.492 HG22 ' OD1' ' A' ' 51' ' ' ASP . 10.5 p -57.92 -38.31 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.55 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.411 ' O ' HD12 ' A' ' 24' ' ' LEU . 23.2 ptp -59.98 -27.34 66.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.936 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.85 -32.44 72.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 110.123 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -80.07 -35.85 36.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.658 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 60.3 t -59.11 -52.69 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.811 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 20' ' ' MET . 8.7 mp -65.85 -31.74 72.87 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.031 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.16 -44.79 87.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.19 -41.93 99.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 88.8 mt -61.15 -35.6 77.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.144 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.6 m -69.81 -36.71 75.86 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.526 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.2 mt -68.2 -33.36 74.29 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.3 mt -59.4 -39.88 84.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.602 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.91 -27.88 66.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.95 -6.15 56.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.59 14.71 34.11 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 121.049 -0.595 . . . . 0.0 112.866 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.47 96.13 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 122.153 -0.616 . . . . 0.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 p -88.43 -8.15 55.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -131.35 112.86 13.1 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.42 144.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.293 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.5 123.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.544 0.528 . . . . 0.0 110.62 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.04 121.81 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -116.57 127.48 54.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.368 0.604 . . . . 0.0 110.917 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -118.7 157.74 26.87 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.565 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -127.07 146.75 50.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.762 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.7 -116.81 9.69 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.287 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -99.45 4.21 46.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 110.789 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.36 50.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.92 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.8 mt -54.28 -40.05 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.725 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.3 t -64.75 -21.72 66.82 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.596 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -87.88 -29.97 20.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.51 84.83 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.093 0.473 . . . . 0.0 110.402 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -72.94 -33.23 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.0 t70 -64.21 -48.73 74.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -55.95 -50.34 71.04 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.924 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -68.15 -31.01 49.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.903 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 31.5 tt0 -68.19 -37.81 81.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.924 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 51' ' ' ASP . 79.5 mt -58.59 -43.4 87.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.429 0.456 . . . . 0.0 111.047 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.35 -43.75 80.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -79.36 8.79 5.53 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -135.21 7.06 3.36 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -117.53 -68.6 0.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.258 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -79.46 -69.34 0.59 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.567 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 2.5 mm? -122.62 102.61 8.16 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.34 -24.49 27.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.985 0.803 . . . . 0.0 111.214 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -96.97 -45.97 6.39 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.461 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.65 81.17 8.74 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.722 0.773 . . . . 0.0 111.636 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.5 134.52 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.095 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -114.01 141.82 46.94 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 67' ' ' ILE . 2.0 mp -95.74 126.58 48.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -82.21 -68.78 0.67 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.722 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -159.39 140.41 12.67 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -128.14 115.82 40.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -119.34 134.25 55.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.12 128.25 25.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.45 . . . . 0.0 110.099 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.32 -147.14 5.65 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.932 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -109.34 133.56 52.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -116.58 125.46 51.87 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.813 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 . . . . . 0 CA--C 1.5 -0.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.7 t -119.35 134.04 64.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 p -67.28 123.37 20.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 123.703 0.627 . . . . 0.0 109.46 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 p -127.67 152.6 47.48 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.861 0.363 . . . . 0.0 111.366 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.7 tt -139.17 135.19 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.644 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.44 114.34 22.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.97 115.75 50.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.95 55.18 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.48 158.27 34.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.334 0.587 . . . . 0.0 111.629 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -112.77 114.88 27.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.647 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.567 ' NZ ' ' HB2' ' A' ' 61' ' ' LEU . 13.6 mmmt . . . . . 0 C--N 1.286 -2.154 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.576 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 . . . . . 0 CA--C 1.517 -0.323 0 CA-C-O 121.393 0.616 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.47 122.72 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.33 163.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 120.818 0.342 . . . . 0.0 111.012 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 tp -124.19 134.34 53.31 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.93 113.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.074 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.65 -157.62 12.48 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -76.63 26.29 0.13 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.42 148.56 35.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.71 152.3 64.07 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.811 2.341 . . . . 0.0 113.193 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.595 HG22 ' OD2' ' B' ' 51' ' ' ASP . 8.9 p -58.33 -39.86 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.401 ' O ' HD12 ' B' ' 24' ' ' LEU . 22.9 ptp -58.18 -25.64 61.78 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.221 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.9 -32.33 70.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 109.932 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -81.17 -37.04 29.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.485 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 51.9 t -58.81 -52.41 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 123.763 0.664 . . . . 0.0 110.374 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.401 HD12 ' O ' ' B' ' 20' ' ' MET . 8.4 mp -66.47 -30.15 70.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.738 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.34 -45.96 82.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.165 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.408 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.78 -41.23 99.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.558 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.9 mt -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.714 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -72.87 -32.98 65.8 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.295 0.569 . . . . 0.0 110.221 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 94.0 mt -70.72 -32.42 69.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 90.3 mt -60.08 -39.82 87.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.584 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -69.01 -24.39 64.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.616 0.722 . . . . 0.0 110.779 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -83.62 -3.3 57.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.43 12.45 51.21 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.145 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -91.05 95.88 5.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.5 p -89.09 -5.83 57.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.711 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.88 116.15 16.13 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.06 144.32 37.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.689 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.33 121.64 68.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.14 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -107.14 121.89 60.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.3 132.29 56.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.075 0.465 . . . . 0.0 110.174 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.85 159.16 28.74 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.761 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -129.89 143.55 50.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.737 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.13 -117.64 8.71 Favored Glycine 0 CA--C 1.497 -1.065 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.166 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -99.02 0.95 44.87 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.266 0.555 . . . . 0.0 110.176 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.75 -7.09 52.28 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.985 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.34 -40.38 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 110.802 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.39 -28.08 69.74 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.388 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -82.17 -29.7 31.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.73 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.14 -45.28 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.35 -33.59 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.086 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.595 ' OD2' HG22 ' B' ' 19' ' ' VAL . 35.4 t70 -62.4 -46.61 87.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.894 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -58.85 -51.03 71.76 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.907 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.75 -30.63 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.925 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 33.4 tt0 -68.91 -35.49 76.9 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.742 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 51' ' ' ASP . 79.6 mt -61.23 -43.18 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.741 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 67.4 t -68.46 -43.67 83.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.998 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 28.7 ptt180 -79.02 8.72 5.21 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.576 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -131.84 -3.51 3.64 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.395 0.617 . . . . 0.0 111.17 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.74 -64.75 1.2 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.745 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -80.56 -74.63 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.582 ' HB2' ' NZ ' ' B' ' 96' ' ' LYS . 2.4 mm? -119.57 103.2 9.21 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -84.7 -31.93 23.81 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 124.186 0.929 . . . . 0.0 110.809 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.91 -41.17 12.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.266 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -91.62 80.38 5.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.389 0.614 . . . . 0.0 111.814 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -161.24 136.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.693 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.465 ' OE1' ' HD2' ' B' ' 97' ' ' LYS . 47.1 mt-10 -116.75 143.29 45.84 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 125.16 50.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -81.69 -66.93 0.83 Allowed 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 123.274 0.359 . . . . 0.0 110.839 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -161.32 139.67 9.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.43 117.03 45.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -120.01 132.0 55.33 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.96 129.34 44.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.65 -148.39 6.61 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.076 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -106.72 133.54 51.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -118.82 125.75 50.27 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.865 179.063 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.44 135.83 57.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.8 p -69.88 124.72 24.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 50.8 p -128.59 152.86 47.84 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.893 0.377 . . . . 0.0 111.162 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 tt -139.6 136.74 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.04 112.13 18.76 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.775 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.84 117.61 55.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.49 128.1 54.65 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.4 pt -126.23 151.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 111.999 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -105.9 115.33 30.04 Favored 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.924 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.582 ' NZ ' ' HB2' ' B' ' 61' ' ' LEU . 13.8 mmmt -90.43 131.53 36.14 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.999 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.465 ' HD2' ' OE1' ' B' ' 66' ' ' GLU . 28.4 mtpp . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 60.8 t -105.38 114.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.4 147.46 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 120.911 0.386 . . . . 0.0 111.074 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.11 122.72 45.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -88.25 105.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.573 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.17 58.91 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.128 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -163.06 -56.26 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.252 0.549 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -101.05 166.04 13.12 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.601 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -71.31 163.0 40.6 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.993 1.796 . . . . 0.0 111.303 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.29 -41.4 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -62.86 -24.88 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -73.32 -38.17 65.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -72.33 -33.24 67.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.143 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.07 -47.53 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.129 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.64 -31.75 71.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.942 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -71.72 -41.93 67.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.202 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.523 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -70.63 -34.29 71.92 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.68 -51.63 68.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.049 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.532 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 10.0 t -67.77 -35.56 78.92 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.7 mt -62.23 -34.15 75.94 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.8 mt -64.65 -23.9 67.41 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.851 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -100.31 -14.0 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 28' ' ' THR . 78.6 mt-30 -79.44 -20.22 48.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.838 0.351 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.48 -4.72 7.15 Favored Glycine 0 CA--C 1.492 -1.345 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.092 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -86.29 96.0 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.0 m -67.75 -30.43 69.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.501 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.62 126.34 20.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.737 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.77 161.14 22.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.933 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -124.21 121.66 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.1 mt -104.84 125.26 59.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -119.83 120.08 35.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.294 0.568 . . . . 0.0 110.524 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.28 155.51 28.25 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.027 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -131.63 141.47 49.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.232 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.46 -126.91 9.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.548 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -81.98 -10.96 59.09 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.57 35.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.182 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -55.6 -38.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 121.26 0.552 . . . . 0.0 109.61 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.7 p -71.48 -13.77 61.92 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.251 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' HZ1' ' HB2' ' A' ' 48' ' ' LYS . 4.8 ttmp? -95.06 -26.52 16.01 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.6 0.36 . . . . 0.0 110.09 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.07 66.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 110.766 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.67 -36.26 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.513 ' O ' HG13 ' A' ' 55' ' ' ILE . 45.5 t0 -59.92 -52.2 66.44 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.711 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.9 m -54.19 -52.01 62.56 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.56 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 23.7 m -69.3 -33.72 59.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.493 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 24.9 tt0 -72.05 -26.17 62.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.408 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.2 mt -70.09 -46.62 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.733 174.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.428 ' C ' ' H ' ' A' ' 58' ' ' ASN . 61.1 t -59.22 -48.97 85.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.77 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.483 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 38.9 ptt180 -78.29 37.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.518 0.675 . . . . 0.0 110.034 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.538 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 9.6 t30 -153.14 -51.04 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.8 ptm180 -76.69 -11.48 59.85 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -142.94 -60.74 0.43 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.494 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.297 0.6 OUTLIER -110.91 88.97 2.91 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.99 23.79 10.23 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.884 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -143.01 -69.42 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.795 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -86.52 75.16 9.78 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.619 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -161.79 137.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.92 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 9.6 pt-20 -130.37 167.52 18.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.099 0.476 . . . . 0.0 111.235 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.6 mt -104.87 139.54 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -80.92 -59.81 2.53 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -177.49 159.93 1.57 Allowed 'General case' 0 C--O 1.25 1.13 0 C-N-CA 124.869 1.267 . . . . 0.0 107.604 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.62 119.16 45.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -125.11 133.81 52.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.29 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.69 132.63 67.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.97 163.38 33.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.088 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.4 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 52.5 p -90.49 126.32 35.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.564 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -81.7 113.91 20.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 86' ' ' ARG . 24.3 t . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HG2' HG21 ' A' ' 76' ' ' VAL . 50.1 mtm180 . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.4 t -133.42 123.78 47.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -59.51 127.98 34.76 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 120.935 0.398 . . . . 0.0 111.058 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.9 p -133.48 162.17 32.6 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.7 tt -137.7 142.76 35.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.773 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -120.25 108.54 14.32 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.046 0.939 . . . . 0.0 108.711 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -118.77 129.48 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -131.24 130.35 42.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.8 pt -121.62 153.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HD3' ' OE2' ' A' ' 66' ' ' GLU . 35.3 ttt180 -129.99 140.1 50.95 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.247 0.546 . . . . 0.0 112.07 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm . . . . . 0 C--N 1.321 -0.656 0 C-N-CA 124.566 1.146 . . . . 0.0 110.324 175.02 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 61.1 t -109.22 112.56 41.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.0 147.63 12.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.111 0.481 . . . . 0.0 111.272 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 tp -105.73 122.37 45.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.6 mm -88.85 104.59 15.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.01 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.58 59.19 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.793 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -165.02 -57.07 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.331 0.586 . . . . 0.0 110.429 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -100.75 165.59 14.02 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.132 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.08 162.4 42.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.24 1.96 . . . . 0.0 111.313 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.07 -42.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -61.21 -25.08 66.8 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.68 -37.25 65.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.66 -32.88 64.22 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.167 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.76 -48.67 86.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.923 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.94 -30.34 70.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.204 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -72.65 -43.46 63.16 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.539 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -68.68 -32.72 72.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.42 -52.51 65.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.139 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' B' ' 32' ' ' GLN . 10.1 t -65.69 -38.22 88.63 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.656 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -60.29 -36.56 78.16 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 92.5 mt -63.74 -23.82 67.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.031 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -100.14 -15.45 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' B' ' 28' ' ' THR . 79.7 mt-30 -78.14 -27.48 48.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.819 0.342 . . . . 0.0 110.766 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.35 -6.88 3.98 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.466 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.47 97.18 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -67.16 -31.98 72.77 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.456 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -140.37 125.85 18.99 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.072 0.463 . . . . 0.0 111.489 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.442 HD11 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -121.83 158.68 25.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.309 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.94 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 48.9 t -121.5 122.38 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.507 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -104.83 125.32 59.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.738 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -119.57 120.33 36.41 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.39 155.28 28.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.594 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -130.42 140.38 50.57 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.913 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.86 -129.44 10.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.703 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -82.34 -9.33 59.51 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.105 0.479 . . . . 0.0 110.156 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.1 -5.55 36.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.013 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.4 mt -54.26 -40.73 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.48 0.657 . . . . 0.0 109.997 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 75.4 p -67.08 -23.4 65.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.169 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.503 ' HZ1' ' HB2' ' B' ' 48' ' ' LYS . 4.8 ttmp? -85.39 -28.45 25.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.281 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.74 -45.32 75.33 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.77 -37.23 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.005 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.555 ' O ' HG13 ' B' ' 55' ' ' ILE . 44.0 t0 -56.94 -52.89 63.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.576 0.75 . . . . 0.0 109.202 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.2 m -54.7 -52.16 63.29 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.854 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.464 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.2 m -70.29 -32.97 52.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.104 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 24.3 tt0 -71.37 -26.38 62.77 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.973 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.6 mt -70.13 -46.39 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.879 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' B' ' 58' ' ' ASN . 57.4 t -59.14 -49.81 82.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.827 0.346 . . . . 0.0 110.898 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' B' ' 53' ' ' VAL . 39.3 ptt180 -77.48 36.73 0.2 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-O 121.449 0.642 . . . . 0.0 110.032 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' B' ' 56' ' ' VAL . 7.9 t30 -152.1 -52.18 0.12 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 123.092 0.557 . . . . 0.0 110.496 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.2 ptm180 -74.4 -14.84 60.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -139.74 -64.78 0.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.321 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . 0.278 0.5 OUTLIER -107.88 93.98 4.83 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -177.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.69 13.36 35.12 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.693 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.94 -69.25 0.54 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.803 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -83.23 75.73 9.93 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.655 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.0 tp -161.71 143.32 3.53 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 C-N-CA 124.198 0.999 . . . . 0.0 108.768 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.93 164.16 29.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.907 0.384 . . . . 0.0 111.6 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.38 138.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -81.55 -60.54 2.22 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -175.82 160.39 2.38 Favored 'General case' 0 C--O 1.262 1.744 0 C-N-CA 124.795 1.238 . . . . 0.0 107.903 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.7 mt -131.48 119.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -125.88 135.02 51.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.677 0.275 . . . . 0.0 110.354 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.55 131.54 73.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.4 165.83 35.65 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.75 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 37.0 p -89.75 127.27 35.93 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.798 0.332 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -81.35 114.08 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.427 HG21 ' HG2' ' B' ' 86' ' ' ARG . 25.8 t . . . . . 0 C--N 1.3 -1.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.538 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 34.6 mtm180 . . . . . 0 CA--C 1.502 -0.896 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.39 123.13 46.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 m -58.41 127.51 32.5 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.33 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 36.4 p -134.18 159.33 41.21 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 123.595 0.758 . . . . 0.0 109.764 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.42 142.09 41.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.828 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -120.61 106.61 11.92 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 123.915 0.886 . . . . 0.0 108.668 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.37 130.2 71.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.87 132.02 46.28 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -123.49 149.04 27.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.248 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -125.39 144.24 50.6 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.575 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -84.1 -170.11 2.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.063 1.345 . . . . 0.0 110.24 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' B' ' 97' ' ' LYS . 21.3 pttp . . . . . 0 C--O 1.261 1.679 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.233 0.54 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 59.7 t -105.08 123.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.085 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -120.25 142.83 34.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.683 0.278 . . . . 0.0 110.825 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 131.8 47.3 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.786 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.7 mm -93.75 111.68 25.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.878 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.66 28.97 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.03 -1.557 . . . . 0.0 114.622 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.56 -50.01 0.41 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.791 0.795 . . . . 0.0 112.155 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -100.93 160.64 26.14 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.59 159.68 35.58 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 121.741 1.627 . . . . 0.0 110.893 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.486 HG23 ' OD2' ' A' ' 51' ' ' ASP . 7.5 p -55.66 -38.54 50.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.0 ptm -61.05 -26.08 67.38 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.999 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.41 -43.34 77.41 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -70.95 -35.07 72.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.595 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.34 -51.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.647 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.8 mt -65.91 -33.81 76.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.844 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.94 -45.52 85.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.227 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.99 95.53 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.427 0.454 . . . . 0.0 110.481 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.67 -35.11 78.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.427 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 m -73.89 -43.6 57.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.735 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.47 -34.39 78.09 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.147 0.499 . . . . 0.0 110.587 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -58.73 -44.73 90.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.348 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.26 -22.38 63.84 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.94 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -82.0 -2.29 51.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.076 0.465 . . . . 0.0 110.9 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.58 -8.89 32.48 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 t -92.07 92.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.442 ' HA ' HD23 ' A' ' 30' ' ' LEU . 57.4 p -95.78 -9.92 30.43 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.199 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.24 104.99 10.52 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.15 157.67 38.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.151 -175.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.3 t -124.21 116.98 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.194 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.85 121.6 48.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 85.7 mttt -118.14 120.99 39.4 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.269 0.556 . . . . 0.0 110.378 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.65 156.45 25.85 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.951 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HG2' HG21 ' A' ' 89' ' ' THR . 88.3 mtt180 -130.91 143.15 50.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.19 -119.6 11.99 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.515 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -85.73 -8.7 58.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.439 0.638 . . . . 0.0 110.433 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.42 -4.53 42.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.166 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -56.01 -36.71 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.564 0.697 . . . . 0.0 109.912 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.3 p -64.64 -31.51 72.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.576 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -78.85 -31.44 45.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.502 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.77 -46.82 77.33 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.414 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -72.08 -33.87 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.873 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.486 ' OD2' HG23 ' A' ' 19' ' ' VAL . 31.3 t70 -60.24 -47.47 85.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.9 m -53.3 -53.7 47.12 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.414 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.18 -30.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.61 -39.8 88.54 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 51' ' ' ASP . 89.0 mt -59.97 -45.55 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.25 -40.44 86.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.093 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -83.55 15.77 2.95 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.31 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -136.72 12.66 3.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.847 0.832 . . . . 0.0 109.255 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.07 -49.04 0.28 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.147 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' HD22 ' A' ' 61' ' ' LEU . 56.2 t80 -90.24 -70.36 0.67 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.955 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 60' ' ' PHE . 4.1 mm? -129.43 110.38 11.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.128 0.489 . . . . 0.0 111.316 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.7 12.57 36.25 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.943 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -126.04 -64.09 1.07 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.415 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 98.2 mttt -78.76 102.08 7.93 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.686 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tp -160.66 126.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.83 0.452 . . . . 0.0 110.329 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.507 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 41.0 tt0 -119.19 130.64 55.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.3 mt -95.21 128.06 46.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.65 -62.07 1.57 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.258 0.349 . . . . 0.0 111.239 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 10.0 tp10 -162.59 141.71 9.05 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.95 107.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.208 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HE ' ' CD ' ' A' ' 69' ' ' GLU . 91.0 mtt180 -131.18 144.91 51.7 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.519 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.02 132.51 66.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.24 -174.42 22.81 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.122 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -124.78 128.46 48.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -106.84 138.84 42.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.313 -0.99 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.7 120.91 60.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.4 t -63.5 128.19 34.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.526 HG21 ' HG2' ' A' ' 42' ' ' ARG . 61.5 p -120.76 134.35 55.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.424 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -123.12 128.39 75.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -107.65 110.77 22.72 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -103.98 106.78 20.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.76 40.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.901 0.381 . . . . 0.0 110.432 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.11 151.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.364 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.507 ' HD3' ' OE1' ' A' ' 66' ' ' GLU . 75.3 ttt180 -121.85 119.29 31.19 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.493 0.663 . . . . 0.0 110.255 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 64' ' ' LYS . 8.3 mmmm . . . . . 0 C--N 1.284 -2.265 0 CA-C-O 121.392 0.615 . . . . 0.0 112.403 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.898 0.38 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.16 124.56 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.813 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.83 141.08 42.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.019 0.438 . . . . 0.0 111.581 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.24 129.62 46.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.874 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.09 111.36 24.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.469 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.76 28.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 119.105 -1.521 . . . . 0.0 114.911 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.97 -48.72 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.265 0.533 . . . . 0.0 111.661 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -101.55 160.9 25.2 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.61 162.3 21.7 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.981 1.787 . . . . 0.0 111.728 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.415 ' O ' HG22 ' B' ' 23' ' ' VAL . 7.2 p -58.71 -38.46 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.576 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.424 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 25.7 ptm -62.61 -26.24 68.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.639 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -66.69 -46.76 74.56 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -67.21 -34.29 77.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.835 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.415 HG22 ' O ' ' B' ' 19' ' ' VAL . 58.3 t -61.21 -50.51 80.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.618 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' B' ' 20' ' ' MET . 86.3 mt -67.32 -36.03 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.641 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.424 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.01 -44.56 95.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.336 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.49 98.77 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.371 0.419 . . . . 0.0 110.499 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.8 -36.17 82.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.571 . . . . 0.0 111.049 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 59.7 m -72.51 -45.06 61.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.659 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 93.6 mt -64.06 -33.67 76.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.298 0.571 . . . . 0.0 110.262 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 35' ' ' SER . 0.2 OUTLIER -58.41 -46.66 86.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.375 -177.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -68.28 -21.85 64.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.352 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.68 -4.25 55.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.34 -3.92 29.72 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.906 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -95.93 91.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.395 0.616 . . . . 0.0 109.516 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' SER . . . . . 0.401 ' HA ' HD23 ' B' ' 30' ' ' LEU . 58.3 p -94.78 -8.61 37.04 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.346 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.82 104.98 9.63 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.41 HD11 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -125.29 159.11 32.95 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.981 -173.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.7 117.12 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.198 0.523 . . . . 0.0 110.147 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -97.83 121.08 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.4 mttt -118.12 119.97 36.32 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.391 0.615 . . . . 0.0 110.178 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.2 156.56 25.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.667 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.493 ' HG2' HG21 ' B' ' 89' ' ' THR . 92.3 mtt180 -130.73 144.51 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.593 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.28 -123.44 23.3 Favored Glycine 0 C--O 1.215 -1.09 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.232 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -81.18 -12.77 59.11 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.224 0.535 . . . . 0.0 110.915 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.83 -3.47 28.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -55.15 -37.92 44.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.46 0.648 . . . . 0.0 109.793 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.4 p -64.69 -31.68 73.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.836 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -79.12 -29.73 43.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.33 -48.32 73.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 120.78 0.324 . . . . 0.0 110.957 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.98 -34.6 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.511 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.3 t70 -58.49 -48.65 80.09 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -52.46 -53.43 45.69 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.378 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -31.17 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.98 -39.43 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.511 HG13 ' O ' ' B' ' 51' ' ' ASP . 89.8 mt -59.33 -47.69 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.722 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -59.31 -39.4 78.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 CA-C-O 121.123 0.487 . . . . 0.0 110.863 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -84.86 17.12 2.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -141.65 18.47 2.18 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -150.26 -46.44 0.13 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.078 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.464 ' O ' HD23 ' B' ' 61' ' ' LEU . 62.7 t80 -92.37 -68.13 0.82 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.852 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.464 HD23 ' O ' ' B' ' 60' ' ' PHE . 3.9 mm? -132.49 111.84 11.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.805 0.336 . . . . 0.0 111.014 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.79 13.96 31.93 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.534 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -127.53 -64.7 0.97 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.088 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.525 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 98.4 mttt -74.91 99.67 3.88 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.903 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.8 tp -160.34 128.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.499 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 38.2 tt0 -122.64 129.65 52.09 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -94.44 127.21 46.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -87.73 -63.07 1.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.556 0.535 . . . . 0.0 111.188 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 10.5 tp10 -161.63 140.41 9.65 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 pt -143.31 110.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.284 0.564 . . . . 0.0 110.73 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 92.9 mtt180 -133.57 145.62 50.24 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.726 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.29 128.81 75.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.27 -173.52 19.24 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.557 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 126.07 43.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -105.46 139.01 40.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.311 -1.094 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 66.6 t -129.3 117.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -64.02 131.23 46.98 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.493 HG21 ' HG2' ' B' ' 42' ' ' ARG . 59.9 p -123.22 133.73 54.19 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.559 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 16.1 tt -121.44 128.83 75.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.68 107.37 16.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -102.79 107.02 21.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.29 120.97 41.43 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.531 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -127.94 149.46 32.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.298 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.499 ' HD3' ' OE2' ' B' ' 66' ' ' GLU . 71.5 ttt180 -119.37 118.27 30.74 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.5 0.666 . . . . 0.0 110.349 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.525 ' HE3' ' O ' ' B' ' 64' ' ' LYS . 7.6 mmmm -84.16 129.58 34.89 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt . . . . . 0 C--O 1.257 1.492 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.398 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.938 0.399 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 50.9 t -120.4 124.67 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.82 149.38 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.825 0.345 . . . . 0.0 111.189 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.81 123.57 48.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.774 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -89.54 99.36 9.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.43 52.35 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.452 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -166.68 -56.34 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.04 167.76 10.25 Favored Pre-proline 0 CA--C 1.555 1.166 0 O-C-N 122.393 -0.192 . . . . 0.0 111.027 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.33 153.66 61.38 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.162 1.908 . . . . 0.0 112.514 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.91 -40.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.497 1.119 . . . . 0.0 113.469 -177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.416 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.3 ptm -62.5 -25.83 68.22 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.709 0.804 . . . . 0.0 111.823 -175.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -84.05 -27.77 28.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.022 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -73.14 -37.64 66.55 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 89.2 t -57.57 -47.78 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.567 0.698 . . . . 0.0 109.547 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.6 mt -65.26 -36.31 83.71 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.076 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.427 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.791 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.87 87.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.605 0.241 . . . . 0.0 111.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 86.8 mt -66.49 -31.55 72.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.6 0.714 . . . . 0.0 110.296 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 91.2 m -74.18 -40.35 62.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.176 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 97.5 mt -62.27 -38.68 90.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.192 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.9 tp -57.17 -46.12 83.08 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.9 -23.63 66.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.762 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 28' ' ' THR . 83.3 mm-40 -81.35 -11.91 59.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.185 0.516 . . . . 0.0 110.355 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.7 24.36 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.539 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.97 93.96 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 121.397 0.617 . . . . 0.0 109.599 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 p -89.04 -21.31 23.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.61 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -108.04 105.52 15.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -121.08 149.65 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.691 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 49.0 t -122.9 120.78 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.272 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -103.17 122.82 56.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.463 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -115.42 124.55 51.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 111.331 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.69 143.26 47.85 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.351 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -129.81 127.15 39.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.631 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.89 -138.35 14.1 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.934 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -82.97 4.31 26.41 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.487 0.661 . . . . 0.0 110.869 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.99 -4.01 53.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.553 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.71 -43.49 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.119 0.568 . . . . 0.0 110.575 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -19.14 64.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HB2' ' HZ2' ' A' ' 48' ' ' LYS . 4.5 ttmp? -90.45 -32.8 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.63 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.71 -43.59 88.69 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.912 0.387 . . . . 0.0 111.719 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.08 -32.67 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.429 ' O ' HG13 ' A' ' 55' ' ' ILE . 23.9 t70 -65.82 -38.95 90.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.4 m -60.42 -51.33 69.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.078 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.422 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 35.9 m -66.17 -38.15 81.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.666 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mm-40 -59.72 -36.56 76.8 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.1 mt -66.88 -44.19 89.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 0.0 110.292 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.76 -38.75 82.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.725 0.298 . . . . 0.0 111.725 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.666 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 4.1 ptm180 -89.84 11.24 20.81 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.86 -30.71 3.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.268 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -93.78 -59.07 2.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.33 -55.24 12.74 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.964 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.453 ' HB3' ' HZ2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -160.0 108.35 1.71 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.57 -35.12 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 123.972 0.795 . . . . 0.0 112.745 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.05 -26.64 68.34 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -122.36 101.51 7.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.718 0.295 . . . . 0.0 110.765 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tp -156.94 146.7 11.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -135.19 141.26 45.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.27 132.57 40.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -91.45 -48.11 7.06 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.937 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -173.83 145.87 1.18 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.45 97.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.678 0.751 . . . . 0.0 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -127.69 141.89 51.48 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.782 -0.574 . . . . 0.0 110.978 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.85 143.75 29.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.3 -165.69 21.95 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.674 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m -115.46 144.83 43.25 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 59.4 tt0 -101.67 131.17 48.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.416 HG23 ' HG2' ' A' ' 86' ' ' ARG . 49.4 t . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 79.0 mtt180 . . . . . 0 CA--C 1.504 -0.791 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.19 138.78 52.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.9 t -75.24 136.41 40.95 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.7 p -136.14 145.22 45.59 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.4 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.45 138.91 53.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.364 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -115.42 111.69 21.19 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.74 110.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.88 124.13 50.93 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 pt -124.49 162.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 120.848 0.356 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -129.98 108.68 10.29 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HZ2' ' HB3' ' A' ' 61' ' ' LEU . 7.1 tmtm? . . . . . 0 C--N 1.289 -2.022 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 120.95 0.405 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.68 119.71 61.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.53 148.05 15.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.454 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.47 120.24 41.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.707 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.96 100.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.73 51.19 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.509 -1.329 . . . . 0.0 113.916 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -167.08 -55.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -100.14 168.47 9.38 Favored Pre-proline 0 CA--C 1.556 1.176 0 O-C-N 122.129 -0.357 . . . . 0.0 111.106 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.81 156.15 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.236 1.957 . . . . 0.0 112.302 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.81 -43.89 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.0 ptp -54.89 -32.85 61.4 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -77.73 -28.39 50.77 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.929 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.73 -37.95 64.94 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.453 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 79.7 t -57.68 -47.86 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.484 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.072 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.57 -43.54 89.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.2 -38.08 89.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.5 mt -65.89 -31.21 72.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.33 0.586 . . . . 0.0 110.358 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' B' ' 32' ' ' GLN . 64.4 m -74.88 -42.09 58.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.796 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.3 mt -60.86 -38.53 85.87 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.616 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 tp -57.18 -44.24 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.157 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.2 -16.22 62.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.827 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' B' ' 28' ' ' THR . 82.5 mm-40 -87.27 -7.82 57.44 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.306 0.574 . . . . 0.0 109.889 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.61 34.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.757 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.6 t -99.05 95.76 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.274 0.559 . . . . 0.0 109.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 12.8 p -90.49 -25.49 20.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.425 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -103.37 107.6 18.5 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.88 148.0 28.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 120.91 0.386 . . . . 0.0 110.743 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.43 122.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.678 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.3 mt -105.39 120.22 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.997 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -113.55 123.33 49.73 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.362 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.31 147.39 42.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.413 ' NE ' HG11 ' B' ' 87' ' ' VAL . 3.0 tmt_? -133.09 129.48 38.03 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.116 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.77 -142.13 16.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.0 5.67 11.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.35 0.595 . . . . 0.0 110.81 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.25 -5.21 55.83 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.5 -44.38 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.407 0.683 . . . . 0.0 110.81 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.0 t -59.82 -32.64 70.84 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.049 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.41 ' HB2' ' HZ2' ' B' ' 48' ' ' LYS . 4.4 ttmp? -76.8 -34.24 57.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.753 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -45.61 83.22 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 120.803 0.335 . . . . 0.0 111.768 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.51 -35.88 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.42 ' O ' HG13 ' B' ' 55' ' ' ILE . 29.8 t70 -62.59 -41.57 99.04 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 91.5 m -57.03 -50.04 73.94 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.903 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 35.4 m -67.09 -38.42 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.654 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 17.0 mm-40 -59.72 -38.91 82.97 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.42 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.5 mt -64.36 -45.02 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.25 -37.02 77.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 120.96 0.409 . . . . 0.0 111.792 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.654 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 4.5 ptm180 -91.48 11.63 23.4 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -126.13 -29.52 3.03 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.096 0.474 . . . . 0.0 110.968 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -93.86 -58.28 2.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -68.69 -58.39 4.3 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.447 ' HB3' ' HZ2' ' B' ' 96' ' ' LYS . 0.2 OUTLIER -157.95 109.58 2.27 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.34 -42.13 12.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 124.423 1.077 . . . . 0.0 112.63 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.1 -34.25 68.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 0.0 112.585 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -118.05 101.11 7.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.168 0.509 . . . . 0.0 110.966 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.04 146.31 13.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -132.17 143.8 50.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.86 129.74 50.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -90.57 -47.9 7.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -172.55 147.03 1.8 Allowed 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.751 0.657 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.01 94.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.443 0.697 . . . . 0.0 110.54 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -127.56 141.17 51.71 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.311 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.87 144.48 24.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.27 -175.32 35.81 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.618 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.426 ' HG ' ' CD ' ' A' ' 54' ' ' GLU . 45.8 m -107.08 143.91 34.52 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.391 0.615 . . . . 0.0 112.266 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 61.1 tt0 -99.71 132.56 44.97 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' B' ' 86' ' ' ARG . 47.0 t . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 83.2 mtt180 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.413 HG11 ' NE ' ' B' ' 42' ' ' ARG . 96.0 t -126.99 137.42 57.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -74.48 135.49 42.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.571 . . . . 0.0 110.701 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 35.3 p -136.96 146.11 45.0 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.51 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.83 137.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.235 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -113.53 111.33 21.71 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 57.5 mt -110.55 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.93 123.75 50.52 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.802 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.0 pt -124.59 162.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.237 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -128.84 107.33 9.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.554 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 7.0 tmtm? -84.57 131.75 34.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.936 -174.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.554 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 34.7 mmtp . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.17 0.509 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.5 t -122.53 111.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.38 146.62 10.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.941 0.4 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 tp -112.2 124.17 51.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 51.0 mt -88.3 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 O-C-N 123.186 0.303 . . . . 0.0 110.865 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.27 -94.42 0.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.661 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -103.42 6.97 38.02 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -98.25 145.43 29.82 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.636 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.93 151.35 82.34 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.52 2.147 . . . . 0.0 112.503 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.42 HG23 ' OG1' ' A' ' 52' ' ' THR . 7.0 p -52.83 -41.4 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -58.85 -28.81 66.44 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.27 -39.0 86.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 93.2 m-85 -75.03 -37.6 61.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.85 -54.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.329 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.84 -32.54 73.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.97 -47.24 72.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.502 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.78 99.54 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 123.485 0.491 . . . . 0.0 111.064 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.41 -34.74 77.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.021 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.7 m -73.96 -34.19 64.16 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.394 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 84.6 mt -67.26 -32.25 73.13 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-O 120.838 0.351 . . . . 0.0 110.909 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.49 -30.01 71.05 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.328 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -84.28 -4.89 59.14 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.985 0.898 . . . . 0.0 109.805 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -101.72 -19.83 15.22 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.593 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.08 11.29 10.07 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.693 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.61 94.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.626 0.713 . . . . 0.0 109.358 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -71.1 -41.09 71.04 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.464 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.42 124.06 50.21 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.54 0.686 . . . . 0.0 111.857 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -128.69 156.84 41.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.523 -177.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -120.29 128.41 75.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.3 mt -108.72 120.16 59.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.66 133.93 54.44 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.323 0.582 . . . . 0.0 110.122 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.6 162.63 31.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 149.97 30.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.14 -130.29 11.27 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -88.9 1.06 55.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.678 0.751 . . . . 0.0 109.776 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.61 -6.25 58.82 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.6 mt -53.97 -37.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.232 0.539 . . . . 0.0 110.442 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.3 t -61.99 -30.46 70.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -83.01 -21.95 33.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.122 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.46 -47.02 65.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.832 0.348 . . . . 0.0 110.263 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.47 ' HA ' HG21 ' A' ' 53' ' ' VAL . 9.9 p -69.83 -32.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.164 0.506 . . . . 0.0 109.796 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 55' ' ' ILE . 36.4 t70 -61.72 -44.06 97.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.083 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.42 ' OG1' HG23 ' A' ' 19' ' ' VAL . 85.6 m -63.85 -48.06 78.25 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.268 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 50' ' ' VAL . 33.5 m -69.39 -33.81 59.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.72 -43.62 96.01 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.181 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.9 mt -56.68 -46.78 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.65 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.0 -43.87 98.19 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.895 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -83.95 10.22 10.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.133 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -125.1 -16.93 5.89 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.48 0.657 . . . . 0.0 111.142 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -105.82 -47.48 3.87 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.19 -67.5 0.83 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.901 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 3.4 mm? -130.98 104.5 7.16 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 120.979 0.419 . . . . 0.0 110.43 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.98 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.091 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.98 -36.68 59.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.176 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -123.15 89.05 3.04 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.633 0.73 . . . . 0.0 110.54 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.14 131.32 10.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.995 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.21 146.15 51.18 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.29 135.6 35.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -85.45 -57.92 2.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.067 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -168.93 151.4 4.87 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.43 116.9 26.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -126.68 146.24 50.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -147.43 137.53 16.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.1 -157.42 13.92 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.655 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.6 m -113.46 128.51 56.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.03 141.52 45.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.308 -1.234 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.18 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.42 140.5 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 p -71.02 119.9 15.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 123.62 0.575 . . . . 0.0 110.54 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.5 p -116.53 154.11 30.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.948 0.499 . . . . 0.0 109.881 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.9 tt -143.07 132.18 20.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 108.0 16.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.96 116.05 48.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.58 125.12 49.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.413 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.7 pt -122.46 152.22 26.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -122.42 109.29 14.2 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.362 0.601 . . . . 0.0 111.272 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HB3' ' HZ1' ' A' ' 96' ' ' LYS . 4.3 mmmp? . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.235 0.54 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 53.3 t -118.1 111.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.75 148.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.827 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp -115.13 122.39 45.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.456 ' HA ' ' OH ' ' B' ' 22' ' ' TYR . 55.3 mt -86.99 131.71 34.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.945 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.21 -97.41 0.25 Allowed Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.72 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -99.15 -0.11 42.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.119 0.485 . . . . 0.0 110.338 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.01 145.91 32.63 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.655 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.98 154.65 73.13 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.906 2.404 . . . . 0.0 112.21 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.402 HG23 ' OG1' ' B' ' 52' ' ' THR . 7.2 p -56.16 -40.91 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.546 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.12 -30.1 67.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -63.87 -39.19 93.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.709 0.766 . . . . 0.0 109.706 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . 0.456 ' OH ' ' HA ' ' B' ' 14' ' ' ILE . 92.8 m-85 -76.89 -37.85 54.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.676 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 65.4 t -60.65 -52.89 56.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.71 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.52 -33.62 75.99 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.219 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.43 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -64.91 -47.42 77.83 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.576 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.34 96.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.35 -34.48 76.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 111.313 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 73.4 m -73.53 -34.38 65.19 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.523 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.1 mt -67.19 -31.0 71.1 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.921 0.391 . . . . 0.0 111.268 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.21 -26.26 67.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -86.89 -2.64 58.75 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.749 0.785 . . . . 0.0 109.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -105.29 -16.31 14.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.655 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.65 13.27 14.75 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.64 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.74 95.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 22.4 m -73.2 -38.95 65.92 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.136 0.575 . . . . 0.0 112.475 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.25 122.74 44.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.491 0.662 . . . . 0.0 111.623 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.405 ' H ' HD12 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.27 156.88 40.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.85 -176.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 62.1 t -121.36 126.54 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.285 0.564 . . . . 0.0 110.247 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -108.26 121.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.04 135.09 54.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.208 0.528 . . . . 0.0 110.494 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.96 160.67 37.57 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.53 147.65 28.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -126.04 7.21 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -93.98 1.95 56.17 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.735 0.779 . . . . 0.0 109.464 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.67 -6.33 59.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.521 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 71.4 mt -53.97 -36.86 32.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 CA-C-O 121.891 0.853 . . . . 0.0 109.732 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -63.95 -30.54 71.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.047 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -82.36 -25.27 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.715 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.53 80.59 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.924 0.392 . . . . 0.0 110.419 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.433 ' HA ' HG21 ' B' ' 53' ' ' VAL . 12.7 p -71.09 -33.29 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.567 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.427 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.8 t70 -59.51 -47.18 86.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.454 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.402 ' OG1' HG23 ' B' ' 19' ' ' VAL . 63.7 m -60.25 -48.42 81.83 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.4 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 33.4 m -70.26 -32.44 50.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.07 -41.79 94.75 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.982 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.427 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.4 mt -57.8 -48.59 83.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.816 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.02 -43.28 95.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.948 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' B' ' 53' ' ' VAL . 12.8 ptm180 -84.29 11.73 7.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.72 -15.29 4.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.17 0.509 . . . . 0.0 110.753 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -103.69 -52.38 2.99 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -85.8 -65.61 0.99 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.476 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.41 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 3.4 mm? -131.25 106.86 8.58 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 123.027 0.531 . . . . 0.0 110.692 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.92 -19.39 17.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.022 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.76 -33.32 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.763 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -124.38 89.74 3.13 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.01 137.65 19.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.008 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.52 143.2 41.53 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -100.85 138.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -87.21 -55.64 3.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.12 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -171.66 150.73 2.77 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.41 117.7 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -126.62 148.23 49.82 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.709 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -147.73 138.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.43 -155.27 10.17 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.8 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.6 m -118.86 124.93 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -107.45 144.88 33.75 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.282 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -135.77 136.84 49.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 19.1 p -68.4 120.89 15.22 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.734 0.646 . . . . 0.0 110.934 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 51.6 p -117.28 155.44 29.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.821 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 16.6 tt -143.87 132.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -116.21 105.76 12.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.9 mt -103.66 119.04 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.66 124.27 44.82 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.1 pt -121.25 151.99 24.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.62 108.89 14.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.979 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.518 ' HZ1' ' HB3' ' B' ' 96' ' ' LYS . 4.1 mmmp? -80.38 133.99 35.97 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? . . . . . 0 C--N 1.283 -2.321 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 169.051 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.667 0.27 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.9 t -113.82 124.78 70.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.07 145.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.985 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.82 131.12 48.33 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.6 mm -95.97 120.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.047 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.64 50.48 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.911 -1.614 . . . . 0.0 114.185 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -155.57 -57.54 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.437 0.618 . . . . 0.0 110.748 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -101.99 163.9 16.85 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -59.49 158.7 26.32 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.242 1.962 . . . . 0.0 111.699 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG21 ' OD2' ' A' ' 51' ' ' ASP . 10.0 p -52.92 -31.33 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 124.301 1.041 . . . . 0.0 113.437 -175.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.423 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.5 ptm -57.11 -32.58 66.46 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.62 0.368 . . . . 0.0 111.788 -174.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -71.82 -38.24 70.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.098 0.475 . . . . 0.0 110.537 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -76.57 -36.26 57.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.246 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 19' ' ' VAL . 93.2 t -58.03 -53.51 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.089 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.7 mt -58.64 -36.27 73.83 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.398 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.29 96.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.396 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.03 -56.44 20.96 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.56 0.537 . . . . 0.0 111.949 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.43 HD11 ' H ' ' A' ' 27' ' ' LEU 0.342 0.0 OUTLIER -69.53 -19.07 63.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.496 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -72.01 -46.09 58.49 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.8 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.07 -41.18 86.85 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.227 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 96' ' ' LYS . 95.7 mt -55.31 -41.92 73.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.653 0.596 . . . . 0.0 111.509 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.02 5.33 52.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.983 0.42 . . . . 0.0 111.715 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -99.37 -30.14 12.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.82 0.343 . . . . 0.0 110.178 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.49 -15.03 1.09 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.57 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.7 100.53 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 23.2 p -79.49 -22.51 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.1 111.74 14.37 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.263 0.554 . . . . 0.0 110.274 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.418 ' H ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.55 161.16 19.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.035 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 45.3 t -128.86 125.77 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.469 . . . . 0.0 110.861 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.71 120.89 57.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -118.84 118.37 31.38 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.111 0.481 . . . . 0.0 110.683 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.96 148.12 32.2 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' HG2' HG21 ' A' ' 89' ' ' THR . 70.9 mtp180 -122.51 143.78 49.5 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.343 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.74 -130.05 12.63 Favored Glycine 0 N--CA 1.44 -1.088 0 O-C-N 123.5 0.5 . . . . 0.0 112.948 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -90.46 5.7 46.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.629 0.728 . . . . 0.0 110.475 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.23 -3.15 54.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.243 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.7 mt -54.47 -37.21 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.786 0.834 . . . . 0.0 110.404 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.1 t -64.26 -26.95 68.73 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.056 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -83.24 -27.91 29.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.372 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.12 -43.98 77.17 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -71.33 -35.2 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.17 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.505 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.6 t70 -60.64 -47.21 87.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.934 0.772 . . . . 0.0 109.069 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -54.12 -56.25 19.92 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.9 -22.85 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.84 -37.35 62.29 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.529 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.7 mt -61.86 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.709 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -55.14 -43.58 70.9 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.377 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 54.8 mtm180 -71.45 3.09 4.11 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.408 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 2.8 t-20 -137.47 16.4 2.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.956 0.884 . . . . 0.0 109.689 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -128.75 -63.77 0.96 Allowed 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.413 -176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -106.77 -36.87 6.56 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.296 -176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 95.7 mt -131.49 103.74 6.58 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.215 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.51 -73.87 0.61 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.34 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.26 6.91 40.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.075 0.465 . . . . 0.0 110.681 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.93 24.02 12.81 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.478 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.22 153.52 12.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -125.22 169.16 12.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.153 0.501 . . . . 0.0 111.085 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -109.1 135.97 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -86.79 -66.42 0.91 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.116 0.26 . . . . 0.0 110.782 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.405 ' OE1' ' HD2' ' A' ' 71' ' ' ARG . 42.8 tt0 -162.71 145.54 10.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.4 mt -127.75 116.15 42.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.405 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 79.9 mtp180 -121.27 135.98 55.04 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.526 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.97 131.3 73.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.2 -163.81 11.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.115 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.2 p -131.41 111.42 11.81 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -87.61 131.35 34.45 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.132 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 C--N 1.313 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.455 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.485 HH21 ' HG2' ' B' ' 54' ' ' GLU . 39.0 mtm180 . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.72 117.26 50.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.1 m -61.19 127.45 31.59 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.771 0.67 . . . . 0.0 109.226 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.441 HG21 ' HG2' ' A' ' 42' ' ' ARG . 24.5 p -127.97 151.8 48.68 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.002 0.43 . . . . 0.0 111.836 -176.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.8 128.6 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.289 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.33 106.27 15.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -103.98 117.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.66 133.69 55.67 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.8 pt -138.87 151.33 23.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 35' ' ' SER . 12.9 ptp180 -130.66 158.4 40.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 123.496 0.498 . . . . 0.0 110.838 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.449 ' HB2' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 121.484 0.659 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 80.7 t -117.28 124.55 73.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -116.39 143.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 120.897 0.379 . . . . 0.0 110.862 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -100.37 128.99 46.3 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -94.56 119.78 43.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.224 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.89 45.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.391 -1.385 . . . . 0.0 114.213 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -150.56 -58.87 0.18 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.469 0.635 . . . . 0.0 110.432 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -101.45 164.35 16.12 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.511 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -59.99 156.35 39.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.27 1.98 . . . . 0.0 111.751 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.476 ' O ' HG21 ' B' ' 23' ' ' VAL . 8.3 p -50.6 -30.42 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.541 1.136 . . . . 0.0 113.827 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.453 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 24.9 ptm -58.65 -30.38 67.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.028 0.442 . . . . 0.0 111.958 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.78 -38.36 64.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.648 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -76.73 -34.8 58.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.476 HG21 ' O ' ' B' ' 19' ' ' VAL . 78.9 t -58.89 -54.24 36.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 CA-C-O 121.273 0.559 . . . . 0.0 110.122 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 20' ' ' MET . 94.8 mt -57.86 -38.7 76.18 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.02 98.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.276 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -56.7 18.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.049 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.424 HD11 ' O ' ' B' ' 23' ' ' VAL 0.361 0.0 OUTLIER -69.45 -19.46 63.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 118.454 -1.298 . . . . 0.0 114.087 -178.714 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.5 m -72.04 -45.92 58.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.127 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.87 -40.12 91.35 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.215 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' B' ' 96' ' ' LYS . 95.3 mt -57.16 -42.05 80.34 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.638 0.586 . . . . 0.0 111.888 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -92.64 1.83 57.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.898 0.38 . . . . 0.0 111.685 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -95.79 -37.04 10.93 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.002 0.429 . . . . 0.0 110.074 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.66 -18.58 0.29 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 119.803 -1.189 . . . . 0.0 112.802 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.22 99.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.453 0.644 . . . . 0.0 109.362 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 20.3 p -79.75 -17.26 53.91 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.49 -176.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.96 112.36 10.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.766 0.317 . . . . 0.0 110.454 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.437 ' H ' HD12 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -120.01 161.12 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.272 -177.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 41.5 t -128.81 123.21 58.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.066 0.46 . . . . 0.0 110.484 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.57 122.06 55.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.152 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.4 119.31 33.56 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' B' ' 49' ' ' ALA . . . -111.53 146.57 37.08 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.553 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.452 ' HG2' HG21 ' B' ' 89' ' ' THR . 74.0 mtp180 -120.64 142.72 49.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.5 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 -129.12 12.33 Favored Glycine 0 C--N 1.303 -1.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.851 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -89.47 8.24 31.96 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.017 0.437 . . . . 0.0 111.005 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.67 -1.64 57.38 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.228 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 68.5 mt -54.65 -37.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.337 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.19 -32.17 73.5 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.588 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -78.84 -31.16 45.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.831 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.402 ' HB2' ' HB1' ' B' ' 41' ' ' ALA . . . -64.27 -45.76 86.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.242 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.45 -35.65 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.486 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.7 t70 -59.59 -50.19 74.86 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -52.02 -54.87 24.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.305 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.67 -21.35 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.485 ' HG2' HH21 ' A' ' 86' ' ' ARG . 30.2 tt0 -75.97 -37.12 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.421 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.486 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.1 mt -61.86 -49.73 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.846 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.95 -42.39 71.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' B' ' 61' ' ' LEU . 56.4 mtm180 -73.53 6.32 3.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.861 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . 0.424 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 2.6 t-20 -139.21 16.09 2.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.85 0.833 . . . . 0.0 109.589 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.39 -64.46 0.94 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.13 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -105.23 -37.14 6.99 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.303 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 94.8 mt -132.26 103.49 6.26 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.127 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 -74.1 0.61 Allowed 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.125 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.22 5.14 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.141 0.496 . . . . 0.0 110.09 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -111.96 24.91 12.13 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.026 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -148.91 154.43 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.78 164.16 24.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.362 0.601 . . . . 0.0 111.143 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.67 138.69 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -89.96 -60.85 1.82 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.91 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -166.54 144.9 5.39 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.759 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.2 mt -128.67 119.76 50.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -127.06 138.6 53.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.382 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.25 129.58 74.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.93 -164.95 11.86 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.063 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 29.3 p -131.55 109.55 10.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -86.35 130.86 34.36 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.317 -0.839 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.567 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.408 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 53.2 mtm180 . . . . . 0 N--CA 1.422 -1.825 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.35 117.51 51.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -60.96 125.75 24.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 123.833 0.708 . . . . 0.0 109.232 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.452 HG21 ' HG2' ' B' ' 42' ' ' ARG . 25.6 p -128.26 148.85 50.66 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.201 0.524 . . . . 0.0 112.074 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 tt -127.73 132.1 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.53 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.29 107.13 15.17 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.1 mt -105.68 113.45 42.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.536 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.37 132.7 56.53 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -136.9 152.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' B' ' 35' ' ' SER . 12.6 ptp180 -131.53 156.62 45.39 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 120.915 0.388 . . . . 0.0 110.983 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.529 ' HZ2' ' C ' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -125.79 118.15 24.93 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -176.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.529 ' C ' ' HZ2' ' B' ' 96' ' ' LYS . 63.1 mttm . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.251 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.883 0.373 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 71.6 t -102.11 113.21 37.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -102.92 135.45 40.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.023 0.439 . . . . 0.0 110.811 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.71 119.3 37.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.458 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 52.0 mt -90.58 116.48 31.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.145 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.76 41.59 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.896 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -161.04 -55.35 0.05 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.335 0.567 . . . . 0.0 111.715 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -99.98 159.33 30.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.887 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.43 156.0 33.2 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.902 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.4 -35.87 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.144 0.978 . . . . 0.0 112.611 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -64.13 -24.71 67.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.44 -28.1 61.79 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.452 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 99.7 m-85 -83.82 -33.01 25.01 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.833 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 61.2 t -59.72 -52.74 57.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-O 121.314 0.578 . . . . 0.0 109.857 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.92 -30.02 70.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.011 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.408 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -47.91 75.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.64 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.07 98.2 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.356 0.41 . . . . 0.0 110.577 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 96.0 mt -62.5 -42.4 99.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.022 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.1 m -66.61 -36.46 82.67 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.499 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -71.92 -27.49 62.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.678 0.275 . . . . 0.0 111.091 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -36.85 84.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.77 -19.44 65.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.315 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -85.58 -5.64 59.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.45 -7.68 40.02 Favored Glycine 0 C--O 1.242 0.651 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.156 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.15 100.8 11.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.406 0.622 . . . . 0.0 109.701 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 33.8 p -87.22 -25.25 24.11 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.631 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.85 105.25 14.01 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.08 0.552 . . . . 0.0 109.626 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.1 163.36 22.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.616 0.246 . . . . 0.0 111.183 -176.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -126.85 122.37 60.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.29 0.567 . . . . 0.0 110.927 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.18 128.69 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.4 123.4 36.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.53 0.681 . . . . 0.0 110.472 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.68 148.21 41.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.405 ' HG2' HG21 ' A' ' 89' ' ' THR . 67.9 mtm180 -128.29 147.59 50.61 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.212 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.88 -135.83 17.65 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -89.57 9.63 26.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.092 0.472 . . . . 0.0 110.995 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.23 -2.61 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -53.22 -36.26 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -61.57 -28.93 69.69 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.602 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -84.53 -27.78 27.13 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.918 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.77 93.18 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.7 p -73.47 -29.29 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.116 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.443 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.1 t70 -71.28 -43.99 66.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 m -58.68 -50.22 74.68 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.85 -28.64 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.734 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -50.31 70.54 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 51' ' ' ASP . 72.2 mt -58.99 -44.25 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.28 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.34 -36.11 70.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -93.83 -2.43 53.53 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.771 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -123.84 12.18 9.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.891 0.853 . . . . 0.0 110.267 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.78 -50.16 0.83 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -85.83 -66.4 0.9 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.1 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.1 mt -144.91 115.09 7.5 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.99 -34.32 11.82 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 124.165 0.916 . . . . 0.0 110.5 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -76.4 -19.22 58.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.69 71.76 1.18 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.966 0.412 . . . . 0.0 110.775 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -161.86 152.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.88 154.33 46.11 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.65 136.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -90.0 -58.67 2.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.193 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.49 151.33 7.83 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.8 122.79 14.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -132.19 145.38 51.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.64 143.12 23.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.76 -157.25 19.65 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.554 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -110.11 135.67 50.55 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.703 0.287 . . . . 0.0 110.301 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -119.42 130.26 55.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 C--N 1.312 -1.033 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.914 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 . . . . . 0 N--CA 1.438 -1.041 0 CA-C-O 120.8 0.333 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.52 140.96 43.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.4 m -73.01 131.06 41.67 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.405 HG21 ' HG2' ' A' ' 42' ' ' ARG . 40.5 p -132.13 147.09 52.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -129.76 138.04 55.17 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.46 109.46 14.87 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.62 124.27 69.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.871 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.39 37.13 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 120.599 0.238 . . . . 0.0 110.81 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 pt -125.26 151.17 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 35' ' ' SER . 25.4 ptt180 -138.63 147.43 42.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 122.035 0.921 . . . . 0.0 113.451 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 21.6 mmtm . . . . . 0 C--N 1.303 -1.423 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.663 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 . . . . . 0 CA--C 1.512 -0.507 0 CA-C-O 121.267 0.556 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 67.8 t -100.09 112.99 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -103.13 133.6 46.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.69 116.65 30.31 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.66 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.477 ' HA ' ' CZ ' ' B' ' 22' ' ' TYR . 50.4 mt -88.23 116.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.462 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.69 35.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.791 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -156.12 -54.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.235 0.517 . . . . 0.0 112.197 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.405 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 54.1 mtmt -99.64 157.32 34.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.28 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 156.25 22.94 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.844 2.363 . . . . 0.0 112.696 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.406 HG23 ' OD1' ' B' ' 51' ' ' ASP . 7.2 p -52.94 -33.87 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.162 0.985 . . . . 0.0 112.881 -176.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -63.76 -25.58 68.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.663 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -72.76 -33.83 66.6 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . 0.477 ' CZ ' ' HA ' ' B' ' 14' ' ' ILE . 99.7 m-85 -77.92 -33.28 51.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.62 -54.37 36.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.086 0.469 . . . . 0.0 109.964 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.88 -29.82 70.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.429 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.29 -46.3 80.99 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.518 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.16 97.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.456 0.473 . . . . 0.0 110.719 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.45 -41.88 97.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.3 m -64.76 -37.63 88.26 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.928 0.394 . . . . 0.0 110.403 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.98 -27.78 62.99 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.404 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.68 -38.9 92.56 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.87 -22.7 67.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.618 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.76 -10.77 59.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.118 0.485 . . . . 0.0 110.605 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.5 -13.01 20.96 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.139 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.49 100.99 8.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.076 0.465 . . . . 0.0 110.344 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 33.7 p -84.05 -29.35 26.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.845 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.475 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 39.3 tt0 -107.68 111.53 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.3 162.51 32.35 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 43.4 t -124.95 123.09 64.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.644 0.735 . . . . 0.0 111.254 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.18 128.54 54.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -127.96 125.15 38.95 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.275 0.56 . . . . 0.0 110.208 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.24 147.75 43.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -127.5 146.24 50.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.96 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.9 -135.19 15.07 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.794 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -91.47 9.57 31.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.411 0.624 . . . . 0.0 111.036 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.77 -2.12 55.64 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.354 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.8 mt -53.55 -36.43 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-O 121.624 0.726 . . . . 0.0 109.901 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -60.73 -34.93 75.15 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.039 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -79.33 -30.58 42.81 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.346 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.85 92.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.369 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.21 -33.37 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.088 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.441 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.2 t70 -65.51 -45.4 83.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.116 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.0 m -57.45 -50.7 72.18 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.95 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.45 -30.36 48.67 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.575 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -50.08 73.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.441 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.4 mt -58.04 -45.71 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.219 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.03 -34.53 60.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.134 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -94.03 0.01 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -126.8 11.32 7.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.791 0.805 . . . . 0.0 110.23 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -134.85 -49.06 0.75 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.91 -67.07 0.83 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.57 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.441 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 96.0 mt -144.77 115.97 7.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.83 -39.03 10.03 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.903 0.752 . . . . 0.0 110.198 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.69 -13.65 61.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.094 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.92 71.44 1.47 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.767 0.318 . . . . 0.0 111.201 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.424 HD13 ' HZ1' ' B' ' 96' ' ' LYS . 17.7 tt -162.24 156.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -145.6 154.35 42.05 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.15 137.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -90.13 -56.41 3.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.337 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -170.17 153.16 4.44 Favored 'General case' 0 C--O 1.251 1.172 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.98 127.0 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -134.8 144.37 47.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.53 143.09 23.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.8 -158.85 22.88 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.759 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -111.86 131.58 55.27 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -114.69 131.96 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.693 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t . . . . . 0 C--N 1.308 -1.237 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.669 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 . . . . . 0 N--CA 1.438 -1.03 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -122.01 139.22 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -72.85 128.06 34.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -129.39 147.48 51.22 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.69 138.21 54.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.66 109.3 14.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.95 123.89 69.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.65 122.79 44.51 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -126.99 150.03 32.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.475 ' HD3' ' OE1' ' B' ' 36' ' ' GLU . 23.8 ptt180 -137.09 150.51 48.06 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 20.9 mmtm -93.49 -170.91 2.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.18 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' B' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.16 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--O 1.239 0.503 0 CA-C-O 121.596 0.712 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.19 120.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -110.82 145.76 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.264 0.554 . . . . 0.0 111.112 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.79 132.63 51.68 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.075 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -89.66 102.31 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 16' ' ' LYS . . . 178.86 55.55 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 118.229 -1.938 . . . . 0.0 115.551 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 53.8 tttm 178.07 -42.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.472 0.636 . . . . 0.0 110.69 171.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -92.39 159.82 36.19 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.243 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.82 162.15 40.02 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.152 1.901 . . . . 0.0 111.308 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.77 -41.39 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -59.95 -30.19 68.91 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.738 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -72.29 -34.4 68.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.067 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -73.01 -33.18 65.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.65 -55.83 21.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.101 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.52 -27.3 69.06 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.684 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.01 77.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.907 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.31 98.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.294 0.371 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.04 -33.18 75.21 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.47 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.8 m -64.4 -36.73 85.11 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.441 0.639 . . . . 0.0 109.738 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.82 -35.51 72.51 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.7 mt -58.43 -42.58 87.63 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.167 0.508 . . . . 0.0 110.239 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -66.79 -23.76 66.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.892 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -87.65 -2.68 58.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.7 8.93 47.75 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.07 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.38 94.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 m -85.69 -22.6 27.78 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.633 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' CD ' ' HZ1' ' A' ' 68' ' ' LYS . 51.6 mt-10 -109.7 107.45 17.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.42 ' H ' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.47 142.05 36.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -116.1 123.91 71.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.013 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.03 123.92 62.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -120.18 124.02 44.71 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.491 0.662 . . . . 0.0 109.834 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.34 160.04 21.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.457 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -131.37 145.09 51.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.278 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.57 -127.8 20.36 Favored Glycine 0 N--CA 1.433 -1.552 0 O-C-N 123.533 0.52 . . . . 0.0 112.445 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.23 0.02 56.58 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.38 . . . . 0.0 111.35 -176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.74 2.06 27.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.134 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.1 mt -57.25 -40.89 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.463 0.649 . . . . 0.0 109.698 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.3 t -70.66 -16.44 62.81 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.954 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -89.83 -33.97 16.3 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.56 89.45 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.128 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 13.7 p -67.76 -43.32 86.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.556 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.473 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.9 t70 -54.83 -44.51 73.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.6 m -57.96 -53.55 57.0 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.983 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 50' ' ' VAL . 31.3 m -68.54 -30.14 46.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 50' ' ' VAL . 46.4 mt-10 -60.19 -47.93 83.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 123.401 0.438 . . . . 0.0 110.286 174.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.2 mt -60.6 -40.62 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 121.232 0.539 . . . . 0.0 110.62 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.93 -27.51 42.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 CA-C-O 121.14 0.495 . . . . 0.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -100.96 2.63 40.89 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -116.45 9.78 14.42 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.198 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -139.1 -71.24 0.4 Allowed 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.412 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 74.4 t80 -60.5 -64.49 0.93 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.131 0.491 . . . . 0.0 110.842 -174.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.427 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.0 mt -141.28 113.62 8.1 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.27 -35.69 10.66 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 124.161 0.913 . . . . 0.0 110.175 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.1 -45.85 59.01 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.073 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.66 97.65 8.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.591 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.425 HD12 ' HZ2' ' A' ' 96' ' ' LYS . 7.2 tp -158.63 138.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.266 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HG2' HH21 ' A' ' 95' ' ' ARG . 7.9 tp10 -124.74 149.98 46.71 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tp -107.52 137.19 39.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HZ1' ' CD ' ' A' ' 36' ' ' GLU . 82.2 tttt -100.54 -53.64 3.04 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.542 -1.263 . . . . 0.0 111.511 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 71' ' ' ARG . 35.6 tt0 -170.53 144.81 2.47 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.1 mt -135.49 119.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 21.9 mtm180 -128.92 136.61 50.62 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.39 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.58 119.0 58.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.98 167.62 34.87 Favored Glycine 0 C--N 1.303 -1.287 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.631 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 m -85.87 118.65 25.49 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -95.64 131.87 41.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.437 -1.078 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.901 -179.728 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 . . . . . 0 N--CA 1.439 -1.013 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.57 130.23 72.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.696 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.54 118.43 7.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.5 p -125.86 155.16 41.63 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.427 -0.171 . . . . 0.0 111.069 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 tt -136.99 131.27 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.12 110.99 21.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.32 118.32 57.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.0 117.93 30.56 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 123.298 0.374 . . . . 0.0 110.332 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.6 pt -114.87 158.37 15.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.545 HH21 ' HG2' ' A' ' 66' ' ' GLU . 34.4 ttp180 -130.39 111.79 12.66 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.207 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 26.8 mmtm . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.559 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.821 0.343 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.46 119.96 63.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.46 142.05 24.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.192 0.52 . . . . 0.0 111.585 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.33 131.83 51.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.879 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -89.57 99.95 10.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.16 43.63 0.16 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 117.935 -2.079 . . . . 0.0 116.112 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -173.83 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.456 1.128 . . . . 0.0 110.444 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -91.59 160.87 35.67 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.395 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.66 164.09 34.47 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.133 1.888 . . . . 0.0 110.929 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.451 HG21 ' OG1' ' B' ' 52' ' ' THR . 8.4 p -57.24 -37.37 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.118 0.567 . . . . 0.0 111.738 -176.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -64.07 -29.36 70.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.662 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -73.97 -34.94 64.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -70.7 -34.03 71.53 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.799 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.46 -55.16 26.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.429 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.7 -28.69 70.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.53 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.4 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.43 -43.07 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.184 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.17 99.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.124 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.6 -34.73 78.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.806 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.0 m -64.88 -36.3 83.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.137 0.494 . . . . 0.0 110.11 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -69.91 -36.94 75.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.558 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.409 HD23 ' O ' ' B' ' 34' ' ' VAL . 95.2 mt -57.31 -43.42 83.26 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.056 0.455 . . . . 0.0 110.346 177.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.802 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -87.65 -0.87 57.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.158 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.74 13.85 36.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.041 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.409 ' O ' HD23 ' B' ' 30' ' ' LEU . 32.5 t -101.08 92.97 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -82.9 -24.34 33.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.151 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -109.06 109.32 20.31 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.44 142.76 37.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.27 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.02 125.08 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.36 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -107.51 123.87 63.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -120.51 123.2 42.36 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.56 161.73 18.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -132.76 145.72 51.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.941 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.407 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 68.35 -127.88 24.2 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 123.451 0.47 . . . . 0.0 112.654 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.35 -0.77 57.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.022 0.439 . . . . 0.0 111.778 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.88 1.98 25.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 43' ' ' GLY . 73.3 mt -58.14 -41.17 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.69 0.757 . . . . 0.0 109.805 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 44.2 t -67.77 -22.14 65.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.405 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -84.84 -33.57 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.37 86.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.601 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' B' ' 54' ' ' GLU . 14.5 p -66.47 -44.07 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.4 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.484 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.1 t70 -56.55 -39.38 73.34 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.451 ' OG1' HG21 ' B' ' 19' ' ' VAL . 57.3 m -61.68 -52.62 63.55 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.98 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.48 -31.14 49.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.203 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' B' ' 50' ' ' VAL . 44.9 mt-10 -59.38 -45.9 90.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.626 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.484 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.9 mt -61.95 -40.64 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.894 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.84 -26.02 37.65 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.157 0.503 . . . . 0.0 111.59 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -100.75 0.52 39.01 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.864 -0.523 . . . . 0.0 111.914 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -116.41 12.75 15.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.182 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -137.89 -68.96 0.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.01 -62.7 1.47 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.868 0.366 . . . . 0.0 111.148 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.421 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.1 mt -142.8 115.12 8.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.01 -34.17 10.19 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 124.241 0.963 . . . . 0.0 109.968 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.5 -41.47 60.64 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.907 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -103.91 99.11 8.87 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.425 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.449 HD12 ' HZ2' ' B' ' 96' ' ' LYS . 7.0 tp -157.99 140.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.041 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.538 ' HG2' HH21 ' B' ' 95' ' ' ARG . 7.1 tp10 -125.83 146.82 49.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -105.44 134.53 46.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -98.85 -54.01 3.12 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.503 -1.279 . . . . 0.0 111.291 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . 0.4 ' OE2' ' HD3' ' B' ' 71' ' ' ARG . 29.3 tt0 -169.87 143.32 2.57 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.7 mt -131.89 118.81 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.4 ' HD3' ' OE2' ' B' ' 69' ' ' GLU . 25.6 mtm180 -127.55 137.25 52.56 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.582 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.55 117.23 51.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.16 165.77 33.89 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.515 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -84.44 115.98 22.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.45 0.7 . . . . 0.0 109.375 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -94.04 132.44 38.52 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.307 -1.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.644 -179.424 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 CA--C 1.498 -1.043 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -114.46 129.48 70.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -61.86 120.38 10.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.9 p -127.64 155.12 44.4 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.308 -0.245 . . . . 0.0 111.221 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -136.83 131.42 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.838 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.35 109.94 19.12 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 56.1 mt -110.88 117.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.95 118.83 34.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.193 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 pt -116.67 152.03 18.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.836 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.538 HH21 ' HG2' ' B' ' 66' ' ' GLU . 35.0 ttp180 -124.21 114.04 19.1 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.449 ' HZ2' HD12 ' B' ' 65' ' ' ILE . 28.0 mmtm -80.24 146.8 31.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.861 174.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.385 0.428 . . . . 0.0 111.643 -177.347 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 120.898 0.38 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.46 112.27 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.26 133.9 44.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.642 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -120.83 130.42 53.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.29 133.81 44.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.41 48.5 0.02 OUTLIER Glycine 0 C--N 1.348 1.196 0 C-N-CA 119.439 -1.363 . . . . 0.0 115.628 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -174.71 -51.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 118.04 0.92 . . . . 0.0 112.031 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.13 158.1 33.85 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.732 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 165.74 17.89 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.373 2.048 . . . . 0.0 111.417 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.438 HG22 ' OD2' ' A' ' 51' ' ' ASP . 11.6 p -53.06 -28.72 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 C-N-CA 124.353 1.061 . . . . 0.0 113.296 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.6 mtp -62.83 -29.74 70.96 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -71.07 -28.82 64.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.18 0.515 . . . . 0.0 109.64 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -89.62 -42.66 11.26 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.183 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 82.3 t -60.79 -49.82 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.787 0.327 . . . . 0.0 110.68 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.24 -19.79 64.76 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.984 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.37 -48.79 16.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.44 85.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 97.4 mt -60.3 -34.48 73.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.7 m -76.09 -40.95 51.91 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.35 -38.56 87.37 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.1 -42.78 95.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.395 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.73 -16.38 45.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.918 0.39 . . . . 0.0 110.411 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -78.61 -34.12 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.29 -4.0 1.27 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.87 100.36 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -79.34 -21.11 46.3 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.151 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.38 121.48 22.38 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.261 0.553 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.401 ' H ' HD11 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -126.36 158.63 36.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.503 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.86 122.02 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.4 mt -105.45 121.1 57.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 99.6 mttt -108.34 141.25 40.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 49' ' ' ALA . . . -133.38 157.4 45.62 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -133.98 135.09 43.23 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 46' ' ' ILE . . . 67.59 -135.01 30.72 Favored Glycine 0 C--O 1.212 -1.237 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.683 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -74.12 -2.45 24.6 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.35 -9.97 59.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.488 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 43' ' ' GLY . 78.7 mt -53.35 -33.87 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.272 0.629 . . . . 0.0 110.797 178.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 p -63.07 -30.6 71.72 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.095 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -86.98 -25.85 24.09 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.374 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -63.29 -48.38 78.34 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.41 0.624 . . . . 0.0 109.984 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.1 -38.18 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.406 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.4 t70 -59.8 -47.99 83.49 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.518 0.511 . . . . 0.0 109.732 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.2 m -55.82 -54.26 46.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.193 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.31 -31.0 49.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.278 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 26.6 tt0 -67.87 -37.6 82.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.275 0.359 . . . . 0.0 110.531 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.49 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 68.9 mt -64.89 -47.97 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.17 -52.71 55.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.434 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -66.63 -13.51 61.24 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -116.64 2.32 12.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 15.8 ptm180 -117.78 -34.44 4.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.127 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -90.1 -58.85 2.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.697 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.2 tp -155.84 109.49 2.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 -6.04 28.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.443 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -87.95 -41.92 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.006 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -124.43 99.01 6.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -155.2 145.34 13.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.5 148.24 50.5 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.166 0.508 . . . . 0.0 110.131 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.2 mt -102.91 133.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -92.85 -51.42 5.09 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.967 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -160.55 141.36 11.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.2 99.89 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 123.132 0.573 . . . . 0.0 110.388 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.22 153.95 51.76 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.775 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.08 135.95 42.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.27 -165.69 15.5 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.189 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -100.27 128.73 46.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.076 0.55 . . . . 0.0 109.874 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -108.15 112.41 24.92 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.313 -0.984 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.372 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.19 133.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.7 t -66.02 134.88 53.82 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.352 0.596 . . . . 0.0 110.915 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.2 p -132.14 160.34 36.31 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.161 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 18.5 tt -140.78 135.58 34.14 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -111.38 115.79 29.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.64 112.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 123.96 50.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.496 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.6 pt -125.85 152.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.166 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -130.05 124.51 33.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.894 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 . . . . . 0 C--O 1.243 0.735 0 CA-C-O 120.781 0.324 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.92 111.51 30.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.69 131.63 47.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.983 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -118.27 127.18 53.48 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.8 mt -99.76 133.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 48.31 0.02 OUTLIER Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.496 -1.335 . . . . 0.0 115.446 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -172.95 -50.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.868 0.834 . . . . 0.0 112.598 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.412 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 32.0 mmmt -99.64 158.52 32.0 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 122.241 -0.287 . . . . 0.0 110.806 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.91 164.26 22.46 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.557 2.171 . . . . 0.0 111.173 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.476 HG22 ' OD1' ' B' ' 51' ' ' ASP . 13.4 p -52.43 -27.23 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 123.994 0.918 . . . . 0.0 113.326 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 92.9 mtp -65.14 -27.17 68.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -72.9 -26.23 61.35 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.409 0.623 . . . . 0.0 109.625 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . 0.412 ' HE2' ' O ' ' B' ' 17' ' ' LYS . 90.1 m-85 -93.42 -42.84 9.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.101 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 99.0 t -60.8 -49.56 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 121.345 0.593 . . . . 0.0 110.432 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mp -67.46 -24.18 65.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.79 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.11 -45.92 46.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.19 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.75 97.69 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.932 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 98.8 mt -60.33 -38.09 82.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.153 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.1 m -70.19 -43.62 70.38 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -60.18 -39.05 85.13 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -41.34 89.53 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.522 0.514 . . . . 0.0 111.168 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -85.37 -15.05 44.45 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.312 0.577 . . . . 0.0 110.164 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -79.21 -36.42 40.13 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.528 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.26 -3.9 0.92 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.638 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -97.99 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 117.511 0.656 . . . . 0.0 109.389 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -78.29 -21.78 49.21 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.963 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.23 118.32 19.36 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.174 0.511 . . . . 0.0 111.092 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.435 HD11 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -124.95 159.25 31.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.923 -176.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.67 121.49 60.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.029 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -104.94 122.66 58.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 99.3 mttt -110.47 139.24 45.88 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 123.65 0.594 . . . . 0.0 109.979 177.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' B' ' 49' ' ' ALA . . . -132.61 154.92 49.58 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -132.22 134.0 44.81 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.424 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 70.28 -135.53 25.78 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.691 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.6 -2.83 27.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.47 57.98 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.539 0.209 . . . . 0.0 111.275 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 43' ' ' GLY . 77.7 mt -52.96 -35.63 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.479 0.657 . . . . 0.0 110.43 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 53.4 p -62.35 -35.71 79.95 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.92 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -81.61 -26.81 34.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.429 ' HB2' ' HB1' ' B' ' 41' ' ' ALA . . . -62.47 -47.77 82.54 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.25 0.548 . . . . 0.0 110.613 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.66 -38.06 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.661 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.476 ' OD1' HG22 ' B' ' 19' ' ' VAL . 13.3 t70 -57.58 -49.92 74.82 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.417 ' O ' HG23 ' B' ' 56' ' ' VAL . 90.1 m -54.2 -54.3 41.79 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.473 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.0 m -69.3 -30.63 46.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.551 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.441 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 25.8 tt0 -68.11 -37.42 81.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 123.302 0.376 . . . . 0.0 110.71 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.485 ' O ' ' HG2' ' B' ' 59' ' ' ARG . 73.7 mt -64.56 -48.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 52' ' ' THR . 58.8 t -57.7 -53.69 41.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 32.2 ptt180 -65.77 -9.69 30.55 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -120.04 -1.24 10.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 15.5 ptm180 -115.18 -33.79 5.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.166 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -89.41 -59.69 2.15 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.704 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 46.1 tp -153.94 107.74 2.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.87 -1.61 39.73 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.064 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -92.63 -50.75 5.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.918 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -115.22 96.65 5.78 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.817 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -152.14 146.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -132.25 149.53 52.35 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -105.69 132.33 52.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -91.72 -50.28 5.83 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.866 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -163.55 143.24 8.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.566 0.541 . . . . 0.0 109.602 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -143.96 98.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.742 0.817 . . . . 0.0 110.269 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -132.91 153.28 51.53 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.397 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.45 137.42 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.65 -169.88 25.57 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.667 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -93.73 137.17 33.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -115.42 116.33 28.05 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--N 1.308 -1.225 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.696 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 . . . . . 0 CA--C 1.505 -0.777 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.65 135.97 58.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.5 t -69.59 135.98 50.67 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.875 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.03 159.55 38.47 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.491 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 19.2 tt -139.08 135.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.84 113.33 25.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.0 113.49 44.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.15 122.14 44.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 32.7 pt -124.11 149.17 28.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.204 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -127.33 127.57 44.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.988 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 0.7 OUTLIER -78.59 136.74 37.59 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.432 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 27.5 mtpp . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.4 p30 . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 22.9 m -102.38 130.83 51.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.583 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.89 142.45 40.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.526 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.39 129.19 52.34 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.34 113.06 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.935 0.397 . . . . 0.0 111.269 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.08 -161.3 25.51 Favored Glycine 0 C--O 1.253 1.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.322 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.23 5.18 8.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -82.16 158.47 66.91 Favored Pre-proline 0 CA--C 1.547 0.854 0 O-C-N 122.154 -0.341 . . . . 0.0 111.093 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.18 153.81 67.11 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.101 2.534 . . . . 0.0 113.475 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 51' ' ' ASP . 7.1 p -54.76 -39.91 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.06 0.944 . . . . 0.0 113.356 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -55.55 -30.58 61.01 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.33 -39.49 92.49 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.007 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -80.97 -34.31 33.2 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.14 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.2 -49.97 81.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.065 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.14 -34.66 78.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.58 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -50.6 65.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.07 86.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.237 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.25 -41.17 97.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.7 m -62.6 -38.55 90.62 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 88.6 mt -64.25 -38.58 91.54 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.65 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.99 -48.85 78.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.812 0.695 . . . . 0.0 110.536 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -79.38 -12.83 59.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.198 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -79.98 -25.85 40.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.99 -12.47 3.88 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.799 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.98 93.06 3.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.292 0.568 . . . . 0.0 109.479 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -87.65 18.4 4.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -155.73 110.34 2.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.33 160.64 41.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.342 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.3 t -124.59 122.76 64.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.332 0.587 . . . . 0.0 110.662 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -100.93 129.32 52.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.0 119.68 36.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.096 0.474 . . . . 0.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . . . -113.74 153.21 29.4 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -142.86 137.56 29.66 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.535 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.48 -130.83 10.26 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -95.18 10.06 37.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.077 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.56 2.02 49.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.934 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.31 -43.28 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.149 0.579 . . . . 0.0 111.282 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.3 p -66.6 -24.81 66.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.689 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.62 -30.71 52.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.5 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . . . -70.67 -43.77 68.43 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.325 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.85 -33.29 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.075 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.49 ' OD1' HG23 ' A' ' 19' ' ' VAL . 18.0 t70 -58.97 -50.36 74.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.4 m -53.61 -52.76 58.8 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.105 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.8 m -70.31 -36.27 66.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.73 -29.08 68.96 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 121.493 0.663 . . . . 0.0 109.43 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.5 mt -69.57 -48.75 64.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 122.003 -0.435 . . . . 0.0 110.626 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -59.84 -36.31 65.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 120.946 0.403 . . . . 0.0 111.348 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 6.1 ptm180 -82.08 0.81 38.87 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -115.29 -45.77 2.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.884 0.373 . . . . 0.0 111.544 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -72.85 -28.36 62.48 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -105.62 -72.53 0.71 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.231 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.451 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 96.0 mt -142.2 116.52 9.55 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -93.15 -37.57 12.04 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 124.497 1.123 . . . . 0.0 110.42 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.7 -40.33 92.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.79 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -108.12 99.44 8.88 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 121.191 0.519 . . . . 0.0 111.364 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.42 132.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.454 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.49 136.96 53.9 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -99.48 130.05 49.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -80.04 -55.82 4.68 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -171.32 147.3 2.44 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.71 123.92 55.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -122.43 139.93 53.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.039 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -132.57 125.45 53.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.28 25.78 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.494 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 88' ' ' SER . 50.1 m -115.38 129.05 56.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 117.278 0.539 . . . . 0.0 111.082 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 53.5 tt0 -93.18 141.63 28.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.122 0.969 . . . . 0.0 108.543 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 HG21 ' HG2' ' A' ' 86' ' ' ARG . 22.4 t . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 98.1 mtt180 . . . . . 0 CA--C 1.513 -0.451 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -134.75 139.22 47.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 19.2 m -72.35 136.65 46.21 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.556 0.743 . . . . 0.0 112.436 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.443 HG22 ' OE1' ' A' ' 75' ' ' GLN . 80.9 p -129.15 170.73 13.18 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.909 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.7 tt -146.93 123.78 3.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.477 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.14 113.49 26.8 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.03 115.51 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.19 121.14 42.06 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.574 0.225 . . . . 0.0 110.836 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.81 148.32 25.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.636 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.43 147.63 40.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.137 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 4.4 mmtm . . . . . 0 C--N 1.294 -1.818 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.505 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 p30 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 30.0 m -103.87 133.12 48.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.078 0.466 . . . . 0.0 111.493 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.67 143.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.553 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 56.8 tp -106.52 125.65 51.26 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.87 116.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 120.996 0.426 . . . . 0.0 111.099 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.98 -158.8 22.38 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.201 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -79.28 4.17 15.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.02 158.53 67.2 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 122.346 -0.222 . . . . 0.0 110.661 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.69 153.93 68.84 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.214 2.61 . . . . 0.0 113.214 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.493 HG23 ' OD1' ' B' ' 51' ' ' ASP . 7.3 p -54.53 -39.8 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.346 1.058 . . . . 0.0 113.394 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -57.56 -27.26 62.5 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.95 -36.74 80.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -83.19 -35.46 25.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.415 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 82.1 t -58.38 -50.95 76.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.876 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.22 -36.51 84.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.6 -48.09 78.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.832 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.08 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.925 0.393 . . . . 0.0 111.088 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.54 -41.76 98.43 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.9 m -61.16 -39.62 90.8 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.521 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.3 mt -63.51 -38.69 92.1 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.59 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.3 -46.02 86.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.138 0.494 . . . . 0.0 110.696 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.83 -7.51 59.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -84.87 -25.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.81 -15.71 3.31 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.612 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.65 94.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.169 0.509 . . . . 0.0 109.93 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -90.48 19.04 5.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.962 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -155.25 107.84 2.72 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.407 HD11 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.15 158.74 41.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -174.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 53.8 t -124.19 121.72 62.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.508 0.67 . . . . 0.0 111.015 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.77 129.03 50.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.92 122.74 44.09 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.26 0.552 . . . . 0.0 110.777 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . . . -116.77 154.34 30.85 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -142.94 136.03 28.14 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.542 0.526 . . . . 0.0 110.35 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.33 -132.92 11.46 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -93.48 13.56 21.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 110.267 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.95 1.41 56.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.27 -43.78 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.305 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -65.92 -24.25 66.79 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.955 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -79.6 -32.2 41.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.035 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' B' ' 41' ' ' ALA . . . -68.29 -44.18 76.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.08 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.51 -33.91 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.113 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.493 ' OD1' HG23 ' B' ' 19' ' ' VAL . 13.7 t70 -58.51 -49.28 77.95 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -54.58 -51.78 64.19 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.908 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.45 -37.11 69.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -66.97 -30.52 70.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.304 0.573 . . . . 0.0 109.58 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.7 mt -67.33 -49.18 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.106 -0.371 . . . . 0.0 110.649 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.28 -39.42 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.794 0.331 . . . . 0.0 111.542 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' B' ' 62' ' ' ALA . 7.6 ptm180 -79.82 -1.98 41.37 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -110.79 -43.8 3.75 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.769 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -75.16 -34.27 61.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -99.96 -69.15 0.78 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.851 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.469 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.9 mt -144.97 116.6 8.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -93.21 -38.06 11.75 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 124.501 1.125 . . . . 0.0 110.789 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.365 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -108.53 100.14 9.44 Favored 'General case' 0 C--O 1.253 1.254 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.0 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tp -160.18 130.01 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.638 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.15 135.05 53.22 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.73 131.61 45.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.408 ' HD3' ' C ' ' B' ' 68' ' ' LYS . 9.5 tmtt? -83.26 -56.41 3.78 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -170.89 146.22 2.5 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -130.45 123.61 55.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -121.23 140.41 52.07 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.607 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.22 125.67 51.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 88' ' ' SER . . . -165.11 -171.46 31.37 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.001 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' B' ' 88' ' ' SER . 49.0 m -111.0 125.77 54.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.101 0.451 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 53.3 tt0 -89.81 141.9 28.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.899 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.457 HG21 ' HG2' ' B' ' 86' ' ' ARG . 20.7 t . . . . . 0 C--N 1.313 -0.982 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 99.7 mtt180 . . . . . 0 CA--C 1.502 -0.903 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 135.63 56.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' B' ' 74' ' ' SER . 20.1 m -68.08 137.17 54.77 Favored 'General case' 0 C--O 1.261 1.693 0 C-N-CA 123.708 0.803 . . . . 0.0 112.193 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.434 HG22 ' OE1' ' B' ' 75' ' ' GLN . 68.4 p -129.42 171.01 12.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.472 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.57 123.03 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.952 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.81 113.36 26.71 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -110.96 116.39 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.36 120.38 40.16 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.059 0.457 . . . . 0.0 110.922 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -120.69 143.8 31.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -110.78 147.61 34.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.284 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 3.3 mmtm -128.81 136.06 49.98 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 122.733 0.413 . . . . 0.0 111.802 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? . . . . . 0 C--O 1.258 1.504 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -178.992 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 N--CA 1.465 0.304 0 CA-C-O 121.437 0.637 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.75 148.43 8.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.14 135.03 58.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 120.915 0.388 . . . . 0.0 110.606 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.34 132.35 40.47 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.54 111.16 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.712 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.27 0.02 OUTLIER Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.374 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -135.86 -76.37 0.44 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.052 0.426 . . . . 0.0 110.529 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -99.39 169.38 8.22 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.198 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.36 161.74 16.22 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.355 2.037 . . . . 0.0 112.239 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -51.37 -30.87 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.076 1.35 . . . . 0.0 113.591 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptp -62.85 -26.91 68.99 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.33 -31.35 58.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.148 0.499 . . . . 0.0 109.952 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.81 -36.36 50.33 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.9 t -61.13 -50.85 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.011 0.434 . . . . 0.0 109.903 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.71 -26.49 64.37 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.89 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.9 -44.81 72.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.693 0.282 . . . . 0.0 110.287 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.45 -24.4 67.16 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 90.1 mt -77.89 -45.73 23.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.145 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -63.64 -34.95 78.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.177 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 87.6 mt -61.63 -35.06 76.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 111.385 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.62 -31.07 71.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.493 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.75 -23.2 65.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -79.81 -15.82 56.69 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.984 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.66 -12.01 18.38 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.912 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.42 106.95 15.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.956 0.884 . . . . 0.0 112.049 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.1 p -87.82 -31.18 19.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.007 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 44.5 mt-10 -103.67 107.81 18.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.016 0.436 . . . . 0.0 109.837 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.83 157.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.291 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.2 t -126.92 124.1 63.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.119 0.485 . . . . 0.0 111.002 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.26 126.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -123.32 119.08 29.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.168 0.509 . . . . 0.0 110.141 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.5 156.59 27.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.443 ' HG2' HG23 ' A' ' 89' ' ' THR . 44.1 mtp180 -134.77 147.17 49.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.024 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.28 -134.81 20.19 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -85.1 5.84 28.07 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.392 -0.475 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.38 -3.5 52.95 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -57.37 -32.63 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.446 0.698 . . . . 0.0 110.009 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -61.39 -43.56 98.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.017 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.6 -36.44 80.87 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.506 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.86 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.61 -36.3 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.953 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.565 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.3 t70 -62.43 -45.89 91.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.8 m -56.53 -53.66 54.95 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.48 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.03 -34.54 70.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.207 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.583 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 6.0 tp10 -65.75 -40.7 92.34 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 51' ' ' ASP . 75.8 mt -60.11 -42.99 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.016 0.436 . . . . 0.0 110.48 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.04 -44.68 95.36 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.229 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 2.5 ptm180 -80.03 -2.56 44.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.54 20.69 11.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.09 0.471 . . . . 0.0 111.728 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -139.43 -61.41 0.55 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.15 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -92.03 -54.72 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.527 -174.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 90.2 mt -119.03 107.26 13.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -98.25 -46.55 5.78 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.167 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.45 9.87 31.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -132.39 29.05 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.895 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.66 134.59 58.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.5 ' CD ' HH21 ' A' ' 95' ' ' ARG . 40.2 mt-10 -115.95 157.87 23.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.212 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -100.42 123.39 53.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -82.78 -61.82 1.77 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.992 0.425 . . . . 0.0 110.841 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.93 141.27 17.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.3 pt -130.12 121.56 51.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -132.98 144.74 50.32 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.63 144.83 18.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.77 171.72 28.21 Favored Glycine 0 C--N 1.318 -0.431 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 t -79.21 122.8 26.75 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.709 0.766 . . . . 0.0 110.477 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -99.23 122.2 42.09 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.325 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.2 t . . . . . 0 C--N 1.311 -1.081 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.098 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.946 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.7 t -126.46 137.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 p -65.2 121.15 14.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 123.445 0.466 . . . . 0.0 110.065 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 42' ' ' ARG . 73.4 p -127.46 158.59 36.94 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.458 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -139.47 133.97 38.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.78 112.97 23.62 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.98 117.74 55.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.49 130.01 56.74 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -131.1 157.57 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.5 HH21 ' CD ' ' A' ' 66' ' ' GLU . 59.2 ttp180 -122.37 122.95 40.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.66 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp . . . . . 0 C--N 1.306 -1.307 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.773 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 121.098 0.475 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 32.7 m -101.62 151.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.87 135.74 56.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.883 0.373 . . . . 0.0 110.102 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.9 132.77 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 48.2 mm -94.48 112.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.054 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.56 38.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.278 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.21 -76.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.262 0.553 . . . . 0.0 110.747 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -99.5 169.25 8.36 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -60.71 161.45 21.32 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.387 2.058 . . . . 0.0 112.486 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -50.03 -32.4 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.882 1.273 . . . . 0.0 113.544 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 24.2 ptp -60.97 -32.04 71.59 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -71.07 -33.99 70.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.941 0.401 . . . . 0.0 109.958 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -75.53 -36.2 60.55 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.312 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.0 -53.19 52.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.052 0.453 . . . . 0.0 110.039 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mp -67.14 -28.06 67.83 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.981 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.25 76.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.649 0.261 . . . . 0.0 110.453 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -31.1 72.16 Favored 'General case' 0 C--O 1.261 1.687 0 CA-C-O 121.233 0.539 . . . . 0.0 111.025 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -71.4 -43.46 66.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.061 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -65.52 -36.18 83.06 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.728 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.23 -39.04 91.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.105 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.29 -32.84 71.57 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.977 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -66.18 -22.15 66.35 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.156 0.503 . . . . 0.0 110.92 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.92 -12.93 56.95 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.823 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.77 22.52 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.582 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.2 105.14 13.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 122.031 0.919 . . . . 0.0 112.291 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.5 p -87.74 -31.41 19.69 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.174 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' B' ' 94' ' ' ILE . 43.9 mt-10 -101.93 109.42 21.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.95 155.81 41.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.971 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 111.509 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.02 126.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -123.11 116.77 24.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.247 0.546 . . . . 0.0 110.63 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.48 157.11 24.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.444 ' HG2' HG23 ' B' ' 89' ' ' THR . 50.3 mtp180 -135.7 144.97 46.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.195 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.48 -130.14 10.49 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.241 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -89.88 3.92 51.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.157 0.503 . . . . 0.0 110.333 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.24 -6.4 54.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.307 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.24 -35.12 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.759 0.824 . . . . 0.0 110.288 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.0 p -61.23 -43.69 98.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.178 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -66.13 -38.79 89.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.328 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.99 87.86 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -71.7 -35.33 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.889 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.557 ' O ' HG13 ' B' ' 55' ' ' ILE . 25.2 t70 -64.63 -45.09 88.36 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -54.21 -53.65 50.55 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.87 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.9 -33.15 59.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.632 ' OE1' ' HD3' ' B' ' 57' ' ' ARG . 5.8 tp10 -67.41 -40.08 85.56 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.557 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.4 mt -60.66 -42.49 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.142 0.496 . . . . 0.0 110.804 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.09 -42.98 91.81 Favored 'Isoleucine or valine' 0 C--O 1.256 1.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.777 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.632 ' HD3' ' OE1' ' B' ' 54' ' ' GLU . 2.7 ptm180 -81.34 -2.92 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.209 -175.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.94 19.05 12.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.764 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -139.5 -58.06 0.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.647 -0.421 . . . . 0.0 112.116 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.87 -53.04 4.16 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.279 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 91.4 mt -120.82 106.43 11.66 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -97.15 -39.27 9.37 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.54 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -114.58 6.22 15.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.35 31.37 4.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.169 0.509 . . . . 0.0 111.746 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -134.32 136.99 52.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.511 ' CD ' HH21 ' B' ' 95' ' ' ARG . 41.6 mt-10 -119.49 159.29 24.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 110.44 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.99 123.92 55.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -83.57 -60.58 2.08 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.23 0.331 . . . . 0.0 110.364 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -158.03 140.62 14.6 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.85 124.19 60.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -137.45 143.22 41.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.51 142.18 18.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 O-C-N 123.133 0.271 . . . . 0.0 110.336 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.17 172.4 32.58 Favored Glycine 0 C--O 1.238 0.363 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 121.82 25.27 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.515 0.674 . . . . 0.0 110.451 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -98.38 118.68 35.6 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.431 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.475 178.459 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.73 136.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 21.0 p -63.86 122.29 16.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.014 0.526 . . . . 0.0 110.24 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.444 HG23 ' HG2' ' B' ' 42' ' ' ARG . 77.4 p -127.68 157.5 40.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.112 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.4 tt -139.41 131.87 36.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.6 112.91 24.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.43 116.8 53.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.886 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.19 128.62 56.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.387 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' B' ' 36' ' ' GLU . 0.2 OUTLIER -128.84 155.26 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.072 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.511 HH21 ' CD ' ' B' ' 66' ' ' GLU . 60.6 ttp180 -119.54 120.91 38.14 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.686 0.616 . . . . 0.0 110.412 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -82.39 -175.14 5.55 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt . . . . . 0 CA--C 1.548 0.885 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.259 174.433 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.712 0.292 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.7 133.97 63.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.457 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.79 135.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.0 tp -97.26 115.31 27.4 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.8 99.19 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.334 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.71 72.08 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.073 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HG3' ' HG2' ' A' ' 17' ' ' LYS . 5.7 ptpp? 172.69 -48.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.48 1.112 . . . . 0.0 112.475 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.444 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 32.5 mmmt -100.29 164.77 15.69 Favored Pre-proline 0 C--O 1.256 1.403 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.2 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.5 164.14 34.01 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.595 2.196 . . . . 0.0 110.914 172.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.459 HG22 ' OD1' ' A' ' 51' ' ' ASP . 7.8 p -58.26 -42.81 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.405 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.9 ptp -58.89 -25.93 63.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.12 -38.02 81.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -77.59 -33.28 53.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.46 -47.14 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.359 0.6 . . . . 0.0 109.84 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 20' ' ' MET . 87.0 mt -66.17 -29.66 69.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.782 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -67.99 -43.67 78.39 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.8 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.24 -30.52 70.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.132 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.31 -36.08 66.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.998 0.428 . . . . 0.0 110.182 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 m -70.18 -35.05 73.69 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.3 mt -63.88 -27.07 68.91 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.616 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.449 HD23 ' HG3' ' A' ' 96' ' ' LYS . 14.3 mt -57.69 -41.32 81.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 111.6 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -78.28 -5.26 51.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -102.78 -4.45 24.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 109.714 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.28 13.61 58.44 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.193 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 20.7 t -101.01 89.55 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.628 0.727 . . . . 0.0 109.27 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -81.17 -24.71 37.35 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.571 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.521 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 35.2 mt-10 -110.65 111.21 22.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.23 154.07 39.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.042 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.026 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.97 117.91 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 123.794 0.684 . . . . 0.0 110.497 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.89 120.81 40.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -113.37 115.03 27.46 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 122.742 0.417 . . . . 0.0 110.195 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.25 39.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HG2' HG22 ' A' ' 89' ' ' THR . 44.1 mtm180 -133.77 148.52 51.39 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 120.817 0.342 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.96 -130.44 10.97 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.782 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.56 -0.45 57.52 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 122.232 -0.569 . . . . 0.0 112.06 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.77 6.41 24.57 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -57.77 -37.1 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 110.0 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.8 p -67.66 -29.7 69.06 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.989 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.97 -29.2 58.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.296 0.57 . . . . 0.0 109.66 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.24 -45.35 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.397 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.06 -38.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.504 ' O ' HG13 ' A' ' 55' ' ' ILE . 13.6 t70 -57.91 -42.39 84.64 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.3 m -55.3 -52.69 62.64 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.015 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.68 -34.13 51.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . 0.257 11.6 pt-20 -69.96 -31.7 69.55 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.561 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.5 mt -62.4 -47.81 91.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.955 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.9 t -57.91 -48.82 83.03 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 16.6 ptm180 -72.75 -14.56 61.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -109.39 0.72 19.55 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.499 -0.88 . . . . 0.0 113.213 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -108.69 -19.28 13.48 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.04 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -146.25 -70.13 0.26 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.451 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.0 86.06 7.07 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -75.54 -73.6 0.25 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.931 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.6 2.25 55.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -113.88 24.42 12.09 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.187 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.38 133.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.148 0.499 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -101.53 143.62 31.29 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.2 mt -124.65 140.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.99 -73.39 0.52 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.115 0.483 . . . . 0.0 111.242 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -170.49 157.52 5.97 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.32 115.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -113.28 128.61 56.52 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.97 132.79 47.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.78 169.46 41.89 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.905 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 m -81.44 138.45 35.54 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 122.969 0.508 . . . . 0.0 109.67 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -115.87 130.49 56.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.686 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 C--N 1.316 -0.856 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.33 122.24 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 p -65.24 130.47 43.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.439 HG22 ' HG2' ' A' ' 42' ' ' ARG . 41.7 p -128.54 145.42 51.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.68 138.17 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.0 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -121.9 111.0 16.55 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.393 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -107.07 110.5 31.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.16 124.91 53.24 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.4 pt -134.66 168.73 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.521 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 30.5 ttt180 -135.04 155.57 50.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.449 ' HG3' HD23 ' A' ' 30' ' ' LEU . 47.7 mmtm . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.425 0.631 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.59 132.73 69.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.322 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.895 0.379 . . . . 0.0 111.386 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -96.29 114.76 26.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.561 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.82 98.27 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.253 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 72.83 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.435 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' B' ' 17' ' ' LYS . 5.2 ptpp? 172.25 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.789 1.236 . . . . 0.0 112.244 174.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.479 ' HG2' ' HG3' ' B' ' 16' ' ' LYS . 32.3 mmmt -100.19 164.19 16.84 Favored Pre-proline 0 C--O 1.255 1.366 0 O-C-N 122.227 -0.296 . . . . 0.0 111.309 -174.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.02 164.48 29.82 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.997 2.465 . . . . 0.0 110.869 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.9 -42.25 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptp -58.09 -26.12 62.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -68.38 -39.48 81.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.411 0.624 . . . . 0.0 110.104 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.62 -33.34 58.39 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.478 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.31 -48.46 88.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.706 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.32 -29.39 70.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.037 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.06 -46.79 73.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.01 85.82 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.123 0.487 . . . . 0.0 111.134 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.222 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 43.2 m -72.16 -36.55 69.35 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.208 0.527 . . . . 0.0 110.26 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 94.4 mt -62.99 -30.01 71.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.695 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.446 HD23 ' HG3' ' B' ' 96' ' ' LYS . 17.5 mt -54.0 -42.82 69.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.855 171.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.59 -9.57 58.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.418 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -99.38 -3.78 33.07 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.952 0.406 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.08 12.27 57.79 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.459 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' B' ' 29' ' ' LEU . 20.9 t -100.65 90.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.537 0.684 . . . . 0.0 109.695 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 44.3 m -82.05 -25.29 34.72 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.583 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.404 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 37.2 mt-10 -109.58 110.8 21.99 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.76 152.56 37.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.58 119.03 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.492 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.9 121.02 40.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.62 113.89 25.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.045 0.45 . . . . 0.0 110.289 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 152.0 38.07 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.405 ' HG2' HG22 ' B' ' 89' ' ' THR . 46.7 mtm180 -134.8 151.41 50.93 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.764 0.316 . . . . 0.0 110.689 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 -128.01 10.9 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.748 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -91.17 -1.04 57.8 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 122.359 -0.495 . . . . 0.0 112.099 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 8.06 21.04 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.12 -37.86 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.774 0.797 . . . . 0.0 109.924 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 29.2 p -66.39 -30.63 71.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.239 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.67 -31.26 61.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.03 75.98 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.421 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.17 -37.43 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.643 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.502 ' O ' HG13 ' B' ' 55' ' ' ILE . 14.7 t70 -59.11 -40.24 84.75 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.6 m -57.47 -52.99 63.12 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.851 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 m -70.93 -34.65 56.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.97 -33.14 73.21 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.293 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.502 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.9 mt -61.87 -48.78 87.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.126 175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.09 -49.42 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 62' ' ' ALA . 15.5 ptm180 -72.25 -18.26 61.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -104.0 -3.45 24.61 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.882 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -106.54 -15.2 14.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.39 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -149.65 -69.67 0.2 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 mp -88.76 86.94 7.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.146 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -76.86 -73.17 0.3 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.839 -178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.9 4.84 51.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -115.2 26.51 10.04 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.042 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.2 tp -107.25 130.26 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 120.871 0.367 . . . . 0.0 110.98 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -96.99 147.0 24.44 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.1 mt -126.6 138.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -88.08 -73.49 0.49 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -172.02 160.94 5.5 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 65.7 mt -125.83 115.49 43.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -111.79 124.19 51.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.22 136.43 56.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.7 170.17 41.02 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.796 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.4 m -80.61 140.8 35.55 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -118.67 130.99 56.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 C--N 1.314 -0.935 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.475 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 119.32 54.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -63.66 129.05 38.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.405 HG22 ' HG2' ' B' ' 42' ' ' ARG . 47.0 p -127.37 147.3 50.27 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.827 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.36 137.35 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.528 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.05 112.48 19.19 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.046 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.4 mt -107.31 111.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.16 127.15 56.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.975 0.416 . . . . 0.0 110.667 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -136.35 167.48 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.263 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.404 ' HD2' ' OE2' ' B' ' 36' ' ' GLU . 36.8 ttt180 -134.07 153.47 51.78 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.904 0.383 . . . . 0.0 110.138 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.446 ' HG3' HD23 ' B' ' 30' ' ' LEU . 46.7 mmtm -108.35 140.56 41.46 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm . . . . . 0 C--N 1.311 -1.085 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.11 173.137 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 p30 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 19.3 m -98.96 129.98 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.106 0.479 . . . . 0.0 110.458 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' CG2' HG12 ' A' ' 39' ' ' ILE . 35.6 m -118.47 139.36 46.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.836 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.0 127.29 43.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.761 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.52 110.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.37 53.55 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.234 -1.46 . . . . 0.0 113.894 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -157.51 -58.97 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -100.79 162.28 21.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.997 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.72 156.75 55.64 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.236 1.957 . . . . 0.0 112.014 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.474 HG22 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -50.87 -32.4 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.725 1.21 . . . . 0.0 113.776 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.3 ptp -56.81 -31.6 64.88 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -75.93 -37.15 59.01 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.842 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.7 -37.34 73.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.36 -47.5 90.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.254 0.55 . . . . 0.0 110.05 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.18 -32.22 71.38 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.944 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.51 -44.46 78.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.671 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.75 90.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.273 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.44 -35.54 81.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.979 0.419 . . . . 0.0 111.047 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.3 m -69.9 -39.13 76.42 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.73 -35.86 75.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.39 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.8 tm? -59.39 -45.58 91.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.933 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.422 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -79.75 -21.64 44.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.56 -19.84 3.75 Favored Glycine 0 CA--C 1.5 -0.904 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.2 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 22.0 t -71.81 94.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.471 0.653 . . . . 0.0 109.349 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -79.26 -17.47 54.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.216 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.57 130.91 23.62 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.15 156.15 42.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.185 -178.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 43.4 t -121.46 113.55 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.304 0.574 . . . . 0.0 110.425 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.407 HG12 ' CG2' ' A' ' 12' ' ' VAL . 65.2 mt -95.14 122.01 46.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 80.4 mttt -120.92 120.64 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.95 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.64 167.24 12.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.769 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -139.29 141.94 37.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.21 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 59.93 -106.72 1.06 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -83.31 -21.18 33.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.19 0.519 . . . . 0.0 109.95 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.32 -8.7 56.97 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.14 -39.2 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.606 0.717 . . . . 0.0 110.386 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -64.55 -29.51 70.54 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.664 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -78.34 -37.35 44.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.559 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.306 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -73.14 -35.7 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.766 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.474 ' OD2' HG22 ' A' ' 19' ' ' VAL . 18.1 t70 -58.83 -47.92 83.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.3 m -53.07 -54.14 39.87 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.205 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.35 -29.17 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.35 -36.77 79.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.6 mt -65.44 -50.14 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.962 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.27 -44.57 84.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -75.55 -1.95 26.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -130.42 6.6 4.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.612 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -114.13 -61.9 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -76.41 -50.08 15.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.591 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 96' ' ' LYS . 69.4 tp -159.46 105.91 1.69 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.31 -27.67 15.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.506 1.129 . . . . 0.0 111.869 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.76 -42.49 89.03 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.607 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -122.34 108.38 13.17 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.985 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -161.35 145.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.77 156.13 43.89 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.0 mt -104.35 141.21 20.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -95.93 -38.25 10.33 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.332 -0.23 . . . . 0.0 110.902 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -167.78 146.38 4.69 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.486 0.491 . . . . 0.0 109.835 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.52 97.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 124.356 1.062 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.8 142.08 50.38 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.405 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.76 134.95 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.18 151.28 22.6 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.15 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -79.57 124.72 28.77 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -107.69 135.29 49.36 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.953 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.319 -0.757 0 CA-C-O 121.35 0.595 . . . . 0.0 111.092 176.557 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.87 132.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.219 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -71.41 126.77 30.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.937 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 46.5 p -127.99 154.61 45.42 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.964 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -135.28 135.08 52.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.555 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -112.5 111.1 21.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.642 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.5 mm -108.28 110.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.62 122.01 39.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.17 149.4 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -126.6 127.55 45.41 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.458 ' HZ3' ' HB3' ' A' ' 61' ' ' LEU . 53.8 tptt . . . . . 0 C--N 1.299 -1.599 0 CA-C-O 121.689 0.757 . . . . 0.0 112.866 -174.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 C--O 1.243 0.739 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.9 m -96.66 129.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.118 0.485 . . . . 0.0 111.487 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.97 139.41 47.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.893 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.11 124.47 44.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mm -95.22 112.4 27.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.805 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.33 47.31 0.01 OUTLIER Glycine 0 C--N 1.313 -0.727 0 C-N-CA 119.136 -1.507 . . . . 0.0 114.338 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -151.73 -58.05 0.15 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.874 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -101.52 162.62 19.89 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.56 155.43 58.5 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.518 2.145 . . . . 0.0 112.162 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.82 -31.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.5 1.12 . . . . 0.0 113.992 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -57.52 -34.35 69.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -71.76 -40.78 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.751 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -69.16 -38.48 78.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.638 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.26 -46.85 88.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.338 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.5 -37.03 79.72 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.235 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.68 95.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.75 88.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.562 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.11 -35.71 81.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.7 m -67.39 -41.94 84.17 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.49 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.93 -34.77 75.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 2.0 tm? -59.89 -44.17 94.39 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.42 -25.25 66.66 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.306 0.574 . . . . 0.0 111.779 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -79.13 -14.75 58.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.672 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.83 -16.32 6.5 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.964 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 30' ' ' LEU . 21.5 t -74.68 94.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -83.25 -15.03 51.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.1 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.419 ' OE2' ' HE3' ' B' ' 68' ' ' LYS . 10.0 pt-20 -140.01 130.03 24.88 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.32 155.61 41.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.21 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.77 113.52 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.663 0.744 . . . . 0.0 110.872 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 61.7 mt -94.64 123.08 46.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.037 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 82.5 mttt -121.36 123.11 41.35 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.172 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.78 166.77 14.41 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.316 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -139.68 140.72 36.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.203 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.91 -105.41 0.92 Allowed Glycine 0 N--CA 1.466 0.649 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -84.32 -23.29 30.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.867 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.08 -7.22 47.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.1 mt -57.22 -39.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.727 0.775 . . . . 0.0 109.723 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.2 t -64.03 -32.42 73.96 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.54 -37.66 59.86 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.184 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.92 83.67 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.088 0.471 . . . . 0.0 111.525 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.86 -35.22 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.802 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.422 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.5 t70 -59.93 -45.04 93.9 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.7 m -54.88 -56.85 14.99 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.322 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.89 -29.84 44.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.46 -35.27 77.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.779 0.323 . . . . 0.0 110.158 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 51' ' ' ASP . 80.2 mt -67.16 -50.85 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 88.2 t -55.59 -44.87 78.17 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.92 -2.55 27.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -132.48 9.01 4.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.318 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -113.27 -60.1 1.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.296 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.51 -51.44 9.97 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.08 0.467 . . . . 0.0 111.1 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.487 ' HB3' ' HZ3' ' B' ' 96' ' ' LYS . 67.8 tp -158.25 104.67 1.87 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.76 -22.03 19.6 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.329 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.38 -43.87 80.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -117.96 105.67 12.14 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -161.18 141.02 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.56 156.32 45.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.098 0.475 . . . . 0.0 109.739 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.39 140.42 20.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.419 ' HE3' ' OE2' ' B' ' 36' ' ' GLU . 64.9 tttm -93.83 -40.58 10.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.292 -0.255 . . . . 0.0 110.944 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.74 147.05 4.89 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.438 0.462 . . . . 0.0 109.759 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 pt -145.62 100.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 124.521 1.128 . . . . 0.0 109.698 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.104 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.75 135.86 56.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.0 150.94 22.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.353 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -79.48 124.0 28.07 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -106.98 134.87 49.49 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.933 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.24 0.56 0 CA-C-O 121.247 0.546 . . . . 0.0 110.847 176.526 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 . . . . . 0 N--CA 1.441 -0.922 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.74 132.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 128.76 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 58.0 p -130.13 154.27 47.66 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 14.9 tt -134.84 136.34 52.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.504 0.192 . . . . 0.0 110.524 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -115.21 112.32 22.31 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.91 110.61 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.85 120.77 37.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -121.94 149.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -127.43 126.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.487 ' HZ3' ' HB3' ' B' ' 61' ' ' LEU . 53.7 tptt -77.51 151.43 34.58 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.935 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.435 -1.177 0 C-N-CA 125.234 1.414 . . . . 0.0 107.778 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--O 1.223 -0.312 0 CA-C-O 121.668 0.747 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.0 m -120.08 133.45 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.052 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.53 144.45 30.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.255 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -105.83 121.63 44.45 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.09 103.35 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.19 51.11 0.03 OUTLIER Glycine 0 C--O 1.24 0.49 0 C-N-CA 119.515 -1.326 . . . . 0.0 114.086 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -166.33 -55.32 0.03 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.125 0.462 . . . . 0.0 110.831 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.86 154.71 37.1 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.22 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HD2' ' ND2' ' A' ' 21' ' ' ASN . 38.6 Cg_exo -62.7 160.23 33.64 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.327 2.018 . . . . 0.0 111.638 174.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -49.93 -34.17 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.53 1.132 . . . . 0.0 113.267 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.454 ' O ' HD11 ' A' ' 24' ' ' LEU . 26.8 ptm -60.1 -27.35 66.95 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.609 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.473 ' ND2' ' HD2' ' A' ' 18' ' ' PRO . 43.9 m-80 -80.83 -25.81 37.5 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.118 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -83.88 -37.62 22.17 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.553 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' O ' HD11 ' A' ' 27' ' ' LEU . 73.2 t -59.29 -55.59 22.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.045 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 20' ' ' MET . 8.3 mp -62.31 -31.32 71.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.081 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.24 -42.84 99.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 123.117 0.26 . . . . 0.0 111.241 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -64.92 -40.37 94.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.782 0.325 . . . . 0.0 110.403 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.405 HD11 ' O ' ' A' ' 23' ' ' VAL . 8.6 mp -63.13 -39.34 94.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.449 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.6 m -66.0 -34.42 78.05 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.5 mt -70.87 -36.42 72.78 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.664 0.269 . . . . 0.0 111.325 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.5 mt -59.61 -42.6 93.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.05 0.453 . . . . 0.0 110.067 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -65.75 -25.17 67.15 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -89.24 -2.42 58.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.746 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.1 12.2 40.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.171 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.6 t -99.34 115.23 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -101.31 -30.64 11.38 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.93 105.79 14.32 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.036 0.922 . . . . 0.0 112.784 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.415 ' H ' HD11 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -117.38 154.53 19.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.512 -177.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.69 120.63 62.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.103 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -96.78 120.52 46.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.275 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HG2' ' HG2' ' A' ' 91' ' ' GLU . 48.1 mttp -108.26 121.29 44.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.72 138.12 53.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -137.1 120.13 16.55 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 45' ' ' ALA . . . 87.53 76.44 1.27 Allowed Glycine 0 C--O 1.219 -0.804 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.92 176.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 68.0 -15.66 0.2 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 43' ' ' GLY . . . -74.3 6.05 3.97 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.813 0.445 . . . . 0.0 111.869 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.73 -37.91 55.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.448 1.099 . . . . 0.0 109.406 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.1 p -67.56 -24.87 65.57 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.137 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -86.96 -29.96 21.65 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.534 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.24 -42.61 96.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.7 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.63 -40.75 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.214 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 55' ' ' ILE . 17.2 t70 -57.65 -44.18 85.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.445 0.641 . . . . 0.0 109.281 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 56' ' ' VAL . 91.0 m -57.94 -51.08 71.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.678 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 33.8 m -69.85 -32.36 51.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.122 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.35 -36.48 83.84 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.8 mt -67.64 -46.77 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.141 0.496 . . . . 0.0 110.385 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 52' ' ' THR . 67.2 t -59.71 -38.27 75.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.166 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 53' ' ' VAL . 15.9 ptm180 -91.87 17.68 8.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.609 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -133.07 -41.73 0.9 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -86.91 -60.45 1.98 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.629 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.56 -58.28 3.42 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.045 0.45 . . . . 0.0 111.588 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.5 tp -148.0 102.49 3.39 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.3 -26.88 17.11 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.871 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.03 -50.28 66.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.15 0.5 . . . . 0.0 111.775 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -103.81 105.8 16.12 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.106 0.479 . . . . 0.0 110.882 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 tp -159.79 127.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.431 0.692 . . . . 0.0 110.652 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.81 149.57 51.4 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 173.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.77 134.67 46.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -90.95 -60.37 1.93 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.118 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -155.55 147.91 23.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.41 111.02 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -113.73 135.28 54.11 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.546 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -136.65 133.59 48.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.3 179.31 48.14 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.596 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 m -80.71 124.07 28.72 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.636 0.774 . . . . 0.0 110.971 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 25.7 tt0 -88.99 117.54 28.08 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.055 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 89.7 mtt180 . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -124.44 135.1 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.312 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 m -62.94 120.57 11.62 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 123.697 0.799 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 p -127.19 152.02 47.92 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 122.641 0.377 . . . . 0.0 110.364 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.9 tt -143.71 142.2 24.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.163 0 CA-C-O 120.782 0.325 . . . . 0.0 110.607 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' A' ' 40' ' ' LYS . 44.3 mt-10 -123.5 121.14 34.92 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.778 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -113.06 111.61 36.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.84 117.15 31.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.51 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 pt -119.16 168.17 11.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.935 0.398 . . . . 0.0 110.659 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -125.23 118.62 26.43 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.742 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt . . . . . 0 C--N 1.307 -1.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.136 179.309 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 . . . . . 0 C--O 1.238 0.453 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 20.9 m -115.68 131.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.174 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.78 145.78 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 60.5 tp -108.62 118.79 37.7 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.001 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -83.89 113.43 22.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.75 45.16 0.02 OUTLIER Glycine 0 C--O 1.237 0.305 0 C-N-CA 119.48 -1.343 . . . . 0.0 114.057 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -163.34 -59.69 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.241 0.52 . . . . 0.0 110.291 177.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.17 155.52 38.83 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.21 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.456 ' HD2' ' ND2' ' B' ' 21' ' ' ASN . 35.5 Cg_exo -63.26 158.99 41.61 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.569 2.179 . . . . 0.0 111.385 174.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.464 HG23 ' OD2' ' B' ' 51' ' ' ASP . 7.6 p -48.75 -35.1 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.599 1.16 . . . . 0.0 113.113 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.423 ' O ' HD11 ' B' ' 24' ' ' LEU . 26.3 ptm -57.66 -29.77 64.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.969 0.414 . . . . 0.0 111.743 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.456 ' ND2' ' HD2' ' B' ' 18' ' ' PRO . 40.7 m-80 -77.27 -30.58 54.38 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.63 -38.22 40.25 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.42 ' O ' HD11 ' B' ' 27' ' ' LEU . 66.7 t -60.35 -55.83 21.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.423 HD11 ' O ' ' B' ' 20' ' ' MET . 8.3 mp -63.79 -25.27 68.1 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.43 -44.9 85.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.666 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -63.54 -42.91 98.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.967 0.413 . . . . 0.0 110.65 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.42 HD11 ' O ' ' B' ' 23' ' ' VAL . 8.8 mp -61.23 -35.72 77.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.486 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 61.9 m -69.89 -35.74 74.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.294 0.569 . . . . 0.0 109.794 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -68.9 -35.3 76.68 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 122.159 -0.338 . . . . 0.0 111.368 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 91.1 mt -59.5 -41.12 89.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.084 0.469 . . . . 0.0 110.585 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -67.25 -25.04 65.89 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.077 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -87.94 -0.92 57.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.967 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.34 0.02 53.83 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.739 -0.744 . . . . 0.0 114.424 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.48 113.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -100.93 -27.74 13.14 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.901 0.381 . . . . 0.0 111.436 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.06 110.44 20.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.826 0.822 . . . . 0.0 112.198 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 152.75 28.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.963 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.62 119.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 CA-C-O 121.156 0.503 . . . . 0.0 110.29 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -96.3 120.98 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.24 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -107.79 120.99 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.156 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.3 137.14 53.88 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -135.79 117.81 15.34 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.82 76.47 1.31 Allowed Glycine 0 C--O 1.217 -0.931 0 N-CA-C 114.742 0.657 . . . . 0.0 114.742 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 67.18 -15.04 0.17 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.89 6.87 4.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.0 0.429 . . . . 0.0 111.607 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 67.8 mt -55.99 -39.42 57.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 124.57 1.148 . . . . 0.0 109.778 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.0 p -64.66 -29.0 69.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.8 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.21 -28.59 27.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.571 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.52 92.66 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.288 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.63 -40.97 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.171 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.464 ' OD2' HG23 ' B' ' 19' ' ' VAL . 15.6 t70 -54.68 -48.12 72.77 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.613 0.721 . . . . 0.0 109.518 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.46 ' O ' HG22 ' B' ' 56' ' ' VAL . 64.3 m -54.52 -52.0 63.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.941 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.404 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 33.2 m -69.26 -33.47 58.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.313 -176.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.48 -35.91 82.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.098 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.405 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.7 mt -67.66 -47.38 80.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 120.946 0.403 . . . . 0.0 110.259 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.46 HG22 ' O ' ' B' ' 52' ' ' THR . 81.0 t -59.36 -38.49 75.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.936 -177.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' B' ' 53' ' ' VAL . 15.4 ptm180 -90.88 18.46 6.58 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.286 -0.259 . . . . 0.0 111.529 -177.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.73 -48.74 0.88 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.235 0.54 . . . . 0.0 110.603 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -81.23 -52.2 7.59 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -80.81 -60.32 2.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.191 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -146.13 104.12 3.79 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.81 -24.73 16.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.925 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.71 -46.89 64.95 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.36 0.6 . . . . 0.0 111.361 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -104.13 105.83 16.13 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.987 0.423 . . . . 0.0 110.693 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -160.82 131.31 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.387 0.675 . . . . 0.0 109.905 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.81 147.46 42.56 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.5 mt -104.65 133.62 48.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -89.5 -60.43 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.092 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.04 149.28 27.01 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -138.2 109.61 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -112.01 134.85 53.31 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.515 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.29 130.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.59 177.89 46.57 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.063 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.5 m -79.46 125.27 29.34 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.087 0.955 . . . . 0.0 111.254 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 27.5 tt0 -90.1 116.5 28.16 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.426 HG21 ' HG2' ' B' ' 86' ' ' ARG . 40.5 t . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 96.6 mtt180 . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.98 133.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.66 120.25 10.83 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 123.651 0.78 . . . . 0.0 110.609 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.0 p -125.92 151.18 47.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.6 tt -141.74 143.58 26.92 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 120.626 0.251 . . . . 0.0 110.813 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.36 121.75 35.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.886 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.06 113.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.53 115.42 27.95 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 pt -118.83 161.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.728 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -120.23 118.53 30.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -102.97 78.85 1.7 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' B' ' 97' ' ' LYS . 8.9 ptmm? . . . . . 0 C--O 1.279 2.61 0 C-N-CA 124.395 1.078 . . . . 0.0 109.775 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 t -142.3 160.64 39.85 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.5 t -105.71 13.62 29.49 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.47 123.22 7.65 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.347 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -90.91 141.08 26.35 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.83 156.46 48.47 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.527 2.151 . . . . 0.0 111.627 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -133.8 140.85 37.83 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.4 125.41 6.3 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.439 2.093 . . . . 0.0 113.282 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.5 t -133.18 102.1 5.45 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -133.0 1.23 3.54 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.23 138.36 52.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.959 0.409 . . . . 0.0 110.824 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.51 151.03 33.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.0 tp -116.63 131.77 56.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.2 mm -84.41 121.98 37.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.18 -115.74 3.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.453 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.64 12.25 16.0 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.55 147.0 58.37 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.365 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.11 147.93 80.53 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.396 2.064 . . . . 0.0 110.781 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -58.64 -28.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 112.072 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.453 ' O ' HD13 ' A' ' 24' ' ' LEU . 27.1 ptt? -64.03 -24.0 67.55 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.19 0.519 . . . . 0.0 111.331 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.81 -30.49 51.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.021 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -82.82 -37.57 24.28 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.077 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.4 t -58.25 -51.06 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.021 0.439 . . . . 0.0 110.687 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 20' ' ' MET . 9.2 mp -67.37 -30.05 69.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.124 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.65 -44.96 80.53 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.826 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.28 -35.28 80.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.187 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.4 -36.8 79.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -67.74 -35.68 79.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.514 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.4 mt -63.97 -36.45 84.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.21 -46.87 85.01 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.7 -4.01 44.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.573 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.95 -22.94 17.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.7 -8.3 4.91 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.979 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.97 107.28 20.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.156 0.503 . . . . 0.0 110.624 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.6 p -85.6 -25.65 26.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -118.84 113.97 21.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.55 146.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 123.274 0.358 . . . . 0.0 110.701 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.44 118.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.2 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.8 mt -93.66 122.32 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.45 129.28 56.65 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.089 0.471 . . . . 0.0 109.785 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.12 169.59 17.37 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.496 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.401 ' HB3' HG22 ' A' ' 89' ' ' THR 0.309 0.0 OUTLIER -158.64 149.92 20.69 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.498 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.35 -120.02 8.98 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.223 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 ptm180 -87.0 -3.33 59.08 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.235 0.54 . . . . 0.0 110.96 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.63 -6.9 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.303 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.86 -36.13 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.991 0.516 . . . . 0.0 110.382 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -62.27 -35.88 80.34 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.179 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -75.08 -32.84 61.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.173 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.54 96.3 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 110.724 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.52 -39.87 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.51 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.418 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.2 t70 -57.9 -39.02 76.89 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.242 0.617 . . . . 0.0 110.006 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -66.68 -55.53 14.75 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.46 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.9 -31.15 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.635 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 31.0 tt0 -64.94 -44.48 89.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.3 mt -61.3 -49.01 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.95 0.405 . . . . 0.0 110.065 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.22 -36.59 58.34 Favored 'Isoleucine or valine' 0 C--O 1.259 1.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -87.4 -7.43 57.72 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.81 24.74 7.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.284 0.564 . . . . 0.0 111.583 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -137.1 -65.89 0.53 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -86.6 -51.25 6.27 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.687 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mp -132.16 112.84 12.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.19 -57.81 2.01 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.177 0.923 . . . . 0.0 112.096 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.14 -36.02 66.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.212 0.53 . . . . 0.0 111.631 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.04 -15.95 45.66 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -80.22 148.31 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.077 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -139.06 145.04 39.09 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -90.93 145.81 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -105.25 -52.59 2.81 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.114 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -169.39 152.2 4.78 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt -138.47 119.96 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.554 0.742 . . . . 0.0 110.32 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -133.5 133.99 42.91 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.715 -0.615 . . . . 0.0 110.874 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.24 136.79 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.42 162.85 29.87 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.611 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 12.0 p -82.13 125.54 30.99 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.577 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -104.62 146.3 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.767 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.3 t -94.57 106.02 17.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.23 161.54 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.31 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.0 p -97.15 139.17 33.53 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 121.233 0.54 . . . . 0.0 112.016 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -77.51 178.45 7.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.555 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -56.01 -34.55 65.93 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.41 -44.37 21.55 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.4 48.74 0.17 Allowed Glycine 0 C--N 1.296 -1.655 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -112.49 135.52 53.1 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -74.93 110.01 8.87 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.703 0.627 . . . . 0.0 111.077 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -117.11 129.28 55.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -89.79 132.08 35.42 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.61 134.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -66.18 108.21 2.2 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.822 0.701 . . . . 0.0 111.362 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.401 HG22 ' HB3' ' A' ' 42' ' ' ARG . 35.1 p -105.83 150.15 25.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.092 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.53 131.34 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.08 115.99 27.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.9 mt -110.71 114.0 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.47 122.33 47.46 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 120.675 0.274 . . . . 0.0 110.577 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.9 pt -120.99 157.08 24.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.969 0.414 . . . . 0.0 110.421 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -119.56 118.54 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.336 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -98.6 131.48 44.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 C--N 1.303 -1.418 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 175.304 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 C--O 1.223 -0.31 0 CA-C-O 120.379 0.133 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p -135.27 13.75 3.53 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.229 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 34.8 t -78.84 -73.14 0.35 Allowed 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.417 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.32 92.32 1.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.128 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 37.2 p -105.62 132.7 20.66 Favored Pre-proline 0 N--CA 1.432 -1.329 0 O-C-N 122.691 -0.299 . . . . 0.0 111.26 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -71.57 -21.81 25.24 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.168 1.912 . . . . 0.0 109.916 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 56.5 m -84.51 124.68 73.13 Favored Pre-proline 0 N--CA 1.426 -1.649 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.912 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.03 140.33 89.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.355 2.703 . . . . 0.0 111.985 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -98.88 -44.09 6.49 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -107.12 -0.41 22.85 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.4 132.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.224 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.43 152.58 25.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.891 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -117.91 126.39 52.27 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -80.91 119.02 29.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.463 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.72 -116.75 3.72 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.018 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -114.63 15.47 17.67 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.769 0.319 . . . . 0.0 111.078 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -84.07 146.4 48.47 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.683 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.52 143.03 79.92 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.8 2.334 . . . . 0.0 110.858 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.6 -30.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.436 ' O ' HD13 ' B' ' 24' ' ' LEU . 27.0 ptt? -60.95 -28.48 69.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 111.135 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.61 -35.6 67.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.016 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -78.81 -37.37 40.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.19 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.37 -51.93 65.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.694 0.283 . . . . 0.0 110.649 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.436 HD13 ' O ' ' B' ' 20' ' ' MET . 8.1 mp -67.49 -28.63 68.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.908 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -66.23 -46.02 78.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.01 86.24 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 121.35 0.595 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 92.6 mt -65.48 -39.46 91.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.358 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.4 m -65.7 -37.05 85.36 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.394 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.5 mt -62.91 -37.17 85.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.709 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.86 -45.93 91.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -80.4 -2.3 45.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.825 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -93.48 -27.8 16.47 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.9 2.74 3.4 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.62 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.17 111.44 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 117.881 0.84 . . . . 0.0 110.087 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 p -87.79 -32.43 19.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.478 ' CD ' ' HZ2' ' B' ' 68' ' ' LYS . 47.2 mt-10 -112.39 117.95 33.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.19 147.61 29.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.452 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.62 119.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.425 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 55.2 mt -95.05 123.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -115.73 130.49 56.87 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 121.481 0.658 . . . . 0.0 110.11 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.31 169.12 18.35 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.493 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.433 ' HB3' HG22 ' B' ' 89' ' ' THR 0.288 0.0 OUTLIER -158.45 149.79 20.92 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.685 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.92 -117.48 7.51 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.404 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -88.96 -4.6 58.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.032 0.444 . . . . 0.0 110.757 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.79 -9.05 59.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.03 -36.23 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.567 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 33.5 t -62.36 -35.53 79.41 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.248 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -76.3 -34.51 59.06 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.684 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.69 88.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.12 0.486 . . . . 0.0 111.039 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -73.23 -40.38 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.828 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.415 ' O ' HG13 ' B' ' 55' ' ' ILE . 32.4 t70 -58.55 -41.53 85.8 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.064 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 73.0 m -63.44 -54.96 28.31 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.001 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.44 -30.36 49.54 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' A' ' 74' ' ' SER . 27.7 tt0 -66.3 -43.49 86.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 51' ' ' ASP . 76.2 mt -61.71 -47.79 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.184 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.1 -34.36 56.48 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -89.16 -6.49 56.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -123.61 18.56 9.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.961 0.41 . . . . 0.0 111.697 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -131.97 -68.01 0.65 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.426 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -85.56 -49.05 8.35 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.733 -171.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 mp -133.54 112.0 11.14 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.495 ' O ' HG23 ' B' ' 65' ' ' ILE . . . -100.21 -63.36 1.14 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 124.013 0.821 . . . . 0.0 111.472 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.49 -37.03 86.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.112 0.565 . . . . 0.0 112.503 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.06 -15.36 41.55 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.495 HG23 ' O ' ' B' ' 62' ' ' ALA . 16.2 tt -80.41 148.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.608 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.531 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 40.4 tt0 -138.75 147.3 42.49 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -93.71 143.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.478 ' HZ2' ' CD ' ' B' ' 36' ' ' GLU . 86.3 tttt -102.57 -52.46 3.09 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.294 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -169.87 150.97 4.01 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.98 118.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 123.575 0.547 . . . . 0.0 110.746 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.04 134.88 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.685 -0.634 . . . . 0.0 110.752 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.99 137.37 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.8 163.42 31.16 Favored Glycine 0 C--N 1.315 -0.619 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.635 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 17.5 p -83.38 124.27 30.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.361 0.601 . . . . 0.0 112.226 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . 0.57 ' HA ' HE21 ' B' ' 75' ' ' GLN . 0.0 OUTLIER -103.05 145.93 29.15 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.56 107.84 19.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -117.91 163.91 14.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 22.5 p -99.55 139.33 35.36 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.564 0.697 . . . . 0.0 112.099 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 20.4 m -74.85 178.34 5.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.485 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -60.16 -31.71 70.36 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.73 -52.49 8.32 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.182 0.991 . . . . 0.0 108.64 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.88 48.56 0.07 OUTLIER Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -114.39 133.08 55.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -72.43 115.45 11.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 123.621 0.575 . . . . 0.0 110.979 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 24.3 t -122.89 130.5 52.94 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -90.24 132.19 35.65 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.17 134.95 50.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.2 p -66.29 108.66 2.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.472 0.653 . . . . 0.0 111.84 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.433 HG22 ' HB3' ' B' ' 42' ' ' ARG . 33.8 p -106.49 148.98 27.55 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.568 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.05 130.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.813 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -113.64 113.74 25.46 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.93 116.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.4 121.24 44.3 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.606 0.241 . . . . 0.0 110.59 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 pt -119.54 154.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.531 ' HD3' ' OE1' ' B' ' 66' ' ' GLU . 60.3 ttt180 -117.47 121.3 40.65 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -102.35 132.77 48.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.891 176.877 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.5 m -109.21 -35.66 6.24 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 m -101.54 136.69 40.97 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.31 56.7 4.96 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.0 m 66.36 96.88 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 124.301 1.04 . . . . 0.0 112.448 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -73.71 137.21 24.51 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.846 2.364 . . . . 0.0 112.453 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -99.55 135.93 20.48 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.49 116.66 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.117 1.878 . . . . 0.0 112.393 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 m -108.19 7.84 27.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.776 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -92.85 13.1 21.41 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.286 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.16 133.91 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.315 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.88 145.29 32.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.335 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 tp -107.18 124.32 49.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.36 117.23 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 118.685 -1.722 . . . . 0.0 115.171 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -155.07 -41.08 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.976 0.888 . . . . 0.0 110.695 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -101.43 158.06 32.49 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.967 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.3 157.11 55.98 Favored 'Trans proline' 0 C--O 1.248 0.995 0 C-N-CA 121.845 1.696 . . . . 0.0 110.129 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.505 HG21 ' OD1' ' A' ' 51' ' ' ASP . 14.7 p -56.9 -26.91 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.456 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.6 ptp -62.91 -28.57 70.14 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.77 -35.73 32.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.251 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.34 -34.63 72.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.278 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 19' ' ' VAL . 96.4 t -60.57 -48.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.653 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 20' ' ' MET . 88.4 mt -66.29 -31.56 72.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.468 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.493 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.99 -50.76 61.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.43 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.33 -38.89 92.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.65 -45.06 73.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.146 0.978 . . . . 0.0 109.604 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 m -71.57 -41.4 69.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.072 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.1 mt -60.66 -37.67 82.35 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.489 0.316 . . . . 0.0 111.786 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 93.6 mt -61.76 -36.74 81.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.746 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -95.37 0.77 53.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.99 0.424 . . . . 0.0 111.333 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -90.72 -31.35 16.6 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.86 -19.95 2.9 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.673 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -80.03 99.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 m -78.16 -37.34 46.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.388 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.505 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 9.9 pt-20 -120.26 118.66 31.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.8 pt -119.5 160.31 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.71 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.39 112.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.199 0.524 . . . . 0.0 110.745 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.54 126.63 44.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -114.29 112.82 23.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.51 133.87 54.34 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.557 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 89' ' ' THR . 87.4 mtt180 -129.76 143.61 50.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 45' ' ' ALA . . . 63.21 81.35 0.1 OUTLIER Glycine 0 C--O 1.211 -1.333 0 O-C-N 123.784 0.677 . . . . 0.0 114.49 175.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 58.66 -7.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 126.192 1.797 . . . . 0.0 115.083 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 43' ' ' GLY . . . -74.58 -3.12 29.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.7 mt -51.7 -39.33 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.188 1.395 . . . . 0.0 110.663 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -68.27 -24.46 64.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.562 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.86 -27.72 26.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.059 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.58 -44.61 81.79 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.812 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.01 -35.23 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.054 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.505 ' OD1' HG21 ' A' ' 19' ' ' VAL . 15.0 t70 -59.52 -47.87 83.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -54.75 -56.47 18.94 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.338 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 m -67.13 -30.76 50.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.29 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.549 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 27.1 tt0 -65.99 -38.69 89.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.42 0.45 . . . . 0.0 111.014 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.7 mt -66.26 -49.68 74.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.466 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.05 -50.47 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 35.0 ptt180 -68.56 -7.78 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -115.33 -12.07 11.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.716 0.769 . . . . 0.0 110.369 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -105.77 -53.5 2.63 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -82.22 -60.39 2.23 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.201 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.418 HD13 ' H ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -146.85 105.62 3.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -176.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 6.21 46.12 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.05 -65.0 1.01 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.484 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' H ' HD13 ' A' ' 61' ' ' LEU . 45.9 mttm -98.94 94.24 6.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tp -148.91 141.13 17.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 45.0 tt0 -132.58 152.99 51.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.6 132.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -75.03 -53.75 8.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -173.71 156.84 2.98 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -129.96 115.69 34.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -139.46 147.55 41.51 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.414 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.23 146.76 20.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.29 -171.01 36.07 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.181 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.496 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 36.8 p -108.46 123.83 49.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -99.85 117.57 34.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.65 115.39 42.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.12 163.86 36.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.255 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.8 p -97.66 143.66 28.1 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 t -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 175.9 -38.96 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 124.272 1.029 . . . . 0.0 108.324 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -123.47 -156.51 0.71 Allowed 'General case' 0 C--O 1.251 1.144 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.8 75.02 1.1 Allowed Glycine 0 C--N 1.31 -0.901 0 CA-C-O 121.557 0.532 . . . . 0.0 113.767 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -147.38 104.01 3.61 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.2 120.15 24.99 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.341 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.3 m -103.15 123.81 47.4 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.23 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -104.86 117.31 33.72 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.3 t -127.77 125.94 65.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.162 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 p -67.03 121.57 15.85 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.467 HG22 ' HG2' ' A' ' 42' ' ' ARG . 64.6 p -117.47 153.91 32.32 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.6 tt -142.78 129.79 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -107.08 105.83 16.04 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.3 mm -102.26 110.77 29.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.31 128.91 54.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.612 0.244 . . . . 0.0 110.382 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.1 155.07 40.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' HD3' ' OE1' ' A' ' 36' ' ' GLU . 53.1 ttp180 -133.04 126.2 31.34 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.504 0.669 . . . . 0.0 111.592 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.575 ' HZ2' ' C ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -88.8 124.3 34.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.575 ' C ' ' HZ2' ' A' ' 96' ' ' LYS . 68.0 mttm . . . . . 0 C--N 1.317 -0.827 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.62 0.248 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -115.92 -168.8 1.48 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 32.9 t -143.88 146.19 32.84 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.08 147.37 4.53 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 8.1 t -159.18 141.71 10.21 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.75 168.07 25.69 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.072 1.848 . . . . 0.0 109.911 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 39.6 m -101.78 109.74 60.29 Favored Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.664 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.57 166.99 10.31 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.284 1.99 . . . . 0.0 111.295 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -114.61 -78.49 0.58 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.383 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -106.03 14.94 27.17 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 20.9 m -120.37 138.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.428 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.36 145.48 35.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.032 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.17 126.45 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 46.4 mm -90.47 115.89 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.84 44.84 0.02 OUTLIER Glycine 0 CA--C 1.523 0.564 0 C-N-CA 118.849 -1.643 . . . . 0.0 114.855 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.89 -43.08 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 117.655 0.728 . . . . 0.0 110.875 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.431 ' HE2' ' HD2' ' B' ' 18' ' ' PRO . 13.5 mmmm -101.32 156.87 34.65 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.449 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.431 ' HD2' ' HE2' ' B' ' 17' ' ' LYS . 29.1 Cg_endo -64.64 157.77 53.78 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.293 1.996 . . . . 0.0 110.727 172.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.434 ' O ' HG21 ' B' ' 23' ' ' VAL . 13.9 p -56.12 -27.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.421 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.1 ptp -63.05 -29.24 70.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.065 0.459 . . . . 0.0 111.007 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.32 -37.88 36.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.201 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.62 -36.32 78.49 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.531 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.434 HG21 ' O ' ' B' ' 19' ' ' VAL . 66.2 t -61.2 -47.46 93.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 20' ' ' MET . 89.9 mt -67.66 -30.43 69.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.161 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.3 -51.38 53.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.487 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.85 -37.99 89.03 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.353 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 27.7 tp -55.02 -45.61 75.18 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.213 1.005 . . . . 0.0 109.194 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 48.7 m -70.47 -40.72 73.48 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.883 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.5 mt -61.32 -38.1 85.64 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.477 0.311 . . . . 0.0 111.499 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 98.3 mt -61.76 -38.48 88.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.101 0.56 . . . . 0.0 111.882 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.89 -5.37 51.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.424 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -84.13 -31.83 25.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.212 0.53 . . . . 0.0 109.788 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.06 -15.01 3.05 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.063 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.15 97.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -73.95 -39.14 63.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.32 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.535 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 10.2 pt-20 -121.14 118.56 30.0 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.41 0.624 . . . . 0.0 111.576 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.6 162.49 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.859 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 57.4 t -129.18 115.66 36.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.23 0.538 . . . . 0.0 110.369 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.8 mt -94.24 122.4 45.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.01 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -110.43 111.75 23.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.145 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.58 132.52 55.09 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.487 ' HG2' HG22 ' B' ' 89' ' ' THR . 87.8 mtt180 -129.06 144.06 51.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.44 80.98 0.12 Allowed Glycine 0 C--O 1.214 -1.11 0 O-C-N 123.879 0.737 . . . . 0.0 114.338 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 56.35 -3.81 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.998 1.719 . . . . 0.0 115.138 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.16 -3.07 34.24 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.271 0.557 . . . . 0.0 110.851 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 69.2 mt -51.67 -40.46 26.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.857 1.263 . . . . 0.0 110.365 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.6 t -66.12 -28.66 68.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.651 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.98 -28.39 29.76 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.508 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.8 86.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 120.945 0.402 . . . . 0.0 110.748 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.72 -36.69 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.545 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.482 ' O ' HG13 ' B' ' 55' ' ' ILE . 15.0 t70 -58.86 -46.85 86.79 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -54.45 -57.8 9.93 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.672 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.34 -29.3 45.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.871 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.507 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 24.0 tt0 -67.68 -36.93 81.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.968 0.413 . . . . 0.0 111.089 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.482 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.0 mt -66.56 -50.17 68.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.241 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.04 -50.45 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 34.5 ptt180 -67.83 -8.21 34.27 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -116.63 -12.51 10.91 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.759 0.79 . . . . 0.0 110.46 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -104.8 -53.51 2.67 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -82.64 -59.93 2.35 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.943 -172.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.471 HD13 ' H ' ' B' ' 64' ' ' LYS . 0.3 OUTLIER -146.72 106.31 3.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.39 6.32 44.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -94.81 -57.8 2.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.402 0.62 . . . . 0.0 110.924 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.471 ' H ' HD13 ' B' ' 61' ' ' LEU . 48.8 mttm -107.74 95.42 5.67 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.127 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tp -149.22 139.29 16.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.424 ' HB2' ' HE2' ' B' ' 97' ' ' LYS . 45.2 tt0 -130.33 148.39 52.15 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.91 123.94 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -67.45 -59.76 3.12 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.646 0.591 . . . . 0.0 109.847 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.38 154.69 8.72 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.1 mt -129.7 114.14 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 123.617 0.573 . . . . 0.0 109.66 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -138.07 146.68 43.24 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.308 -0.245 . . . . 0.0 111.177 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.6 144.69 23.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.82 -171.42 36.11 Favored Glycine 0 CA--C 1.5 -0.874 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.807 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.509 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 26.3 p -107.35 124.77 50.3 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 122.563 0.345 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -100.71 117.08 34.09 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.0 110.5 28.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.8 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.28 160.73 35.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 120.711 0.291 . . . . 0.0 110.409 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 13.1 p -92.62 145.64 24.28 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.004 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 41.2 t -69.69 -42.31 74.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 174.04 -38.38 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' B' ' 82' ' ' GLY . 14.5 t70 -122.44 -158.84 0.8 Allowed 'General case' 0 C--O 1.253 1.267 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.414 ' H ' ' CG ' ' B' ' 81' ' ' ASP . . . -75.04 76.99 1.18 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-O 121.331 0.406 . . . . 0.0 112.724 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -149.66 105.66 3.46 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.05 122.16 28.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.688 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.2 m -104.48 125.92 51.1 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.686 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -107.52 114.78 29.01 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.37 126.07 68.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.084 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 73.8 p -67.32 122.99 19.1 Favored 'General case' 0 C--O 1.266 1.956 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.487 HG22 ' HG2' ' B' ' 42' ' ' ARG . 60.7 p -119.4 153.49 35.13 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 18.3 tt -142.46 131.28 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -109.02 105.5 15.04 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.588 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mm -102.6 110.72 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.87 129.85 55.89 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.874 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.597 0.236 . . . . 0.0 110.66 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.535 ' HD3' ' OE2' ' B' ' 36' ' ' GLU . 51.2 ttp180 -126.62 125.3 41.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.978 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.591 ' HZ2' ' C ' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -89.34 120.67 30.89 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.591 ' C ' ' HZ2' ' B' ' 96' ' ' LYS . 67.3 mttm . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m -92.44 98.05 11.23 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.709 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.3 t -102.59 136.3 42.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.882 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.15 -27.36 18.77 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.913 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.7 p -95.51 153.22 39.56 Favored Pre-proline 0 N--CA 1.428 -1.526 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.311 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -73.61 -57.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p 51.51 76.41 0.55 Allowed Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.206 1.002 . . . . 0.0 113.277 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.71 -75.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.392 2.061 . . . . 0.0 113.51 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.2 p -150.14 14.9 0.81 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 120.927 0.394 . . . . 0.0 111.486 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -95.09 3.37 54.86 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.761 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.36 112.49 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -110.55 134.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.264 0.555 . . . . 0.0 110.74 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.59 129.5 43.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.8 mm -91.28 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.99 50.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.103 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -157.6 -65.05 0.09 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 117.22 0.51 . . . . 0.0 110.682 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -101.82 168.45 9.02 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.36 167.13 19.35 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.058 1.839 . . . . 0.0 112.253 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.468 HG12 ' OD2' ' A' ' 51' ' ' ASP . 93.1 t -50.32 -38.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.373 1.069 . . . . 0.0 112.602 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.3 ptp -52.02 -31.45 29.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.03 -32.87 63.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 121.507 0.67 . . . . 0.0 110.404 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -80.52 -34.64 35.47 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.285 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.01 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.291 0.567 . . . . 0.0 109.693 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.56 -35.95 81.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.032 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.47 96.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.288 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -9.19 57.69 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.11 0.481 . . . . 0.0 111.76 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.97 -43.99 7.56 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -60.3 -40.33 90.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.55 -36.07 81.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.396 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.436 HD22 ' HG3' ' A' ' 96' ' ' LYS . 3.4 tm? -64.86 -39.23 93.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -67.29 -17.82 64.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.17 0.51 . . . . 0.0 111.188 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -91.96 -4.56 54.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.4 -7.56 32.34 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.098 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.44 99.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -89.45 -29.64 18.87 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.095 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.32 115.99 30.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.782 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.81 156.14 39.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.555 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.0 t -124.95 124.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.807 0.692 . . . . 0.0 110.549 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.7 mt -105.65 130.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.419 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.39 122.99 41.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.189 0.519 . . . . 0.0 110.897 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.73 155.05 33.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -133.01 141.07 48.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.449 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.47 -118.58 7.91 Favored Glycine 0 CA--C 1.505 -0.574 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.304 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -94.65 8.08 43.58 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.84 -0.38 57.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.888 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.25 -38.3 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 p -62.72 -32.01 73.04 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.305 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -70.19 -37.27 75.06 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.1 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.93 91.22 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.546 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.89 -33.95 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.551 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.535 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 t70 -62.63 -45.24 93.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.7 m -57.0 -53.35 59.04 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.552 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.9 m -66.05 -36.05 76.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.27 -45.18 94.19 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 123.132 0.27 . . . . 0.0 111.563 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.4 mt -60.59 -43.03 93.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.49 -43.95 98.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.503 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -83.45 13.64 4.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.273 0.558 . . . . 0.0 111.41 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -119.99 -45.68 2.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.845 0.355 . . . . 0.0 110.277 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.4 ptp180 -81.8 -21.65 37.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 60.9 t80 -117.56 -70.12 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.391 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.537 ' HG ' ' CD2' ' A' ' 60' ' ' PHE . 90.0 mt -132.61 114.82 14.67 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.08 -33.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.245 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.33 -52.61 9.6 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.451 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -97.21 88.46 4.47 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.607 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -160.73 120.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.899 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.526 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 10.2 pt-20 -121.7 134.95 54.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 111.056 177.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.8 mt -88.81 139.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HZ3' ' NH2' ' A' ' 95' ' ' ARG . 31.1 mmmt -84.62 -54.92 4.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.074 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -170.69 152.62 3.83 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.1 mt -134.08 116.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 77.1 mtp180 -116.83 137.47 52.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.866 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.91 124.44 50.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 -168.37 24.71 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.537 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.6 p -118.04 124.34 47.87 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.128 0.489 . . . . 0.0 110.783 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -100.01 128.19 46.13 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.96 115.58 28.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.68 160.59 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.426 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.6 p -91.72 126.92 36.98 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 120.794 0.33 . . . . 0.0 110.35 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -79.94 -20.43 45.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.403 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -163.38 -82.37 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.19 -80.03 0.58 Allowed 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.35 31.35 6.24 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.12 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -106.56 106.57 17.16 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.02 136.39 34.52 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.24 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 t -130.83 136.81 49.02 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -101.07 120.4 40.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.25 126.43 73.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -67.64 128.45 36.5 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.473 0.483 . . . . 0.0 110.96 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.4 p -123.0 160.41 26.34 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 71' ' ' ARG . 13.0 tt -146.06 124.35 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -105.0 110.46 22.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.286 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -109.93 116.77 53.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.25 125.18 51.86 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.02 159.0 32.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.526 ' HD2' ' OE2' ' A' ' 66' ' ' GLU . 41.6 ttm180 -126.22 132.32 51.77 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 123.46 0.704 . . . . 0.0 111.18 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.436 ' HG3' HD22 ' A' ' 30' ' ' LEU . 34.2 mmtp -92.87 149.9 20.96 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.642 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.254 1.333 0 C-N-CA 124.074 0.95 . . . . 0.0 109.489 175.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttm . . . . . 0 CA--C 1.51 -0.561 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -107.23 149.67 27.48 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.1 t -83.63 173.4 11.41 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.61 67.49 1.11 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.103 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -140.51 139.15 19.77 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.69 -7.13 11.57 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.203 1.935 . . . . 0.0 112.486 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 31.2 p -119.89 123.58 28.37 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.17 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.05 114.41 2.43 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 C-N-CA 122.808 2.338 . . . . 0.0 112.491 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 36.8 t -89.66 118.64 29.43 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -128.26 9.44 6.16 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.64 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.1 115.17 47.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.14 134.57 53.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.086 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 tp -97.58 127.63 43.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.342 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mm -88.52 110.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.3 52.23 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.016 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -159.72 -65.4 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.219 0.509 . . . . 0.0 110.405 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -101.54 168.04 9.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.423 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.59 164.62 30.37 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.978 1.785 . . . . 0.0 112.393 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 95.2 t -46.77 -38.39 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.128 1.371 . . . . 0.0 113.22 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptp -52.31 -35.08 49.65 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -69.9 -35.39 74.57 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.19 0.519 . . . . 0.0 110.685 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -78.75 -35.49 44.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.16 -50.82 78.72 Favored 'Isoleucine or valine' 0 C--O 1.252 1.231 0 CA-C-O 121.601 0.715 . . . . 0.0 109.124 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.89 -32.53 74.28 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.158 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.85 94.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.021 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.16 68.38 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.168 0.509 . . . . 0.0 110.754 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.83 -44.19 42.22 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.468 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -63.21 -38.55 91.6 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.832 0.349 . . . . 0.0 111.152 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.24 -39.04 89.25 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 122.315 -0.241 . . . . 0.0 110.92 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.401 HD22 ' HG3' ' B' ' 96' ' ' LYS . 3.4 tm? -60.19 -40.13 88.96 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.709 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.87 -20.92 66.01 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.045 0.45 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -87.17 -9.28 55.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.11 -4.55 23.82 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.844 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.24 96.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 0.0 109.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -84.03 -28.24 27.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -114.84 120.42 39.93 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.98 154.56 40.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 O-C-N 123.16 0.288 . . . . 0.0 111.348 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.68 124.36 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.216 0.532 . . . . 0.0 110.56 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.64 130.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.343 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.26 123.95 44.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.173 0.511 . . . . 0.0 110.904 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 153.94 35.18 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -129.1 143.39 50.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.47 -122.76 15.35 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 116.312 -0.404 . . . . 0.0 113.533 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.17 11.64 24.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.905 0.383 . . . . 0.0 110.944 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.33 -1.04 57.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.509 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.49 -37.25 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.126 0.571 . . . . 0.0 110.36 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.5 p -66.12 -31.36 72.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.233 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -69.15 -39.96 78.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.31 91.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.606 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -72.4 -34.28 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.589 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.549 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.0 t70 -62.73 -45.18 93.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 90.4 m -56.23 -53.74 53.55 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.622 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.24 -34.23 67.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.959 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -60.99 -47.97 84.0 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.549 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.8 mt -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.883 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.01 -41.03 91.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -85.76 14.7 5.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.24 0.543 . . . . 0.0 111.043 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -121.33 -45.44 2.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.277 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.8 ptp180 -83.28 -19.28 36.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.462 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.535 ' CD2' ' HG ' ' B' ' 61' ' ' LEU . 57.8 t80 -118.66 -71.56 0.73 Allowed 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.64 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.535 ' HG ' ' CD2' ' B' ' 60' ' ' PHE . 94.0 mt -131.15 114.91 15.69 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.158 0.504 . . . . 0.0 111.71 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.26 -32.16 11.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.551 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.83 -49.48 11.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.0 87.35 3.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.413 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -160.71 119.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 11.0 pt-20 -122.04 136.16 54.89 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.131 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.42 143.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.677 ' HZ3' ' NH2' ' B' ' 95' ' ' ARG . 31.4 mmmt -87.76 -58.14 2.68 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.925 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -167.67 152.0 6.61 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 67.0 mt -133.35 115.56 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 90' ' ' ILE . 73.9 mtp180 -115.06 136.41 53.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.822 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.72 126.08 56.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.12 -168.45 26.19 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.156 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.2 p -116.27 121.14 41.12 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.359 0.6 . . . . 0.0 111.235 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -96.22 127.2 42.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.643 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.3 114.99 26.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -121.38 157.44 24.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.009 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 16.9 p -87.94 127.44 35.37 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 120.894 0.378 . . . . 0.0 110.476 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 47.1 t -76.76 -31.93 57.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.468 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -153.42 -77.67 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -120.17 -76.37 0.58 Allowed 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 121.086 0.47 . . . . 0.0 110.058 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.84 35.96 4.16 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.782 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -114.66 111.83 21.93 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.28 136.85 32.79 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.536 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 35.4 t -129.69 137.73 50.78 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -100.77 118.89 37.76 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 72.7 t -115.7 125.24 72.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -67.26 127.08 31.31 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.969 0.414 . . . . 0.0 111.232 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 67.8 p -121.42 159.37 26.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.095 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' B' ' 71' ' ' ARG . 12.3 tt -146.21 124.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.933 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -103.59 113.16 26.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.31 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.9 mt -112.02 114.64 47.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.32 125.45 53.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 pt -126.07 158.54 35.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.677 ' NH2' ' HZ3' ' B' ' 68' ' ' LYS . 41.5 ttm180 -124.53 134.95 52.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.401 ' HG3' HD22 ' B' ' 30' ' ' LEU . 34.1 mmtp -97.66 148.52 23.24 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 123.849 0.86 . . . . 0.0 109.517 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.517 175.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 C--O 1.216 -0.698 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 p -127.0 -52.09 1.43 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.064 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 m -145.43 167.97 21.67 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 122.122 -0.361 . . . . 0.0 110.424 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.24 58.16 0.02 OUTLIER Glycine 0 CA--C 1.499 -0.929 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 p -106.35 133.98 19.99 Favored Pre-proline 0 N--CA 1.433 -1.307 0 C-N-CA 122.22 0.208 . . . . 0.0 110.983 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.79 23.34 0.82 Allowed 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.597 2.198 . . . . 0.0 111.031 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.6 p -110.25 152.2 43.06 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.621 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.13 169.38 18.25 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.054 1.836 . . . . 0.0 110.365 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 p -81.63 81.89 7.55 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.264 0.554 . . . . 0.0 110.846 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -121.33 11.53 10.77 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.394 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 58.3 t -116.06 119.59 62.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.11 147.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.098 0.475 . . . . 0.0 111.284 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 tp -110.76 134.82 52.16 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.52 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.412 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.69 -138.06 4.59 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -101.68 18.3 20.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.86 154.67 38.23 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.152 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.44 148.15 53.81 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.187 2.591 . . . . 0.0 112.499 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.524 HG22 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -54.68 -36.15 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.762 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.415 ' O ' HD12 ' A' ' 24' ' ' LEU . 26.9 ptt? -59.31 -24.76 63.58 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -64.86 -38.59 91.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -85.33 -33.42 22.07 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.987 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.5 t -62.29 -55.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.169 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 20' ' ' MET . 9.3 mp -62.05 -26.45 68.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.692 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.68 -45.75 70.86 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.118 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -61.58 -42.45 98.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp -61.84 -38.26 87.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.1 m -68.2 -37.94 81.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.924 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 96.7 mt -63.18 -34.99 78.83 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.368 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.9 mt -57.52 -41.8 81.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.28 -16.89 62.49 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -91.63 2.05 56.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.51 0.672 . . . . 0.0 110.338 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.68 -3.81 59.31 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.56 91.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 t -90.24 -12.13 38.87 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.96 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -124.56 111.98 16.3 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.444 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.89 156.82 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.823 0.345 . . . . 0.0 111.698 -177.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -126.35 125.49 67.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.009 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.81 129.45 61.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.125 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -118.73 123.54 45.1 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.01 153.07 37.82 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -129.59 140.95 51.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.089 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.7 -135.04 18.6 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.292 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -83.05 2.63 34.1 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.5 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.5 30.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.579 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.35 -36.95 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.361 0.601 . . . . 0.0 109.705 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.1 p -61.55 -37.42 83.73 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.543 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HB2' ' NZ ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -67.64 -42.84 81.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.153 -178.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.27 89.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.466 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.8 -36.77 65.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.805 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.524 ' OD2' HG22 ' A' ' 19' ' ' VAL . 17.9 t70 -59.59 -47.63 84.83 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.2 m -53.36 -53.56 49.28 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.444 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -69.98 -31.18 46.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.493 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 25.3 tt0 -68.61 -32.17 71.87 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.947 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.3 mt -68.69 -42.83 83.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.119 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.19 -30.93 47.98 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 CA-C-O 121.25 0.548 . . . . 0.0 111.292 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 40.4 ptt180 -88.88 14.98 9.16 Favored 'General case' 0 C--O 1.211 -0.94 0 O-C-N 122.023 -0.423 . . . . 0.0 110.299 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -128.67 -56.02 1.22 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -73.27 -29.15 62.54 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -97.96 -63.21 1.15 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.023 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.48 110.55 5.69 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.798 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.41 -46.69 8.2 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.555 1.159 . . . . 0.0 110.777 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.91 -29.52 58.45 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.77 97.23 7.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -160.95 143.69 4.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.957 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.72 141.72 51.48 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.35 125.6 68.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -86.05 -62.48 1.51 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.28 149.29 5.91 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.014 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.2 mt -139.15 99.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.22 136.79 54.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.8 t -102.16 132.7 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.82 167.29 28.24 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.881 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 p -93.88 135.89 34.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.829 0.347 . . . . 0.0 110.825 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.41 ' HG2' HG11 ' A' ' 77' ' ' VAL . 36.0 tt0 -100.48 114.18 27.56 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.451 HG21 ' HG2' ' A' ' 86' ' ' ARG . 45.1 t -95.86 108.19 20.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG11 ' HG2' ' A' ' 75' ' ' GLN . 26.1 m -124.52 165.79 20.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.269 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.7 p -88.36 131.74 34.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 120.902 0.382 . . . . 0.0 110.461 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.4 t -86.21 -30.55 22.31 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.762 0.315 . . . . 0.0 111.032 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -144.87 -76.5 0.22 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.322 0.582 . . . . 0.0 110.711 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -123.24 -79.42 0.61 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.406 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.34 7.43 26.67 Favored Glycine 0 CA--C 1.506 -0.493 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.017 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -84.3 107.47 16.61 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -79.0 137.11 37.42 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.703 0.627 . . . . 0.0 110.582 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.9 t -125.07 129.28 49.93 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.451 ' HG2' HG21 ' A' ' 76' ' ' VAL . 99.5 mtt180 -102.83 125.53 49.61 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.58 136.44 58.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.7 p -70.24 127.26 32.19 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.518 0.675 . . . . 0.0 111.956 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.0 p -133.11 160.15 38.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.774 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.67 139.53 48.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -118.13 110.76 18.0 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -111.5 119.74 60.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.41 120.26 30.56 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.723 0.297 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.34 168.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 ttt180 -136.85 133.7 36.12 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.22 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 70.7 mmtt -95.72 -170.46 2.15 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt . . . . . 0 C--O 1.255 1.351 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.998 176.172 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.5 tpp . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m 71.06 176.46 0.28 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.073 0.949 . . . . 0.0 111.301 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 45.8 t -107.0 -52.2 2.8 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.715 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.49 -7.82 53.42 Favored Glycine 0 CA--C 1.503 -0.683 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.597 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 40.5 p 52.9 82.28 0.25 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.458 1.103 . . . . 0.0 113.417 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -90.97 173.21 2.93 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 122.501 2.134 . . . . 0.0 111.447 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p 55.98 91.53 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.65 1.18 . . . . 0.0 113.264 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.99 112.99 1.46 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.051 2.5 . . . . 0.0 112.614 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -95.5 11.32 33.38 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.508 0.67 . . . . 0.0 109.976 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -94.57 9.26 39.31 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.734 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 62.2 t -113.03 114.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -111.29 143.46 21.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.01 138.28 43.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -86.18 125.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.792 0.329 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.56 -140.0 7.46 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.777 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -99.81 14.87 28.82 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -91.31 154.38 44.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.328 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.96 146.68 56.14 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.203 2.602 . . . . 0.0 112.391 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.425 HG22 ' OD1' ' B' ' 51' ' ' ASP . 7.1 p -51.66 -35.52 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.307 1.043 . . . . 0.0 113.516 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.09 -25.34 66.89 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.27 -36.96 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.495 0.664 . . . . 0.0 110.117 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -87.04 -33.66 19.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.205 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 65.6 t -61.31 -55.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.583 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.66 -26.16 68.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.761 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -68.34 -44.18 75.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.173 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -41.72 96.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.14 -36.81 80.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.958 0.408 . . . . 0.0 110.671 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 37.9 m -68.66 -38.36 80.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 95.6 mt -63.58 -35.18 79.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.254 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.2 mt -55.84 -42.81 76.32 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -71.61 -15.14 62.24 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -93.38 1.7 56.8 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.37 0.605 . . . . 0.0 110.382 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.42 -8.27 58.55 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.657 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.92 91.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.249 0.547 . . . . 0.0 109.605 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -90.16 -13.17 36.19 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.773 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -123.91 116.62 23.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.906 -0.496 . . . . 0.0 109.669 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 157.9 42.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-O 120.806 0.336 . . . . 0.0 111.633 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 58.9 t -127.0 124.7 65.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.218 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.9 mt -106.97 127.43 62.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.03 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . 0.411 ' NZ ' ' OE2' ' B' ' 91' ' ' GLU . 65.3 mttm -117.22 122.32 43.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.689 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.59 40.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -128.17 139.82 52.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.332 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.83 -136.14 20.25 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.239 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -80.52 0.53 33.36 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 122.439 -0.447 . . . . 0.0 111.53 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.43 -0.81 27.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.627 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 75.2 mt -55.91 -38.87 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.15 0.5 . . . . 0.0 110.021 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -61.71 -38.03 86.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.733 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.466 ' HZ1' ' HB2' ' B' ' 48' ' ' LYS . 0.0 OUTLIER -66.14 -41.56 90.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.28 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.89 81.23 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.209 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.11 -34.09 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.462 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.535 ' O ' HG13 ' B' ' 55' ' ' ILE . 12.3 t70 -60.9 -47.18 87.56 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -54.84 -55.08 34.21 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 18.0 m -68.14 -31.88 53.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.131 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 27.3 tt0 -68.6 -31.01 69.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.099 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.535 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.0 mt -69.54 -43.59 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.191 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.41 -31.36 52.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 CA-C-O 121.297 0.57 . . . . 0.0 111.335 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 40.0 ptt180 -88.66 17.27 5.64 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -131.56 -57.08 1.0 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.138 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -72.55 -26.68 61.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -101.65 -64.03 1.09 Allowed 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.975 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -141.93 112.33 7.07 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.7 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.9 -50.23 5.82 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 124.293 0.995 . . . . 0.0 110.875 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.49 -28.76 62.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -105.54 98.02 7.77 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.442 0.639 . . . . 0.0 110.755 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tp -161.15 145.12 4.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.869 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -126.17 138.48 53.66 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.24 126.72 63.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -86.63 -64.47 1.15 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -166.33 146.98 6.31 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.393 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.3 mt -139.43 100.82 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.19 143.46 50.49 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.59 123.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.56 168.64 24.1 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.761 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 35.1 p -92.96 133.34 36.22 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.659 0.384 . . . . 0.0 110.907 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 36.1 tt0 -99.61 114.49 27.57 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.438 HG21 ' HG2' ' B' ' 86' ' ' ARG . 46.7 t -96.19 107.81 20.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 19.9 m -124.21 168.11 17.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.158 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 17.4 p -91.02 132.83 35.76 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.843 0.354 . . . . 0.0 110.102 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 36.7 t -88.35 -26.36 22.26 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.329 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -148.57 -84.36 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.093 0.557 . . . . 0.0 110.596 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -113.03 -80.27 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.671 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.84 3.79 25.87 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.11 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -78.47 103.84 8.68 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -77.68 137.2 38.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.505 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.2 t -124.39 130.01 51.71 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.438 ' HG2' HG21 ' B' ' 76' ' ' VAL . 99.6 mtt180 -101.5 128.17 47.85 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.62 137.4 56.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 7.2 p -72.31 127.47 32.67 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.464 0.649 . . . . 0.0 112.223 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.75 158.38 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.114 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.04 139.54 50.06 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . 0.411 ' OE2' ' NZ ' ' B' ' 40' ' ' LYS . 42.4 tt0 -119.16 112.38 19.44 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -112.39 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.01 35.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 pt -125.14 163.26 26.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 120.983 0.421 . . . . 0.0 110.482 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' B' ' 96' ' ' LYS . 76.4 ttt180 -132.44 134.21 44.81 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' B' ' 95' ' ' ARG . 69.4 mmtt -97.6 -170.36 1.99 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.318 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt . . . . . 0 C--O 1.256 1.4 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.195 176.773 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.496 -1.107 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 p -170.94 135.49 1.05 Allowed 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 123.828 0.705 . . . . 0.0 109.155 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m -133.39 4.22 3.67 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.983 0.421 . . . . 0.0 110.762 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.09 -10.17 75.72 Favored Glycine 0 N--CA 1.463 0.449 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.7 p -85.39 147.02 45.96 Favored Pre-proline 0 N--CA 1.418 -2.07 0 CA-C-N 115.084 -0.558 . . . . 0.0 109.75 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.83 23.41 0.77 Allowed 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.695 2.264 . . . . 0.0 111.419 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.8 p -91.41 116.74 67.04 Favored Pre-proline 0 N--CA 1.434 -1.237 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.351 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.51 138.65 27.3 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.912 1.741 . . . . 0.0 111.251 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.3 p -83.32 87.23 6.96 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.161 0.505 . . . . 0.0 110.32 176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -118.3 12.46 13.42 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.547 0.689 . . . . 0.0 110.385 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.65 120.37 60.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.156 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.53 139.69 42.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.991 0.424 . . . . 0.0 110.693 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.3 tp -104.21 136.73 43.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.313 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -84.09 123.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.4 -159.49 11.77 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.03 13.41 1.79 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -86.07 152.48 56.03 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 121.95 -0.469 . . . . 0.0 112.162 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.65 150.79 59.16 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.859 2.373 . . . . 0.0 112.213 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.532 HG22 ' OD2' ' A' ' 51' ' ' ASP . 7.4 p -56.23 -35.31 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.503 0.721 . . . . 0.0 112.388 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.1 ptp -57.89 -30.81 66.17 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.93 -34.08 74.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -79.09 -33.34 44.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.196 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 66.1 t -61.62 -48.52 88.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.84 -38.54 91.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.645 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.81 -44.64 96.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.2 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.38 96.61 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.19 0.519 . . . . 0.0 111.012 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 95.3 mt -64.92 -38.97 92.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.806 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.9 m -67.74 -31.79 71.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.2 mt -70.6 -40.37 73.25 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 122.088 -0.383 . . . . 0.0 110.245 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.56 -40.97 89.07 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.372 0.606 . . . . 0.0 109.406 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -59.13 -30.21 67.96 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.44 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -91.26 3.19 55.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.52 11.99 57.58 Favored Glycine 0 C--O 1.244 0.759 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.921 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.31 98.04 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 13.1 p -87.46 -13.87 42.01 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' OE1' ' HG3' ' A' ' 68' ' ' LYS . 36.6 tt0 -128.66 111.79 13.56 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.35 159.66 35.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.02 127.29 51.46 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-O 121.573 0.701 . . . . 0.0 110.86 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -101.88 124.29 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.52 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 81.8 mttt -115.46 114.27 24.81 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.32 0.581 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.07 158.49 17.7 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.848 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.503 ' HG2' HG23 ' A' ' 89' ' ' THR . 54.8 mtm180 -133.54 148.68 51.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.91 -121.58 19.57 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 123.559 0.537 . . . . 0.0 113.016 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -92.0 -0.28 57.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.63 -4.03 46.92 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -54.9 -36.07 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.7 0.8 . . . . 0.0 110.529 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -63.39 -35.49 80.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.616 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.23 -30.04 60.42 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.3 82.35 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.31 -37.19 64.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.184 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 19' ' ' VAL . 34.9 t70 -60.66 -43.39 97.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.875 0.369 . . . . 0.0 110.086 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -58.71 -51.25 70.77 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.279 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.96 -32.37 51.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.59 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.512 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 7.6 tp10 -63.66 -40.3 96.51 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.1 mt -64.21 -44.33 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.81 -39.59 82.34 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.831 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.512 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 2.6 ptm180 -80.66 1.33 30.43 Favored 'General case' 0 C--O 1.206 -1.199 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -128.17 11.35 6.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.081 0.467 . . . . 0.0 111.789 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -118.1 -66.71 1.05 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.709 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -75.9 -67.17 0.7 Allowed 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.827 0.346 . . . . 0.0 110.386 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.23 109.25 6.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -87.04 -44.9 11.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.429 1.08 . . . . 0.0 110.343 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.96 -28.71 67.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.619 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -121.02 106.84 11.96 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -159.26 120.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.291 0.567 . . . . 0.0 110.506 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 21.3 mm-40 -98.45 134.39 41.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.264 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.5 mt -101.2 122.64 53.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 1.9 tmtp? -83.58 -55.59 4.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.398 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -173.55 154.25 2.49 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -133.4 116.18 24.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -119.31 134.79 55.02 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.725 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.84 131.57 71.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.88 28.92 Favored Glycine 0 CA--C 1.493 -1.335 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -115.18 145.11 42.71 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 117.228 0.514 . . . . 0.0 111.238 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -114.48 134.81 54.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.2 m -88.98 123.34 41.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.408 0.623 . . . . 0.0 110.93 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.26 136.5 59.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.65 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.0 p -83.93 115.3 22.23 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.165 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.8 t -63.29 -41.45 98.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.163 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -140.31 -73.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -122.56 -82.14 0.65 Allowed 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.784 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.67 46.7 1.13 Allowed Glycine 0 CA--C 1.498 -0.981 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.96 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -128.56 95.3 4.09 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -84.76 120.64 26.66 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.595 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 t -105.33 134.6 48.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.72 114.79 29.16 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.85 139.62 42.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.8 p -67.41 126.29 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 O-C-N 123.757 0.661 . . . . 0.0 110.828 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.503 HG23 ' HG2' ' A' ' 42' ' ' ARG . 46.6 p -132.03 151.19 51.89 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.2 tt -136.11 140.0 44.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.92 109.42 15.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.68 111.8 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.12 122.58 47.98 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.978 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.32 157.65 24.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.783 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.5 ttp180 -126.02 133.44 51.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 3.1 tmtm? -108.1 139.46 42.73 Favored 'General case' 0 N--CA 1.413 -2.288 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.235 -174.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 73.9 mmtt . . . . . 0 C--O 1.256 1.395 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.5 p -89.72 -35.99 15.45 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m 71.73 -38.83 0.43 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.947 1.299 . . . . 0.0 112.212 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.6 -153.87 7.61 Favored Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 38.3 p -79.89 130.56 66.54 Favored Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 122.253 0.221 . . . . 0.0 111.024 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.73 178.63 6.91 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 123.107 2.538 . . . . 0.0 112.096 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 60.0 m -88.71 127.22 57.09 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.191 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.24 122.08 11.06 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 123.428 2.752 . . . . 0.0 112.55 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -103.08 85.83 2.58 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.215 0.531 . . . . 0.0 110.016 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -129.04 15.09 6.29 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.614 0.721 . . . . 0.0 110.886 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.38 126.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.067 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.51 139.8 46.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.104 0.478 . . . . 0.0 110.495 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 tp -104.32 138.23 41.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.299 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -85.34 123.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.253 0.549 . . . . 0.0 111.295 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.9 -160.49 11.91 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.48 12.46 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -84.64 153.42 61.29 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.805 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.28 154.32 29.58 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.755 2.304 . . . . 0.0 111.772 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.428 HG22 ' OD2' ' B' ' 51' ' ' ASP . 7.1 p -61.58 -35.88 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.028 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.404 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.3 ptp -56.93 -28.74 62.44 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.179 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.18 -36.83 77.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -76.42 -32.92 58.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.422 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 70.2 t -60.94 -50.48 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 20' ' ' MET . 91.9 mt -64.1 -34.36 77.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.35 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.72 81.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.73 97.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.963 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 97.6 mt -63.8 -37.93 89.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.618 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -34.54 77.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.191 0.519 . . . . 0.0 110.251 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.38 -40.55 81.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.201 -0.312 . . . . 0.0 110.421 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.67 -39.35 80.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.096 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.25 -28.78 69.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.354 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -92.5 6.67 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.873 0.368 . . . . 0.0 111.909 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.73 60.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.433 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.82 97.57 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 31.7 p -83.8 -21.71 32.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -122.2 115.27 22.09 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.65 154.34 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.04 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.06 128.48 67.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 CA-C-O 121.775 0.798 . . . . 0.0 111.22 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -101.91 124.67 55.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.728 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.6 mttt -114.82 115.68 27.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.398 0.618 . . . . 0.0 110.744 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.41 158.54 18.36 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.458 ' HG2' HG23 ' B' ' 89' ' ' THR . 50.9 mtm180 -132.33 149.94 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.61 -117.08 9.84 Favored Glycine 0 N--CA 1.446 -0.643 0 O-C-N 123.604 0.565 . . . . 0.0 113.02 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -97.43 0.5 47.85 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.16 -2.96 43.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.686 0.279 . . . . 0.0 111.699 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.79 -36.21 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.887 0.875 . . . . 0.0 110.268 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.2 p -63.64 -35.4 80.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.37 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -76.29 -29.42 57.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.44 77.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -71.04 -34.91 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.518 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.0 t70 -60.87 -42.97 98.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.003 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.1 m -60.63 -53.17 60.7 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.512 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.35 -31.78 52.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 8.3 tp10 -64.92 -39.72 93.95 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 51' ' ' ASP . 81.7 mt -63.08 -45.65 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.6 t -60.52 -39.23 80.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.498 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 2.9 ptm180 -79.64 -2.87 44.68 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -127.21 20.75 6.81 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.041 0.448 . . . . 0.0 111.383 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -125.8 -66.58 0.93 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.547 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -77.61 -67.47 0.72 Allowed 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.21 110.0 7.6 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -86.59 -47.34 9.3 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 124.264 0.977 . . . . 0.0 110.71 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.56 -30.89 65.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.796 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -117.8 102.54 9.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.546 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -156.16 121.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.102 0.477 . . . . 0.0 110.647 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' B' ' 95' ' ' ARG . 23.5 mm-40 -99.98 133.79 43.85 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.061 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.45 123.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.21 -52.85 5.92 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.79 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -176.88 152.95 0.99 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.83 115.5 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -118.2 134.59 54.88 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.822 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.52 134.51 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.58 -167.44 37.9 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.9 p -109.66 149.28 29.94 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 117.59 0.695 . . . . 0.0 111.076 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.45 132.8 56.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 m -88.47 120.74 37.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.387 0.613 . . . . 0.0 111.318 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.3 138.41 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.34 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 12.6 p -82.74 118.1 23.13 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.765 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 48.4 t -63.82 -42.02 97.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.133 0.492 . . . . 0.0 110.977 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -139.5 -75.38 0.36 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -126.53 -79.23 0.6 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.409 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.63 58.78 0.44 Allowed Glycine 0 C--N 1.306 -1.116 0 C-N-CA 119.866 -1.159 . . . . 0.0 112.989 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -144.28 103.6 4.0 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -93.1 118.16 30.89 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.732 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -100.39 136.18 40.68 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.5 112.61 25.74 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.41 138.99 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 13.1 p -66.24 128.02 34.47 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.216 0.532 . . . . 0.0 110.859 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.458 HG23 ' HG2' ' B' ' 42' ' ' ARG . 47.9 p -132.87 148.64 52.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.118 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 15.4 tt -133.62 139.37 48.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -118.09 108.9 15.78 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.72 111.8 37.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.0 123.24 49.88 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.815 0.341 . . . . 0.0 110.216 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -121.97 155.85 26.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' B' ' 35' ' ' SER . 60.7 ttp180 -126.06 128.5 47.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' B' ' 97' ' ' LYS . 2.7 tmtm? -104.94 143.34 33.3 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 -174.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.466 ' H ' ' HD3' ' B' ' 96' ' ' LYS . 74.4 mmtt . . . . . 0 C--O 1.263 1.8 0 CA-C-O 117.253 -1.356 . . . . 0.0 107.697 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mmm . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -68.25 -27.02 65.98 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.792 0.33 . . . . 0.0 111.239 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 m -123.95 165.84 16.72 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.09 -53.82 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 p -87.74 161.73 43.82 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -84.94 9.81 4.0 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.649 2.233 . . . . 0.0 113.005 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 m -91.5 112.34 53.75 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.08 120.34 6.76 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.328 2.019 . . . . 0.0 111.972 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 m -98.64 137.31 37.45 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.658 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -112.45 9.01 19.6 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.701 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -95.19 117.58 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 m -107.95 136.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.441 0.638 . . . . 0.0 111.57 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.26 104.74 14.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.819 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.89 107.7 12.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.375 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.53 36.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.921 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -160.21 -50.95 0.05 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.85 0.86 . . . . 0.0 110.611 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -97.97 154.88 37.6 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.777 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.78 156.37 62.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.914 2.409 . . . . 0.0 113.077 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.34 -41.73 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.811 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -62.85 -25.19 68.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.954 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.14 -21.83 56.13 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.294 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.0 -35.53 17.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.57 -50.65 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.143 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.09 -29.07 69.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.06 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -70.22 -48.15 58.31 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.621 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.86 91.03 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.516 0.51 . . . . 0.0 110.681 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.1 -30.6 71.56 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.305 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 93.7 m -78.89 -42.57 26.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 99.0 mt -62.78 -31.73 72.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.821 0.344 . . . . 0.0 110.732 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.96 -45.12 96.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.84 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.05 -25.64 64.57 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.421 0.629 . . . . 0.0 110.006 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 28' ' ' THR . 15.1 mm100 -80.01 -3.64 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.386 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 -7.93 36.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.447 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -85.44 97.18 5.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 m -98.38 0.01 44.58 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.796 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -135.38 115.15 12.89 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 155.35 41.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 O-C-N 123.306 0.379 . . . . 0.0 110.684 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.22 122.93 62.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.55 132.6 47.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.285 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -121.53 122.13 39.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.34 0.591 . . . . 0.0 111.359 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.68 147.73 50.77 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.158 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.401 ' HG3' HG21 ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.0 152.04 50.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 -124.25 9.12 Favored Glycine 0 C--N 1.309 -0.964 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.274 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -92.69 2.66 56.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.209 0.528 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.56 -7.68 55.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.967 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -55.83 -40.78 63.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.7 t -63.11 -33.38 75.33 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.959 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.79 -35.82 62.51 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.157 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.26 93.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.743 0.306 . . . . 0.0 111.508 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.88 -33.23 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 110.768 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.1 t70 -66.23 -40.82 90.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -57.46 -46.51 83.56 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.566 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -71.38 -36.74 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.07 -45.81 79.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.413 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 51' ' ' ASP . 74.1 mt -59.16 -50.35 80.1 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.788 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.83 -46.4 96.6 Favored 'Isoleucine or valine' 0 C--O 1.256 1.407 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -80.18 -5.48 56.15 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.119 0.485 . . . . 0.0 112.265 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -125.69 12.02 7.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -123.09 -41.49 2.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.772 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -123.71 -57.58 1.63 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.338 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.27 76.68 7.58 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.459 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 18.26 19.05 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.321 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -149.65 -59.7 0.21 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.515 0.674 . . . . 0.0 110.414 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HB3' ' OXT' ' A' ' 97' ' ' LYS . 48.3 mttm -94.07 80.75 4.08 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.098 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.404 ' O ' ' HE3' ' A' ' 97' ' ' LYS . 8.5 tp -159.2 145.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.291 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.41 167.93 21.0 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.036 0.446 . . . . 0.0 110.78 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.71 128.26 55.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.86 -57.45 3.75 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -177.03 146.9 0.53 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.4 pt -130.55 129.64 64.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.27 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -135.97 143.73 45.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.409 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 p -137.44 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.98 -145.42 5.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 m -138.38 134.47 34.21 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 65.2 tt0 -96.83 140.29 31.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.804 0.335 . . . . 0.0 110.276 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -100.91 109.96 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.28 150.71 18.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 120.812 0.339 . . . . 0.0 110.604 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 p -85.69 124.26 32.02 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.286 0.565 . . . . 0.0 109.897 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.2 m -92.17 -19.67 22.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.299 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -141.15 -82.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 110.589 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -135.18 -72.25 0.47 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.64 -16.19 29.69 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.614 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -65.75 110.49 2.83 Favored 'General case' 0 C--O 1.253 1.284 0 O-C-N 122.621 -0.341 . . . . 0.0 110.944 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -90.99 152.36 20.72 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.15 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.1 t -141.57 152.67 44.27 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 94.3 mtt180 -121.36 131.69 54.33 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 120.893 0.378 . . . . 0.0 110.743 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.55 136.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 m -62.81 123.99 19.89 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 123.566 0.541 . . . . 0.0 109.855 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.401 HG21 ' HG3' ' A' ' 42' ' ' ARG . 33.7 p -130.57 146.53 52.11 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.365 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -135.6 140.11 45.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.729 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.13 115.49 23.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.868 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.06 115.49 49.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.66 128.13 55.08 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -132.77 159.72 43.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -140.93 145.56 36.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HZ3' ' C ' ' A' ' 97' ' ' LYS . 12.7 tmtt? -89.72 141.48 28.57 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.976 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' OXT' ' HB3' ' A' ' 64' ' ' LYS . 98.2 mttt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 CA--C 1.494 -1.203 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -125.5 -52.54 1.6 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.951 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 40.1 t 66.84 96.6 0.06 Allowed 'General case' 0 C--N 1.35 0.625 0 O-C-N 124.094 0.871 . . . . 0.0 111.482 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.33 -121.74 2.62 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 66.8 p -84.94 145.97 44.8 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.57 -162.43 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.29 1.993 . . . . 0.0 110.909 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -55.49 131.22 70.75 Favored Pre-proline 0 C--O 1.253 1.276 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.06 107.77 0.19 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.571 2.847 . . . . 0.0 113.219 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.7 p -163.92 -47.02 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.701 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -89.58 8.42 31.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.185 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 48.4 t -102.36 109.27 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.8 m -103.16 137.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.763 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.45 108.38 19.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.917 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.38 116.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.097 0.475 . . . . 0.0 109.927 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.38 35.46 0.02 OUTLIER Glycine 0 C--N 1.311 -0.823 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.829 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -161.92 -48.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.967 0.907 . . . . 0.0 111.212 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -99.88 155.48 36.41 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.391 -174.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.77 153.1 79.61 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.736 2.291 . . . . 0.0 112.374 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.439 ' O ' HG22 ' B' ' 23' ' ' VAL . 7.1 p -52.51 -39.47 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.616 0.767 . . . . 0.0 112.858 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -63.38 -26.78 68.91 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.76 -25.86 60.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.317 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.04 -37.85 21.61 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.439 HG22 ' O ' ' B' ' 19' ' ' VAL . 61.4 t -58.55 -49.56 81.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.426 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.3 -28.4 68.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.748 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.417 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -69.66 -47.9 61.71 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.447 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -45.62 87.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.606 0.566 . . . . 0.0 110.977 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.04 -31.49 72.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.157 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 90.6 m -77.12 -44.47 30.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.595 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 96.6 mt -61.57 -31.64 71.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.92 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.5 -45.29 94.32 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.128 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -69.57 -24.78 63.75 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.428 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -79.91 -8.56 59.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.153 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.48 2.83 33.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.231 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.86 96.19 5.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 41.4 m -100.08 2.81 43.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -137.48 111.35 8.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.23 157.2 40.62 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.063 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 60.4 t -127.13 122.23 59.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.268 0.556 . . . . 0.0 111.073 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.07 130.43 50.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -120.5 122.77 41.36 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.46 0.648 . . . . 0.0 111.291 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.98 151.85 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.97 -126.19 11.8 Favored Glycine 0 C--N 1.303 -1.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.177 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -89.79 1.21 56.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.07 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.82 -8.16 55.6 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.235 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.45 -39.96 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.407 0.683 . . . . 0.0 110.799 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 40.6 t -63.25 -33.48 75.58 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.065 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -75.31 -35.18 61.29 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.321 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.14 88.86 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.263 0.554 . . . . 0.0 111.381 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.72 -30.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.501 ' O ' HG13 ' B' ' 55' ' ' ILE . 22.9 t70 -66.4 -42.98 87.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 70.4 m -56.5 -47.5 79.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.786 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.6 m -70.1 -38.1 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.83 -46.45 78.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.15 0.281 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.1 mt -58.56 -51.1 75.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.017 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.18 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--O 1.254 1.341 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -79.98 -5.04 54.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -127.28 14.86 7.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -125.86 -38.69 2.18 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.818 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -126.69 -57.96 1.33 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.16 74.85 8.73 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.983 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.88 24.96 8.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.293 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -153.52 -59.77 0.13 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.772 0.796 . . . . 0.0 109.754 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.482 ' HB3' ' OXT' ' B' ' 97' ' ' LYS . 46.7 mttm -98.25 81.71 2.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.106 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.421 ' O ' ' HE3' ' B' ' 97' ' ' LYS . 8.9 tp -157.53 146.13 10.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.84 169.49 17.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.148 0.499 . . . . 0.0 110.854 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.47 128.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -79.9 -58.59 3.1 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . 0.415 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 43.5 tt0 -175.82 145.04 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.03 0.932 . . . . 0.0 108.913 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.91 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.415 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 53.5 mtt180 -135.79 139.67 43.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.09 144.07 36.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.41 -145.69 6.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -136.37 137.68 40.81 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -99.1 139.69 34.38 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.728 0.299 . . . . 0.0 110.197 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -100.71 112.1 32.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.99 153.04 18.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.301 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 9.7 p -88.16 124.89 34.27 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.095 0.474 . . . . 0.0 109.779 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 22.4 m -92.2 -19.06 22.62 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.787 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -144.48 -79.56 0.19 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.162 0.505 . . . . 0.0 110.269 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -136.15 -75.88 0.43 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.441 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.17 -8.78 46.63 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.5 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -72.7 109.64 6.47 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -89.65 153.87 20.4 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 124.046 0.841 . . . . 0.0 109.154 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -141.12 144.72 35.03 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -114.91 130.57 56.93 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 123.334 0.396 . . . . 0.0 110.836 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.6 133.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 20.3 m -60.0 124.6 20.72 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.546 0.529 . . . . 0.0 109.904 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 33.5 p -132.22 144.69 50.81 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.249 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.8 tt -134.04 140.44 46.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.548 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -120.28 115.18 23.07 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.273 0.629 . . . . 0.0 109.611 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.37 115.98 51.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.15 128.26 54.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -132.75 159.98 42.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.418 ' O ' HD11 ' B' ' 65' ' ' ILE . 59.2 ttp180 -141.22 146.29 36.7 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.977 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 12.7 tmtt? -91.34 141.81 28.37 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.482 ' OXT' ' HB3' ' B' ' 64' ' ' LYS . 98.1 mttt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m 56.69 20.76 5.29 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 173.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.3 t -133.42 176.95 8.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.93 -104.28 0.17 Allowed Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.0 m 66.45 97.38 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 123.823 0.849 . . . . 0.0 112.322 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -67.58 127.23 16.03 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.74 2.293 . . . . 0.0 112.336 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -84.07 133.58 45.28 Favored Pre-proline 0 N--CA 1.429 -1.481 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.116 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.9 104.01 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.85 2.366 . . . . 0.0 111.772 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -97.31 -27.57 14.44 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.0 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -132.83 10.52 4.28 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.304 0.573 . . . . 0.0 110.812 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.25 122.24 68.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.6 156.55 14.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.073 0.463 . . . . 0.0 111.441 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.45 133.5 55.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.4 112.52 21.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.74 -155.71 13.24 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.68 26.27 0.18 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.92 150.56 36.96 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.75 150.58 81.97 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.939 2.426 . . . . 0.0 112.852 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.492 HG22 ' OD1' ' A' ' 51' ' ' ASP . 10.5 p -57.92 -38.31 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.55 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.411 ' O ' HD12 ' A' ' 24' ' ' LEU . 23.2 ptp -59.98 -27.34 66.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.936 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.85 -32.44 72.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 110.123 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -80.07 -35.85 36.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.658 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 60.3 t -59.11 -52.69 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.811 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 20' ' ' MET . 8.7 mp -65.85 -31.74 72.87 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.031 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.16 -44.79 87.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.19 -41.93 99.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 88.8 mt -61.15 -35.6 77.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.144 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.6 m -69.81 -36.71 75.86 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.526 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.2 mt -68.2 -33.36 74.29 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.3 mt -59.4 -39.88 84.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.602 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.91 -27.88 66.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.95 -6.15 56.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.59 14.71 34.11 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 121.049 -0.595 . . . . 0.0 112.866 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.47 96.13 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 122.153 -0.616 . . . . 0.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 p -88.43 -8.15 55.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -131.35 112.86 13.1 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.42 144.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.293 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.5 123.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.544 0.528 . . . . 0.0 110.62 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.04 121.81 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -116.57 127.48 54.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.368 0.604 . . . . 0.0 110.917 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -118.7 157.74 26.87 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.565 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -127.07 146.75 50.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.762 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.7 -116.81 9.69 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.287 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -99.45 4.21 46.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 110.789 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.36 50.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.92 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.8 mt -54.28 -40.05 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.725 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.3 t -64.75 -21.72 66.82 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.596 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -87.88 -29.97 20.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.51 84.83 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.093 0.473 . . . . 0.0 110.402 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -72.94 -33.23 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.0 t70 -64.21 -48.73 74.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -55.95 -50.34 71.04 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.924 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -68.15 -31.01 49.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.903 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 31.5 tt0 -68.19 -37.81 81.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.924 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 51' ' ' ASP . 79.5 mt -58.59 -43.4 87.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.429 0.456 . . . . 0.0 111.047 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.35 -43.75 80.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -79.36 8.79 5.53 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -135.21 7.06 3.36 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -117.53 -68.6 0.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.258 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -79.46 -69.34 0.59 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.567 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 2.5 mm? -122.62 102.61 8.16 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.34 -24.49 27.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.985 0.803 . . . . 0.0 111.214 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -96.97 -45.97 6.39 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.461 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.65 81.17 8.74 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.722 0.773 . . . . 0.0 111.636 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.5 134.52 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.095 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.529 ' OE1' ' HD2' ' A' ' 97' ' ' LYS . 47.2 mt-10 -114.01 141.82 46.94 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 67' ' ' ILE . 2.0 mp -95.74 126.58 48.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -82.21 -68.78 0.67 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.722 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -159.39 140.41 12.67 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -128.14 115.82 40.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -119.34 134.25 55.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.12 128.25 25.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.45 . . . . 0.0 110.099 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.32 -147.14 5.65 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.932 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -109.34 133.56 52.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -116.58 125.46 51.87 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.61 108.64 18.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.16 160.77 9.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.153 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.5 p -93.91 119.84 33.37 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.496 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.3 t -57.74 -62.6 1.68 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.892 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -144.81 -78.54 0.19 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.69 -69.86 0.55 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.817 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.64 29.99 0.45 Allowed Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.913 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -92.85 125.76 37.61 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -82.1 143.67 31.33 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 123.511 0.507 . . . . 0.0 110.508 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.6 t -139.9 136.03 33.48 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -93.99 112.42 24.25 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.7 t -119.35 134.04 64.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 p -67.28 123.37 20.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 123.703 0.627 . . . . 0.0 109.46 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 p -127.67 152.6 47.48 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.861 0.363 . . . . 0.0 111.366 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.7 tt -139.17 135.19 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.644 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.44 114.34 22.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.97 115.75 50.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.95 55.18 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.48 158.27 34.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.334 0.587 . . . . 0.0 111.629 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -112.77 114.88 27.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.647 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.567 ' NZ ' ' HB2' ' A' ' 61' ' ' LEU . 13.6 mmmt -88.93 131.98 34.9 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.576 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.529 ' HD2' ' OE1' ' A' ' 66' ' ' GLU . 28.5 mtpp . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 120.726 0.298 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -75.82 -61.54 1.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m 63.51 26.3 14.73 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.094 0.558 . . . . 0.0 111.767 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.63 118.97 15.42 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.368 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 24.6 m -88.87 -45.98 0.44 Allowed Pre-proline 0 CA--C 1.586 2.341 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.09 138.81 44.78 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 121.644 1.562 . . . . 0.0 113.027 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 33.1 m -81.95 121.38 79.08 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.967 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.9 98.69 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.898 2.399 . . . . 0.0 112.017 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 17.1 m -116.91 8.03 13.41 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-O 121.397 0.618 . . . . 0.0 109.852 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -144.98 12.63 1.43 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.108 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.47 122.72 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.33 163.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 120.818 0.342 . . . . 0.0 111.012 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 tp -124.19 134.34 53.31 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.93 113.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.074 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.65 -157.62 12.48 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -76.63 26.29 0.13 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.42 148.56 35.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.71 152.3 64.07 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.811 2.341 . . . . 0.0 113.193 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.595 HG22 ' OD2' ' B' ' 51' ' ' ASP . 8.9 p -58.33 -39.86 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.401 ' O ' HD12 ' B' ' 24' ' ' LEU . 22.9 ptp -58.18 -25.64 61.78 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.221 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.9 -32.33 70.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 109.932 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -81.17 -37.04 29.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.485 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 51.9 t -58.81 -52.41 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 123.763 0.664 . . . . 0.0 110.374 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.401 HD12 ' O ' ' B' ' 20' ' ' MET . 8.4 mp -66.47 -30.15 70.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.738 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.34 -45.96 82.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.165 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.408 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.78 -41.23 99.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.558 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.9 mt -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.714 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -72.87 -32.98 65.8 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.295 0.569 . . . . 0.0 110.221 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 94.0 mt -70.72 -32.42 69.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 90.3 mt -60.08 -39.82 87.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.584 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -69.01 -24.39 64.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.616 0.722 . . . . 0.0 110.779 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -83.62 -3.3 57.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.43 12.45 51.21 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.145 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -91.05 95.88 5.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.5 p -89.09 -5.83 57.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.711 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.88 116.15 16.13 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.06 144.32 37.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.689 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.33 121.64 68.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.14 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -107.14 121.89 60.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.3 132.29 56.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.075 0.465 . . . . 0.0 110.174 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.85 159.16 28.74 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.761 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -129.89 143.55 50.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.737 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.13 -117.64 8.71 Favored Glycine 0 CA--C 1.497 -1.065 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.166 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -99.02 0.95 44.87 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.266 0.555 . . . . 0.0 110.176 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.75 -7.09 52.28 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.985 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.34 -40.38 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 110.802 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.39 -28.08 69.74 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.388 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -82.17 -29.7 31.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.73 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.14 -45.28 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.35 -33.59 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.086 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.595 ' OD2' HG22 ' B' ' 19' ' ' VAL . 35.4 t70 -62.4 -46.61 87.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.894 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -58.85 -51.03 71.76 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.907 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.75 -30.63 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.925 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 33.4 tt0 -68.91 -35.49 76.9 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.742 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 51' ' ' ASP . 79.6 mt -61.23 -43.18 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.741 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 67.4 t -68.46 -43.67 83.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.998 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 28.7 ptt180 -79.02 8.72 5.21 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.576 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -131.84 -3.51 3.64 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.395 0.617 . . . . 0.0 111.17 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.74 -64.75 1.2 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.745 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -80.56 -74.63 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.582 ' HB2' ' NZ ' ' B' ' 96' ' ' LYS . 2.4 mm? -119.57 103.2 9.21 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -84.7 -31.93 23.81 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 124.186 0.929 . . . . 0.0 110.809 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.91 -41.17 12.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.266 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -91.62 80.38 5.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.389 0.614 . . . . 0.0 111.814 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -161.24 136.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.693 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.465 ' OE1' ' HD2' ' B' ' 97' ' ' LYS . 47.1 mt-10 -116.75 143.29 45.84 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 125.16 50.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -81.69 -66.93 0.83 Allowed 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 123.274 0.359 . . . . 0.0 110.839 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -161.32 139.67 9.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.43 117.03 45.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -120.01 132.0 55.33 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.96 129.34 44.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.65 -148.39 6.61 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.076 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -106.72 133.54 51.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -118.82 125.75 50.27 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.58 111.12 21.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.865 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.28 160.44 11.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.293 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 31.2 p -95.84 117.79 31.24 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.676 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 41.2 t -56.46 -60.86 2.91 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.923 0.764 . . . . 0.0 112.247 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -145.43 -77.2 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.498 0.666 . . . . 0.0 109.216 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.95 -70.45 0.51 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.967 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.54 36.05 0.43 Allowed Glycine 0 C--O 1.22 -0.75 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.09 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -97.62 122.76 41.07 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -80.06 143.61 33.86 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.74 0.65 . . . . 0.0 111.006 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 41.4 t -138.38 137.98 37.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.78 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -96.69 110.56 22.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.44 135.83 57.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.8 p -69.88 124.72 24.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 50.8 p -128.59 152.86 47.84 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.893 0.377 . . . . 0.0 111.162 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 tt -139.6 136.74 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.04 112.13 18.76 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.775 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.84 117.61 55.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.49 128.1 54.65 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.4 pt -126.23 151.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 111.999 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -105.9 115.33 30.04 Favored 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.924 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.582 ' NZ ' ' HB2' ' B' ' 61' ' ' LEU . 13.8 mmmt -90.43 131.53 36.14 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.999 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.465 ' HD2' ' OE1' ' B' ' 66' ' ' GLU . 28.4 mtpp . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 CA--C 1.514 -0.436 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 m -130.74 -47.2 1.04 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.614 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -85.27 6.58 25.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.193 0.521 . . . . 0.0 112.17 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.23 79.27 0.3 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.7 p -93.25 107.22 24.07 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 122.286 0.235 . . . . 0.0 110.794 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.97 -36.47 10.19 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.525 2.15 . . . . 0.0 111.741 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.3 m 71.93 90.23 0.07 OUTLIER Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 124.458 1.103 . . . . 0.0 111.437 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -98.55 15.68 0.57 Allowed 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.199 2.6 . . . . 0.0 111.116 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 t -101.99 140.53 36.14 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.353 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -88.03 0.63 55.71 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 60.8 t -105.38 114.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.4 147.46 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 120.911 0.386 . . . . 0.0 111.074 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.11 122.72 45.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -88.25 105.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.573 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.17 58.91 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.128 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -163.06 -56.26 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.252 0.549 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -101.05 166.04 13.12 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.601 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -71.31 163.0 40.6 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.993 1.796 . . . . 0.0 111.303 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.29 -41.4 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -62.86 -24.88 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -73.32 -38.17 65.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -72.33 -33.24 67.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.143 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.07 -47.53 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.129 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.64 -31.75 71.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.942 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -71.72 -41.93 67.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.202 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.523 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -70.63 -34.29 71.92 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.68 -51.63 68.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.049 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.532 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 10.0 t -67.77 -35.56 78.92 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.7 mt -62.23 -34.15 75.94 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.8 mt -64.65 -23.9 67.41 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.851 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -100.31 -14.0 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 28' ' ' THR . 78.6 mt-30 -79.44 -20.22 48.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.838 0.351 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.48 -4.72 7.15 Favored Glycine 0 CA--C 1.492 -1.345 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.092 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -86.29 96.0 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.0 m -67.75 -30.43 69.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.501 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.62 126.34 20.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.737 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.77 161.14 22.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.933 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -124.21 121.66 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.1 mt -104.84 125.26 59.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -119.83 120.08 35.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.294 0.568 . . . . 0.0 110.524 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.28 155.51 28.25 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.027 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -131.63 141.47 49.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.232 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.46 -126.91 9.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.548 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -81.98 -10.96 59.09 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.57 35.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.182 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -55.6 -38.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 121.26 0.552 . . . . 0.0 109.61 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.7 p -71.48 -13.77 61.92 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.251 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' HZ1' ' HB2' ' A' ' 48' ' ' LYS . 4.8 ttmp? -95.06 -26.52 16.01 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.6 0.36 . . . . 0.0 110.09 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.07 66.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 110.766 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.67 -36.26 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.513 ' O ' HG13 ' A' ' 55' ' ' ILE . 45.5 t0 -59.92 -52.2 66.44 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.711 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.9 m -54.19 -52.01 62.56 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.56 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 23.7 m -69.3 -33.72 59.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.493 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 24.9 tt0 -72.05 -26.17 62.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.408 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.2 mt -70.09 -46.62 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.733 174.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.428 ' C ' ' H ' ' A' ' 58' ' ' ASN . 61.1 t -59.22 -48.97 85.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.77 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.483 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 38.9 ptt180 -78.29 37.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.518 0.675 . . . . 0.0 110.034 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.538 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 9.6 t30 -153.14 -51.04 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.8 ptm180 -76.69 -11.48 59.85 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -142.94 -60.74 0.43 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.494 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.297 0.6 OUTLIER -110.91 88.97 2.91 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.99 23.79 10.23 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.884 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -143.01 -69.42 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.795 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -86.52 75.16 9.78 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.619 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -161.79 137.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.92 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 9.6 pt-20 -130.37 167.52 18.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.099 0.476 . . . . 0.0 111.235 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.6 mt -104.87 139.54 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -80.92 -59.81 2.53 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -177.49 159.93 1.57 Allowed 'General case' 0 C--O 1.25 1.13 0 C-N-CA 124.869 1.267 . . . . 0.0 107.604 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.62 119.16 45.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -125.11 133.81 52.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.29 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.69 132.63 67.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.97 163.38 33.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.088 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.4 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 52.5 p -90.49 126.32 35.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.564 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -81.7 113.91 20.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 86' ' ' ARG . 24.3 t -100.6 106.9 20.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.57 163.91 31.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.035 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.5 p -98.23 130.38 44.95 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.796 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.5 m -62.3 -59.67 4.68 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.442 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -165.14 -49.6 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.444 ' HB2' ' HG3' ' A' ' 83' ' ' ARG . 6.9 m-20 -82.7 5.26 21.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.875 0.47 . . . . 0.0 111.002 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.5 11.83 56.6 Favored Glycine 0 C--O 1.21 -1.357 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG3' ' HB2' ' A' ' 81' ' ' ASP . 78.3 mtp180 -71.25 109.7 5.44 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -73.71 131.47 41.65 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.224 0.328 . . . . 0.0 110.623 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.1 t -129.39 133.88 47.59 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HG2' HG21 ' A' ' 76' ' ' VAL . 50.1 mtm180 -98.54 135.37 40.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.4 t -133.42 123.78 47.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -59.51 127.98 34.76 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 120.935 0.398 . . . . 0.0 111.058 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.9 p -133.48 162.17 32.6 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.7 tt -137.7 142.76 35.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.773 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -120.25 108.54 14.32 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.046 0.939 . . . . 0.0 108.711 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -118.77 129.48 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -131.24 130.35 42.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.8 pt -121.62 153.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HD3' ' OE2' ' A' ' 66' ' ' GLU . 35.3 ttt180 -129.99 140.1 50.95 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.247 0.546 . . . . 0.0 112.07 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -79.29 -174.31 4.1 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.566 1.146 . . . . 0.0 110.324 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 C--O 1.261 1.682 0 CA-C-O 117.964 -1.017 . . . . 0.0 108.533 174.256 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.426 ' HG3' ' H ' ' B' ' 2' ' ' SER . 20.5 ptp . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.426 ' H ' ' HG3' ' B' ' 1' ' ' MET . 15.6 m -69.2 134.66 49.52 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m -104.15 106.23 16.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.229 0.538 . . . . 0.0 110.955 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.66 60.45 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 41.4 m -69.84 -59.47 4.49 Favored Pre-proline 0 CA--C 1.561 1.382 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.35 -18.07 9.9 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 121.171 1.247 . . . . 0.0 113.002 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -167.56 144.27 3.6 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.7 150.89 27.94 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.102 1.868 . . . . 0.0 110.882 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.7 p -105.63 -20.51 13.44 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -114.83 4.74 14.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 61.1 t -109.22 112.56 41.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.0 147.63 12.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.111 0.481 . . . . 0.0 111.272 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 tp -105.73 122.37 45.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.6 mm -88.85 104.59 15.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.01 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.58 59.19 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.793 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -165.02 -57.07 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.331 0.586 . . . . 0.0 110.429 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -100.75 165.59 14.02 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.132 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.08 162.4 42.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.24 1.96 . . . . 0.0 111.313 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.07 -42.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -61.21 -25.08 66.8 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.68 -37.25 65.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.66 -32.88 64.22 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.167 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.76 -48.67 86.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.923 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.94 -30.34 70.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.204 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -72.65 -43.46 63.16 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.539 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -68.68 -32.72 72.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.42 -52.51 65.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.139 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' B' ' 32' ' ' GLN . 10.1 t -65.69 -38.22 88.63 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.656 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -60.29 -36.56 78.16 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 92.5 mt -63.74 -23.82 67.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.031 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -100.14 -15.45 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' B' ' 28' ' ' THR . 79.7 mt-30 -78.14 -27.48 48.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.819 0.342 . . . . 0.0 110.766 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.35 -6.88 3.98 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.466 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.47 97.18 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -67.16 -31.98 72.77 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.456 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -140.37 125.85 18.99 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.072 0.463 . . . . 0.0 111.489 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.442 HD11 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -121.83 158.68 25.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.309 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.94 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 48.9 t -121.5 122.38 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.507 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -104.83 125.32 59.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.738 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -119.57 120.33 36.41 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.39 155.28 28.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.594 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -130.42 140.38 50.57 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.913 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.86 -129.44 10.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.703 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -82.34 -9.33 59.51 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.105 0.479 . . . . 0.0 110.156 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.1 -5.55 36.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.013 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.4 mt -54.26 -40.73 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.48 0.657 . . . . 0.0 109.997 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 75.4 p -67.08 -23.4 65.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.169 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.503 ' HZ1' ' HB2' ' B' ' 48' ' ' LYS . 4.8 ttmp? -85.39 -28.45 25.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.281 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.74 -45.32 75.33 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.77 -37.23 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.005 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.555 ' O ' HG13 ' B' ' 55' ' ' ILE . 44.0 t0 -56.94 -52.89 63.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.576 0.75 . . . . 0.0 109.202 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.2 m -54.7 -52.16 63.29 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.854 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.464 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.2 m -70.29 -32.97 52.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.104 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 24.3 tt0 -71.37 -26.38 62.77 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.973 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.6 mt -70.13 -46.39 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.879 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' B' ' 58' ' ' ASN . 57.4 t -59.14 -49.81 82.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.827 0.346 . . . . 0.0 110.898 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' B' ' 53' ' ' VAL . 39.3 ptt180 -77.48 36.73 0.2 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-O 121.449 0.642 . . . . 0.0 110.032 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' B' ' 56' ' ' VAL . 7.9 t30 -152.1 -52.18 0.12 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 123.092 0.557 . . . . 0.0 110.496 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.2 ptm180 -74.4 -14.84 60.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -139.74 -64.78 0.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.321 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . 0.278 0.5 OUTLIER -107.88 93.98 4.83 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -177.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.69 13.36 35.12 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.693 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.94 -69.25 0.54 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.803 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -83.23 75.73 9.93 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.655 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.0 tp -161.71 143.32 3.53 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 C-N-CA 124.198 0.999 . . . . 0.0 108.768 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.93 164.16 29.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.907 0.384 . . . . 0.0 111.6 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.38 138.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -81.55 -60.54 2.22 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -175.82 160.39 2.38 Favored 'General case' 0 C--O 1.262 1.744 0 C-N-CA 124.795 1.238 . . . . 0.0 107.903 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.7 mt -131.48 119.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -125.88 135.02 51.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.677 0.275 . . . . 0.0 110.354 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.55 131.54 73.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.4 165.83 35.65 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.75 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 37.0 p -89.75 127.27 35.93 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.798 0.332 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -81.35 114.08 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.427 HG21 ' HG2' ' B' ' 86' ' ' ARG . 25.8 t -101.32 106.63 19.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.01 162.05 37.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.596 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 14.9 p -96.39 130.07 43.6 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 24.1 m -63.05 -58.93 5.63 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.541 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -164.89 -53.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.426 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.76 7.62 8.27 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.679 0.392 . . . . 0.0 111.369 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.13 9.65 59.2 Favored Glycine 0 C--O 1.206 -1.647 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.619 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -71.64 108.95 5.25 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -73.71 137.18 43.88 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.094 0.473 . . . . 0.0 110.571 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 32.9 t -133.5 138.14 45.97 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.538 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 34.6 mtm180 -102.48 135.23 44.48 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 177.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.39 123.13 46.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 m -58.41 127.51 32.5 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.33 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 36.4 p -134.18 159.33 41.21 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 123.595 0.758 . . . . 0.0 109.764 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.42 142.09 41.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.828 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -120.61 106.61 11.92 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 123.915 0.886 . . . . 0.0 108.668 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.37 130.2 71.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.87 132.02 46.28 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -123.49 149.04 27.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.248 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -125.39 144.24 50.6 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.575 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -84.1 -170.11 2.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.063 1.345 . . . . 0.0 110.24 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' B' ' 97' ' ' LYS . 21.3 pttp . . . . . 0 C--O 1.261 1.679 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.3 t -69.33 -55.57 10.03 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 123.6 0.562 . . . . 0.0 112.441 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.3 t -95.18 -56.65 2.66 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.733 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.36 28.31 27.93 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.898 -1.144 . . . . 0.0 111.637 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 p -120.86 148.1 47.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.35 115.47 2.89 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.58 2.186 . . . . 0.0 113.097 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -83.07 142.47 44.4 Favored Pre-proline 0 C--N 1.311 -1.075 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.205 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.64 178.89 3.47 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 122.871 2.381 . . . . 0.0 112.44 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -85.18 35.33 0.58 Allowed 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.537 0.735 . . . . 0.0 110.551 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.83 8.85 39.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.233 0.54 . . . . 0.0 109.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 59.7 t -105.08 123.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.085 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -120.25 142.83 34.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.683 0.278 . . . . 0.0 110.825 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 131.8 47.3 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.786 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.7 mm -93.75 111.68 25.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.878 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.66 28.97 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.03 -1.557 . . . . 0.0 114.622 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.56 -50.01 0.41 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.791 0.795 . . . . 0.0 112.155 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -100.93 160.64 26.14 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.59 159.68 35.58 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 121.741 1.627 . . . . 0.0 110.893 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.486 HG23 ' OD2' ' A' ' 51' ' ' ASP . 7.5 p -55.66 -38.54 50.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.0 ptm -61.05 -26.08 67.38 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.999 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.41 -43.34 77.41 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -70.95 -35.07 72.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.595 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.34 -51.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.647 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.8 mt -65.91 -33.81 76.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.844 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.94 -45.52 85.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.227 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.99 95.53 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.427 0.454 . . . . 0.0 110.481 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.67 -35.11 78.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.427 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 m -73.89 -43.6 57.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.735 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.47 -34.39 78.09 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.147 0.499 . . . . 0.0 110.587 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -58.73 -44.73 90.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.348 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.26 -22.38 63.84 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.94 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -82.0 -2.29 51.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.076 0.465 . . . . 0.0 110.9 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.58 -8.89 32.48 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 t -92.07 92.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.442 ' HA ' HD23 ' A' ' 30' ' ' LEU . 57.4 p -95.78 -9.92 30.43 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.199 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.24 104.99 10.52 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.15 157.67 38.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.151 -175.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.3 t -124.21 116.98 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.194 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.85 121.6 48.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 85.7 mttt -118.14 120.99 39.4 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.269 0.556 . . . . 0.0 110.378 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.65 156.45 25.85 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.951 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HG2' HG21 ' A' ' 89' ' ' THR . 88.3 mtt180 -130.91 143.15 50.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.19 -119.6 11.99 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.515 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -85.73 -8.7 58.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.439 0.638 . . . . 0.0 110.433 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.42 -4.53 42.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.166 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -56.01 -36.71 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.564 0.697 . . . . 0.0 109.912 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.3 p -64.64 -31.51 72.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.576 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -78.85 -31.44 45.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.502 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.77 -46.82 77.33 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.414 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -72.08 -33.87 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.873 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.486 ' OD2' HG23 ' A' ' 19' ' ' VAL . 31.3 t70 -60.24 -47.47 85.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.9 m -53.3 -53.7 47.12 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.414 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.18 -30.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.61 -39.8 88.54 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 51' ' ' ASP . 89.0 mt -59.97 -45.55 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.25 -40.44 86.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.093 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -83.55 15.77 2.95 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.31 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -136.72 12.66 3.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.847 0.832 . . . . 0.0 109.255 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.07 -49.04 0.28 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.147 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' HD22 ' A' ' 61' ' ' LEU . 56.2 t80 -90.24 -70.36 0.67 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.955 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 60' ' ' PHE . 4.1 mm? -129.43 110.38 11.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.128 0.489 . . . . 0.0 111.316 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.7 12.57 36.25 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.943 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -126.04 -64.09 1.07 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.415 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 98.2 mttt -78.76 102.08 7.93 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.686 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tp -160.66 126.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.83 0.452 . . . . 0.0 110.329 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.507 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 41.0 tt0 -119.19 130.64 55.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.3 mt -95.21 128.06 46.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.65 -62.07 1.57 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.258 0.349 . . . . 0.0 111.239 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 10.0 tp10 -162.59 141.71 9.05 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.95 107.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.208 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HE ' ' CD ' ' A' ' 69' ' ' GLU . 91.0 mtt180 -131.18 144.91 51.7 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.519 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.02 132.51 66.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.24 -174.42 22.81 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.122 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -124.78 128.46 48.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -106.84 138.84 42.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.98 107.89 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.36 151.19 18.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.619 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.0 p -93.2 115.8 28.41 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.0 t -75.43 -38.93 59.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -128.93 -96.84 0.39 Allowed 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.84 0.353 . . . . 0.0 111.13 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -93.42 -76.1 0.48 Allowed 'General case' 0 C--O 1.216 -0.695 0 CA-C-O 121.788 0.804 . . . . 0.0 109.268 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.67 21.39 6.31 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -79.54 101.8 8.47 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -85.07 132.65 34.29 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.434 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 t -133.66 130.95 38.95 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -88.69 124.75 34.41 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.7 120.91 60.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.4 t -63.5 128.19 34.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.526 HG21 ' HG2' ' A' ' 42' ' ' ARG . 61.5 p -120.76 134.35 55.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.424 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -123.12 128.39 75.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -107.65 110.77 22.72 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -103.98 106.78 20.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.76 40.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.901 0.381 . . . . 0.0 110.432 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.11 151.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.364 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.507 ' HD3' ' OE1' ' A' ' 66' ' ' GLU . 75.3 ttt180 -121.85 119.29 31.19 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.493 0.663 . . . . 0.0 110.255 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 64' ' ' LYS . 8.3 mmmm -85.29 131.02 34.48 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.392 0.615 . . . . 0.0 112.403 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' OXT' ' HB3' ' A' ' 64' ' ' LYS . 55.9 mtpt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 CA--C 1.502 -0.877 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.9 m -147.04 136.28 22.59 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 24.5 t 65.98 -165.61 0.23 Allowed 'General case' 0 CA--C 1.551 0.99 0 O-C-N 123.922 0.764 . . . . 0.0 110.203 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.49 65.22 0.6 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.44 ' HB ' ' HD3' ' B' ' 6' ' ' PRO . 27.5 m -54.19 -50.88 82.11 Favored Pre-proline 0 CA--C 1.579 2.088 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.44 ' HD3' ' HB ' ' B' ' 5' ' ' THR . 18.6 Cg_exo -69.88 -50.53 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 121.553 1.502 . . . . 0.0 112.23 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -169.56 138.51 1.61 Allowed Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -82.07 115.53 2.67 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.442 2.095 . . . . 0.0 111.843 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 50.6 m -99.13 16.11 23.78 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.869 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -114.48 9.8 16.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.994 -0.441 . . . . 0.0 110.7 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.16 124.56 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.813 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.83 141.08 42.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.019 0.438 . . . . 0.0 111.581 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.24 129.62 46.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.874 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.09 111.36 24.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.469 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.76 28.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 119.105 -1.521 . . . . 0.0 114.911 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.97 -48.72 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.265 0.533 . . . . 0.0 111.661 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -101.55 160.9 25.2 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.61 162.3 21.7 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.981 1.787 . . . . 0.0 111.728 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.415 ' O ' HG22 ' B' ' 23' ' ' VAL . 7.2 p -58.71 -38.46 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.576 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.424 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 25.7 ptm -62.61 -26.24 68.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.639 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -66.69 -46.76 74.56 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -67.21 -34.29 77.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.835 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.415 HG22 ' O ' ' B' ' 19' ' ' VAL . 58.3 t -61.21 -50.51 80.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.618 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' B' ' 20' ' ' MET . 86.3 mt -67.32 -36.03 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.641 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.424 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.01 -44.56 95.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.336 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.49 98.77 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.371 0.419 . . . . 0.0 110.499 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.8 -36.17 82.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.571 . . . . 0.0 111.049 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 59.7 m -72.51 -45.06 61.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.659 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 93.6 mt -64.06 -33.67 76.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.298 0.571 . . . . 0.0 110.262 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 35' ' ' SER . 0.2 OUTLIER -58.41 -46.66 86.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.375 -177.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -68.28 -21.85 64.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.352 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.68 -4.25 55.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.34 -3.92 29.72 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.906 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -95.93 91.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.395 0.616 . . . . 0.0 109.516 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' SER . . . . . 0.401 ' HA ' HD23 ' B' ' 30' ' ' LEU . 58.3 p -94.78 -8.61 37.04 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.346 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.82 104.98 9.63 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.41 HD11 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -125.29 159.11 32.95 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.981 -173.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.7 117.12 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.198 0.523 . . . . 0.0 110.147 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -97.83 121.08 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.4 mttt -118.12 119.97 36.32 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.391 0.615 . . . . 0.0 110.178 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.2 156.56 25.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.667 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.493 ' HG2' HG21 ' B' ' 89' ' ' THR . 92.3 mtt180 -130.73 144.51 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.593 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.28 -123.44 23.3 Favored Glycine 0 C--O 1.215 -1.09 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.232 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -81.18 -12.77 59.11 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.224 0.535 . . . . 0.0 110.915 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.83 -3.47 28.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -55.15 -37.92 44.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.46 0.648 . . . . 0.0 109.793 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.4 p -64.69 -31.68 73.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.836 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -79.12 -29.73 43.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.33 -48.32 73.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 120.78 0.324 . . . . 0.0 110.957 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.98 -34.6 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.511 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.3 t70 -58.49 -48.65 80.09 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -52.46 -53.43 45.69 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.378 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -31.17 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.98 -39.43 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.511 HG13 ' O ' ' B' ' 51' ' ' ASP . 89.8 mt -59.33 -47.69 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.722 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -59.31 -39.4 78.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 CA-C-O 121.123 0.487 . . . . 0.0 110.863 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -84.86 17.12 2.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -141.65 18.47 2.18 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -150.26 -46.44 0.13 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.078 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.464 ' O ' HD23 ' B' ' 61' ' ' LEU . 62.7 t80 -92.37 -68.13 0.82 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.852 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.464 HD23 ' O ' ' B' ' 60' ' ' PHE . 3.9 mm? -132.49 111.84 11.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.805 0.336 . . . . 0.0 111.014 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.79 13.96 31.93 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.534 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -127.53 -64.7 0.97 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.088 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.525 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 98.4 mttt -74.91 99.67 3.88 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.903 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.8 tp -160.34 128.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.499 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 38.2 tt0 -122.64 129.65 52.09 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -94.44 127.21 46.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -87.73 -63.07 1.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.556 0.535 . . . . 0.0 111.188 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 10.5 tp10 -161.63 140.41 9.65 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 pt -143.31 110.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.284 0.564 . . . . 0.0 110.73 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 92.9 mtt180 -133.57 145.62 50.24 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.726 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.29 128.81 75.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.27 -173.52 19.24 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.557 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 126.07 43.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -105.46 139.01 40.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.56 109.63 24.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.39 154.34 17.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.319 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 30.3 p -95.56 116.43 28.82 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 46.2 t -76.46 -34.09 58.7 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -132.27 -99.71 0.29 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.102 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.51 -73.42 0.54 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.31 20.18 5.91 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -77.04 99.93 5.49 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -82.46 136.36 34.93 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 123.761 0.663 . . . . 0.0 110.105 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 18.9 t -139.74 133.19 30.14 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -87.27 130.71 34.49 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 66.6 t -129.3 117.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -64.02 131.23 46.98 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.493 HG21 ' HG2' ' B' ' 42' ' ' ARG . 59.9 p -123.22 133.73 54.19 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.559 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 16.1 tt -121.44 128.83 75.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.68 107.37 16.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -102.79 107.02 21.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.29 120.97 41.43 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.531 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -127.94 149.46 32.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.298 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.499 ' HD3' ' OE2' ' B' ' 66' ' ' GLU . 71.5 ttt180 -119.37 118.27 30.74 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.5 0.666 . . . . 0.0 110.349 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.525 ' HE3' ' O ' ' B' ' 64' ' ' LYS . 7.6 mmmm -84.16 129.58 34.89 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt . . . . . 0 C--O 1.257 1.492 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.398 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.7 t -76.83 111.08 11.97 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 m -145.03 152.28 39.88 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.87 178.11 20.72 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.2 p 56.1 96.47 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 124.426 1.09 . . . . 0.0 113.032 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.04 130.27 33.81 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 122.888 2.392 . . . . 0.0 113.017 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -88.28 141.18 30.65 Favored Pre-proline 0 N--CA 1.436 -1.163 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.37 178.21 4.55 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.448 2.099 . . . . 0.0 111.199 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.5 m -78.44 78.75 4.9 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.367 0.603 . . . . 0.0 110.293 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -140.21 11.34 2.37 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.164 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 50.9 t -120.4 124.67 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.82 149.38 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.825 0.345 . . . . 0.0 111.189 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.81 123.57 48.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.774 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -89.54 99.36 9.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.43 52.35 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.452 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -166.68 -56.34 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.04 167.76 10.25 Favored Pre-proline 0 CA--C 1.555 1.166 0 O-C-N 122.393 -0.192 . . . . 0.0 111.027 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.33 153.66 61.38 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.162 1.908 . . . . 0.0 112.514 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.91 -40.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.497 1.119 . . . . 0.0 113.469 -177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.416 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.3 ptm -62.5 -25.83 68.22 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.709 0.804 . . . . 0.0 111.823 -175.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -84.05 -27.77 28.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.022 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -73.14 -37.64 66.55 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 89.2 t -57.57 -47.78 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.567 0.698 . . . . 0.0 109.547 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.6 mt -65.26 -36.31 83.71 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.076 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.427 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.791 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.87 87.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.605 0.241 . . . . 0.0 111.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 86.8 mt -66.49 -31.55 72.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.6 0.714 . . . . 0.0 110.296 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 91.2 m -74.18 -40.35 62.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.176 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 97.5 mt -62.27 -38.68 90.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.192 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.9 tp -57.17 -46.12 83.08 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.9 -23.63 66.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.762 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 28' ' ' THR . 83.3 mm-40 -81.35 -11.91 59.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.185 0.516 . . . . 0.0 110.355 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.7 24.36 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.539 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.97 93.96 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 121.397 0.617 . . . . 0.0 109.599 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 p -89.04 -21.31 23.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.61 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -108.04 105.52 15.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -121.08 149.65 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.691 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 49.0 t -122.9 120.78 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.272 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -103.17 122.82 56.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.463 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -115.42 124.55 51.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 111.331 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.69 143.26 47.85 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.351 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -129.81 127.15 39.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.631 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.89 -138.35 14.1 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.934 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -82.97 4.31 26.41 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.487 0.661 . . . . 0.0 110.869 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.99 -4.01 53.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.553 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.71 -43.49 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.119 0.568 . . . . 0.0 110.575 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -19.14 64.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HB2' ' HZ2' ' A' ' 48' ' ' LYS . 4.5 ttmp? -90.45 -32.8 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.63 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.71 -43.59 88.69 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.912 0.387 . . . . 0.0 111.719 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.08 -32.67 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.429 ' O ' HG13 ' A' ' 55' ' ' ILE . 23.9 t70 -65.82 -38.95 90.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.4 m -60.42 -51.33 69.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.078 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.422 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 35.9 m -66.17 -38.15 81.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.666 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mm-40 -59.72 -36.56 76.8 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.1 mt -66.88 -44.19 89.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 0.0 110.292 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.76 -38.75 82.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.725 0.298 . . . . 0.0 111.725 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.666 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 4.1 ptm180 -89.84 11.24 20.81 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.86 -30.71 3.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.268 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -93.78 -59.07 2.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.33 -55.24 12.74 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.964 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.453 ' HB3' ' HZ2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -160.0 108.35 1.71 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.57 -35.12 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 123.972 0.795 . . . . 0.0 112.745 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.05 -26.64 68.34 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -122.36 101.51 7.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.718 0.295 . . . . 0.0 110.765 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tp -156.94 146.7 11.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -135.19 141.26 45.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.27 132.57 40.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -91.45 -48.11 7.06 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.937 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -173.83 145.87 1.18 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.45 97.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.678 0.751 . . . . 0.0 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -127.69 141.89 51.48 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.782 -0.574 . . . . 0.0 110.978 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.85 143.75 29.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.3 -165.69 21.95 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.674 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m -115.46 144.83 43.25 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 59.4 tt0 -101.67 131.17 48.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.416 HG23 ' HG2' ' A' ' 86' ' ' ARG . 49.4 t -112.81 111.31 35.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -123.98 157.43 30.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.921 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.3 p -97.52 123.36 41.36 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.845 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.4 t -71.92 -41.35 67.97 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.209 0.528 . . . . 0.0 110.887 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -128.73 -70.2 0.68 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -138.36 -80.11 0.34 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.546 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.99 -7.1 61.39 Favored Glycine 0 C--N 1.31 -0.885 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -72.97 97.58 2.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -91.12 148.65 22.22 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.863 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.6 m -139.5 135.56 33.62 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.484 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 79.0 mtt180 -102.02 124.78 48.23 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.19 138.78 52.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.9 t -75.24 136.41 40.95 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.7 p -136.14 145.22 45.59 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.4 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.45 138.91 53.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.364 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -115.42 111.69 21.19 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.74 110.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.88 124.13 50.93 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 pt -124.49 162.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 120.848 0.356 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -129.98 108.68 10.29 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 7.1 tmtm? -84.15 130.87 34.82 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 -173.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.541 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 35.3 mmtp . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -85.73 -75.2 0.38 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 24.3 p -93.8 138.97 31.41 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.472 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.79 49.6 0.85 Allowed Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -82.05 122.7 79.91 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 123.384 0.674 . . . . 0.0 110.557 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.47 -32.23 80.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.502 2.135 . . . . 0.0 112.907 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -99.62 133.09 22.09 Favored Pre-proline 0 C--N 1.31 -1.136 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.27 114.6 3.93 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.538 2.158 . . . . 0.0 112.235 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -87.81 -4.43 58.87 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.661 0.743 . . . . 0.0 109.812 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -94.27 8.81 40.5 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.946 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.68 119.71 61.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.53 148.05 15.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.454 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.47 120.24 41.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.707 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.96 100.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.73 51.19 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.509 -1.329 . . . . 0.0 113.916 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -167.08 -55.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -100.14 168.47 9.38 Favored Pre-proline 0 CA--C 1.556 1.176 0 O-C-N 122.129 -0.357 . . . . 0.0 111.106 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.81 156.15 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.236 1.957 . . . . 0.0 112.302 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.81 -43.89 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.0 ptp -54.89 -32.85 61.4 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -77.73 -28.39 50.77 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.929 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.73 -37.95 64.94 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.453 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 79.7 t -57.68 -47.86 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.484 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.072 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.57 -43.54 89.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.2 -38.08 89.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.5 mt -65.89 -31.21 72.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.33 0.586 . . . . 0.0 110.358 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' B' ' 32' ' ' GLN . 64.4 m -74.88 -42.09 58.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.796 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.3 mt -60.86 -38.53 85.87 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.616 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 tp -57.18 -44.24 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.157 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.2 -16.22 62.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.827 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' B' ' 28' ' ' THR . 82.5 mm-40 -87.27 -7.82 57.44 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.306 0.574 . . . . 0.0 109.889 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.61 34.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.757 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.6 t -99.05 95.76 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.274 0.559 . . . . 0.0 109.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 12.8 p -90.49 -25.49 20.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.425 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -103.37 107.6 18.5 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.88 148.0 28.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 120.91 0.386 . . . . 0.0 110.743 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.43 122.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.678 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.3 mt -105.39 120.22 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.997 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -113.55 123.33 49.73 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.362 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.31 147.39 42.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.413 ' NE ' HG11 ' B' ' 87' ' ' VAL . 3.0 tmt_? -133.09 129.48 38.03 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.116 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.77 -142.13 16.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.0 5.67 11.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.35 0.595 . . . . 0.0 110.81 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.25 -5.21 55.83 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.5 -44.38 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.407 0.683 . . . . 0.0 110.81 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.0 t -59.82 -32.64 70.84 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.049 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.41 ' HB2' ' HZ2' ' B' ' 48' ' ' LYS . 4.4 ttmp? -76.8 -34.24 57.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.753 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -45.61 83.22 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 120.803 0.335 . . . . 0.0 111.768 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.51 -35.88 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.42 ' O ' HG13 ' B' ' 55' ' ' ILE . 29.8 t70 -62.59 -41.57 99.04 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 91.5 m -57.03 -50.04 73.94 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.903 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 35.4 m -67.09 -38.42 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.654 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 17.0 mm-40 -59.72 -38.91 82.97 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.42 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.5 mt -64.36 -45.02 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.25 -37.02 77.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 120.96 0.409 . . . . 0.0 111.792 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.654 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 4.5 ptm180 -91.48 11.63 23.4 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -126.13 -29.52 3.03 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.096 0.474 . . . . 0.0 110.968 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -93.86 -58.28 2.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -68.69 -58.39 4.3 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.447 ' HB3' ' HZ2' ' B' ' 96' ' ' LYS . 0.2 OUTLIER -157.95 109.58 2.27 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.34 -42.13 12.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 124.423 1.077 . . . . 0.0 112.63 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.1 -34.25 68.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 0.0 112.585 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -118.05 101.11 7.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.168 0.509 . . . . 0.0 110.966 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.04 146.31 13.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -132.17 143.8 50.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.86 129.74 50.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -90.57 -47.9 7.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -172.55 147.03 1.8 Allowed 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.751 0.657 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.01 94.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.443 0.697 . . . . 0.0 110.54 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -127.56 141.17 51.71 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.311 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.87 144.48 24.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.27 -175.32 35.81 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.618 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.426 ' HG ' ' CD ' ' A' ' 54' ' ' GLU . 45.8 m -107.08 143.91 34.52 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.391 0.615 . . . . 0.0 112.266 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 61.1 tt0 -99.71 132.56 44.97 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' B' ' 86' ' ' ARG . 47.0 t -115.01 108.31 25.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.45 157.53 23.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.28 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 32.0 p -96.94 124.41 40.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.941 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 48.2 t -74.55 -36.29 63.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.965 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -133.84 -74.44 0.48 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -133.66 -80.7 0.47 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.755 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.76 -3.88 62.18 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.151 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -74.07 97.98 3.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -87.87 154.26 20.67 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.239 -177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.7 m -143.85 134.88 25.49 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.599 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 83.2 mtt180 -103.95 125.58 50.44 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 173.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.413 HG11 ' NE ' ' B' ' 42' ' ' ARG . 96.0 t -126.99 137.42 57.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -74.48 135.49 42.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.571 . . . . 0.0 110.701 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 35.3 p -136.96 146.11 45.0 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.51 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.83 137.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.235 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -113.53 111.33 21.71 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 57.5 mt -110.55 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.93 123.75 50.52 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.802 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.0 pt -124.59 162.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.237 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -128.84 107.33 9.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.554 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 7.0 tmtm? -84.57 131.75 34.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.936 -174.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.554 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 34.7 mmtp . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 tpp . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.623 0.249 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 t -110.84 -75.18 0.62 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.815 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -119.56 170.16 9.42 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.56 159.29 16.17 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.1 m -70.4 -46.3 19.61 Favored Pre-proline 0 CA--C 1.577 1.987 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.2 123.11 13.05 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 121.737 1.624 . . . . 0.0 111.914 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.3 m -72.73 118.56 69.1 Favored Pre-proline 0 N--CA 1.435 -1.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.503 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.31 121.23 7.58 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.886 2.391 . . . . 0.0 112.205 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.7 m -89.01 16.01 7.72 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.235 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -98.7 15.55 24.88 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.17 0.509 . . . . 0.0 110.481 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.5 t -122.53 111.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.38 146.62 10.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.941 0.4 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 tp -112.2 124.17 51.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 51.0 mt -88.3 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 O-C-N 123.186 0.303 . . . . 0.0 110.865 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.27 -94.42 0.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.661 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -103.42 6.97 38.02 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -98.25 145.43 29.82 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.636 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.93 151.35 82.34 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.52 2.147 . . . . 0.0 112.503 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.42 HG23 ' OG1' ' A' ' 52' ' ' THR . 7.0 p -52.83 -41.4 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -58.85 -28.81 66.44 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.27 -39.0 86.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 93.2 m-85 -75.03 -37.6 61.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.85 -54.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.329 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.84 -32.54 73.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.97 -47.24 72.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.502 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.78 99.54 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 123.485 0.491 . . . . 0.0 111.064 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.41 -34.74 77.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.021 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.7 m -73.96 -34.19 64.16 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.394 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 84.6 mt -67.26 -32.25 73.13 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-O 120.838 0.351 . . . . 0.0 110.909 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.49 -30.01 71.05 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.328 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -84.28 -4.89 59.14 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.985 0.898 . . . . 0.0 109.805 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -101.72 -19.83 15.22 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.593 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.08 11.29 10.07 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.693 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.61 94.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.626 0.713 . . . . 0.0 109.358 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -71.1 -41.09 71.04 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.464 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.42 124.06 50.21 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.54 0.686 . . . . 0.0 111.857 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -128.69 156.84 41.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.523 -177.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -120.29 128.41 75.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.3 mt -108.72 120.16 59.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.66 133.93 54.44 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.323 0.582 . . . . 0.0 110.122 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.6 162.63 31.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 149.97 30.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.14 -130.29 11.27 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -88.9 1.06 55.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.678 0.751 . . . . 0.0 109.776 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.61 -6.25 58.82 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.6 mt -53.97 -37.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.232 0.539 . . . . 0.0 110.442 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.3 t -61.99 -30.46 70.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -83.01 -21.95 33.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.122 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.46 -47.02 65.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.832 0.348 . . . . 0.0 110.263 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.47 ' HA ' HG21 ' A' ' 53' ' ' VAL . 9.9 p -69.83 -32.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.164 0.506 . . . . 0.0 109.796 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 55' ' ' ILE . 36.4 t70 -61.72 -44.06 97.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.083 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.42 ' OG1' HG23 ' A' ' 19' ' ' VAL . 85.6 m -63.85 -48.06 78.25 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.268 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 50' ' ' VAL . 33.5 m -69.39 -33.81 59.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.72 -43.62 96.01 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.181 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.9 mt -56.68 -46.78 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.65 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.0 -43.87 98.19 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.895 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -83.95 10.22 10.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.133 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -125.1 -16.93 5.89 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.48 0.657 . . . . 0.0 111.142 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -105.82 -47.48 3.87 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.19 -67.5 0.83 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.901 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 3.4 mm? -130.98 104.5 7.16 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 120.979 0.419 . . . . 0.0 110.43 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.98 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.091 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.98 -36.68 59.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.176 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -123.15 89.05 3.04 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.633 0.73 . . . . 0.0 110.54 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.14 131.32 10.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.995 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.21 146.15 51.18 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.29 135.6 35.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -85.45 -57.92 2.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.067 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -168.93 151.4 4.87 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.43 116.9 26.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -126.68 146.24 50.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -147.43 137.53 16.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.1 -157.42 13.92 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.655 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.6 m -113.46 128.51 56.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.03 141.52 45.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.8 t -95.39 113.84 30.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.15 158.84 35.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.207 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.1 p -85.98 146.57 26.61 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -72.98 -48.24 38.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.324 0.583 . . . . 0.0 110.146 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 179.08 -41.18 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.86 -167.09 1.38 Allowed 'General case' 0 C--O 1.251 1.163 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.18 56.48 4.86 Favored Glycine 0 C--N 1.316 -0.579 0 CA-C-N 118.341 0.519 . . . . 0.0 112.081 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -124.33 114.71 19.91 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -83.73 130.09 34.95 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 123.887 0.742 . . . . 0.0 110.706 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.3 t -127.19 138.61 53.16 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -98.07 129.22 44.91 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.42 140.5 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 p -71.02 119.9 15.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 123.62 0.575 . . . . 0.0 110.54 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.5 p -116.53 154.11 30.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.948 0.499 . . . . 0.0 109.881 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.9 tt -143.07 132.18 20.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 108.0 16.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.96 116.05 48.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.58 125.12 49.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.413 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.7 pt -122.46 152.22 26.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -122.42 109.29 14.2 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.362 0.601 . . . . 0.0 111.272 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HB3' ' HZ1' ' A' ' 96' ' ' LYS . 4.3 mmmp? -79.31 135.07 36.63 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? . . . . . 0 C--N 1.285 -2.198 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.039 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 C--O 1.211 -0.955 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 35.5 t -71.76 -36.88 70.52 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.1 t -130.47 162.42 29.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.07 -167.71 24.82 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -106.26 106.28 56.74 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -84.59 -179.43 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.584 2.189 . . . . 0.0 112.109 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -83.47 145.48 48.19 Favored Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.222 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.26 140.36 53.13 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.829 2.352 . . . . 0.0 112.032 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 35.0 p -115.88 2.98 13.67 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.907 0.384 . . . . 0.0 111.777 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -97.92 13.34 31.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.235 0.54 . . . . 0.0 110.405 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 53.3 t -118.1 111.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.75 148.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.827 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp -115.13 122.39 45.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.456 ' HA ' ' OH ' ' B' ' 22' ' ' TYR . 55.3 mt -86.99 131.71 34.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.945 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.21 -97.41 0.25 Allowed Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.72 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -99.15 -0.11 42.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.119 0.485 . . . . 0.0 110.338 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.01 145.91 32.63 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.655 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.98 154.65 73.13 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.906 2.404 . . . . 0.0 112.21 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.402 HG23 ' OG1' ' B' ' 52' ' ' THR . 7.2 p -56.16 -40.91 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.546 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.12 -30.1 67.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -63.87 -39.19 93.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.709 0.766 . . . . 0.0 109.706 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . 0.456 ' OH ' ' HA ' ' B' ' 14' ' ' ILE . 92.8 m-85 -76.89 -37.85 54.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.676 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 65.4 t -60.65 -52.89 56.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.71 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.52 -33.62 75.99 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.219 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.43 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -64.91 -47.42 77.83 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.576 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.34 96.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.35 -34.48 76.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 111.313 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 73.4 m -73.53 -34.38 65.19 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.523 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.1 mt -67.19 -31.0 71.1 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.921 0.391 . . . . 0.0 111.268 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.21 -26.26 67.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -86.89 -2.64 58.75 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.749 0.785 . . . . 0.0 109.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -105.29 -16.31 14.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.655 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.65 13.27 14.75 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.64 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.74 95.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 22.4 m -73.2 -38.95 65.92 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.136 0.575 . . . . 0.0 112.475 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.25 122.74 44.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.491 0.662 . . . . 0.0 111.623 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.405 ' H ' HD12 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.27 156.88 40.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.85 -176.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 62.1 t -121.36 126.54 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.285 0.564 . . . . 0.0 110.247 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -108.26 121.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.04 135.09 54.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.208 0.528 . . . . 0.0 110.494 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.96 160.67 37.57 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.53 147.65 28.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -126.04 7.21 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -93.98 1.95 56.17 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.735 0.779 . . . . 0.0 109.464 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.67 -6.33 59.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.521 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 71.4 mt -53.97 -36.86 32.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 CA-C-O 121.891 0.853 . . . . 0.0 109.732 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -63.95 -30.54 71.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.047 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -82.36 -25.27 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.715 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.53 80.59 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.924 0.392 . . . . 0.0 110.419 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.433 ' HA ' HG21 ' B' ' 53' ' ' VAL . 12.7 p -71.09 -33.29 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.567 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.427 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.8 t70 -59.51 -47.18 86.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.454 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.402 ' OG1' HG23 ' B' ' 19' ' ' VAL . 63.7 m -60.25 -48.42 81.83 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.4 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 33.4 m -70.26 -32.44 50.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.07 -41.79 94.75 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.982 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.427 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.4 mt -57.8 -48.59 83.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.816 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.02 -43.28 95.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.948 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' B' ' 53' ' ' VAL . 12.8 ptm180 -84.29 11.73 7.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.72 -15.29 4.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.17 0.509 . . . . 0.0 110.753 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -103.69 -52.38 2.99 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -85.8 -65.61 0.99 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.476 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.41 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 3.4 mm? -131.25 106.86 8.58 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 123.027 0.531 . . . . 0.0 110.692 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.92 -19.39 17.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.022 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.76 -33.32 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.763 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -124.38 89.74 3.13 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.01 137.65 19.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.008 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.52 143.2 41.53 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -100.85 138.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -87.21 -55.64 3.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.12 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -171.66 150.73 2.77 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.41 117.7 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -126.62 148.23 49.82 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.709 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -147.73 138.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.43 -155.27 10.17 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.8 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.6 m -118.86 124.93 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -107.45 144.88 33.75 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.92 113.35 33.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.91 157.37 35.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.466 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 15.8 p -84.27 143.14 29.74 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.796 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 22.7 m -71.29 -43.43 67.14 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.003 0.43 . . . . 0.0 110.865 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 172.93 -39.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.689 1.596 . . . . 0.0 107.304 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -103.52 -164.72 1.09 Allowed 'General case' 0 C--O 1.252 1.216 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.13 56.79 4.86 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 118.632 0.651 . . . . 0.0 112.317 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -124.31 115.35 20.86 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -84.66 128.6 34.68 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.757 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -126.11 140.65 52.41 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -97.08 132.62 42.69 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -135.77 136.84 49.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 19.1 p -68.4 120.89 15.22 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.734 0.646 . . . . 0.0 110.934 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 51.6 p -117.28 155.44 29.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.821 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 16.6 tt -143.87 132.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -116.21 105.76 12.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.9 mt -103.66 119.04 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.66 124.27 44.82 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.1 pt -121.25 151.99 24.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.62 108.89 14.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.979 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.518 ' HZ1' ' HB3' ' B' ' 96' ' ' LYS . 4.1 mmmp? -80.38 133.99 35.97 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? . . . . . 0 C--N 1.283 -2.321 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 169.051 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.433 -1.278 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 m 64.61 12.45 7.53 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 174.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t 70.62 10.48 7.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.134 0.974 . . . . 0.0 111.141 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.21 136.66 3.19 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.6 p -128.96 104.21 18.51 Favored Pre-proline 0 C--N 1.309 -1.163 0 CA-C-O 120.998 0.428 . . . . 0.0 111.745 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.35 162.59 8.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.391 2.06 . . . . 0.0 112.239 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 m -134.34 118.61 13.9 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -84.09 -172.85 1.39 Allowed 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.615 2.21 . . . . 0.0 113.854 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 p -145.43 165.45 28.5 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -103.61 14.17 31.74 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.667 0.27 . . . . 0.0 111.235 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.9 t -113.82 124.78 70.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.07 145.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.985 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.82 131.12 48.33 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.6 mm -95.97 120.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.047 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.64 50.48 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.911 -1.614 . . . . 0.0 114.185 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -155.57 -57.54 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.437 0.618 . . . . 0.0 110.748 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -101.99 163.9 16.85 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -59.49 158.7 26.32 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.242 1.962 . . . . 0.0 111.699 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG21 ' OD2' ' A' ' 51' ' ' ASP . 10.0 p -52.92 -31.33 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 124.301 1.041 . . . . 0.0 113.437 -175.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.423 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.5 ptm -57.11 -32.58 66.46 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.62 0.368 . . . . 0.0 111.788 -174.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -71.82 -38.24 70.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.098 0.475 . . . . 0.0 110.537 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -76.57 -36.26 57.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.246 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 19' ' ' VAL . 93.2 t -58.03 -53.51 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.089 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.7 mt -58.64 -36.27 73.83 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.398 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.29 96.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.396 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.03 -56.44 20.96 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.56 0.537 . . . . 0.0 111.949 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.43 HD11 ' H ' ' A' ' 27' ' ' LEU 0.342 0.0 OUTLIER -69.53 -19.07 63.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.496 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -72.01 -46.09 58.49 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.8 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.07 -41.18 86.85 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.227 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 96' ' ' LYS . 95.7 mt -55.31 -41.92 73.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.653 0.596 . . . . 0.0 111.509 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.02 5.33 52.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.983 0.42 . . . . 0.0 111.715 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -99.37 -30.14 12.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.82 0.343 . . . . 0.0 110.178 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.49 -15.03 1.09 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.57 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.7 100.53 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 23.2 p -79.49 -22.51 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.1 111.74 14.37 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.263 0.554 . . . . 0.0 110.274 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.418 ' H ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.55 161.16 19.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.035 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 45.3 t -128.86 125.77 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.469 . . . . 0.0 110.861 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.71 120.89 57.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -118.84 118.37 31.38 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.111 0.481 . . . . 0.0 110.683 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.96 148.12 32.2 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' HG2' HG21 ' A' ' 89' ' ' THR . 70.9 mtp180 -122.51 143.78 49.5 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.343 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.74 -130.05 12.63 Favored Glycine 0 N--CA 1.44 -1.088 0 O-C-N 123.5 0.5 . . . . 0.0 112.948 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -90.46 5.7 46.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.629 0.728 . . . . 0.0 110.475 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.23 -3.15 54.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.243 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.7 mt -54.47 -37.21 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.786 0.834 . . . . 0.0 110.404 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.1 t -64.26 -26.95 68.73 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.056 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -83.24 -27.91 29.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.372 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.12 -43.98 77.17 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -71.33 -35.2 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.17 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.505 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.6 t70 -60.64 -47.21 87.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.934 0.772 . . . . 0.0 109.069 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -54.12 -56.25 19.92 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.9 -22.85 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.84 -37.35 62.29 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.529 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.7 mt -61.86 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.709 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -55.14 -43.58 70.9 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.377 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 54.8 mtm180 -71.45 3.09 4.11 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.408 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 2.8 t-20 -137.47 16.4 2.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.956 0.884 . . . . 0.0 109.689 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -128.75 -63.77 0.96 Allowed 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.413 -176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -106.77 -36.87 6.56 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.296 -176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 95.7 mt -131.49 103.74 6.58 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.215 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.51 -73.87 0.61 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.34 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.26 6.91 40.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.075 0.465 . . . . 0.0 110.681 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.93 24.02 12.81 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.478 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.22 153.52 12.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -125.22 169.16 12.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.153 0.501 . . . . 0.0 111.085 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -109.1 135.97 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -86.79 -66.42 0.91 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.116 0.26 . . . . 0.0 110.782 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' OE1' ' HD2' ' A' ' 71' ' ' ARG . 42.8 tt0 -162.71 145.54 10.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.4 mt -127.75 116.15 42.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.405 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 79.9 mtp180 -121.27 135.98 55.04 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.526 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.97 131.3 73.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.2 -163.81 11.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.115 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.2 p -131.41 111.42 11.81 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -87.61 131.35 34.45 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.132 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -90.87 118.31 35.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.12 156.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.946 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 29.3 p -96.97 119.16 34.92 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.557 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.2 m -65.69 -31.22 72.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.081 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -153.17 -80.35 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.12 -82.99 0.46 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.497 0.665 . . . . 0.0 110.418 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.22 18.34 9.6 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.806 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 78' ' ' THR . 76.6 mtp180 -82.14 101.68 10.58 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -87.86 124.14 33.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.846 0.716 . . . . 0.0 110.241 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.8 t -126.11 147.36 49.62 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.485 HH21 ' HG2' ' B' ' 54' ' ' GLU . 39.0 mtm180 -97.09 139.11 33.57 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 119.104 -1.038 . . . . 0.0 108.43 173.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.72 117.26 50.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.1 m -61.19 127.45 31.59 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.771 0.67 . . . . 0.0 109.226 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.441 HG21 ' HG2' ' A' ' 42' ' ' ARG . 24.5 p -127.97 151.8 48.68 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.002 0.43 . . . . 0.0 111.836 -176.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.8 128.6 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.289 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.33 106.27 15.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -103.98 117.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.66 133.69 55.67 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.8 pt -138.87 151.33 23.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 35' ' ' SER . 12.9 ptp180 -130.66 158.4 40.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 123.496 0.498 . . . . 0.0 110.838 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.543 ' HZ2' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -127.01 117.44 22.48 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' C ' ' HZ2' ' A' ' 96' ' ' LYS . 64.8 mttm . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.102 174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.6 p -110.58 116.54 31.53 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 120.926 0.394 . . . . 0.0 110.68 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 11.0 p -85.28 159.87 19.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.91 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.18 141.56 17.64 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.479 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 30.3 m -131.19 108.87 15.07 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.43 -44.3 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.074 1.85 . . . . 0.0 112.782 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -123.69 148.37 56.05 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.038 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.63 121.51 8.76 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.883 2.389 . . . . 0.0 111.465 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 35.9 t -122.48 16.62 10.46 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -93.96 16.78 13.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.888 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 80.7 t -117.28 124.55 73.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -116.39 143.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 120.897 0.379 . . . . 0.0 110.862 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -100.37 128.99 46.3 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -94.56 119.78 43.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.224 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.89 45.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.391 -1.385 . . . . 0.0 114.213 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -150.56 -58.87 0.18 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.469 0.635 . . . . 0.0 110.432 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -101.45 164.35 16.12 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.511 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -59.99 156.35 39.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.27 1.98 . . . . 0.0 111.751 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.476 ' O ' HG21 ' B' ' 23' ' ' VAL . 8.3 p -50.6 -30.42 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.541 1.136 . . . . 0.0 113.827 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.453 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 24.9 ptm -58.65 -30.38 67.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.028 0.442 . . . . 0.0 111.958 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.78 -38.36 64.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.648 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -76.73 -34.8 58.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.476 HG21 ' O ' ' B' ' 19' ' ' VAL . 78.9 t -58.89 -54.24 36.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 CA-C-O 121.273 0.559 . . . . 0.0 110.122 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 20' ' ' MET . 94.8 mt -57.86 -38.7 76.18 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.02 98.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.276 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -56.7 18.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.049 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.424 HD11 ' O ' ' B' ' 23' ' ' VAL 0.361 0.0 OUTLIER -69.45 -19.46 63.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 118.454 -1.298 . . . . 0.0 114.087 -178.714 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.5 m -72.04 -45.92 58.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.127 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.87 -40.12 91.35 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.215 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' B' ' 96' ' ' LYS . 95.3 mt -57.16 -42.05 80.34 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.638 0.586 . . . . 0.0 111.888 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -92.64 1.83 57.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.898 0.38 . . . . 0.0 111.685 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -95.79 -37.04 10.93 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.002 0.429 . . . . 0.0 110.074 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.66 -18.58 0.29 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 119.803 -1.189 . . . . 0.0 112.802 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.22 99.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.453 0.644 . . . . 0.0 109.362 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 20.3 p -79.75 -17.26 53.91 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.49 -176.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.96 112.36 10.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.766 0.317 . . . . 0.0 110.454 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.437 ' H ' HD12 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -120.01 161.12 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.272 -177.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 41.5 t -128.81 123.21 58.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.066 0.46 . . . . 0.0 110.484 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.57 122.06 55.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.152 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.4 119.31 33.56 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' B' ' 49' ' ' ALA . . . -111.53 146.57 37.08 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.553 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.452 ' HG2' HG21 ' B' ' 89' ' ' THR . 74.0 mtp180 -120.64 142.72 49.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.5 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 -129.12 12.33 Favored Glycine 0 C--N 1.303 -1.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.851 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -89.47 8.24 31.96 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.017 0.437 . . . . 0.0 111.005 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.67 -1.64 57.38 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.228 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 68.5 mt -54.65 -37.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.337 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.19 -32.17 73.5 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.588 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -78.84 -31.16 45.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.831 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.402 ' HB2' ' HB1' ' B' ' 41' ' ' ALA . . . -64.27 -45.76 86.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.242 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.45 -35.65 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.486 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.7 t70 -59.59 -50.19 74.86 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -52.02 -54.87 24.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.305 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.67 -21.35 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.485 ' HG2' HH21 ' A' ' 86' ' ' ARG . 30.2 tt0 -75.97 -37.12 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.421 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.486 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.1 mt -61.86 -49.73 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.846 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.95 -42.39 71.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' B' ' 61' ' ' LEU . 56.4 mtm180 -73.53 6.32 3.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.861 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . 0.424 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 2.6 t-20 -139.21 16.09 2.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.85 0.833 . . . . 0.0 109.589 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.39 -64.46 0.94 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.13 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -105.23 -37.14 6.99 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.303 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 94.8 mt -132.26 103.49 6.26 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.127 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 -74.1 0.61 Allowed 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.125 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.22 5.14 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.141 0.496 . . . . 0.0 110.09 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -111.96 24.91 12.13 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.026 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -148.91 154.43 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.78 164.16 24.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.362 0.601 . . . . 0.0 111.143 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.67 138.69 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -89.96 -60.85 1.82 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.91 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -166.54 144.9 5.39 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.759 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.2 mt -128.67 119.76 50.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -127.06 138.6 53.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.382 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.25 129.58 74.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.93 -164.95 11.86 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.063 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 29.3 p -131.55 109.55 10.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -86.35 130.86 34.36 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -90.38 114.19 27.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.3 155.7 36.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.57 0.224 . . . . 0.0 110.818 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 83' ' ' ARG . 15.8 p -96.48 118.27 32.64 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.025 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 16.3 m -64.79 -35.55 81.45 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.358 0.663 . . . . 0.0 112.039 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -149.28 -81.74 0.12 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.954 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -101.65 -77.86 0.54 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.289 0.566 . . . . 0.0 110.938 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.77 19.36 8.43 Favored Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.326 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' B' ' 78' ' ' THR . 79.8 mtp180 -84.59 105.92 15.76 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.458 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -90.95 128.95 36.99 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.965 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -130.78 144.97 51.82 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.408 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 53.2 mtm180 -93.46 137.76 32.43 Favored 'General case' 0 N--CA 1.422 -1.825 0 C-N-CA 119.537 -0.865 . . . . 0.0 108.712 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.35 117.51 51.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -60.96 125.75 24.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 123.833 0.708 . . . . 0.0 109.232 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.452 HG21 ' HG2' ' B' ' 42' ' ' ARG . 25.6 p -128.26 148.85 50.66 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.201 0.524 . . . . 0.0 112.074 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 tt -127.73 132.1 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.53 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.29 107.13 15.17 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.1 mt -105.68 113.45 42.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.536 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.37 132.7 56.53 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -136.9 152.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' B' ' 35' ' ' SER . 12.6 ptp180 -131.53 156.62 45.39 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 120.915 0.388 . . . . 0.0 110.983 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.529 ' HZ2' ' C ' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -125.79 118.15 24.93 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -176.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.529 ' C ' ' HZ2' ' B' ' 96' ' ' LYS . 63.1 mttm . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.251 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 C--O 1.213 -0.842 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m -96.61 -21.82 17.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.57 0.7 . . . . 0.0 109.449 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -139.98 154.64 47.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.79 118.33 2.53 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.336 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.479 ' OG1' ' HD3' ' A' ' 6' ' ' PRO . 20.6 p -94.26 -46.78 0.28 Allowed Pre-proline 0 CA--C 1.565 1.548 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HD3' ' OG1' ' A' ' 5' ' ' THR . 2.3 Cg_endo -84.91 23.25 0.85 Allowed 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 122.282 1.988 . . . . 0.0 112.102 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -74.37 131.17 80.82 Favored Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.62 122.5 11.13 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.033 2.489 . . . . 0.0 111.776 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.8 t -150.16 -82.89 0.1 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -146.77 3.47 0.84 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.284 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 71.6 t -102.11 113.21 37.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -102.92 135.45 40.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.023 0.439 . . . . 0.0 110.811 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.71 119.3 37.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.458 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 52.0 mt -90.58 116.48 31.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.145 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.76 41.59 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.896 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -161.04 -55.35 0.05 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.335 0.567 . . . . 0.0 111.715 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -99.98 159.33 30.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.887 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.43 156.0 33.2 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.902 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.4 -35.87 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.144 0.978 . . . . 0.0 112.611 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -64.13 -24.71 67.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.44 -28.1 61.79 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.452 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 99.7 m-85 -83.82 -33.01 25.01 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.833 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 61.2 t -59.72 -52.74 57.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-O 121.314 0.578 . . . . 0.0 109.857 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.92 -30.02 70.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.011 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.408 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -47.91 75.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.64 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.07 98.2 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.356 0.41 . . . . 0.0 110.577 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 96.0 mt -62.5 -42.4 99.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.022 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.1 m -66.61 -36.46 82.67 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.499 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -71.92 -27.49 62.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.678 0.275 . . . . 0.0 111.091 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -36.85 84.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.77 -19.44 65.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.315 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -85.58 -5.64 59.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.45 -7.68 40.02 Favored Glycine 0 C--O 1.242 0.651 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.156 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.15 100.8 11.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.406 0.622 . . . . 0.0 109.701 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 33.8 p -87.22 -25.25 24.11 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.631 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.85 105.25 14.01 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.08 0.552 . . . . 0.0 109.626 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.1 163.36 22.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.616 0.246 . . . . 0.0 111.183 -176.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -126.85 122.37 60.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.29 0.567 . . . . 0.0 110.927 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.18 128.69 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.4 123.4 36.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.53 0.681 . . . . 0.0 110.472 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.68 148.21 41.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.405 ' HG2' HG21 ' A' ' 89' ' ' THR . 67.9 mtm180 -128.29 147.59 50.61 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.212 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.88 -135.83 17.65 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -89.57 9.63 26.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.092 0.472 . . . . 0.0 110.995 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.23 -2.61 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -53.22 -36.26 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -61.57 -28.93 69.69 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.602 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -84.53 -27.78 27.13 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.918 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.77 93.18 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.7 p -73.47 -29.29 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.116 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.443 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.1 t70 -71.28 -43.99 66.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 m -58.68 -50.22 74.68 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.85 -28.64 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.734 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -50.31 70.54 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 51' ' ' ASP . 72.2 mt -58.99 -44.25 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.28 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.34 -36.11 70.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -93.83 -2.43 53.53 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.771 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -123.84 12.18 9.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.891 0.853 . . . . 0.0 110.267 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.78 -50.16 0.83 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -85.83 -66.4 0.9 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.1 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.1 mt -144.91 115.09 7.5 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.99 -34.32 11.82 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 124.165 0.916 . . . . 0.0 110.5 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -76.4 -19.22 58.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.69 71.76 1.18 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.966 0.412 . . . . 0.0 110.775 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -161.86 152.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.88 154.33 46.11 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.65 136.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -90.0 -58.67 2.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.193 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.49 151.33 7.83 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.8 122.79 14.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -132.19 145.38 51.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.64 143.12 23.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.76 -157.25 19.65 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.554 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -110.11 135.67 50.55 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.703 0.287 . . . . 0.0 110.301 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -119.42 130.26 55.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.41 110.01 24.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.8 153.44 7.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.054 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.6 m -106.57 123.51 48.21 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 m -89.82 -31.85 17.19 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.899 0.381 . . . . 0.0 111.874 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -137.3 -150.59 0.36 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.29 -33.07 55.82 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -173.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.29 42.02 1.02 Allowed Glycine 0 C--O 1.211 -1.296 0 C-N-CA 119.67 -1.253 . . . . 0.0 112.426 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -125.35 105.34 9.02 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 122.272 -0.546 . . . . 0.0 110.257 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -93.29 151.88 19.52 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -148.62 138.2 22.01 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -109.97 116.96 32.56 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.8 0.333 . . . . 0.0 110.177 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.52 140.96 43.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.4 m -73.01 131.06 41.67 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.405 HG21 ' HG2' ' A' ' 42' ' ' ARG . 40.5 p -132.13 147.09 52.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -129.76 138.04 55.17 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.46 109.46 14.87 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.62 124.27 69.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.871 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.39 37.13 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 120.599 0.238 . . . . 0.0 110.81 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 pt -125.26 151.17 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 35' ' ' SER . 25.4 ptt180 -138.63 147.43 42.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 122.035 0.921 . . . . 0.0 113.451 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 21.6 mmtm -91.47 -171.23 2.86 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.663 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' NZ ' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.544 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.578 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 120.009 -0.043 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.0 p -69.54 -42.76 74.18 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.501 0.667 . . . . 0.0 110.04 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 22.4 t -131.18 118.16 20.06 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.02 140.48 7.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.928 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 27.1 m -132.37 93.24 25.97 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -90.51 4.92 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.306 2.004 . . . . 0.0 113.096 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.7 m -121.14 97.26 47.93 Favored Pre-proline 0 N--CA 1.433 -1.314 0 CA-C-O 121.036 0.446 . . . . 0.0 110.019 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.36 137.61 7.13 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.126 1.884 . . . . 0.0 111.396 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -78.11 91.77 4.34 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.277 0.561 . . . . 0.0 109.919 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -121.53 2.35 10.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.334 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 67.8 t -100.09 112.99 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -103.13 133.6 46.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.69 116.65 30.31 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.66 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.477 ' HA ' ' CZ ' ' B' ' 22' ' ' TYR . 50.4 mt -88.23 116.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.462 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.69 35.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.791 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -156.12 -54.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.235 0.517 . . . . 0.0 112.197 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.405 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 54.1 mtmt -99.64 157.32 34.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.28 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 156.25 22.94 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.844 2.363 . . . . 0.0 112.696 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.406 HG23 ' OD1' ' B' ' 51' ' ' ASP . 7.2 p -52.94 -33.87 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.162 0.985 . . . . 0.0 112.881 -176.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -63.76 -25.58 68.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.663 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -72.76 -33.83 66.6 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . 0.477 ' CZ ' ' HA ' ' B' ' 14' ' ' ILE . 99.7 m-85 -77.92 -33.28 51.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.62 -54.37 36.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.086 0.469 . . . . 0.0 109.964 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.88 -29.82 70.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.429 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.29 -46.3 80.99 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.518 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.16 97.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.456 0.473 . . . . 0.0 110.719 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.45 -41.88 97.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.3 m -64.76 -37.63 88.26 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.928 0.394 . . . . 0.0 110.403 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.98 -27.78 62.99 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.404 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.68 -38.9 92.56 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.87 -22.7 67.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.618 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.76 -10.77 59.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.118 0.485 . . . . 0.0 110.605 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.5 -13.01 20.96 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.139 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.49 100.99 8.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.076 0.465 . . . . 0.0 110.344 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 33.7 p -84.05 -29.35 26.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.845 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.475 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 39.3 tt0 -107.68 111.53 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.3 162.51 32.35 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 43.4 t -124.95 123.09 64.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.644 0.735 . . . . 0.0 111.254 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.18 128.54 54.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -127.96 125.15 38.95 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.275 0.56 . . . . 0.0 110.208 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.24 147.75 43.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -127.5 146.24 50.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.96 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.9 -135.19 15.07 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.794 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -91.47 9.57 31.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.411 0.624 . . . . 0.0 111.036 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.77 -2.12 55.64 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.354 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.8 mt -53.55 -36.43 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-O 121.624 0.726 . . . . 0.0 109.901 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -60.73 -34.93 75.15 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.039 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -79.33 -30.58 42.81 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.346 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.85 92.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.369 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.21 -33.37 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.088 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.441 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.2 t70 -65.51 -45.4 83.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.116 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.0 m -57.45 -50.7 72.18 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.95 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.45 -30.36 48.67 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.575 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -50.08 73.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.441 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.4 mt -58.04 -45.71 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.219 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.03 -34.53 60.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.134 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -94.03 0.01 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -126.8 11.32 7.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.791 0.805 . . . . 0.0 110.23 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -134.85 -49.06 0.75 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.91 -67.07 0.83 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.57 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.441 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 96.0 mt -144.77 115.97 7.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.83 -39.03 10.03 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.903 0.752 . . . . 0.0 110.198 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.69 -13.65 61.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.094 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.92 71.44 1.47 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.767 0.318 . . . . 0.0 111.201 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.424 HD13 ' HZ1' ' B' ' 96' ' ' LYS . 17.7 tt -162.24 156.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -145.6 154.35 42.05 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.15 137.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -90.13 -56.41 3.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.337 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -170.17 153.16 4.44 Favored 'General case' 0 C--O 1.251 1.172 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.98 127.0 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -134.8 144.37 47.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.53 143.09 23.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.8 -158.85 22.88 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.759 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -111.86 131.58 55.27 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -114.69 131.96 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.693 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -98.69 107.97 21.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 m -101.99 153.76 5.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.541 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 22.1 m -106.25 121.59 44.51 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 22.5 m -89.86 -29.51 18.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -137.89 -150.89 0.37 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.21 -31.79 58.6 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 120.746 0.307 . . . . 0.0 110.64 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.6 39.97 0.88 Allowed Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.912 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -121.16 109.58 15.16 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -97.22 152.85 18.44 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.772 0.67 . . . . 0.0 109.653 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -149.83 136.42 19.21 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -106.13 117.97 35.41 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.387 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -122.01 139.22 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -72.85 128.06 34.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -129.39 147.48 51.22 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.69 138.21 54.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.66 109.3 14.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.95 123.89 69.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.65 122.79 44.51 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -126.99 150.03 32.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.475 ' HD3' ' OE1' ' B' ' 36' ' ' GLU . 23.8 ptt180 -137.09 150.51 48.06 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 20.9 mmtm -93.49 -170.91 2.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.18 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' B' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.16 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 CA--C 1.514 -0.439 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 p -91.6 161.22 15.02 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.602 0.239 . . . . 0.0 110.464 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.1 m -125.9 12.48 7.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.136 0.493 . . . . 0.0 111.473 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.57 -55.89 0.27 Allowed Glycine 0 CA--C 1.502 -0.739 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.2 p -81.19 144.4 54.18 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -63.38 -40.34 32.2 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.966 1.777 . . . . 0.0 110.677 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -71.28 127.77 90.98 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.662 176.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.77 -49.64 1.49 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.996 1.797 . . . . 0.0 111.344 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.3 m -159.6 -83.49 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.014 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -134.86 17.51 3.53 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.596 0.712 . . . . 0.0 110.029 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.19 120.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -110.82 145.76 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.264 0.554 . . . . 0.0 111.112 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.79 132.63 51.68 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.075 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -89.66 102.31 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 16' ' ' LYS . . . 178.86 55.55 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 118.229 -1.938 . . . . 0.0 115.551 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 53.8 tttm 178.07 -42.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.472 0.636 . . . . 0.0 110.69 171.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -92.39 159.82 36.19 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.243 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.82 162.15 40.02 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.152 1.901 . . . . 0.0 111.308 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.77 -41.39 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -59.95 -30.19 68.91 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.738 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -72.29 -34.4 68.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.067 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -73.01 -33.18 65.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.65 -55.83 21.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.101 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.52 -27.3 69.06 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.684 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.01 77.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.907 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.31 98.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.294 0.371 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.04 -33.18 75.21 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.47 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.8 m -64.4 -36.73 85.11 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.441 0.639 . . . . 0.0 109.738 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.82 -35.51 72.51 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.7 mt -58.43 -42.58 87.63 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.167 0.508 . . . . 0.0 110.239 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -66.79 -23.76 66.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.892 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -87.65 -2.68 58.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.7 8.93 47.75 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.07 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.38 94.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 m -85.69 -22.6 27.78 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.633 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' CD ' ' HZ1' ' A' ' 68' ' ' LYS . 51.6 mt-10 -109.7 107.45 17.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.42 ' H ' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.47 142.05 36.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -116.1 123.91 71.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.013 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.03 123.92 62.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -120.18 124.02 44.71 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.491 0.662 . . . . 0.0 109.834 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.34 160.04 21.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.457 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -131.37 145.09 51.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.278 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.57 -127.8 20.36 Favored Glycine 0 N--CA 1.433 -1.552 0 O-C-N 123.533 0.52 . . . . 0.0 112.445 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.23 0.02 56.58 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.38 . . . . 0.0 111.35 -176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.74 2.06 27.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.134 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.1 mt -57.25 -40.89 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.463 0.649 . . . . 0.0 109.698 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.3 t -70.66 -16.44 62.81 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.954 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -89.83 -33.97 16.3 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.56 89.45 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.128 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 13.7 p -67.76 -43.32 86.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.556 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.473 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.9 t70 -54.83 -44.51 73.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.6 m -57.96 -53.55 57.0 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.983 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 50' ' ' VAL . 31.3 m -68.54 -30.14 46.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 50' ' ' VAL . 46.4 mt-10 -60.19 -47.93 83.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 123.401 0.438 . . . . 0.0 110.286 174.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.2 mt -60.6 -40.62 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 121.232 0.539 . . . . 0.0 110.62 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.93 -27.51 42.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 CA-C-O 121.14 0.495 . . . . 0.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -100.96 2.63 40.89 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -116.45 9.78 14.42 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.198 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -139.1 -71.24 0.4 Allowed 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.412 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 74.4 t80 -60.5 -64.49 0.93 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.131 0.491 . . . . 0.0 110.842 -174.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.427 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.0 mt -141.28 113.62 8.1 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.27 -35.69 10.66 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 124.161 0.913 . . . . 0.0 110.175 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.1 -45.85 59.01 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.073 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.66 97.65 8.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.591 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.425 HD12 ' HZ2' ' A' ' 96' ' ' LYS . 7.2 tp -158.63 138.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.266 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HG2' HH21 ' A' ' 95' ' ' ARG . 7.9 tp10 -124.74 149.98 46.71 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tp -107.52 137.19 39.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HZ1' ' CD ' ' A' ' 36' ' ' GLU . 82.2 tttt -100.54 -53.64 3.04 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.542 -1.263 . . . . 0.0 111.511 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 71' ' ' ARG . 35.6 tt0 -170.53 144.81 2.47 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.1 mt -135.49 119.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 21.9 mtm180 -128.92 136.61 50.62 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.39 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.58 119.0 58.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.98 167.62 34.87 Favored Glycine 0 C--N 1.303 -1.287 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.631 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 m -85.87 118.65 25.49 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -95.64 131.87 41.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.94 107.45 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.901 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.38 161.24 16.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.644 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.4 p -100.21 152.44 20.28 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.0 t -82.7 -72.56 0.44 Allowed 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.744 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -155.24 11.71 0.34 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.473 0.654 . . . . 0.0 109.838 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 82' ' ' GLY . 24.5 t70 -160.68 -159.38 0.68 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 81' ' ' ASP . . . -76.42 11.06 14.09 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.213 0.915 . . . . 0.0 112.709 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -73.45 107.31 5.66 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -88.54 137.65 32.13 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.2 m -129.0 130.49 46.71 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -95.53 120.08 35.15 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.57 130.23 72.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.696 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.54 118.43 7.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.5 p -125.86 155.16 41.63 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.427 -0.171 . . . . 0.0 111.069 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 tt -136.99 131.27 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.12 110.99 21.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.32 118.32 57.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.0 117.93 30.56 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 123.298 0.374 . . . . 0.0 110.332 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.6 pt -114.87 158.37 15.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.545 HH21 ' HG2' ' A' ' 66' ' ' GLU . 34.4 ttp180 -130.39 111.79 12.66 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.207 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 26.8 mmtm -79.03 143.45 35.63 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.559 174.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt . . . . . 0 C--N 1.307 -1.263 0 O-C-N 123.127 0.267 . . . . 0.0 110.832 -178.57 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 C--O 1.213 -0.83 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.4 p -102.4 -63.36 1.16 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 120.882 0.373 . . . . 0.0 111.148 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 17.1 p -68.06 -60.66 2.32 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 123.787 0.835 . . . . 0.0 111.248 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.82 -148.62 19.28 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.6 p -148.58 138.12 12.49 Favored Pre-proline 0 C--N 1.317 -0.84 0 C-N-CA 123.234 0.613 . . . . 0.0 109.835 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -82.24 160.47 17.68 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.704 2.269 . . . . 0.0 112.8 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -91.17 132.44 34.09 Favored Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.605 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -89.13 141.34 4.18 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.884 2.39 . . . . 0.0 113.108 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -115.95 -18.24 10.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.246 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -112.66 17.7 18.92 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.821 0.343 . . . . 0.0 111.402 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.46 119.96 63.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.46 142.05 24.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.192 0.52 . . . . 0.0 111.585 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.33 131.83 51.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.879 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -89.57 99.95 10.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.16 43.63 0.16 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 117.935 -2.079 . . . . 0.0 116.112 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -173.83 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.456 1.128 . . . . 0.0 110.444 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -91.59 160.87 35.67 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.395 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.66 164.09 34.47 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.133 1.888 . . . . 0.0 110.929 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.451 HG21 ' OG1' ' B' ' 52' ' ' THR . 8.4 p -57.24 -37.37 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.118 0.567 . . . . 0.0 111.738 -176.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -64.07 -29.36 70.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.662 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -73.97 -34.94 64.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -70.7 -34.03 71.53 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.799 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.46 -55.16 26.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.429 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.7 -28.69 70.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.53 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.4 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.43 -43.07 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.184 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.17 99.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.124 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.6 -34.73 78.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.806 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.0 m -64.88 -36.3 83.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.137 0.494 . . . . 0.0 110.11 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -69.91 -36.94 75.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.558 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.409 HD23 ' O ' ' B' ' 34' ' ' VAL . 95.2 mt -57.31 -43.42 83.26 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.056 0.455 . . . . 0.0 110.346 177.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.802 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -87.65 -0.87 57.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.158 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.74 13.85 36.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.041 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.409 ' O ' HD23 ' B' ' 30' ' ' LEU . 32.5 t -101.08 92.97 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -82.9 -24.34 33.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.151 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -109.06 109.32 20.31 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.44 142.76 37.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.27 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.02 125.08 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.36 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -107.51 123.87 63.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -120.51 123.2 42.36 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.56 161.73 18.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -132.76 145.72 51.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.941 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.407 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 68.35 -127.88 24.2 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 123.451 0.47 . . . . 0.0 112.654 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.35 -0.77 57.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.022 0.439 . . . . 0.0 111.778 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.88 1.98 25.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 43' ' ' GLY . 73.3 mt -58.14 -41.17 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.69 0.757 . . . . 0.0 109.805 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 44.2 t -67.77 -22.14 65.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.405 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -84.84 -33.57 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.37 86.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.601 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' B' ' 54' ' ' GLU . 14.5 p -66.47 -44.07 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.4 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.484 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.1 t70 -56.55 -39.38 73.34 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.451 ' OG1' HG21 ' B' ' 19' ' ' VAL . 57.3 m -61.68 -52.62 63.55 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.98 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.48 -31.14 49.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.203 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' B' ' 50' ' ' VAL . 44.9 mt-10 -59.38 -45.9 90.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.626 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.484 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.9 mt -61.95 -40.64 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.894 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.84 -26.02 37.65 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.157 0.503 . . . . 0.0 111.59 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -100.75 0.52 39.01 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.864 -0.523 . . . . 0.0 111.914 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -116.41 12.75 15.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.182 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -137.89 -68.96 0.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.01 -62.7 1.47 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.868 0.366 . . . . 0.0 111.148 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.421 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.1 mt -142.8 115.12 8.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.01 -34.17 10.19 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 124.241 0.963 . . . . 0.0 109.968 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.5 -41.47 60.64 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.907 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -103.91 99.11 8.87 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.425 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.449 HD12 ' HZ2' ' B' ' 96' ' ' LYS . 7.0 tp -157.99 140.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.041 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.538 ' HG2' HH21 ' B' ' 95' ' ' ARG . 7.1 tp10 -125.83 146.82 49.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -105.44 134.53 46.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -98.85 -54.01 3.12 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.503 -1.279 . . . . 0.0 111.291 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . 0.4 ' OE2' ' HD3' ' B' ' 71' ' ' ARG . 29.3 tt0 -169.87 143.32 2.57 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.7 mt -131.89 118.81 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.4 ' HD3' ' OE2' ' B' ' 69' ' ' GLU . 25.6 mtm180 -127.55 137.25 52.56 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.582 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.55 117.23 51.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.16 165.77 33.89 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.515 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -84.44 115.98 22.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.45 0.7 . . . . 0.0 109.375 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -94.04 132.44 38.52 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.48 108.96 21.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.644 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -118.56 164.82 14.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.71 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 25.5 p -103.94 145.87 29.51 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 47.8 t -78.13 -62.34 1.71 Allowed 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.762 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.15 6.69 0.07 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.935 0.398 . . . . 0.0 110.756 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' B' ' 82' ' ' GLY . 24.6 t70 -161.09 -156.29 0.45 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.514 ' H ' ' CG ' ' B' ' 81' ' ' ASP . . . -73.25 6.48 14.87 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 118.787 0.721 . . . . 0.0 113.657 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.36 108.8 5.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -88.59 144.42 26.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 123.52 0.512 . . . . 0.0 109.983 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.1 m -132.92 125.56 30.15 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.755 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -91.97 114.42 26.95 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -114.46 129.48 70.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -61.86 120.38 10.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.9 p -127.64 155.12 44.4 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.308 -0.245 . . . . 0.0 111.221 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -136.83 131.42 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.838 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.35 109.94 19.12 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 56.1 mt -110.88 117.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.95 118.83 34.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.193 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 pt -116.67 152.03 18.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.836 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.538 HH21 ' HG2' ' B' ' 66' ' ' GLU . 35.0 ttp180 -124.21 114.04 19.1 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.449 ' HZ2' HD12 ' B' ' 65' ' ' ILE . 28.0 mmtm -80.24 146.8 31.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.861 174.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.385 0.428 . . . . 0.0 111.643 -177.347 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.5 p 56.39 94.49 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 t -146.28 -41.58 0.2 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.832 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.72 175.61 14.15 Favored Glycine 0 N--CA 1.422 -2.291 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 p -100.57 151.06 37.47 Favored Pre-proline 0 C--N 1.286 -2.184 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.29 -17.1 55.39 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.844 2.362 . . . . 0.0 112.66 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -142.61 140.27 18.41 Favored Pre-proline 0 N--CA 1.422 -1.846 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.61 124.1 10.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.271 1.981 . . . . 0.0 111.973 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 t -137.57 -50.4 0.61 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.78 0.324 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -100.14 13.57 33.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.898 0.38 . . . . 0.0 111.08 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.46 112.27 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.26 133.9 44.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.642 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -120.83 130.42 53.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.29 133.81 44.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.41 48.5 0.02 OUTLIER Glycine 0 C--N 1.348 1.196 0 C-N-CA 119.439 -1.363 . . . . 0.0 115.628 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -174.71 -51.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 118.04 0.92 . . . . 0.0 112.031 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.13 158.1 33.85 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.732 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 165.74 17.89 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.373 2.048 . . . . 0.0 111.417 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.438 HG22 ' OD2' ' A' ' 51' ' ' ASP . 11.6 p -53.06 -28.72 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 C-N-CA 124.353 1.061 . . . . 0.0 113.296 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.6 mtp -62.83 -29.74 70.96 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -71.07 -28.82 64.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.18 0.515 . . . . 0.0 109.64 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -89.62 -42.66 11.26 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.183 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 82.3 t -60.79 -49.82 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.787 0.327 . . . . 0.0 110.68 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.24 -19.79 64.76 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.984 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.37 -48.79 16.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.44 85.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 97.4 mt -60.3 -34.48 73.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.7 m -76.09 -40.95 51.91 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.35 -38.56 87.37 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.1 -42.78 95.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.395 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.73 -16.38 45.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.918 0.39 . . . . 0.0 110.411 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -78.61 -34.12 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.29 -4.0 1.27 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.87 100.36 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -79.34 -21.11 46.3 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.151 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.38 121.48 22.38 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.261 0.553 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.401 ' H ' HD11 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -126.36 158.63 36.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.503 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.86 122.02 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.4 mt -105.45 121.1 57.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 99.6 mttt -108.34 141.25 40.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 49' ' ' ALA . . . -133.38 157.4 45.62 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -133.98 135.09 43.23 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 46' ' ' ILE . . . 67.59 -135.01 30.72 Favored Glycine 0 C--O 1.212 -1.237 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.683 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -74.12 -2.45 24.6 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.35 -9.97 59.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.488 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 43' ' ' GLY . 78.7 mt -53.35 -33.87 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.272 0.629 . . . . 0.0 110.797 178.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 p -63.07 -30.6 71.72 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.095 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -86.98 -25.85 24.09 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.374 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -63.29 -48.38 78.34 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.41 0.624 . . . . 0.0 109.984 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.1 -38.18 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.406 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.4 t70 -59.8 -47.99 83.49 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.518 0.511 . . . . 0.0 109.732 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.2 m -55.82 -54.26 46.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.193 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.31 -31.0 49.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.278 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 26.6 tt0 -67.87 -37.6 82.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.275 0.359 . . . . 0.0 110.531 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.49 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 68.9 mt -64.89 -47.97 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.17 -52.71 55.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.434 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -66.63 -13.51 61.24 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -116.64 2.32 12.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 15.8 ptm180 -117.78 -34.44 4.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.127 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -90.1 -58.85 2.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.697 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.2 tp -155.84 109.49 2.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 -6.04 28.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.443 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -87.95 -41.92 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.006 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -124.43 99.01 6.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -155.2 145.34 13.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.5 148.24 50.5 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.166 0.508 . . . . 0.0 110.131 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.2 mt -102.91 133.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -92.85 -51.42 5.09 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.967 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -160.55 141.36 11.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.2 99.89 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 123.132 0.573 . . . . 0.0 110.388 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.22 153.95 51.76 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.775 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.08 135.95 42.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.27 -165.69 15.5 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.189 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -100.27 128.73 46.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.076 0.55 . . . . 0.0 109.874 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -108.15 112.41 24.92 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 85' ' ' SER . 21.9 t -102.03 111.94 33.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.52 163.96 32.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.035 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.6 p -85.87 130.47 34.54 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.3 m -79.53 -27.17 41.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.067 0.461 . . . . 0.0 110.043 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -143.28 -80.84 0.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -133.8 -83.9 0.45 Allowed 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.845 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.1 45.75 2.07 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.091 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -133.13 104.12 6.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -91.38 126.65 36.53 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.818 0.699 . . . . 0.0 110.242 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 32.3 t -114.94 137.74 51.64 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -113.4 109.01 18.0 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.19 133.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.7 t -66.02 134.88 53.82 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.352 0.596 . . . . 0.0 110.915 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.2 p -132.14 160.34 36.31 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.161 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 18.5 tt -140.78 135.58 34.14 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -111.38 115.79 29.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.64 112.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 123.96 50.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.496 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.6 pt -125.85 152.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.166 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -130.05 124.51 33.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.894 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -74.6 140.01 44.06 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 28.1 mtpp . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 52.3 p -142.89 -44.67 0.3 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.834 0.35 . . . . 0.0 111.714 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.3 t -85.28 -9.81 57.24 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.843 0.354 . . . . 0.0 111.414 -177.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.32 98.78 2.31 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.874 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -133.32 143.89 50.1 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.35 -5.55 11.86 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.416 2.077 . . . . 0.0 113.521 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -159.75 142.39 10.06 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.7 101.11 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.982 2.455 . . . . 0.0 112.127 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -112.4 -0.14 15.44 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.412 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -113.99 14.61 18.45 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 120.781 0.324 . . . . 0.0 110.841 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.92 111.51 30.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.69 131.63 47.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.983 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -118.27 127.18 53.48 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.8 mt -99.76 133.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 48.31 0.02 OUTLIER Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.496 -1.335 . . . . 0.0 115.446 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -172.95 -50.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.868 0.834 . . . . 0.0 112.598 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.412 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 32.0 mmmt -99.64 158.52 32.0 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 122.241 -0.287 . . . . 0.0 110.806 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.91 164.26 22.46 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.557 2.171 . . . . 0.0 111.173 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.476 HG22 ' OD1' ' B' ' 51' ' ' ASP . 13.4 p -52.43 -27.23 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 123.994 0.918 . . . . 0.0 113.326 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 92.9 mtp -65.14 -27.17 68.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -72.9 -26.23 61.35 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.409 0.623 . . . . 0.0 109.625 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . 0.412 ' HE2' ' O ' ' B' ' 17' ' ' LYS . 90.1 m-85 -93.42 -42.84 9.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.101 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 99.0 t -60.8 -49.56 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 121.345 0.593 . . . . 0.0 110.432 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mp -67.46 -24.18 65.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.79 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.11 -45.92 46.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.19 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.75 97.69 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.932 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 98.8 mt -60.33 -38.09 82.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.153 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.1 m -70.19 -43.62 70.38 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -60.18 -39.05 85.13 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -41.34 89.53 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.522 0.514 . . . . 0.0 111.168 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -85.37 -15.05 44.45 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.312 0.577 . . . . 0.0 110.164 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -79.21 -36.42 40.13 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.528 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.26 -3.9 0.92 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.638 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -97.99 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 117.511 0.656 . . . . 0.0 109.389 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -78.29 -21.78 49.21 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.963 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.23 118.32 19.36 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.174 0.511 . . . . 0.0 111.092 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.435 HD11 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -124.95 159.25 31.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.923 -176.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.67 121.49 60.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.029 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -104.94 122.66 58.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 99.3 mttt -110.47 139.24 45.88 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 123.65 0.594 . . . . 0.0 109.979 177.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' B' ' 49' ' ' ALA . . . -132.61 154.92 49.58 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -132.22 134.0 44.81 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.424 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 70.28 -135.53 25.78 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.691 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.6 -2.83 27.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.47 57.98 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.539 0.209 . . . . 0.0 111.275 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 43' ' ' GLY . 77.7 mt -52.96 -35.63 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.479 0.657 . . . . 0.0 110.43 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 53.4 p -62.35 -35.71 79.95 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.92 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -81.61 -26.81 34.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.429 ' HB2' ' HB1' ' B' ' 41' ' ' ALA . . . -62.47 -47.77 82.54 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.25 0.548 . . . . 0.0 110.613 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.66 -38.06 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.661 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.476 ' OD1' HG22 ' B' ' 19' ' ' VAL . 13.3 t70 -57.58 -49.92 74.82 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.417 ' O ' HG23 ' B' ' 56' ' ' VAL . 90.1 m -54.2 -54.3 41.79 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.473 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.0 m -69.3 -30.63 46.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.551 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.441 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 25.8 tt0 -68.11 -37.42 81.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 123.302 0.376 . . . . 0.0 110.71 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.485 ' O ' ' HG2' ' B' ' 59' ' ' ARG . 73.7 mt -64.56 -48.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 52' ' ' THR . 58.8 t -57.7 -53.69 41.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 32.2 ptt180 -65.77 -9.69 30.55 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -120.04 -1.24 10.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 15.5 ptm180 -115.18 -33.79 5.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.166 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -89.41 -59.69 2.15 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.704 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 46.1 tp -153.94 107.74 2.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.87 -1.61 39.73 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.064 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -92.63 -50.75 5.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.918 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -115.22 96.65 5.78 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.817 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -152.14 146.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -132.25 149.53 52.35 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -105.69 132.33 52.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -91.72 -50.28 5.83 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.866 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -163.55 143.24 8.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.566 0.541 . . . . 0.0 109.602 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -143.96 98.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.742 0.817 . . . . 0.0 110.269 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -132.91 153.28 51.53 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.397 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.45 137.42 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.65 -169.88 25.57 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.667 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -93.73 137.17 33.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -115.42 116.33 28.05 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' B' ' 85' ' ' SER . 26.3 t -106.09 108.32 24.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.12 166.81 28.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.783 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 17.6 p -89.89 127.76 36.07 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.337 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 18.0 m -77.33 -25.22 50.95 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.371 0.605 . . . . 0.0 110.958 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -145.22 -81.99 0.15 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -132.26 -74.24 0.51 Allowed 'General case' 0 C--O 1.209 -1.074 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.869 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.02 30.0 11.31 Favored Glycine 0 C--O 1.22 -0.762 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.667 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -116.62 105.11 12.07 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -88.07 128.86 35.42 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.492 0.495 . . . . 0.0 110.135 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' B' ' 76' ' ' VAL . 32.6 t -117.53 138.83 51.64 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -114.12 108.97 17.7 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.65 135.97 58.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.5 t -69.59 135.98 50.67 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.875 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.03 159.55 38.47 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.491 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 19.2 tt -139.08 135.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.84 113.33 25.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.0 113.49 44.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.15 122.14 44.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 32.7 pt -124.11 149.17 28.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.204 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -127.33 127.57 44.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.988 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 0.7 OUTLIER -78.59 136.74 37.59 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.432 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 27.5 mtpp . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 ttp . . . . . 0 CA--C 1.487 -1.452 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 t 56.99 87.67 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.493 1.121 . . . . 0.0 110.174 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 m -119.25 18.61 12.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.841 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.84 178.7 26.83 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -86.73 115.51 62.64 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -56.34 -33.18 90.88 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.557 2.838 . . . . 0.0 113.649 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 m -145.77 101.59 4.25 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -88.9 118.45 0.93 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.574 2.183 . . . . 0.0 112.909 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.3 m -97.4 104.58 16.62 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.128 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -123.61 10.25 9.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.089 0.471 . . . . 0.0 110.66 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 22.9 m -102.38 130.83 51.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.583 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.89 142.45 40.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.526 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.39 129.19 52.34 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.34 113.06 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.935 0.397 . . . . 0.0 111.269 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.08 -161.3 25.51 Favored Glycine 0 C--O 1.253 1.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.322 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.23 5.18 8.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -82.16 158.47 66.91 Favored Pre-proline 0 CA--C 1.547 0.854 0 O-C-N 122.154 -0.341 . . . . 0.0 111.093 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.18 153.81 67.11 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.101 2.534 . . . . 0.0 113.475 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 51' ' ' ASP . 7.1 p -54.76 -39.91 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.06 0.944 . . . . 0.0 113.356 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -55.55 -30.58 61.01 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.33 -39.49 92.49 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.007 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -80.97 -34.31 33.2 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.14 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.2 -49.97 81.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.065 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.14 -34.66 78.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.58 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -50.6 65.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.07 86.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.237 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.25 -41.17 97.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.7 m -62.6 -38.55 90.62 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 88.6 mt -64.25 -38.58 91.54 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.65 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.99 -48.85 78.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.812 0.695 . . . . 0.0 110.536 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -79.38 -12.83 59.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.198 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -79.98 -25.85 40.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.99 -12.47 3.88 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.799 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.98 93.06 3.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.292 0.568 . . . . 0.0 109.479 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -87.65 18.4 4.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -155.73 110.34 2.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.33 160.64 41.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.342 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.3 t -124.59 122.76 64.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.332 0.587 . . . . 0.0 110.662 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -100.93 129.32 52.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.0 119.68 36.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.096 0.474 . . . . 0.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . . . -113.74 153.21 29.4 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -142.86 137.56 29.66 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.535 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.48 -130.83 10.26 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -95.18 10.06 37.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.077 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.56 2.02 49.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.934 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.31 -43.28 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.149 0.579 . . . . 0.0 111.282 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.3 p -66.6 -24.81 66.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.689 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.62 -30.71 52.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.5 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . . . -70.67 -43.77 68.43 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.325 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.85 -33.29 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.075 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' OD1' HG23 ' A' ' 19' ' ' VAL . 18.0 t70 -58.97 -50.36 74.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.4 m -53.61 -52.76 58.8 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.105 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.8 m -70.31 -36.27 66.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.73 -29.08 68.96 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 121.493 0.663 . . . . 0.0 109.43 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.5 mt -69.57 -48.75 64.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 122.003 -0.435 . . . . 0.0 110.626 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -59.84 -36.31 65.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 120.946 0.403 . . . . 0.0 111.348 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 6.1 ptm180 -82.08 0.81 38.87 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -115.29 -45.77 2.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.884 0.373 . . . . 0.0 111.544 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -72.85 -28.36 62.48 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -105.62 -72.53 0.71 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.231 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.451 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 96.0 mt -142.2 116.52 9.55 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -93.15 -37.57 12.04 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 124.497 1.123 . . . . 0.0 110.42 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.7 -40.33 92.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.79 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HZ3' ' C ' ' A' ' 97' ' ' LYS . 43.1 mtmt -108.12 99.44 8.88 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 121.191 0.519 . . . . 0.0 111.364 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.42 132.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.454 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.49 136.96 53.9 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -99.48 130.05 49.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -80.04 -55.82 4.68 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -171.32 147.3 2.44 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.71 123.92 55.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -122.43 139.93 53.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.039 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -132.57 125.45 53.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.28 25.78 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.494 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 88' ' ' SER . 50.1 m -115.38 129.05 56.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 117.278 0.539 . . . . 0.0 111.082 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 53.5 tt0 -93.18 141.63 28.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.122 0.969 . . . . 0.0 108.543 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 HG21 ' HG2' ' A' ' 86' ' ' ARG . 22.4 t -116.1 113.25 42.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.18 170.59 18.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 120.673 0.273 . . . . 0.0 110.599 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 81' ' ' ASP . 26.2 p -95.92 142.52 28.06 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.4 t -78.06 -22.15 49.51 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.589 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 178.57 -45.95 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.902 0.881 . . . . 0.0 109.037 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 78' ' ' THR . 17.6 t70 -123.56 -154.22 0.6 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 81' ' ' ASP . . . -64.62 -2.43 7.63 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.092 0.797 . . . . 0.0 115.092 -176.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.39 103.06 0.76 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -77.7 140.6 39.56 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.392 0.677 . . . . 0.0 111.719 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.9 m -131.59 123.04 27.09 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.285 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 98.1 mtt180 -102.77 120.06 39.92 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -134.75 139.22 47.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 19.2 m -72.35 136.65 46.21 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.556 0.743 . . . . 0.0 112.436 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.443 HG22 ' OE1' ' A' ' 75' ' ' GLN . 80.9 p -129.15 170.73 13.18 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.909 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.7 tt -146.93 123.78 3.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.477 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.14 113.49 26.8 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.03 115.51 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.19 121.14 42.06 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.574 0.225 . . . . 0.0 110.836 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.81 148.32 25.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.636 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.43 147.63 40.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.137 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 4.4 mmtm -128.05 137.4 52.16 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.505 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' C ' ' HZ3' ' A' ' 64' ' ' LYS . 9.9 ptmm? . . . . . 0 C--O 1.265 1.886 0 O-C-N 123.337 0.398 . . . . 0.0 110.585 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtp . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.7 p -69.81 3.69 2.43 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -78.77 -19.12 52.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.758 0.79 . . . . 0.0 108.902 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.43 -101.77 0.44 Allowed Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.828 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -84.05 157.13 63.32 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -88.97 1.97 5.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.046 2.498 . . . . 0.0 111.44 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -85.05 125.4 70.53 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.838 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.68 98.67 0.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.584 2.19 . . . . 0.0 112.395 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 30.1 m -123.99 9.64 8.76 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.354 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -141.2 17.21 2.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.639 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 30.0 m -103.87 133.12 48.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.078 0.466 . . . . 0.0 111.493 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.67 143.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.553 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 56.8 tp -106.52 125.65 51.26 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.87 116.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 120.996 0.426 . . . . 0.0 111.099 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.98 -158.8 22.38 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.201 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -79.28 4.17 15.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.02 158.53 67.2 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 122.346 -0.222 . . . . 0.0 110.661 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.69 153.93 68.84 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.214 2.61 . . . . 0.0 113.214 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.493 HG23 ' OD1' ' B' ' 51' ' ' ASP . 7.3 p -54.53 -39.8 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.346 1.058 . . . . 0.0 113.394 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -57.56 -27.26 62.5 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.95 -36.74 80.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -83.19 -35.46 25.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.415 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 82.1 t -58.38 -50.95 76.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.876 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.22 -36.51 84.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.6 -48.09 78.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.832 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.08 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.925 0.393 . . . . 0.0 111.088 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.54 -41.76 98.43 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.9 m -61.16 -39.62 90.8 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.521 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.3 mt -63.51 -38.69 92.1 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.59 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.3 -46.02 86.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.138 0.494 . . . . 0.0 110.696 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.83 -7.51 59.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -84.87 -25.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.81 -15.71 3.31 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.612 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.65 94.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.169 0.509 . . . . 0.0 109.93 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -90.48 19.04 5.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.962 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -155.25 107.84 2.72 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.407 HD11 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.15 158.74 41.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -174.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 53.8 t -124.19 121.72 62.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.508 0.67 . . . . 0.0 111.015 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.77 129.03 50.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.92 122.74 44.09 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.26 0.552 . . . . 0.0 110.777 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . . . -116.77 154.34 30.85 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -142.94 136.03 28.14 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.542 0.526 . . . . 0.0 110.35 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.33 -132.92 11.46 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -93.48 13.56 21.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 110.267 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.95 1.41 56.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.27 -43.78 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.305 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -65.92 -24.25 66.79 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.955 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -79.6 -32.2 41.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.035 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' B' ' 41' ' ' ALA . . . -68.29 -44.18 76.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.08 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.51 -33.91 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.113 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.493 ' OD1' HG23 ' B' ' 19' ' ' VAL . 13.7 t70 -58.51 -49.28 77.95 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -54.58 -51.78 64.19 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.908 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.45 -37.11 69.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -66.97 -30.52 70.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.304 0.573 . . . . 0.0 109.58 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.7 mt -67.33 -49.18 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.106 -0.371 . . . . 0.0 110.649 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.28 -39.42 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.794 0.331 . . . . 0.0 111.542 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' B' ' 62' ' ' ALA . 7.6 ptm180 -79.82 -1.98 41.37 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -110.79 -43.8 3.75 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.769 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -75.16 -34.27 61.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -99.96 -69.15 0.78 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.851 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.469 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.9 mt -144.97 116.6 8.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -93.21 -38.06 11.75 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 124.501 1.125 . . . . 0.0 110.789 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.365 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -108.53 100.14 9.44 Favored 'General case' 0 C--O 1.253 1.254 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.0 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tp -160.18 130.01 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.638 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.15 135.05 53.22 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.73 131.61 45.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.408 ' HD3' ' C ' ' B' ' 68' ' ' LYS . 9.5 tmtt? -83.26 -56.41 3.78 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -170.89 146.22 2.5 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -130.45 123.61 55.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -121.23 140.41 52.07 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.607 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.22 125.67 51.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 88' ' ' SER . . . -165.11 -171.46 31.37 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.001 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' B' ' 88' ' ' SER . 49.0 m -111.0 125.77 54.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.101 0.451 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 53.3 tt0 -89.81 141.9 28.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.899 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.457 HG21 ' HG2' ' B' ' 86' ' ' ARG . 20.7 t -116.39 115.79 50.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.36 172.38 16.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' B' ' 81' ' ' ASP . 25.6 p -97.51 143.28 28.38 Favored 'General case' 0 N--CA 1.413 -2.292 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 46.6 t -77.21 -23.01 51.47 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 178.9 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.508 ' O ' ' HB ' ' B' ' 78' ' ' THR . 15.6 t70 -123.56 -154.7 0.62 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 177.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' B' ' 81' ' ' ASP . . . -65.51 -1.17 7.47 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 114.974 0.75 . . . . 0.0 114.974 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.59 105.6 1.26 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 117.472 0.636 . . . . 0.0 109.437 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -78.85 144.35 35.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.484 0.659 . . . . 0.0 111.895 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -132.43 127.93 36.41 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.539 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 99.7 mtt180 -108.89 116.76 32.6 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 135.63 56.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' B' ' 74' ' ' SER . 20.1 m -68.08 137.17 54.77 Favored 'General case' 0 C--O 1.261 1.693 0 C-N-CA 123.708 0.803 . . . . 0.0 112.193 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.434 HG22 ' OE1' ' B' ' 75' ' ' GLN . 68.4 p -129.42 171.01 12.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.472 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.57 123.03 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.952 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.81 113.36 26.71 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -110.96 116.39 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.36 120.38 40.16 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.059 0.457 . . . . 0.0 110.922 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -120.69 143.8 31.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -110.78 147.61 34.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.284 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 3.3 mmtm -128.81 136.06 49.98 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 122.733 0.413 . . . . 0.0 111.802 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? . . . . . 0 C--O 1.258 1.504 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -178.992 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 119.911 -0.09 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 p 55.56 -173.61 0.06 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.772 0.829 . . . . 0.0 112.737 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.6 m -89.93 -56.59 3.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.263 0.554 . . . . 0.0 109.882 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.602 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -122.24 161.65 16.32 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 p -102.62 98.28 10.72 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 34.3 Cg_endo -98.07 -172.77 0.16 Allowed 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 123.015 2.477 . . . . 0.0 110.356 175.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -114.88 87.78 15.62 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-O 121.141 0.496 . . . . 0.0 112.201 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 6' ' ' PRO . 22.4 Cg_endo -96.03 101.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.908 0 C-N-CA 122.863 2.375 . . . . 0.0 110.753 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -138.76 -66.58 0.47 Allowed 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.683 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -111.84 18.97 18.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.437 0.637 . . . . 0.0 111.518 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.75 148.43 8.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.14 135.03 58.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 120.915 0.388 . . . . 0.0 110.606 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.34 132.35 40.47 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.54 111.16 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.712 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.27 0.02 OUTLIER Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.374 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -135.86 -76.37 0.44 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.052 0.426 . . . . 0.0 110.529 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -99.39 169.38 8.22 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.198 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.36 161.74 16.22 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.355 2.037 . . . . 0.0 112.239 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -51.37 -30.87 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.076 1.35 . . . . 0.0 113.591 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptp -62.85 -26.91 68.99 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.33 -31.35 58.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.148 0.499 . . . . 0.0 109.952 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.81 -36.36 50.33 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.9 t -61.13 -50.85 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.011 0.434 . . . . 0.0 109.903 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.71 -26.49 64.37 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.89 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.9 -44.81 72.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.693 0.282 . . . . 0.0 110.287 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.45 -24.4 67.16 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 90.1 mt -77.89 -45.73 23.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.145 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -63.64 -34.95 78.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.177 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 87.6 mt -61.63 -35.06 76.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 111.385 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.62 -31.07 71.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.493 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.75 -23.2 65.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -79.81 -15.82 56.69 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.984 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.66 -12.01 18.38 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.912 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.42 106.95 15.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.956 0.884 . . . . 0.0 112.049 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.1 p -87.82 -31.18 19.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.007 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 44.5 mt-10 -103.67 107.81 18.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.016 0.436 . . . . 0.0 109.837 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.83 157.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.291 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.2 t -126.92 124.1 63.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.119 0.485 . . . . 0.0 111.002 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.26 126.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -123.32 119.08 29.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.168 0.509 . . . . 0.0 110.141 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.5 156.59 27.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.443 ' HG2' HG23 ' A' ' 89' ' ' THR . 44.1 mtp180 -134.77 147.17 49.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.024 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.28 -134.81 20.19 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -85.1 5.84 28.07 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.392 -0.475 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.38 -3.5 52.95 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -57.37 -32.63 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.446 0.698 . . . . 0.0 110.009 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -61.39 -43.56 98.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.017 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.6 -36.44 80.87 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.506 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.86 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.61 -36.3 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.953 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.565 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.3 t70 -62.43 -45.89 91.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.8 m -56.53 -53.66 54.95 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.48 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.03 -34.54 70.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.207 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.583 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 6.0 tp10 -65.75 -40.7 92.34 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 51' ' ' ASP . 75.8 mt -60.11 -42.99 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.016 0.436 . . . . 0.0 110.48 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.04 -44.68 95.36 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.229 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 2.5 ptm180 -80.03 -2.56 44.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.54 20.69 11.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.09 0.471 . . . . 0.0 111.728 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -139.43 -61.41 0.55 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.15 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -92.03 -54.72 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.527 -174.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 90.2 mt -119.03 107.26 13.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -98.25 -46.55 5.78 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.167 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.45 9.87 31.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -132.39 29.05 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.895 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.66 134.59 58.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.5 ' CD ' HH21 ' A' ' 95' ' ' ARG . 40.2 mt-10 -115.95 157.87 23.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.212 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -100.42 123.39 53.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -82.78 -61.82 1.77 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.992 0.425 . . . . 0.0 110.841 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.93 141.27 17.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.3 pt -130.12 121.56 51.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -132.98 144.74 50.32 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.63 144.83 18.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.77 171.72 28.21 Favored Glycine 0 C--N 1.318 -0.431 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 t -79.21 122.8 26.75 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.709 0.766 . . . . 0.0 110.477 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -99.23 122.2 42.09 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.325 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.2 t -81.98 120.69 33.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.57 145.75 33.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.699 0.285 . . . . 0.0 110.287 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.7 p -90.9 125.67 35.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.042 0.449 . . . . 0.0 110.688 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 m -79.66 -23.56 42.42 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.574 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.0 -91.04 0.11 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 122.656 0.382 . . . . 0.0 111.079 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.07 -67.32 0.94 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.0 14.28 6.64 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.292 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -76.85 96.26 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.37 107.95 18.24 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.845 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.9 m -98.32 121.08 39.81 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.13 113.14 26.38 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.7 t -126.46 137.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 p -65.2 121.15 14.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 123.445 0.466 . . . . 0.0 110.065 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 42' ' ' ARG . 73.4 p -127.46 158.59 36.94 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.458 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -139.47 133.97 38.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.78 112.97 23.62 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.98 117.74 55.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.49 130.01 56.74 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -131.1 157.57 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.5 HH21 ' CD ' ' A' ' 66' ' ' GLU . 59.2 ttp180 -122.37 122.95 40.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.66 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -84.08 -173.98 5.02 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt . . . . . 0 C--O 1.251 1.152 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.654 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.499 -0.985 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 84.0 p 49.51 -160.4 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 O-C-N 124.683 1.239 . . . . 0.0 112.422 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 35.4 t -86.48 6.68 29.33 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.283 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.5 143.64 15.24 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.944 -0.645 . . . . 0.0 112.184 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 29.9 m 70.04 93.6 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.18 0 CA-C-O 121.559 0.695 . . . . 0.0 112.135 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -96.6 24.27 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.188 2.592 . . . . 0.0 112.375 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.1 t -115.74 138.43 23.92 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.25 157.89 59.56 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.644 2.229 . . . . 0.0 111.918 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.407 ' OG ' HG21 ' B' ' 11' ' ' VAL . 33.6 p -106.73 -169.49 1.56 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.198 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -97.46 24.21 6.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.098 0.475 . . . . 0.0 111.235 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.407 HG21 ' OG ' ' B' ' 9' ' ' SER . 32.7 m -101.62 151.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.87 135.74 56.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.883 0.373 . . . . 0.0 110.102 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.9 132.77 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 48.2 mm -94.48 112.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.054 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.56 38.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.278 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.21 -76.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.262 0.553 . . . . 0.0 110.747 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -99.5 169.25 8.36 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -60.71 161.45 21.32 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.387 2.058 . . . . 0.0 112.486 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -50.03 -32.4 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.882 1.273 . . . . 0.0 113.544 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 24.2 ptp -60.97 -32.04 71.59 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -71.07 -33.99 70.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.941 0.401 . . . . 0.0 109.958 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -75.53 -36.2 60.55 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.312 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.0 -53.19 52.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.052 0.453 . . . . 0.0 110.039 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mp -67.14 -28.06 67.83 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.981 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.25 76.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.649 0.261 . . . . 0.0 110.453 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -31.1 72.16 Favored 'General case' 0 C--O 1.261 1.687 0 CA-C-O 121.233 0.539 . . . . 0.0 111.025 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -71.4 -43.46 66.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.061 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -65.52 -36.18 83.06 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.728 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.23 -39.04 91.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.105 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.29 -32.84 71.57 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.977 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -66.18 -22.15 66.35 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.156 0.503 . . . . 0.0 110.92 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.92 -12.93 56.95 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.823 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.77 22.52 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.582 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.2 105.14 13.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 122.031 0.919 . . . . 0.0 112.291 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.5 p -87.74 -31.41 19.69 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.174 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' B' ' 94' ' ' ILE . 43.9 mt-10 -101.93 109.42 21.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.95 155.81 41.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.971 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 111.509 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.02 126.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -123.11 116.77 24.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.247 0.546 . . . . 0.0 110.63 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.48 157.11 24.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.444 ' HG2' HG23 ' B' ' 89' ' ' THR . 50.3 mtp180 -135.7 144.97 46.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.195 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.48 -130.14 10.49 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.241 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -89.88 3.92 51.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.157 0.503 . . . . 0.0 110.333 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.24 -6.4 54.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.307 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.24 -35.12 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.759 0.824 . . . . 0.0 110.288 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.0 p -61.23 -43.69 98.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.178 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -66.13 -38.79 89.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.328 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.99 87.86 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -71.7 -35.33 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.889 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.557 ' O ' HG13 ' B' ' 55' ' ' ILE . 25.2 t70 -64.63 -45.09 88.36 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -54.21 -53.65 50.55 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.87 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.9 -33.15 59.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.632 ' OE1' ' HD3' ' B' ' 57' ' ' ARG . 5.8 tp10 -67.41 -40.08 85.56 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.557 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.4 mt -60.66 -42.49 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.142 0.496 . . . . 0.0 110.804 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.09 -42.98 91.81 Favored 'Isoleucine or valine' 0 C--O 1.256 1.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.777 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.632 ' HD3' ' OE1' ' B' ' 54' ' ' GLU . 2.7 ptm180 -81.34 -2.92 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.209 -175.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.94 19.05 12.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.764 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -139.5 -58.06 0.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.647 -0.421 . . . . 0.0 112.116 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.87 -53.04 4.16 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.279 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 91.4 mt -120.82 106.43 11.66 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -97.15 -39.27 9.37 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.54 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -114.58 6.22 15.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.35 31.37 4.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.169 0.509 . . . . 0.0 111.746 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -134.32 136.99 52.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.511 ' CD ' HH21 ' B' ' 95' ' ' ARG . 41.6 mt-10 -119.49 159.29 24.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 110.44 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.99 123.92 55.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -83.57 -60.58 2.08 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.23 0.331 . . . . 0.0 110.364 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -158.03 140.62 14.6 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.85 124.19 60.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -137.45 143.22 41.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.51 142.18 18.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 O-C-N 123.133 0.271 . . . . 0.0 110.336 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.17 172.4 32.58 Favored Glycine 0 C--O 1.238 0.363 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 121.82 25.27 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.515 0.674 . . . . 0.0 110.451 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -98.38 118.68 35.6 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.431 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 43.5 t -78.67 120.28 29.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.475 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.61 148.86 30.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 27.7 p -94.41 126.7 39.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.119 0.485 . . . . 0.0 110.887 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -78.37 -29.41 47.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.77 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -139.71 -89.17 0.19 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.796 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -106.12 -76.01 0.62 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.87 18.98 10.43 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.72 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -82.72 96.8 8.27 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -85.37 112.26 20.67 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 123.83 0.707 . . . . 0.0 111.513 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 63.7 m -99.67 124.48 44.94 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.07 112.43 25.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.73 136.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 21.0 p -63.86 122.29 16.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.014 0.526 . . . . 0.0 110.24 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.444 HG23 ' HG2' ' B' ' 42' ' ' ARG . 77.4 p -127.68 157.5 40.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.112 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.4 tt -139.41 131.87 36.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.6 112.91 24.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.43 116.8 53.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.886 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.19 128.62 56.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.387 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' B' ' 36' ' ' GLU . 0.2 OUTLIER -128.84 155.26 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.072 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.511 HH21 ' CD ' ' B' ' 66' ' ' GLU . 60.6 ttp180 -119.54 120.91 38.14 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.686 0.616 . . . . 0.0 110.412 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -82.39 -175.14 5.55 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt . . . . . 0 CA--C 1.548 0.885 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.259 174.433 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.645 -0.132 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t -77.43 -35.1 54.35 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.8 p -151.64 -171.26 3.88 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . 103.12 -169.68 19.02 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.845 178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.0 m -91.33 107.19 19.78 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 98.7 Cg_endo -93.93 7.16 2.55 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.54 2.16 . . . . 0.0 112.655 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.272 20.4 p 47.57 88.11 0.11 Allowed Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -88.13 -173.45 0.95 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.669 2.246 . . . . 0.0 112.074 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.0 m -147.32 -81.46 0.14 Allowed 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.542 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -127.87 15.66 6.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.712 0.292 . . . . 0.0 111.306 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.7 133.97 63.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.457 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.79 135.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.0 tp -97.26 115.31 27.4 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.8 99.19 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.334 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.71 72.08 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.073 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HG3' ' HG2' ' A' ' 17' ' ' LYS . 5.7 ptpp? 172.69 -48.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.48 1.112 . . . . 0.0 112.475 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.444 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 32.5 mmmt -100.29 164.77 15.69 Favored Pre-proline 0 C--O 1.256 1.403 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.2 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.5 164.14 34.01 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.595 2.196 . . . . 0.0 110.914 172.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.459 HG22 ' OD1' ' A' ' 51' ' ' ASP . 7.8 p -58.26 -42.81 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.405 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.9 ptp -58.89 -25.93 63.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.12 -38.02 81.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -77.59 -33.28 53.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.46 -47.14 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.359 0.6 . . . . 0.0 109.84 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 20' ' ' MET . 87.0 mt -66.17 -29.66 69.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.782 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -67.99 -43.67 78.39 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.8 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.24 -30.52 70.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.132 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.31 -36.08 66.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.998 0.428 . . . . 0.0 110.182 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 m -70.18 -35.05 73.69 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.3 mt -63.88 -27.07 68.91 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.616 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.449 HD23 ' HG3' ' A' ' 96' ' ' LYS . 14.3 mt -57.69 -41.32 81.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 111.6 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -78.28 -5.26 51.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -102.78 -4.45 24.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 109.714 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.28 13.61 58.44 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.193 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 20.7 t -101.01 89.55 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.628 0.727 . . . . 0.0 109.27 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -81.17 -24.71 37.35 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.571 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.521 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 35.2 mt-10 -110.65 111.21 22.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.23 154.07 39.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.042 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.026 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.97 117.91 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 123.794 0.684 . . . . 0.0 110.497 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.89 120.81 40.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -113.37 115.03 27.46 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 122.742 0.417 . . . . 0.0 110.195 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.25 39.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HG2' HG22 ' A' ' 89' ' ' THR . 44.1 mtm180 -133.77 148.52 51.39 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 120.817 0.342 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.96 -130.44 10.97 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.782 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.56 -0.45 57.52 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 122.232 -0.569 . . . . 0.0 112.06 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.77 6.41 24.57 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -57.77 -37.1 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 110.0 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.8 p -67.66 -29.7 69.06 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.989 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.97 -29.2 58.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.296 0.57 . . . . 0.0 109.66 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.24 -45.35 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.397 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.06 -38.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.504 ' O ' HG13 ' A' ' 55' ' ' ILE . 13.6 t70 -57.91 -42.39 84.64 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.3 m -55.3 -52.69 62.64 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.015 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.68 -34.13 51.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . 0.257 11.6 pt-20 -69.96 -31.7 69.55 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.561 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.5 mt -62.4 -47.81 91.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.955 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.9 t -57.91 -48.82 83.03 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 16.6 ptm180 -72.75 -14.56 61.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -109.39 0.72 19.55 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.499 -0.88 . . . . 0.0 113.213 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -108.69 -19.28 13.48 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.04 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -146.25 -70.13 0.26 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.451 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.0 86.06 7.07 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -75.54 -73.6 0.25 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.931 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.6 2.25 55.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -113.88 24.42 12.09 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.187 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.38 133.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.148 0.499 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -101.53 143.62 31.29 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.2 mt -124.65 140.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.99 -73.39 0.52 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.115 0.483 . . . . 0.0 111.242 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -170.49 157.52 5.97 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.32 115.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -113.28 128.61 56.52 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.97 132.79 47.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.78 169.46 41.89 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.905 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 m -81.44 138.45 35.54 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 122.969 0.508 . . . . 0.0 109.67 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -115.87 130.49 56.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.686 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -96.56 112.33 28.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.01 148.38 20.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 120.859 0.361 . . . . 0.0 111.129 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.8 p -94.24 120.62 34.74 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.349 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.4 t -74.12 -47.97 32.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.565 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -119.0 -86.09 0.65 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.416 0.627 . . . . 0.0 110.547 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -116.0 -61.49 1.73 Allowed 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.327 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.59 8.27 7.81 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.063 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -76.67 92.62 3.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -87.46 134.12 33.64 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.285 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.0 t -128.67 160.28 32.97 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -113.25 125.08 53.92 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.33 122.24 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 p -65.24 130.47 43.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.439 HG22 ' HG2' ' A' ' 42' ' ' ARG . 41.7 p -128.54 145.42 51.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.68 138.17 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.0 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -121.9 111.0 16.55 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.393 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -107.07 110.5 31.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.16 124.91 53.24 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.4 pt -134.66 168.73 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.521 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 30.5 ttt180 -135.04 155.57 50.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.449 ' HG3' HD23 ' A' ' 30' ' ' LEU . 47.7 mmtm -109.27 145.2 36.33 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm . . . . . 0 C--O 1.254 1.301 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.01 175.503 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.421 0.153 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.8 p -73.28 150.14 42.19 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 123.47 0.708 . . . . 0.0 112.29 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.0 p -100.82 -70.94 0.72 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.561 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.98 -37.3 2.24 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 41.3 p -99.71 127.45 33.94 Favored Pre-proline 0 C--N 1.318 -0.773 0 C-N-CA 122.588 0.355 . . . . 0.0 110.058 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.12 18.41 1.31 Allowed 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 123.17 2.58 . . . . 0.0 113.34 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -97.2 130.95 28.46 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.049 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -48.76 115.16 1.51 Allowed 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 123.412 2.741 . . . . 0.0 113.543 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -100.83 22.46 12.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.182 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -95.98 18.23 13.78 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.425 0.631 . . . . 0.0 110.425 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.59 132.73 69.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.322 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.895 0.379 . . . . 0.0 111.386 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -96.29 114.76 26.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.561 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.82 98.27 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.253 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 72.83 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.435 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' B' ' 17' ' ' LYS . 5.2 ptpp? 172.25 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.789 1.236 . . . . 0.0 112.244 174.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.479 ' HG2' ' HG3' ' B' ' 16' ' ' LYS . 32.3 mmmt -100.19 164.19 16.84 Favored Pre-proline 0 C--O 1.255 1.366 0 O-C-N 122.227 -0.296 . . . . 0.0 111.309 -174.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.02 164.48 29.82 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.997 2.465 . . . . 0.0 110.869 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.9 -42.25 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptp -58.09 -26.12 62.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -68.38 -39.48 81.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.411 0.624 . . . . 0.0 110.104 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.62 -33.34 58.39 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.478 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.31 -48.46 88.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.706 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.32 -29.39 70.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.037 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.06 -46.79 73.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.01 85.82 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.123 0.487 . . . . 0.0 111.134 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.222 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 43.2 m -72.16 -36.55 69.35 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.208 0.527 . . . . 0.0 110.26 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 94.4 mt -62.99 -30.01 71.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.695 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.446 HD23 ' HG3' ' B' ' 96' ' ' LYS . 17.5 mt -54.0 -42.82 69.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.855 171.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.59 -9.57 58.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.418 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -99.38 -3.78 33.07 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.952 0.406 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.08 12.27 57.79 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.459 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' B' ' 29' ' ' LEU . 20.9 t -100.65 90.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.537 0.684 . . . . 0.0 109.695 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 44.3 m -82.05 -25.29 34.72 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.583 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.404 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 37.2 mt-10 -109.58 110.8 21.99 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.76 152.56 37.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.58 119.03 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.492 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.9 121.02 40.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.62 113.89 25.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.045 0.45 . . . . 0.0 110.289 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 152.0 38.07 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.405 ' HG2' HG22 ' B' ' 89' ' ' THR . 46.7 mtm180 -134.8 151.41 50.93 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.764 0.316 . . . . 0.0 110.689 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 -128.01 10.9 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.748 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -91.17 -1.04 57.8 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 122.359 -0.495 . . . . 0.0 112.099 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 8.06 21.04 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.12 -37.86 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.774 0.797 . . . . 0.0 109.924 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 29.2 p -66.39 -30.63 71.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.239 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.67 -31.26 61.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.03 75.98 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.421 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.17 -37.43 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.643 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.502 ' O ' HG13 ' B' ' 55' ' ' ILE . 14.7 t70 -59.11 -40.24 84.75 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.6 m -57.47 -52.99 63.12 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.851 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 m -70.93 -34.65 56.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.97 -33.14 73.21 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.293 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.502 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.9 mt -61.87 -48.78 87.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.126 175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.09 -49.42 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 62' ' ' ALA . 15.5 ptm180 -72.25 -18.26 61.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -104.0 -3.45 24.61 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.882 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -106.54 -15.2 14.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.39 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -149.65 -69.67 0.2 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 mp -88.76 86.94 7.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.146 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -76.86 -73.17 0.3 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.839 -178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.9 4.84 51.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -115.2 26.51 10.04 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.042 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.2 tp -107.25 130.26 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 120.871 0.367 . . . . 0.0 110.98 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -96.99 147.0 24.44 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.1 mt -126.6 138.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -88.08 -73.49 0.49 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -172.02 160.94 5.5 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 65.7 mt -125.83 115.49 43.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -111.79 124.19 51.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.22 136.43 56.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.7 170.17 41.02 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.796 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.4 m -80.61 140.8 35.55 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -118.67 130.99 56.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t -97.4 114.47 34.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.75 148.88 22.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.055 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 31.7 p -94.43 117.49 30.2 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.969 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 43.8 t -69.57 -53.78 17.28 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 122.97 0.508 . . . . 0.0 111.409 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -112.74 -84.83 0.58 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.35 0.595 . . . . 0.0 110.444 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -117.03 -62.07 1.63 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.293 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.79 7.19 8.9 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.066 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -76.47 95.13 3.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -91.73 134.43 34.73 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.836 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 34.0 t -127.42 162.7 25.73 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -115.16 125.83 53.88 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 119.32 54.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -63.66 129.05 38.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.405 HG22 ' HG2' ' B' ' 42' ' ' ARG . 47.0 p -127.37 147.3 50.27 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.827 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.36 137.35 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.528 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.05 112.48 19.19 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.046 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.4 mt -107.31 111.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.16 127.15 56.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.975 0.416 . . . . 0.0 110.667 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -136.35 167.48 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.263 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.404 ' HD2' ' OE2' ' B' ' 36' ' ' GLU . 36.8 ttt180 -134.07 153.47 51.78 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.904 0.383 . . . . 0.0 110.138 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.446 ' HG3' HD23 ' B' ' 30' ' ' LEU . 46.7 mmtm -108.35 140.56 41.46 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm . . . . . 0 C--N 1.311 -1.085 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.11 173.137 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.218 -0.601 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 t -60.83 -45.52 94.13 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 121.331 0.586 . . . . 0.0 110.555 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 p -100.18 20.75 14.03 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.386 0.612 . . . . 0.0 110.505 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.34 92.78 0.17 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -61.73 117.25 26.45 Favored Pre-proline 0 C--O 1.244 0.813 0 O-C-N 124.318 0.658 . . . . 0.0 112.591 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -100.52 6.87 0.69 Allowed 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.66 2.24 . . . . 0.0 111.699 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.2 m 66.45 103.23 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.55 0.74 . . . . 0.0 110.985 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -74.33 -175.14 2.07 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.162 1.908 . . . . 0.0 113.222 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -130.8 -176.85 4.12 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.178 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -84.96 12.8 6.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.05 0.54 . . . . 0.0 112.196 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 19.3 m -98.96 129.98 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.106 0.479 . . . . 0.0 110.458 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' CG2' HG12 ' A' ' 39' ' ' ILE . 35.6 m -118.47 139.36 46.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.836 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.0 127.29 43.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.761 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.52 110.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.37 53.55 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.234 -1.46 . . . . 0.0 113.894 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -157.51 -58.97 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -100.79 162.28 21.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.997 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.72 156.75 55.64 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.236 1.957 . . . . 0.0 112.014 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.474 HG22 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -50.87 -32.4 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.725 1.21 . . . . 0.0 113.776 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.3 ptp -56.81 -31.6 64.88 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -75.93 -37.15 59.01 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.842 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.7 -37.34 73.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.36 -47.5 90.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.254 0.55 . . . . 0.0 110.05 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.18 -32.22 71.38 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.944 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.51 -44.46 78.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.671 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.75 90.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.273 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.44 -35.54 81.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.979 0.419 . . . . 0.0 111.047 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.3 m -69.9 -39.13 76.42 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.73 -35.86 75.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.39 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.8 tm? -59.39 -45.58 91.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.933 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.422 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -79.75 -21.64 44.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.56 -19.84 3.75 Favored Glycine 0 CA--C 1.5 -0.904 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.2 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 22.0 t -71.81 94.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.471 0.653 . . . . 0.0 109.349 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -79.26 -17.47 54.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.216 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.57 130.91 23.62 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.15 156.15 42.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.185 -178.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 43.4 t -121.46 113.55 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.304 0.574 . . . . 0.0 110.425 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.407 HG12 ' CG2' ' A' ' 12' ' ' VAL . 65.2 mt -95.14 122.01 46.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 80.4 mttt -120.92 120.64 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.95 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.64 167.24 12.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.769 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -139.29 141.94 37.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.21 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 59.93 -106.72 1.06 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -83.31 -21.18 33.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.19 0.519 . . . . 0.0 109.95 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.32 -8.7 56.97 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.14 -39.2 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.606 0.717 . . . . 0.0 110.386 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -64.55 -29.51 70.54 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.664 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -78.34 -37.35 44.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.559 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.306 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -73.14 -35.7 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.766 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.474 ' OD2' HG22 ' A' ' 19' ' ' VAL . 18.1 t70 -58.83 -47.92 83.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.3 m -53.07 -54.14 39.87 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.205 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.35 -29.17 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.35 -36.77 79.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.6 mt -65.44 -50.14 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.962 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.27 -44.57 84.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -75.55 -1.95 26.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -130.42 6.6 4.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.612 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -114.13 -61.9 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -76.41 -50.08 15.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.591 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 96' ' ' LYS . 69.4 tp -159.46 105.91 1.69 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.31 -27.67 15.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.506 1.129 . . . . 0.0 111.869 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.76 -42.49 89.03 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.607 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -122.34 108.38 13.17 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.985 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -161.35 145.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.77 156.13 43.89 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.0 mt -104.35 141.21 20.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -95.93 -38.25 10.33 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.332 -0.23 . . . . 0.0 110.902 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -167.78 146.38 4.69 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.486 0.491 . . . . 0.0 109.835 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.52 97.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 124.356 1.062 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.8 142.08 50.38 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.405 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.76 134.95 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.18 151.28 22.6 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.15 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -79.57 124.72 28.77 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -107.69 135.29 49.36 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.953 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -103.8 115.28 45.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.35 0.595 . . . . 0.0 111.092 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.22 135.05 59.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.11 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.4 p -80.15 121.67 25.86 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.45 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.9 t -59.61 -41.17 89.78 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.651 0.594 . . . . 0.0 111.397 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -178.56 -40.06 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -120.17 -155.41 0.62 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.19 17.39 1.02 Allowed Glycine 0 CA--C 1.537 1.464 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -78.5 100.44 6.88 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -85.77 103.52 14.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.0 m -84.46 114.82 22.2 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.261 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -89.35 110.06 20.9 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.87 132.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.219 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -71.41 126.77 30.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.937 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 46.5 p -127.99 154.61 45.42 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.964 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -135.28 135.08 52.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.555 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -112.5 111.1 21.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.642 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.5 mm -108.28 110.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.62 122.01 39.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.17 149.4 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -126.6 127.55 45.41 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.458 ' HZ3' ' HB3' ' A' ' 61' ' ' LEU . 53.8 tptt -77.61 151.92 34.14 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.689 0.757 . . . . 0.0 112.866 -174.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 N--CA 1.437 -1.117 0 C-N-CA 126.154 1.782 . . . . 0.0 106.459 179.138 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 111.165 0.061 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m 62.82 13.39 6.47 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m 60.42 93.01 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.64 78.99 0.87 Allowed Glycine 0 CA--C 1.501 -0.819 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.414 ' HB ' ' HD3' ' B' ' 6' ' ' PRO . 23.3 m -61.19 -53.39 63.56 Favored Pre-proline 0 CA--C 1.568 1.662 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' HB ' ' B' ' 5' ' ' THR . 85.2 Cg_endo -85.64 -39.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 121.164 1.243 . . . . 0.0 112.695 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -136.02 100.0 10.96 Favored Pre-proline 0 C--O 1.249 1.034 0 C-N-CA 122.659 0.384 . . . . 0.0 110.419 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -89.57 108.33 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.86 2.374 . . . . 0.0 111.516 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -92.56 17.86 9.5 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.313 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -106.81 7.29 30.17 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 18.9 m -96.66 129.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.118 0.485 . . . . 0.0 111.487 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.97 139.41 47.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.893 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.11 124.47 44.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mm -95.22 112.4 27.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.805 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.33 47.31 0.01 OUTLIER Glycine 0 C--N 1.313 -0.727 0 C-N-CA 119.136 -1.507 . . . . 0.0 114.338 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -151.73 -58.05 0.15 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.874 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -101.52 162.62 19.89 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.56 155.43 58.5 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.518 2.145 . . . . 0.0 112.162 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.82 -31.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.5 1.12 . . . . 0.0 113.992 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -57.52 -34.35 69.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -71.76 -40.78 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.751 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -69.16 -38.48 78.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.638 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.26 -46.85 88.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.338 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.5 -37.03 79.72 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.235 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.68 95.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.75 88.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.562 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.11 -35.71 81.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.7 m -67.39 -41.94 84.17 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.49 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.93 -34.77 75.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 2.0 tm? -59.89 -44.17 94.39 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.42 -25.25 66.66 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.306 0.574 . . . . 0.0 111.779 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -79.13 -14.75 58.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.672 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.83 -16.32 6.5 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.964 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 30' ' ' LEU . 21.5 t -74.68 94.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -83.25 -15.03 51.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.1 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.419 ' OE2' ' HE3' ' B' ' 68' ' ' LYS . 10.0 pt-20 -140.01 130.03 24.88 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.32 155.61 41.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.21 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.77 113.52 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.663 0.744 . . . . 0.0 110.872 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 61.7 mt -94.64 123.08 46.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.037 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 82.5 mttt -121.36 123.11 41.35 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.172 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.78 166.77 14.41 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.316 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -139.68 140.72 36.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.203 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.91 -105.41 0.92 Allowed Glycine 0 N--CA 1.466 0.649 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -84.32 -23.29 30.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.867 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.08 -7.22 47.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.1 mt -57.22 -39.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.727 0.775 . . . . 0.0 109.723 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.2 t -64.03 -32.42 73.96 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.54 -37.66 59.86 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.184 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.92 83.67 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.088 0.471 . . . . 0.0 111.525 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.86 -35.22 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.802 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.422 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.5 t70 -59.93 -45.04 93.9 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.7 m -54.88 -56.85 14.99 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.322 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.89 -29.84 44.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.46 -35.27 77.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.779 0.323 . . . . 0.0 110.158 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 51' ' ' ASP . 80.2 mt -67.16 -50.85 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 88.2 t -55.59 -44.87 78.17 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.92 -2.55 27.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -132.48 9.01 4.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.318 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -113.27 -60.1 1.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.296 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.51 -51.44 9.97 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.08 0.467 . . . . 0.0 111.1 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.487 ' HB3' ' HZ3' ' B' ' 96' ' ' LYS . 67.8 tp -158.25 104.67 1.87 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.76 -22.03 19.6 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.329 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.38 -43.87 80.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -117.96 105.67 12.14 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -161.18 141.02 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.56 156.32 45.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.098 0.475 . . . . 0.0 109.739 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.39 140.42 20.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.419 ' HE3' ' OE2' ' B' ' 36' ' ' GLU . 64.9 tttm -93.83 -40.58 10.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.292 -0.255 . . . . 0.0 110.944 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.74 147.05 4.89 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.438 0.462 . . . . 0.0 109.759 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 pt -145.62 100.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 124.521 1.128 . . . . 0.0 109.698 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.104 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.75 135.86 56.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.0 150.94 22.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.353 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -79.48 124.0 28.07 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -106.98 134.87 49.49 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.933 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -103.63 115.86 46.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.247 0.546 . . . . 0.0 110.847 176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.14 134.18 64.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.09 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 35.2 p -80.23 120.79 24.79 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.096 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 35.8 t -60.34 -40.5 90.9 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.47 0.481 . . . . 0.0 111.71 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -178.06 -39.2 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' B' ' 82' ' ' GLY . 18.9 t70 -121.46 -156.7 0.7 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 174.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.435 ' H ' ' CG ' ' B' ' 81' ' ' ASP . . . -71.98 25.77 0.66 Allowed Glycine 0 CA--C 1.534 1.243 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -174.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -84.89 96.23 9.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -81.46 105.48 12.66 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.733 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.6 m -83.67 112.97 20.53 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -87.07 109.39 19.38 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.74 132.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 128.76 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 58.0 p -130.13 154.27 47.66 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 14.9 tt -134.84 136.34 52.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.504 0.192 . . . . 0.0 110.524 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -115.21 112.32 22.31 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.91 110.61 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.85 120.77 37.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -121.94 149.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -127.43 126.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.487 ' HZ3' ' HB3' ' B' ' 61' ' ' LEU . 53.7 tptt -77.51 151.43 34.58 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.935 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.435 -1.177 0 C-N-CA 125.234 1.414 . . . . 0.0 107.778 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.509 -0.623 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p -68.89 137.88 54.22 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.358 0.412 . . . . 0.0 111.389 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -114.29 -1.49 13.57 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.963 0.411 . . . . 0.0 110.695 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.7 -42.7 5.35 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.896 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 37.8 m -130.98 126.07 21.51 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 4.1 Cg_exo -77.17 162.95 31.06 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.865 2.376 . . . . 0.0 112.505 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 p -87.73 125.51 64.72 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.267 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.16 164.96 11.29 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.833 2.355 . . . . 0.0 112.575 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -138.3 105.22 5.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -135.92 16.09 3.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.668 0.747 . . . . 0.0 109.713 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.0 m -120.08 133.45 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.052 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.53 144.45 30.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.255 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -105.83 121.63 44.45 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.09 103.35 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.19 51.11 0.03 OUTLIER Glycine 0 C--O 1.24 0.49 0 C-N-CA 119.515 -1.326 . . . . 0.0 114.086 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -166.33 -55.32 0.03 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.125 0.462 . . . . 0.0 110.831 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.86 154.71 37.1 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.22 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HD2' ' ND2' ' A' ' 21' ' ' ASN . 38.6 Cg_exo -62.7 160.23 33.64 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.327 2.018 . . . . 0.0 111.638 174.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -49.93 -34.17 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.53 1.132 . . . . 0.0 113.267 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.454 ' O ' HD11 ' A' ' 24' ' ' LEU . 26.8 ptm -60.1 -27.35 66.95 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.609 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.473 ' ND2' ' HD2' ' A' ' 18' ' ' PRO . 43.9 m-80 -80.83 -25.81 37.5 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.118 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -83.88 -37.62 22.17 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.553 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' O ' HD11 ' A' ' 27' ' ' LEU . 73.2 t -59.29 -55.59 22.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.045 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 20' ' ' MET . 8.3 mp -62.31 -31.32 71.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.081 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.24 -42.84 99.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 123.117 0.26 . . . . 0.0 111.241 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -64.92 -40.37 94.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.782 0.325 . . . . 0.0 110.403 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.405 HD11 ' O ' ' A' ' 23' ' ' VAL . 8.6 mp -63.13 -39.34 94.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.449 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.6 m -66.0 -34.42 78.05 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.5 mt -70.87 -36.42 72.78 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.664 0.269 . . . . 0.0 111.325 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.5 mt -59.61 -42.6 93.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.05 0.453 . . . . 0.0 110.067 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -65.75 -25.17 67.15 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -89.24 -2.42 58.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.746 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.1 12.2 40.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.171 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.6 t -99.34 115.23 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -101.31 -30.64 11.38 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.93 105.79 14.32 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.036 0.922 . . . . 0.0 112.784 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.415 ' H ' HD11 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -117.38 154.53 19.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.512 -177.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.69 120.63 62.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.103 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -96.78 120.52 46.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.275 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HG2' ' HG2' ' A' ' 91' ' ' GLU . 48.1 mttp -108.26 121.29 44.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.72 138.12 53.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -137.1 120.13 16.55 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 45' ' ' ALA . . . 87.53 76.44 1.27 Allowed Glycine 0 C--O 1.219 -0.804 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.92 176.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 68.0 -15.66 0.2 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 43' ' ' GLY . . . -74.3 6.05 3.97 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.813 0.445 . . . . 0.0 111.869 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.73 -37.91 55.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.448 1.099 . . . . 0.0 109.406 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.1 p -67.56 -24.87 65.57 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.137 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -86.96 -29.96 21.65 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.534 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.24 -42.61 96.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.7 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.63 -40.75 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.214 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 55' ' ' ILE . 17.2 t70 -57.65 -44.18 85.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.445 0.641 . . . . 0.0 109.281 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 56' ' ' VAL . 91.0 m -57.94 -51.08 71.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.678 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 33.8 m -69.85 -32.36 51.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.122 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.35 -36.48 83.84 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.8 mt -67.64 -46.77 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.141 0.496 . . . . 0.0 110.385 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 52' ' ' THR . 67.2 t -59.71 -38.27 75.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.166 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 53' ' ' VAL . 15.9 ptm180 -91.87 17.68 8.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.609 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -133.07 -41.73 0.9 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -86.91 -60.45 1.98 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.629 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.56 -58.28 3.42 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.045 0.45 . . . . 0.0 111.588 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.5 tp -148.0 102.49 3.39 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.3 -26.88 17.11 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.871 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.03 -50.28 66.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.15 0.5 . . . . 0.0 111.775 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -103.81 105.8 16.12 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.106 0.479 . . . . 0.0 110.882 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 tp -159.79 127.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.431 0.692 . . . . 0.0 110.652 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.81 149.57 51.4 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 173.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.77 134.67 46.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -90.95 -60.37 1.93 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.118 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -155.55 147.91 23.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.41 111.02 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -113.73 135.28 54.11 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.546 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -136.65 133.59 48.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.3 179.31 48.14 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.596 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 m -80.71 124.07 28.72 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.636 0.774 . . . . 0.0 110.971 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 25.7 tt0 -88.99 117.54 28.08 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t -103.88 108.87 25.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.39 145.77 34.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.326 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.9 p -83.78 127.12 33.57 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m -53.92 -54.09 43.6 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.545 0.528 . . . . 0.0 111.322 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -167.25 -57.84 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.28 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -86.53 -79.61 0.26 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.906 0.384 . . . . 0.0 110.605 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.85 29.77 1.01 Allowed Glycine 0 C--O 1.223 -0.532 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.139 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -93.63 105.62 17.65 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -70.53 109.16 4.67 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.591 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -100.35 109.27 21.45 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 89.7 mtt180 -101.63 117.87 35.79 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -124.44 135.1 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.312 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 m -62.94 120.57 11.62 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 123.697 0.799 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 p -127.19 152.02 47.92 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 122.641 0.377 . . . . 0.0 110.364 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.9 tt -143.71 142.2 24.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.163 0 CA-C-O 120.782 0.325 . . . . 0.0 110.607 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' A' ' 40' ' ' LYS . 44.3 mt-10 -123.5 121.14 34.92 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.778 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -113.06 111.61 36.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.84 117.15 31.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.51 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 pt -119.16 168.17 11.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.935 0.398 . . . . 0.0 110.659 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -125.23 118.62 26.43 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.742 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -105.1 78.74 1.42 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.136 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 8.4 ptmm? . . . . . 0 C--O 1.274 2.354 0 C-N-CA 124.082 0.953 . . . . 0.0 110.004 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 16.8 m -84.31 -7.33 59.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.511 0.324 . . . . 0.0 111.826 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t 69.53 18.9 7.65 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.858 0.863 . . . . 0.0 111.015 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.65 145.28 17.64 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -137.97 143.18 38.7 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.19 -2.95 13.19 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.414 2.076 . . . . 0.0 113.276 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -112.81 129.13 24.76 Favored Pre-proline 0 N--CA 1.436 -1.173 0 CA-C-O 120.99 0.424 . . . . 0.0 110.26 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.21 98.08 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.198 1.932 . . . . 0.0 111.873 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 30.1 t -104.71 -40.57 5.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.928 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -136.84 16.05 3.08 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 20.9 m -115.68 131.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.174 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.78 145.78 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 60.5 tp -108.62 118.79 37.7 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.001 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -83.89 113.43 22.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.75 45.16 0.02 OUTLIER Glycine 0 C--O 1.237 0.305 0 C-N-CA 119.48 -1.343 . . . . 0.0 114.057 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -163.34 -59.69 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.241 0.52 . . . . 0.0 110.291 177.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.17 155.52 38.83 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.21 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.456 ' HD2' ' ND2' ' B' ' 21' ' ' ASN . 35.5 Cg_exo -63.26 158.99 41.61 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.569 2.179 . . . . 0.0 111.385 174.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.464 HG23 ' OD2' ' B' ' 51' ' ' ASP . 7.6 p -48.75 -35.1 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.599 1.16 . . . . 0.0 113.113 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.423 ' O ' HD11 ' B' ' 24' ' ' LEU . 26.3 ptm -57.66 -29.77 64.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.969 0.414 . . . . 0.0 111.743 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.456 ' ND2' ' HD2' ' B' ' 18' ' ' PRO . 40.7 m-80 -77.27 -30.58 54.38 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.63 -38.22 40.25 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.42 ' O ' HD11 ' B' ' 27' ' ' LEU . 66.7 t -60.35 -55.83 21.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.423 HD11 ' O ' ' B' ' 20' ' ' MET . 8.3 mp -63.79 -25.27 68.1 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.43 -44.9 85.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.666 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -63.54 -42.91 98.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.967 0.413 . . . . 0.0 110.65 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.42 HD11 ' O ' ' B' ' 23' ' ' VAL . 8.8 mp -61.23 -35.72 77.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.486 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 61.9 m -69.89 -35.74 74.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.294 0.569 . . . . 0.0 109.794 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -68.9 -35.3 76.68 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 122.159 -0.338 . . . . 0.0 111.368 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 91.1 mt -59.5 -41.12 89.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.084 0.469 . . . . 0.0 110.585 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -67.25 -25.04 65.89 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.077 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -87.94 -0.92 57.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.967 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.34 0.02 53.83 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.739 -0.744 . . . . 0.0 114.424 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.48 113.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -100.93 -27.74 13.14 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.901 0.381 . . . . 0.0 111.436 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.06 110.44 20.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.826 0.822 . . . . 0.0 112.198 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 152.75 28.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.963 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.62 119.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 CA-C-O 121.156 0.503 . . . . 0.0 110.29 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -96.3 120.98 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.24 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -107.79 120.99 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.156 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.3 137.14 53.88 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -135.79 117.81 15.34 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.82 76.47 1.31 Allowed Glycine 0 C--O 1.217 -0.931 0 N-CA-C 114.742 0.657 . . . . 0.0 114.742 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 67.18 -15.04 0.17 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.89 6.87 4.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.0 0.429 . . . . 0.0 111.607 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 67.8 mt -55.99 -39.42 57.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 124.57 1.148 . . . . 0.0 109.778 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.0 p -64.66 -29.0 69.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.8 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.21 -28.59 27.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.571 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.52 92.66 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.288 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.63 -40.97 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.171 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.464 ' OD2' HG23 ' B' ' 19' ' ' VAL . 15.6 t70 -54.68 -48.12 72.77 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.613 0.721 . . . . 0.0 109.518 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.46 ' O ' HG22 ' B' ' 56' ' ' VAL . 64.3 m -54.52 -52.0 63.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.941 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.404 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 33.2 m -69.26 -33.47 58.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.313 -176.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.48 -35.91 82.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.098 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.405 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.7 mt -67.66 -47.38 80.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 120.946 0.403 . . . . 0.0 110.259 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.46 HG22 ' O ' ' B' ' 52' ' ' THR . 81.0 t -59.36 -38.49 75.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.936 -177.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' B' ' 53' ' ' VAL . 15.4 ptm180 -90.88 18.46 6.58 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.286 -0.259 . . . . 0.0 111.529 -177.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.73 -48.74 0.88 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.235 0.54 . . . . 0.0 110.603 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -81.23 -52.2 7.59 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -80.81 -60.32 2.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.191 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -146.13 104.12 3.79 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.81 -24.73 16.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.925 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.71 -46.89 64.95 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.36 0.6 . . . . 0.0 111.361 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -104.13 105.83 16.13 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.987 0.423 . . . . 0.0 110.693 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -160.82 131.31 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.387 0.675 . . . . 0.0 109.905 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.81 147.46 42.56 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.5 mt -104.65 133.62 48.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -89.5 -60.43 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.092 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.04 149.28 27.01 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -138.2 109.61 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -112.01 134.85 53.31 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.515 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.29 130.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.59 177.89 46.57 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.063 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.5 m -79.46 125.27 29.34 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.087 0.955 . . . . 0.0 111.254 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 27.5 tt0 -90.1 116.5 28.16 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.426 HG21 ' HG2' ' B' ' 86' ' ' ARG . 40.5 t -101.55 107.4 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.48 146.58 33.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 120.707 0.289 . . . . 0.0 110.249 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 25.3 p -85.51 128.26 34.68 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -57.23 -51.52 69.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.017 0.437 . . . . 0.0 111.341 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -168.98 -60.19 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.541 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -85.79 -78.16 0.28 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.191 0.52 . . . . 0.0 110.765 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.36 35.21 0.76 Allowed Glycine 0 CA--C 1.501 -0.782 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.108 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -98.72 108.18 20.81 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -74.66 110.14 8.71 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.375 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 36.7 m -99.06 112.8 24.83 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 96.6 mtt180 -105.31 111.17 23.8 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.98 133.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.66 120.25 10.83 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 123.651 0.78 . . . . 0.0 110.609 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.0 p -125.92 151.18 47.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.6 tt -141.74 143.58 26.92 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 120.626 0.251 . . . . 0.0 110.813 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.36 121.75 35.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.886 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.06 113.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.53 115.42 27.95 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 pt -118.83 161.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.728 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -120.23 118.53 30.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -102.97 78.85 1.7 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' B' ' 97' ' ' LYS . 8.9 ptmm? . . . . . 0 C--O 1.279 2.61 0 C-N-CA 124.395 1.078 . . . . 0.0 109.775 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 p30 . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.23 138.36 52.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.959 0.409 . . . . 0.0 110.824 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.51 151.03 33.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.0 tp -116.63 131.77 56.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 48' ' ' LYS . 51.2 mm -84.41 121.98 37.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.18 -115.74 3.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.453 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.64 12.25 16.0 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.55 147.0 58.37 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.365 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.11 147.93 80.53 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.396 2.064 . . . . 0.0 110.781 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 23' ' ' VAL . 13.8 p -58.64 -28.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 112.072 -175.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 24' ' ' LEU . 27.1 ptt? -64.03 -24.0 67.55 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.19 0.519 . . . . 0.0 111.331 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.81 -30.49 51.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.021 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -82.82 -37.57 24.28 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.077 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 19' ' ' VAL . 67.4 t -58.25 -51.06 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.021 0.439 . . . . 0.0 110.687 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 20' ' ' MET . 9.2 mp -67.37 -30.05 69.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.124 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.65 -44.96 80.53 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.826 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.28 -35.28 80.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.187 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.4 -36.8 79.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -67.74 -35.68 79.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.514 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.4 mt -63.97 -36.45 84.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' A' ' 96' ' ' LYS . 3.4 tm? -63.21 -46.87 85.01 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.7 -4.01 44.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.573 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -94.95 -22.94 17.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.7 -8.3 4.91 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.979 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.97 107.28 20.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.156 0.503 . . . . 0.0 110.624 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.6 p -85.6 -25.65 26.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -118.84 113.97 21.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -122.55 146.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 123.274 0.358 . . . . 0.0 110.701 -178.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.44 118.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.2 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.8 mt -93.66 122.32 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.45 129.28 56.65 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.089 0.471 . . . . 0.0 109.785 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.12 169.59 17.37 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.496 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HB3' HG22 ' A' ' 89' ' ' THR 0.309 0.0 OUTLIER -158.64 149.92 20.69 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.498 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.35 -120.02 8.98 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.223 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 ptm180 -87.0 -3.33 59.08 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.235 0.54 . . . . 0.0 110.96 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.63 -6.9 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.303 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.86 -36.13 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.991 0.516 . . . . 0.0 110.382 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -62.27 -35.88 80.34 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.179 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.445 ' HB2' HG21 ' A' ' 14' ' ' ILE . 65.3 mttm -75.08 -32.84 61.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.173 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.54 96.3 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 110.724 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.52 -39.87 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.51 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.2 t70 -57.9 -39.02 76.89 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.242 0.617 . . . . 0.0 110.006 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -66.68 -55.53 14.75 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.46 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.9 -31.15 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.647 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 31.0 tt0 -64.94 -44.48 89.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.3 mt -61.3 -49.01 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.95 0.405 . . . . 0.0 110.065 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.22 -36.59 58.34 Favored 'Isoleucine or valine' 0 C--O 1.259 1.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -87.4 -7.43 57.72 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -124.81 24.74 7.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.284 0.564 . . . . 0.0 111.583 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -137.1 -65.89 0.53 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -86.6 -51.25 6.27 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.687 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mp -132.16 112.84 12.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -101.19 -57.81 2.01 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.177 0.923 . . . . 0.0 112.096 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.14 -36.02 66.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.212 0.53 . . . . 0.0 111.631 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.04 -15.95 45.66 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 62' ' ' ALA . 16.6 tt -80.22 148.31 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.077 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -139.06 145.04 39.09 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -173.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -90.93 145.81 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -105.25 -52.59 2.81 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.114 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -169.39 152.2 4.78 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt -138.47 119.96 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.554 0.742 . . . . 0.0 110.32 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -133.5 133.99 42.91 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.715 -0.615 . . . . 0.0 110.874 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.24 136.79 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.42 162.85 29.87 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.622 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 12.0 p -82.13 125.54 30.99 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -104.62 146.3 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.767 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.31 -1.142 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.61 134.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -66.18 108.21 2.2 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.822 0.701 . . . . 0.0 111.362 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.514 HG22 ' HB3' ' A' ' 42' ' ' ARG . 35.1 p -105.83 150.15 25.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.092 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.53 131.34 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.08 115.99 27.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.9 mt -110.71 114.0 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.47 122.33 47.46 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 120.675 0.274 . . . . 0.0 110.577 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.9 pt -120.99 157.08 24.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.969 0.414 . . . . 0.0 110.421 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -119.56 118.54 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.336 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HB2' HD23 ' A' ' 30' ' ' LEU . 32.3 mmmt . . . . . 0 C--N 1.286 -2.18 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p30 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.4 132.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.224 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.43 152.58 25.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.891 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -117.91 126.39 52.27 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' B' ' 48' ' ' LYS . 49.3 mm -80.91 119.02 29.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.463 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.72 -116.75 3.72 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.018 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -114.63 15.47 17.67 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.769 0.319 . . . . 0.0 111.078 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -84.07 146.4 48.47 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.683 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.52 143.03 79.92 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.8 2.334 . . . . 0.0 110.858 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.6 -30.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.446 ' O ' HD13 ' B' ' 24' ' ' LEU . 27.0 ptt? -60.95 -28.48 69.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 111.135 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.61 -35.6 67.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.016 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -78.81 -37.37 40.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.19 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.37 -51.93 65.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.694 0.283 . . . . 0.0 110.649 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 20' ' ' MET . 8.1 mp -67.49 -28.63 68.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.908 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -66.23 -46.02 78.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.01 86.24 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 121.35 0.595 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 92.6 mt -65.48 -39.46 91.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.358 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.4 m -65.7 -37.05 85.36 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.394 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.5 mt -62.91 -37.17 85.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.709 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' B' ' 96' ' ' LYS . 3.4 tm? -61.86 -45.93 91.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -80.4 -2.3 45.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.825 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -93.48 -27.8 16.47 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.9 2.74 3.4 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.62 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.17 111.44 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 117.881 0.84 . . . . 0.0 110.087 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 p -87.79 -32.43 19.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -112.39 117.95 33.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.444 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -125.19 147.61 29.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.452 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.62 119.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.425 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 55.2 mt -95.05 123.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -115.73 130.49 56.87 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 121.481 0.658 . . . . 0.0 110.11 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.31 169.12 18.35 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.493 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.533 ' HB3' HG22 ' B' ' 89' ' ' THR 0.288 0.0 OUTLIER -158.45 149.79 20.92 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.685 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.92 -117.48 7.51 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.404 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -88.96 -4.6 58.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.032 0.444 . . . . 0.0 110.757 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.79 -9.05 59.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.03 -36.23 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.567 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 33.5 t -62.36 -35.53 79.41 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.248 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.445 ' HB2' HG21 ' B' ' 14' ' ' ILE . 64.9 mttm -76.3 -34.51 59.06 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.684 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.69 88.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.12 0.486 . . . . 0.0 111.039 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -73.23 -40.38 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.828 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.417 ' O ' HG13 ' B' ' 55' ' ' ILE . 32.4 t70 -58.55 -41.53 85.8 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.064 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 73.0 m -63.44 -54.96 28.31 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.001 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.44 -30.36 49.54 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.622 ' OE1' ' HB3' ' A' ' 74' ' ' SER . 27.7 tt0 -66.3 -43.49 86.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.417 HG13 ' O ' ' B' ' 51' ' ' ASP . 76.2 mt -61.71 -47.79 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.184 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.1 -34.36 56.48 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -89.16 -6.49 56.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -123.61 18.56 9.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.961 0.41 . . . . 0.0 111.697 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -131.97 -68.01 0.65 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.426 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -85.56 -49.05 8.35 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.733 -171.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 mp -133.54 112.0 11.14 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.507 ' O ' HG22 ' B' ' 65' ' ' ILE . . . -100.21 -63.36 1.14 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 124.013 0.821 . . . . 0.0 111.472 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.49 -37.03 86.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.112 0.565 . . . . 0.0 112.503 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.06 -15.36 41.55 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.507 HG22 ' O ' ' B' ' 62' ' ' ALA . 16.2 tt -80.41 148.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.608 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.545 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 40.4 tt0 -138.75 147.3 42.49 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -93.71 143.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -102.57 -52.46 3.09 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.294 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -169.87 150.97 4.01 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.98 118.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 123.575 0.547 . . . . 0.0 110.746 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.04 134.88 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.685 -0.634 . . . . 0.0 110.752 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.99 137.37 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.8 163.42 31.16 Favored Glycine 0 C--N 1.315 -0.619 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.647 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 17.5 p -83.38 124.27 30.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.361 0.601 . . . . 0.0 112.226 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -103.05 145.93 29.15 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 C--N 1.305 -1.35 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.813 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' ' 86' ' ' ARG . 22.7 mtp180 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.17 134.95 50.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.2 p -66.29 108.66 2.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.472 0.653 . . . . 0.0 111.84 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.533 HG22 ' HB3' ' B' ' 42' ' ' ARG . 33.8 p -106.49 148.98 27.55 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.568 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.05 130.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.813 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -113.64 113.74 25.46 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.93 116.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.4 121.24 44.3 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.606 0.241 . . . . 0.0 110.59 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 pt -119.54 154.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.545 ' HD3' ' OE1' ' B' ' 66' ' ' GLU . 60.3 ttt180 -117.47 121.3 40.65 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.508 ' HB2' HD23 ' B' ' 30' ' ' LEU . 32.2 mmmt -102.35 132.77 48.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.891 176.877 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 120.92 0.39 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.16 133.91 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.315 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.88 145.29 32.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.335 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 tp -107.18 124.32 49.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 48' ' ' LYS . 46.3 mm -89.36 117.23 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 118.685 -1.722 . . . . 0.0 115.171 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -155.07 -41.08 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.976 0.888 . . . . 0.0 110.695 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -101.43 158.06 32.49 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.967 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.3 157.11 55.98 Favored 'Trans proline' 0 C--O 1.248 0.995 0 C-N-CA 121.845 1.696 . . . . 0.0 110.129 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG21 ' OD1' ' A' ' 51' ' ' ASP . 14.7 p -56.9 -26.91 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.463 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.6 ptp -62.91 -28.57 70.14 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.77 -35.73 32.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.251 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.34 -34.63 72.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.278 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 19' ' ' VAL . 96.4 t -60.57 -48.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.653 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 20' ' ' MET . 88.4 mt -66.29 -31.56 72.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.468 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.99 -50.76 61.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.43 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.33 -38.89 92.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.65 -45.06 73.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.146 0.978 . . . . 0.0 109.604 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 m -71.57 -41.4 69.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.072 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.1 mt -60.66 -37.67 82.35 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.489 0.316 . . . . 0.0 111.786 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 93.6 mt -61.76 -36.74 81.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.746 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -95.37 0.77 53.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.99 0.424 . . . . 0.0 111.333 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -90.72 -31.35 16.6 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.86 -19.95 2.9 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.673 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -80.03 99.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 m -78.16 -37.34 46.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.388 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.514 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 9.9 pt-20 -120.26 118.66 31.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.8 pt -119.5 160.31 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.71 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.39 112.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.199 0.524 . . . . 0.0 110.745 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.54 126.63 44.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -114.29 112.82 23.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.51 133.87 54.34 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.557 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.593 ' HG2' HG22 ' A' ' 89' ' ' THR . 87.4 mtt180 -129.76 143.61 50.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.21 81.35 0.1 OUTLIER Glycine 0 C--O 1.211 -1.333 0 O-C-N 123.784 0.677 . . . . 0.0 114.49 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 58.66 -7.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 126.192 1.797 . . . . 0.0 115.083 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.58 -3.12 29.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.411 HG23 HG21 ' A' ' 90' ' ' ILE . 69.7 mt -51.7 -39.33 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.188 1.395 . . . . 0.0 110.663 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -68.27 -24.46 64.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.562 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.4 ' HB2' HG21 ' A' ' 14' ' ' ILE . 69.0 mttm -84.86 -27.72 26.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.059 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.58 -44.61 81.79 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.812 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.01 -35.23 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.054 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.52 ' OD1' HG21 ' A' ' 19' ' ' VAL . 15.0 t70 -59.52 -47.87 83.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -54.75 -56.47 18.94 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.338 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 m -67.13 -30.76 50.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.29 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.562 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 27.1 tt0 -65.99 -38.69 89.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.42 0.45 . . . . 0.0 111.014 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.7 mt -66.26 -49.68 74.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.466 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.05 -50.47 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.562 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 35.0 ptt180 -68.56 -7.78 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -115.33 -12.07 11.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.716 0.769 . . . . 0.0 110.369 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -105.77 -53.5 2.63 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -82.22 -60.39 2.23 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.201 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.481 HD12 ' H ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -146.85 105.62 3.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -176.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 6.21 46.12 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.441 ' H ' HD13 ' A' ' 61' ' ' LEU . 31.4 t70 -95.05 -65.0 1.01 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.484 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' H ' HD12 ' A' ' 61' ' ' LEU . 45.9 mttm -98.94 94.24 6.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tp -148.91 141.13 17.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -132.58 152.99 51.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.6 132.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -75.03 -53.75 8.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -173.71 156.84 2.98 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -129.96 115.69 34.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 91' ' ' GLU . 12.5 ptm180 -139.46 147.55 41.51 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.414 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.414 HG12 HG21 ' B' ' 70' ' ' ILE . 11.6 p -144.23 146.76 20.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.29 -171.01 36.07 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.181 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.518 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 36.8 p -108.46 123.83 49.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -99.85 117.57 34.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 C--N 1.319 -0.729 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.102 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 . . . . . 0 CA--C 1.501 -0.913 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.3 t -127.77 125.94 65.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.162 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 p -67.03 121.57 15.85 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.593 HG22 ' HG2' ' A' ' 42' ' ' ARG . 64.6 p -117.47 153.91 32.32 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.411 HG21 HG23 ' A' ' 46' ' ' ILE . 17.6 tt -142.78 129.79 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.454 ' HB2' ' HG3' ' A' ' 71' ' ' ARG . 3.4 mp0 -107.08 105.83 16.04 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.3 mm -102.26 110.77 29.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.31 128.91 54.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.612 0.244 . . . . 0.0 110.382 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.1 155.07 40.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.514 ' HD3' ' OE1' ' A' ' 36' ' ' GLU . 53.1 ttp180 -133.04 126.2 31.34 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.504 0.669 . . . . 0.0 111.592 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.41 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--O 1.239 0.513 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 20.9 m -120.37 138.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.428 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.36 145.48 35.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.032 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.17 126.45 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.413 HG21 ' HB2' ' B' ' 48' ' ' LYS . 46.4 mm -90.47 115.89 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.84 44.84 0.02 OUTLIER Glycine 0 CA--C 1.523 0.564 0 C-N-CA 118.849 -1.643 . . . . 0.0 114.855 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.89 -43.08 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 117.655 0.728 . . . . 0.0 110.875 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.472 ' HE2' ' HD2' ' B' ' 18' ' ' PRO . 13.5 mmmm -101.32 156.87 34.65 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.449 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.472 ' HD2' ' HE2' ' B' ' 17' ' ' LYS . 29.1 Cg_endo -64.64 157.77 53.78 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.293 1.996 . . . . 0.0 110.727 172.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.444 ' O ' HG23 ' B' ' 23' ' ' VAL . 13.9 p -56.12 -27.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.1 ptp -63.05 -29.24 70.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.065 0.459 . . . . 0.0 111.007 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.32 -37.88 36.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.201 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.62 -36.32 78.49 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.531 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.444 HG23 ' O ' ' B' ' 19' ' ' VAL . 66.2 t -61.2 -47.46 93.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 20' ' ' MET . 89.9 mt -67.66 -30.43 69.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.161 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.3 -51.38 53.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.85 -37.99 89.03 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.353 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 27.7 tp -55.02 -45.61 75.18 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.213 1.005 . . . . 0.0 109.194 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 48.7 m -70.47 -40.72 73.48 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.883 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.5 mt -61.32 -38.1 85.64 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.477 0.311 . . . . 0.0 111.499 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 98.3 mt -61.76 -38.48 88.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.101 0.56 . . . . 0.0 111.882 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -92.89 -5.37 51.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.424 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -84.13 -31.83 25.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.212 0.53 . . . . 0.0 109.788 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.06 -15.01 3.05 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.063 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.15 97.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -73.95 -39.14 63.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.32 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.552 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 10.2 pt-20 -121.14 118.56 30.0 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.41 0.624 . . . . 0.0 111.576 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.6 162.49 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.859 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 57.4 t -129.18 115.66 36.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.23 0.538 . . . . 0.0 110.369 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.8 mt -94.24 122.4 45.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.01 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -110.43 111.75 23.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.145 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.58 132.52 55.09 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.642 ' HG2' HG22 ' B' ' 89' ' ' THR . 87.8 mtt180 -129.06 144.06 51.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.44 80.98 0.12 Allowed Glycine 0 C--O 1.214 -1.11 0 O-C-N 123.879 0.737 . . . . 0.0 114.338 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 56.35 -3.81 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.998 1.719 . . . . 0.0 115.138 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.16 -3.07 34.24 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.271 0.557 . . . . 0.0 110.851 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.404 HG23 HG21 ' B' ' 90' ' ' ILE . 69.2 mt -51.67 -40.46 26.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.857 1.263 . . . . 0.0 110.365 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.6 t -66.12 -28.66 68.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.651 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.413 ' HB2' HG21 ' B' ' 14' ' ' ILE . 68.7 mttm -82.98 -28.39 29.76 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.508 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.8 86.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 120.945 0.402 . . . . 0.0 110.748 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.72 -36.69 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.545 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.468 ' O ' HG13 ' B' ' 55' ' ' ILE . 15.0 t70 -58.86 -46.85 86.79 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -54.45 -57.8 9.93 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.672 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.34 -29.3 45.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.871 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.525 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 24.0 tt0 -67.68 -36.93 81.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.968 0.413 . . . . 0.0 111.089 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.468 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.0 mt -66.56 -50.17 68.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.241 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.04 -50.45 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.525 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 34.5 ptt180 -67.83 -8.21 34.27 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -116.63 -12.51 10.91 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.759 0.79 . . . . 0.0 110.46 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -104.8 -53.51 2.67 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -82.64 -59.93 2.35 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.943 -172.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.558 HD12 ' H ' ' B' ' 64' ' ' LYS . 0.3 OUTLIER -146.72 106.31 3.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.39 6.32 44.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.407 ' H ' HD13 ' B' ' 61' ' ' LEU . 33.0 t70 -94.81 -57.8 2.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.402 0.62 . . . . 0.0 110.924 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.558 ' H ' HD12 ' B' ' 61' ' ' LEU . 48.8 mttm -107.74 95.42 5.67 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.127 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tp -149.22 139.29 16.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.457 ' HB2' ' HE2' ' B' ' 97' ' ' LYS . 45.2 tt0 -130.33 148.39 52.15 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.91 123.94 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -67.45 -59.76 3.12 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.646 0.591 . . . . 0.0 109.847 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.38 154.69 8.72 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.414 HG21 HG12 ' A' ' 72' ' ' VAL . 71.1 mt -129.7 114.14 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 123.617 0.573 . . . . 0.0 109.66 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' B' ' 91' ' ' GLU . 12.4 ptm180 -138.07 146.68 43.24 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.308 -0.245 . . . . 0.0 111.177 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.6 144.69 23.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.82 -171.42 36.11 Favored Glycine 0 CA--C 1.5 -0.874 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.807 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.525 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 26.3 p -107.35 124.77 50.3 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 122.563 0.345 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -100.71 117.08 34.09 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.313 -1.01 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.8 179.636 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 . . . . . 0 CA--C 1.502 -0.901 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.37 126.07 68.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.084 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 73.8 p -67.32 122.99 19.1 Favored 'General case' 0 C--O 1.266 1.956 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.642 HG22 ' HG2' ' B' ' 42' ' ' ARG . 60.7 p -119.4 153.49 35.13 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.404 HG21 HG23 ' B' ' 46' ' ' ILE . 18.3 tt -142.46 131.28 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.456 ' HB2' ' HG3' ' B' ' 71' ' ' ARG . 3.4 mp0 -109.02 105.5 15.04 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.588 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mm -102.6 110.72 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.87 129.85 55.89 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.874 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' B' ' 36' ' ' GLU . 35.4 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.597 0.236 . . . . 0.0 110.66 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.552 ' HD3' ' OE2' ' B' ' 36' ' ' GLU . 51.2 ttp180 -126.62 125.3 41.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.978 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.402 ' HB2' HD22 ' B' ' 30' ' ' LEU . 0.0 OUTLIER -89.34 120.67 30.89 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' B' ' 66' ' ' GLU . 67.3 mttm . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.7 p30 . . . . . 0 CA--C 1.51 -0.568 0 CA-C-O 120.698 0.285 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.36 112.49 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -110.55 134.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.264 0.555 . . . . 0.0 110.74 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.59 129.5 43.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.8 mm -91.28 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.99 50.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.103 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -157.6 -65.05 0.09 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 117.22 0.51 . . . . 0.0 110.682 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -101.82 168.45 9.02 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.36 167.13 19.35 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.058 1.839 . . . . 0.0 112.253 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.48 HG11 ' OD2' ' A' ' 51' ' ' ASP . 93.1 t -50.32 -38.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.373 1.069 . . . . 0.0 112.602 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.3 ptp -52.02 -31.45 29.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.03 -32.87 63.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 121.507 0.67 . . . . 0.0 110.404 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -80.52 -34.64 35.47 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.285 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.01 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.291 0.567 . . . . 0.0 109.693 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.56 -35.95 81.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.032 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.47 96.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.288 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -9.19 57.69 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.11 0.481 . . . . 0.0 111.76 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.97 -43.99 7.56 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -60.3 -40.33 90.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.55 -36.07 81.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.396 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.529 HD23 ' HG3' ' A' ' 96' ' ' LYS . 3.4 tm? -64.86 -39.23 93.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -67.29 -17.82 64.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.17 0.51 . . . . 0.0 111.188 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -91.96 -4.56 54.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.4 -7.56 32.34 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.098 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.44 99.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -89.45 -29.64 18.87 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.095 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.32 115.99 30.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.782 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -127.81 156.14 39.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.555 -178.044 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.0 t -124.95 124.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.807 0.692 . . . . 0.0 110.549 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.7 mt -105.65 130.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.419 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.39 122.99 41.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.189 0.519 . . . . 0.0 110.897 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.73 155.05 33.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -133.01 141.07 48.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.449 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.47 -118.58 7.91 Favored Glycine 0 CA--C 1.505 -0.574 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.304 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -94.65 8.08 43.58 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.84 -0.38 57.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.888 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.25 -38.3 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 p -62.72 -32.01 73.04 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.305 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -70.19 -37.27 75.06 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.1 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.93 91.22 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.546 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.89 -33.95 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.551 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.529 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 t70 -62.63 -45.24 93.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.7 m -57.0 -53.35 59.04 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.552 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.9 m -66.05 -36.05 76.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.27 -45.18 94.19 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 123.132 0.27 . . . . 0.0 111.563 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.4 mt -60.59 -43.03 93.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.49 -43.95 98.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.503 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -83.45 13.64 4.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.273 0.558 . . . . 0.0 111.41 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -119.99 -45.68 2.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.845 0.355 . . . . 0.0 110.277 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.4 ptp180 -81.8 -21.65 37.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.544 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 60.9 t80 -117.56 -70.12 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.391 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.544 ' HG ' ' CD2' ' A' ' 60' ' ' PHE . 90.0 mt -132.61 114.82 14.67 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.08 -33.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.245 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.33 -52.61 9.6 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.451 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -97.21 88.46 4.47 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.607 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -160.73 120.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.899 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.541 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 10.2 pt-20 -121.7 134.95 54.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 111.056 177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.8 mt -88.81 139.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -84.62 -54.92 4.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.074 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -170.69 152.62 3.83 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.1 mt -134.08 116.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 77.1 mtp180 -116.83 137.47 52.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.866 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.91 124.44 50.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 -168.37 24.71 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.537 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.6 p -118.04 124.34 47.87 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.128 0.489 . . . . 0.0 110.783 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -100.01 128.19 46.13 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--N 1.312 -1.038 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 CA--C 1.506 -0.733 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.25 126.43 73.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -67.64 128.45 36.5 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.473 0.483 . . . . 0.0 110.96 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.4 p -123.0 160.41 26.34 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 71' ' ' ARG . 13.0 tt -146.06 124.35 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -105.0 110.46 22.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.286 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -109.93 116.77 53.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.25 125.18 51.86 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.02 159.0 32.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.541 ' HD2' ' OE2' ' A' ' 66' ' ' GLU . 41.6 ttm180 -126.22 132.32 51.77 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 123.46 0.704 . . . . 0.0 111.18 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HG3' HD23 ' A' ' 30' ' ' LEU . 34.2 mmtp . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.642 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p30 . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.88 0.371 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.1 115.17 47.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.14 134.57 53.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.086 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 tp -97.58 127.63 43.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.342 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mm -88.52 110.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.3 52.23 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.016 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -159.72 -65.4 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.219 0.509 . . . . 0.0 110.405 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -101.54 168.04 9.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.423 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.59 164.62 30.37 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.978 1.785 . . . . 0.0 112.393 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 95.2 t -46.77 -38.39 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.128 1.371 . . . . 0.0 113.22 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptp -52.31 -35.08 49.65 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -69.9 -35.39 74.57 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.19 0.519 . . . . 0.0 110.685 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -78.75 -35.49 44.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.16 -50.82 78.72 Favored 'Isoleucine or valine' 0 C--O 1.252 1.231 0 CA-C-O 121.601 0.715 . . . . 0.0 109.124 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.89 -32.53 74.28 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.158 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.85 94.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.021 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.16 68.38 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.168 0.509 . . . . 0.0 110.754 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.83 -44.19 42.22 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.468 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -63.21 -38.55 91.6 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.832 0.349 . . . . 0.0 111.152 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.24 -39.04 89.25 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 122.315 -0.241 . . . . 0.0 110.92 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.475 HD23 ' HG3' ' B' ' 96' ' ' LYS . 3.4 tm? -60.19 -40.13 88.96 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.709 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.87 -20.92 66.01 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.045 0.45 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -87.17 -9.28 55.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.11 -4.55 23.82 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.844 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.24 96.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 0.0 109.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -84.03 -28.24 27.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -114.84 120.42 39.93 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.436 ' H ' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.98 154.56 40.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 O-C-N 123.16 0.288 . . . . 0.0 111.348 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.68 124.36 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.216 0.532 . . . . 0.0 110.56 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.64 130.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.343 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.26 123.95 44.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.173 0.511 . . . . 0.0 110.904 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 153.94 35.18 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -129.1 143.39 50.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.47 -122.76 15.35 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 116.312 -0.404 . . . . 0.0 113.533 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.17 11.64 24.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.905 0.383 . . . . 0.0 110.944 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.33 -1.04 57.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.509 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.49 -37.25 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.126 0.571 . . . . 0.0 110.36 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.5 p -66.12 -31.36 72.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.233 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -69.15 -39.96 78.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.31 91.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.606 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -72.4 -34.28 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.589 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.556 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.0 t70 -62.73 -45.18 93.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 90.4 m -56.23 -53.74 53.55 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.622 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.24 -34.23 67.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.959 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -60.99 -47.97 84.0 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.556 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.8 mt -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.883 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.01 -41.03 91.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -85.76 14.7 5.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.24 0.543 . . . . 0.0 111.043 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -121.33 -45.44 2.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.277 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.8 ptp180 -83.28 -19.28 36.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.462 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.55 ' CD2' ' HG ' ' B' ' 61' ' ' LEU . 57.8 t80 -118.66 -71.56 0.73 Allowed 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.64 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.55 ' HG ' ' CD2' ' B' ' 60' ' ' PHE . 94.0 mt -131.15 114.91 15.69 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.158 0.504 . . . . 0.0 111.71 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.26 -32.16 11.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.551 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.83 -49.48 11.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.0 87.35 3.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.413 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -160.71 119.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 11.0 pt-20 -122.04 136.16 54.89 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.131 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.42 143.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.76 -58.14 2.68 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.925 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -167.67 152.0 6.61 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 67.0 mt -133.35 115.56 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' B' ' 90' ' ' ILE . 73.9 mtp180 -115.06 136.41 53.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.822 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.72 126.08 56.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.12 -168.45 26.19 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.156 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.2 p -116.27 121.14 41.12 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.359 0.6 . . . . 0.0 111.235 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -96.22 127.2 42.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.643 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.228 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.437 -1.111 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 72.7 t -115.7 125.24 72.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -67.26 127.08 31.31 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.969 0.414 . . . . 0.0 111.232 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 67.8 p -121.42 159.37 26.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.095 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' B' ' 71' ' ' ARG . 12.3 tt -146.21 124.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.933 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -103.59 113.16 26.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.31 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.9 mt -112.02 114.64 47.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.32 125.45 53.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 pt -126.07 158.54 35.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' B' ' 66' ' ' GLU . 41.5 ttm180 -124.53 134.95 52.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.475 ' HG3' HD23 ' B' ' 30' ' ' LEU . 34.1 mmtp -97.66 148.52 23.24 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 123.849 0.86 . . . . 0.0 109.517 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.517 175.994 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.508 0.671 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 58.3 t -116.06 119.59 62.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.11 147.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.098 0.475 . . . . 0.0 111.284 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 tp -110.76 134.82 52.16 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.52 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.412 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.69 -138.06 4.59 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -101.68 18.3 20.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.86 154.67 38.23 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.152 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.44 148.15 53.81 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.187 2.591 . . . . 0.0 112.499 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.532 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -54.68 -36.15 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.762 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.417 ' O ' HD13 ' A' ' 24' ' ' LEU . 26.9 ptt? -59.31 -24.76 63.58 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -64.86 -38.59 91.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -85.33 -33.42 22.07 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.987 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.5 t -62.29 -55.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.169 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 20' ' ' MET . 9.3 mp -62.05 -26.45 68.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.692 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.481 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.68 -45.75 70.86 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.118 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -61.58 -42.45 98.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp -61.84 -38.26 87.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.1 m -68.2 -37.94 81.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.924 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 96.7 mt -63.18 -34.99 78.83 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.368 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.9 mt -57.52 -41.8 81.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.28 -16.89 62.49 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -91.63 2.05 56.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.51 0.672 . . . . 0.0 110.338 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.68 -3.81 59.31 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.56 91.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 t -90.24 -12.13 38.87 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.96 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 43.3 tt0 -124.56 111.98 16.3 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.444 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -125.89 156.82 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.823 0.345 . . . . 0.0 111.698 -177.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -126.35 125.49 67.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.009 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.81 129.45 61.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.125 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -118.73 123.54 45.1 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -121.01 153.07 37.82 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -129.59 140.95 51.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.089 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.7 -135.04 18.6 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.292 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -83.05 2.63 34.1 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.5 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.5 30.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.579 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.35 -36.95 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.361 0.601 . . . . 0.0 109.705 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.1 p -61.55 -37.42 83.73 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.543 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -67.64 -42.84 81.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.153 -178.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -64.02 -45.27 89.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.466 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.8 -36.77 65.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.805 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.532 ' OD2' HG21 ' A' ' 19' ' ' VAL . 17.9 t70 -59.59 -47.63 84.83 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 56' ' ' VAL . 87.2 m -53.36 -53.56 49.28 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.444 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -69.98 -31.18 46.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 25.3 tt0 -68.61 -32.17 71.87 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.947 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.3 mt -68.69 -42.83 83.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.119 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 52' ' ' THR . 59.8 t -69.19 -30.93 47.98 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 CA-C-O 121.25 0.548 . . . . 0.0 111.292 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 40.4 ptt180 -88.88 14.98 9.16 Favored 'General case' 0 C--O 1.211 -0.94 0 O-C-N 122.023 -0.423 . . . . 0.0 110.299 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -128.67 -56.02 1.22 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -73.27 -29.15 62.54 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -97.96 -63.21 1.15 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.023 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.48 110.55 5.69 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.798 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.41 -46.69 8.2 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.555 1.159 . . . . 0.0 110.777 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.91 -29.52 58.45 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.77 97.23 7.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -160.95 143.69 4.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.957 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.72 141.72 51.48 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.35 125.6 68.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HD2' ' HG3' ' A' ' 36' ' ' GLU . 29.6 mtpp -86.05 -62.48 1.51 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.28 149.29 5.91 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.014 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.2 mt -139.15 99.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.22 136.79 54.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.8 t -102.16 132.7 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.82 167.29 28.24 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.881 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 p -93.88 135.89 34.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.829 0.347 . . . . 0.0 110.825 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 36.0 tt0 -100.48 114.18 27.56 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.479 HG22 ' HG2' ' A' ' 86' ' ' ARG . 45.1 t . . . . . 0 C--N 1.321 -0.652 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.479 ' HG2' HG22 ' A' ' 76' ' ' VAL . 99.5 mtt180 . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.58 136.44 58.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.7 p -70.24 127.26 32.19 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.518 0.675 . . . . 0.0 111.956 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.0 p -133.11 160.15 38.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.774 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.67 139.53 48.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -118.13 110.76 18.0 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -111.5 119.74 60.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.41 120.26 30.56 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.723 0.297 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.34 168.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 ttt180 -136.85 133.7 36.12 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.22 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 70.7 mmtt . . . . . 0 C--N 1.289 -2.052 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.241 0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.03 114.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -111.29 143.46 21.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.01 138.28 43.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -86.18 125.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.792 0.329 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.56 -140.0 7.46 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.777 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -99.81 14.87 28.82 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -91.31 154.38 44.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.328 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.96 146.68 56.14 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.203 2.602 . . . . 0.0 112.391 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.435 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.1 p -51.66 -35.52 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.307 1.043 . . . . 0.0 113.516 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.09 -25.34 66.89 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.27 -36.96 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.495 0.664 . . . . 0.0 110.117 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -87.04 -33.66 19.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.205 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 19' ' ' VAL . 65.6 t -61.31 -55.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.583 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.66 -26.16 68.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.761 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -68.34 -44.18 75.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.173 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -41.72 96.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.14 -36.81 80.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.958 0.408 . . . . 0.0 110.671 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 37.9 m -68.66 -38.36 80.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 95.6 mt -63.58 -35.18 79.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.254 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.2 mt -55.84 -42.81 76.32 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -71.61 -15.14 62.24 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -93.38 1.7 56.8 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.37 0.605 . . . . 0.0 110.382 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.42 -8.27 58.55 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.657 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.92 91.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.249 0.547 . . . . 0.0 109.605 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -90.16 -13.17 36.19 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.773 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -123.91 116.62 23.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.906 -0.496 . . . . 0.0 109.669 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 157.9 42.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-O 120.806 0.336 . . . . 0.0 111.633 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.0 124.7 65.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.218 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.9 mt -106.97 127.43 62.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.03 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -117.22 122.32 43.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.689 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.59 40.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -128.17 139.82 52.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.332 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.83 -136.14 20.25 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.239 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -80.52 0.53 33.36 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 122.439 -0.447 . . . . 0.0 111.53 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.43 -0.81 27.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.627 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 75.2 mt -55.91 -38.87 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.15 0.5 . . . . 0.0 110.021 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -61.71 -38.03 86.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.733 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.401 ' NZ ' ' HB2' ' B' ' 48' ' ' LYS . 0.0 OUTLIER -66.14 -41.56 90.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.28 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.89 81.23 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.209 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.11 -34.09 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.462 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.525 ' O ' HG13 ' B' ' 55' ' ' ILE . 12.3 t70 -60.9 -47.18 87.56 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -54.84 -55.08 34.21 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 18.0 m -68.14 -31.88 53.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.131 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.521 ' HG3' ' HE ' ' B' ' 57' ' ' ARG . 27.3 tt0 -68.6 -31.01 69.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.099 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.525 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.0 mt -69.54 -43.59 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.191 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.41 -31.36 52.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 CA-C-O 121.297 0.57 . . . . 0.0 111.335 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.521 ' HE ' ' HG3' ' B' ' 54' ' ' GLU . 40.0 ptt180 -88.66 17.27 5.64 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -131.56 -57.08 1.0 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.138 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -72.55 -26.68 61.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -101.65 -64.03 1.09 Allowed 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.975 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -141.93 112.33 7.07 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.7 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.9 -50.23 5.82 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 124.293 0.995 . . . . 0.0 110.875 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.49 -28.76 62.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -105.54 98.02 7.77 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.442 0.639 . . . . 0.0 110.755 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tp -161.15 145.12 4.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.869 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -126.17 138.48 53.66 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.24 126.72 63.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -86.63 -64.47 1.15 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -166.33 146.98 6.31 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.393 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.3 mt -139.43 100.82 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.19 143.46 50.49 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.59 123.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.56 168.64 24.1 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.761 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.51 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 35.1 p -92.96 133.34 36.22 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.659 0.384 . . . . 0.0 110.907 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 36.1 tt0 -99.61 114.49 27.57 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' B' ' 86' ' ' ARG . 46.7 t . . . . . 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.474 ' HG2' HG22 ' B' ' 76' ' ' VAL . 99.6 mtt180 . . . . . 0 N--CA 1.435 -1.199 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.62 137.4 56.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 7.2 p -72.31 127.47 32.67 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.464 0.649 . . . . 0.0 112.223 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.75 158.38 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.114 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.04 139.54 50.06 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -119.16 112.38 19.44 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -112.39 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.01 35.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 pt -125.14 163.26 26.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 120.983 0.421 . . . . 0.0 110.482 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' B' ' 96' ' ' LYS . 76.4 ttt180 -132.44 134.21 44.81 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' B' ' 95' ' ' ARG . 69.4 mmtt -97.6 -170.36 1.99 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.318 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt . . . . . 0 C--O 1.256 1.4 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.195 176.773 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 121.547 0.689 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.65 120.37 60.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.156 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.53 139.69 42.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.991 0.424 . . . . 0.0 110.693 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.3 tp -104.21 136.73 43.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.313 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -84.09 123.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.4 -159.49 11.77 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.03 13.41 1.79 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -86.07 152.48 56.03 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 121.95 -0.469 . . . . 0.0 112.162 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.65 150.79 59.16 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.859 2.373 . . . . 0.0 112.213 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.545 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.4 p -56.23 -35.31 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.503 0.721 . . . . 0.0 112.388 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.1 ptp -57.89 -30.81 66.17 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.93 -34.08 74.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -79.09 -33.34 44.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.196 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 66.1 t -61.62 -48.52 88.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.84 -38.54 91.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.645 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.81 -44.64 96.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.2 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.38 96.61 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.19 0.519 . . . . 0.0 111.012 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 95.3 mt -64.92 -38.97 92.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.806 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.9 m -67.74 -31.79 71.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.2 mt -70.6 -40.37 73.25 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 122.088 -0.383 . . . . 0.0 110.245 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.56 -40.97 89.07 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.372 0.606 . . . . 0.0 109.406 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -59.13 -30.21 67.96 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.44 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -91.26 3.19 55.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.52 11.99 57.58 Favored Glycine 0 C--O 1.244 0.759 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.921 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.31 98.04 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 13.1 p -87.46 -13.87 42.01 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.404 ' OE1' ' HG3' ' A' ' 68' ' ' LYS . 36.6 tt0 -128.66 111.79 13.56 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -126.35 159.66 35.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.02 127.29 51.46 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-O 121.573 0.701 . . . . 0.0 110.86 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -101.88 124.29 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.52 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 81.8 mttt -115.46 114.27 24.81 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.32 0.581 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.07 158.49 17.7 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.848 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.546 ' HG2' HG22 ' A' ' 89' ' ' THR . 54.8 mtm180 -133.54 148.68 51.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.91 -121.58 19.57 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 123.559 0.537 . . . . 0.0 113.016 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -92.0 -0.28 57.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.63 -4.03 46.92 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -54.9 -36.07 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.7 0.8 . . . . 0.0 110.529 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -63.39 -35.49 80.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.616 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.23 -30.04 60.42 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.3 82.35 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.31 -37.19 64.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.184 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.545 ' OD2' HG21 ' A' ' 19' ' ' VAL . 34.9 t70 -60.66 -43.39 97.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.875 0.369 . . . . 0.0 110.086 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -58.71 -51.25 70.77 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.279 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.96 -32.37 51.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.59 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 7.6 tp10 -63.66 -40.3 96.51 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.1 mt -64.21 -44.33 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.81 -39.59 82.34 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.831 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.522 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 2.6 ptm180 -80.66 1.33 30.43 Favored 'General case' 0 C--O 1.206 -1.199 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -128.17 11.35 6.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.081 0.467 . . . . 0.0 111.789 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -118.1 -66.71 1.05 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.709 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -75.9 -67.17 0.7 Allowed 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.827 0.346 . . . . 0.0 110.386 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.484 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -138.23 109.25 6.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -87.04 -44.9 11.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.429 1.08 . . . . 0.0 110.343 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.96 -28.71 67.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.619 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -121.02 106.84 11.96 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -159.26 120.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.291 0.567 . . . . 0.0 110.506 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -98.45 134.39 41.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.264 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.5 mt -101.2 122.64 53.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 1.9 tmtp? -83.58 -55.59 4.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.398 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -173.55 154.25 2.49 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -133.4 116.18 24.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -119.31 134.79 55.02 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.725 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 90' ' ' ILE . 46.4 t -125.84 131.57 71.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.88 28.92 Favored Glycine 0 CA--C 1.493 -1.335 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -115.18 145.11 42.71 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 117.228 0.514 . . . . 0.0 111.238 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -114.48 134.81 54.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 C--N 1.311 -1.072 0 CA-C-O 121.408 0.623 . . . . 0.0 110.93 178.075 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.836 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.85 139.62 42.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.8 p -67.41 126.29 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 O-C-N 123.757 0.661 . . . . 0.0 110.828 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.546 HG22 ' HG2' ' A' ' 42' ' ' ARG . 46.6 p -132.03 151.19 51.89 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.2 tt -136.11 140.0 44.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.92 109.42 15.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.68 111.8 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.12 122.58 47.98 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.978 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.32 157.65 24.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.783 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.5 ttp180 -126.02 133.44 51.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.484 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 3.1 tmtm? . . . . . 0 N--CA 1.413 -2.288 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.235 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 C--O 1.246 0.87 0 CA-C-O 121.614 0.721 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.38 126.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.067 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.51 139.8 46.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.104 0.478 . . . . 0.0 110.495 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 tp -104.32 138.23 41.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.299 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -85.34 123.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.253 0.549 . . . . 0.0 111.295 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.9 -160.49 11.91 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.48 12.46 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -84.64 153.42 61.29 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.805 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.28 154.32 29.58 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.755 2.304 . . . . 0.0 111.772 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.443 HG21 ' OD2' ' B' ' 51' ' ' ASP . 7.1 p -61.58 -35.88 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.028 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.408 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.3 ptp -56.93 -28.74 62.44 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.179 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.18 -36.83 77.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -76.42 -32.92 58.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.434 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 70.2 t -60.94 -50.48 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 20' ' ' MET . 91.9 mt -64.1 -34.36 77.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.35 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.72 81.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.73 97.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.963 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 97.6 mt -63.8 -37.93 89.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.618 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -34.54 77.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.191 0.519 . . . . 0.0 110.251 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.38 -40.55 81.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.201 -0.312 . . . . 0.0 110.421 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.67 -39.35 80.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.096 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.25 -28.78 69.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.354 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -92.5 6.67 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.873 0.368 . . . . 0.0 111.909 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.73 60.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.433 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.82 97.57 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 31.7 p -83.8 -21.71 32.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -122.2 115.27 22.09 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.454 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.65 154.34 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.04 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.06 128.48 67.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 CA-C-O 121.775 0.798 . . . . 0.0 111.22 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -101.91 124.67 55.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.728 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.6 mttt -114.82 115.68 27.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.398 0.618 . . . . 0.0 110.744 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.41 158.54 18.36 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.488 ' HG2' HG22 ' B' ' 89' ' ' THR . 50.9 mtm180 -132.33 149.94 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.61 -117.08 9.84 Favored Glycine 0 N--CA 1.446 -0.643 0 O-C-N 123.604 0.565 . . . . 0.0 113.02 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -97.43 0.5 47.85 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.16 -2.96 43.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.686 0.279 . . . . 0.0 111.699 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.79 -36.21 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.887 0.875 . . . . 0.0 110.268 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.2 p -63.64 -35.4 80.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.37 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -76.29 -29.42 57.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.44 77.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -71.04 -34.91 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.515 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.0 t70 -60.87 -42.97 98.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.003 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.1 m -60.63 -53.17 60.7 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.512 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.35 -31.78 52.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 8.3 tp10 -64.92 -39.72 93.95 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.515 HG13 ' O ' ' B' ' 51' ' ' ASP . 81.7 mt -63.08 -45.65 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.6 t -60.52 -39.23 80.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.507 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 2.9 ptm180 -79.64 -2.87 44.68 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -127.21 20.75 6.81 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.041 0.448 . . . . 0.0 111.383 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -125.8 -66.58 0.93 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.547 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -77.61 -67.47 0.72 Allowed 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.479 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 0.6 OUTLIER -137.21 110.0 7.6 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -86.59 -47.34 9.3 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 124.264 0.977 . . . . 0.0 110.71 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.56 -30.89 65.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.796 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -117.8 102.54 9.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.546 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -156.16 121.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.102 0.477 . . . . 0.0 110.647 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' B' ' 95' ' ' ARG . 23.5 mm-40 -99.98 133.79 43.85 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.061 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.45 123.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.21 -52.85 5.92 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.79 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -176.88 152.95 0.99 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.83 115.5 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -118.2 134.59 54.88 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.822 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.52 134.51 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.58 -167.44 37.9 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.9 p -109.66 149.28 29.94 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 117.59 0.695 . . . . 0.0 111.076 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.45 132.8 56.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.316 -0.849 0 CA-C-O 121.387 0.613 . . . . 0.0 111.318 177.312 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.41 138.99 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 13.1 p -66.24 128.02 34.47 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.216 0.532 . . . . 0.0 110.859 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.488 HG22 ' HG2' ' B' ' 42' ' ' ARG . 47.9 p -132.87 148.64 52.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.118 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 15.4 tt -133.62 139.37 48.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -118.09 108.9 15.78 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.72 111.8 37.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.0 123.24 49.88 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.815 0.341 . . . . 0.0 110.216 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -121.97 155.85 26.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' B' ' 35' ' ' SER . 60.7 ttp180 -126.06 128.5 47.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.484 ' HD3' ' H ' ' B' ' 97' ' ' LYS . 2.7 tmtm? -104.94 143.34 33.3 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 -174.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.484 ' H ' ' HD3' ' B' ' 96' ' ' LYS . 74.4 mmtt . . . . . 0 C--O 1.263 1.8 0 CA-C-O 117.253 -1.356 . . . . 0.0 107.697 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.184 0.516 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -95.19 117.58 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 m -107.95 136.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.441 0.638 . . . . 0.0 111.57 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.26 104.74 14.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.819 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.89 107.7 12.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.375 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.53 36.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.921 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -160.21 -50.95 0.05 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.85 0.86 . . . . 0.0 110.611 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -97.97 154.88 37.6 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.777 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.78 156.37 62.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.914 2.409 . . . . 0.0 113.077 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.34 -41.73 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.811 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -62.85 -25.19 68.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.954 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.14 -21.83 56.13 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.294 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.0 -35.53 17.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.57 -50.65 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.143 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.09 -29.07 69.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.06 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -70.22 -48.15 58.31 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.621 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.86 91.03 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.516 0.51 . . . . 0.0 110.681 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.1 -30.6 71.56 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.305 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 93.7 m -78.89 -42.57 26.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 99.0 mt -62.78 -31.73 72.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.821 0.344 . . . . 0.0 110.732 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.96 -45.12 96.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.84 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.05 -25.64 64.57 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.421 0.629 . . . . 0.0 110.006 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' THR . 15.1 mm100 -80.01 -3.64 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.386 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 -7.93 36.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.447 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -85.44 97.18 5.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 42.5 m -98.38 0.01 44.58 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.796 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -135.38 115.15 12.89 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 155.35 41.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 O-C-N 123.306 0.379 . . . . 0.0 110.684 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.22 122.93 62.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.55 132.6 47.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.285 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.454 ' HG2' ' HG2' ' A' ' 91' ' ' GLU . 53.5 mttp -121.53 122.13 39.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.34 0.591 . . . . 0.0 111.359 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.68 147.73 50.77 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.158 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HG3' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.0 152.04 50.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 -124.25 9.12 Favored Glycine 0 C--N 1.309 -0.964 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.274 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -92.69 2.66 56.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.209 0.528 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.56 -7.68 55.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.967 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -55.83 -40.78 63.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.7 t -63.11 -33.38 75.33 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.959 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.79 -35.82 62.51 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.157 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.26 93.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.743 0.306 . . . . 0.0 111.508 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.88 -33.23 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 110.768 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.1 t70 -66.23 -40.82 90.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -57.46 -46.51 83.56 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.566 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -71.38 -36.74 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.07 -45.81 79.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.413 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 74.1 mt -59.16 -50.35 80.1 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.788 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.83 -46.4 96.6 Favored 'Isoleucine or valine' 0 C--O 1.256 1.407 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -80.18 -5.48 56.15 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.119 0.485 . . . . 0.0 112.265 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -125.69 12.02 7.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -123.09 -41.49 2.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.772 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -123.71 -57.58 1.63 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.338 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.27 76.68 7.58 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.459 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 18.26 19.05 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.321 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -149.65 -59.7 0.21 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.515 0.674 . . . . 0.0 110.414 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -94.07 80.75 4.08 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.098 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.5 tp -159.2 145.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.291 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.41 167.93 21.0 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.036 0.446 . . . . 0.0 110.78 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.71 128.26 55.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.86 -57.45 3.75 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -177.03 146.9 0.53 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.4 pt -130.55 129.64 64.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.27 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -135.97 143.73 45.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.409 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 p -137.44 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.98 -145.42 5.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 m -138.38 134.47 34.21 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 65.2 tt0 -96.83 140.29 31.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.804 0.335 . . . . 0.0 110.276 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.705 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 94.3 mtt180 . . . . . 0 CA--C 1.491 -1.293 0 CA-C-O 120.893 0.378 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.55 136.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 m -62.81 123.99 19.89 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 123.566 0.541 . . . . 0.0 109.855 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 42' ' ' ARG . 33.7 p -130.57 146.53 52.11 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.365 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -135.6 140.11 45.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.729 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.454 ' HG2' ' HG2' ' A' ' 40' ' ' LYS . 43.8 mt-10 -120.13 115.49 23.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.868 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.06 115.49 49.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.66 128.13 55.08 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -132.77 159.72 43.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 35' ' ' SER . 59.4 ttp180 -140.93 145.56 36.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' C ' ' HD3' ' A' ' 96' ' ' LYS . 12.7 tmtt? . . . . . 0 C--N 1.302 -1.473 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.976 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.5 p30 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.094 0.474 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 48.4 t -102.36 109.27 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.8 m -103.16 137.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.763 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.45 108.38 19.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.917 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.38 116.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.097 0.475 . . . . 0.0 109.927 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.38 35.46 0.02 OUTLIER Glycine 0 C--N 1.311 -0.823 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.829 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -161.92 -48.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.967 0.907 . . . . 0.0 111.212 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -99.88 155.48 36.41 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.391 -174.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.77 153.1 79.61 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.736 2.291 . . . . 0.0 112.374 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.446 ' O ' HG23 ' B' ' 23' ' ' VAL . 7.1 p -52.51 -39.47 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.616 0.767 . . . . 0.0 112.858 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -63.38 -26.78 68.91 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.76 -25.86 60.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.317 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.04 -37.85 21.61 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 19' ' ' VAL . 61.4 t -58.55 -49.56 81.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.426 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.3 -28.4 68.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.748 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -69.66 -47.9 61.71 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.447 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -45.62 87.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.606 0.566 . . . . 0.0 110.977 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.04 -31.49 72.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.157 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 90.6 m -77.12 -44.47 30.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.595 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 96.6 mt -61.57 -31.64 71.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.92 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.5 -45.29 94.32 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.128 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -69.57 -24.78 63.75 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.428 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -79.91 -8.56 59.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.153 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.48 2.83 33.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.231 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.86 96.19 5.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 41.4 m -100.08 2.81 43.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -137.48 111.35 8.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.437 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.23 157.2 40.62 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.063 -176.147 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 60.4 t -127.13 122.23 59.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.268 0.556 . . . . 0.0 111.073 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.07 130.43 50.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' B' ' 91' ' ' GLU . 52.4 mttp -120.5 122.77 41.36 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.46 0.648 . . . . 0.0 111.291 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.45 ' HG3' HG22 ' B' ' 89' ' ' THR . 0.1 OUTLIER -130.98 151.85 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.97 -126.19 11.8 Favored Glycine 0 C--N 1.303 -1.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.177 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -89.79 1.21 56.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.07 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.82 -8.16 55.6 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.235 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.45 -39.96 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.407 0.683 . . . . 0.0 110.799 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 40.6 t -63.25 -33.48 75.58 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.065 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -75.31 -35.18 61.29 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.321 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.14 88.86 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.263 0.554 . . . . 0.0 111.381 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.72 -30.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.503 ' O ' HG13 ' B' ' 55' ' ' ILE . 22.9 t70 -66.4 -42.98 87.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 70.4 m -56.5 -47.5 79.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.786 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.6 m -70.1 -38.1 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.83 -46.45 78.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.15 0.281 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.1 mt -58.56 -51.1 75.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.017 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.18 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--O 1.254 1.341 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -79.98 -5.04 54.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -127.28 14.86 7.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -125.86 -38.69 2.18 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.818 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -126.69 -57.96 1.33 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.16 74.85 8.73 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.983 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.88 24.96 8.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.293 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -153.52 -59.77 0.13 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.772 0.796 . . . . 0.0 109.754 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.488 ' HB3' ' OXT' ' B' ' 97' ' ' LYS . 46.7 mttm -98.25 81.71 2.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.106 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.415 ' O ' ' HE3' ' B' ' 97' ' ' LYS . 8.9 tp -157.53 146.13 10.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.84 169.49 17.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.148 0.499 . . . . 0.0 110.854 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.47 128.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -79.9 -58.59 3.1 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 43.5 tt0 -175.82 145.04 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.03 0.932 . . . . 0.0 108.913 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.91 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.45 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 53.5 mtt180 -135.79 139.67 43.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.09 144.07 36.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.41 -145.69 6.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -136.37 137.68 40.81 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -99.1 139.69 34.38 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.728 0.299 . . . . 0.0 110.197 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.315 -0.916 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.999 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.6 133.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 20.3 m -60.0 124.6 20.72 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.546 0.529 . . . . 0.0 109.904 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.45 HG22 ' HG3' ' B' ' 42' ' ' ARG . 33.5 p -132.22 144.69 50.81 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.249 -176.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.8 tt -134.04 140.44 46.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.548 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' B' ' 40' ' ' LYS . 45.0 mt-10 -120.28 115.18 23.07 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.273 0.629 . . . . 0.0 109.611 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.37 115.98 51.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.15 128.26 54.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -132.75 159.98 42.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' B' ' 35' ' ' SER . 59.2 ttp180 -141.22 146.29 36.7 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.977 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 12.7 tmtt? -91.34 141.81 28.37 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.488 ' OXT' ' HB3' ' B' ' 64' ' ' LYS . 98.1 mttt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 121.304 0.573 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.25 122.24 68.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.6 156.55 14.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.073 0.463 . . . . 0.0 111.441 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.45 133.5 55.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.4 112.52 21.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.74 -155.71 13.24 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.68 26.27 0.18 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.137 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.92 150.56 36.96 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.75 150.58 81.97 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.939 2.426 . . . . 0.0 112.852 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.49 HG21 ' OD1' ' A' ' 51' ' ' ASP . 10.5 p -57.92 -38.31 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.55 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.401 ' O ' HD13 ' A' ' 24' ' ' LEU . 23.2 ptp -59.98 -27.34 66.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.936 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.85 -32.44 72.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 110.123 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -80.07 -35.85 36.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.658 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 60.3 t -59.11 -52.69 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.811 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 20' ' ' MET . 8.7 mp -65.85 -31.74 72.87 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.031 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.16 -44.79 87.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.19 -41.93 99.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 88.8 mt -61.15 -35.6 77.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.144 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.6 m -69.81 -36.71 75.86 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.526 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.2 mt -68.2 -33.36 74.29 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.3 mt -59.4 -39.88 84.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.602 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.91 -27.88 66.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.95 -6.15 56.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.59 14.71 34.11 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 121.049 -0.595 . . . . 0.0 112.866 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.47 96.13 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 122.153 -0.616 . . . . 0.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 p -88.43 -8.15 55.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -131.35 112.86 13.1 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.476 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -123.42 144.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.293 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.5 123.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.544 0.528 . . . . 0.0 110.62 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.04 121.81 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -116.57 127.48 54.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.368 0.604 . . . . 0.0 110.917 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -118.7 157.74 26.87 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.565 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -127.07 146.75 50.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.762 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.7 -116.81 9.69 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.287 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -99.45 4.21 46.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 110.789 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.36 50.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.92 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.8 mt -54.28 -40.05 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.725 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.3 t -64.75 -21.72 66.82 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.596 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -87.88 -29.97 20.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.51 84.83 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.093 0.473 . . . . 0.0 110.402 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -72.94 -33.23 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.0 t70 -64.21 -48.73 74.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -55.95 -50.34 71.04 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.924 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -68.15 -31.01 49.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.903 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 31.5 tt0 -68.19 -37.81 81.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.924 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 51' ' ' ASP . 79.5 mt -58.59 -43.4 87.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.429 0.456 . . . . 0.0 111.047 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.35 -43.75 80.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -79.36 8.79 5.53 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -135.21 7.06 3.36 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -117.53 -68.6 0.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.258 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HB3' HD22 ' A' ' 61' ' ' LEU . 87.4 m-85 -79.46 -69.34 0.59 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 2.5 mm? -122.62 102.61 8.16 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.34 -24.49 27.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.985 0.803 . . . . 0.0 111.214 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -96.97 -45.97 6.39 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.461 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.65 81.17 8.74 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.722 0.773 . . . . 0.0 111.636 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.5 134.52 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.095 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -114.01 141.82 46.94 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.74 126.58 48.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -82.21 -68.78 0.67 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.722 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -159.39 140.41 12.67 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -128.14 115.82 40.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -119.34 134.25 55.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.12 128.25 25.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.45 . . . . 0.0 110.099 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.32 -147.14 5.65 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.932 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -109.34 133.56 52.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -116.58 125.46 51.87 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.813 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 . . . . . 0 CA--C 1.5 -0.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.7 t -119.35 134.04 64.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 p -67.28 123.37 20.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 123.703 0.627 . . . . 0.0 109.46 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 p -127.67 152.6 47.48 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.861 0.363 . . . . 0.0 111.366 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.7 tt -139.17 135.19 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.644 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.44 114.34 22.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.97 115.75 50.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.95 55.18 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.48 158.27 34.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.334 0.587 . . . . 0.0 111.629 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -112.77 114.88 27.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.647 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.583 ' NZ ' ' HB2' ' A' ' 61' ' ' LEU . 13.6 mmmt . . . . . 0 C--N 1.286 -2.154 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.576 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 . . . . . 0 CA--C 1.517 -0.323 0 CA-C-O 121.393 0.616 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.47 122.72 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.33 163.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 120.818 0.342 . . . . 0.0 111.012 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 tp -124.19 134.34 53.31 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.93 113.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.074 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.65 -157.62 12.48 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.543 ' H ' ' HD3' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -76.63 26.29 0.13 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.42 148.56 35.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.71 152.3 64.07 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.811 2.341 . . . . 0.0 113.193 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.606 HG21 ' OD2' ' B' ' 51' ' ' ASP . 8.9 p -58.33 -39.86 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.414 ' O ' HD13 ' B' ' 24' ' ' LEU . 22.9 ptp -58.18 -25.64 61.78 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.221 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.9 -32.33 70.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 109.932 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -81.17 -37.04 29.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.485 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 51.9 t -58.81 -52.41 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 123.763 0.664 . . . . 0.0 110.374 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.414 HD13 ' O ' ' B' ' 20' ' ' MET . 8.4 mp -66.47 -30.15 70.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.738 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.449 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.34 -45.96 82.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.165 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.78 -41.23 99.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.558 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.9 mt -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.714 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -72.87 -32.98 65.8 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.295 0.569 . . . . 0.0 110.221 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 94.0 mt -70.72 -32.42 69.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 90.3 mt -60.08 -39.82 87.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.584 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -69.01 -24.39 64.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.616 0.722 . . . . 0.0 110.779 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -83.62 -3.3 57.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.43 12.45 51.21 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.145 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -91.05 95.88 5.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.5 p -89.09 -5.83 57.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.711 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.88 116.15 16.13 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.438 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -127.06 144.32 37.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.689 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.33 121.64 68.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.14 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -107.14 121.89 60.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.3 132.29 56.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.075 0.465 . . . . 0.0 110.174 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.85 159.16 28.74 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.761 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -129.89 143.55 50.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.737 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.13 -117.64 8.71 Favored Glycine 0 CA--C 1.497 -1.065 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.166 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -99.02 0.95 44.87 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.266 0.555 . . . . 0.0 110.176 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.75 -7.09 52.28 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.985 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.34 -40.38 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 110.802 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.39 -28.08 69.74 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.388 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -82.17 -29.7 31.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.73 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.14 -45.28 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.35 -33.59 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.086 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.606 ' OD2' HG21 ' B' ' 19' ' ' VAL . 35.4 t70 -62.4 -46.61 87.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.894 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -58.85 -51.03 71.76 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.907 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.75 -30.63 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.925 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 33.4 tt0 -68.91 -35.49 76.9 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.742 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.455 HG13 ' O ' ' B' ' 51' ' ' ASP . 79.6 mt -61.23 -43.18 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.741 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 67.4 t -68.46 -43.67 83.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.998 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 28.7 ptt180 -79.02 8.72 5.21 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.576 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -131.84 -3.51 3.64 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.395 0.617 . . . . 0.0 111.17 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.74 -64.75 1.2 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.745 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' B' ' 61' ' ' LEU . 90.1 m-85 -80.56 -74.63 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.595 ' HB2' ' NZ ' ' B' ' 96' ' ' LYS . 2.4 mm? -119.57 103.2 9.21 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -84.7 -31.93 23.81 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 124.186 0.929 . . . . 0.0 110.809 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.91 -41.17 12.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.266 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -91.62 80.38 5.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.389 0.614 . . . . 0.0 111.814 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -161.24 136.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.693 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.48 ' OE1' ' HD2' ' B' ' 97' ' ' LYS . 47.1 mt-10 -116.75 143.29 45.84 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 125.16 50.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -81.69 -66.93 0.83 Allowed 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 123.274 0.359 . . . . 0.0 110.839 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -161.32 139.67 9.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.43 117.03 45.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -120.01 132.0 55.33 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.96 129.34 44.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.65 -148.39 6.61 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.076 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -106.72 133.54 51.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -118.82 125.75 50.27 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.865 179.063 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.44 135.83 57.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.8 p -69.88 124.72 24.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 50.8 p -128.59 152.86 47.84 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.893 0.377 . . . . 0.0 111.162 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 tt -139.6 136.74 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.04 112.13 18.76 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.775 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.84 117.61 55.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.49 128.1 54.65 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.4 pt -126.23 151.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 111.999 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -105.9 115.33 30.04 Favored 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.924 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.595 ' NZ ' ' HB2' ' B' ' 61' ' ' LEU . 13.8 mmmt -90.43 131.53 36.14 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.999 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HD2' ' OE1' ' B' ' 66' ' ' GLU . 28.4 mtpp . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 60.8 t -105.38 114.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.4 147.46 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 120.911 0.386 . . . . 0.0 111.074 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.11 122.72 45.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -88.25 105.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.573 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.17 58.91 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.128 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -163.06 -56.26 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.252 0.549 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -101.05 166.04 13.12 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.601 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -71.31 163.0 40.6 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.993 1.796 . . . . 0.0 111.303 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.29 -41.4 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -62.86 -24.88 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -73.32 -38.17 65.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -72.33 -33.24 67.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.143 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.07 -47.53 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.129 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.64 -31.75 71.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.942 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -71.72 -41.93 67.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.202 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -70.63 -34.29 71.92 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.68 -51.63 68.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.049 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.534 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 10.0 t -67.77 -35.56 78.92 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.7 mt -62.23 -34.15 75.94 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.8 mt -64.65 -23.9 67.41 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.851 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -100.31 -14.0 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 28' ' ' THR . 78.6 mt-30 -79.44 -20.22 48.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.838 0.351 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.48 -4.72 7.15 Favored Glycine 0 CA--C 1.492 -1.345 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.092 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -86.29 96.0 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.0 m -67.75 -30.43 69.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.501 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.62 126.34 20.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.737 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -121.77 161.14 22.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.933 -176.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -124.21 121.66 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.1 mt -104.84 125.26 59.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 66.0 mttm -119.83 120.08 35.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.294 0.568 . . . . 0.0 110.524 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -116.28 155.51 28.25 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.027 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -131.63 141.47 49.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.232 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.46 -126.91 9.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.548 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -81.98 -10.96 59.09 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.57 35.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.182 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -55.6 -38.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 121.26 0.552 . . . . 0.0 109.61 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.7 p -71.48 -13.77 61.92 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.251 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -95.06 -26.52 16.01 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.6 0.36 . . . . 0.0 110.09 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -69.8 -46.07 66.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 110.766 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.67 -36.26 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 55' ' ' ILE . 45.5 t0 -59.92 -52.2 66.44 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.711 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.9 m -54.19 -52.01 62.56 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.56 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.405 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 23.7 m -69.3 -33.72 59.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 24.9 tt0 -72.05 -26.17 62.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.408 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.2 mt -70.09 -46.62 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.733 174.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.22 -48.97 85.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.77 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 38.9 ptt180 -78.29 37.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.518 0.675 . . . . 0.0 110.034 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.54 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 9.6 t30 -153.14 -51.04 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.8 ptm180 -76.69 -11.48 59.85 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -142.94 -60.74 0.43 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.494 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD13 ' HB ' ' A' ' 65' ' ' ILE 0.297 0.6 OUTLIER -110.91 88.97 2.91 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.984 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.99 23.79 10.23 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.884 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -143.01 -69.42 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.795 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -86.52 75.16 9.78 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.619 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.5 tp -161.79 137.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.92 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 9.6 pt-20 -130.37 167.52 18.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.099 0.476 . . . . 0.0 111.235 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.6 mt -104.87 139.54 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 50.9 tptt -80.92 -59.81 2.53 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -177.49 159.93 1.57 Allowed 'General case' 0 C--O 1.25 1.13 0 C-N-CA 124.869 1.267 . . . . 0.0 107.604 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.62 119.16 45.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -125.11 133.81 52.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.29 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.69 132.63 67.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.97 163.38 33.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.088 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.417 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 52.5 p -90.49 126.32 35.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.564 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -81.7 113.91 20.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 86' ' ' ARG . 24.3 t . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG2' HG22 ' A' ' 76' ' ' VAL . 50.1 mtm180 . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.4 t -133.42 123.78 47.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -59.51 127.98 34.76 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 120.935 0.398 . . . . 0.0 111.058 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.9 p -133.48 162.17 32.6 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 17.7 tt -137.7 142.76 35.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.773 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -120.25 108.54 14.32 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.046 0.939 . . . . 0.0 108.711 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -118.77 129.48 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . . . -131.24 130.35 42.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.8 pt -121.62 153.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.427 ' HD3' ' OE2' ' A' ' 66' ' ' GLU . 35.3 ttt180 -129.99 140.1 50.95 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.247 0.546 . . . . 0.0 112.07 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm . . . . . 0 C--N 1.321 -0.656 0 C-N-CA 124.566 1.146 . . . . 0.0 110.324 175.02 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 61.1 t -109.22 112.56 41.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.0 147.63 12.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.111 0.481 . . . . 0.0 111.272 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 tp -105.73 122.37 45.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.6 mm -88.85 104.59 15.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.01 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.58 59.19 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.793 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -165.02 -57.07 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.331 0.586 . . . . 0.0 110.429 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -100.75 165.59 14.02 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.132 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.08 162.4 42.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.24 1.96 . . . . 0.0 111.313 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.07 -42.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -61.21 -25.08 66.8 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.68 -37.25 65.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.66 -32.88 64.22 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.167 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.76 -48.67 86.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.923 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.94 -30.34 70.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.204 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.577 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -72.65 -43.46 63.16 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -68.68 -32.72 72.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.42 -52.51 65.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.139 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' B' ' 32' ' ' GLN . 10.1 t -65.69 -38.22 88.63 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.656 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -60.29 -36.56 78.16 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 92.5 mt -63.74 -23.82 67.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.031 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -100.14 -15.45 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' B' ' 28' ' ' THR . 79.7 mt-30 -78.14 -27.48 48.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.819 0.342 . . . . 0.0 110.766 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.35 -6.88 3.98 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.466 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.47 97.18 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -67.16 -31.98 72.77 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.456 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -140.37 125.85 18.99 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.072 0.463 . . . . 0.0 111.489 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.538 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -121.83 158.68 25.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.309 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.94 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 48.9 t -121.5 122.38 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.507 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -104.83 125.32 59.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.738 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 67.6 mttm -119.57 120.33 36.41 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -116.39 155.28 28.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.594 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -130.42 140.38 50.57 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.913 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.86 -129.44 10.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.703 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -82.34 -9.33 59.51 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.105 0.479 . . . . 0.0 110.156 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.1 -5.55 36.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.013 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.4 mt -54.26 -40.73 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.48 0.657 . . . . 0.0 109.997 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 75.4 p -67.08 -23.4 65.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.169 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -85.39 -28.45 25.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.281 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -67.74 -45.32 75.33 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.77 -37.23 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.005 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.57 ' O ' HG13 ' B' ' 55' ' ' ILE . 44.0 t0 -56.94 -52.89 63.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.576 0.75 . . . . 0.0 109.202 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.2 m -54.7 -52.16 63.29 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.854 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.445 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.2 m -70.29 -32.97 52.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.104 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 24.3 tt0 -71.37 -26.38 62.77 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.973 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.6 mt -70.13 -46.39 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.879 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.14 -49.81 82.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.827 0.346 . . . . 0.0 110.898 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 39.3 ptt180 -77.48 36.73 0.2 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-O 121.449 0.642 . . . . 0.0 110.032 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ASN . . . . . 0.414 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 7.9 t30 -152.1 -52.18 0.12 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 123.092 0.557 . . . . 0.0 110.496 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.2 ptm180 -74.4 -14.84 60.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -139.74 -64.78 0.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.321 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.425 HD13 ' HB ' ' B' ' 65' ' ' ILE 0.278 0.5 OUTLIER -107.88 93.98 4.83 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -177.565 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.69 13.36 35.12 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.693 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.94 -69.25 0.54 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.803 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -83.23 75.73 9.93 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.655 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.425 ' HB ' HD13 ' B' ' 61' ' ' LEU . 8.0 tp -161.71 143.32 3.53 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 C-N-CA 124.198 0.999 . . . . 0.0 108.768 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' B' ' 95' ' ' ARG . 10.2 pt-20 -137.93 164.16 29.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.907 0.384 . . . . 0.0 111.6 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.38 138.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' B' ' 93' ' ' ALA . 52.3 tptt -81.55 -60.54 2.22 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -175.82 160.39 2.38 Favored 'General case' 0 C--O 1.262 1.744 0 C-N-CA 124.795 1.238 . . . . 0.0 107.903 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.7 mt -131.48 119.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -125.88 135.02 51.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.677 0.275 . . . . 0.0 110.354 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.55 131.54 73.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.4 165.83 35.65 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.75 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.503 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 37.0 p -89.75 127.27 35.93 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.798 0.332 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -81.35 114.08 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' B' ' 86' ' ' ARG . 25.8 t . . . . . 0 C--N 1.3 -1.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.54 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 34.6 mtm180 . . . . . 0 CA--C 1.502 -0.896 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.39 123.13 46.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 m -58.41 127.51 32.5 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.33 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 36.4 p -134.18 159.33 41.21 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 123.595 0.758 . . . . 0.0 109.764 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 16.3 tt -134.42 142.09 41.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -120.61 106.61 11.92 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 123.915 0.886 . . . . 0.0 108.668 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.37 130.2 71.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 68' ' ' LYS . . . -129.87 132.02 46.28 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -123.49 149.04 27.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.248 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.416 ' HB3' ' HG3' ' B' ' 66' ' ' GLU . 41.7 ttt180 -125.39 144.24 50.6 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.575 -174.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -84.1 -170.11 2.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.063 1.345 . . . . 0.0 110.24 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 97' ' ' LYS . 21.3 pttp . . . . . 0 C--O 1.261 1.679 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.233 0.54 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 59.7 t -105.08 123.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.085 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -120.25 142.83 34.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.683 0.278 . . . . 0.0 110.825 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 131.8 47.3 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.786 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.426 HG21 ' HB2' ' A' ' 48' ' ' LYS . 44.7 mm -93.75 111.68 25.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.878 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.66 28.97 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.03 -1.557 . . . . 0.0 114.622 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.56 -50.01 0.41 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.791 0.795 . . . . 0.0 112.155 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -100.93 160.64 26.14 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.59 159.68 35.58 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 121.741 1.627 . . . . 0.0 110.893 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.507 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.5 p -55.66 -38.54 50.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.0 ptm -61.05 -26.08 67.38 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.999 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.41 -43.34 77.41 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -70.95 -35.07 72.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.595 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 19' ' ' VAL . 59.2 t -60.34 -51.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.647 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.8 mt -65.91 -33.81 76.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.844 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -64.94 -45.52 85.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.227 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.99 95.53 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.427 0.454 . . . . 0.0 110.481 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.67 -35.11 78.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.427 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 m -73.89 -43.6 57.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.735 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 94.1 mt -64.47 -34.39 78.09 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.147 0.499 . . . . 0.0 110.587 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -58.73 -44.73 90.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.348 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -69.26 -22.38 63.84 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.94 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -82.0 -2.29 51.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.076 0.465 . . . . 0.0 110.9 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.58 -8.89 32.48 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 t -92.07 92.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.568 ' HA ' HD22 ' A' ' 30' ' ' LEU . 57.4 p -95.78 -9.92 30.43 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.199 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.24 104.99 10.52 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -127.15 157.67 38.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.151 -175.092 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.3 t -124.21 116.98 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.194 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.85 121.6 48.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 85.7 mttt -118.14 120.99 39.4 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.269 0.556 . . . . 0.0 110.378 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -115.65 156.45 25.85 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.951 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HG2' HG22 ' A' ' 89' ' ' THR . 88.3 mtt180 -130.91 143.15 50.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.19 -119.6 11.99 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.515 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -85.73 -8.7 58.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.439 0.638 . . . . 0.0 110.433 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.42 -4.53 42.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.166 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -56.01 -36.71 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.564 0.697 . . . . 0.0 109.912 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.3 p -64.64 -31.51 72.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.576 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HB2' HG21 ' A' ' 14' ' ' ILE . 28.5 mtpp -78.85 -31.44 45.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.502 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -65.77 -46.82 77.33 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.414 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -72.08 -33.87 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.873 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' OD2' HG21 ' A' ' 19' ' ' VAL . 31.3 t70 -60.24 -47.47 85.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.9 m -53.3 -53.7 47.12 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.414 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.18 -30.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.61 -39.8 88.54 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 51' ' ' ASP . 89.0 mt -59.97 -45.55 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.25 -40.44 86.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.093 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -83.55 15.77 2.95 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.31 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -136.72 12.66 3.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.847 0.832 . . . . 0.0 109.255 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.07 -49.04 0.28 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.147 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.46 ' CD2' HD23 ' A' ' 61' ' ' LEU . 56.2 t80 -90.24 -70.36 0.67 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.955 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.46 HD23 ' CD2' ' A' ' 60' ' ' PHE . 4.1 mm? -129.43 110.38 11.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.128 0.489 . . . . 0.0 111.316 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.7 12.57 36.25 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.943 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -126.04 -64.09 1.07 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.415 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 98.2 mttt -78.76 102.08 7.93 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.686 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tp -160.66 126.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.83 0.452 . . . . 0.0 110.329 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.517 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 41.0 tt0 -119.19 130.64 55.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.3 mt -95.21 128.06 46.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.65 -62.07 1.57 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.258 0.349 . . . . 0.0 111.239 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 10.0 tp10 -162.59 141.71 9.05 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.95 107.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.208 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.495 ' HE ' ' CD ' ' A' ' 69' ' ' GLU . 91.0 mtt180 -131.18 144.91 51.7 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.519 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.02 132.51 66.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.24 -174.42 22.81 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.122 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -124.78 128.46 48.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -106.84 138.84 42.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.313 -0.99 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.7 120.91 60.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.4 t -63.5 128.19 34.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.602 HG22 ' HG2' ' A' ' 42' ' ' ARG . 61.5 p -120.76 134.35 55.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.424 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -123.12 128.39 75.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -107.65 110.77 22.72 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -103.98 106.78 20.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.76 40.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.901 0.381 . . . . 0.0 110.432 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.11 151.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.364 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HD3' ' OE1' ' A' ' 66' ' ' GLU . 75.3 ttt180 -121.85 119.29 31.19 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.493 0.663 . . . . 0.0 110.255 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HE3' ' O ' ' A' ' 64' ' ' LYS . 8.3 mmmm . . . . . 0 C--N 1.284 -2.265 0 CA-C-O 121.392 0.615 . . . . 0.0 112.403 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.898 0.38 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.16 124.56 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.813 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.83 141.08 42.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.019 0.438 . . . . 0.0 111.581 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.24 129.62 46.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.874 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.09 111.36 24.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.469 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.76 28.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 119.105 -1.521 . . . . 0.0 114.911 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.97 -48.72 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.265 0.533 . . . . 0.0 111.661 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -101.55 160.9 25.2 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.61 162.3 21.7 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.981 1.787 . . . . 0.0 111.728 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.426 ' O ' HG23 ' B' ' 23' ' ' VAL . 7.2 p -58.71 -38.46 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.576 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 25.7 ptm -62.61 -26.24 68.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.639 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -66.69 -46.76 74.56 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -67.21 -34.29 77.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.835 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 19' ' ' VAL . 58.3 t -61.21 -50.51 80.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.618 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 20' ' ' MET . 86.3 mt -67.32 -36.03 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.641 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.428 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.01 -44.56 95.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.336 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.49 98.77 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.371 0.419 . . . . 0.0 110.499 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.8 -36.17 82.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.571 . . . . 0.0 111.049 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 59.7 m -72.51 -45.06 61.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.659 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 93.6 mt -64.06 -33.67 76.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.298 0.571 . . . . 0.0 110.262 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' B' ' 35' ' ' SER . 0.2 OUTLIER -58.41 -46.66 86.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.375 -177.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -68.28 -21.85 64.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.352 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.68 -4.25 55.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.34 -3.92 29.72 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.906 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -95.93 91.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.395 0.616 . . . . 0.0 109.516 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' SER . . . . . 0.508 ' HA ' HD22 ' B' ' 30' ' ' LEU . 58.3 p -94.78 -8.61 37.04 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.346 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.82 104.98 9.63 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.515 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -125.29 159.11 32.95 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.981 -173.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.7 117.12 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.198 0.523 . . . . 0.0 110.147 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -97.83 121.08 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.4 mttt -118.12 119.97 36.32 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.391 0.615 . . . . 0.0 110.178 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -115.2 156.56 25.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.667 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.563 ' HG2' HG22 ' B' ' 89' ' ' THR . 92.3 mtt180 -130.73 144.51 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.593 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.28 -123.44 23.3 Favored Glycine 0 C--O 1.215 -1.09 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.232 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -81.18 -12.77 59.11 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.224 0.535 . . . . 0.0 110.915 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.83 -3.47 28.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -55.15 -37.92 44.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.46 0.648 . . . . 0.0 109.793 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.4 p -64.69 -31.68 73.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.836 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -79.12 -29.73 43.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -65.33 -48.32 73.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 120.78 0.324 . . . . 0.0 110.957 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.98 -34.6 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.514 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.3 t70 -58.49 -48.65 80.09 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -52.46 -53.43 45.69 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.378 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -31.17 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.98 -39.43 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 51' ' ' ASP . 89.8 mt -59.33 -47.69 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.722 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -59.31 -39.4 78.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 CA-C-O 121.123 0.487 . . . . 0.0 110.863 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -84.86 17.12 2.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -141.65 18.47 2.18 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -150.26 -46.44 0.13 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.078 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.48 ' O ' HD22 ' B' ' 61' ' ' LEU . 62.7 t80 -92.37 -68.13 0.82 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.852 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.48 HD22 ' O ' ' B' ' 60' ' ' PHE . 3.9 mm? -132.49 111.84 11.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.805 0.336 . . . . 0.0 111.014 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.79 13.96 31.93 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.534 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -127.53 -64.7 0.97 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.088 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.536 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 98.4 mttt -74.91 99.67 3.88 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.903 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.8 tp -160.34 128.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.506 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 38.2 tt0 -122.64 129.65 52.09 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -94.44 127.21 46.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LYS . . . . . 0.422 ' HD3' ' HB1' ' B' ' 93' ' ' ALA . 49.2 tttp -87.73 -63.07 1.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.556 0.535 . . . . 0.0 111.188 -175.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 10.5 tp10 -161.63 140.41 9.65 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 pt -143.31 110.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.284 0.564 . . . . 0.0 110.73 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 92.9 mtt180 -133.57 145.62 50.24 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.726 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.29 128.81 75.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.27 -173.52 19.24 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.557 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 126.07 43.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -105.46 139.01 40.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.311 -1.094 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 66.6 t -129.3 117.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -64.02 131.23 46.98 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.563 HG22 ' HG2' ' B' ' 42' ' ' ARG . 59.9 p -123.22 133.73 54.19 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.559 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 16.1 tt -121.44 128.83 75.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.68 107.37 16.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.401 HD11 HD11 ' B' ' 90' ' ' ILE . 44.9 mm -102.79 107.02 21.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' ALA . . . . . 0.422 ' HB1' ' HD3' ' B' ' 68' ' ' LYS . . . -115.29 120.97 41.43 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.531 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -127.94 149.46 32.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.298 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.506 ' HD3' ' OE2' ' B' ' 66' ' ' GLU . 71.5 ttt180 -119.37 118.27 30.74 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.5 0.666 . . . . 0.0 110.349 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' B' ' 64' ' ' LYS . 7.6 mmmm -84.16 129.58 34.89 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.407 ' OXT' ' HB3' ' B' ' 64' ' ' LYS . 55.8 mtpt . . . . . 0 C--O 1.257 1.492 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.938 0.399 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.9 t -120.4 124.67 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.82 149.38 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.825 0.345 . . . . 0.0 111.189 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.81 123.57 48.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.774 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -89.54 99.36 9.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.43 52.35 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.452 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -166.68 -56.34 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.04 167.76 10.25 Favored Pre-proline 0 CA--C 1.555 1.166 0 O-C-N 122.393 -0.192 . . . . 0.0 111.027 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.33 153.66 61.38 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.162 1.908 . . . . 0.0 112.514 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.91 -40.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.497 1.119 . . . . 0.0 113.469 -177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.42 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.3 ptm -62.5 -25.83 68.22 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.709 0.804 . . . . 0.0 111.823 -175.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -84.05 -27.77 28.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.022 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -73.14 -37.64 66.55 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 89.2 t -57.57 -47.78 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.567 0.698 . . . . 0.0 109.547 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.6 mt -65.26 -36.31 83.71 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.076 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.791 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.87 87.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.605 0.241 . . . . 0.0 111.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 86.8 mt -66.49 -31.55 72.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.6 0.714 . . . . 0.0 110.296 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 91.2 m -74.18 -40.35 62.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.176 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 97.5 mt -62.27 -38.68 90.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.192 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.9 tp -57.17 -46.12 83.08 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.9 -23.63 66.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.762 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 28' ' ' THR . 83.3 mm-40 -81.35 -11.91 59.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.185 0.516 . . . . 0.0 110.355 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.7 24.36 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.539 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.97 93.96 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 121.397 0.617 . . . . 0.0 109.599 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 p -89.04 -21.31 23.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.61 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -108.04 105.52 15.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -121.08 149.65 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.691 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.9 120.78 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.272 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -103.17 122.82 56.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.463 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -115.42 124.55 51.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 111.331 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.69 143.26 47.85 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.351 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -129.81 127.15 39.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.631 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.89 -138.35 14.1 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.934 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -82.97 4.31 26.41 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.487 0.661 . . . . 0.0 110.869 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.99 -4.01 53.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.553 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.71 -43.49 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.119 0.568 . . . . 0.0 110.575 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -19.14 64.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -90.45 -32.8 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.63 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.71 -43.59 88.69 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.912 0.387 . . . . 0.0 111.719 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.08 -32.67 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.434 ' O ' HG13 ' A' ' 55' ' ' ILE . 23.9 t70 -65.82 -38.95 90.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.4 m -60.42 -51.33 69.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.078 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 35.9 m -66.17 -38.15 81.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.675 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mm-40 -59.72 -36.56 76.8 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.1 mt -66.88 -44.19 89.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 0.0 110.292 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.76 -38.75 82.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.725 0.298 . . . . 0.0 111.725 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.675 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 4.1 ptm180 -89.84 11.24 20.81 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.86 -30.71 3.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.268 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -93.78 -59.07 2.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.33 -55.24 12.74 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.964 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -160.0 108.35 1.71 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.57 -35.12 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 123.972 0.795 . . . . 0.0 112.745 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.05 -26.64 68.34 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' H ' HD12 ' A' ' 61' ' ' LEU . 35.0 mmtp -122.36 101.51 7.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.718 0.295 . . . . 0.0 110.765 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tp -156.94 146.7 11.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG2' HH21 ' A' ' 95' ' ' ARG . 7.8 tp10 -135.19 141.26 45.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.27 132.57 40.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -91.45 -48.11 7.06 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.937 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -173.83 145.87 1.18 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.45 97.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.678 0.751 . . . . 0.0 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -127.69 141.89 51.48 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.782 -0.574 . . . . 0.0 110.978 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.85 143.75 29.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.3 -165.69 21.95 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.674 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m -115.46 144.83 43.25 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 59.4 tt0 -101.67 131.17 48.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 86' ' ' ARG . 49.4 t . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.449 ' HG2' HG22 ' A' ' 76' ' ' VAL . 79.0 mtt180 . . . . . 0 CA--C 1.504 -0.791 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.19 138.78 52.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.9 t -75.24 136.41 40.95 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.7 p -136.14 145.22 45.59 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.4 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.45 138.91 53.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.364 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -115.42 111.69 21.19 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.74 110.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.88 124.13 50.93 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 pt -124.49 162.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 120.848 0.356 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.4 HH21 ' HG2' ' A' ' 66' ' ' GLU . 49.1 ttp180 -129.98 108.68 10.29 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? . . . . . 0 C--N 1.289 -2.022 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 -173.053 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 120.95 0.405 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.68 119.71 61.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.53 148.05 15.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.454 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.47 120.24 41.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.707 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.96 100.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.73 51.19 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.509 -1.329 . . . . 0.0 113.916 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -167.08 -55.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -100.14 168.47 9.38 Favored Pre-proline 0 CA--C 1.556 1.176 0 O-C-N 122.129 -0.357 . . . . 0.0 111.106 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.81 156.15 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.236 1.957 . . . . 0.0 112.302 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.81 -43.89 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.0 ptp -54.89 -32.85 61.4 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -77.73 -28.39 50.77 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.929 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.73 -37.95 64.94 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 79.7 t -57.68 -47.86 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.484 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.072 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.57 -43.54 89.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.2 -38.08 89.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.5 mt -65.89 -31.21 72.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.33 0.586 . . . . 0.0 110.358 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' B' ' 32' ' ' GLN . 64.4 m -74.88 -42.09 58.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.796 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.3 mt -60.86 -38.53 85.87 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.616 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 tp -57.18 -44.24 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.157 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.2 -16.22 62.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.827 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' B' ' 28' ' ' THR . 82.5 mm-40 -87.27 -7.82 57.44 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.306 0.574 . . . . 0.0 109.889 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.61 34.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.757 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.6 t -99.05 95.76 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.274 0.559 . . . . 0.0 109.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 12.8 p -90.49 -25.49 20.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.425 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -103.37 107.6 18.5 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.466 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -123.88 148.0 28.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 120.91 0.386 . . . . 0.0 110.743 -179.326 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.43 122.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.678 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.3 mt -105.39 120.22 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.997 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -113.55 123.33 49.73 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.362 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.31 147.39 42.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.426 ' NE ' HG11 ' B' ' 87' ' ' VAL . 3.0 tmt_? -133.09 129.48 38.03 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.116 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.77 -142.13 16.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.0 5.67 11.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.35 0.595 . . . . 0.0 110.81 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.25 -5.21 55.83 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.5 -44.38 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.407 0.683 . . . . 0.0 110.81 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.0 t -59.82 -32.64 70.84 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.049 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -76.8 -34.24 57.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.753 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -45.61 83.22 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 120.803 0.335 . . . . 0.0 111.768 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.51 -35.88 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.424 ' O ' HG13 ' B' ' 55' ' ' ILE . 29.8 t70 -62.59 -41.57 99.04 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 91.5 m -57.03 -50.04 73.94 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.903 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 35.4 m -67.09 -38.42 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.659 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 17.0 mm-40 -59.72 -38.91 82.97 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.5 mt -64.36 -45.02 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.25 -37.02 77.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 120.96 0.409 . . . . 0.0 111.792 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.659 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 4.5 ptm180 -91.48 11.63 23.4 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -126.13 -29.52 3.03 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.096 0.474 . . . . 0.0 110.968 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -93.86 -58.28 2.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -68.69 -58.39 4.3 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.47 HD12 ' H ' ' B' ' 64' ' ' LYS . 0.2 OUTLIER -157.95 109.58 2.27 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.34 -42.13 12.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 124.423 1.077 . . . . 0.0 112.63 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.1 -34.25 68.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 0.0 112.585 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.47 ' H ' HD12 ' B' ' 61' ' ' LEU . 35.1 mmtp -118.05 101.11 7.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.168 0.509 . . . . 0.0 110.966 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.04 146.31 13.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.467 ' HG2' HH21 ' B' ' 95' ' ' ARG . 9.0 tp10 -132.17 143.8 50.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.86 129.74 50.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -90.57 -47.9 7.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -172.55 147.03 1.8 Allowed 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.751 0.657 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.01 94.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.443 0.697 . . . . 0.0 110.54 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -127.56 141.17 51.71 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.311 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.87 144.48 24.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.27 -175.32 35.81 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.618 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 45.8 m -107.08 143.91 34.52 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.391 0.615 . . . . 0.0 112.266 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 61.1 tt0 -99.71 132.56 44.97 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' B' ' 86' ' ' ARG . 47.0 t . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.446 ' HG2' HG22 ' B' ' 76' ' ' VAL . 83.2 mtt180 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.426 HG11 ' NE ' ' B' ' 42' ' ' ARG . 96.0 t -126.99 137.42 57.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -74.48 135.49 42.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.571 . . . . 0.0 110.701 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 35.3 p -136.96 146.11 45.0 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.51 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.83 137.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.235 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -113.53 111.33 21.71 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 57.5 mt -110.55 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.93 123.75 50.52 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.802 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.0 pt -124.59 162.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.237 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.467 HH21 ' HG2' ' B' ' 66' ' ' GLU . 47.5 ttp180 -128.84 107.33 9.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 7.0 tmtm? -84.57 131.75 34.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.936 -174.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.57 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 34.7 mmtp . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.17 0.509 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.5 t -122.53 111.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.38 146.62 10.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.941 0.4 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 tp -112.2 124.17 51.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 51.0 mt -88.3 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 O-C-N 123.186 0.303 . . . . 0.0 110.865 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.27 -94.42 0.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.661 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -103.42 6.97 38.02 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -98.25 145.43 29.82 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.636 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.93 151.35 82.34 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.52 2.147 . . . . 0.0 112.503 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.43 HG23 ' OG1' ' A' ' 52' ' ' THR . 7.0 p -52.83 -41.4 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -58.85 -28.81 66.44 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.27 -39.0 86.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 93.2 m-85 -75.03 -37.6 61.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 69.4 t -60.85 -54.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.329 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.84 -32.54 73.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.97 -47.24 72.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.502 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.78 99.54 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 123.485 0.491 . . . . 0.0 111.064 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 88.0 mt -62.41 -34.74 77.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.021 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.7 m -73.96 -34.19 64.16 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.394 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 84.6 mt -67.26 -32.25 73.13 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-O 120.838 0.351 . . . . 0.0 110.909 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.49 -30.01 71.05 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.328 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -84.28 -4.89 59.14 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.985 0.898 . . . . 0.0 109.805 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -101.72 -19.83 15.22 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.593 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.08 11.29 10.07 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.693 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.61 94.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.626 0.713 . . . . 0.0 109.358 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -71.1 -41.09 71.04 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.464 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.42 124.06 50.21 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.54 0.686 . . . . 0.0 111.857 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -128.69 156.84 41.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.523 -177.191 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -120.29 128.41 75.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.3 mt -108.72 120.16 59.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.66 133.93 54.44 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.323 0.582 . . . . 0.0 110.122 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.6 162.63 31.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.435 ' HE ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -150.86 149.97 30.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.254 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.14 -130.29 11.27 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -88.9 1.06 55.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.678 0.751 . . . . 0.0 109.776 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.61 -6.25 58.82 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.432 HG23 HG21 ' A' ' 90' ' ' ILE . 75.6 mt -53.97 -37.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.232 0.539 . . . . 0.0 110.442 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.3 t -61.99 -30.46 70.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -83.01 -21.95 33.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.122 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.46 -47.02 65.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.832 0.348 . . . . 0.0 110.263 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.511 ' HA ' HG22 ' A' ' 53' ' ' VAL . 9.9 p -69.83 -32.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.164 0.506 . . . . 0.0 109.796 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.416 ' OD2' HG21 ' A' ' 19' ' ' VAL . 36.4 t70 -61.72 -44.06 97.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.083 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 19' ' ' VAL . 85.6 m -63.85 -48.06 78.25 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.268 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 50' ' ' VAL . 33.5 m -69.39 -33.81 59.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.72 -43.62 96.01 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.181 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.9 mt -56.68 -46.78 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.65 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.0 -43.87 98.19 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.895 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -83.95 10.22 10.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.133 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -125.1 -16.93 5.89 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.48 0.657 . . . . 0.0 111.142 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -105.82 -47.48 3.87 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.19 -67.5 0.83 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.901 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 3.4 mm? -130.98 104.5 7.16 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 120.979 0.419 . . . . 0.0 110.43 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.98 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.091 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.98 -36.68 59.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.176 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -123.15 89.05 3.04 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.633 0.73 . . . . 0.0 110.54 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.14 131.32 10.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.995 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.21 146.15 51.18 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.29 135.6 35.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -85.45 -57.92 2.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.067 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -168.93 151.4 4.87 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.43 116.9 26.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -126.68 146.24 50.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -147.43 137.53 16.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.1 -157.42 13.92 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.655 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.6 m -113.46 128.51 56.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.03 141.52 45.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.308 -1.234 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.18 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.435 HG11 ' HE ' ' A' ' 42' ' ' ARG . 45.8 t -132.42 140.5 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 p -71.02 119.9 15.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 123.62 0.575 . . . . 0.0 110.54 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.5 p -116.53 154.11 30.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.948 0.499 . . . . 0.0 109.881 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.432 HG21 HG23 ' A' ' 46' ' ' ILE . 16.9 tt -143.07 132.18 20.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 108.0 16.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.96 116.05 48.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.58 125.12 49.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.413 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.7 pt -122.46 152.22 26.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -122.42 109.29 14.2 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.362 0.601 . . . . 0.0 111.272 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HE2' ' HB2' ' A' ' 61' ' ' LEU . 4.3 mmmp? . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.539 ' N ' HD21 ' B' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.235 0.54 . . . . 0.0 110.405 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 53.3 t -118.1 111.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.75 148.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.827 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp -115.13 122.39 45.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.463 ' HA ' ' CZ ' ' B' ' 22' ' ' TYR . 55.3 mt -86.99 131.71 34.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.945 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.21 -97.41 0.25 Allowed Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.72 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -99.15 -0.11 42.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.119 0.485 . . . . 0.0 110.338 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.01 145.91 32.63 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.655 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.98 154.65 73.13 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.906 2.404 . . . . 0.0 112.21 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.413 HG23 ' OG1' ' B' ' 52' ' ' THR . 7.2 p -56.16 -40.91 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.546 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.12 -30.1 67.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -63.87 -39.19 93.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.709 0.766 . . . . 0.0 109.706 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' TYR . . . . . 0.463 ' CZ ' ' HA ' ' B' ' 14' ' ' ILE . 92.8 m-85 -76.89 -37.85 54.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.676 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 65.4 t -60.65 -52.89 56.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.71 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.52 -33.62 75.99 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.219 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -64.91 -47.42 77.83 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.576 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.34 96.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.35 -34.48 76.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 111.313 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 73.4 m -73.53 -34.38 65.19 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.523 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.1 mt -67.19 -31.0 71.1 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.921 0.391 . . . . 0.0 111.268 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.21 -26.26 67.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -86.89 -2.64 58.75 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.749 0.785 . . . . 0.0 109.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -105.29 -16.31 14.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.655 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.65 13.27 14.75 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.64 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.74 95.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 22.4 m -73.2 -38.95 65.92 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.136 0.575 . . . . 0.0 112.475 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.25 122.74 44.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.491 0.662 . . . . 0.0 111.623 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.494 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.27 156.88 40.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.85 -176.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 62.1 t -121.36 126.54 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.285 0.564 . . . . 0.0 110.247 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -108.26 121.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.04 135.09 54.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.208 0.528 . . . . 0.0 110.494 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.96 160.67 37.57 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.437 ' HE ' HG11 ' B' ' 87' ' ' VAL . 0.0 OUTLIER -149.53 147.65 28.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -126.04 7.21 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -93.98 1.95 56.17 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.735 0.779 . . . . 0.0 109.464 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.67 -6.33 59.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.521 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.404 HG23 HG21 ' B' ' 90' ' ' ILE . 71.4 mt -53.97 -36.86 32.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 CA-C-O 121.891 0.853 . . . . 0.0 109.732 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -63.95 -30.54 71.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.047 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -82.36 -25.27 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.715 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.53 80.59 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.924 0.392 . . . . 0.0 110.419 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' B' ' 53' ' ' VAL . 12.7 p -71.09 -33.29 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.567 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.429 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.8 t70 -59.51 -47.18 86.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.454 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.413 ' OG1' HG23 ' B' ' 19' ' ' VAL . 63.7 m -60.25 -48.42 81.83 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.4 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.441 HG22 ' HA ' ' B' ' 50' ' ' VAL . 33.4 m -70.26 -32.44 50.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.07 -41.79 94.75 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.982 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.429 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.4 mt -57.8 -48.59 83.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.816 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.02 -43.28 95.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.948 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' B' ' 53' ' ' VAL . 12.8 ptm180 -84.29 11.73 7.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.72 -15.29 4.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.17 0.509 . . . . 0.0 110.753 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -103.69 -52.38 2.99 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -85.8 -65.61 0.99 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.476 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.462 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 3.4 mm? -131.25 106.86 8.58 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 123.027 0.531 . . . . 0.0 110.692 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.92 -19.39 17.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.022 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.76 -33.32 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.763 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -124.38 89.74 3.13 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.01 137.65 19.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.008 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.52 143.2 41.53 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -100.85 138.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -87.21 -55.64 3.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.12 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -171.66 150.73 2.77 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.41 117.7 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -126.62 148.23 49.82 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.709 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -147.73 138.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.43 -155.27 10.17 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.8 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.6 m -118.86 124.93 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -107.45 144.88 33.75 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.282 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.437 HG11 ' HE ' ' B' ' 42' ' ' ARG . 48.0 t -135.77 136.84 49.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 19.1 p -68.4 120.89 15.22 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.734 0.646 . . . . 0.0 110.934 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 51.6 p -117.28 155.44 29.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.821 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.404 HG21 HG23 ' B' ' 46' ' ' ILE . 16.6 tt -143.87 132.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -116.21 105.76 12.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.9 mt -103.66 119.04 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.66 124.27 44.82 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.1 pt -121.25 151.99 24.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.62 108.89 14.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.979 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.462 ' HE2' ' HB2' ' B' ' 61' ' ' LEU . 4.1 mmmp? -80.38 133.99 35.97 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? . . . . . 0 C--N 1.283 -2.321 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 169.051 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.553 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.667 0.27 . . . . 0.0 111.235 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.9 t -113.82 124.78 70.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.07 145.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.985 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.82 131.12 48.33 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.6 mm -95.97 120.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.047 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.64 50.48 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.911 -1.614 . . . . 0.0 114.185 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -155.57 -57.54 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.437 0.618 . . . . 0.0 110.748 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -101.99 163.9 16.85 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -59.49 158.7 26.32 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.242 1.962 . . . . 0.0 111.699 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.446 HG21 ' OD2' ' A' ' 51' ' ' ASP . 10.0 p -52.92 -31.33 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 124.301 1.041 . . . . 0.0 113.437 -175.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.429 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.5 ptm -57.11 -32.58 66.46 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.62 0.368 . . . . 0.0 111.788 -174.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -71.82 -38.24 70.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.098 0.475 . . . . 0.0 110.537 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -76.57 -36.26 57.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.246 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 19' ' ' VAL . 93.2 t -58.03 -53.51 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.089 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.7 mt -58.64 -36.27 73.83 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.398 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.29 96.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.396 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.03 -56.44 20.96 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.56 0.537 . . . . 0.0 111.949 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 27' ' ' LEU 0.342 0.0 OUTLIER -69.53 -19.07 63.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.496 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -72.01 -46.09 58.49 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.8 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.07 -41.18 86.85 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.227 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 96' ' ' LYS . 95.7 mt -55.31 -41.92 73.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.653 0.596 . . . . 0.0 111.509 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.02 5.33 52.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.983 0.42 . . . . 0.0 111.715 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -99.37 -30.14 12.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.82 0.343 . . . . 0.0 110.178 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.49 -15.03 1.09 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.57 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.7 100.53 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 23.2 p -79.49 -22.51 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.1 111.74 14.37 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.263 0.554 . . . . 0.0 110.274 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.55 161.16 19.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.035 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 45.3 t -128.86 125.77 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.469 . . . . 0.0 110.861 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.71 120.89 57.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -118.84 118.37 31.38 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.111 0.481 . . . . 0.0 110.683 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -109.96 148.12 32.2 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HG2' HG22 ' A' ' 89' ' ' THR . 70.9 mtp180 -122.51 143.78 49.5 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.343 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.74 -130.05 12.63 Favored Glycine 0 N--CA 1.44 -1.088 0 O-C-N 123.5 0.5 . . . . 0.0 112.948 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -90.46 5.7 46.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.629 0.728 . . . . 0.0 110.475 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.23 -3.15 54.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.243 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.451 HG23 HG21 ' A' ' 90' ' ' ILE . 69.7 mt -54.47 -37.21 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.786 0.834 . . . . 0.0 110.404 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.1 t -64.26 -26.95 68.73 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.056 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -83.24 -27.91 29.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.372 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -68.12 -43.98 77.17 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -71.33 -35.2 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.17 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.6 t70 -60.64 -47.21 87.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.934 0.772 . . . . 0.0 109.069 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -54.12 -56.25 19.92 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.9 -22.85 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.4 ' HG2' HH21 ' B' ' 86' ' ' ARG . 28.8 tt0 -74.84 -37.35 62.29 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.529 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.7 mt -61.86 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.709 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -55.14 -43.58 70.9 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.377 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 54.8 mtm180 -71.45 3.09 4.11 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.426 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 63.7 t30 -137.47 16.4 2.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.956 0.884 . . . . 0.0 109.689 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -128.75 -63.77 0.96 Allowed 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.413 -176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -106.77 -36.87 6.56 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.296 -176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 95.7 mt -131.49 103.74 6.58 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.215 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.51 -73.87 0.61 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.34 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.26 6.91 40.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.075 0.465 . . . . 0.0 110.681 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.93 24.02 12.81 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.478 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.22 153.52 12.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -125.22 169.16 12.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.153 0.501 . . . . 0.0 111.085 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -109.1 135.97 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -86.79 -66.42 0.91 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.116 0.26 . . . . 0.0 110.782 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 71' ' ' ARG . 42.8 tt0 -162.71 145.54 10.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.4 mt -127.75 116.15 42.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.425 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 79.9 mtp180 -121.27 135.98 55.04 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.526 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.97 131.3 73.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.2 -163.81 11.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.115 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.2 p -131.41 111.42 11.81 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -87.61 131.35 34.45 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.132 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 C--N 1.313 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.455 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.514 HH21 ' HG2' ' B' ' 54' ' ' GLU . 39.0 mtm180 . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.72 117.26 50.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.1 m -61.19 127.45 31.59 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.771 0.67 . . . . 0.0 109.226 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 42' ' ' ARG . 24.5 p -127.97 151.8 48.68 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.002 0.43 . . . . 0.0 111.836 -176.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.451 HG21 HG23 ' A' ' 46' ' ' ILE . 15.5 tt -129.8 128.6 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.289 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.33 106.27 15.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -103.98 117.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.66 133.69 55.67 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.8 pt -138.87 151.33 23.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 35' ' ' SER . 12.9 ptp180 -130.66 158.4 40.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 123.496 0.498 . . . . 0.0 110.838 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.516 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 121.484 0.659 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 80.7 t -117.28 124.55 73.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -116.39 143.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 120.897 0.379 . . . . 0.0 110.862 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -100.37 128.99 46.3 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -94.56 119.78 43.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.224 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.89 45.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.391 -1.385 . . . . 0.0 114.213 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -150.56 -58.87 0.18 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.469 0.635 . . . . 0.0 110.432 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -101.45 164.35 16.12 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.511 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -59.99 156.35 39.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.27 1.98 . . . . 0.0 111.751 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.484 ' O ' HG23 ' B' ' 23' ' ' VAL . 8.3 p -50.6 -30.42 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.541 1.136 . . . . 0.0 113.827 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.457 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 24.9 ptm -58.65 -30.38 67.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.028 0.442 . . . . 0.0 111.958 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.78 -38.36 64.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.648 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -76.73 -34.8 58.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 19' ' ' VAL . 78.9 t -58.89 -54.24 36.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 CA-C-O 121.273 0.559 . . . . 0.0 110.122 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 20' ' ' MET . 94.8 mt -57.86 -38.7 76.18 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.02 98.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.276 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -56.7 18.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.049 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.566 HD13 ' H ' ' B' ' 27' ' ' LEU 0.361 0.0 OUTLIER -69.45 -19.46 63.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 118.454 -1.298 . . . . 0.0 114.087 -178.714 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.5 m -72.04 -45.92 58.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.127 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.87 -40.12 91.35 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.215 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' B' ' 96' ' ' LYS . 95.3 mt -57.16 -42.05 80.34 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.638 0.586 . . . . 0.0 111.888 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -92.64 1.83 57.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.898 0.38 . . . . 0.0 111.685 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -95.79 -37.04 10.93 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.002 0.429 . . . . 0.0 110.074 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.66 -18.58 0.29 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 119.803 -1.189 . . . . 0.0 112.802 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.22 99.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.453 0.644 . . . . 0.0 109.362 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 20.3 p -79.75 -17.26 53.91 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.49 -176.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.96 112.36 10.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.766 0.317 . . . . 0.0 110.454 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.567 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -120.01 161.12 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.272 -177.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 41.5 t -128.81 123.21 58.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.066 0.46 . . . . 0.0 110.484 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.57 122.06 55.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.152 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.4 119.31 33.56 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -111.53 146.57 37.08 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.553 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' B' ' 89' ' ' THR . 74.0 mtp180 -120.64 142.72 49.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.5 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 -129.12 12.33 Favored Glycine 0 C--N 1.303 -1.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.851 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -89.47 8.24 31.96 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.017 0.437 . . . . 0.0 111.005 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.67 -1.64 57.38 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.228 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.416 HG23 HG21 ' B' ' 90' ' ' ILE . 68.5 mt -54.65 -37.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.337 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.19 -32.17 73.5 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.588 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -78.84 -31.16 45.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.831 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -64.27 -45.76 86.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.242 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.45 -35.65 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.484 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.7 t70 -59.59 -50.19 74.86 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -52.02 -54.87 24.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.305 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.67 -21.35 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.514 ' HG2' HH21 ' A' ' 86' ' ' ARG . 30.2 tt0 -75.97 -37.12 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.421 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.484 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.1 mt -61.86 -49.73 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.846 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.95 -42.39 71.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' B' ' 61' ' ' LEU . 56.4 mtm180 -73.53 6.32 3.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.861 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' ASN . . . . . 0.433 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 63.1 t30 -139.21 16.09 2.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.85 0.833 . . . . 0.0 109.589 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.39 -64.46 0.94 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.13 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -105.23 -37.14 6.99 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.303 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 94.8 mt -132.26 103.49 6.26 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.127 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 -74.1 0.61 Allowed 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.125 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.22 5.14 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.141 0.496 . . . . 0.0 110.09 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -111.96 24.91 12.13 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.026 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -148.91 154.43 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.78 164.16 24.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.362 0.601 . . . . 0.0 111.143 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.67 138.69 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -89.96 -60.85 1.82 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.91 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -166.54 144.9 5.39 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.759 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.2 mt -128.67 119.76 50.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -127.06 138.6 53.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.382 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.25 129.58 74.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.93 -164.95 11.86 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.063 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 29.3 p -131.55 109.55 10.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -86.35 130.86 34.36 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.317 -0.839 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.567 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.426 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 53.2 mtm180 . . . . . 0 N--CA 1.422 -1.825 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.35 117.51 51.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -60.96 125.75 24.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 123.833 0.708 . . . . 0.0 109.232 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.527 HG22 ' HG2' ' B' ' 42' ' ' ARG . 25.6 p -128.26 148.85 50.66 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.201 0.524 . . . . 0.0 112.074 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.416 HG21 HG23 ' B' ' 46' ' ' ILE . 14.4 tt -127.73 132.1 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.53 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.29 107.13 15.17 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.1 mt -105.68 113.45 42.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.536 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.37 132.7 56.53 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -136.9 152.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' B' ' 35' ' ' SER . 12.6 ptp180 -131.53 156.62 45.39 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 120.915 0.388 . . . . 0.0 110.983 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' B' ' 30' ' ' LEU . 0.0 OUTLIER -125.79 118.15 24.93 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -176.014 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 mttm . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.251 174.053 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.883 0.373 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 71.6 t -102.11 113.21 37.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -102.92 135.45 40.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.023 0.439 . . . . 0.0 110.811 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.71 119.3 37.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.458 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 52.0 mt -90.58 116.48 31.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.145 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.76 41.59 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.896 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -161.04 -55.35 0.05 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.335 0.567 . . . . 0.0 111.715 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -99.98 159.33 30.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.887 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.43 156.0 33.2 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.902 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.4 -35.87 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.144 0.978 . . . . 0.0 112.611 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.415 ' HG3' HD22 ' A' ' 21' ' ' ASN . 26.9 ptt? -64.13 -24.71 67.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.415 HD22 ' HG3' ' A' ' 20' ' ' MET . 0.9 OUTLIER -73.44 -28.1 61.79 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 99.7 m-85 -83.82 -33.01 25.01 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.833 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 61.2 t -59.72 -52.74 57.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-O 121.314 0.578 . . . . 0.0 109.857 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.92 -30.02 70.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.011 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -47.91 75.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.64 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.07 98.2 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.356 0.41 . . . . 0.0 110.577 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 96.0 mt -62.5 -42.4 99.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.022 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.1 m -66.61 -36.46 82.67 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.499 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -71.92 -27.49 62.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.678 0.275 . . . . 0.0 111.091 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -65.75 -36.85 84.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.057 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.77 -19.44 65.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.315 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -85.58 -5.64 59.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.45 -7.68 40.02 Favored Glycine 0 C--O 1.242 0.651 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.156 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.15 100.8 11.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.406 0.622 . . . . 0.0 109.701 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.451 ' HA ' HD22 ' A' ' 30' ' ' LEU . 33.8 p -87.22 -25.25 24.11 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.631 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.85 105.25 14.01 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.08 0.552 . . . . 0.0 109.626 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -123.1 163.36 22.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.616 0.246 . . . . 0.0 111.183 -176.382 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -126.85 122.37 60.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.29 0.567 . . . . 0.0 110.927 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.18 128.69 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.4 123.4 36.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.53 0.681 . . . . 0.0 110.472 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.68 148.21 41.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HG2' HG22 ' A' ' 89' ' ' THR . 67.9 mtm180 -128.29 147.59 50.61 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.212 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.88 -135.83 17.65 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -89.57 9.63 26.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.092 0.472 . . . . 0.0 110.995 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 14' ' ' ILE . . . -84.23 -2.61 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -53.22 -36.26 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -61.57 -28.93 69.69 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.602 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB2' HG21 ' A' ' 14' ' ' ILE . 60.8 mttm -84.53 -27.78 27.13 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.918 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.77 93.18 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.7 p -73.47 -29.29 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.116 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.448 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.1 t70 -71.28 -43.99 66.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 m -58.68 -50.22 74.68 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.85 -28.64 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.734 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -50.31 70.54 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 51' ' ' ASP . 72.2 mt -58.99 -44.25 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.28 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.34 -36.11 70.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -93.83 -2.43 53.53 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.771 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -123.84 12.18 9.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.891 0.853 . . . . 0.0 110.267 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.78 -50.16 0.83 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -85.83 -66.4 0.9 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.1 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.1 mt -144.91 115.09 7.5 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.99 -34.32 11.82 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 124.165 0.916 . . . . 0.0 110.5 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -76.4 -19.22 58.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.69 71.76 1.18 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.966 0.412 . . . . 0.0 110.775 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -161.86 152.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.88 154.33 46.11 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.65 136.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -90.0 -58.67 2.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.193 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.49 151.33 7.83 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.8 122.79 14.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -132.19 145.38 51.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.64 143.12 23.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.76 -157.25 19.65 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.554 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -110.11 135.67 50.55 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.703 0.287 . . . . 0.0 110.301 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -119.42 130.26 55.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 C--N 1.312 -1.033 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.914 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 . . . . . 0 N--CA 1.438 -1.041 0 CA-C-O 120.8 0.333 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.52 140.96 43.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.4 m -73.01 131.06 41.67 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.437 HG22 ' HG2' ' A' ' 42' ' ' ARG . 40.5 p -132.13 147.09 52.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -129.76 138.04 55.17 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.46 109.46 14.87 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.62 124.27 69.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.871 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.39 37.13 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 120.599 0.238 . . . . 0.0 110.81 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 pt -125.26 151.17 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 35' ' ' SER . 25.4 ptt180 -138.63 147.43 42.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 122.035 0.921 . . . . 0.0 113.451 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 21.6 mmtm . . . . . 0 C--N 1.303 -1.423 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.663 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 . . . . . 0 CA--C 1.512 -0.507 0 CA-C-O 121.267 0.556 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 67.8 t -100.09 112.99 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -103.13 133.6 46.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.69 116.65 30.31 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.66 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.492 ' HA ' ' CZ ' ' B' ' 22' ' ' TYR . 50.4 mt -88.23 116.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.462 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.69 35.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.791 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -156.12 -54.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.235 0.517 . . . . 0.0 112.197 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.402 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 54.1 mtmt -99.64 157.32 34.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.28 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 156.25 22.94 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.844 2.363 . . . . 0.0 112.696 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.413 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.2 p -52.94 -33.87 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.162 0.985 . . . . 0.0 112.881 -176.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -63.76 -25.58 68.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.663 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -72.76 -33.83 66.6 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' TYR . . . . . 0.492 ' CZ ' ' HA ' ' B' ' 14' ' ' ILE . 99.7 m-85 -77.92 -33.28 51.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.62 -54.37 36.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.086 0.469 . . . . 0.0 109.964 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.88 -29.82 70.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.429 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.29 -46.3 80.99 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.518 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.16 97.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.456 0.473 . . . . 0.0 110.719 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.45 -41.88 97.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.3 m -64.76 -37.63 88.26 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.928 0.394 . . . . 0.0 110.403 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.98 -27.78 62.99 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.404 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' B' ' 35' ' ' SER . 0.5 OUTLIER -64.68 -38.9 92.56 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.87 -22.7 67.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.618 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.76 -10.77 59.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.118 0.485 . . . . 0.0 110.605 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.5 -13.01 20.96 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.139 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.49 100.99 8.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.076 0.465 . . . . 0.0 110.344 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' SER . . . . . 0.423 ' HA ' HD22 ' B' ' 30' ' ' LEU . 33.7 p -84.05 -29.35 26.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.845 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.49 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 39.3 tt0 -107.68 111.53 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.491 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -127.3 162.51 32.35 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.139 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 43.4 t -124.95 123.09 64.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.644 0.735 . . . . 0.0 111.254 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.18 128.54 54.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -127.96 125.15 38.95 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.275 0.56 . . . . 0.0 110.208 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.24 147.75 43.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' B' ' 89' ' ' THR . 53.9 mtm180 -127.5 146.24 50.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.96 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.9 -135.19 15.07 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.794 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -91.47 9.57 31.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.411 0.624 . . . . 0.0 111.036 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.44 ' HB1' HG22 ' B' ' 14' ' ' ILE . . . -83.77 -2.12 55.64 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.354 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.8 mt -53.55 -36.43 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-O 121.624 0.726 . . . . 0.0 109.901 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -60.73 -34.93 75.15 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.039 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -79.33 -30.58 42.81 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.346 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.85 92.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.369 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.21 -33.37 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.088 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.445 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.2 t70 -65.51 -45.4 83.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.116 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.0 m -57.45 -50.7 72.18 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.95 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.45 -30.36 48.67 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.575 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -50.08 73.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.4 mt -58.04 -45.71 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.219 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.03 -34.53 60.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.134 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -94.03 0.01 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -126.8 11.32 7.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.791 0.805 . . . . 0.0 110.23 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -134.85 -49.06 0.75 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.91 -67.07 0.83 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.57 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.481 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 96.0 mt -144.77 115.97 7.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.83 -39.03 10.03 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.903 0.752 . . . . 0.0 110.198 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.69 -13.65 61.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.094 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.92 71.44 1.47 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.767 0.318 . . . . 0.0 111.201 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.402 HD12 ' NZ ' ' B' ' 96' ' ' LYS . 17.7 tt -162.24 156.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -145.6 154.35 42.05 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.15 137.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -90.13 -56.41 3.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.337 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -170.17 153.16 4.44 Favored 'General case' 0 C--O 1.251 1.172 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.98 127.0 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -134.8 144.37 47.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.53 143.09 23.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.8 -158.85 22.88 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.759 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -111.86 131.58 55.27 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -114.69 131.96 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.693 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t . . . . . 0 C--N 1.308 -1.237 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.669 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 . . . . . 0 N--CA 1.438 -1.03 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -122.01 139.22 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -72.85 128.06 34.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.422 HG22 ' HG2' ' B' ' 42' ' ' ARG . 40.8 p -129.39 147.48 51.22 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -175.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.69 138.21 54.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.66 109.3 14.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.95 123.89 69.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.65 122.79 44.51 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -126.99 150.03 32.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.49 ' HD3' ' OE1' ' B' ' 36' ' ' GLU . 23.8 ptt180 -137.09 150.51 48.06 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 20.9 mmtm -93.49 -170.91 2.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.18 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.416 ' HB2' ' NZ ' ' B' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.16 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--O 1.239 0.503 0 CA-C-O 121.596 0.712 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.19 120.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -110.82 145.76 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.264 0.554 . . . . 0.0 111.112 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.79 132.63 51.68 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.075 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -89.66 102.31 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 16' ' ' LYS . . . 178.86 55.55 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 118.229 -1.938 . . . . 0.0 115.551 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 53.8 tttm 178.07 -42.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.472 0.636 . . . . 0.0 110.69 171.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -92.39 159.82 36.19 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.243 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.82 162.15 40.02 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.152 1.901 . . . . 0.0 111.308 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.408 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.4 p -54.77 -41.39 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -59.95 -30.19 68.91 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.738 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -72.29 -34.4 68.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.067 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -73.01 -33.18 65.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.65 -55.83 21.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.101 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.52 -27.3 69.06 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.684 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.01 77.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.907 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.31 98.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.294 0.371 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.04 -33.18 75.21 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.47 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.8 m -64.4 -36.73 85.11 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.441 0.639 . . . . 0.0 109.738 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.82 -35.51 72.51 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.7 mt -58.43 -42.58 87.63 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.167 0.508 . . . . 0.0 110.239 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -66.79 -23.76 66.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.892 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -87.65 -2.68 58.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.7 8.93 47.75 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.07 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.38 94.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 m -85.69 -22.6 27.78 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.633 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -109.7 107.45 17.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.47 142.05 36.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -116.1 123.91 71.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.013 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.03 123.92 62.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 85.7 mttt -120.18 124.02 44.71 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.491 0.662 . . . . 0.0 109.834 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.34 160.04 21.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.457 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -131.37 145.09 51.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.278 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' O ' HG13 ' A' ' 46' ' ' ILE . . . 69.57 -127.8 20.36 Favored Glycine 0 N--CA 1.433 -1.552 0 O-C-N 123.533 0.52 . . . . 0.0 112.445 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.23 0.02 56.58 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.38 . . . . 0.0 111.35 -176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.74 2.06 27.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.134 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 43' ' ' GLY . 75.1 mt -57.25 -40.89 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.463 0.649 . . . . 0.0 109.698 175.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.3 t -70.66 -16.44 62.81 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.954 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -89.83 -33.97 16.3 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.56 89.45 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.128 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 13.7 p -67.76 -43.32 86.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.556 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.9 t70 -54.83 -44.51 73.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.6 m -57.96 -53.55 57.0 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.983 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.54 -30.14 46.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 50' ' ' VAL . 46.4 mt-10 -60.19 -47.93 83.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 123.401 0.438 . . . . 0.0 110.286 174.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.2 mt -60.6 -40.62 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 121.232 0.539 . . . . 0.0 110.62 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.93 -27.51 42.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 CA-C-O 121.14 0.495 . . . . 0.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -100.96 2.63 40.89 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -116.45 9.78 14.42 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.198 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -139.1 -71.24 0.4 Allowed 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.419 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 74.4 t80 -60.5 -64.49 0.93 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.131 0.491 . . . . 0.0 110.842 -174.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.473 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.0 mt -141.28 113.62 8.1 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.27 -35.69 10.66 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 124.161 0.913 . . . . 0.0 110.175 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.1 -45.85 59.01 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.073 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.66 97.65 8.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.591 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.466 HD13 ' HZ2' ' A' ' 96' ' ' LYS . 7.2 tp -158.63 138.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.266 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.617 ' HG2' HH21 ' A' ' 95' ' ' ARG . 7.9 tp10 -124.74 149.98 46.71 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tp -107.52 137.19 39.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -100.54 -53.64 3.04 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.542 -1.263 . . . . 0.0 111.511 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 71' ' ' ARG . 35.6 tt0 -170.53 144.81 2.47 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.1 mt -135.49 119.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.498 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 21.9 mtm180 -128.92 136.61 50.62 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.39 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.58 119.0 58.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.98 167.62 34.87 Favored Glycine 0 C--N 1.303 -1.287 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.631 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 m -85.87 118.65 25.49 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 5.9 tp60 -95.64 131.87 41.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.437 -1.078 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.901 -179.728 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 . . . . . 0 N--CA 1.439 -1.013 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.57 130.23 72.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.696 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.54 118.43 7.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.5 p -125.86 155.16 41.63 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.427 -0.171 . . . . 0.0 111.069 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 14.4 tt -136.99 131.27 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.12 110.99 21.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.32 118.32 57.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.0 117.93 30.56 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 123.298 0.374 . . . . 0.0 110.332 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.6 pt -114.87 158.37 15.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.617 HH21 ' HG2' ' A' ' 66' ' ' GLU . 34.4 ttp180 -130.39 111.79 12.66 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.207 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 26.8 mmtm . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.559 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.821 0.343 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.46 119.96 63.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.46 142.05 24.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.192 0.52 . . . . 0.0 111.585 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.33 131.83 51.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.879 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -89.57 99.95 10.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.16 43.63 0.16 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 117.935 -2.079 . . . . 0.0 116.112 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -173.83 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.456 1.128 . . . . 0.0 110.444 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -91.59 160.87 35.67 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.395 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.66 164.09 34.47 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.133 1.888 . . . . 0.0 110.929 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.464 HG23 ' OG1' ' B' ' 52' ' ' THR . 8.4 p -57.24 -37.37 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.118 0.567 . . . . 0.0 111.738 -176.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -64.07 -29.36 70.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.662 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -73.97 -34.94 64.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -70.7 -34.03 71.53 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.799 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.46 -55.16 26.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.429 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.7 -28.69 70.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.53 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.413 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.43 -43.07 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.184 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.17 99.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.124 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.6 -34.73 78.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.806 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.0 m -64.88 -36.3 83.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.137 0.494 . . . . 0.0 110.11 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -69.91 -36.94 75.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.558 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.42 HD23 ' O ' ' B' ' 34' ' ' VAL . 95.2 mt -57.31 -43.42 83.26 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.056 0.455 . . . . 0.0 110.346 177.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.802 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -87.65 -0.87 57.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.158 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.74 13.85 36.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.041 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.42 ' O ' HD23 ' B' ' 30' ' ' LEU . 32.5 t -101.08 92.97 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -82.9 -24.34 33.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.151 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -109.06 109.32 20.31 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.448 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -122.44 142.76 37.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.27 179.229 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.02 125.08 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.36 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -107.51 123.87 63.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -120.51 123.2 42.36 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.56 161.73 18.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -132.76 145.72 51.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.941 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.4 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 68.35 -127.88 24.2 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 123.451 0.47 . . . . 0.0 112.654 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.35 -0.77 57.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.022 0.439 . . . . 0.0 111.778 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.88 1.98 25.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.4 HG13 ' O ' ' B' ' 43' ' ' GLY . 73.3 mt -58.14 -41.17 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.69 0.757 . . . . 0.0 109.805 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 44.2 t -67.77 -22.14 65.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.405 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -84.84 -33.57 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.37 86.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.601 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' B' ' 54' ' ' GLU . 14.5 p -66.47 -44.07 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.4 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.486 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.1 t70 -56.55 -39.38 73.34 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.464 ' OG1' HG23 ' B' ' 19' ' ' VAL . 57.3 m -61.68 -52.62 63.55 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.98 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.48 -31.14 49.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.203 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' B' ' 50' ' ' VAL . 44.9 mt-10 -59.38 -45.9 90.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.626 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.486 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.9 mt -61.95 -40.64 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.894 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.84 -26.02 37.65 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.157 0.503 . . . . 0.0 111.59 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -100.75 0.52 39.01 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.864 -0.523 . . . . 0.0 111.914 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -116.41 12.75 15.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.182 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -137.89 -68.96 0.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.01 -62.7 1.47 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.868 0.366 . . . . 0.0 111.148 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.446 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.1 mt -142.8 115.12 8.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.01 -34.17 10.19 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 124.241 0.963 . . . . 0.0 109.968 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.5 -41.47 60.64 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.907 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -103.91 99.11 8.87 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.425 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.415 HD13 ' HZ2' ' B' ' 96' ' ' LYS . 7.0 tp -157.99 140.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.041 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.621 ' HG2' HH21 ' B' ' 95' ' ' ARG . 7.1 tp10 -125.83 146.82 49.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -105.44 134.53 46.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -98.85 -54.01 3.12 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.503 -1.279 . . . . 0.0 111.291 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLU . . . . . 0.401 ' OE2' ' HD3' ' B' ' 71' ' ' ARG . 29.3 tt0 -169.87 143.32 2.57 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.7 mt -131.89 118.81 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.401 ' HD3' ' OE2' ' B' ' 69' ' ' GLU . 25.6 mtm180 -127.55 137.25 52.56 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.582 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.55 117.23 51.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.16 165.77 33.89 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.515 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -84.44 115.98 22.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.45 0.7 . . . . 0.0 109.375 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -94.04 132.44 38.52 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.307 -1.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.644 -179.424 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 CA--C 1.498 -1.043 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -114.46 129.48 70.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -61.86 120.38 10.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.9 p -127.64 155.12 44.4 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.308 -0.245 . . . . 0.0 111.221 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -136.83 131.42 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.838 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.35 109.94 19.12 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 56.1 mt -110.88 117.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.95 118.83 34.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.193 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 pt -116.67 152.03 18.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.836 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.621 HH21 ' HG2' ' B' ' 66' ' ' GLU . 35.0 ttp180 -124.21 114.04 19.1 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 28.0 mmtm -80.24 146.8 31.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.861 174.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.385 0.428 . . . . 0.0 111.643 -177.347 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.492 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 120.898 0.38 . . . . 0.0 111.08 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.46 112.27 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.26 133.9 44.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.642 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -120.83 130.42 53.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.29 133.81 44.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.41 48.5 0.02 OUTLIER Glycine 0 C--N 1.348 1.196 0 C-N-CA 119.439 -1.363 . . . . 0.0 115.628 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -174.71 -51.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 118.04 0.92 . . . . 0.0 112.031 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.13 158.1 33.85 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.732 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 165.74 17.89 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.373 2.048 . . . . 0.0 111.417 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG21 ' OD2' ' A' ' 51' ' ' ASP . 11.6 p -53.06 -28.72 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 C-N-CA 124.353 1.061 . . . . 0.0 113.296 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.6 mtp -62.83 -29.74 70.96 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -71.07 -28.82 64.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.18 0.515 . . . . 0.0 109.64 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -89.62 -42.66 11.26 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.183 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 82.3 t -60.79 -49.82 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.787 0.327 . . . . 0.0 110.68 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.24 -19.79 64.76 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.984 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.406 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -77.37 -48.79 16.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.44 85.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 97.4 mt -60.3 -34.48 73.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.7 m -76.09 -40.95 51.91 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.0 mt -61.35 -38.56 87.37 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.1 -42.78 95.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.395 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.73 -16.38 45.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.918 0.39 . . . . 0.0 110.411 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -78.61 -34.12 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.29 -4.0 1.27 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.87 100.36 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -79.34 -21.11 46.3 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.151 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.38 121.48 22.38 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.261 0.553 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -126.36 158.63 36.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.503 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.86 122.02 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.4 mt -105.45 121.1 57.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 99.6 mttt -108.34 141.25 40.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -133.38 157.4 45.62 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -133.98 135.09 43.23 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 46' ' ' ILE . . . 67.59 -135.01 30.72 Favored Glycine 0 C--O 1.212 -1.237 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.683 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -74.12 -2.45 24.6 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.35 -9.97 59.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.488 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 43' ' ' GLY . 78.7 mt -53.35 -33.87 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.272 0.629 . . . . 0.0 110.797 178.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 p -63.07 -30.6 71.72 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.095 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -86.98 -25.85 24.09 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.374 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -63.29 -48.38 78.34 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.41 0.624 . . . . 0.0 109.984 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.1 -38.18 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.406 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.4 t70 -59.8 -47.99 83.49 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.518 0.511 . . . . 0.0 109.732 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 56' ' ' VAL . 95.2 m -55.82 -54.26 46.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.193 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.31 -31.0 49.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.278 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 26.6 tt0 -67.87 -37.6 82.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.275 0.359 . . . . 0.0 110.531 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 68.9 mt -64.89 -47.97 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 52' ' ' THR . 61.4 t -58.17 -52.71 55.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.449 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -66.63 -13.51 61.24 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -116.64 2.32 12.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 15.8 ptm180 -117.78 -34.44 4.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.127 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -90.1 -58.85 2.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.697 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' A' ' 64' ' ' LYS . 47.2 tp -155.84 109.49 2.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 -6.04 28.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.443 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -87.95 -41.92 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.006 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 67.2 mttm -124.43 99.01 6.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -155.2 145.34 13.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.5 148.24 50.5 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.166 0.508 . . . . 0.0 110.131 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.2 mt -102.91 133.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -92.85 -51.42 5.09 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.967 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -160.55 141.36 11.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.2 99.89 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 123.132 0.573 . . . . 0.0 110.388 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.22 153.95 51.76 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.775 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.08 135.95 42.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.27 -165.69 15.5 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.189 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -100.27 128.73 46.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.076 0.55 . . . . 0.0 109.874 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -108.15 112.41 24.92 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 86' ' ' ARG . 21.9 t . . . . . 0 C--N 1.313 -0.984 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.403 ' HG2' HG22 ' A' ' 76' ' ' VAL . 46.1 mtm180 . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.19 133.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.7 t -66.02 134.88 53.82 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.352 0.596 . . . . 0.0 110.915 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.2 p -132.14 160.34 36.31 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.161 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 18.5 tt -140.78 135.58 34.14 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -111.38 115.79 29.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.64 112.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 123.96 50.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.496 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.6 pt -125.85 152.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.166 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -130.05 124.51 33.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.894 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.497 ' N ' HD21 ' B' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.735 0 CA-C-O 120.781 0.324 . . . . 0.0 110.841 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.92 111.51 30.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.69 131.63 47.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.983 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -118.27 127.18 53.48 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.8 mt -99.76 133.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 48.31 0.02 OUTLIER Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.496 -1.335 . . . . 0.0 115.446 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -172.95 -50.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.868 0.834 . . . . 0.0 112.598 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.416 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 32.0 mmmt -99.64 158.52 32.0 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 122.241 -0.287 . . . . 0.0 110.806 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.91 164.26 22.46 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.557 2.171 . . . . 0.0 111.173 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.476 HG21 ' OD1' ' B' ' 51' ' ' ASP . 13.4 p -52.43 -27.23 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 123.994 0.918 . . . . 0.0 113.326 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 92.9 mtp -65.14 -27.17 68.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -72.9 -26.23 61.35 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.409 0.623 . . . . 0.0 109.625 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' TYR . . . . . 0.416 ' HE2' ' O ' ' B' ' 17' ' ' LYS . 90.1 m-85 -93.42 -42.84 9.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.101 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.453 HG23 HG22 ' B' ' 19' ' ' VAL . 99.0 t -60.8 -49.56 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 121.345 0.593 . . . . 0.0 110.432 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mp -67.46 -24.18 65.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.79 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.11 -45.92 46.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.19 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.75 97.69 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.932 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 98.8 mt -60.33 -38.09 82.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.153 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.1 m -70.19 -43.62 70.38 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -60.18 -39.05 85.13 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -41.34 89.53 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.522 0.514 . . . . 0.0 111.168 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -85.37 -15.05 44.45 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.312 0.577 . . . . 0.0 110.164 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -79.21 -36.42 40.13 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.528 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.26 -3.9 0.92 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.638 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -97.99 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 117.511 0.656 . . . . 0.0 109.389 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -78.29 -21.78 49.21 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.963 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.23 118.32 19.36 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.174 0.511 . . . . 0.0 111.092 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.533 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -124.95 159.25 31.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.923 -176.323 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.67 121.49 60.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.029 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -104.94 122.66 58.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 99.3 mttt -110.47 139.24 45.88 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 123.65 0.594 . . . . 0.0 109.979 177.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -132.61 154.92 49.58 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -132.22 134.0 44.81 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.42 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 70.28 -135.53 25.78 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.691 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.6 -2.83 27.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.47 57.98 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.539 0.209 . . . . 0.0 111.275 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.42 HG13 ' O ' ' B' ' 43' ' ' GLY . 77.7 mt -52.96 -35.63 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.479 0.657 . . . . 0.0 110.43 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 53.4 p -62.35 -35.71 79.95 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.92 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -81.61 -26.81 34.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -62.47 -47.77 82.54 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.25 0.548 . . . . 0.0 110.613 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.66 -38.06 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.661 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.476 ' OD1' HG21 ' B' ' 19' ' ' VAL . 13.3 t70 -57.58 -49.92 74.82 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.418 ' O ' HG23 ' B' ' 56' ' ' VAL . 90.1 m -54.2 -54.3 41.79 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.473 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.0 m -69.3 -30.63 46.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.551 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.447 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 25.8 tt0 -68.11 -37.42 81.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 123.302 0.376 . . . . 0.0 110.71 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' B' ' 59' ' ' ARG . 73.7 mt -64.56 -48.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 52' ' ' THR . 58.8 t -57.7 -53.69 41.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 32.2 ptt180 -65.77 -9.69 30.55 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -120.04 -1.24 10.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 15.5 ptm180 -115.18 -33.79 5.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.166 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -89.41 -59.69 2.15 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.704 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' B' ' 64' ' ' LYS . 46.1 tp -153.94 107.74 2.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.87 -1.61 39.73 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.064 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -92.63 -50.75 5.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.918 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.413 ' HB2' HD21 ' B' ' 61' ' ' LEU . 66.3 mttm -115.22 96.65 5.78 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.817 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -152.14 146.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -132.25 149.53 52.35 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -105.69 132.33 52.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -91.72 -50.28 5.83 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.866 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -163.55 143.24 8.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.566 0.541 . . . . 0.0 109.602 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -143.96 98.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.742 0.817 . . . . 0.0 110.269 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -132.91 153.28 51.53 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.397 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.45 137.42 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.65 -169.88 25.57 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.667 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -93.73 137.17 33.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -115.42 116.33 28.05 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' B' ' 86' ' ' ARG . 26.3 t . . . . . 0 C--N 1.308 -1.225 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' B' ' 76' ' ' VAL . 52.3 mtm180 . . . . . 0 CA--C 1.505 -0.777 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.65 135.97 58.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.5 t -69.59 135.98 50.67 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.875 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.03 159.55 38.47 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.491 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 19.2 tt -139.08 135.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.84 113.33 25.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.0 113.49 44.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.15 122.14 44.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 32.7 pt -124.11 149.17 28.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.204 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -127.33 127.57 44.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.988 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 0.7 OUTLIER -78.59 136.74 37.59 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.459 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 27.5 mtpp . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.4 p30 . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 22.9 m -102.38 130.83 51.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.583 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.89 142.45 40.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.526 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.39 129.19 52.34 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.34 113.06 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.935 0.397 . . . . 0.0 111.269 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.08 -161.3 25.51 Favored Glycine 0 C--O 1.253 1.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.322 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.23 5.18 8.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -82.16 158.47 66.91 Favored Pre-proline 0 CA--C 1.547 0.854 0 O-C-N 122.154 -0.341 . . . . 0.0 111.093 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.18 153.81 67.11 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.101 2.534 . . . . 0.0 113.475 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.507 HG21 ' OD1' ' A' ' 51' ' ' ASP . 7.1 p -54.76 -39.91 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.06 0.944 . . . . 0.0 113.356 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -55.55 -30.58 61.01 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.33 -39.49 92.49 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.007 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -80.97 -34.31 33.2 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.14 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 19' ' ' VAL . 57.4 t -59.2 -49.97 81.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.065 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.14 -34.66 78.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.58 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -50.6 65.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.07 86.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.237 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.25 -41.17 97.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.7 m -62.6 -38.55 90.62 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 88.6 mt -64.25 -38.58 91.54 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.65 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.99 -48.85 78.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.812 0.695 . . . . 0.0 110.536 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -79.38 -12.83 59.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.198 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -79.98 -25.85 40.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.99 -12.47 3.88 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.799 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.98 93.06 3.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.292 0.568 . . . . 0.0 109.479 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -87.65 18.4 4.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -155.73 110.34 2.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.473 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -130.33 160.64 41.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.342 -175.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.3 t -124.59 122.76 64.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.332 0.587 . . . . 0.0 110.662 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -100.93 129.32 52.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.0 119.68 36.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.096 0.474 . . . . 0.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -113.74 153.21 29.4 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -142.86 137.56 29.66 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.535 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.48 -130.83 10.26 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -95.18 10.06 37.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.077 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.56 2.02 49.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.934 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.405 HG23 HG21 ' A' ' 90' ' ' ILE . 73.9 mt -57.31 -43.28 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.149 0.579 . . . . 0.0 111.282 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.3 p -66.6 -24.81 66.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.689 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.62 -30.71 52.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.5 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -70.67 -43.77 68.43 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.325 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.85 -33.29 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.075 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' OD1' HG21 ' A' ' 19' ' ' VAL . 18.0 t70 -58.97 -50.36 74.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.4 m -53.61 -52.76 58.8 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.105 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.8 m -70.31 -36.27 66.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.73 -29.08 68.96 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 121.493 0.663 . . . . 0.0 109.43 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.5 mt -69.57 -48.75 64.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 122.003 -0.435 . . . . 0.0 110.626 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -59.84 -36.31 65.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 120.946 0.403 . . . . 0.0 111.348 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 6.1 ptm180 -82.08 0.81 38.87 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -115.29 -45.77 2.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.884 0.373 . . . . 0.0 111.544 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 16.2 ptm180 -72.85 -28.36 62.48 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -105.62 -72.53 0.71 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.231 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.507 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 96.0 mt -142.2 116.52 9.55 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -93.15 -37.57 12.04 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 124.497 1.123 . . . . 0.0 110.42 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.7 -40.33 92.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.79 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -108.12 99.44 8.88 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 121.191 0.519 . . . . 0.0 111.364 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.42 132.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.454 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.49 136.96 53.9 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -99.48 130.05 49.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -80.04 -55.82 4.68 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -171.32 147.3 2.44 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.71 123.92 55.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -122.43 139.93 53.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.039 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -132.57 125.45 53.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.28 25.78 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.494 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 88' ' ' SER . 50.1 m -115.38 129.05 56.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 117.278 0.539 . . . . 0.0 111.082 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 53.5 tt0 -93.18 141.63 28.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.122 0.969 . . . . 0.0 108.543 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.481 HG22 ' HG2' ' A' ' 86' ' ' ARG . 22.4 t . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 98.1 mtt180 . . . . . 0 CA--C 1.513 -0.451 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -134.75 139.22 47.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 19.2 m -72.35 136.65 46.21 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.556 0.743 . . . . 0.0 112.436 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.448 HG21 ' OE1' ' A' ' 75' ' ' GLN . 80.9 p -129.15 170.73 13.18 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.909 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.405 HG21 HG23 ' A' ' 46' ' ' ILE . 13.7 tt -146.93 123.78 3.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.477 176.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.14 113.49 26.8 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.03 115.51 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.19 121.14 42.06 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.574 0.225 . . . . 0.0 110.836 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.81 148.32 25.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.636 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.43 147.63 40.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.137 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 4.4 mmtm . . . . . 0 C--N 1.294 -1.818 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.505 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 p30 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.87 133.12 48.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.078 0.466 . . . . 0.0 111.493 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.67 143.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.553 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 56.8 tp -106.52 125.65 51.26 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.87 116.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 120.996 0.426 . . . . 0.0 111.099 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.98 -158.8 22.38 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.201 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -79.28 4.17 15.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.02 158.53 67.2 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 122.346 -0.222 . . . . 0.0 110.661 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.69 153.93 68.84 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.214 2.61 . . . . 0.0 113.214 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.502 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.3 p -54.53 -39.8 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.346 1.058 . . . . 0.0 113.394 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -57.56 -27.26 62.5 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.95 -36.74 80.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -83.19 -35.46 25.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.415 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 19' ' ' VAL . 82.1 t -58.38 -50.95 76.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.876 178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.22 -36.51 84.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.6 -48.09 78.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.832 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.08 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.925 0.393 . . . . 0.0 111.088 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.54 -41.76 98.43 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.9 m -61.16 -39.62 90.8 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.521 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.3 mt -63.51 -38.69 92.1 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.59 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.3 -46.02 86.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.138 0.494 . . . . 0.0 110.696 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.83 -7.51 59.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -84.87 -25.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.81 -15.71 3.31 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.612 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.65 94.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.169 0.509 . . . . 0.0 109.93 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -90.48 19.04 5.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.962 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -155.25 107.84 2.72 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.505 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.15 158.74 41.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -174.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.19 121.72 62.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.508 0.67 . . . . 0.0 111.015 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.77 129.03 50.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.92 122.74 44.09 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.26 0.552 . . . . 0.0 110.777 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -116.77 154.34 30.85 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -142.94 136.03 28.14 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.542 0.526 . . . . 0.0 110.35 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.33 -132.92 11.46 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -93.48 13.56 21.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 110.267 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.95 1.41 56.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.27 -43.78 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.305 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -65.92 -24.25 66.79 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.955 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -79.6 -32.2 41.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.035 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -68.29 -44.18 76.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.08 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.51 -33.91 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.113 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.502 ' OD1' HG21 ' B' ' 19' ' ' VAL . 13.7 t70 -58.51 -49.28 77.95 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -54.58 -51.78 64.19 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.908 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.45 -37.11 69.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -66.97 -30.52 70.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.304 0.573 . . . . 0.0 109.58 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.7 mt -67.33 -49.18 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.106 -0.371 . . . . 0.0 110.649 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.28 -39.42 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.794 0.331 . . . . 0.0 111.542 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' B' ' 62' ' ' ALA . 7.6 ptm180 -79.82 -1.98 41.37 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -110.79 -43.8 3.75 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.769 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -75.16 -34.27 61.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -99.96 -69.15 0.78 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.851 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.529 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.9 mt -144.97 116.6 8.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -93.21 -38.06 11.75 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 124.501 1.125 . . . . 0.0 110.789 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.365 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -108.53 100.14 9.44 Favored 'General case' 0 C--O 1.253 1.254 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.0 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tp -160.18 130.01 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.638 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.15 135.05 53.22 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.73 131.61 45.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' B' ' 68' ' ' LYS . 9.5 tmtt? -83.26 -56.41 3.78 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -170.89 146.22 2.5 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -130.45 123.61 55.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -121.23 140.41 52.07 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.607 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.22 125.67 51.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' B' ' 88' ' ' SER . . . -165.11 -171.46 31.37 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.001 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 88' ' ' SER . 49.0 m -111.0 125.77 54.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.101 0.451 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 53.3 tt0 -89.81 141.9 28.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.899 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.494 HG22 ' HG2' ' B' ' 86' ' ' ARG . 20.7 t . . . . . 0 C--N 1.313 -0.982 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 99.7 mtt180 . . . . . 0 CA--C 1.502 -0.903 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 135.63 56.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 74' ' ' SER . 20.1 m -68.08 137.17 54.77 Favored 'General case' 0 C--O 1.261 1.693 0 C-N-CA 123.708 0.803 . . . . 0.0 112.193 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.444 HG21 ' OE1' ' B' ' 75' ' ' GLN . 68.4 p -129.42 171.01 12.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.472 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.57 123.03 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.952 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.81 113.36 26.71 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -110.96 116.39 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.36 120.38 40.16 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.059 0.457 . . . . 0.0 110.922 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -120.69 143.8 31.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -110.78 147.61 34.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.284 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.529 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 3.3 mmtm -128.81 136.06 49.98 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 122.733 0.413 . . . . 0.0 111.802 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? . . . . . 0 C--O 1.258 1.504 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -178.992 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.465 0.304 0 CA-C-O 121.437 0.637 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.75 148.43 8.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.14 135.03 58.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 120.915 0.388 . . . . 0.0 110.606 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.34 132.35 40.47 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.439 HG21 ' HB2' ' A' ' 48' ' ' LYS . 49.4 mm -94.54 111.16 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.712 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.27 0.02 OUTLIER Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.374 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -135.86 -76.37 0.44 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.052 0.426 . . . . 0.0 110.529 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -99.39 169.38 8.22 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.198 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.36 161.74 16.22 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.355 2.037 . . . . 0.0 112.239 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -51.37 -30.87 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.076 1.35 . . . . 0.0 113.591 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptp -62.85 -26.91 68.99 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.33 -31.35 58.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.148 0.499 . . . . 0.0 109.952 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.81 -36.36 50.33 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.9 t -61.13 -50.85 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.011 0.434 . . . . 0.0 109.903 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.71 -26.49 64.37 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.89 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.9 -44.81 72.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.693 0.282 . . . . 0.0 110.287 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.45 -24.4 67.16 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 90.1 mt -77.89 -45.73 23.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.145 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -63.64 -34.95 78.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.177 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 87.6 mt -61.63 -35.06 76.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 111.385 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.62 -31.07 71.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.493 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.75 -23.2 65.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -79.81 -15.82 56.69 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.984 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.66 -12.01 18.38 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.912 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.42 106.95 15.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.956 0.884 . . . . 0.0 112.049 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.1 p -87.82 -31.18 19.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.007 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 44.5 mt-10 -103.67 107.81 18.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.016 0.436 . . . . 0.0 109.837 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -129.83 157.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.291 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.2 t -126.92 124.1 63.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.119 0.485 . . . . 0.0 111.002 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.26 126.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -123.32 119.08 29.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.168 0.509 . . . . 0.0 110.141 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.5 156.59 27.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.632 ' HG2' HG22 ' A' ' 89' ' ' THR . 44.1 mtp180 -134.77 147.17 49.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.024 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.28 -134.81 20.19 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -85.1 5.84 28.07 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.392 -0.475 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.38 -3.5 52.95 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -57.37 -32.63 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.446 0.698 . . . . 0.0 110.009 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -61.39 -43.56 98.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.017 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 14' ' ' ILE . 99.7 mttt -67.6 -36.44 80.87 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.506 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.86 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.61 -36.3 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.953 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.571 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.3 t70 -62.43 -45.89 91.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.8 m -56.53 -53.66 54.95 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.48 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.03 -34.54 70.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.207 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.583 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 6.0 tp10 -65.75 -40.7 92.34 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 51' ' ' ASP . 75.8 mt -60.11 -42.99 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.016 0.436 . . . . 0.0 110.48 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.04 -44.68 95.36 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.229 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 2.5 ptm180 -80.03 -2.56 44.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.54 20.69 11.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.09 0.471 . . . . 0.0 111.728 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -139.43 -61.41 0.55 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.15 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -92.03 -54.72 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.527 -174.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 90.2 mt -119.03 107.26 13.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -98.25 -46.55 5.78 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.167 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.45 9.87 31.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -132.39 29.05 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.895 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.66 134.59 58.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' CD ' HH21 ' A' ' 95' ' ' ARG . 40.2 mt-10 -115.95 157.87 23.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.212 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -100.42 123.39 53.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -82.78 -61.82 1.77 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.992 0.425 . . . . 0.0 110.841 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.93 141.27 17.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.3 pt -130.12 121.56 51.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -132.98 144.74 50.32 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.63 144.83 18.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.77 171.72 28.21 Favored Glycine 0 C--N 1.318 -0.431 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 t -79.21 122.8 26.75 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.709 0.766 . . . . 0.0 110.477 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -99.23 122.2 42.09 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.325 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.459 HG22 ' HG3' ' A' ' 86' ' ' ARG . 44.2 t . . . . . 0 C--N 1.311 -1.081 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HG3' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.946 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.413 ' HB ' HH21 ' A' ' 42' ' ' ARG . 62.7 t -126.46 137.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 p -65.2 121.15 14.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 123.445 0.466 . . . . 0.0 110.065 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.632 HG22 ' HG2' ' A' ' 42' ' ' ARG . 73.4 p -127.46 158.59 36.94 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.458 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -139.47 133.97 38.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.78 112.97 23.62 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.98 117.74 55.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.49 130.01 56.74 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -131.1 157.57 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.499 HH21 ' CD ' ' A' ' 66' ' ' GLU . 59.2 ttp180 -122.37 122.95 40.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.66 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp . . . . . 0 C--N 1.306 -1.307 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.773 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 121.098 0.475 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 32.7 m -101.62 151.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.87 135.74 56.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.883 0.373 . . . . 0.0 110.102 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.9 132.77 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' B' ' 48' ' ' LYS . 48.2 mm -94.48 112.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.054 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.56 38.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.278 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.21 -76.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.262 0.553 . . . . 0.0 110.747 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -99.5 169.25 8.36 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -60.71 161.45 21.32 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.387 2.058 . . . . 0.0 112.486 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -50.03 -32.4 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.882 1.273 . . . . 0.0 113.544 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 24.2 ptp -60.97 -32.04 71.59 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -71.07 -33.99 70.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.941 0.401 . . . . 0.0 109.958 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -75.53 -36.2 60.55 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.312 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.0 -53.19 52.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.052 0.453 . . . . 0.0 110.039 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mp -67.14 -28.06 67.83 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.981 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.25 76.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.649 0.261 . . . . 0.0 110.453 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -31.1 72.16 Favored 'General case' 0 C--O 1.261 1.687 0 CA-C-O 121.233 0.539 . . . . 0.0 111.025 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -71.4 -43.46 66.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.061 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -65.52 -36.18 83.06 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.728 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.23 -39.04 91.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.105 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.29 -32.84 71.57 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.977 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -66.18 -22.15 66.35 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.156 0.503 . . . . 0.0 110.92 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.92 -12.93 56.95 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.823 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.77 22.52 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.582 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.2 105.14 13.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 122.031 0.919 . . . . 0.0 112.291 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.5 p -87.74 -31.41 19.69 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.174 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' B' ' 94' ' ' ILE . 43.9 mt-10 -101.93 109.42 21.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.412 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -131.95 155.81 41.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.971 -179.482 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 111.509 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.02 126.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -123.11 116.77 24.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.247 0.546 . . . . 0.0 110.63 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.48 157.11 24.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.65 ' HG2' HG22 ' B' ' 89' ' ' THR . 50.3 mtp180 -135.7 144.97 46.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.195 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.48 -130.14 10.49 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.241 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -89.88 3.92 51.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.157 0.503 . . . . 0.0 110.333 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.24 -6.4 54.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.307 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.24 -35.12 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.759 0.824 . . . . 0.0 110.288 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.0 p -61.23 -43.69 98.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.178 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.425 ' HB2' HG21 ' B' ' 14' ' ' ILE . 99.7 mttt -66.13 -38.79 89.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.328 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.99 87.86 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -71.7 -35.33 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.889 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.563 ' O ' HG13 ' B' ' 55' ' ' ILE . 25.2 t70 -64.63 -45.09 88.36 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -54.21 -53.65 50.55 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.87 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.9 -33.15 59.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.639 ' OE1' ' HD3' ' B' ' 57' ' ' ARG . 5.8 tp10 -67.41 -40.08 85.56 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.563 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.4 mt -60.66 -42.49 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.142 0.496 . . . . 0.0 110.804 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.09 -42.98 91.81 Favored 'Isoleucine or valine' 0 C--O 1.256 1.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.777 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.639 ' HD3' ' OE1' ' B' ' 54' ' ' GLU . 2.7 ptm180 -81.34 -2.92 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.209 -175.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.94 19.05 12.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.764 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -139.5 -58.06 0.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.647 -0.421 . . . . 0.0 112.116 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.87 -53.04 4.16 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.279 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 91.4 mt -120.82 106.43 11.66 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -97.15 -39.27 9.37 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.54 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -114.58 6.22 15.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.35 31.37 4.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.169 0.509 . . . . 0.0 111.746 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -134.32 136.99 52.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.505 ' CD ' HH21 ' B' ' 95' ' ' ARG . 41.6 mt-10 -119.49 159.29 24.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 110.44 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.99 123.92 55.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -83.57 -60.58 2.08 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.23 0.331 . . . . 0.0 110.364 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -158.03 140.62 14.6 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.85 124.19 60.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -137.45 143.22 41.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.51 142.18 18.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 O-C-N 123.133 0.271 . . . . 0.0 110.336 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.17 172.4 32.58 Favored Glycine 0 C--O 1.238 0.363 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 121.82 25.27 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.515 0.674 . . . . 0.0 110.451 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -98.38 118.68 35.6 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.431 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' B' ' 86' ' ' ARG . 43.5 t . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.475 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.422 ' HG3' HG22 ' B' ' 76' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.73 136.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 21.0 p -63.86 122.29 16.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.014 0.526 . . . . 0.0 110.24 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.65 HG22 ' HG2' ' B' ' 42' ' ' ARG . 77.4 p -127.68 157.5 40.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.112 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.4 tt -139.41 131.87 36.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.6 112.91 24.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.43 116.8 53.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.886 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.19 128.62 56.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.387 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.501 HD13 ' H ' ' B' ' 94' ' ' ILE . 0.2 OUTLIER -128.84 155.26 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.072 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.505 HH21 ' CD ' ' B' ' 66' ' ' GLU . 60.6 ttp180 -119.54 120.91 38.14 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.686 0.616 . . . . 0.0 110.412 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -82.39 -175.14 5.55 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt . . . . . 0 CA--C 1.548 0.885 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.259 174.433 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.473 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.712 0.292 . . . . 0.0 111.306 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.7 133.97 63.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.457 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.79 135.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.0 tp -97.26 115.31 27.4 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.8 99.19 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.334 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.71 72.08 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.073 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 17' ' ' LYS . 5.7 ptpp? 172.69 -48.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.48 1.112 . . . . 0.0 112.475 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 32.5 mmmt -100.29 164.77 15.69 Favored Pre-proline 0 C--O 1.256 1.403 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.2 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.5 164.14 34.01 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.595 2.196 . . . . 0.0 110.914 172.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.484 HG21 ' OD1' ' A' ' 51' ' ' ASP . 7.8 p -58.26 -42.81 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.414 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.9 ptp -58.89 -25.93 63.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.12 -38.02 81.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -77.59 -33.28 53.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.46 -47.14 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.359 0.6 . . . . 0.0 109.84 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 20' ' ' MET . 87.0 mt -66.17 -29.66 69.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.782 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -67.99 -43.67 78.39 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.8 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.24 -30.52 70.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.132 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.31 -36.08 66.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.998 0.428 . . . . 0.0 110.182 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 m -70.18 -35.05 73.69 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.3 mt -63.88 -27.07 68.91 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.616 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.618 HD21 ' HG3' ' A' ' 96' ' ' LYS . 14.3 mt -57.69 -41.32 81.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 111.6 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -78.28 -5.26 51.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -102.78 -4.45 24.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 109.714 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.28 13.61 58.44 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.193 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 20.7 t -101.01 89.55 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.628 0.727 . . . . 0.0 109.27 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 50.9 m -81.17 -24.71 37.35 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.571 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 35.2 mt-10 -110.65 111.21 22.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -129.23 154.07 39.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.042 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.026 -177.451 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.97 117.91 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 123.794 0.684 . . . . 0.0 110.497 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.89 120.81 40.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -113.37 115.03 27.46 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 122.742 0.417 . . . . 0.0 110.195 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.25 39.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HG2' HG22 ' A' ' 89' ' ' THR . 44.1 mtm180 -133.77 148.52 51.39 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 120.817 0.342 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.96 -130.44 10.97 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.782 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.56 -0.45 57.52 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 122.232 -0.569 . . . . 0.0 112.06 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.77 6.41 24.57 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -57.77 -37.1 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 110.0 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.8 p -67.66 -29.7 69.06 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.989 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.97 -29.2 58.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.296 0.57 . . . . 0.0 109.66 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.24 -45.35 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.397 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.06 -38.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 55' ' ' ILE . 13.6 t70 -57.91 -42.39 84.64 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.3 m -55.3 -52.69 62.64 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.015 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.68 -34.13 51.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . 0.257 11.6 pt-20 -69.96 -31.7 69.55 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.561 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.5 mt -62.4 -47.81 91.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.955 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.9 t -57.91 -48.82 83.03 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 16.6 ptm180 -72.75 -14.56 61.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -109.39 0.72 19.55 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.499 -0.88 . . . . 0.0 113.213 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -108.69 -19.28 13.48 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.04 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -146.25 -70.13 0.26 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.451 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.0 86.06 7.07 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -75.54 -73.6 0.25 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.931 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.6 2.25 55.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -113.88 24.42 12.09 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.187 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.38 133.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.148 0.499 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -101.53 143.62 31.29 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.2 mt -124.65 140.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.99 -73.39 0.52 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.115 0.483 . . . . 0.0 111.242 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -170.49 157.52 5.97 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.32 115.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -113.28 128.61 56.52 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.97 132.79 47.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.78 169.46 41.89 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.905 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 m -81.44 138.45 35.54 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 122.969 0.508 . . . . 0.0 109.67 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -115.87 130.49 56.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.686 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 C--N 1.316 -0.856 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.33 122.24 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 p -65.24 130.47 43.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.465 HG22 ' HG2' ' A' ' 42' ' ' ARG . 41.7 p -128.54 145.42 51.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.68 138.17 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.0 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -121.9 111.0 16.55 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.393 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -107.07 110.5 31.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.16 124.91 53.24 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.4 pt -134.66 168.73 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.526 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 30.5 ttt180 -135.04 155.57 50.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.618 ' HG3' HD21 ' A' ' 30' ' ' LEU . 47.7 mmtm . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.425 0.631 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.59 132.73 69.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.322 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.895 0.379 . . . . 0.0 111.386 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -96.29 114.76 26.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.561 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.82 98.27 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.253 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 72.83 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.435 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.498 ' HG3' ' HG2' ' B' ' 17' ' ' LYS . 5.2 ptpp? 172.25 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.789 1.236 . . . . 0.0 112.244 174.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' B' ' 16' ' ' LYS . 32.3 mmmt -100.19 164.19 16.84 Favored Pre-proline 0 C--O 1.255 1.366 0 O-C-N 122.227 -0.296 . . . . 0.0 111.309 -174.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.02 164.48 29.82 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.997 2.465 . . . . 0.0 110.869 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.9 -42.25 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptp -58.09 -26.12 62.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -68.38 -39.48 81.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.411 0.624 . . . . 0.0 110.104 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.62 -33.34 58.39 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.478 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.31 -48.46 88.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.706 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.32 -29.39 70.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.037 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.06 -46.79 73.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.01 85.82 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.123 0.487 . . . . 0.0 111.134 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.222 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 43.2 m -72.16 -36.55 69.35 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.208 0.527 . . . . 0.0 110.26 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.458 ' HB3' ' HB ' ' B' ' 34' ' ' VAL . 94.4 mt -62.99 -30.01 71.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.695 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.604 HD21 ' HG3' ' B' ' 96' ' ' LYS . 17.5 mt -54.0 -42.82 69.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.855 171.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.59 -9.57 58.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.418 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -99.38 -3.78 33.07 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.952 0.406 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.08 12.27 57.79 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.459 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' B' ' 29' ' ' LEU . 20.9 t -100.65 90.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.537 0.684 . . . . 0.0 109.695 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 44.3 m -82.05 -25.29 34.72 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.583 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 37.2 mt-10 -109.58 110.8 21.99 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.444 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.76 152.56 37.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 -177.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.58 119.03 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.492 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.9 121.02 40.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.62 113.89 25.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.045 0.45 . . . . 0.0 110.289 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 152.0 38.07 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.438 ' HG2' HG22 ' B' ' 89' ' ' THR . 46.7 mtm180 -134.8 151.41 50.93 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.764 0.316 . . . . 0.0 110.689 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 -128.01 10.9 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.748 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -91.17 -1.04 57.8 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 122.359 -0.495 . . . . 0.0 112.099 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 8.06 21.04 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.408 HG23 HG21 ' B' ' 90' ' ' ILE . 67.6 mt -58.12 -37.86 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.774 0.797 . . . . 0.0 109.924 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 29.2 p -66.39 -30.63 71.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.239 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.67 -31.26 61.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.03 75.98 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.421 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.17 -37.43 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.643 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.499 ' O ' HG13 ' B' ' 55' ' ' ILE . 14.7 t70 -59.11 -40.24 84.75 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.6 m -57.47 -52.99 63.12 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.851 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 m -70.93 -34.65 56.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.97 -33.14 73.21 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.293 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.499 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.9 mt -61.87 -48.78 87.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.126 175.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.09 -49.42 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -72.25 -18.26 61.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -104.0 -3.45 24.61 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.882 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -106.54 -15.2 14.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.39 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -149.65 -69.67 0.2 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 mp -88.76 86.94 7.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.146 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.86 -73.17 0.3 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.839 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.9 4.84 51.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -115.2 26.51 10.04 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.042 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.2 tp -107.25 130.26 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 120.871 0.367 . . . . 0.0 110.98 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -96.99 147.0 24.44 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.1 mt -126.6 138.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -88.08 -73.49 0.49 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -172.02 160.94 5.5 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 65.7 mt -125.83 115.49 43.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -111.79 124.19 51.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.22 136.43 56.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.7 170.17 41.02 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.796 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.4 m -80.61 140.8 35.55 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -118.67 130.99 56.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 C--N 1.314 -0.935 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.475 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 119.32 54.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -63.66 129.05 38.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.438 HG22 ' HG2' ' B' ' 42' ' ' ARG . 47.0 p -127.37 147.3 50.27 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.827 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.408 HG21 HG23 ' B' ' 46' ' ' ILE . 15.2 tt -139.36 137.35 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.528 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.05 112.48 19.19 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.046 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.4 mt -107.31 111.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.16 127.15 56.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.975 0.416 . . . . 0.0 110.667 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -136.35 167.48 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.263 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' OE2' ' B' ' 36' ' ' GLU . 36.8 ttt180 -134.07 153.47 51.78 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.904 0.383 . . . . 0.0 110.138 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.604 ' HG3' HD21 ' B' ' 30' ' ' LEU . 46.7 mmtm -108.35 140.56 41.46 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm . . . . . 0 C--N 1.311 -1.085 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.11 173.137 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 p30 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 19.3 m -98.96 129.98 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.106 0.479 . . . . 0.0 110.458 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' HG12 ' A' ' 39' ' ' ILE . 35.6 m -118.47 139.36 46.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.836 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.0 127.29 43.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.761 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.52 110.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.37 53.55 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.234 -1.46 . . . . 0.0 113.894 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -157.51 -58.97 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -100.79 162.28 21.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.997 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.72 156.75 55.64 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.236 1.957 . . . . 0.0 112.014 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.48 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -50.87 -32.4 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.725 1.21 . . . . 0.0 113.776 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.3 ptp -56.81 -31.6 64.88 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -75.93 -37.15 59.01 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.842 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.7 -37.34 73.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.36 -47.5 90.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.254 0.55 . . . . 0.0 110.05 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.18 -32.22 71.38 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.944 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -67.51 -44.46 78.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.671 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.75 90.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.273 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.44 -35.54 81.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.979 0.419 . . . . 0.0 111.047 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.3 m -69.9 -39.13 76.42 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 95.1 mt -69.73 -35.86 75.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.39 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.8 tm? -59.39 -45.58 91.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.933 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.422 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -79.75 -21.64 44.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.56 -19.84 3.75 Favored Glycine 0 CA--C 1.5 -0.904 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.2 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 22.0 t -71.81 94.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.471 0.653 . . . . 0.0 109.349 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -79.26 -17.47 54.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.216 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.57 130.91 23.62 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -130.15 156.15 42.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.185 -178.396 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 43.4 t -121.46 113.55 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.304 0.574 . . . . 0.0 110.425 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.419 HG12 ' CG2' ' A' ' 12' ' ' VAL . 65.2 mt -95.14 122.01 46.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 80.4 mttt -120.92 120.64 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.95 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.64 167.24 12.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.769 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -139.29 141.94 37.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.21 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 59.93 -106.72 1.06 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -83.31 -21.18 33.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.19 0.519 . . . . 0.0 109.95 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.32 -8.7 56.97 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.14 -39.2 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.606 0.717 . . . . 0.0 110.386 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -64.55 -29.51 70.54 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.664 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -78.34 -37.35 44.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.559 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.306 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -73.14 -35.7 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.766 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.48 ' OD2' HG21 ' A' ' 19' ' ' VAL . 18.1 t70 -58.83 -47.92 83.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.3 m -53.07 -54.14 39.87 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.205 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.35 -29.17 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.35 -36.77 79.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.6 mt -65.44 -50.14 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.962 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.27 -44.57 84.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -75.55 -1.95 26.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -130.42 6.6 4.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.612 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -114.13 -61.9 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -76.41 -50.08 15.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.591 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.4 tp -159.46 105.91 1.69 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.31 -27.67 15.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.506 1.129 . . . . 0.0 111.869 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.76 -42.49 89.03 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.607 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -122.34 108.38 13.17 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.985 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -161.35 145.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.77 156.13 43.89 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.0 mt -104.35 141.21 20.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -95.93 -38.25 10.33 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.332 -0.23 . . . . 0.0 110.902 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -167.78 146.38 4.69 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.486 0.491 . . . . 0.0 109.835 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.52 97.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 124.356 1.062 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.8 142.08 50.38 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.405 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.76 134.95 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.18 151.28 22.6 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.15 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -79.57 124.72 28.77 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -107.69 135.29 49.36 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.953 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.319 -0.757 0 CA-C-O 121.35 0.595 . . . . 0.0 111.092 176.557 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.87 132.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.219 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -71.41 126.77 30.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.937 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 46.5 p -127.99 154.61 45.42 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.964 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -135.28 135.08 52.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.555 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -112.5 111.1 21.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.642 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 90' ' ' ILE . 43.5 mm -108.28 110.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.62 122.01 39.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.17 149.4 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -126.6 127.55 45.41 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.8 tptt . . . . . 0 C--N 1.299 -1.599 0 CA-C-O 121.689 0.757 . . . . 0.0 112.866 -174.462 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 C--O 1.243 0.739 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 18.9 m -96.66 129.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.118 0.485 . . . . 0.0 111.487 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.407 ' CG2' HG12 ' B' ' 39' ' ' ILE . 34.4 m -119.97 139.41 47.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.893 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.11 124.47 44.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mm -95.22 112.4 27.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.805 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.33 47.31 0.01 OUTLIER Glycine 0 C--N 1.313 -0.727 0 C-N-CA 119.136 -1.507 . . . . 0.0 114.338 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -151.73 -58.05 0.15 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.874 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' B' ' 18' ' ' PRO . 56.0 mtpt -101.52 162.62 19.89 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' B' ' 17' ' ' LYS . 28.7 Cg_endo -62.56 155.43 58.5 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.518 2.145 . . . . 0.0 112.162 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.82 -31.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.5 1.12 . . . . 0.0 113.992 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -57.52 -34.35 69.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -71.76 -40.78 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.751 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -69.16 -38.48 78.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.638 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.26 -46.85 88.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.338 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.5 -37.03 79.72 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.235 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.68 95.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.75 88.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.562 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.11 -35.71 81.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.7 m -67.39 -41.94 84.17 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.49 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.93 -34.77 75.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 2.0 tm? -59.89 -44.17 94.39 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.42 -25.25 66.66 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.306 0.574 . . . . 0.0 111.779 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -79.13 -14.75 58.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.672 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.83 -16.32 6.5 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.964 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' B' ' 30' ' ' LEU . 21.5 t -74.68 94.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -83.25 -15.03 51.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.1 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.425 ' OE2' ' HE3' ' B' ' 68' ' ' LYS . 10.0 pt-20 -140.01 130.03 24.88 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.424 ' H ' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -131.32 155.61 41.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.21 -178.175 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 43.0 t -121.77 113.52 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.663 0.744 . . . . 0.0 110.872 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.407 HG12 ' CG2' ' B' ' 12' ' ' VAL . 61.7 mt -94.64 123.08 46.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.037 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 82.5 mttt -121.36 123.11 41.35 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.172 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.78 166.77 14.41 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.316 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -139.68 140.72 36.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.203 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.91 -105.41 0.92 Allowed Glycine 0 N--CA 1.466 0.649 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -84.32 -23.29 30.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.867 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.08 -7.22 47.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.1 mt -57.22 -39.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.727 0.775 . . . . 0.0 109.723 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.2 t -64.03 -32.42 73.96 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.54 -37.66 59.86 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.184 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.92 83.67 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.088 0.471 . . . . 0.0 111.525 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.86 -35.22 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.802 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.439 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.5 t70 -59.93 -45.04 93.9 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.7 m -54.88 -56.85 14.99 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.322 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.89 -29.84 44.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.46 -35.27 77.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.779 0.323 . . . . 0.0 110.158 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 51' ' ' ASP . 80.2 mt -67.16 -50.85 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 88.2 t -55.59 -44.87 78.17 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.92 -2.55 27.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' B' ' 62' ' ' ALA . 12.8 t30 -132.48 9.01 4.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.318 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -113.27 -60.1 1.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.296 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.51 -51.44 9.97 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.08 0.467 . . . . 0.0 111.1 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 67.8 tp -158.25 104.67 1.87 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' B' ' 58' ' ' ASN . . . -92.76 -22.03 19.6 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.329 -176.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.38 -43.87 80.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -117.96 105.67 12.14 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -161.18 141.02 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.56 156.32 45.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.098 0.475 . . . . 0.0 109.739 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.39 140.42 20.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' LYS . . . . . 0.425 ' HE3' ' OE2' ' B' ' 36' ' ' GLU . 64.9 tttm -93.83 -40.58 10.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.292 -0.255 . . . . 0.0 110.944 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.74 147.05 4.89 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.438 0.462 . . . . 0.0 109.759 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 pt -145.62 100.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 124.521 1.128 . . . . 0.0 109.698 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.104 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.75 135.86 56.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.0 150.94 22.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.353 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -79.48 124.0 28.07 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -106.98 134.87 49.49 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.933 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.24 0.56 0 CA-C-O 121.247 0.546 . . . . 0.0 110.847 176.526 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 . . . . . 0 N--CA 1.441 -0.922 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.74 132.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 128.76 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 58.0 p -130.13 154.27 47.66 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 14.9 tt -134.84 136.34 52.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.504 0.192 . . . . 0.0 110.524 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -115.21 112.32 22.31 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.417 HD11 HD11 ' B' ' 90' ' ' ILE . 43.6 mm -108.91 110.61 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.85 120.77 37.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -121.94 149.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -127.43 126.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -77.51 151.43 34.58 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.935 -174.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.435 -1.177 0 C-N-CA 125.234 1.414 . . . . 0.0 107.778 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--O 1.223 -0.312 0 CA-C-O 121.668 0.747 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 ' HB ' ' A' ' 38' ' ' VAL . 31.0 m -120.08 133.45 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.052 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.53 144.45 30.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.255 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -105.83 121.63 44.45 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.09 103.35 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.19 51.11 0.03 OUTLIER Glycine 0 C--O 1.24 0.49 0 C-N-CA 119.515 -1.326 . . . . 0.0 114.086 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -166.33 -55.32 0.03 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.125 0.462 . . . . 0.0 110.831 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.86 154.71 37.1 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.22 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -62.7 160.23 33.64 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.327 2.018 . . . . 0.0 111.638 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -49.93 -34.17 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.53 1.132 . . . . 0.0 113.267 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.458 ' O ' HD13 ' A' ' 24' ' ' LEU . 26.8 ptm -60.1 -27.35 66.95 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.609 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -80.83 -25.81 37.5 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.118 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -83.88 -37.62 22.17 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.553 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.426 ' O ' HD13 ' A' ' 27' ' ' LEU . 73.2 t -59.29 -55.59 22.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.045 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 20' ' ' MET . 8.3 mp -62.31 -31.32 71.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.081 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.24 -42.84 99.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 123.117 0.26 . . . . 0.0 111.241 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.495 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -64.92 -40.37 94.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.782 0.325 . . . . 0.0 110.403 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 23' ' ' VAL . 8.6 mp -63.13 -39.34 94.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.449 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.6 m -66.0 -34.42 78.05 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.5 mt -70.87 -36.42 72.78 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.664 0.269 . . . . 0.0 111.325 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.5 mt -59.61 -42.6 93.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.05 0.453 . . . . 0.0 110.067 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -65.75 -25.17 67.15 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -89.24 -2.42 58.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.746 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.1 12.2 40.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.171 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.6 t -99.34 115.23 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -101.31 -30.64 11.38 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.93 105.79 14.32 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.036 0.922 . . . . 0.0 112.784 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -117.38 154.53 19.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.512 -177.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HB ' HG12 ' A' ' 11' ' ' VAL . 50.3 t -121.69 120.63 62.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.103 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -96.78 120.52 46.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.275 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 91' ' ' GLU . 48.1 mttp -108.26 121.29 44.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.72 138.12 53.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -137.1 120.13 16.55 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.53 76.44 1.27 Allowed Glycine 0 C--O 1.219 -0.804 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.92 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 68.0 -15.66 0.2 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.3 6.05 3.97 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.813 0.445 . . . . 0.0 111.869 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.426 HG23 HG21 ' A' ' 90' ' ' ILE . 68.2 mt -56.73 -37.91 55.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.448 1.099 . . . . 0.0 109.406 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.1 p -67.56 -24.87 65.57 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.137 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -86.96 -29.96 21.65 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.534 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.24 -42.61 96.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.7 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.63 -40.75 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.214 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 55' ' ' ILE . 17.2 t70 -57.65 -44.18 85.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.445 0.641 . . . . 0.0 109.281 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 91.0 m -57.94 -51.08 71.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.678 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.448 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 33.8 m -69.85 -32.36 51.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.122 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.35 -36.48 83.84 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.8 mt -67.64 -46.77 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.141 0.496 . . . . 0.0 110.385 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' THR . 67.2 t -59.71 -38.27 75.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.166 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 53' ' ' VAL . 15.9 ptm180 -91.87 17.68 8.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.609 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -133.07 -41.73 0.9 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -86.91 -60.45 1.98 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.629 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.56 -58.28 3.42 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.045 0.45 . . . . 0.0 111.588 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.5 tp -148.0 102.49 3.39 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.3 -26.88 17.11 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.871 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.03 -50.28 66.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.15 0.5 . . . . 0.0 111.775 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -103.81 105.8 16.12 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.106 0.479 . . . . 0.0 110.882 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 tp -159.79 127.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.431 0.692 . . . . 0.0 110.652 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.81 149.57 51.4 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 173.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.77 134.67 46.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -90.95 -60.37 1.93 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.118 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -155.55 147.91 23.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.41 111.02 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -113.73 135.28 54.11 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.546 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -136.65 133.59 48.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.3 179.31 48.14 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.596 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 m -80.71 124.07 28.72 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.636 0.774 . . . . 0.0 110.971 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 25.7 tt0 -88.99 117.54 28.08 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.055 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 89.7 mtt180 . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -124.44 135.1 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.312 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 m -62.94 120.57 11.62 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 123.697 0.799 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 p -127.19 152.02 47.92 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 122.641 0.377 . . . . 0.0 110.364 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.426 HG21 HG23 ' A' ' 46' ' ' ILE . 15.9 tt -143.71 142.2 24.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.163 0 CA-C-O 120.782 0.325 . . . . 0.0 110.607 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' A' ' 40' ' ' LYS . 44.3 mt-10 -123.5 121.14 34.92 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.778 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -113.06 111.61 36.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.84 117.15 31.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.51 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 pt -119.16 168.17 11.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.935 0.398 . . . . 0.0 110.659 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -125.23 118.62 26.43 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.742 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt . . . . . 0 C--N 1.307 -1.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.136 179.309 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 . . . . . 0 C--O 1.238 0.453 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 20.9 m -115.68 131.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.174 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.78 145.78 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 60.5 tp -108.62 118.79 37.7 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.001 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -83.89 113.43 22.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.75 45.16 0.02 OUTLIER Glycine 0 C--O 1.237 0.305 0 C-N-CA 119.48 -1.343 . . . . 0.0 114.057 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -163.34 -59.69 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.241 0.52 . . . . 0.0 110.291 177.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.17 155.52 38.83 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.21 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.26 158.99 41.61 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.569 2.179 . . . . 0.0 111.385 174.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.478 HG21 ' OD2' ' B' ' 51' ' ' ASP . 7.6 p -48.75 -35.1 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.599 1.16 . . . . 0.0 113.113 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.418 ' O ' HD13 ' B' ' 24' ' ' LEU . 26.3 ptm -57.66 -29.77 64.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.969 0.414 . . . . 0.0 111.743 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.27 -30.58 54.38 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.63 -38.22 40.25 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.434 ' O ' HD13 ' B' ' 27' ' ' LEU . 66.7 t -60.35 -55.83 21.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.418 HD13 ' O ' ' B' ' 20' ' ' MET . 8.3 mp -63.79 -25.27 68.1 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.43 -44.9 85.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.666 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.459 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -63.54 -42.91 98.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.967 0.413 . . . . 0.0 110.65 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.434 HD13 ' O ' ' B' ' 23' ' ' VAL . 8.8 mp -61.23 -35.72 77.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.486 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 61.9 m -69.89 -35.74 74.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.294 0.569 . . . . 0.0 109.794 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -68.9 -35.3 76.68 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 122.159 -0.338 . . . . 0.0 111.368 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 91.1 mt -59.5 -41.12 89.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.084 0.469 . . . . 0.0 110.585 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -67.25 -25.04 65.89 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.077 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -87.94 -0.92 57.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.967 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.34 0.02 53.83 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.739 -0.744 . . . . 0.0 114.424 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.48 113.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -100.93 -27.74 13.14 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.901 0.381 . . . . 0.0 111.436 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.06 110.44 20.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.826 0.822 . . . . 0.0 112.198 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.492 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -123.16 152.75 28.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.963 -175.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.62 119.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 CA-C-O 121.156 0.503 . . . . 0.0 110.29 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -96.3 120.98 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.24 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.42 ' HG2' ' HG2' ' B' ' 91' ' ' GLU . 49.4 mttp -107.79 120.99 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.156 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -119.3 137.14 53.88 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -135.79 117.81 15.34 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.82 76.47 1.31 Allowed Glycine 0 C--O 1.217 -0.931 0 N-CA-C 114.742 0.657 . . . . 0.0 114.742 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 67.18 -15.04 0.17 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.89 6.87 4.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.0 0.429 . . . . 0.0 111.607 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.4 HG23 HG21 ' B' ' 90' ' ' ILE . 67.8 mt -55.99 -39.42 57.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 124.57 1.148 . . . . 0.0 109.778 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.0 p -64.66 -29.0 69.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.8 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.21 -28.59 27.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.571 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -65.62 -40.52 92.66 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.288 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.63 -40.97 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.171 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.478 ' OD2' HG21 ' B' ' 19' ' ' VAL . 15.6 t70 -54.68 -48.12 72.77 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.613 0.721 . . . . 0.0 109.518 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.46 ' O ' HG23 ' B' ' 56' ' ' VAL . 64.3 m -54.52 -52.0 63.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.941 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.26 -33.47 58.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.313 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.48 -35.91 82.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.098 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.7 mt -67.66 -47.38 80.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 120.946 0.403 . . . . 0.0 110.259 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 52' ' ' THR . 81.0 t -59.36 -38.49 75.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.936 -177.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -90.88 18.46 6.58 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.286 -0.259 . . . . 0.0 111.529 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.73 -48.74 0.88 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.235 0.54 . . . . 0.0 110.603 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -81.23 -52.2 7.59 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -80.81 -60.32 2.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.191 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -146.13 104.12 3.79 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.81 -24.73 16.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.925 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.71 -46.89 64.95 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.36 0.6 . . . . 0.0 111.361 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -104.13 105.83 16.13 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.987 0.423 . . . . 0.0 110.693 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -160.82 131.31 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.387 0.675 . . . . 0.0 109.905 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.81 147.46 42.56 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.5 mt -104.65 133.62 48.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -89.5 -60.43 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.092 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.04 149.28 27.01 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -138.2 109.61 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -112.01 134.85 53.31 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.515 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.29 130.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.59 177.89 46.57 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.063 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.5 m -79.46 125.27 29.34 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.087 0.955 . . . . 0.0 111.254 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 27.5 tt0 -90.1 116.5 28.16 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.448 HG22 ' HG2' ' B' ' 86' ' ' ARG . 40.5 t . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 96.6 mtt180 . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.98 133.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.66 120.25 10.83 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 123.651 0.78 . . . . 0.0 110.609 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.0 p -125.92 151.18 47.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.4 HG21 HG23 ' B' ' 46' ' ' ILE . 15.6 tt -141.74 143.58 26.92 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 120.626 0.251 . . . . 0.0 110.813 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.42 ' HG2' ' HG2' ' B' ' 40' ' ' LYS . 42.5 mt-10 -124.36 121.75 35.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.886 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.06 113.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.53 115.42 27.95 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 pt -118.83 161.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.728 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -120.23 118.53 30.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -102.97 78.85 1.7 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? . . . . . 0 C--O 1.279 2.61 0 C-N-CA 124.395 1.078 . . . . 0.0 109.775 177.315 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 t -142.3 160.64 39.85 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.5 t -105.71 13.62 29.49 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.47 123.22 7.65 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.347 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -90.91 141.08 26.35 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.83 156.46 48.47 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.527 2.151 . . . . 0.0 111.627 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 9.0 t -133.8 140.85 37.83 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 3.0 Cg_exo -79.4 125.41 6.3 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.439 2.093 . . . . 0.0 113.282 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.5 t -133.18 102.1 5.45 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -133.0 1.23 3.54 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.23 138.36 52.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.959 0.409 . . . . 0.0 110.824 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.51 151.03 33.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.0 tp -116.63 131.77 56.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 48' ' ' LYS . 51.2 mm -84.41 121.98 37.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.18 -115.74 3.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.453 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.64 12.25 16.0 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.55 147.0 58.37 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.365 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.11 147.93 80.53 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.396 2.064 . . . . 0.0 110.781 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 23' ' ' VAL . 13.8 p -58.64 -28.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 112.072 -175.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 24' ' ' LEU . 27.1 ptt? -64.03 -24.0 67.55 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.19 0.519 . . . . 0.0 111.331 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.81 -30.49 51.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.021 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -82.82 -37.57 24.28 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.077 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 19' ' ' VAL . 67.4 t -58.25 -51.06 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.021 0.439 . . . . 0.0 110.687 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 20' ' ' MET . 9.2 mp -67.37 -30.05 69.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.124 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.65 -44.96 80.53 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.826 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.28 -35.28 80.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.187 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.4 -36.8 79.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -67.74 -35.68 79.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.514 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.4 mt -63.97 -36.45 84.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' A' ' 96' ' ' LYS . 3.4 tm? -63.21 -46.87 85.01 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.7 -4.01 44.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.573 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -94.95 -22.94 17.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.7 -8.3 4.91 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.979 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.97 107.28 20.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.156 0.503 . . . . 0.0 110.624 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.6 p -85.6 -25.65 26.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -118.84 113.97 21.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -122.55 146.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 123.274 0.358 . . . . 0.0 110.701 -178.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.44 118.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.2 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.8 mt -93.66 122.32 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.45 129.28 56.65 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.089 0.471 . . . . 0.0 109.785 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.12 169.59 17.37 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.496 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HB3' HG22 ' A' ' 89' ' ' THR 0.309 0.0 OUTLIER -158.64 149.92 20.69 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.498 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.35 -120.02 8.98 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.223 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 ptm180 -87.0 -3.33 59.08 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.235 0.54 . . . . 0.0 110.96 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.63 -6.9 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.303 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.86 -36.13 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.991 0.516 . . . . 0.0 110.382 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -62.27 -35.88 80.34 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.179 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.445 ' HB2' HG21 ' A' ' 14' ' ' ILE . 65.3 mttm -75.08 -32.84 61.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.173 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.54 96.3 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 110.724 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.52 -39.87 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.51 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.2 t70 -57.9 -39.02 76.89 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.242 0.617 . . . . 0.0 110.006 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -66.68 -55.53 14.75 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.46 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.9 -31.15 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.647 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 31.0 tt0 -64.94 -44.48 89.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.3 mt -61.3 -49.01 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.95 0.405 . . . . 0.0 110.065 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.22 -36.59 58.34 Favored 'Isoleucine or valine' 0 C--O 1.259 1.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -87.4 -7.43 57.72 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -124.81 24.74 7.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.284 0.564 . . . . 0.0 111.583 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -137.1 -65.89 0.53 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -86.6 -51.25 6.27 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.687 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mp -132.16 112.84 12.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -101.19 -57.81 2.01 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.177 0.923 . . . . 0.0 112.096 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.14 -36.02 66.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.212 0.53 . . . . 0.0 111.631 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.04 -15.95 45.66 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 62' ' ' ALA . 16.6 tt -80.22 148.31 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.077 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -139.06 145.04 39.09 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -173.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -90.93 145.81 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -105.25 -52.59 2.81 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.114 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -169.39 152.2 4.78 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt -138.47 119.96 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.554 0.742 . . . . 0.0 110.32 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -133.5 133.99 42.91 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.715 -0.615 . . . . 0.0 110.874 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.24 136.79 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.42 162.85 29.87 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.622 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 12.0 p -82.13 125.54 30.99 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -104.62 146.3 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.767 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.3 t -94.57 106.02 17.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.23 161.54 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.31 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.0 p -97.15 139.17 33.53 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 121.233 0.54 . . . . 0.0 112.016 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -77.51 178.45 7.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.555 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -56.01 -34.55 65.93 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.41 -44.37 21.55 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.4 48.74 0.17 Allowed Glycine 0 C--N 1.296 -1.655 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -112.49 135.52 53.1 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -74.93 110.01 8.87 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.703 0.627 . . . . 0.0 111.077 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -117.11 129.28 55.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -89.79 132.08 35.42 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.61 134.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -66.18 108.21 2.2 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.822 0.701 . . . . 0.0 111.362 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.514 HG22 ' HB3' ' A' ' 42' ' ' ARG . 35.1 p -105.83 150.15 25.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.092 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.53 131.34 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.08 115.99 27.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.9 mt -110.71 114.0 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.47 122.33 47.46 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 120.675 0.274 . . . . 0.0 110.577 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.9 pt -120.99 157.08 24.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.969 0.414 . . . . 0.0 110.421 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -119.56 118.54 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.336 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HB2' HD23 ' A' ' 30' ' ' LEU . 32.3 mmmt -98.6 131.48 44.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 C--N 1.303 -1.418 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 175.304 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 C--O 1.223 -0.31 0 CA-C-O 120.379 0.133 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p -135.27 13.75 3.53 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.229 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 34.8 t -78.84 -73.14 0.35 Allowed 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.417 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.32 92.32 1.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.128 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 37.2 p -105.62 132.7 20.66 Favored Pre-proline 0 N--CA 1.432 -1.329 0 O-C-N 122.691 -0.299 . . . . 0.0 111.26 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 5' ' ' THR . 14.3 Cg_exo -71.57 -21.81 25.24 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.168 1.912 . . . . 0.0 109.916 173.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 56.5 m -84.51 124.68 73.13 Favored Pre-proline 0 N--CA 1.426 -1.649 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.912 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.03 140.33 89.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.355 2.703 . . . . 0.0 111.985 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -98.88 -44.09 6.49 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -107.12 -0.41 22.85 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.4 132.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.224 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.43 152.58 25.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.891 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -117.91 126.39 52.27 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' B' ' 48' ' ' LYS . 49.3 mm -80.91 119.02 29.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.463 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.72 -116.75 3.72 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.018 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -114.63 15.47 17.67 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.769 0.319 . . . . 0.0 111.078 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -84.07 146.4 48.47 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.683 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.52 143.03 79.92 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.8 2.334 . . . . 0.0 110.858 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.6 -30.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.446 ' O ' HD13 ' B' ' 24' ' ' LEU . 27.0 ptt? -60.95 -28.48 69.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 111.135 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.61 -35.6 67.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.016 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -78.81 -37.37 40.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.19 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.37 -51.93 65.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.694 0.283 . . . . 0.0 110.649 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 20' ' ' MET . 8.1 mp -67.49 -28.63 68.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.908 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -66.23 -46.02 78.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.01 86.24 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 121.35 0.595 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 92.6 mt -65.48 -39.46 91.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.358 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.4 m -65.7 -37.05 85.36 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.394 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.5 mt -62.91 -37.17 85.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.709 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' B' ' 96' ' ' LYS . 3.4 tm? -61.86 -45.93 91.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -80.4 -2.3 45.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.825 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -93.48 -27.8 16.47 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.9 2.74 3.4 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.62 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.17 111.44 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 117.881 0.84 . . . . 0.0 110.087 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 p -87.79 -32.43 19.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -112.39 117.95 33.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.444 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -125.19 147.61 29.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.452 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.62 119.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.425 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 55.2 mt -95.05 123.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -115.73 130.49 56.87 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 121.481 0.658 . . . . 0.0 110.11 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.31 169.12 18.35 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.493 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.533 ' HB3' HG22 ' B' ' 89' ' ' THR 0.288 0.0 OUTLIER -158.45 149.79 20.92 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.685 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.92 -117.48 7.51 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.404 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -88.96 -4.6 58.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.032 0.444 . . . . 0.0 110.757 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.79 -9.05 59.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.03 -36.23 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.567 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 33.5 t -62.36 -35.53 79.41 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.248 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.445 ' HB2' HG21 ' B' ' 14' ' ' ILE . 64.9 mttm -76.3 -34.51 59.06 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.684 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.69 88.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.12 0.486 . . . . 0.0 111.039 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -73.23 -40.38 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.828 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.417 ' O ' HG13 ' B' ' 55' ' ' ILE . 32.4 t70 -58.55 -41.53 85.8 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.064 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 73.0 m -63.44 -54.96 28.31 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.001 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.44 -30.36 49.54 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.622 ' OE1' ' HB3' ' A' ' 74' ' ' SER . 27.7 tt0 -66.3 -43.49 86.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.417 HG13 ' O ' ' B' ' 51' ' ' ASP . 76.2 mt -61.71 -47.79 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.184 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.1 -34.36 56.48 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -89.16 -6.49 56.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -123.61 18.56 9.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.961 0.41 . . . . 0.0 111.697 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -131.97 -68.01 0.65 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.426 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -85.56 -49.05 8.35 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.733 -171.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 mp -133.54 112.0 11.14 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.507 ' O ' HG22 ' B' ' 65' ' ' ILE . . . -100.21 -63.36 1.14 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 124.013 0.821 . . . . 0.0 111.472 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.49 -37.03 86.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.112 0.565 . . . . 0.0 112.503 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.06 -15.36 41.55 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.507 HG22 ' O ' ' B' ' 62' ' ' ALA . 16.2 tt -80.41 148.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.608 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.545 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 40.4 tt0 -138.75 147.3 42.49 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -93.71 143.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -102.57 -52.46 3.09 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.294 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -169.87 150.97 4.01 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.98 118.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 123.575 0.547 . . . . 0.0 110.746 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.04 134.88 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.685 -0.634 . . . . 0.0 110.752 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.99 137.37 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.8 163.42 31.16 Favored Glycine 0 C--N 1.315 -0.619 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.647 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 17.5 p -83.38 124.27 30.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.361 0.601 . . . . 0.0 112.226 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -103.05 145.93 29.15 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.56 107.84 19.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -117.91 163.91 14.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 22.5 p -99.55 139.33 35.36 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.564 0.697 . . . . 0.0 112.099 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 20.4 m -74.85 178.34 5.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.485 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -60.16 -31.71 70.36 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.73 -52.49 8.32 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.182 0.991 . . . . 0.0 108.64 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.88 48.56 0.07 OUTLIER Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -114.39 133.08 55.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -72.43 115.45 11.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 123.621 0.575 . . . . 0.0 110.979 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 24.3 t -122.89 130.5 52.94 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' ' 86' ' ' ARG . 22.7 mtp180 -90.24 132.19 35.65 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.17 134.95 50.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.2 p -66.29 108.66 2.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.472 0.653 . . . . 0.0 111.84 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.533 HG22 ' HB3' ' B' ' 42' ' ' ARG . 33.8 p -106.49 148.98 27.55 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.568 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.05 130.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.813 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -113.64 113.74 25.46 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.93 116.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.4 121.24 44.3 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.606 0.241 . . . . 0.0 110.59 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 pt -119.54 154.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.545 ' HD3' ' OE1' ' B' ' 66' ' ' GLU . 60.3 ttt180 -117.47 121.3 40.65 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.508 ' HB2' HD23 ' B' ' 30' ' ' LEU . 32.2 mmmt -102.35 132.77 48.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.891 176.877 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.5 m -109.21 -35.66 6.24 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 m -101.54 136.69 40.97 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.31 56.7 4.96 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.0 m 66.36 96.88 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 124.301 1.04 . . . . 0.0 112.448 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -73.71 137.21 24.51 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.846 2.364 . . . . 0.0 112.453 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 9.8 t -99.55 135.93 20.48 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 3.4 Cg_exo -80.49 116.66 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.117 1.878 . . . . 0.0 112.393 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 m -108.19 7.84 27.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.776 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -92.85 13.1 21.41 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.286 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.16 133.91 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.315 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.88 145.29 32.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.335 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 tp -107.18 124.32 49.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 48' ' ' LYS . 46.3 mm -89.36 117.23 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 118.685 -1.722 . . . . 0.0 115.171 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -155.07 -41.08 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.976 0.888 . . . . 0.0 110.695 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -101.43 158.06 32.49 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.967 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.3 157.11 55.98 Favored 'Trans proline' 0 C--O 1.248 0.995 0 C-N-CA 121.845 1.696 . . . . 0.0 110.129 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG21 ' OD1' ' A' ' 51' ' ' ASP . 14.7 p -56.9 -26.91 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.463 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.6 ptp -62.91 -28.57 70.14 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.77 -35.73 32.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.251 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.34 -34.63 72.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.278 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 19' ' ' VAL . 96.4 t -60.57 -48.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.653 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 20' ' ' MET . 88.4 mt -66.29 -31.56 72.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.468 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.99 -50.76 61.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.43 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.33 -38.89 92.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.65 -45.06 73.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.146 0.978 . . . . 0.0 109.604 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 m -71.57 -41.4 69.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.072 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.1 mt -60.66 -37.67 82.35 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.489 0.316 . . . . 0.0 111.786 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 93.6 mt -61.76 -36.74 81.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.746 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -95.37 0.77 53.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.99 0.424 . . . . 0.0 111.333 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -90.72 -31.35 16.6 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.86 -19.95 2.9 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.673 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -80.03 99.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 m -78.16 -37.34 46.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.388 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 9.9 pt-20 -120.26 118.66 31.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.8 pt -119.5 160.31 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.71 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.39 112.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.199 0.524 . . . . 0.0 110.745 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.54 126.63 44.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -114.29 112.82 23.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.51 133.87 54.34 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.557 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.593 ' HG2' HG22 ' A' ' 89' ' ' THR . 87.4 mtt180 -129.76 143.61 50.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.21 81.35 0.1 OUTLIER Glycine 0 C--O 1.211 -1.333 0 O-C-N 123.784 0.677 . . . . 0.0 114.49 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 58.66 -7.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 126.192 1.797 . . . . 0.0 115.083 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.58 -3.12 29.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.411 HG23 HG21 ' A' ' 90' ' ' ILE . 69.7 mt -51.7 -39.33 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.188 1.395 . . . . 0.0 110.663 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -68.27 -24.46 64.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.562 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.4 ' HB2' HG21 ' A' ' 14' ' ' ILE . 69.0 mttm -84.86 -27.72 26.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.059 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.58 -44.61 81.79 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.812 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.01 -35.23 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.054 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.52 ' OD1' HG21 ' A' ' 19' ' ' VAL . 15.0 t70 -59.52 -47.87 83.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -54.75 -56.47 18.94 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.338 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 m -67.13 -30.76 50.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.29 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.562 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 27.1 tt0 -65.99 -38.69 89.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.42 0.45 . . . . 0.0 111.014 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.7 mt -66.26 -49.68 74.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.466 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.05 -50.47 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.562 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 35.0 ptt180 -68.56 -7.78 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -115.33 -12.07 11.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.716 0.769 . . . . 0.0 110.369 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -105.77 -53.5 2.63 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -82.22 -60.39 2.23 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.201 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.481 HD12 ' H ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -146.85 105.62 3.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -176.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 6.21 46.12 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.441 ' H ' HD13 ' A' ' 61' ' ' LEU . 31.4 t70 -95.05 -65.0 1.01 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.484 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' H ' HD12 ' A' ' 61' ' ' LEU . 45.9 mttm -98.94 94.24 6.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tp -148.91 141.13 17.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 45.0 tt0 -132.58 152.99 51.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.6 132.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -75.03 -53.75 8.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -173.71 156.84 2.98 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -129.96 115.69 34.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 91' ' ' GLU . 12.5 ptm180 -139.46 147.55 41.51 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.414 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.414 HG12 HG21 ' B' ' 70' ' ' ILE . 11.6 p -144.23 146.76 20.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.29 -171.01 36.07 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.181 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.518 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 36.8 p -108.46 123.83 49.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -99.85 117.57 34.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.65 115.39 42.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.12 163.86 36.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.255 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.8 p -97.66 143.66 28.1 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 t -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 175.9 -38.96 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 124.272 1.029 . . . . 0.0 108.324 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -123.47 -156.51 0.71 Allowed 'General case' 0 C--O 1.251 1.144 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.8 75.02 1.1 Allowed Glycine 0 C--N 1.31 -0.901 0 CA-C-O 121.557 0.532 . . . . 0.0 113.767 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -147.38 104.01 3.61 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.2 120.15 24.99 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.341 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.3 m -103.15 123.81 47.4 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.23 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -104.86 117.31 33.72 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.3 t -127.77 125.94 65.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.162 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 p -67.03 121.57 15.85 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.593 HG22 ' HG2' ' A' ' 42' ' ' ARG . 64.6 p -117.47 153.91 32.32 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.411 HG21 HG23 ' A' ' 46' ' ' ILE . 17.6 tt -142.78 129.79 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.454 ' HB2' ' HG3' ' A' ' 71' ' ' ARG . 3.4 mp0 -107.08 105.83 16.04 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.3 mm -102.26 110.77 29.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.31 128.91 54.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.612 0.244 . . . . 0.0 110.382 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.1 155.07 40.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.514 ' HD3' ' OE1' ' A' ' 36' ' ' GLU . 53.1 ttp180 -133.04 126.2 31.34 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.504 0.669 . . . . 0.0 111.592 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.41 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -88.8 124.3 34.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 66' ' ' GLU . 68.0 mttm . . . . . 0 C--N 1.317 -0.827 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.62 0.248 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -115.92 -168.8 1.48 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 32.9 t -143.88 146.19 32.84 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.08 147.37 4.53 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 8.1 t -159.18 141.71 10.21 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.75 168.07 25.69 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.072 1.848 . . . . 0.0 109.911 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 39.6 m -101.78 109.74 60.29 Favored Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.664 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.57 166.99 10.31 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.284 1.99 . . . . 0.0 111.295 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -114.61 -78.49 0.58 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.383 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -106.03 14.94 27.17 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 20.9 m -120.37 138.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.428 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.36 145.48 35.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.032 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.17 126.45 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.413 HG21 ' HB2' ' B' ' 48' ' ' LYS . 46.4 mm -90.47 115.89 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.84 44.84 0.02 OUTLIER Glycine 0 CA--C 1.523 0.564 0 C-N-CA 118.849 -1.643 . . . . 0.0 114.855 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.89 -43.08 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 117.655 0.728 . . . . 0.0 110.875 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.472 ' HE2' ' HD2' ' B' ' 18' ' ' PRO . 13.5 mmmm -101.32 156.87 34.65 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.449 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.472 ' HD2' ' HE2' ' B' ' 17' ' ' LYS . 29.1 Cg_endo -64.64 157.77 53.78 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.293 1.996 . . . . 0.0 110.727 172.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.444 ' O ' HG23 ' B' ' 23' ' ' VAL . 13.9 p -56.12 -27.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.1 ptp -63.05 -29.24 70.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.065 0.459 . . . . 0.0 111.007 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.32 -37.88 36.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.201 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.62 -36.32 78.49 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.531 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.444 HG23 ' O ' ' B' ' 19' ' ' VAL . 66.2 t -61.2 -47.46 93.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 20' ' ' MET . 89.9 mt -67.66 -30.43 69.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.161 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.3 -51.38 53.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.85 -37.99 89.03 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.353 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 27.7 tp -55.02 -45.61 75.18 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.213 1.005 . . . . 0.0 109.194 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 48.7 m -70.47 -40.72 73.48 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.883 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.5 mt -61.32 -38.1 85.64 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.477 0.311 . . . . 0.0 111.499 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 98.3 mt -61.76 -38.48 88.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.101 0.56 . . . . 0.0 111.882 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -92.89 -5.37 51.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.424 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -84.13 -31.83 25.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.212 0.53 . . . . 0.0 109.788 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.06 -15.01 3.05 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.063 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.15 97.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -73.95 -39.14 63.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.32 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.552 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 10.2 pt-20 -121.14 118.56 30.0 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.41 0.624 . . . . 0.0 111.576 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.6 162.49 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.859 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 57.4 t -129.18 115.66 36.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.23 0.538 . . . . 0.0 110.369 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.8 mt -94.24 122.4 45.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.01 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -110.43 111.75 23.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.145 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.58 132.52 55.09 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.642 ' HG2' HG22 ' B' ' 89' ' ' THR . 87.8 mtt180 -129.06 144.06 51.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.44 80.98 0.12 Allowed Glycine 0 C--O 1.214 -1.11 0 O-C-N 123.879 0.737 . . . . 0.0 114.338 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 56.35 -3.81 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.998 1.719 . . . . 0.0 115.138 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.16 -3.07 34.24 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.271 0.557 . . . . 0.0 110.851 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.404 HG23 HG21 ' B' ' 90' ' ' ILE . 69.2 mt -51.67 -40.46 26.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.857 1.263 . . . . 0.0 110.365 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.6 t -66.12 -28.66 68.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.651 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.413 ' HB2' HG21 ' B' ' 14' ' ' ILE . 68.7 mttm -82.98 -28.39 29.76 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.508 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.8 86.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 120.945 0.402 . . . . 0.0 110.748 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.72 -36.69 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.545 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.468 ' O ' HG13 ' B' ' 55' ' ' ILE . 15.0 t70 -58.86 -46.85 86.79 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -54.45 -57.8 9.93 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.672 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.34 -29.3 45.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.871 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.525 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 24.0 tt0 -67.68 -36.93 81.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.968 0.413 . . . . 0.0 111.089 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.468 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.0 mt -66.56 -50.17 68.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.241 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.04 -50.45 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.525 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 34.5 ptt180 -67.83 -8.21 34.27 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -116.63 -12.51 10.91 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.759 0.79 . . . . 0.0 110.46 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -104.8 -53.51 2.67 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -82.64 -59.93 2.35 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.943 -172.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.558 HD12 ' H ' ' B' ' 64' ' ' LYS . 0.3 OUTLIER -146.72 106.31 3.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.39 6.32 44.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.407 ' H ' HD13 ' B' ' 61' ' ' LEU . 33.0 t70 -94.81 -57.8 2.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.402 0.62 . . . . 0.0 110.924 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.558 ' H ' HD12 ' B' ' 61' ' ' LEU . 48.8 mttm -107.74 95.42 5.67 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.127 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tp -149.22 139.29 16.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.457 ' HB2' ' HE2' ' B' ' 97' ' ' LYS . 45.2 tt0 -130.33 148.39 52.15 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.91 123.94 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -67.45 -59.76 3.12 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.646 0.591 . . . . 0.0 109.847 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.38 154.69 8.72 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.414 HG21 HG12 ' A' ' 72' ' ' VAL . 71.1 mt -129.7 114.14 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 123.617 0.573 . . . . 0.0 109.66 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' B' ' 91' ' ' GLU . 12.4 ptm180 -138.07 146.68 43.24 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.308 -0.245 . . . . 0.0 111.177 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.6 144.69 23.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.82 -171.42 36.11 Favored Glycine 0 CA--C 1.5 -0.874 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.807 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.525 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 26.3 p -107.35 124.77 50.3 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 122.563 0.345 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -100.71 117.08 34.09 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.0 110.5 28.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.8 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.28 160.73 35.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 120.711 0.291 . . . . 0.0 110.409 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 13.1 p -92.62 145.64 24.28 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.004 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 41.2 t -69.69 -42.31 74.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 174.04 -38.38 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -122.44 -158.84 0.8 Allowed 'General case' 0 C--O 1.253 1.267 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.04 76.99 1.18 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-O 121.331 0.406 . . . . 0.0 112.724 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -149.66 105.66 3.46 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.05 122.16 28.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.688 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.2 m -104.48 125.92 51.1 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.686 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -107.52 114.78 29.01 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.37 126.07 68.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.084 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 73.8 p -67.32 122.99 19.1 Favored 'General case' 0 C--O 1.266 1.956 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.642 HG22 ' HG2' ' B' ' 42' ' ' ARG . 60.7 p -119.4 153.49 35.13 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.404 HG21 HG23 ' B' ' 46' ' ' ILE . 18.3 tt -142.46 131.28 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.456 ' HB2' ' HG3' ' B' ' 71' ' ' ARG . 3.4 mp0 -109.02 105.5 15.04 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.588 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mm -102.6 110.72 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.87 129.85 55.89 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.874 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' B' ' 36' ' ' GLU . 35.4 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.597 0.236 . . . . 0.0 110.66 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.552 ' HD3' ' OE2' ' B' ' 36' ' ' GLU . 51.2 ttp180 -126.62 125.3 41.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.978 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.402 ' HB2' HD22 ' B' ' 30' ' ' LEU . 0.0 OUTLIER -89.34 120.67 30.89 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' B' ' 66' ' ' GLU . 67.3 mttm . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m -92.44 98.05 11.23 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.709 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.3 t -102.59 136.3 42.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.882 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.15 -27.36 18.77 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.913 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.7 p -95.51 153.22 39.56 Favored Pre-proline 0 N--CA 1.428 -1.526 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.311 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -73.61 -57.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p 51.51 76.41 0.55 Allowed Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.206 1.002 . . . . 0.0 113.277 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.71 -75.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.392 2.061 . . . . 0.0 113.51 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.2 p -150.14 14.9 0.81 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 120.927 0.394 . . . . 0.0 111.486 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -95.09 3.37 54.86 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.761 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.36 112.49 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -110.55 134.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.264 0.555 . . . . 0.0 110.74 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.59 129.5 43.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.8 mm -91.28 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.99 50.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.103 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -157.6 -65.05 0.09 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 117.22 0.51 . . . . 0.0 110.682 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -101.82 168.45 9.02 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.36 167.13 19.35 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.058 1.839 . . . . 0.0 112.253 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG11 ' OD2' ' A' ' 51' ' ' ASP . 93.1 t -50.32 -38.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.373 1.069 . . . . 0.0 112.602 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.3 ptp -52.02 -31.45 29.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.03 -32.87 63.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 121.507 0.67 . . . . 0.0 110.404 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -80.52 -34.64 35.47 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.285 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.01 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.291 0.567 . . . . 0.0 109.693 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.56 -35.95 81.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.032 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.47 96.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.288 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -9.19 57.69 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.11 0.481 . . . . 0.0 111.76 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.97 -43.99 7.56 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -60.3 -40.33 90.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.55 -36.07 81.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.396 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.529 HD23 ' HG3' ' A' ' 96' ' ' LYS . 3.4 tm? -64.86 -39.23 93.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -67.29 -17.82 64.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.17 0.51 . . . . 0.0 111.188 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -91.96 -4.56 54.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.4 -7.56 32.34 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.098 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.44 99.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -89.45 -29.64 18.87 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.095 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.32 115.99 30.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.782 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -127.81 156.14 39.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.555 -178.044 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.0 t -124.95 124.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.807 0.692 . . . . 0.0 110.549 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.7 mt -105.65 130.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.419 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.39 122.99 41.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.189 0.519 . . . . 0.0 110.897 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.73 155.05 33.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -133.01 141.07 48.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.449 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.47 -118.58 7.91 Favored Glycine 0 CA--C 1.505 -0.574 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.304 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -94.65 8.08 43.58 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.84 -0.38 57.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.888 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.25 -38.3 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 p -62.72 -32.01 73.04 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.305 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -70.19 -37.27 75.06 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.1 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.93 91.22 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.546 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.89 -33.95 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.551 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.529 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 t70 -62.63 -45.24 93.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.7 m -57.0 -53.35 59.04 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.552 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.9 m -66.05 -36.05 76.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.27 -45.18 94.19 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 123.132 0.27 . . . . 0.0 111.563 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.4 mt -60.59 -43.03 93.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.49 -43.95 98.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.503 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -83.45 13.64 4.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.273 0.558 . . . . 0.0 111.41 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -119.99 -45.68 2.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.845 0.355 . . . . 0.0 110.277 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.4 ptp180 -81.8 -21.65 37.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.544 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 60.9 t80 -117.56 -70.12 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.391 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.544 ' HG ' ' CD2' ' A' ' 60' ' ' PHE . 90.0 mt -132.61 114.82 14.67 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.08 -33.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.245 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.33 -52.61 9.6 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.451 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -97.21 88.46 4.47 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.607 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -160.73 120.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.899 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.541 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 10.2 pt-20 -121.7 134.95 54.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 111.056 177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.8 mt -88.81 139.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -84.62 -54.92 4.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.074 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -170.69 152.62 3.83 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.1 mt -134.08 116.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 77.1 mtp180 -116.83 137.47 52.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.866 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.91 124.44 50.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 -168.37 24.71 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.537 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.6 p -118.04 124.34 47.87 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.128 0.489 . . . . 0.0 110.783 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -100.01 128.19 46.13 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.96 115.58 28.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.68 160.59 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.426 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.6 p -91.72 126.92 36.98 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 120.794 0.33 . . . . 0.0 110.35 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -79.94 -20.43 45.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.403 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -163.38 -82.37 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.19 -80.03 0.58 Allowed 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.35 31.35 6.24 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.12 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -106.56 106.57 17.16 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -83.02 136.39 34.52 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.24 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 t -130.83 136.81 49.02 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -101.07 120.4 40.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.25 126.43 73.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -67.64 128.45 36.5 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.473 0.483 . . . . 0.0 110.96 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.4 p -123.0 160.41 26.34 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 71' ' ' ARG . 13.0 tt -146.06 124.35 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -105.0 110.46 22.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.286 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -109.93 116.77 53.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.25 125.18 51.86 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.02 159.0 32.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.541 ' HD2' ' OE2' ' A' ' 66' ' ' GLU . 41.6 ttm180 -126.22 132.32 51.77 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 123.46 0.704 . . . . 0.0 111.18 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HG3' HD23 ' A' ' 30' ' ' LEU . 34.2 mmtp -92.87 149.9 20.96 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.642 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.254 1.333 0 C-N-CA 124.074 0.95 . . . . 0.0 109.489 175.992 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttm . . . . . 0 CA--C 1.51 -0.561 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -107.23 149.67 27.48 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.1 t -83.63 173.4 11.41 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.61 67.49 1.11 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.103 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 9.4 t -140.51 139.15 19.77 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 5' ' ' THR . 1.3 Cg_endo -82.69 -7.13 11.57 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.203 1.935 . . . . 0.0 112.486 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 31.2 p -119.89 123.58 28.37 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.17 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.05 114.41 2.43 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 C-N-CA 122.808 2.338 . . . . 0.0 112.491 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 36.8 t -89.66 118.64 29.43 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -128.26 9.44 6.16 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.64 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.1 115.17 47.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.14 134.57 53.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.086 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 tp -97.58 127.63 43.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.342 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mm -88.52 110.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.3 52.23 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.016 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -159.72 -65.4 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.219 0.509 . . . . 0.0 110.405 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -101.54 168.04 9.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.423 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.59 164.62 30.37 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.978 1.785 . . . . 0.0 112.393 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 95.2 t -46.77 -38.39 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.128 1.371 . . . . 0.0 113.22 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptp -52.31 -35.08 49.65 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -69.9 -35.39 74.57 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.19 0.519 . . . . 0.0 110.685 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -78.75 -35.49 44.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.16 -50.82 78.72 Favored 'Isoleucine or valine' 0 C--O 1.252 1.231 0 CA-C-O 121.601 0.715 . . . . 0.0 109.124 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.89 -32.53 74.28 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.158 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.85 94.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.021 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.16 68.38 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.168 0.509 . . . . 0.0 110.754 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.83 -44.19 42.22 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.468 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -63.21 -38.55 91.6 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.832 0.349 . . . . 0.0 111.152 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.24 -39.04 89.25 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 122.315 -0.241 . . . . 0.0 110.92 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.475 HD23 ' HG3' ' B' ' 96' ' ' LYS . 3.4 tm? -60.19 -40.13 88.96 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.709 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.87 -20.92 66.01 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.045 0.45 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -87.17 -9.28 55.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.11 -4.55 23.82 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.844 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.24 96.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 0.0 109.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -84.03 -28.24 27.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -114.84 120.42 39.93 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.436 ' H ' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.98 154.56 40.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 O-C-N 123.16 0.288 . . . . 0.0 111.348 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.68 124.36 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.216 0.532 . . . . 0.0 110.56 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.64 130.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.343 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.26 123.95 44.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.173 0.511 . . . . 0.0 110.904 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 153.94 35.18 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -129.1 143.39 50.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.47 -122.76 15.35 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 116.312 -0.404 . . . . 0.0 113.533 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.17 11.64 24.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.905 0.383 . . . . 0.0 110.944 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.33 -1.04 57.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.509 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.49 -37.25 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.126 0.571 . . . . 0.0 110.36 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.5 p -66.12 -31.36 72.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.233 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -69.15 -39.96 78.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.31 91.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.606 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -72.4 -34.28 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.589 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.556 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.0 t70 -62.73 -45.18 93.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 90.4 m -56.23 -53.74 53.55 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.622 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.24 -34.23 67.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.959 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -60.99 -47.97 84.0 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.556 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.8 mt -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.883 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.01 -41.03 91.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -85.76 14.7 5.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.24 0.543 . . . . 0.0 111.043 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -121.33 -45.44 2.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.277 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.8 ptp180 -83.28 -19.28 36.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.462 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.55 ' CD2' ' HG ' ' B' ' 61' ' ' LEU . 57.8 t80 -118.66 -71.56 0.73 Allowed 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.64 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.55 ' HG ' ' CD2' ' B' ' 60' ' ' PHE . 94.0 mt -131.15 114.91 15.69 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.158 0.504 . . . . 0.0 111.71 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.26 -32.16 11.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.551 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.83 -49.48 11.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.0 87.35 3.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.413 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -160.71 119.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 11.0 pt-20 -122.04 136.16 54.89 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.131 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.42 143.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.76 -58.14 2.68 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.925 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -167.67 152.0 6.61 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 67.0 mt -133.35 115.56 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' B' ' 90' ' ' ILE . 73.9 mtp180 -115.06 136.41 53.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.822 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.72 126.08 56.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.12 -168.45 26.19 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.156 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.2 p -116.27 121.14 41.12 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.359 0.6 . . . . 0.0 111.235 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -96.22 127.2 42.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.643 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.3 114.99 26.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -121.38 157.44 24.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.009 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 16.9 p -87.94 127.44 35.37 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 120.894 0.378 . . . . 0.0 110.476 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 47.1 t -76.76 -31.93 57.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.468 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -153.42 -77.67 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -120.17 -76.37 0.58 Allowed 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 121.086 0.47 . . . . 0.0 110.058 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.84 35.96 4.16 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.782 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -114.66 111.83 21.93 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -90.28 136.85 32.79 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.536 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 35.4 t -129.69 137.73 50.78 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -100.77 118.89 37.76 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 72.7 t -115.7 125.24 72.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -67.26 127.08 31.31 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.969 0.414 . . . . 0.0 111.232 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 67.8 p -121.42 159.37 26.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.095 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' B' ' 71' ' ' ARG . 12.3 tt -146.21 124.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.933 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -103.59 113.16 26.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.31 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.9 mt -112.02 114.64 47.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.32 125.45 53.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 pt -126.07 158.54 35.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' B' ' 66' ' ' GLU . 41.5 ttm180 -124.53 134.95 52.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.475 ' HG3' HD23 ' B' ' 30' ' ' LEU . 34.1 mmtp -97.66 148.52 23.24 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 123.849 0.86 . . . . 0.0 109.517 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.517 175.994 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 C--O 1.216 -0.698 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 p -127.0 -52.09 1.43 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.064 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 m -145.43 167.97 21.67 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 122.122 -0.361 . . . . 0.0 110.424 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.24 58.16 0.02 OUTLIER Glycine 0 CA--C 1.499 -0.929 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 22.0 p -106.35 133.98 19.99 Favored Pre-proline 0 N--CA 1.433 -1.307 0 C-N-CA 122.22 0.208 . . . . 0.0 110.983 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 2.0 Cg_endo -82.79 23.34 0.82 Allowed 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.597 2.198 . . . . 0.0 111.031 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.6 p -110.25 152.2 43.06 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.621 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.13 169.38 18.25 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.054 1.836 . . . . 0.0 110.365 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 p -81.63 81.89 7.55 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.264 0.554 . . . . 0.0 110.846 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -121.33 11.53 10.77 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.394 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 58.3 t -116.06 119.59 62.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.11 147.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.098 0.475 . . . . 0.0 111.284 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 tp -110.76 134.82 52.16 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.52 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.412 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.69 -138.06 4.59 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -101.68 18.3 20.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.86 154.67 38.23 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.152 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.44 148.15 53.81 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.187 2.591 . . . . 0.0 112.499 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.532 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -54.68 -36.15 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.762 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.417 ' O ' HD13 ' A' ' 24' ' ' LEU . 26.9 ptt? -59.31 -24.76 63.58 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -64.86 -38.59 91.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -85.33 -33.42 22.07 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.987 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.5 t -62.29 -55.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.169 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 20' ' ' MET . 9.3 mp -62.05 -26.45 68.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.692 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.481 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.68 -45.75 70.86 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.118 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -61.58 -42.45 98.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp -61.84 -38.26 87.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.1 m -68.2 -37.94 81.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.924 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 96.7 mt -63.18 -34.99 78.83 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.368 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.9 mt -57.52 -41.8 81.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.28 -16.89 62.49 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -91.63 2.05 56.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.51 0.672 . . . . 0.0 110.338 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.68 -3.81 59.31 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.56 91.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 t -90.24 -12.13 38.87 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.96 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 43.3 tt0 -124.56 111.98 16.3 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.444 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -125.89 156.82 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.823 0.345 . . . . 0.0 111.698 -177.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -126.35 125.49 67.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.009 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.81 129.45 61.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.125 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -118.73 123.54 45.1 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -121.01 153.07 37.82 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -129.59 140.95 51.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.089 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.7 -135.04 18.6 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.292 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -83.05 2.63 34.1 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.5 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.5 30.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.579 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.35 -36.95 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.361 0.601 . . . . 0.0 109.705 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.1 p -61.55 -37.42 83.73 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.543 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -67.64 -42.84 81.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.153 -178.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -64.02 -45.27 89.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.466 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.8 -36.77 65.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.805 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.532 ' OD2' HG21 ' A' ' 19' ' ' VAL . 17.9 t70 -59.59 -47.63 84.83 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 56' ' ' VAL . 87.2 m -53.36 -53.56 49.28 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.444 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -69.98 -31.18 46.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 25.3 tt0 -68.61 -32.17 71.87 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.947 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.3 mt -68.69 -42.83 83.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.119 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 52' ' ' THR . 59.8 t -69.19 -30.93 47.98 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 CA-C-O 121.25 0.548 . . . . 0.0 111.292 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 40.4 ptt180 -88.88 14.98 9.16 Favored 'General case' 0 C--O 1.211 -0.94 0 O-C-N 122.023 -0.423 . . . . 0.0 110.299 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -128.67 -56.02 1.22 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -73.27 -29.15 62.54 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -97.96 -63.21 1.15 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.023 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.48 110.55 5.69 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.798 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.41 -46.69 8.2 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.555 1.159 . . . . 0.0 110.777 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.91 -29.52 58.45 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.77 97.23 7.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -160.95 143.69 4.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.957 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.72 141.72 51.48 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.35 125.6 68.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HD2' ' HG3' ' A' ' 36' ' ' GLU . 29.6 mtpp -86.05 -62.48 1.51 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.28 149.29 5.91 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.014 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.2 mt -139.15 99.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.22 136.79 54.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.8 t -102.16 132.7 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.82 167.29 28.24 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.881 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 p -93.88 135.89 34.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.829 0.347 . . . . 0.0 110.825 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.486 ' HG2' HG13 ' A' ' 77' ' ' VAL . 36.0 tt0 -100.48 114.18 27.56 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG22 ' HG2' ' A' ' 86' ' ' ARG . 45.1 t -95.86 108.19 20.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.486 HG13 ' HG2' ' A' ' 75' ' ' GLN . 26.1 m -124.52 165.79 20.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.269 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.7 p -88.36 131.74 34.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 120.902 0.382 . . . . 0.0 110.461 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.4 t -86.21 -30.55 22.31 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.762 0.315 . . . . 0.0 111.032 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -144.87 -76.5 0.22 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.322 0.582 . . . . 0.0 110.711 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -123.24 -79.42 0.61 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.406 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.34 7.43 26.67 Favored Glycine 0 CA--C 1.506 -0.493 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.017 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -84.3 107.47 16.61 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -79.0 137.11 37.42 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.703 0.627 . . . . 0.0 110.582 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.9 t -125.07 129.28 49.93 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.479 ' HG2' HG22 ' A' ' 76' ' ' VAL . 99.5 mtt180 -102.83 125.53 49.61 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.58 136.44 58.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.7 p -70.24 127.26 32.19 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.518 0.675 . . . . 0.0 111.956 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.0 p -133.11 160.15 38.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.774 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.67 139.53 48.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -118.13 110.76 18.0 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -111.5 119.74 60.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.41 120.26 30.56 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.723 0.297 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.34 168.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 ttt180 -136.85 133.7 36.12 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.22 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 70.7 mmtt -95.72 -170.46 2.15 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt . . . . . 0 C--O 1.255 1.351 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.998 176.172 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.5 tpp . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m 71.06 176.46 0.28 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.073 0.949 . . . . 0.0 111.301 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 45.8 t -107.0 -52.2 2.8 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.715 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.49 -7.82 53.42 Favored Glycine 0 CA--C 1.503 -0.683 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.597 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 40.5 p 52.9 82.28 0.25 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.458 1.103 . . . . 0.0 113.417 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -90.97 173.21 2.93 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 122.501 2.134 . . . . 0.0 111.447 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p 55.98 91.53 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.65 1.18 . . . . 0.0 113.264 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.99 112.99 1.46 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.051 2.5 . . . . 0.0 112.614 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -95.5 11.32 33.38 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.508 0.67 . . . . 0.0 109.976 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -94.57 9.26 39.31 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.734 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.03 114.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -111.29 143.46 21.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.01 138.28 43.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -86.18 125.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.792 0.329 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.56 -140.0 7.46 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.777 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -99.81 14.87 28.82 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -91.31 154.38 44.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.328 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.96 146.68 56.14 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.203 2.602 . . . . 0.0 112.391 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.435 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.1 p -51.66 -35.52 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.307 1.043 . . . . 0.0 113.516 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.09 -25.34 66.89 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.27 -36.96 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.495 0.664 . . . . 0.0 110.117 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -87.04 -33.66 19.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.205 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 19' ' ' VAL . 65.6 t -61.31 -55.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.583 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.66 -26.16 68.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.761 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -68.34 -44.18 75.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.173 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -41.72 96.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.14 -36.81 80.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.958 0.408 . . . . 0.0 110.671 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 37.9 m -68.66 -38.36 80.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 95.6 mt -63.58 -35.18 79.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.254 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.2 mt -55.84 -42.81 76.32 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -71.61 -15.14 62.24 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -93.38 1.7 56.8 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.37 0.605 . . . . 0.0 110.382 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.42 -8.27 58.55 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.657 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.92 91.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.249 0.547 . . . . 0.0 109.605 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -90.16 -13.17 36.19 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.773 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -123.91 116.62 23.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.906 -0.496 . . . . 0.0 109.669 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 157.9 42.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-O 120.806 0.336 . . . . 0.0 111.633 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.0 124.7 65.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.218 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.9 mt -106.97 127.43 62.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.03 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -117.22 122.32 43.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.689 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.59 40.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -128.17 139.82 52.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.332 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.83 -136.14 20.25 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.239 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -80.52 0.53 33.36 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 122.439 -0.447 . . . . 0.0 111.53 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.43 -0.81 27.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.627 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 75.2 mt -55.91 -38.87 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.15 0.5 . . . . 0.0 110.021 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -61.71 -38.03 86.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.733 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.401 ' NZ ' ' HB2' ' B' ' 48' ' ' LYS . 0.0 OUTLIER -66.14 -41.56 90.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.28 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.89 81.23 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.209 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.11 -34.09 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.462 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.525 ' O ' HG13 ' B' ' 55' ' ' ILE . 12.3 t70 -60.9 -47.18 87.56 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -54.84 -55.08 34.21 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 18.0 m -68.14 -31.88 53.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.131 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.521 ' HG3' ' HE ' ' B' ' 57' ' ' ARG . 27.3 tt0 -68.6 -31.01 69.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.099 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.525 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.0 mt -69.54 -43.59 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.191 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.41 -31.36 52.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 CA-C-O 121.297 0.57 . . . . 0.0 111.335 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.521 ' HE ' ' HG3' ' B' ' 54' ' ' GLU . 40.0 ptt180 -88.66 17.27 5.64 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -131.56 -57.08 1.0 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.138 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -72.55 -26.68 61.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -101.65 -64.03 1.09 Allowed 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.975 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -141.93 112.33 7.07 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.7 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.9 -50.23 5.82 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 124.293 0.995 . . . . 0.0 110.875 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.49 -28.76 62.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -105.54 98.02 7.77 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.442 0.639 . . . . 0.0 110.755 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tp -161.15 145.12 4.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.869 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -126.17 138.48 53.66 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.24 126.72 63.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -86.63 -64.47 1.15 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -166.33 146.98 6.31 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.393 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.3 mt -139.43 100.82 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.19 143.46 50.49 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.59 123.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.56 168.64 24.1 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.761 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.51 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 35.1 p -92.96 133.34 36.22 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.659 0.384 . . . . 0.0 110.907 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' GLN . . . . . 0.454 ' HG2' HG13 ' B' ' 77' ' ' VAL . 36.1 tt0 -99.61 114.49 27.57 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' B' ' 86' ' ' ARG . 46.7 t -96.19 107.81 20.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.454 HG13 ' HG2' ' B' ' 75' ' ' GLN . 19.9 m -124.21 168.11 17.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.158 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 17.4 p -91.02 132.83 35.76 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.843 0.354 . . . . 0.0 110.102 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 36.7 t -88.35 -26.36 22.26 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.329 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -148.57 -84.36 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.093 0.557 . . . . 0.0 110.596 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -113.03 -80.27 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.671 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.84 3.79 25.87 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.11 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -78.47 103.84 8.68 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -77.68 137.2 38.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.505 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.2 t -124.39 130.01 51.71 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.474 ' HG2' HG22 ' B' ' 76' ' ' VAL . 99.6 mtt180 -101.5 128.17 47.85 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.62 137.4 56.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 7.2 p -72.31 127.47 32.67 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.464 0.649 . . . . 0.0 112.223 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.75 158.38 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.114 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.04 139.54 50.06 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -119.16 112.38 19.44 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -112.39 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.01 35.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 pt -125.14 163.26 26.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 120.983 0.421 . . . . 0.0 110.482 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' B' ' 96' ' ' LYS . 76.4 ttt180 -132.44 134.21 44.81 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' B' ' 95' ' ' ARG . 69.4 mmtt -97.6 -170.36 1.99 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.318 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt . . . . . 0 C--O 1.256 1.4 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.195 176.773 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.496 -1.107 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 p -170.94 135.49 1.05 Allowed 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 123.828 0.705 . . . . 0.0 109.155 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m -133.39 4.22 3.67 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.983 0.421 . . . . 0.0 110.762 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.09 -10.17 75.72 Favored Glycine 0 N--CA 1.463 0.449 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 34.7 p -85.39 147.02 45.96 Favored Pre-proline 0 N--CA 1.418 -2.07 0 CA-C-N 115.084 -0.558 . . . . 0.0 109.75 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 3.7 Cg_exo -81.83 23.41 0.77 Allowed 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.695 2.264 . . . . 0.0 111.419 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.8 p -91.41 116.74 67.04 Favored Pre-proline 0 N--CA 1.434 -1.237 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.351 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.51 138.65 27.3 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.912 1.741 . . . . 0.0 111.251 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.3 p -83.32 87.23 6.96 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.161 0.505 . . . . 0.0 110.32 176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -118.3 12.46 13.42 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.547 0.689 . . . . 0.0 110.385 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.65 120.37 60.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.156 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.53 139.69 42.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.991 0.424 . . . . 0.0 110.693 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.3 tp -104.21 136.73 43.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.313 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -84.09 123.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.4 -159.49 11.77 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.03 13.41 1.79 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -86.07 152.48 56.03 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 121.95 -0.469 . . . . 0.0 112.162 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.65 150.79 59.16 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.859 2.373 . . . . 0.0 112.213 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.545 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.4 p -56.23 -35.31 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.503 0.721 . . . . 0.0 112.388 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.1 ptp -57.89 -30.81 66.17 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.93 -34.08 74.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -79.09 -33.34 44.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.196 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 66.1 t -61.62 -48.52 88.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.84 -38.54 91.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.645 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.81 -44.64 96.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.2 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.38 96.61 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.19 0.519 . . . . 0.0 111.012 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 95.3 mt -64.92 -38.97 92.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.806 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.9 m -67.74 -31.79 71.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.2 mt -70.6 -40.37 73.25 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 122.088 -0.383 . . . . 0.0 110.245 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.56 -40.97 89.07 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.372 0.606 . . . . 0.0 109.406 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -59.13 -30.21 67.96 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.44 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -91.26 3.19 55.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.52 11.99 57.58 Favored Glycine 0 C--O 1.244 0.759 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.921 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.31 98.04 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 13.1 p -87.46 -13.87 42.01 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.404 ' OE1' ' HG3' ' A' ' 68' ' ' LYS . 36.6 tt0 -128.66 111.79 13.56 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -126.35 159.66 35.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.02 127.29 51.46 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-O 121.573 0.701 . . . . 0.0 110.86 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -101.88 124.29 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.52 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 81.8 mttt -115.46 114.27 24.81 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.32 0.581 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.07 158.49 17.7 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.848 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.546 ' HG2' HG22 ' A' ' 89' ' ' THR . 54.8 mtm180 -133.54 148.68 51.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.91 -121.58 19.57 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 123.559 0.537 . . . . 0.0 113.016 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -92.0 -0.28 57.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.63 -4.03 46.92 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -54.9 -36.07 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.7 0.8 . . . . 0.0 110.529 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -63.39 -35.49 80.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.616 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.23 -30.04 60.42 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.3 82.35 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.31 -37.19 64.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.184 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.545 ' OD2' HG21 ' A' ' 19' ' ' VAL . 34.9 t70 -60.66 -43.39 97.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.875 0.369 . . . . 0.0 110.086 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -58.71 -51.25 70.77 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.279 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.96 -32.37 51.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.59 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 7.6 tp10 -63.66 -40.3 96.51 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.1 mt -64.21 -44.33 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.81 -39.59 82.34 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.831 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.522 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 2.6 ptm180 -80.66 1.33 30.43 Favored 'General case' 0 C--O 1.206 -1.199 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -128.17 11.35 6.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.081 0.467 . . . . 0.0 111.789 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -118.1 -66.71 1.05 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.709 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -75.9 -67.17 0.7 Allowed 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.827 0.346 . . . . 0.0 110.386 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.484 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -138.23 109.25 6.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -87.04 -44.9 11.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.429 1.08 . . . . 0.0 110.343 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.96 -28.71 67.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.619 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -121.02 106.84 11.96 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -159.26 120.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.291 0.567 . . . . 0.0 110.506 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -98.45 134.39 41.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.264 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.5 mt -101.2 122.64 53.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 1.9 tmtp? -83.58 -55.59 4.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.398 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -173.55 154.25 2.49 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -133.4 116.18 24.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -119.31 134.79 55.02 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.725 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 90' ' ' ILE . 46.4 t -125.84 131.57 71.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.88 28.92 Favored Glycine 0 CA--C 1.493 -1.335 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -115.18 145.11 42.71 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 117.228 0.514 . . . . 0.0 111.238 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -114.48 134.81 54.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.2 m -88.98 123.34 41.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.408 0.623 . . . . 0.0 110.93 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.26 136.5 59.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.65 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.0 p -83.93 115.3 22.23 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.165 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.8 t -63.29 -41.45 98.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.163 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -140.31 -73.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -122.56 -82.14 0.65 Allowed 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.784 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.67 46.7 1.13 Allowed Glycine 0 CA--C 1.498 -0.981 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.96 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -128.56 95.3 4.09 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -84.76 120.64 26.66 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.595 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 t -105.33 134.6 48.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.72 114.79 29.16 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.85 139.62 42.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.8 p -67.41 126.29 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 O-C-N 123.757 0.661 . . . . 0.0 110.828 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.546 HG22 ' HG2' ' A' ' 42' ' ' ARG . 46.6 p -132.03 151.19 51.89 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.2 tt -136.11 140.0 44.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.92 109.42 15.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.68 111.8 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.12 122.58 47.98 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.978 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.32 157.65 24.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.783 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.5 ttp180 -126.02 133.44 51.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.484 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 3.1 tmtm? -108.1 139.46 42.73 Favored 'General case' 0 N--CA 1.413 -2.288 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.235 -174.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 73.9 mmtt . . . . . 0 C--O 1.256 1.395 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.5 p -89.72 -35.99 15.45 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m 71.73 -38.83 0.43 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.947 1.299 . . . . 0.0 112.212 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.6 -153.87 7.61 Favored Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 38.3 p -79.89 130.56 66.54 Favored Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 122.253 0.221 . . . . 0.0 111.024 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.73 178.63 6.91 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 123.107 2.538 . . . . 0.0 112.096 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 60.0 m -88.71 127.22 57.09 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.191 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.24 122.08 11.06 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 123.428 2.752 . . . . 0.0 112.55 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -103.08 85.83 2.58 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.215 0.531 . . . . 0.0 110.016 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -129.04 15.09 6.29 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.614 0.721 . . . . 0.0 110.886 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.38 126.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.067 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.51 139.8 46.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.104 0.478 . . . . 0.0 110.495 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 tp -104.32 138.23 41.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.299 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -85.34 123.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.253 0.549 . . . . 0.0 111.295 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.9 -160.49 11.91 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.48 12.46 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -84.64 153.42 61.29 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.805 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.28 154.32 29.58 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.755 2.304 . . . . 0.0 111.772 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.443 HG21 ' OD2' ' B' ' 51' ' ' ASP . 7.1 p -61.58 -35.88 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.028 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.408 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.3 ptp -56.93 -28.74 62.44 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.179 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.18 -36.83 77.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -76.42 -32.92 58.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.434 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 70.2 t -60.94 -50.48 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 20' ' ' MET . 91.9 mt -64.1 -34.36 77.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.35 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.72 81.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.73 97.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.963 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 97.6 mt -63.8 -37.93 89.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.618 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -34.54 77.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.191 0.519 . . . . 0.0 110.251 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.38 -40.55 81.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.201 -0.312 . . . . 0.0 110.421 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.67 -39.35 80.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.096 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.25 -28.78 69.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.354 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -92.5 6.67 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.873 0.368 . . . . 0.0 111.909 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.73 60.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.433 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.82 97.57 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 31.7 p -83.8 -21.71 32.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -122.2 115.27 22.09 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.454 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.65 154.34 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.04 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.06 128.48 67.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 CA-C-O 121.775 0.798 . . . . 0.0 111.22 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -101.91 124.67 55.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.728 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.6 mttt -114.82 115.68 27.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.398 0.618 . . . . 0.0 110.744 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.41 158.54 18.36 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.488 ' HG2' HG22 ' B' ' 89' ' ' THR . 50.9 mtm180 -132.33 149.94 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.61 -117.08 9.84 Favored Glycine 0 N--CA 1.446 -0.643 0 O-C-N 123.604 0.565 . . . . 0.0 113.02 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -97.43 0.5 47.85 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.16 -2.96 43.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.686 0.279 . . . . 0.0 111.699 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.79 -36.21 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.887 0.875 . . . . 0.0 110.268 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.2 p -63.64 -35.4 80.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.37 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -76.29 -29.42 57.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.44 77.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -71.04 -34.91 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.515 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.0 t70 -60.87 -42.97 98.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.003 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.1 m -60.63 -53.17 60.7 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.512 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.35 -31.78 52.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 8.3 tp10 -64.92 -39.72 93.95 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.515 HG13 ' O ' ' B' ' 51' ' ' ASP . 81.7 mt -63.08 -45.65 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.6 t -60.52 -39.23 80.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.507 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 2.9 ptm180 -79.64 -2.87 44.68 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -127.21 20.75 6.81 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.041 0.448 . . . . 0.0 111.383 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -125.8 -66.58 0.93 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.547 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -77.61 -67.47 0.72 Allowed 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.479 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 0.6 OUTLIER -137.21 110.0 7.6 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -86.59 -47.34 9.3 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 124.264 0.977 . . . . 0.0 110.71 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.56 -30.89 65.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.796 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -117.8 102.54 9.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.546 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -156.16 121.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.102 0.477 . . . . 0.0 110.647 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' B' ' 95' ' ' ARG . 23.5 mm-40 -99.98 133.79 43.85 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.061 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.45 123.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.21 -52.85 5.92 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.79 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -176.88 152.95 0.99 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.83 115.5 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -118.2 134.59 54.88 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.822 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.52 134.51 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.58 -167.44 37.9 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.9 p -109.66 149.28 29.94 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 117.59 0.695 . . . . 0.0 111.076 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.45 132.8 56.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 m -88.47 120.74 37.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.387 0.613 . . . . 0.0 111.318 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.3 138.41 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.34 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 12.6 p -82.74 118.1 23.13 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.765 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 48.4 t -63.82 -42.02 97.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.133 0.492 . . . . 0.0 110.977 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -139.5 -75.38 0.36 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -126.53 -79.23 0.6 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.409 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.63 58.78 0.44 Allowed Glycine 0 C--N 1.306 -1.116 0 C-N-CA 119.866 -1.159 . . . . 0.0 112.989 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -144.28 103.6 4.0 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -93.1 118.16 30.89 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.732 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -100.39 136.18 40.68 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.5 112.61 25.74 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.41 138.99 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 13.1 p -66.24 128.02 34.47 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.216 0.532 . . . . 0.0 110.859 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.488 HG22 ' HG2' ' B' ' 42' ' ' ARG . 47.9 p -132.87 148.64 52.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.118 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 15.4 tt -133.62 139.37 48.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -118.09 108.9 15.78 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.72 111.8 37.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.0 123.24 49.88 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.815 0.341 . . . . 0.0 110.216 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -121.97 155.85 26.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' B' ' 35' ' ' SER . 60.7 ttp180 -126.06 128.5 47.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.484 ' HD3' ' H ' ' B' ' 97' ' ' LYS . 2.7 tmtm? -104.94 143.34 33.3 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 -174.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.484 ' H ' ' HD3' ' B' ' 96' ' ' LYS . 74.4 mmtt . . . . . 0 C--O 1.263 1.8 0 CA-C-O 117.253 -1.356 . . . . 0.0 107.697 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mmm . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -68.25 -27.02 65.98 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.792 0.33 . . . . 0.0 111.239 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 m -123.95 165.84 16.72 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.09 -53.82 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 p -87.74 161.73 43.82 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -84.94 9.81 4.0 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.649 2.233 . . . . 0.0 113.005 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 m -91.5 112.34 53.75 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.08 120.34 6.76 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.328 2.019 . . . . 0.0 111.972 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 m -98.64 137.31 37.45 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.658 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -112.45 9.01 19.6 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.701 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -95.19 117.58 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 m -107.95 136.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.441 0.638 . . . . 0.0 111.57 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.26 104.74 14.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.819 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.89 107.7 12.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.375 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.53 36.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.921 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -160.21 -50.95 0.05 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.85 0.86 . . . . 0.0 110.611 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -97.97 154.88 37.6 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.777 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.78 156.37 62.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.914 2.409 . . . . 0.0 113.077 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.34 -41.73 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.811 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -62.85 -25.19 68.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.954 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.14 -21.83 56.13 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.294 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.0 -35.53 17.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.57 -50.65 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.143 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.09 -29.07 69.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.06 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -70.22 -48.15 58.31 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.621 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.86 91.03 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.516 0.51 . . . . 0.0 110.681 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.1 -30.6 71.56 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.305 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 93.7 m -78.89 -42.57 26.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 99.0 mt -62.78 -31.73 72.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.821 0.344 . . . . 0.0 110.732 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.96 -45.12 96.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.84 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.05 -25.64 64.57 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.421 0.629 . . . . 0.0 110.006 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' THR . 15.1 mm100 -80.01 -3.64 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.386 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 -7.93 36.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.447 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -85.44 97.18 5.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 42.5 m -98.38 0.01 44.58 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.796 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -135.38 115.15 12.89 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 155.35 41.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 O-C-N 123.306 0.379 . . . . 0.0 110.684 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.22 122.93 62.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.55 132.6 47.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.285 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' HG2' ' HG2' ' A' ' 91' ' ' GLU . 53.5 mttp -121.53 122.13 39.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.34 0.591 . . . . 0.0 111.359 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.68 147.73 50.77 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.158 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HG3' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.0 152.04 50.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 -124.25 9.12 Favored Glycine 0 C--N 1.309 -0.964 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.274 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -92.69 2.66 56.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.209 0.528 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.56 -7.68 55.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.967 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -55.83 -40.78 63.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.7 t -63.11 -33.38 75.33 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.959 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.79 -35.82 62.51 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.157 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.26 93.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.743 0.306 . . . . 0.0 111.508 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.88 -33.23 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 110.768 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.1 t70 -66.23 -40.82 90.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -57.46 -46.51 83.56 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.566 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -71.38 -36.74 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.07 -45.81 79.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.413 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 74.1 mt -59.16 -50.35 80.1 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.788 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.83 -46.4 96.6 Favored 'Isoleucine or valine' 0 C--O 1.256 1.407 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -80.18 -5.48 56.15 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.119 0.485 . . . . 0.0 112.265 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -125.69 12.02 7.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -123.09 -41.49 2.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.772 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -123.71 -57.58 1.63 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.338 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.27 76.68 7.58 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.459 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 18.26 19.05 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.321 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -149.65 -59.7 0.21 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.515 0.674 . . . . 0.0 110.414 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HB3' ' OXT' ' A' ' 97' ' ' LYS . 48.3 mttm -94.07 80.75 4.08 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.098 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' O ' ' HE3' ' A' ' 97' ' ' LYS . 8.5 tp -159.2 145.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.291 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.41 167.93 21.0 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.036 0.446 . . . . 0.0 110.78 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.71 128.26 55.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.86 -57.45 3.75 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -177.03 146.9 0.53 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.4 pt -130.55 129.64 64.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.27 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -135.97 143.73 45.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.409 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 p -137.44 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.98 -145.42 5.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 m -138.38 134.47 34.21 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 65.2 tt0 -96.83 140.29 31.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.804 0.335 . . . . 0.0 110.276 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -100.91 109.96 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.28 150.71 18.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 120.812 0.339 . . . . 0.0 110.604 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 p -85.69 124.26 32.02 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.286 0.565 . . . . 0.0 109.897 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.2 m -92.17 -19.67 22.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.299 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -141.15 -82.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 110.589 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -135.18 -72.25 0.47 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.64 -16.19 29.69 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.614 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -65.75 110.49 2.83 Favored 'General case' 0 C--O 1.253 1.284 0 O-C-N 122.621 -0.341 . . . . 0.0 110.944 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -90.99 152.36 20.72 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.15 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.1 t -141.57 152.67 44.27 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 94.3 mtt180 -121.36 131.69 54.33 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 120.893 0.378 . . . . 0.0 110.743 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.55 136.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 m -62.81 123.99 19.89 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 123.566 0.541 . . . . 0.0 109.855 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 42' ' ' ARG . 33.7 p -130.57 146.53 52.11 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.365 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -135.6 140.11 45.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.729 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.454 ' HG2' ' HG2' ' A' ' 40' ' ' LYS . 43.8 mt-10 -120.13 115.49 23.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.868 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.06 115.49 49.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.66 128.13 55.08 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -132.77 159.72 43.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 35' ' ' SER . 59.4 ttp180 -140.93 145.56 36.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' C ' ' HD3' ' A' ' 96' ' ' LYS . 12.7 tmtt? -89.72 141.48 28.57 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.976 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' OXT' ' HB3' ' A' ' 64' ' ' LYS . 98.2 mttt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 CA--C 1.494 -1.203 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -125.5 -52.54 1.6 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.951 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 40.1 t 66.84 96.6 0.06 Allowed 'General case' 0 C--N 1.35 0.625 0 O-C-N 124.094 0.871 . . . . 0.0 111.482 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.33 -121.74 2.62 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 66.8 p -84.94 145.97 44.8 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.57 -162.43 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.29 1.993 . . . . 0.0 110.909 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -55.49 131.22 70.75 Favored Pre-proline 0 C--O 1.253 1.276 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.06 107.77 0.19 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.571 2.847 . . . . 0.0 113.219 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.7 p -163.92 -47.02 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.701 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -89.58 8.42 31.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.185 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 48.4 t -102.36 109.27 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.8 m -103.16 137.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.763 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.45 108.38 19.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.917 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.38 116.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.097 0.475 . . . . 0.0 109.927 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.38 35.46 0.02 OUTLIER Glycine 0 C--N 1.311 -0.823 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.829 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -161.92 -48.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.967 0.907 . . . . 0.0 111.212 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -99.88 155.48 36.41 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.391 -174.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.77 153.1 79.61 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.736 2.291 . . . . 0.0 112.374 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.446 ' O ' HG23 ' B' ' 23' ' ' VAL . 7.1 p -52.51 -39.47 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.616 0.767 . . . . 0.0 112.858 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -63.38 -26.78 68.91 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.76 -25.86 60.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.317 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.04 -37.85 21.61 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 19' ' ' VAL . 61.4 t -58.55 -49.56 81.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.426 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.3 -28.4 68.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.748 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -69.66 -47.9 61.71 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.447 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -45.62 87.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.606 0.566 . . . . 0.0 110.977 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.04 -31.49 72.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.157 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 90.6 m -77.12 -44.47 30.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.595 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 96.6 mt -61.57 -31.64 71.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.92 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.5 -45.29 94.32 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.128 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -69.57 -24.78 63.75 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.428 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -79.91 -8.56 59.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.153 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.48 2.83 33.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.231 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.86 96.19 5.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 41.4 m -100.08 2.81 43.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -137.48 111.35 8.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.437 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.23 157.2 40.62 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.063 -176.147 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 60.4 t -127.13 122.23 59.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.268 0.556 . . . . 0.0 111.073 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.07 130.43 50.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' B' ' 91' ' ' GLU . 52.4 mttp -120.5 122.77 41.36 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.46 0.648 . . . . 0.0 111.291 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.45 ' HG3' HG22 ' B' ' 89' ' ' THR . 0.1 OUTLIER -130.98 151.85 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.97 -126.19 11.8 Favored Glycine 0 C--N 1.303 -1.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.177 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -89.79 1.21 56.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.07 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.82 -8.16 55.6 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.235 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.45 -39.96 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.407 0.683 . . . . 0.0 110.799 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 40.6 t -63.25 -33.48 75.58 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.065 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -75.31 -35.18 61.29 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.321 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.14 88.86 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.263 0.554 . . . . 0.0 111.381 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.72 -30.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.503 ' O ' HG13 ' B' ' 55' ' ' ILE . 22.9 t70 -66.4 -42.98 87.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 70.4 m -56.5 -47.5 79.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.786 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.6 m -70.1 -38.1 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.83 -46.45 78.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.15 0.281 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.1 mt -58.56 -51.1 75.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.017 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.18 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--O 1.254 1.341 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -79.98 -5.04 54.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -127.28 14.86 7.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -125.86 -38.69 2.18 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.818 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -126.69 -57.96 1.33 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.16 74.85 8.73 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.983 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.88 24.96 8.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.293 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -153.52 -59.77 0.13 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.772 0.796 . . . . 0.0 109.754 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.488 ' HB3' ' OXT' ' B' ' 97' ' ' LYS . 46.7 mttm -98.25 81.71 2.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.106 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.415 ' O ' ' HE3' ' B' ' 97' ' ' LYS . 8.9 tp -157.53 146.13 10.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.84 169.49 17.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.148 0.499 . . . . 0.0 110.854 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.47 128.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -79.9 -58.59 3.1 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 43.5 tt0 -175.82 145.04 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.03 0.932 . . . . 0.0 108.913 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.91 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.45 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 53.5 mtt180 -135.79 139.67 43.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.09 144.07 36.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.41 -145.69 6.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -136.37 137.68 40.81 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -99.1 139.69 34.38 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.728 0.299 . . . . 0.0 110.197 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -100.71 112.1 32.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.99 153.04 18.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.301 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 9.7 p -88.16 124.89 34.27 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.095 0.474 . . . . 0.0 109.779 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 22.4 m -92.2 -19.06 22.62 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.787 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -144.48 -79.56 0.19 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.162 0.505 . . . . 0.0 110.269 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -136.15 -75.88 0.43 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.441 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.17 -8.78 46.63 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.5 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -72.7 109.64 6.47 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -89.65 153.87 20.4 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 124.046 0.841 . . . . 0.0 109.154 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -141.12 144.72 35.03 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -114.91 130.57 56.93 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 123.334 0.396 . . . . 0.0 110.836 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.6 133.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 20.3 m -60.0 124.6 20.72 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.546 0.529 . . . . 0.0 109.904 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.45 HG22 ' HG3' ' B' ' 42' ' ' ARG . 33.5 p -132.22 144.69 50.81 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.249 -176.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.8 tt -134.04 140.44 46.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.548 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' B' ' 40' ' ' LYS . 45.0 mt-10 -120.28 115.18 23.07 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.273 0.629 . . . . 0.0 109.611 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.37 115.98 51.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.15 128.26 54.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -132.75 159.98 42.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' B' ' 35' ' ' SER . 59.2 ttp180 -141.22 146.29 36.7 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.977 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 12.7 tmtt? -91.34 141.81 28.37 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.488 ' OXT' ' HB3' ' B' ' 64' ' ' LYS . 98.1 mttt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m 56.69 20.76 5.29 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 173.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.3 t -133.42 176.95 8.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.93 -104.28 0.17 Allowed Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.0 m 66.45 97.38 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 123.823 0.849 . . . . 0.0 112.322 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -67.58 127.23 16.03 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.74 2.293 . . . . 0.0 112.336 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -84.07 133.58 45.28 Favored Pre-proline 0 N--CA 1.429 -1.481 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.116 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.9 104.01 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.85 2.366 . . . . 0.0 111.772 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -97.31 -27.57 14.44 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.0 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -132.83 10.52 4.28 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.304 0.573 . . . . 0.0 110.812 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.25 122.24 68.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.6 156.55 14.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.073 0.463 . . . . 0.0 111.441 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.45 133.5 55.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.4 112.52 21.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.74 -155.71 13.24 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.68 26.27 0.18 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.137 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.92 150.56 36.96 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.75 150.58 81.97 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.939 2.426 . . . . 0.0 112.852 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG21 ' OD1' ' A' ' 51' ' ' ASP . 10.5 p -57.92 -38.31 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.55 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.401 ' O ' HD13 ' A' ' 24' ' ' LEU . 23.2 ptp -59.98 -27.34 66.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.936 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.85 -32.44 72.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 110.123 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -80.07 -35.85 36.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.658 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 60.3 t -59.11 -52.69 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.811 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 20' ' ' MET . 8.7 mp -65.85 -31.74 72.87 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.031 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.16 -44.79 87.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.19 -41.93 99.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 88.8 mt -61.15 -35.6 77.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.144 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.6 m -69.81 -36.71 75.86 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.526 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.2 mt -68.2 -33.36 74.29 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.3 mt -59.4 -39.88 84.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.602 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.91 -27.88 66.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.95 -6.15 56.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.59 14.71 34.11 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 121.049 -0.595 . . . . 0.0 112.866 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.47 96.13 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 122.153 -0.616 . . . . 0.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 p -88.43 -8.15 55.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -131.35 112.86 13.1 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.476 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -123.42 144.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.293 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.5 123.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.544 0.528 . . . . 0.0 110.62 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.04 121.81 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -116.57 127.48 54.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.368 0.604 . . . . 0.0 110.917 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -118.7 157.74 26.87 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.565 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -127.07 146.75 50.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.762 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.7 -116.81 9.69 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.287 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -99.45 4.21 46.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 110.789 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.36 50.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.92 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.8 mt -54.28 -40.05 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.725 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.3 t -64.75 -21.72 66.82 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.596 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -87.88 -29.97 20.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.51 84.83 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.093 0.473 . . . . 0.0 110.402 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -72.94 -33.23 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.0 t70 -64.21 -48.73 74.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -55.95 -50.34 71.04 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.924 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -68.15 -31.01 49.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.903 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 31.5 tt0 -68.19 -37.81 81.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.924 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 51' ' ' ASP . 79.5 mt -58.59 -43.4 87.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.429 0.456 . . . . 0.0 111.047 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.35 -43.75 80.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -79.36 8.79 5.53 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -135.21 7.06 3.36 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -117.53 -68.6 0.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.258 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HB3' HD22 ' A' ' 61' ' ' LEU . 87.4 m-85 -79.46 -69.34 0.59 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 2.5 mm? -122.62 102.61 8.16 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.34 -24.49 27.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.985 0.803 . . . . 0.0 111.214 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -96.97 -45.97 6.39 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.461 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.65 81.17 8.74 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.722 0.773 . . . . 0.0 111.636 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.5 134.52 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.095 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.544 ' OE1' ' HD2' ' A' ' 97' ' ' LYS . 47.2 mt-10 -114.01 141.82 46.94 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.74 126.58 48.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -82.21 -68.78 0.67 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.722 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -159.39 140.41 12.67 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -128.14 115.82 40.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -119.34 134.25 55.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.12 128.25 25.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.45 . . . . 0.0 110.099 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.32 -147.14 5.65 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.932 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -109.34 133.56 52.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -116.58 125.46 51.87 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.61 108.64 18.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.16 160.77 9.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.153 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.5 p -93.91 119.84 33.37 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.496 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.3 t -57.74 -62.6 1.68 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.892 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -144.81 -78.54 0.19 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.69 -69.86 0.55 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.817 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.64 29.99 0.45 Allowed Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.913 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -92.85 125.76 37.61 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -82.1 143.67 31.33 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 123.511 0.507 . . . . 0.0 110.508 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.6 t -139.9 136.03 33.48 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -93.99 112.42 24.25 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.7 t -119.35 134.04 64.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 p -67.28 123.37 20.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 123.703 0.627 . . . . 0.0 109.46 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 p -127.67 152.6 47.48 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.861 0.363 . . . . 0.0 111.366 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.7 tt -139.17 135.19 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.644 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.44 114.34 22.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.97 115.75 50.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.95 55.18 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.48 158.27 34.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.334 0.587 . . . . 0.0 111.629 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -112.77 114.88 27.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.647 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.583 ' NZ ' ' HB2' ' A' ' 61' ' ' LEU . 13.6 mmmt -88.93 131.98 34.9 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.576 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.544 ' HD2' ' OE1' ' A' ' 66' ' ' GLU . 28.5 mtpp . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 120.726 0.298 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -75.82 -61.54 1.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m 63.51 26.3 14.73 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.094 0.558 . . . . 0.0 111.767 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.63 118.97 15.42 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.368 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 24.6 m -88.87 -45.98 0.44 Allowed Pre-proline 0 CA--C 1.586 2.341 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.09 138.81 44.78 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 121.644 1.562 . . . . 0.0 113.027 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 33.1 m -81.95 121.38 79.08 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.967 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.9 98.69 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.898 2.399 . . . . 0.0 112.017 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 17.1 m -116.91 8.03 13.41 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-O 121.397 0.618 . . . . 0.0 109.852 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -144.98 12.63 1.43 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.108 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.47 122.72 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.33 163.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 120.818 0.342 . . . . 0.0 111.012 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 tp -124.19 134.34 53.31 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.93 113.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.074 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.65 -157.62 12.48 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.543 ' H ' ' HD3' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -76.63 26.29 0.13 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.42 148.56 35.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.71 152.3 64.07 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.811 2.341 . . . . 0.0 113.193 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.606 HG21 ' OD2' ' B' ' 51' ' ' ASP . 8.9 p -58.33 -39.86 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.414 ' O ' HD13 ' B' ' 24' ' ' LEU . 22.9 ptp -58.18 -25.64 61.78 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.221 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.9 -32.33 70.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 109.932 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -81.17 -37.04 29.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.485 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 51.9 t -58.81 -52.41 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 123.763 0.664 . . . . 0.0 110.374 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.414 HD13 ' O ' ' B' ' 20' ' ' MET . 8.4 mp -66.47 -30.15 70.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.738 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.449 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.34 -45.96 82.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.165 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.78 -41.23 99.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.558 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.9 mt -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.714 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -72.87 -32.98 65.8 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.295 0.569 . . . . 0.0 110.221 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 94.0 mt -70.72 -32.42 69.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 90.3 mt -60.08 -39.82 87.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.584 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -69.01 -24.39 64.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.616 0.722 . . . . 0.0 110.779 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -83.62 -3.3 57.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.43 12.45 51.21 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.145 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -91.05 95.88 5.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.5 p -89.09 -5.83 57.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.711 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.88 116.15 16.13 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.438 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -127.06 144.32 37.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.689 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.33 121.64 68.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.14 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -107.14 121.89 60.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.3 132.29 56.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.075 0.465 . . . . 0.0 110.174 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.85 159.16 28.74 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.761 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -129.89 143.55 50.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.737 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.13 -117.64 8.71 Favored Glycine 0 CA--C 1.497 -1.065 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.166 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -99.02 0.95 44.87 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.266 0.555 . . . . 0.0 110.176 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.75 -7.09 52.28 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.985 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.34 -40.38 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 110.802 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.39 -28.08 69.74 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.388 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -82.17 -29.7 31.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.73 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.14 -45.28 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.35 -33.59 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.086 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.606 ' OD2' HG21 ' B' ' 19' ' ' VAL . 35.4 t70 -62.4 -46.61 87.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.894 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -58.85 -51.03 71.76 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.907 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.75 -30.63 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.925 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 33.4 tt0 -68.91 -35.49 76.9 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.742 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.455 HG13 ' O ' ' B' ' 51' ' ' ASP . 79.6 mt -61.23 -43.18 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.741 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 67.4 t -68.46 -43.67 83.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.998 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 28.7 ptt180 -79.02 8.72 5.21 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.576 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -131.84 -3.51 3.64 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.395 0.617 . . . . 0.0 111.17 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.74 -64.75 1.2 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.745 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' B' ' 61' ' ' LEU . 90.1 m-85 -80.56 -74.63 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.595 ' HB2' ' NZ ' ' B' ' 96' ' ' LYS . 2.4 mm? -119.57 103.2 9.21 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -84.7 -31.93 23.81 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 124.186 0.929 . . . . 0.0 110.809 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.91 -41.17 12.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.266 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -91.62 80.38 5.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.389 0.614 . . . . 0.0 111.814 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -161.24 136.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.693 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.48 ' OE1' ' HD2' ' B' ' 97' ' ' LYS . 47.1 mt-10 -116.75 143.29 45.84 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 125.16 50.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -81.69 -66.93 0.83 Allowed 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 123.274 0.359 . . . . 0.0 110.839 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -161.32 139.67 9.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.43 117.03 45.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -120.01 132.0 55.33 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.96 129.34 44.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.65 -148.39 6.61 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.076 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -106.72 133.54 51.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -118.82 125.75 50.27 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.58 111.12 21.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.865 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.28 160.44 11.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.293 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 31.2 p -95.84 117.79 31.24 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.676 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 41.2 t -56.46 -60.86 2.91 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.923 0.764 . . . . 0.0 112.247 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -145.43 -77.2 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.498 0.666 . . . . 0.0 109.216 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.95 -70.45 0.51 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.967 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.54 36.05 0.43 Allowed Glycine 0 C--O 1.22 -0.75 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.09 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -97.62 122.76 41.07 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -80.06 143.61 33.86 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.74 0.65 . . . . 0.0 111.006 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 41.4 t -138.38 137.98 37.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.78 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -96.69 110.56 22.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.44 135.83 57.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.8 p -69.88 124.72 24.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 50.8 p -128.59 152.86 47.84 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.893 0.377 . . . . 0.0 111.162 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 tt -139.6 136.74 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.04 112.13 18.76 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.775 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.84 117.61 55.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.49 128.1 54.65 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.4 pt -126.23 151.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 111.999 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -105.9 115.33 30.04 Favored 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.924 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.595 ' NZ ' ' HB2' ' B' ' 61' ' ' LEU . 13.8 mmmt -90.43 131.53 36.14 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.999 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HD2' ' OE1' ' B' ' 66' ' ' GLU . 28.4 mtpp . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 CA--C 1.514 -0.436 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 m -130.74 -47.2 1.04 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.614 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -85.27 6.58 25.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.193 0.521 . . . . 0.0 112.17 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.23 79.27 0.3 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.7 p -93.25 107.22 24.07 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 122.286 0.235 . . . . 0.0 110.794 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.97 -36.47 10.19 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.525 2.15 . . . . 0.0 111.741 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.3 m 71.93 90.23 0.07 OUTLIER Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 124.458 1.103 . . . . 0.0 111.437 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -98.55 15.68 0.57 Allowed 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.199 2.6 . . . . 0.0 111.116 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 t -101.99 140.53 36.14 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.353 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -88.03 0.63 55.71 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 60.8 t -105.38 114.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.4 147.46 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 120.911 0.386 . . . . 0.0 111.074 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.11 122.72 45.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -88.25 105.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.573 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.17 58.91 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.128 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -163.06 -56.26 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.252 0.549 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -101.05 166.04 13.12 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.601 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -71.31 163.0 40.6 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.993 1.796 . . . . 0.0 111.303 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.29 -41.4 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -62.86 -24.88 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -73.32 -38.17 65.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -72.33 -33.24 67.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.143 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.07 -47.53 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.129 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.64 -31.75 71.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.942 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -71.72 -41.93 67.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.202 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -70.63 -34.29 71.92 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.68 -51.63 68.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.049 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.534 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 10.0 t -67.77 -35.56 78.92 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.7 mt -62.23 -34.15 75.94 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.8 mt -64.65 -23.9 67.41 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.851 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -100.31 -14.0 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 28' ' ' THR . 78.6 mt-30 -79.44 -20.22 48.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.838 0.351 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.48 -4.72 7.15 Favored Glycine 0 CA--C 1.492 -1.345 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.092 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -86.29 96.0 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.0 m -67.75 -30.43 69.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.501 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.62 126.34 20.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.737 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -121.77 161.14 22.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.933 -176.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -124.21 121.66 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.1 mt -104.84 125.26 59.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 66.0 mttm -119.83 120.08 35.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.294 0.568 . . . . 0.0 110.524 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -116.28 155.51 28.25 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.027 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -131.63 141.47 49.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.232 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.46 -126.91 9.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.548 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -81.98 -10.96 59.09 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.57 35.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.182 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -55.6 -38.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 121.26 0.552 . . . . 0.0 109.61 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.7 p -71.48 -13.77 61.92 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.251 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -95.06 -26.52 16.01 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.6 0.36 . . . . 0.0 110.09 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -69.8 -46.07 66.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 110.766 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.67 -36.26 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 55' ' ' ILE . 45.5 t0 -59.92 -52.2 66.44 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.711 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.9 m -54.19 -52.01 62.56 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.56 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.405 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 23.7 m -69.3 -33.72 59.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 24.9 tt0 -72.05 -26.17 62.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.408 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.2 mt -70.09 -46.62 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.733 174.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.22 -48.97 85.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.77 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 38.9 ptt180 -78.29 37.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.518 0.675 . . . . 0.0 110.034 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.54 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 9.6 t30 -153.14 -51.04 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.8 ptm180 -76.69 -11.48 59.85 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -142.94 -60.74 0.43 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.494 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD13 ' HB ' ' A' ' 65' ' ' ILE 0.297 0.6 OUTLIER -110.91 88.97 2.91 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.984 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.99 23.79 10.23 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.884 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -143.01 -69.42 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.795 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -86.52 75.16 9.78 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.619 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.5 tp -161.79 137.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.92 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 9.6 pt-20 -130.37 167.52 18.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.099 0.476 . . . . 0.0 111.235 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.6 mt -104.87 139.54 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 50.9 tptt -80.92 -59.81 2.53 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -177.49 159.93 1.57 Allowed 'General case' 0 C--O 1.25 1.13 0 C-N-CA 124.869 1.267 . . . . 0.0 107.604 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.62 119.16 45.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -125.11 133.81 52.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.29 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.69 132.63 67.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.97 163.38 33.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.088 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.417 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 52.5 p -90.49 126.32 35.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.564 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.419 ' HG2' HG13 ' A' ' 77' ' ' VAL . 22.1 tt0 -81.7 113.91 20.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 86' ' ' ARG . 24.3 t -100.6 106.9 20.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' A' ' 75' ' ' GLN . 28.5 m -128.57 163.91 31.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.035 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.5 p -98.23 130.38 44.95 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.796 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.5 m -62.3 -59.67 4.68 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.442 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -165.14 -49.6 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.475 ' HB2' ' HG3' ' A' ' 83' ' ' ARG . 6.9 m-20 -82.7 5.26 21.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.875 0.47 . . . . 0.0 111.002 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.5 11.83 56.6 Favored Glycine 0 C--O 1.21 -1.357 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 81' ' ' ASP . 78.3 mtp180 -71.25 109.7 5.44 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -73.71 131.47 41.65 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.224 0.328 . . . . 0.0 110.623 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.1 t -129.39 133.88 47.59 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG2' HG22 ' A' ' 76' ' ' VAL . 50.1 mtm180 -98.54 135.37 40.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.4 t -133.42 123.78 47.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -59.51 127.98 34.76 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 120.935 0.398 . . . . 0.0 111.058 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.9 p -133.48 162.17 32.6 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 17.7 tt -137.7 142.76 35.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.773 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -120.25 108.54 14.32 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.046 0.939 . . . . 0.0 108.711 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -118.77 129.48 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . . . -131.24 130.35 42.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.8 pt -121.62 153.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.427 ' HD3' ' OE2' ' A' ' 66' ' ' GLU . 35.3 ttt180 -129.99 140.1 50.95 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.247 0.546 . . . . 0.0 112.07 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -79.29 -174.31 4.1 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.566 1.146 . . . . 0.0 110.324 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 C--O 1.261 1.682 0 CA-C-O 117.964 -1.017 . . . . 0.0 108.533 174.256 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.462 ' HG3' ' H ' ' B' ' 2' ' ' SER . 20.5 ptp . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.462 ' H ' ' HG3' ' B' ' 1' ' ' MET . 15.6 m -69.2 134.66 49.52 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m -104.15 106.23 16.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.229 0.538 . . . . 0.0 110.955 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.66 60.45 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' B' ' 6' ' ' PRO . 41.4 m -69.84 -59.47 4.49 Favored Pre-proline 0 CA--C 1.561 1.382 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' B' ' 5' ' ' THR . 83.6 Cg_endo -80.35 -18.07 9.9 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 121.171 1.247 . . . . 0.0 113.002 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -167.56 144.27 3.6 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.7 150.89 27.94 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.102 1.868 . . . . 0.0 110.882 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.7 p -105.63 -20.51 13.44 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -114.83 4.74 14.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 61.1 t -109.22 112.56 41.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.0 147.63 12.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.111 0.481 . . . . 0.0 111.272 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 tp -105.73 122.37 45.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.6 mm -88.85 104.59 15.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.01 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.58 59.19 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.793 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -165.02 -57.07 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.331 0.586 . . . . 0.0 110.429 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -100.75 165.59 14.02 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.132 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.08 162.4 42.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.24 1.96 . . . . 0.0 111.313 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.07 -42.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -61.21 -25.08 66.8 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.68 -37.25 65.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.66 -32.88 64.22 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.167 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.76 -48.67 86.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.923 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.94 -30.34 70.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.204 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.577 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -72.65 -43.46 63.16 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -68.68 -32.72 72.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.42 -52.51 65.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.139 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' B' ' 32' ' ' GLN . 10.1 t -65.69 -38.22 88.63 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.656 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -60.29 -36.56 78.16 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 92.5 mt -63.74 -23.82 67.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.031 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -100.14 -15.45 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' B' ' 28' ' ' THR . 79.7 mt-30 -78.14 -27.48 48.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.819 0.342 . . . . 0.0 110.766 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.35 -6.88 3.98 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.466 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.47 97.18 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -67.16 -31.98 72.77 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.456 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -140.37 125.85 18.99 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.072 0.463 . . . . 0.0 111.489 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.538 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -121.83 158.68 25.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.309 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.94 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 48.9 t -121.5 122.38 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.507 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -104.83 125.32 59.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.738 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 67.6 mttm -119.57 120.33 36.41 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -116.39 155.28 28.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.594 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -130.42 140.38 50.57 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.913 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.86 -129.44 10.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.703 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -82.34 -9.33 59.51 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.105 0.479 . . . . 0.0 110.156 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.1 -5.55 36.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.013 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.4 mt -54.26 -40.73 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.48 0.657 . . . . 0.0 109.997 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 75.4 p -67.08 -23.4 65.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.169 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -85.39 -28.45 25.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.281 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -67.74 -45.32 75.33 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.77 -37.23 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.005 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.57 ' O ' HG13 ' B' ' 55' ' ' ILE . 44.0 t0 -56.94 -52.89 63.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.576 0.75 . . . . 0.0 109.202 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.2 m -54.7 -52.16 63.29 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.854 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.445 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.2 m -70.29 -32.97 52.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.104 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 24.3 tt0 -71.37 -26.38 62.77 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.973 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.6 mt -70.13 -46.39 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.879 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.14 -49.81 82.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.827 0.346 . . . . 0.0 110.898 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 39.3 ptt180 -77.48 36.73 0.2 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-O 121.449 0.642 . . . . 0.0 110.032 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ASN . . . . . 0.414 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 7.9 t30 -152.1 -52.18 0.12 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 123.092 0.557 . . . . 0.0 110.496 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.2 ptm180 -74.4 -14.84 60.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -139.74 -64.78 0.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.321 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.425 HD13 ' HB ' ' B' ' 65' ' ' ILE 0.278 0.5 OUTLIER -107.88 93.98 4.83 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -177.565 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.69 13.36 35.12 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.693 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.94 -69.25 0.54 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.803 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -83.23 75.73 9.93 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.655 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.425 ' HB ' HD13 ' B' ' 61' ' ' LEU . 8.0 tp -161.71 143.32 3.53 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 C-N-CA 124.198 0.999 . . . . 0.0 108.768 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' B' ' 95' ' ' ARG . 10.2 pt-20 -137.93 164.16 29.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.907 0.384 . . . . 0.0 111.6 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.38 138.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' B' ' 93' ' ' ALA . 52.3 tptt -81.55 -60.54 2.22 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -175.82 160.39 2.38 Favored 'General case' 0 C--O 1.262 1.744 0 C-N-CA 124.795 1.238 . . . . 0.0 107.903 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.7 mt -131.48 119.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -125.88 135.02 51.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.677 0.275 . . . . 0.0 110.354 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.55 131.54 73.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.4 165.83 35.65 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.75 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.503 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 37.0 p -89.75 127.27 35.93 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.798 0.332 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' GLN . . . . . 0.419 ' HG2' HG13 ' B' ' 77' ' ' VAL . 24.2 tt0 -81.35 114.08 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' B' ' 86' ' ' ARG . 25.8 t -101.32 106.63 19.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' B' ' 75' ' ' GLN . 28.6 m -129.01 162.05 37.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.596 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 14.9 p -96.39 130.07 43.6 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 24.1 m -63.05 -58.93 5.63 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.541 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -164.89 -53.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.426 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.4 ' HB2' ' HG3' ' B' ' 83' ' ' ARG . 9.3 m-20 -79.76 7.62 8.27 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.679 0.392 . . . . 0.0 111.369 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.13 9.65 59.2 Favored Glycine 0 C--O 1.206 -1.647 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.619 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ARG . . . . . 0.4 ' HG3' ' HB2' ' B' ' 81' ' ' ASP . 81.1 mtp180 -71.64 108.95 5.25 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -73.71 137.18 43.88 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.094 0.473 . . . . 0.0 110.571 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 32.9 t -133.5 138.14 45.97 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.54 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 34.6 mtm180 -102.48 135.23 44.48 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 177.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.39 123.13 46.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 m -58.41 127.51 32.5 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.33 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 36.4 p -134.18 159.33 41.21 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 123.595 0.758 . . . . 0.0 109.764 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 16.3 tt -134.42 142.09 41.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -120.61 106.61 11.92 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 123.915 0.886 . . . . 0.0 108.668 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.37 130.2 71.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 68' ' ' LYS . . . -129.87 132.02 46.28 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -123.49 149.04 27.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.248 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.416 ' HB3' ' HG3' ' B' ' 66' ' ' GLU . 41.7 ttt180 -125.39 144.24 50.6 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.575 -174.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -84.1 -170.11 2.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.063 1.345 . . . . 0.0 110.24 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 97' ' ' LYS . 21.3 pttp . . . . . 0 C--O 1.261 1.679 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.3 t -69.33 -55.57 10.03 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 123.6 0.562 . . . . 0.0 112.441 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.3 t -95.18 -56.65 2.66 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.733 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.36 28.31 27.93 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.898 -1.144 . . . . 0.0 111.637 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 p -120.86 148.1 47.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.35 115.47 2.89 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.58 2.186 . . . . 0.0 113.097 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 9.8 t -83.07 142.47 44.4 Favored Pre-proline 0 C--N 1.311 -1.075 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.205 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 15.9 Cg_exo -68.64 178.89 3.47 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 122.871 2.381 . . . . 0.0 112.44 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -85.18 35.33 0.58 Allowed 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.537 0.735 . . . . 0.0 110.551 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.83 8.85 39.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.233 0.54 . . . . 0.0 109.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 59.7 t -105.08 123.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.085 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -120.25 142.83 34.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.683 0.278 . . . . 0.0 110.825 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 131.8 47.3 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.786 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.426 HG21 ' HB2' ' A' ' 48' ' ' LYS . 44.7 mm -93.75 111.68 25.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.878 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.66 28.97 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.03 -1.557 . . . . 0.0 114.622 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.56 -50.01 0.41 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.791 0.795 . . . . 0.0 112.155 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -100.93 160.64 26.14 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.59 159.68 35.58 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 121.741 1.627 . . . . 0.0 110.893 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.507 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.5 p -55.66 -38.54 50.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.0 ptm -61.05 -26.08 67.38 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.999 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.41 -43.34 77.41 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -70.95 -35.07 72.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.595 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 19' ' ' VAL . 59.2 t -60.34 -51.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.647 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.8 mt -65.91 -33.81 76.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.844 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -64.94 -45.52 85.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.227 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.99 95.53 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.427 0.454 . . . . 0.0 110.481 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.67 -35.11 78.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.427 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 m -73.89 -43.6 57.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.735 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 94.1 mt -64.47 -34.39 78.09 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.147 0.499 . . . . 0.0 110.587 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -58.73 -44.73 90.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.348 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -69.26 -22.38 63.84 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.94 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -82.0 -2.29 51.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.076 0.465 . . . . 0.0 110.9 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.58 -8.89 32.48 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 t -92.07 92.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.568 ' HA ' HD22 ' A' ' 30' ' ' LEU . 57.4 p -95.78 -9.92 30.43 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.199 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.24 104.99 10.52 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -127.15 157.67 38.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.151 -175.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.3 t -124.21 116.98 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.194 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.85 121.6 48.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 85.7 mttt -118.14 120.99 39.4 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.269 0.556 . . . . 0.0 110.378 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -115.65 156.45 25.85 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.951 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HG2' HG22 ' A' ' 89' ' ' THR . 88.3 mtt180 -130.91 143.15 50.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.19 -119.6 11.99 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.515 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -85.73 -8.7 58.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.439 0.638 . . . . 0.0 110.433 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.42 -4.53 42.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.166 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -56.01 -36.71 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.564 0.697 . . . . 0.0 109.912 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.3 p -64.64 -31.51 72.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.576 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HB2' HG21 ' A' ' 14' ' ' ILE . 28.5 mtpp -78.85 -31.44 45.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.502 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -65.77 -46.82 77.33 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.414 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -72.08 -33.87 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.873 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' OD2' HG21 ' A' ' 19' ' ' VAL . 31.3 t70 -60.24 -47.47 85.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.9 m -53.3 -53.7 47.12 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.414 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.18 -30.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.61 -39.8 88.54 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 51' ' ' ASP . 89.0 mt -59.97 -45.55 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.25 -40.44 86.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.093 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -83.55 15.77 2.95 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.31 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -136.72 12.66 3.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.847 0.832 . . . . 0.0 109.255 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.07 -49.04 0.28 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.147 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.46 ' CD2' HD23 ' A' ' 61' ' ' LEU . 56.2 t80 -90.24 -70.36 0.67 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.955 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.46 HD23 ' CD2' ' A' ' 60' ' ' PHE . 4.1 mm? -129.43 110.38 11.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.128 0.489 . . . . 0.0 111.316 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.7 12.57 36.25 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.943 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -126.04 -64.09 1.07 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.415 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 98.2 mttt -78.76 102.08 7.93 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.686 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tp -160.66 126.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.83 0.452 . . . . 0.0 110.329 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.517 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 41.0 tt0 -119.19 130.64 55.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.3 mt -95.21 128.06 46.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.65 -62.07 1.57 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.258 0.349 . . . . 0.0 111.239 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 10.0 tp10 -162.59 141.71 9.05 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.95 107.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.208 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.495 ' HE ' ' CD ' ' A' ' 69' ' ' GLU . 91.0 mtt180 -131.18 144.91 51.7 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.519 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.02 132.51 66.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.24 -174.42 22.81 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.122 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -124.78 128.46 48.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -106.84 138.84 42.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.98 107.89 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.36 151.19 18.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.619 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.0 p -93.2 115.8 28.41 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.0 t -75.43 -38.93 59.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -128.93 -96.84 0.39 Allowed 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.84 0.353 . . . . 0.0 111.13 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 5.6 m-20 -93.42 -76.1 0.48 Allowed 'General case' 0 C--O 1.216 -0.695 0 CA-C-O 121.788 0.804 . . . . 0.0 109.268 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 81' ' ' ASP . . . -125.67 21.39 6.31 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -79.54 101.8 8.47 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -85.07 132.65 34.29 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.434 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 t -133.66 130.95 38.95 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -88.69 124.75 34.41 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.7 120.91 60.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.4 t -63.5 128.19 34.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.602 HG22 ' HG2' ' A' ' 42' ' ' ARG . 61.5 p -120.76 134.35 55.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.424 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -123.12 128.39 75.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -107.65 110.77 22.72 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -103.98 106.78 20.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.76 40.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.901 0.381 . . . . 0.0 110.432 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.11 151.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.364 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HD3' ' OE1' ' A' ' 66' ' ' GLU . 75.3 ttt180 -121.85 119.29 31.19 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.493 0.663 . . . . 0.0 110.255 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HE3' ' O ' ' A' ' 64' ' ' LYS . 8.3 mmmm -85.29 131.02 34.48 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.392 0.615 . . . . 0.0 112.403 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' OXT' ' HB3' ' A' ' 64' ' ' LYS . 55.9 mtpt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 CA--C 1.502 -0.877 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.9 m -147.04 136.28 22.59 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 24.5 t 65.98 -165.61 0.23 Allowed 'General case' 0 CA--C 1.551 0.99 0 O-C-N 123.922 0.764 . . . . 0.0 110.203 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.49 65.22 0.6 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.476 ' HB ' ' HD3' ' B' ' 6' ' ' PRO . 27.5 m -54.19 -50.88 82.11 Favored Pre-proline 0 CA--C 1.579 2.088 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' B' ' 5' ' ' THR . 18.6 Cg_exo -69.88 -50.53 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 121.553 1.502 . . . . 0.0 112.23 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' B' ' 8' ' ' PRO . 10.0 t -169.56 138.51 1.61 Allowed Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 7' ' ' THR . 1.1 Cg_endo -82.07 115.53 2.67 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.442 2.095 . . . . 0.0 111.843 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 50.6 m -99.13 16.11 23.78 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.869 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -114.48 9.8 16.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.994 -0.441 . . . . 0.0 110.7 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.16 124.56 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.813 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.83 141.08 42.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.019 0.438 . . . . 0.0 111.581 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.24 129.62 46.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.874 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.09 111.36 24.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.469 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.76 28.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 119.105 -1.521 . . . . 0.0 114.911 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.97 -48.72 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.265 0.533 . . . . 0.0 111.661 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -101.55 160.9 25.2 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.61 162.3 21.7 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.981 1.787 . . . . 0.0 111.728 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.426 ' O ' HG23 ' B' ' 23' ' ' VAL . 7.2 p -58.71 -38.46 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.576 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 25.7 ptm -62.61 -26.24 68.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.639 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -66.69 -46.76 74.56 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -67.21 -34.29 77.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.835 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 19' ' ' VAL . 58.3 t -61.21 -50.51 80.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.618 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 20' ' ' MET . 86.3 mt -67.32 -36.03 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.641 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.428 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.01 -44.56 95.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.336 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.49 98.77 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.371 0.419 . . . . 0.0 110.499 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.8 -36.17 82.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.571 . . . . 0.0 111.049 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 59.7 m -72.51 -45.06 61.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.659 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 93.6 mt -64.06 -33.67 76.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.298 0.571 . . . . 0.0 110.262 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' B' ' 35' ' ' SER . 0.2 OUTLIER -58.41 -46.66 86.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.375 -177.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -68.28 -21.85 64.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.352 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.68 -4.25 55.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.34 -3.92 29.72 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.906 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -95.93 91.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.395 0.616 . . . . 0.0 109.516 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' SER . . . . . 0.508 ' HA ' HD22 ' B' ' 30' ' ' LEU . 58.3 p -94.78 -8.61 37.04 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.346 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.82 104.98 9.63 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.515 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -125.29 159.11 32.95 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.981 -173.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.7 117.12 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.198 0.523 . . . . 0.0 110.147 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -97.83 121.08 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.4 mttt -118.12 119.97 36.32 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.391 0.615 . . . . 0.0 110.178 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -115.2 156.56 25.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.667 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.563 ' HG2' HG22 ' B' ' 89' ' ' THR . 92.3 mtt180 -130.73 144.51 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.593 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.28 -123.44 23.3 Favored Glycine 0 C--O 1.215 -1.09 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.232 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -81.18 -12.77 59.11 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.224 0.535 . . . . 0.0 110.915 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.83 -3.47 28.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -55.15 -37.92 44.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.46 0.648 . . . . 0.0 109.793 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.4 p -64.69 -31.68 73.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.836 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -79.12 -29.73 43.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -65.33 -48.32 73.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 120.78 0.324 . . . . 0.0 110.957 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.98 -34.6 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.514 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.3 t70 -58.49 -48.65 80.09 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -52.46 -53.43 45.69 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.378 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -31.17 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.98 -39.43 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 51' ' ' ASP . 89.8 mt -59.33 -47.69 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.722 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -59.31 -39.4 78.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 CA-C-O 121.123 0.487 . . . . 0.0 110.863 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -84.86 17.12 2.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -141.65 18.47 2.18 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -150.26 -46.44 0.13 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.078 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.48 ' O ' HD22 ' B' ' 61' ' ' LEU . 62.7 t80 -92.37 -68.13 0.82 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.852 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.48 HD22 ' O ' ' B' ' 60' ' ' PHE . 3.9 mm? -132.49 111.84 11.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.805 0.336 . . . . 0.0 111.014 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.79 13.96 31.93 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.534 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -127.53 -64.7 0.97 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.088 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.536 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 98.4 mttt -74.91 99.67 3.88 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.903 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.8 tp -160.34 128.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.506 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 38.2 tt0 -122.64 129.65 52.09 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -94.44 127.21 46.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.422 ' HD3' ' HB1' ' B' ' 93' ' ' ALA . 49.2 tttp -87.73 -63.07 1.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.556 0.535 . . . . 0.0 111.188 -175.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 10.5 tp10 -161.63 140.41 9.65 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 pt -143.31 110.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.284 0.564 . . . . 0.0 110.73 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 92.9 mtt180 -133.57 145.62 50.24 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.726 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.29 128.81 75.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.27 -173.52 19.24 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.557 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 126.07 43.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -105.46 139.01 40.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.56 109.63 24.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.39 154.34 17.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.319 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 30.3 p -95.56 116.43 28.82 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 46.2 t -76.46 -34.09 58.7 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -132.27 -99.71 0.29 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.102 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.51 -73.42 0.54 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.31 20.18 5.91 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -77.04 99.93 5.49 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -82.46 136.36 34.93 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 123.761 0.663 . . . . 0.0 110.105 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 18.9 t -139.74 133.19 30.14 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -87.27 130.71 34.49 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 66.6 t -129.3 117.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -64.02 131.23 46.98 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.563 HG22 ' HG2' ' B' ' 42' ' ' ARG . 59.9 p -123.22 133.73 54.19 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.559 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 16.1 tt -121.44 128.83 75.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.68 107.37 16.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.401 HD11 HD11 ' B' ' 90' ' ' ILE . 44.9 mm -102.79 107.02 21.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ALA . . . . . 0.422 ' HB1' ' HD3' ' B' ' 68' ' ' LYS . . . -115.29 120.97 41.43 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.531 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -127.94 149.46 32.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.298 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.506 ' HD3' ' OE2' ' B' ' 66' ' ' GLU . 71.5 ttt180 -119.37 118.27 30.74 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.5 0.666 . . . . 0.0 110.349 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' B' ' 64' ' ' LYS . 7.6 mmmm -84.16 129.58 34.89 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.407 ' OXT' ' HB3' ' B' ' 64' ' ' LYS . 55.8 mtpt . . . . . 0 C--O 1.257 1.492 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.7 t -76.83 111.08 11.97 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 m -145.03 152.28 39.88 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.87 178.11 20.72 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.2 p 56.1 96.47 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 124.426 1.09 . . . . 0.0 113.032 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.04 130.27 33.81 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 122.888 2.392 . . . . 0.0 113.017 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 10.2 t -88.28 141.18 30.65 Favored Pre-proline 0 N--CA 1.436 -1.163 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 15.9 Cg_exo -69.37 178.21 4.55 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.448 2.099 . . . . 0.0 111.199 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.5 m -78.44 78.75 4.9 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.367 0.603 . . . . 0.0 110.293 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -140.21 11.34 2.37 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.164 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.9 t -120.4 124.67 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.82 149.38 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.825 0.345 . . . . 0.0 111.189 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.81 123.57 48.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.774 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -89.54 99.36 9.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.43 52.35 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.452 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -166.68 -56.34 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.04 167.76 10.25 Favored Pre-proline 0 CA--C 1.555 1.166 0 O-C-N 122.393 -0.192 . . . . 0.0 111.027 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.33 153.66 61.38 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.162 1.908 . . . . 0.0 112.514 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.91 -40.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.497 1.119 . . . . 0.0 113.469 -177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.42 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.3 ptm -62.5 -25.83 68.22 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.709 0.804 . . . . 0.0 111.823 -175.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -84.05 -27.77 28.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.022 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -73.14 -37.64 66.55 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 89.2 t -57.57 -47.78 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.567 0.698 . . . . 0.0 109.547 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.6 mt -65.26 -36.31 83.71 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.076 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.791 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.87 87.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.605 0.241 . . . . 0.0 111.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 86.8 mt -66.49 -31.55 72.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.6 0.714 . . . . 0.0 110.296 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 91.2 m -74.18 -40.35 62.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.176 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 97.5 mt -62.27 -38.68 90.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.192 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.9 tp -57.17 -46.12 83.08 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.9 -23.63 66.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.762 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 28' ' ' THR . 83.3 mm-40 -81.35 -11.91 59.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.185 0.516 . . . . 0.0 110.355 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.7 24.36 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.539 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.97 93.96 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 121.397 0.617 . . . . 0.0 109.599 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 p -89.04 -21.31 23.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.61 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -108.04 105.52 15.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -121.08 149.65 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.691 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.9 120.78 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.272 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -103.17 122.82 56.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.463 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -115.42 124.55 51.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 111.331 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.69 143.26 47.85 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.351 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -129.81 127.15 39.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.631 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.89 -138.35 14.1 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.934 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -82.97 4.31 26.41 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.487 0.661 . . . . 0.0 110.869 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.99 -4.01 53.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.553 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.71 -43.49 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.119 0.568 . . . . 0.0 110.575 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -19.14 64.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -90.45 -32.8 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.63 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.71 -43.59 88.69 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.912 0.387 . . . . 0.0 111.719 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.08 -32.67 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.434 ' O ' HG13 ' A' ' 55' ' ' ILE . 23.9 t70 -65.82 -38.95 90.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.4 m -60.42 -51.33 69.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.078 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 35.9 m -66.17 -38.15 81.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.675 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mm-40 -59.72 -36.56 76.8 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.1 mt -66.88 -44.19 89.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 0.0 110.292 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.76 -38.75 82.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.725 0.298 . . . . 0.0 111.725 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.675 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 4.1 ptm180 -89.84 11.24 20.81 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.86 -30.71 3.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.268 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -93.78 -59.07 2.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.33 -55.24 12.74 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.964 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -160.0 108.35 1.71 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.57 -35.12 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 123.972 0.795 . . . . 0.0 112.745 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.05 -26.64 68.34 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' H ' HD12 ' A' ' 61' ' ' LEU . 35.0 mmtp -122.36 101.51 7.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.718 0.295 . . . . 0.0 110.765 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tp -156.94 146.7 11.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG2' HH21 ' A' ' 95' ' ' ARG . 7.8 tp10 -135.19 141.26 45.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.27 132.57 40.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -91.45 -48.11 7.06 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.937 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -173.83 145.87 1.18 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.45 97.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.678 0.751 . . . . 0.0 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -127.69 141.89 51.48 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.782 -0.574 . . . . 0.0 110.978 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.85 143.75 29.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.3 -165.69 21.95 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.674 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m -115.46 144.83 43.25 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 59.4 tt0 -101.67 131.17 48.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 86' ' ' ARG . 49.4 t -112.81 111.31 35.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -123.98 157.43 30.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.921 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.3 p -97.52 123.36 41.36 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.845 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.4 t -71.92 -41.35 67.97 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.209 0.528 . . . . 0.0 110.887 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -128.73 -70.2 0.68 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -138.36 -80.11 0.34 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.546 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.99 -7.1 61.39 Favored Glycine 0 C--N 1.31 -0.885 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -72.97 97.58 2.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -91.12 148.65 22.22 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.863 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.6 m -139.5 135.56 33.62 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.484 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.449 ' HG2' HG22 ' A' ' 76' ' ' VAL . 79.0 mtt180 -102.02 124.78 48.23 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.19 138.78 52.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.9 t -75.24 136.41 40.95 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.7 p -136.14 145.22 45.59 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.4 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.45 138.91 53.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.364 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -115.42 111.69 21.19 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.74 110.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.88 124.13 50.93 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 pt -124.49 162.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 120.848 0.356 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.4 HH21 ' HG2' ' A' ' 66' ' ' GLU . 49.1 ttp180 -129.98 108.68 10.29 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 7.1 tmtm? -84.15 130.87 34.82 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 -173.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 35.3 mmtp . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -85.73 -75.2 0.38 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 24.3 p -93.8 138.97 31.41 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.472 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.79 49.6 0.85 Allowed Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -82.05 122.7 79.91 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 123.384 0.674 . . . . 0.0 110.557 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.47 -32.23 80.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.502 2.135 . . . . 0.0 112.907 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -99.62 133.09 22.09 Favored Pre-proline 0 C--N 1.31 -1.136 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.27 114.6 3.93 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.538 2.158 . . . . 0.0 112.235 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -87.81 -4.43 58.87 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.661 0.743 . . . . 0.0 109.812 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -94.27 8.81 40.5 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.946 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.68 119.71 61.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.53 148.05 15.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.454 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.47 120.24 41.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.707 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.96 100.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.73 51.19 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.509 -1.329 . . . . 0.0 113.916 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -167.08 -55.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -100.14 168.47 9.38 Favored Pre-proline 0 CA--C 1.556 1.176 0 O-C-N 122.129 -0.357 . . . . 0.0 111.106 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.81 156.15 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.236 1.957 . . . . 0.0 112.302 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.81 -43.89 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.0 ptp -54.89 -32.85 61.4 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -77.73 -28.39 50.77 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.929 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.73 -37.95 64.94 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 79.7 t -57.68 -47.86 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.484 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.072 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.57 -43.54 89.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.2 -38.08 89.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.5 mt -65.89 -31.21 72.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.33 0.586 . . . . 0.0 110.358 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' B' ' 32' ' ' GLN . 64.4 m -74.88 -42.09 58.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.796 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.3 mt -60.86 -38.53 85.87 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.616 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 tp -57.18 -44.24 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.157 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.2 -16.22 62.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.827 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' B' ' 28' ' ' THR . 82.5 mm-40 -87.27 -7.82 57.44 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.306 0.574 . . . . 0.0 109.889 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.61 34.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.757 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.6 t -99.05 95.76 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.274 0.559 . . . . 0.0 109.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 12.8 p -90.49 -25.49 20.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.425 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -103.37 107.6 18.5 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.466 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -123.88 148.0 28.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 120.91 0.386 . . . . 0.0 110.743 -179.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.43 122.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.678 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.3 mt -105.39 120.22 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.997 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -113.55 123.33 49.73 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.362 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.31 147.39 42.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.426 ' NE ' HG11 ' B' ' 87' ' ' VAL . 3.0 tmt_? -133.09 129.48 38.03 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.116 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.77 -142.13 16.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.0 5.67 11.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.35 0.595 . . . . 0.0 110.81 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.25 -5.21 55.83 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.5 -44.38 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.407 0.683 . . . . 0.0 110.81 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.0 t -59.82 -32.64 70.84 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.049 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -76.8 -34.24 57.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.753 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -45.61 83.22 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 120.803 0.335 . . . . 0.0 111.768 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.51 -35.88 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.424 ' O ' HG13 ' B' ' 55' ' ' ILE . 29.8 t70 -62.59 -41.57 99.04 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 91.5 m -57.03 -50.04 73.94 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.903 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 35.4 m -67.09 -38.42 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.659 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 17.0 mm-40 -59.72 -38.91 82.97 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.5 mt -64.36 -45.02 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.25 -37.02 77.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 120.96 0.409 . . . . 0.0 111.792 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.659 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 4.5 ptm180 -91.48 11.63 23.4 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -126.13 -29.52 3.03 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.096 0.474 . . . . 0.0 110.968 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -93.86 -58.28 2.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -68.69 -58.39 4.3 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.47 HD12 ' H ' ' B' ' 64' ' ' LYS . 0.2 OUTLIER -157.95 109.58 2.27 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.34 -42.13 12.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 124.423 1.077 . . . . 0.0 112.63 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.1 -34.25 68.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 0.0 112.585 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.47 ' H ' HD12 ' B' ' 61' ' ' LEU . 35.1 mmtp -118.05 101.11 7.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.168 0.509 . . . . 0.0 110.966 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.04 146.31 13.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.467 ' HG2' HH21 ' B' ' 95' ' ' ARG . 9.0 tp10 -132.17 143.8 50.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.86 129.74 50.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -90.57 -47.9 7.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -172.55 147.03 1.8 Allowed 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.751 0.657 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.01 94.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.443 0.697 . . . . 0.0 110.54 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -127.56 141.17 51.71 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.311 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.87 144.48 24.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.27 -175.32 35.81 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.618 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 45.8 m -107.08 143.91 34.52 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.391 0.615 . . . . 0.0 112.266 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 61.1 tt0 -99.71 132.56 44.97 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' B' ' 86' ' ' ARG . 47.0 t -115.01 108.31 25.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.45 157.53 23.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.28 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 32.0 p -96.94 124.41 40.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.941 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 48.2 t -74.55 -36.29 63.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.965 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -133.84 -74.44 0.48 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -133.66 -80.7 0.47 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.755 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.76 -3.88 62.18 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.151 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -74.07 97.98 3.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -87.87 154.26 20.67 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.239 -177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.7 m -143.85 134.88 25.49 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.599 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.446 ' HG2' HG22 ' B' ' 76' ' ' VAL . 83.2 mtt180 -103.95 125.58 50.44 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 173.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.426 HG11 ' NE ' ' B' ' 42' ' ' ARG . 96.0 t -126.99 137.42 57.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -74.48 135.49 42.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.571 . . . . 0.0 110.701 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 35.3 p -136.96 146.11 45.0 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.51 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.83 137.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.235 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -113.53 111.33 21.71 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 57.5 mt -110.55 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.93 123.75 50.52 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.802 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.0 pt -124.59 162.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.237 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.467 HH21 ' HG2' ' B' ' 66' ' ' GLU . 47.5 ttp180 -128.84 107.33 9.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 7.0 tmtm? -84.57 131.75 34.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.936 -174.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.57 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 34.7 mmtp . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 tpp . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.623 0.249 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 t -110.84 -75.18 0.62 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.815 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -119.56 170.16 9.42 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.56 159.29 16.17 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.1 m -70.4 -46.3 19.61 Favored Pre-proline 0 CA--C 1.577 1.987 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.2 123.11 13.05 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 121.737 1.624 . . . . 0.0 111.914 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.3 m -72.73 118.56 69.1 Favored Pre-proline 0 N--CA 1.435 -1.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.503 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.31 121.23 7.58 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.886 2.391 . . . . 0.0 112.205 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.7 m -89.01 16.01 7.72 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.235 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -98.7 15.55 24.88 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.17 0.509 . . . . 0.0 110.481 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.5 t -122.53 111.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.38 146.62 10.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.941 0.4 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 tp -112.2 124.17 51.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 51.0 mt -88.3 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 O-C-N 123.186 0.303 . . . . 0.0 110.865 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.27 -94.42 0.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.661 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -103.42 6.97 38.02 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -98.25 145.43 29.82 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.636 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.93 151.35 82.34 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.52 2.147 . . . . 0.0 112.503 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.43 HG23 ' OG1' ' A' ' 52' ' ' THR . 7.0 p -52.83 -41.4 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -58.85 -28.81 66.44 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.27 -39.0 86.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 93.2 m-85 -75.03 -37.6 61.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 69.4 t -60.85 -54.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.329 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.84 -32.54 73.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.97 -47.24 72.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.502 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.78 99.54 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 123.485 0.491 . . . . 0.0 111.064 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 88.0 mt -62.41 -34.74 77.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.021 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.7 m -73.96 -34.19 64.16 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.394 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 84.6 mt -67.26 -32.25 73.13 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-O 120.838 0.351 . . . . 0.0 110.909 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.49 -30.01 71.05 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.328 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -84.28 -4.89 59.14 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.985 0.898 . . . . 0.0 109.805 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -101.72 -19.83 15.22 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.593 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.08 11.29 10.07 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.693 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.61 94.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.626 0.713 . . . . 0.0 109.358 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -71.1 -41.09 71.04 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.464 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.42 124.06 50.21 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.54 0.686 . . . . 0.0 111.857 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -128.69 156.84 41.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.523 -177.191 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -120.29 128.41 75.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.3 mt -108.72 120.16 59.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.66 133.93 54.44 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.323 0.582 . . . . 0.0 110.122 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.6 162.63 31.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.435 ' HE ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -150.86 149.97 30.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.14 -130.29 11.27 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -88.9 1.06 55.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.678 0.751 . . . . 0.0 109.776 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.61 -6.25 58.82 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.432 HG23 HG21 ' A' ' 90' ' ' ILE . 75.6 mt -53.97 -37.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.232 0.539 . . . . 0.0 110.442 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.3 t -61.99 -30.46 70.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -83.01 -21.95 33.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.122 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.46 -47.02 65.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.832 0.348 . . . . 0.0 110.263 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.511 ' HA ' HG22 ' A' ' 53' ' ' VAL . 9.9 p -69.83 -32.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.164 0.506 . . . . 0.0 109.796 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.416 ' OD2' HG21 ' A' ' 19' ' ' VAL . 36.4 t70 -61.72 -44.06 97.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.083 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 19' ' ' VAL . 85.6 m -63.85 -48.06 78.25 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.268 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 50' ' ' VAL . 33.5 m -69.39 -33.81 59.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.72 -43.62 96.01 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.181 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.9 mt -56.68 -46.78 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.65 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.0 -43.87 98.19 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.895 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -83.95 10.22 10.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.133 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -125.1 -16.93 5.89 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.48 0.657 . . . . 0.0 111.142 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -105.82 -47.48 3.87 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.19 -67.5 0.83 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.901 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 3.4 mm? -130.98 104.5 7.16 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 120.979 0.419 . . . . 0.0 110.43 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.98 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.091 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.98 -36.68 59.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.176 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -123.15 89.05 3.04 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.633 0.73 . . . . 0.0 110.54 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.14 131.32 10.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.995 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.21 146.15 51.18 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.29 135.6 35.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -85.45 -57.92 2.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.067 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -168.93 151.4 4.87 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.43 116.9 26.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -126.68 146.24 50.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -147.43 137.53 16.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.1 -157.42 13.92 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.655 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.6 m -113.46 128.51 56.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.03 141.52 45.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.8 t -95.39 113.84 30.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.15 158.84 35.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.207 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.1 p -85.98 146.57 26.61 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -72.98 -48.24 38.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.324 0.583 . . . . 0.0 110.146 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 179.08 -41.18 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.86 -167.09 1.38 Allowed 'General case' 0 C--O 1.251 1.163 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.18 56.48 4.86 Favored Glycine 0 C--N 1.316 -0.579 0 CA-C-N 118.341 0.519 . . . . 0.0 112.081 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -124.33 114.71 19.91 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -83.73 130.09 34.95 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 123.887 0.742 . . . . 0.0 110.706 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.3 t -127.19 138.61 53.16 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -98.07 129.22 44.91 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.435 HG11 ' HE ' ' A' ' 42' ' ' ARG . 45.8 t -132.42 140.5 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 p -71.02 119.9 15.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 123.62 0.575 . . . . 0.0 110.54 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.5 p -116.53 154.11 30.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.948 0.499 . . . . 0.0 109.881 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.432 HG21 HG23 ' A' ' 46' ' ' ILE . 16.9 tt -143.07 132.18 20.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 108.0 16.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.96 116.05 48.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.58 125.12 49.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.413 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.7 pt -122.46 152.22 26.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -122.42 109.29 14.2 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.362 0.601 . . . . 0.0 111.272 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HE2' ' HB2' ' A' ' 61' ' ' LEU . 4.3 mmmp? -79.31 135.07 36.63 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? . . . . . 0 C--N 1.285 -2.198 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.039 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 C--O 1.211 -0.955 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 35.5 t -71.76 -36.88 70.52 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.1 t -130.47 162.42 29.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.07 -167.71 24.82 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -106.26 106.28 56.74 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -84.59 -179.43 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.584 2.189 . . . . 0.0 112.109 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -83.47 145.48 48.19 Favored Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.222 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.26 140.36 53.13 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.829 2.352 . . . . 0.0 112.032 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 35.0 p -115.88 2.98 13.67 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.907 0.384 . . . . 0.0 111.777 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -97.92 13.34 31.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.235 0.54 . . . . 0.0 110.405 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 53.3 t -118.1 111.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.75 148.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.827 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp -115.13 122.39 45.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.463 ' HA ' ' CZ ' ' B' ' 22' ' ' TYR . 55.3 mt -86.99 131.71 34.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.945 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.21 -97.41 0.25 Allowed Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.72 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -99.15 -0.11 42.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.119 0.485 . . . . 0.0 110.338 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.01 145.91 32.63 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.655 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.98 154.65 73.13 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.906 2.404 . . . . 0.0 112.21 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.413 HG23 ' OG1' ' B' ' 52' ' ' THR . 7.2 p -56.16 -40.91 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.546 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.12 -30.1 67.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -63.87 -39.19 93.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.709 0.766 . . . . 0.0 109.706 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' TYR . . . . . 0.463 ' CZ ' ' HA ' ' B' ' 14' ' ' ILE . 92.8 m-85 -76.89 -37.85 54.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.676 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 65.4 t -60.65 -52.89 56.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.71 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.52 -33.62 75.99 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.219 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -64.91 -47.42 77.83 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.576 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.34 96.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.35 -34.48 76.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 111.313 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 73.4 m -73.53 -34.38 65.19 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.523 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.1 mt -67.19 -31.0 71.1 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.921 0.391 . . . . 0.0 111.268 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.21 -26.26 67.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -86.89 -2.64 58.75 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.749 0.785 . . . . 0.0 109.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -105.29 -16.31 14.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.655 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.65 13.27 14.75 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.64 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.74 95.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 22.4 m -73.2 -38.95 65.92 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.136 0.575 . . . . 0.0 112.475 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.25 122.74 44.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.491 0.662 . . . . 0.0 111.623 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.494 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.27 156.88 40.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.85 -176.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 62.1 t -121.36 126.54 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.285 0.564 . . . . 0.0 110.247 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -108.26 121.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.04 135.09 54.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.208 0.528 . . . . 0.0 110.494 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.96 160.67 37.57 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.437 ' HE ' HG11 ' B' ' 87' ' ' VAL . 0.0 OUTLIER -149.53 147.65 28.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -126.04 7.21 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -93.98 1.95 56.17 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.735 0.779 . . . . 0.0 109.464 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.67 -6.33 59.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.521 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.404 HG23 HG21 ' B' ' 90' ' ' ILE . 71.4 mt -53.97 -36.86 32.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 CA-C-O 121.891 0.853 . . . . 0.0 109.732 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -63.95 -30.54 71.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.047 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -82.36 -25.27 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.715 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.53 80.59 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.924 0.392 . . . . 0.0 110.419 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' B' ' 53' ' ' VAL . 12.7 p -71.09 -33.29 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.567 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.429 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.8 t70 -59.51 -47.18 86.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.454 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.413 ' OG1' HG23 ' B' ' 19' ' ' VAL . 63.7 m -60.25 -48.42 81.83 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.4 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.441 HG22 ' HA ' ' B' ' 50' ' ' VAL . 33.4 m -70.26 -32.44 50.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.07 -41.79 94.75 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.982 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.429 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.4 mt -57.8 -48.59 83.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.816 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.02 -43.28 95.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.948 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' B' ' 53' ' ' VAL . 12.8 ptm180 -84.29 11.73 7.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.72 -15.29 4.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.17 0.509 . . . . 0.0 110.753 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -103.69 -52.38 2.99 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -85.8 -65.61 0.99 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.476 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.462 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 3.4 mm? -131.25 106.86 8.58 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 123.027 0.531 . . . . 0.0 110.692 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.92 -19.39 17.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.022 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.76 -33.32 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.763 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -124.38 89.74 3.13 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.01 137.65 19.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.008 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.52 143.2 41.53 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -100.85 138.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -87.21 -55.64 3.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.12 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -171.66 150.73 2.77 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.41 117.7 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -126.62 148.23 49.82 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.709 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -147.73 138.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.43 -155.27 10.17 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.8 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.6 m -118.86 124.93 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -107.45 144.88 33.75 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.92 113.35 33.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.91 157.37 35.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.466 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 15.8 p -84.27 143.14 29.74 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.796 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 22.7 m -71.29 -43.43 67.14 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.003 0.43 . . . . 0.0 110.865 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 172.93 -39.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.689 1.596 . . . . 0.0 107.304 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -103.52 -164.72 1.09 Allowed 'General case' 0 C--O 1.252 1.216 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.13 56.79 4.86 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 118.632 0.651 . . . . 0.0 112.317 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -124.31 115.35 20.86 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -84.66 128.6 34.68 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.757 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -126.11 140.65 52.41 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -97.08 132.62 42.69 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.437 HG11 ' HE ' ' B' ' 42' ' ' ARG . 48.0 t -135.77 136.84 49.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 19.1 p -68.4 120.89 15.22 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.734 0.646 . . . . 0.0 110.934 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 51.6 p -117.28 155.44 29.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.821 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.404 HG21 HG23 ' B' ' 46' ' ' ILE . 16.6 tt -143.87 132.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -116.21 105.76 12.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.9 mt -103.66 119.04 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.66 124.27 44.82 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.1 pt -121.25 151.99 24.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.62 108.89 14.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.979 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.462 ' HE2' ' HB2' ' B' ' 61' ' ' LEU . 4.1 mmmp? -80.38 133.99 35.97 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? . . . . . 0 C--N 1.283 -2.321 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 169.051 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.433 -1.278 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 m 64.61 12.45 7.53 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 174.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t 70.62 10.48 7.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.134 0.974 . . . . 0.0 111.141 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.21 136.66 3.19 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.6 p -128.96 104.21 18.51 Favored Pre-proline 0 C--N 1.309 -1.163 0 CA-C-O 120.998 0.428 . . . . 0.0 111.745 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.35 162.59 8.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.391 2.06 . . . . 0.0 112.239 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 m -134.34 118.61 13.9 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -84.09 -172.85 1.39 Allowed 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.615 2.21 . . . . 0.0 113.854 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 p -145.43 165.45 28.5 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -103.61 14.17 31.74 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.667 0.27 . . . . 0.0 111.235 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.9 t -113.82 124.78 70.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.07 145.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.985 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.82 131.12 48.33 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.6 mm -95.97 120.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.047 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.64 50.48 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.911 -1.614 . . . . 0.0 114.185 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -155.57 -57.54 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.437 0.618 . . . . 0.0 110.748 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -101.99 163.9 16.85 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -59.49 158.7 26.32 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.242 1.962 . . . . 0.0 111.699 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.446 HG21 ' OD2' ' A' ' 51' ' ' ASP . 10.0 p -52.92 -31.33 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 124.301 1.041 . . . . 0.0 113.437 -175.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.429 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.5 ptm -57.11 -32.58 66.46 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.62 0.368 . . . . 0.0 111.788 -174.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -71.82 -38.24 70.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.098 0.475 . . . . 0.0 110.537 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -76.57 -36.26 57.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.246 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 19' ' ' VAL . 93.2 t -58.03 -53.51 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.089 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.7 mt -58.64 -36.27 73.83 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.398 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.29 96.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.396 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.03 -56.44 20.96 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.56 0.537 . . . . 0.0 111.949 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 27' ' ' LEU 0.342 0.0 OUTLIER -69.53 -19.07 63.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.496 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -72.01 -46.09 58.49 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.8 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.07 -41.18 86.85 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.227 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 96' ' ' LYS . 95.7 mt -55.31 -41.92 73.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.653 0.596 . . . . 0.0 111.509 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.02 5.33 52.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.983 0.42 . . . . 0.0 111.715 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -99.37 -30.14 12.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.82 0.343 . . . . 0.0 110.178 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.49 -15.03 1.09 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.57 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.7 100.53 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 23.2 p -79.49 -22.51 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.1 111.74 14.37 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.263 0.554 . . . . 0.0 110.274 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.55 161.16 19.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.035 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 45.3 t -128.86 125.77 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.469 . . . . 0.0 110.861 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.71 120.89 57.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -118.84 118.37 31.38 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.111 0.481 . . . . 0.0 110.683 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -109.96 148.12 32.2 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HG2' HG22 ' A' ' 89' ' ' THR . 70.9 mtp180 -122.51 143.78 49.5 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.343 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.74 -130.05 12.63 Favored Glycine 0 N--CA 1.44 -1.088 0 O-C-N 123.5 0.5 . . . . 0.0 112.948 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -90.46 5.7 46.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.629 0.728 . . . . 0.0 110.475 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.23 -3.15 54.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.243 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.451 HG23 HG21 ' A' ' 90' ' ' ILE . 69.7 mt -54.47 -37.21 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.786 0.834 . . . . 0.0 110.404 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.1 t -64.26 -26.95 68.73 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.056 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -83.24 -27.91 29.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.372 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -68.12 -43.98 77.17 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -71.33 -35.2 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.17 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.6 t70 -60.64 -47.21 87.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.934 0.772 . . . . 0.0 109.069 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -54.12 -56.25 19.92 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.9 -22.85 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.4 ' HG2' HH21 ' B' ' 86' ' ' ARG . 28.8 tt0 -74.84 -37.35 62.29 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.529 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.7 mt -61.86 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.709 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -55.14 -43.58 70.9 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.377 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 54.8 mtm180 -71.45 3.09 4.11 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.426 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 63.7 t30 -137.47 16.4 2.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.956 0.884 . . . . 0.0 109.689 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -128.75 -63.77 0.96 Allowed 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.413 -176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -106.77 -36.87 6.56 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.296 -176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 95.7 mt -131.49 103.74 6.58 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.215 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.51 -73.87 0.61 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.34 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.26 6.91 40.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.075 0.465 . . . . 0.0 110.681 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.93 24.02 12.81 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.478 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.22 153.52 12.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -125.22 169.16 12.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.153 0.501 . . . . 0.0 111.085 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -109.1 135.97 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -86.79 -66.42 0.91 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.116 0.26 . . . . 0.0 110.782 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 71' ' ' ARG . 42.8 tt0 -162.71 145.54 10.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.4 mt -127.75 116.15 42.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.425 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 79.9 mtp180 -121.27 135.98 55.04 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.526 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.97 131.3 73.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.2 -163.81 11.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.115 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.2 p -131.41 111.42 11.81 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -87.61 131.35 34.45 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.132 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -90.87 118.31 35.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.12 156.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.946 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 29.3 p -96.97 119.16 34.92 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.557 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.2 m -65.69 -31.22 72.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.081 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -153.17 -80.35 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.12 -82.99 0.46 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.497 0.665 . . . . 0.0 110.418 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.22 18.34 9.6 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.806 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 78' ' ' THR . 76.6 mtp180 -82.14 101.68 10.58 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -87.86 124.14 33.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.846 0.716 . . . . 0.0 110.241 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.8 t -126.11 147.36 49.62 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.514 HH21 ' HG2' ' B' ' 54' ' ' GLU . 39.0 mtm180 -97.09 139.11 33.57 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 119.104 -1.038 . . . . 0.0 108.43 173.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.72 117.26 50.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.1 m -61.19 127.45 31.59 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.771 0.67 . . . . 0.0 109.226 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 42' ' ' ARG . 24.5 p -127.97 151.8 48.68 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.002 0.43 . . . . 0.0 111.836 -176.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.451 HG21 HG23 ' A' ' 46' ' ' ILE . 15.5 tt -129.8 128.6 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.289 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.33 106.27 15.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -103.98 117.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.66 133.69 55.67 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.8 pt -138.87 151.33 23.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 35' ' ' SER . 12.9 ptp180 -130.66 158.4 40.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 123.496 0.498 . . . . 0.0 110.838 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.516 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -127.01 117.44 22.48 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.034 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.8 mttm . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.102 174.967 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.6 p -110.58 116.54 31.53 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 120.926 0.394 . . . . 0.0 110.68 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 11.0 p -85.28 159.87 19.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.91 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.18 141.56 17.64 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.479 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 30.3 m -131.19 108.87 15.07 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.43 -44.3 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.074 1.85 . . . . 0.0 112.782 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -123.69 148.37 56.05 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.038 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.63 121.51 8.76 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.883 2.389 . . . . 0.0 111.465 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 35.9 t -122.48 16.62 10.46 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -93.96 16.78 13.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.888 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 80.7 t -117.28 124.55 73.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -116.39 143.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 120.897 0.379 . . . . 0.0 110.862 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -100.37 128.99 46.3 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -94.56 119.78 43.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.224 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.89 45.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.391 -1.385 . . . . 0.0 114.213 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -150.56 -58.87 0.18 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.469 0.635 . . . . 0.0 110.432 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -101.45 164.35 16.12 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.511 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -59.99 156.35 39.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.27 1.98 . . . . 0.0 111.751 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.484 ' O ' HG23 ' B' ' 23' ' ' VAL . 8.3 p -50.6 -30.42 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.541 1.136 . . . . 0.0 113.827 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.457 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 24.9 ptm -58.65 -30.38 67.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.028 0.442 . . . . 0.0 111.958 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.78 -38.36 64.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.648 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -76.73 -34.8 58.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 19' ' ' VAL . 78.9 t -58.89 -54.24 36.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 CA-C-O 121.273 0.559 . . . . 0.0 110.122 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 20' ' ' MET . 94.8 mt -57.86 -38.7 76.18 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.02 98.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.276 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -56.7 18.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.049 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.566 HD13 ' H ' ' B' ' 27' ' ' LEU 0.361 0.0 OUTLIER -69.45 -19.46 63.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 118.454 -1.298 . . . . 0.0 114.087 -178.714 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.5 m -72.04 -45.92 58.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.127 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.87 -40.12 91.35 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.215 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' B' ' 96' ' ' LYS . 95.3 mt -57.16 -42.05 80.34 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.638 0.586 . . . . 0.0 111.888 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -92.64 1.83 57.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.898 0.38 . . . . 0.0 111.685 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -95.79 -37.04 10.93 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.002 0.429 . . . . 0.0 110.074 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.66 -18.58 0.29 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 119.803 -1.189 . . . . 0.0 112.802 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.22 99.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.453 0.644 . . . . 0.0 109.362 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 20.3 p -79.75 -17.26 53.91 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.49 -176.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.96 112.36 10.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.766 0.317 . . . . 0.0 110.454 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.567 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -120.01 161.12 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.272 -177.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 41.5 t -128.81 123.21 58.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.066 0.46 . . . . 0.0 110.484 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.57 122.06 55.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.152 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.4 119.31 33.56 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -111.53 146.57 37.08 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.553 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' B' ' 89' ' ' THR . 74.0 mtp180 -120.64 142.72 49.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.5 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 -129.12 12.33 Favored Glycine 0 C--N 1.303 -1.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.851 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -89.47 8.24 31.96 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.017 0.437 . . . . 0.0 111.005 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.67 -1.64 57.38 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.228 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.416 HG23 HG21 ' B' ' 90' ' ' ILE . 68.5 mt -54.65 -37.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.337 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.19 -32.17 73.5 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.588 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -78.84 -31.16 45.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.831 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -64.27 -45.76 86.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.242 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.45 -35.65 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.484 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.7 t70 -59.59 -50.19 74.86 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -52.02 -54.87 24.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.305 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.67 -21.35 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.514 ' HG2' HH21 ' A' ' 86' ' ' ARG . 30.2 tt0 -75.97 -37.12 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.421 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.484 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.1 mt -61.86 -49.73 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.846 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.95 -42.39 71.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' B' ' 61' ' ' LEU . 56.4 mtm180 -73.53 6.32 3.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.861 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ASN . . . . . 0.433 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 63.1 t30 -139.21 16.09 2.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.85 0.833 . . . . 0.0 109.589 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.39 -64.46 0.94 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.13 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -105.23 -37.14 6.99 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.303 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 94.8 mt -132.26 103.49 6.26 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.127 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 -74.1 0.61 Allowed 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.125 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.22 5.14 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.141 0.496 . . . . 0.0 110.09 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -111.96 24.91 12.13 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.026 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -148.91 154.43 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.78 164.16 24.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.362 0.601 . . . . 0.0 111.143 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.67 138.69 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -89.96 -60.85 1.82 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.91 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -166.54 144.9 5.39 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.759 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.2 mt -128.67 119.76 50.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -127.06 138.6 53.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.382 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.25 129.58 74.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.93 -164.95 11.86 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.063 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 29.3 p -131.55 109.55 10.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -86.35 130.86 34.36 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -90.38 114.19 27.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.3 155.7 36.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.57 0.224 . . . . 0.0 110.818 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' B' ' 83' ' ' ARG . 15.8 p -96.48 118.27 32.64 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.025 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 16.3 m -64.79 -35.55 81.45 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.358 0.663 . . . . 0.0 112.039 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -149.28 -81.74 0.12 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.954 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -101.65 -77.86 0.54 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.289 0.566 . . . . 0.0 110.938 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.77 19.36 8.43 Favored Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.326 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' B' ' 78' ' ' THR . 79.8 mtp180 -84.59 105.92 15.76 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.458 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -90.95 128.95 36.99 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.965 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -130.78 144.97 51.82 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.426 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 53.2 mtm180 -93.46 137.76 32.43 Favored 'General case' 0 N--CA 1.422 -1.825 0 C-N-CA 119.537 -0.865 . . . . 0.0 108.712 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.35 117.51 51.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -60.96 125.75 24.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 123.833 0.708 . . . . 0.0 109.232 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.527 HG22 ' HG2' ' B' ' 42' ' ' ARG . 25.6 p -128.26 148.85 50.66 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.201 0.524 . . . . 0.0 112.074 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.416 HG21 HG23 ' B' ' 46' ' ' ILE . 14.4 tt -127.73 132.1 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.53 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.29 107.13 15.17 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.1 mt -105.68 113.45 42.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.536 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.37 132.7 56.53 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -136.9 152.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' B' ' 35' ' ' SER . 12.6 ptp180 -131.53 156.62 45.39 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 120.915 0.388 . . . . 0.0 110.983 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' B' ' 30' ' ' LEU . 0.0 OUTLIER -125.79 118.15 24.93 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -176.014 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 mttm . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.251 174.053 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 C--O 1.213 -0.842 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m -96.61 -21.82 17.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.57 0.7 . . . . 0.0 109.449 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -139.98 154.64 47.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.79 118.33 2.53 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.336 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 6' ' ' PRO . 20.6 p -94.26 -46.78 0.28 Allowed Pre-proline 0 CA--C 1.565 1.548 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HD3' ' OG1' ' A' ' 5' ' ' THR . 2.3 Cg_endo -84.91 23.25 0.85 Allowed 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 122.282 1.988 . . . . 0.0 112.102 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -74.37 131.17 80.82 Favored Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.62 122.5 11.13 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.033 2.489 . . . . 0.0 111.776 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.8 t -150.16 -82.89 0.1 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -146.77 3.47 0.84 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.284 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 71.6 t -102.11 113.21 37.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -102.92 135.45 40.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.023 0.439 . . . . 0.0 110.811 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.71 119.3 37.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.458 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 52.0 mt -90.58 116.48 31.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.145 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.76 41.59 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.896 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -161.04 -55.35 0.05 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.335 0.567 . . . . 0.0 111.715 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -99.98 159.33 30.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.887 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.43 156.0 33.2 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.902 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.4 -35.87 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.144 0.978 . . . . 0.0 112.611 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.415 ' HG3' HD22 ' A' ' 21' ' ' ASN . 26.9 ptt? -64.13 -24.71 67.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.415 HD22 ' HG3' ' A' ' 20' ' ' MET . 0.9 OUTLIER -73.44 -28.1 61.79 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 99.7 m-85 -83.82 -33.01 25.01 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.833 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 61.2 t -59.72 -52.74 57.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-O 121.314 0.578 . . . . 0.0 109.857 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.92 -30.02 70.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.011 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -47.91 75.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.64 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.07 98.2 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.356 0.41 . . . . 0.0 110.577 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 96.0 mt -62.5 -42.4 99.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.022 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.1 m -66.61 -36.46 82.67 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.499 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -71.92 -27.49 62.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.678 0.275 . . . . 0.0 111.091 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -65.75 -36.85 84.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.057 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.77 -19.44 65.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.315 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -85.58 -5.64 59.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.45 -7.68 40.02 Favored Glycine 0 C--O 1.242 0.651 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.156 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.15 100.8 11.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.406 0.622 . . . . 0.0 109.701 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.451 ' HA ' HD22 ' A' ' 30' ' ' LEU . 33.8 p -87.22 -25.25 24.11 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.631 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.85 105.25 14.01 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.08 0.552 . . . . 0.0 109.626 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -123.1 163.36 22.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.616 0.246 . . . . 0.0 111.183 -176.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -126.85 122.37 60.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.29 0.567 . . . . 0.0 110.927 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.18 128.69 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.4 123.4 36.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.53 0.681 . . . . 0.0 110.472 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.68 148.21 41.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HG2' HG22 ' A' ' 89' ' ' THR . 67.9 mtm180 -128.29 147.59 50.61 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.212 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.88 -135.83 17.65 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -89.57 9.63 26.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.092 0.472 . . . . 0.0 110.995 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 14' ' ' ILE . . . -84.23 -2.61 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -53.22 -36.26 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -61.57 -28.93 69.69 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.602 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB2' HG21 ' A' ' 14' ' ' ILE . 60.8 mttm -84.53 -27.78 27.13 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.918 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.77 93.18 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.7 p -73.47 -29.29 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.116 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.448 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.1 t70 -71.28 -43.99 66.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 m -58.68 -50.22 74.68 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.85 -28.64 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.734 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -50.31 70.54 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 51' ' ' ASP . 72.2 mt -58.99 -44.25 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.28 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.34 -36.11 70.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -93.83 -2.43 53.53 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.771 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -123.84 12.18 9.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.891 0.853 . . . . 0.0 110.267 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.78 -50.16 0.83 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -85.83 -66.4 0.9 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.1 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.1 mt -144.91 115.09 7.5 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.99 -34.32 11.82 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 124.165 0.916 . . . . 0.0 110.5 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -76.4 -19.22 58.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.69 71.76 1.18 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.966 0.412 . . . . 0.0 110.775 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -161.86 152.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.88 154.33 46.11 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.65 136.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -90.0 -58.67 2.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.193 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.49 151.33 7.83 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.8 122.79 14.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -132.19 145.38 51.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.64 143.12 23.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.76 -157.25 19.65 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.554 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -110.11 135.67 50.55 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.703 0.287 . . . . 0.0 110.301 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -119.42 130.26 55.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.41 110.01 24.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.8 153.44 7.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.054 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.6 m -106.57 123.51 48.21 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 m -89.82 -31.85 17.19 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.899 0.381 . . . . 0.0 111.874 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -137.3 -150.59 0.36 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.29 -33.07 55.82 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -173.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.29 42.02 1.02 Allowed Glycine 0 C--O 1.211 -1.296 0 C-N-CA 119.67 -1.253 . . . . 0.0 112.426 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -125.35 105.34 9.02 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 122.272 -0.546 . . . . 0.0 110.257 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -93.29 151.88 19.52 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -148.62 138.2 22.01 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -109.97 116.96 32.56 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.8 0.333 . . . . 0.0 110.177 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.52 140.96 43.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.4 m -73.01 131.06 41.67 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.437 HG22 ' HG2' ' A' ' 42' ' ' ARG . 40.5 p -132.13 147.09 52.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -129.76 138.04 55.17 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.46 109.46 14.87 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.62 124.27 69.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.871 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.39 37.13 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 120.599 0.238 . . . . 0.0 110.81 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 pt -125.26 151.17 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 35' ' ' SER . 25.4 ptt180 -138.63 147.43 42.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 122.035 0.921 . . . . 0.0 113.451 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 21.6 mmtm -91.47 -171.23 2.86 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.663 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.544 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.578 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 120.009 -0.043 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.0 p -69.54 -42.76 74.18 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.501 0.667 . . . . 0.0 110.04 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 22.4 t -131.18 118.16 20.06 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.02 140.48 7.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.928 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 27.1 m -132.37 93.24 25.97 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -90.51 4.92 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.306 2.004 . . . . 0.0 113.096 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.7 m -121.14 97.26 47.93 Favored Pre-proline 0 N--CA 1.433 -1.314 0 CA-C-O 121.036 0.446 . . . . 0.0 110.019 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.36 137.61 7.13 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.126 1.884 . . . . 0.0 111.396 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -78.11 91.77 4.34 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.277 0.561 . . . . 0.0 109.919 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -121.53 2.35 10.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.334 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 67.8 t -100.09 112.99 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -103.13 133.6 46.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.69 116.65 30.31 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.66 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.492 ' HA ' ' CZ ' ' B' ' 22' ' ' TYR . 50.4 mt -88.23 116.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.462 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.69 35.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.791 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -156.12 -54.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.235 0.517 . . . . 0.0 112.197 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.402 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 54.1 mtmt -99.64 157.32 34.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.28 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 156.25 22.94 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.844 2.363 . . . . 0.0 112.696 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.413 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.2 p -52.94 -33.87 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.162 0.985 . . . . 0.0 112.881 -176.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -63.76 -25.58 68.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.663 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -72.76 -33.83 66.6 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' TYR . . . . . 0.492 ' CZ ' ' HA ' ' B' ' 14' ' ' ILE . 99.7 m-85 -77.92 -33.28 51.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.62 -54.37 36.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.086 0.469 . . . . 0.0 109.964 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.88 -29.82 70.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.429 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.29 -46.3 80.99 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.518 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.16 97.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.456 0.473 . . . . 0.0 110.719 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.45 -41.88 97.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.3 m -64.76 -37.63 88.26 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.928 0.394 . . . . 0.0 110.403 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.98 -27.78 62.99 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.404 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' B' ' 35' ' ' SER . 0.5 OUTLIER -64.68 -38.9 92.56 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.87 -22.7 67.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.618 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.76 -10.77 59.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.118 0.485 . . . . 0.0 110.605 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.5 -13.01 20.96 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.139 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.49 100.99 8.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.076 0.465 . . . . 0.0 110.344 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' SER . . . . . 0.423 ' HA ' HD22 ' B' ' 30' ' ' LEU . 33.7 p -84.05 -29.35 26.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.845 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.49 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 39.3 tt0 -107.68 111.53 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.491 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -127.3 162.51 32.35 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.139 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 43.4 t -124.95 123.09 64.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.644 0.735 . . . . 0.0 111.254 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.18 128.54 54.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -127.96 125.15 38.95 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.275 0.56 . . . . 0.0 110.208 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.24 147.75 43.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' B' ' 89' ' ' THR . 53.9 mtm180 -127.5 146.24 50.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.96 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.9 -135.19 15.07 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.794 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -91.47 9.57 31.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.411 0.624 . . . . 0.0 111.036 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.44 ' HB1' HG22 ' B' ' 14' ' ' ILE . . . -83.77 -2.12 55.64 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.354 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.8 mt -53.55 -36.43 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-O 121.624 0.726 . . . . 0.0 109.901 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -60.73 -34.93 75.15 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.039 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -79.33 -30.58 42.81 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.346 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.85 92.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.369 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.21 -33.37 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.088 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.445 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.2 t70 -65.51 -45.4 83.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.116 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.0 m -57.45 -50.7 72.18 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.95 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.45 -30.36 48.67 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.575 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -50.08 73.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.4 mt -58.04 -45.71 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.219 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.03 -34.53 60.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.134 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -94.03 0.01 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -126.8 11.32 7.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.791 0.805 . . . . 0.0 110.23 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -134.85 -49.06 0.75 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.91 -67.07 0.83 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.57 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.481 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 96.0 mt -144.77 115.97 7.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.83 -39.03 10.03 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.903 0.752 . . . . 0.0 110.198 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.69 -13.65 61.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.094 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.92 71.44 1.47 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.767 0.318 . . . . 0.0 111.201 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.402 HD12 ' NZ ' ' B' ' 96' ' ' LYS . 17.7 tt -162.24 156.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -145.6 154.35 42.05 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.15 137.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -90.13 -56.41 3.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.337 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -170.17 153.16 4.44 Favored 'General case' 0 C--O 1.251 1.172 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.98 127.0 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -134.8 144.37 47.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.53 143.09 23.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.8 -158.85 22.88 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.759 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -111.86 131.58 55.27 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -114.69 131.96 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.693 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -98.69 107.97 21.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 m -101.99 153.76 5.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.541 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 22.1 m -106.25 121.59 44.51 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 22.5 m -89.86 -29.51 18.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -137.89 -150.89 0.37 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.21 -31.79 58.6 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 120.746 0.307 . . . . 0.0 110.64 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.6 39.97 0.88 Allowed Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.912 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -121.16 109.58 15.16 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -97.22 152.85 18.44 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.772 0.67 . . . . 0.0 109.653 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -149.83 136.42 19.21 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -106.13 117.97 35.41 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.387 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -122.01 139.22 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -72.85 128.06 34.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.422 HG22 ' HG2' ' B' ' 42' ' ' ARG . 40.8 p -129.39 147.48 51.22 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -175.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.69 138.21 54.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.66 109.3 14.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.95 123.89 69.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.65 122.79 44.51 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -126.99 150.03 32.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.49 ' HD3' ' OE1' ' B' ' 36' ' ' GLU . 23.8 ptt180 -137.09 150.51 48.06 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 20.9 mmtm -93.49 -170.91 2.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.18 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.416 ' HB2' ' NZ ' ' B' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.16 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 CA--C 1.514 -0.439 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 p -91.6 161.22 15.02 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.602 0.239 . . . . 0.0 110.464 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.1 m -125.9 12.48 7.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.136 0.493 . . . . 0.0 111.473 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.57 -55.89 0.27 Allowed Glycine 0 CA--C 1.502 -0.739 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.2 p -81.19 144.4 54.18 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -63.38 -40.34 32.2 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.966 1.777 . . . . 0.0 110.677 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.5 t -71.28 127.77 90.98 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.662 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 21.3 Cg_exo -66.77 -49.64 1.49 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.996 1.797 . . . . 0.0 111.344 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.3 m -159.6 -83.49 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.014 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -134.86 17.51 3.53 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.596 0.712 . . . . 0.0 110.029 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.19 120.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -110.82 145.76 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.264 0.554 . . . . 0.0 111.112 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.79 132.63 51.68 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.075 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -89.66 102.31 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 16' ' ' LYS . . . 178.86 55.55 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 118.229 -1.938 . . . . 0.0 115.551 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 53.8 tttm 178.07 -42.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.472 0.636 . . . . 0.0 110.69 171.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -92.39 159.82 36.19 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.243 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.82 162.15 40.02 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.152 1.901 . . . . 0.0 111.308 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.408 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.4 p -54.77 -41.39 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -59.95 -30.19 68.91 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.738 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -72.29 -34.4 68.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.067 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -73.01 -33.18 65.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.65 -55.83 21.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.101 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.52 -27.3 69.06 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.684 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.01 77.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.907 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.31 98.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.294 0.371 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.04 -33.18 75.21 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.47 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.8 m -64.4 -36.73 85.11 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.441 0.639 . . . . 0.0 109.738 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.82 -35.51 72.51 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.7 mt -58.43 -42.58 87.63 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.167 0.508 . . . . 0.0 110.239 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -66.79 -23.76 66.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.892 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -87.65 -2.68 58.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.7 8.93 47.75 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.07 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.38 94.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 m -85.69 -22.6 27.78 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.633 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -109.7 107.45 17.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.47 142.05 36.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -116.1 123.91 71.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.013 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.03 123.92 62.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 85.7 mttt -120.18 124.02 44.71 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.491 0.662 . . . . 0.0 109.834 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.34 160.04 21.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.457 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -131.37 145.09 51.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.278 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' O ' HG13 ' A' ' 46' ' ' ILE . . . 69.57 -127.8 20.36 Favored Glycine 0 N--CA 1.433 -1.552 0 O-C-N 123.533 0.52 . . . . 0.0 112.445 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.23 0.02 56.58 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.38 . . . . 0.0 111.35 -176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.74 2.06 27.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.134 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 43' ' ' GLY . 75.1 mt -57.25 -40.89 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.463 0.649 . . . . 0.0 109.698 175.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.3 t -70.66 -16.44 62.81 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.954 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -89.83 -33.97 16.3 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.56 89.45 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.128 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 13.7 p -67.76 -43.32 86.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.556 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.9 t70 -54.83 -44.51 73.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.6 m -57.96 -53.55 57.0 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.983 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.54 -30.14 46.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 50' ' ' VAL . 46.4 mt-10 -60.19 -47.93 83.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 123.401 0.438 . . . . 0.0 110.286 174.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.2 mt -60.6 -40.62 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 121.232 0.539 . . . . 0.0 110.62 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.93 -27.51 42.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 CA-C-O 121.14 0.495 . . . . 0.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -100.96 2.63 40.89 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -116.45 9.78 14.42 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.198 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -139.1 -71.24 0.4 Allowed 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.419 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 74.4 t80 -60.5 -64.49 0.93 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.131 0.491 . . . . 0.0 110.842 -174.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.473 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.0 mt -141.28 113.62 8.1 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.27 -35.69 10.66 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 124.161 0.913 . . . . 0.0 110.175 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.1 -45.85 59.01 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.073 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.66 97.65 8.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.591 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.466 HD13 ' HZ2' ' A' ' 96' ' ' LYS . 7.2 tp -158.63 138.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.266 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.617 ' HG2' HH21 ' A' ' 95' ' ' ARG . 7.9 tp10 -124.74 149.98 46.71 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tp -107.52 137.19 39.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -100.54 -53.64 3.04 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.542 -1.263 . . . . 0.0 111.511 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 71' ' ' ARG . 35.6 tt0 -170.53 144.81 2.47 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.1 mt -135.49 119.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.498 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 21.9 mtm180 -128.92 136.61 50.62 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.39 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.58 119.0 58.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.98 167.62 34.87 Favored Glycine 0 C--N 1.303 -1.287 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.631 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 m -85.87 118.65 25.49 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 5.9 tp60 -95.64 131.87 41.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.94 107.45 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.901 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.38 161.24 16.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.644 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.4 p -100.21 152.44 20.28 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.0 t -82.7 -72.56 0.44 Allowed 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.744 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -155.24 11.71 0.34 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.473 0.654 . . . . 0.0 109.838 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 82' ' ' GLY . 24.5 t70 -160.68 -159.38 0.68 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.433 ' H ' ' CG ' ' A' ' 81' ' ' ASP . . . -76.42 11.06 14.09 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.213 0.915 . . . . 0.0 112.709 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -73.45 107.31 5.66 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -88.54 137.65 32.13 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.2 m -129.0 130.49 46.71 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -95.53 120.08 35.15 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.57 130.23 72.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.696 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.54 118.43 7.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.5 p -125.86 155.16 41.63 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.427 -0.171 . . . . 0.0 111.069 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 14.4 tt -136.99 131.27 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.12 110.99 21.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.32 118.32 57.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.0 117.93 30.56 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 123.298 0.374 . . . . 0.0 110.332 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.6 pt -114.87 158.37 15.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.617 HH21 ' HG2' ' A' ' 66' ' ' GLU . 34.4 ttp180 -130.39 111.79 12.66 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.207 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 26.8 mmtm -79.03 143.45 35.63 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.559 174.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt . . . . . 0 C--N 1.307 -1.263 0 O-C-N 123.127 0.267 . . . . 0.0 110.832 -178.57 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 C--O 1.213 -0.83 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.4 p -102.4 -63.36 1.16 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 120.882 0.373 . . . . 0.0 111.148 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 17.1 p -68.06 -60.66 2.32 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 123.787 0.835 . . . . 0.0 111.248 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.82 -148.62 19.28 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 11.6 p -148.58 138.12 12.49 Favored Pre-proline 0 C--N 1.317 -0.84 0 C-N-CA 123.234 0.613 . . . . 0.0 109.835 177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 5' ' ' THR . 10.1 Cg_endo -82.24 160.47 17.68 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.704 2.269 . . . . 0.0 112.8 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -91.17 132.44 34.09 Favored Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.605 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -89.13 141.34 4.18 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.884 2.39 . . . . 0.0 113.108 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -115.95 -18.24 10.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.246 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -112.66 17.7 18.92 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.821 0.343 . . . . 0.0 111.402 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.46 119.96 63.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.46 142.05 24.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.192 0.52 . . . . 0.0 111.585 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.33 131.83 51.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.879 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -89.57 99.95 10.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.16 43.63 0.16 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 117.935 -2.079 . . . . 0.0 116.112 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -173.83 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.456 1.128 . . . . 0.0 110.444 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -91.59 160.87 35.67 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.395 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.66 164.09 34.47 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.133 1.888 . . . . 0.0 110.929 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.464 HG23 ' OG1' ' B' ' 52' ' ' THR . 8.4 p -57.24 -37.37 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.118 0.567 . . . . 0.0 111.738 -176.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -64.07 -29.36 70.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.662 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -73.97 -34.94 64.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -70.7 -34.03 71.53 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.799 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.46 -55.16 26.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.429 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.7 -28.69 70.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.53 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.413 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.43 -43.07 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.184 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.17 99.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.124 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.6 -34.73 78.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.806 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.0 m -64.88 -36.3 83.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.137 0.494 . . . . 0.0 110.11 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -69.91 -36.94 75.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.558 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.42 HD23 ' O ' ' B' ' 34' ' ' VAL . 95.2 mt -57.31 -43.42 83.26 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.056 0.455 . . . . 0.0 110.346 177.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.802 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -87.65 -0.87 57.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.158 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.74 13.85 36.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.041 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.42 ' O ' HD23 ' B' ' 30' ' ' LEU . 32.5 t -101.08 92.97 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -82.9 -24.34 33.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.151 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -109.06 109.32 20.31 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.448 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -122.44 142.76 37.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.27 179.229 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.02 125.08 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.36 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -107.51 123.87 63.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -120.51 123.2 42.36 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.56 161.73 18.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -132.76 145.72 51.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.941 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.4 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 68.35 -127.88 24.2 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 123.451 0.47 . . . . 0.0 112.654 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.35 -0.77 57.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.022 0.439 . . . . 0.0 111.778 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.88 1.98 25.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.4 HG13 ' O ' ' B' ' 43' ' ' GLY . 73.3 mt -58.14 -41.17 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.69 0.757 . . . . 0.0 109.805 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 44.2 t -67.77 -22.14 65.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.405 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -84.84 -33.57 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.37 86.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.601 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' B' ' 54' ' ' GLU . 14.5 p -66.47 -44.07 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.4 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.486 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.1 t70 -56.55 -39.38 73.34 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.464 ' OG1' HG23 ' B' ' 19' ' ' VAL . 57.3 m -61.68 -52.62 63.55 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.98 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.48 -31.14 49.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.203 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' B' ' 50' ' ' VAL . 44.9 mt-10 -59.38 -45.9 90.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.626 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.486 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.9 mt -61.95 -40.64 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.894 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.84 -26.02 37.65 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.157 0.503 . . . . 0.0 111.59 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -100.75 0.52 39.01 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.864 -0.523 . . . . 0.0 111.914 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -116.41 12.75 15.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.182 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -137.89 -68.96 0.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.01 -62.7 1.47 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.868 0.366 . . . . 0.0 111.148 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.446 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.1 mt -142.8 115.12 8.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.01 -34.17 10.19 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 124.241 0.963 . . . . 0.0 109.968 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.5 -41.47 60.64 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.907 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -103.91 99.11 8.87 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.425 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.415 HD13 ' HZ2' ' B' ' 96' ' ' LYS . 7.0 tp -157.99 140.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.041 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.621 ' HG2' HH21 ' B' ' 95' ' ' ARG . 7.1 tp10 -125.83 146.82 49.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -105.44 134.53 46.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -98.85 -54.01 3.12 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.503 -1.279 . . . . 0.0 111.291 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLU . . . . . 0.401 ' OE2' ' HD3' ' B' ' 71' ' ' ARG . 29.3 tt0 -169.87 143.32 2.57 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.7 mt -131.89 118.81 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.401 ' HD3' ' OE2' ' B' ' 69' ' ' GLU . 25.6 mtm180 -127.55 137.25 52.56 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.582 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.55 117.23 51.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.16 165.77 33.89 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.515 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -84.44 115.98 22.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.45 0.7 . . . . 0.0 109.375 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -94.04 132.44 38.52 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.48 108.96 21.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.644 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -118.56 164.82 14.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.71 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 25.5 p -103.94 145.87 29.51 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 47.8 t -78.13 -62.34 1.71 Allowed 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.762 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.15 6.69 0.07 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.935 0.398 . . . . 0.0 110.756 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' B' ' 82' ' ' GLY . 24.6 t70 -161.09 -156.29 0.45 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' B' ' 81' ' ' ASP . . . -73.25 6.48 14.87 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 118.787 0.721 . . . . 0.0 113.657 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.36 108.8 5.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -88.59 144.42 26.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 123.52 0.512 . . . . 0.0 109.983 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.1 m -132.92 125.56 30.15 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.755 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -91.97 114.42 26.95 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -114.46 129.48 70.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -61.86 120.38 10.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.9 p -127.64 155.12 44.4 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.308 -0.245 . . . . 0.0 111.221 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -136.83 131.42 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.838 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.35 109.94 19.12 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 56.1 mt -110.88 117.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.95 118.83 34.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.193 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 pt -116.67 152.03 18.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.836 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.621 HH21 ' HG2' ' B' ' 66' ' ' GLU . 35.0 ttp180 -124.21 114.04 19.1 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 28.0 mmtm -80.24 146.8 31.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.861 174.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.385 0.428 . . . . 0.0 111.643 -177.347 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.5 p 56.39 94.49 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 t -146.28 -41.58 0.2 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.832 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.72 175.61 14.15 Favored Glycine 0 N--CA 1.422 -2.291 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 p -100.57 151.06 37.47 Favored Pre-proline 0 C--N 1.286 -2.184 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.29 -17.1 55.39 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.844 2.362 . . . . 0.0 112.66 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -142.61 140.27 18.41 Favored Pre-proline 0 N--CA 1.422 -1.846 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.61 124.1 10.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.271 1.981 . . . . 0.0 111.973 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 t -137.57 -50.4 0.61 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.78 0.324 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -100.14 13.57 33.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.898 0.38 . . . . 0.0 111.08 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.46 112.27 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.26 133.9 44.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.642 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -120.83 130.42 53.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.29 133.81 44.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.41 48.5 0.02 OUTLIER Glycine 0 C--N 1.348 1.196 0 C-N-CA 119.439 -1.363 . . . . 0.0 115.628 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -174.71 -51.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 118.04 0.92 . . . . 0.0 112.031 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.13 158.1 33.85 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.732 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 165.74 17.89 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.373 2.048 . . . . 0.0 111.417 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG21 ' OD2' ' A' ' 51' ' ' ASP . 11.6 p -53.06 -28.72 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 C-N-CA 124.353 1.061 . . . . 0.0 113.296 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.6 mtp -62.83 -29.74 70.96 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -71.07 -28.82 64.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.18 0.515 . . . . 0.0 109.64 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -89.62 -42.66 11.26 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.183 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 82.3 t -60.79 -49.82 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.787 0.327 . . . . 0.0 110.68 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.24 -19.79 64.76 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.984 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.406 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -77.37 -48.79 16.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.44 85.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 97.4 mt -60.3 -34.48 73.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.7 m -76.09 -40.95 51.91 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.0 mt -61.35 -38.56 87.37 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.1 -42.78 95.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.395 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.73 -16.38 45.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.918 0.39 . . . . 0.0 110.411 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -78.61 -34.12 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.29 -4.0 1.27 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.87 100.36 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -79.34 -21.11 46.3 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.151 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.38 121.48 22.38 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.261 0.553 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -126.36 158.63 36.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.503 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.86 122.02 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.4 mt -105.45 121.1 57.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 99.6 mttt -108.34 141.25 40.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -133.38 157.4 45.62 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -133.98 135.09 43.23 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 46' ' ' ILE . . . 67.59 -135.01 30.72 Favored Glycine 0 C--O 1.212 -1.237 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.683 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -74.12 -2.45 24.6 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.35 -9.97 59.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.488 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 43' ' ' GLY . 78.7 mt -53.35 -33.87 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.272 0.629 . . . . 0.0 110.797 178.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 p -63.07 -30.6 71.72 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.095 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -86.98 -25.85 24.09 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.374 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -63.29 -48.38 78.34 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.41 0.624 . . . . 0.0 109.984 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.1 -38.18 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.406 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.4 t70 -59.8 -47.99 83.49 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.518 0.511 . . . . 0.0 109.732 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 56' ' ' VAL . 95.2 m -55.82 -54.26 46.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.193 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.31 -31.0 49.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.278 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 26.6 tt0 -67.87 -37.6 82.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.275 0.359 . . . . 0.0 110.531 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 68.9 mt -64.89 -47.97 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 52' ' ' THR . 61.4 t -58.17 -52.71 55.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.449 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -66.63 -13.51 61.24 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -116.64 2.32 12.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 15.8 ptm180 -117.78 -34.44 4.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.127 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -90.1 -58.85 2.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.697 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' A' ' 64' ' ' LYS . 47.2 tp -155.84 109.49 2.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 -6.04 28.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.443 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -87.95 -41.92 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.006 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 67.2 mttm -124.43 99.01 6.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -155.2 145.34 13.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.5 148.24 50.5 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.166 0.508 . . . . 0.0 110.131 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.2 mt -102.91 133.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -92.85 -51.42 5.09 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.967 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -160.55 141.36 11.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.2 99.89 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 123.132 0.573 . . . . 0.0 110.388 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.22 153.95 51.76 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.775 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.08 135.95 42.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.27 -165.69 15.5 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.189 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -100.27 128.73 46.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.076 0.55 . . . . 0.0 109.874 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -108.15 112.41 24.92 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 85' ' ' SER . 21.9 t -102.03 111.94 33.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.52 163.96 32.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.035 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.6 p -85.87 130.47 34.54 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.3 m -79.53 -27.17 41.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.067 0.461 . . . . 0.0 110.043 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -143.28 -80.84 0.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -133.8 -83.9 0.45 Allowed 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.845 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.1 45.75 2.07 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.091 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -133.13 104.12 6.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -91.38 126.65 36.53 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.818 0.699 . . . . 0.0 110.242 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 32.3 t -114.94 137.74 51.64 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.403 ' HG2' HG22 ' A' ' 76' ' ' VAL . 46.1 mtm180 -113.4 109.01 18.0 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.19 133.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.7 t -66.02 134.88 53.82 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.352 0.596 . . . . 0.0 110.915 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.2 p -132.14 160.34 36.31 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.161 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 18.5 tt -140.78 135.58 34.14 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -111.38 115.79 29.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.64 112.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 123.96 50.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.496 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.6 pt -125.85 152.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.166 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -130.05 124.51 33.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.894 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -74.6 140.01 44.06 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 28.1 mtpp . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 52.3 p -142.89 -44.67 0.3 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.834 0.35 . . . . 0.0 111.714 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.3 t -85.28 -9.81 57.24 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.843 0.354 . . . . 0.0 111.414 -177.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.32 98.78 2.31 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.874 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -133.32 143.89 50.1 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.35 -5.55 11.86 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.416 2.077 . . . . 0.0 113.521 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -159.75 142.39 10.06 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.7 101.11 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.982 2.455 . . . . 0.0 112.127 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -112.4 -0.14 15.44 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.412 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -113.99 14.61 18.45 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 120.781 0.324 . . . . 0.0 110.841 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.92 111.51 30.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.69 131.63 47.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.983 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -118.27 127.18 53.48 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.8 mt -99.76 133.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 48.31 0.02 OUTLIER Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.496 -1.335 . . . . 0.0 115.446 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -172.95 -50.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.868 0.834 . . . . 0.0 112.598 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.416 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 32.0 mmmt -99.64 158.52 32.0 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 122.241 -0.287 . . . . 0.0 110.806 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.91 164.26 22.46 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.557 2.171 . . . . 0.0 111.173 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.476 HG21 ' OD1' ' B' ' 51' ' ' ASP . 13.4 p -52.43 -27.23 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 123.994 0.918 . . . . 0.0 113.326 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 92.9 mtp -65.14 -27.17 68.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -72.9 -26.23 61.35 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.409 0.623 . . . . 0.0 109.625 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' TYR . . . . . 0.416 ' HE2' ' O ' ' B' ' 17' ' ' LYS . 90.1 m-85 -93.42 -42.84 9.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.101 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.453 HG23 HG22 ' B' ' 19' ' ' VAL . 99.0 t -60.8 -49.56 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 121.345 0.593 . . . . 0.0 110.432 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mp -67.46 -24.18 65.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.79 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.11 -45.92 46.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.19 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.75 97.69 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.932 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 98.8 mt -60.33 -38.09 82.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.153 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.1 m -70.19 -43.62 70.38 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -60.18 -39.05 85.13 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -41.34 89.53 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.522 0.514 . . . . 0.0 111.168 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -85.37 -15.05 44.45 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.312 0.577 . . . . 0.0 110.164 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -79.21 -36.42 40.13 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.528 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.26 -3.9 0.92 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.638 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -97.99 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 117.511 0.656 . . . . 0.0 109.389 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -78.29 -21.78 49.21 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.963 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.23 118.32 19.36 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.174 0.511 . . . . 0.0 111.092 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.533 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -124.95 159.25 31.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.923 -176.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.67 121.49 60.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.029 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -104.94 122.66 58.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 99.3 mttt -110.47 139.24 45.88 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 123.65 0.594 . . . . 0.0 109.979 177.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -132.61 154.92 49.58 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -132.22 134.0 44.81 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.42 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 70.28 -135.53 25.78 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.691 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.6 -2.83 27.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.47 57.98 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.539 0.209 . . . . 0.0 111.275 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.42 HG13 ' O ' ' B' ' 43' ' ' GLY . 77.7 mt -52.96 -35.63 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.479 0.657 . . . . 0.0 110.43 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 53.4 p -62.35 -35.71 79.95 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.92 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -81.61 -26.81 34.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -62.47 -47.77 82.54 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.25 0.548 . . . . 0.0 110.613 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.66 -38.06 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.661 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.476 ' OD1' HG21 ' B' ' 19' ' ' VAL . 13.3 t70 -57.58 -49.92 74.82 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.418 ' O ' HG23 ' B' ' 56' ' ' VAL . 90.1 m -54.2 -54.3 41.79 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.473 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.0 m -69.3 -30.63 46.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.551 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.447 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 25.8 tt0 -68.11 -37.42 81.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 123.302 0.376 . . . . 0.0 110.71 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' B' ' 59' ' ' ARG . 73.7 mt -64.56 -48.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 52' ' ' THR . 58.8 t -57.7 -53.69 41.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 32.2 ptt180 -65.77 -9.69 30.55 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -120.04 -1.24 10.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 15.5 ptm180 -115.18 -33.79 5.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.166 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -89.41 -59.69 2.15 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.704 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' B' ' 64' ' ' LYS . 46.1 tp -153.94 107.74 2.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.87 -1.61 39.73 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.064 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -92.63 -50.75 5.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.918 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.413 ' HB2' HD21 ' B' ' 61' ' ' LEU . 66.3 mttm -115.22 96.65 5.78 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.817 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -152.14 146.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -132.25 149.53 52.35 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -105.69 132.33 52.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -91.72 -50.28 5.83 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.866 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -163.55 143.24 8.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.566 0.541 . . . . 0.0 109.602 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -143.96 98.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.742 0.817 . . . . 0.0 110.269 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -132.91 153.28 51.53 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.397 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.45 137.42 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.65 -169.88 25.57 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.667 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -93.73 137.17 33.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -115.42 116.33 28.05 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' B' ' 85' ' ' SER . 26.3 t -106.09 108.32 24.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.12 166.81 28.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.783 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' B' ' 83' ' ' ARG . 17.6 p -89.89 127.76 36.07 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.337 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 18.0 m -77.33 -25.22 50.95 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.371 0.605 . . . . 0.0 110.958 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -145.22 -81.99 0.15 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -132.26 -74.24 0.51 Allowed 'General case' 0 C--O 1.209 -1.074 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.869 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.02 30.0 11.31 Favored Glycine 0 C--O 1.22 -0.762 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.667 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' B' ' 78' ' ' THR . 77.4 ttt180 -116.62 105.11 12.07 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -88.07 128.86 35.42 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.492 0.495 . . . . 0.0 110.135 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' B' ' 76' ' ' VAL . 32.6 t -117.53 138.83 51.64 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' B' ' 76' ' ' VAL . 52.3 mtm180 -114.12 108.97 17.7 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.65 135.97 58.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.5 t -69.59 135.98 50.67 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.875 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.03 159.55 38.47 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.491 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 19.2 tt -139.08 135.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.84 113.33 25.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.0 113.49 44.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.15 122.14 44.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 32.7 pt -124.11 149.17 28.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.204 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -127.33 127.57 44.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.988 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 0.7 OUTLIER -78.59 136.74 37.59 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.459 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 27.5 mtpp . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 ttp . . . . . 0 CA--C 1.487 -1.452 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 t 56.99 87.67 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.493 1.121 . . . . 0.0 110.174 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 m -119.25 18.61 12.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.841 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.84 178.7 26.83 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -86.73 115.51 62.64 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -56.34 -33.18 90.88 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.557 2.838 . . . . 0.0 113.649 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 m -145.77 101.59 4.25 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -88.9 118.45 0.93 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.574 2.183 . . . . 0.0 112.909 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.3 m -97.4 104.58 16.62 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.128 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -123.61 10.25 9.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.089 0.471 . . . . 0.0 110.66 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 22.9 m -102.38 130.83 51.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.583 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.89 142.45 40.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.526 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.39 129.19 52.34 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.34 113.06 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.935 0.397 . . . . 0.0 111.269 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.08 -161.3 25.51 Favored Glycine 0 C--O 1.253 1.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.322 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.23 5.18 8.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -82.16 158.47 66.91 Favored Pre-proline 0 CA--C 1.547 0.854 0 O-C-N 122.154 -0.341 . . . . 0.0 111.093 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.18 153.81 67.11 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.101 2.534 . . . . 0.0 113.475 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.507 HG21 ' OD1' ' A' ' 51' ' ' ASP . 7.1 p -54.76 -39.91 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.06 0.944 . . . . 0.0 113.356 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -55.55 -30.58 61.01 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.33 -39.49 92.49 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.007 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -80.97 -34.31 33.2 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.14 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 19' ' ' VAL . 57.4 t -59.2 -49.97 81.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.065 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.14 -34.66 78.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.58 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -50.6 65.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.07 86.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.237 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.25 -41.17 97.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.7 m -62.6 -38.55 90.62 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 88.6 mt -64.25 -38.58 91.54 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.65 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.99 -48.85 78.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.812 0.695 . . . . 0.0 110.536 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -79.38 -12.83 59.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.198 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -79.98 -25.85 40.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.99 -12.47 3.88 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.799 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.98 93.06 3.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.292 0.568 . . . . 0.0 109.479 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -87.65 18.4 4.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -155.73 110.34 2.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.473 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -130.33 160.64 41.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.342 -175.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.3 t -124.59 122.76 64.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.332 0.587 . . . . 0.0 110.662 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -100.93 129.32 52.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.0 119.68 36.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.096 0.474 . . . . 0.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -113.74 153.21 29.4 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -142.86 137.56 29.66 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.535 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.48 -130.83 10.26 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -95.18 10.06 37.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.077 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.56 2.02 49.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.934 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.405 HG23 HG21 ' A' ' 90' ' ' ILE . 73.9 mt -57.31 -43.28 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.149 0.579 . . . . 0.0 111.282 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.3 p -66.6 -24.81 66.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.689 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.62 -30.71 52.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.5 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -70.67 -43.77 68.43 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.325 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.85 -33.29 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.075 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' OD1' HG21 ' A' ' 19' ' ' VAL . 18.0 t70 -58.97 -50.36 74.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.4 m -53.61 -52.76 58.8 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.105 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.8 m -70.31 -36.27 66.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.73 -29.08 68.96 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 121.493 0.663 . . . . 0.0 109.43 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.5 mt -69.57 -48.75 64.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 122.003 -0.435 . . . . 0.0 110.626 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -59.84 -36.31 65.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 120.946 0.403 . . . . 0.0 111.348 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 6.1 ptm180 -82.08 0.81 38.87 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -115.29 -45.77 2.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.884 0.373 . . . . 0.0 111.544 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 16.2 ptm180 -72.85 -28.36 62.48 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -105.62 -72.53 0.71 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.231 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.507 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 96.0 mt -142.2 116.52 9.55 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -93.15 -37.57 12.04 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 124.497 1.123 . . . . 0.0 110.42 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.7 -40.33 92.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.79 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -108.12 99.44 8.88 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 121.191 0.519 . . . . 0.0 111.364 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.42 132.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.454 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.49 136.96 53.9 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -99.48 130.05 49.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -80.04 -55.82 4.68 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -171.32 147.3 2.44 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.71 123.92 55.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -122.43 139.93 53.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.039 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -132.57 125.45 53.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.28 25.78 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.494 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 88' ' ' SER . 50.1 m -115.38 129.05 56.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 117.278 0.539 . . . . 0.0 111.082 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 53.5 tt0 -93.18 141.63 28.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.122 0.969 . . . . 0.0 108.543 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.481 HG22 ' HG2' ' A' ' 86' ' ' ARG . 22.4 t -116.1 113.25 42.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.18 170.59 18.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 120.673 0.273 . . . . 0.0 110.599 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 81' ' ' ASP . 26.2 p -95.92 142.52 28.06 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.4 t -78.06 -22.15 49.51 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.589 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 178.57 -45.95 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.902 0.881 . . . . 0.0 109.037 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.493 ' O ' ' HB ' ' A' ' 78' ' ' THR . 17.6 t70 -123.56 -154.22 0.6 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.62 -2.43 7.63 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.092 0.797 . . . . 0.0 115.092 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.39 103.06 0.76 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -77.7 140.6 39.56 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.392 0.677 . . . . 0.0 111.719 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.9 m -131.59 123.04 27.09 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.285 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 98.1 mtt180 -102.77 120.06 39.92 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -134.75 139.22 47.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 19.2 m -72.35 136.65 46.21 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.556 0.743 . . . . 0.0 112.436 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.448 HG21 ' OE1' ' A' ' 75' ' ' GLN . 80.9 p -129.15 170.73 13.18 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.909 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.405 HG21 HG23 ' A' ' 46' ' ' ILE . 13.7 tt -146.93 123.78 3.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.477 176.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.14 113.49 26.8 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.03 115.51 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.19 121.14 42.06 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.574 0.225 . . . . 0.0 110.836 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.81 148.32 25.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.636 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.43 147.63 40.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.137 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 4.4 mmtm -128.05 137.4 52.16 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.505 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? . . . . . 0 C--O 1.265 1.886 0 O-C-N 123.337 0.398 . . . . 0.0 110.585 -178.915 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtp . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.7 p -69.81 3.69 2.43 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -78.77 -19.12 52.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.758 0.79 . . . . 0.0 108.902 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.43 -101.77 0.44 Allowed Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.828 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -84.05 157.13 63.32 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -88.97 1.97 5.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.046 2.498 . . . . 0.0 111.44 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -85.05 125.4 70.53 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.838 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.68 98.67 0.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.584 2.19 . . . . 0.0 112.395 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 30.1 m -123.99 9.64 8.76 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.354 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -141.2 17.21 2.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.639 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.87 133.12 48.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.078 0.466 . . . . 0.0 111.493 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.67 143.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.553 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 56.8 tp -106.52 125.65 51.26 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.87 116.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 120.996 0.426 . . . . 0.0 111.099 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.98 -158.8 22.38 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.201 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -79.28 4.17 15.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.02 158.53 67.2 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 122.346 -0.222 . . . . 0.0 110.661 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.69 153.93 68.84 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.214 2.61 . . . . 0.0 113.214 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.502 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.3 p -54.53 -39.8 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.346 1.058 . . . . 0.0 113.394 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -57.56 -27.26 62.5 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.95 -36.74 80.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -83.19 -35.46 25.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.415 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 19' ' ' VAL . 82.1 t -58.38 -50.95 76.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.876 178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.22 -36.51 84.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.6 -48.09 78.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.832 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.08 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.925 0.393 . . . . 0.0 111.088 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.54 -41.76 98.43 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.9 m -61.16 -39.62 90.8 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.521 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.3 mt -63.51 -38.69 92.1 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.59 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.3 -46.02 86.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.138 0.494 . . . . 0.0 110.696 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.83 -7.51 59.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -84.87 -25.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.81 -15.71 3.31 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.612 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.65 94.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.169 0.509 . . . . 0.0 109.93 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -90.48 19.04 5.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.962 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -155.25 107.84 2.72 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.505 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.15 158.74 41.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -174.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.19 121.72 62.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.508 0.67 . . . . 0.0 111.015 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.77 129.03 50.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.92 122.74 44.09 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.26 0.552 . . . . 0.0 110.777 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -116.77 154.34 30.85 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -142.94 136.03 28.14 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.542 0.526 . . . . 0.0 110.35 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.33 -132.92 11.46 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -93.48 13.56 21.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 110.267 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.95 1.41 56.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.27 -43.78 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.305 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -65.92 -24.25 66.79 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.955 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -79.6 -32.2 41.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.035 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -68.29 -44.18 76.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.08 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.51 -33.91 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.113 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.502 ' OD1' HG21 ' B' ' 19' ' ' VAL . 13.7 t70 -58.51 -49.28 77.95 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -54.58 -51.78 64.19 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.908 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.45 -37.11 69.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -66.97 -30.52 70.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.304 0.573 . . . . 0.0 109.58 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.7 mt -67.33 -49.18 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.106 -0.371 . . . . 0.0 110.649 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.28 -39.42 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.794 0.331 . . . . 0.0 111.542 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' B' ' 62' ' ' ALA . 7.6 ptm180 -79.82 -1.98 41.37 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -110.79 -43.8 3.75 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.769 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -75.16 -34.27 61.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -99.96 -69.15 0.78 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.851 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.529 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.9 mt -144.97 116.6 8.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -93.21 -38.06 11.75 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 124.501 1.125 . . . . 0.0 110.789 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.365 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -108.53 100.14 9.44 Favored 'General case' 0 C--O 1.253 1.254 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.0 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tp -160.18 130.01 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.638 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.15 135.05 53.22 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.73 131.61 45.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' B' ' 68' ' ' LYS . 9.5 tmtt? -83.26 -56.41 3.78 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -170.89 146.22 2.5 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -130.45 123.61 55.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -121.23 140.41 52.07 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.607 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.22 125.67 51.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' B' ' 88' ' ' SER . . . -165.11 -171.46 31.37 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.001 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 88' ' ' SER . 49.0 m -111.0 125.77 54.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.101 0.451 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 53.3 tt0 -89.81 141.9 28.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.899 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.494 HG22 ' HG2' ' B' ' 86' ' ' ARG . 20.7 t -116.39 115.79 50.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.36 172.38 16.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' B' ' 81' ' ' ASP . 25.6 p -97.51 143.28 28.38 Favored 'General case' 0 N--CA 1.413 -2.292 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 46.6 t -77.21 -23.01 51.47 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 178.9 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.525 ' O ' ' HB ' ' B' ' 78' ' ' THR . 15.6 t70 -123.56 -154.7 0.62 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 177.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.51 -1.17 7.47 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 114.974 0.75 . . . . 0.0 114.974 -175.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.59 105.6 1.26 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 117.472 0.636 . . . . 0.0 109.437 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -78.85 144.35 35.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.484 0.659 . . . . 0.0 111.895 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -132.43 127.93 36.41 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.539 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 99.7 mtt180 -108.89 116.76 32.6 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 135.63 56.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 74' ' ' SER . 20.1 m -68.08 137.17 54.77 Favored 'General case' 0 C--O 1.261 1.693 0 C-N-CA 123.708 0.803 . . . . 0.0 112.193 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.444 HG21 ' OE1' ' B' ' 75' ' ' GLN . 68.4 p -129.42 171.01 12.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.472 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.57 123.03 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.952 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.81 113.36 26.71 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -110.96 116.39 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.36 120.38 40.16 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.059 0.457 . . . . 0.0 110.922 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -120.69 143.8 31.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -110.78 147.61 34.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.284 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.529 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 3.3 mmtm -128.81 136.06 49.98 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 122.733 0.413 . . . . 0.0 111.802 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? . . . . . 0 C--O 1.258 1.504 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -178.992 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 119.911 -0.09 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 p 55.56 -173.61 0.06 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.772 0.829 . . . . 0.0 112.737 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.6 m -89.93 -56.59 3.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.263 0.554 . . . . 0.0 109.882 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.616 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -122.24 161.65 16.32 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 p -102.62 98.28 10.72 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 34.3 Cg_endo -98.07 -172.77 0.16 Allowed 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 123.015 2.477 . . . . 0.0 110.356 175.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -114.88 87.78 15.62 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-O 121.141 0.496 . . . . 0.0 112.201 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 6' ' ' PRO . 22.4 Cg_endo -96.03 101.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.908 0 C-N-CA 122.863 2.375 . . . . 0.0 110.753 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -138.76 -66.58 0.47 Allowed 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.683 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -111.84 18.97 18.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.437 0.637 . . . . 0.0 111.518 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.75 148.43 8.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.14 135.03 58.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 120.915 0.388 . . . . 0.0 110.606 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.34 132.35 40.47 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.439 HG21 ' HB2' ' A' ' 48' ' ' LYS . 49.4 mm -94.54 111.16 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.712 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.27 0.02 OUTLIER Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.374 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -135.86 -76.37 0.44 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.052 0.426 . . . . 0.0 110.529 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -99.39 169.38 8.22 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.198 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.36 161.74 16.22 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.355 2.037 . . . . 0.0 112.239 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -51.37 -30.87 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.076 1.35 . . . . 0.0 113.591 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptp -62.85 -26.91 68.99 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.33 -31.35 58.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.148 0.499 . . . . 0.0 109.952 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.81 -36.36 50.33 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.9 t -61.13 -50.85 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.011 0.434 . . . . 0.0 109.903 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.71 -26.49 64.37 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.89 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.9 -44.81 72.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.693 0.282 . . . . 0.0 110.287 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.45 -24.4 67.16 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 90.1 mt -77.89 -45.73 23.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.145 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -63.64 -34.95 78.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.177 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 87.6 mt -61.63 -35.06 76.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 111.385 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.62 -31.07 71.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.493 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.75 -23.2 65.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -79.81 -15.82 56.69 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.984 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.66 -12.01 18.38 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.912 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.42 106.95 15.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.956 0.884 . . . . 0.0 112.049 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.1 p -87.82 -31.18 19.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.007 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 44.5 mt-10 -103.67 107.81 18.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.016 0.436 . . . . 0.0 109.837 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -129.83 157.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.291 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.2 t -126.92 124.1 63.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.119 0.485 . . . . 0.0 111.002 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.26 126.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -123.32 119.08 29.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.168 0.509 . . . . 0.0 110.141 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.5 156.59 27.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.632 ' HG2' HG22 ' A' ' 89' ' ' THR . 44.1 mtp180 -134.77 147.17 49.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.024 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.28 -134.81 20.19 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -85.1 5.84 28.07 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.392 -0.475 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.38 -3.5 52.95 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -57.37 -32.63 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.446 0.698 . . . . 0.0 110.009 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -61.39 -43.56 98.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.017 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 14' ' ' ILE . 99.7 mttt -67.6 -36.44 80.87 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.506 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.86 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.61 -36.3 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.953 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.571 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.3 t70 -62.43 -45.89 91.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.8 m -56.53 -53.66 54.95 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.48 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.03 -34.54 70.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.207 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.583 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 6.0 tp10 -65.75 -40.7 92.34 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 51' ' ' ASP . 75.8 mt -60.11 -42.99 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.016 0.436 . . . . 0.0 110.48 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.04 -44.68 95.36 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.229 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 2.5 ptm180 -80.03 -2.56 44.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.54 20.69 11.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.09 0.471 . . . . 0.0 111.728 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -139.43 -61.41 0.55 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.15 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -92.03 -54.72 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.527 -174.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 90.2 mt -119.03 107.26 13.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -98.25 -46.55 5.78 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.167 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.45 9.87 31.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -132.39 29.05 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.895 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.66 134.59 58.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' CD ' HH21 ' A' ' 95' ' ' ARG . 40.2 mt-10 -115.95 157.87 23.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.212 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -100.42 123.39 53.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -82.78 -61.82 1.77 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.992 0.425 . . . . 0.0 110.841 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.93 141.27 17.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.3 pt -130.12 121.56 51.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -132.98 144.74 50.32 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.63 144.83 18.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.77 171.72 28.21 Favored Glycine 0 C--N 1.318 -0.431 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 t -79.21 122.8 26.75 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.709 0.766 . . . . 0.0 110.477 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -99.23 122.2 42.09 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.325 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.459 HG22 ' HG3' ' A' ' 86' ' ' ARG . 44.2 t -81.98 120.69 33.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.57 145.75 33.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.699 0.285 . . . . 0.0 110.287 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.7 p -90.9 125.67 35.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.042 0.449 . . . . 0.0 110.688 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 m -79.66 -23.56 42.42 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.574 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.0 -91.04 0.11 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 122.656 0.382 . . . . 0.0 111.079 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.07 -67.32 0.94 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.0 14.28 6.64 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.292 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -76.85 96.26 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.37 107.95 18.24 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.845 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.9 m -98.32 121.08 39.81 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HG3' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -103.13 113.14 26.38 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.413 ' HB ' HH21 ' A' ' 42' ' ' ARG . 62.7 t -126.46 137.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 p -65.2 121.15 14.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 123.445 0.466 . . . . 0.0 110.065 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.632 HG22 ' HG2' ' A' ' 42' ' ' ARG . 73.4 p -127.46 158.59 36.94 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.458 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -139.47 133.97 38.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.78 112.97 23.62 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.98 117.74 55.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.49 130.01 56.74 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -131.1 157.57 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.499 HH21 ' CD ' ' A' ' 66' ' ' GLU . 59.2 ttp180 -122.37 122.95 40.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.66 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -84.08 -173.98 5.02 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 97' ' ' LYS . 18.3 ptmt . . . . . 0 C--O 1.251 1.152 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.499 -0.985 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 84.0 p 49.51 -160.4 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 O-C-N 124.683 1.239 . . . . 0.0 112.422 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 35.4 t -86.48 6.68 29.33 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.283 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.5 143.64 15.24 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.944 -0.645 . . . . 0.0 112.184 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 29.9 m 70.04 93.6 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.18 0 CA-C-O 121.559 0.695 . . . . 0.0 112.135 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -96.6 24.27 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.188 2.592 . . . . 0.0 112.375 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' B' ' 8' ' ' PRO . 7.1 t -115.74 138.43 23.92 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 7' ' ' THR . 24.2 Cg_exo -67.25 157.89 59.56 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.644 2.229 . . . . 0.0 111.918 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.408 ' OG ' HG22 ' B' ' 11' ' ' VAL . 33.6 p -106.73 -169.49 1.56 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.198 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -97.46 24.21 6.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.098 0.475 . . . . 0.0 111.235 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.408 HG22 ' OG ' ' B' ' 9' ' ' SER . 32.7 m -101.62 151.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.87 135.74 56.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.883 0.373 . . . . 0.0 110.102 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.9 132.77 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' B' ' 48' ' ' LYS . 48.2 mm -94.48 112.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.054 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.56 38.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.278 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.21 -76.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.262 0.553 . . . . 0.0 110.747 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -99.5 169.25 8.36 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -60.71 161.45 21.32 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.387 2.058 . . . . 0.0 112.486 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -50.03 -32.4 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.882 1.273 . . . . 0.0 113.544 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 24.2 ptp -60.97 -32.04 71.59 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -71.07 -33.99 70.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.941 0.401 . . . . 0.0 109.958 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -75.53 -36.2 60.55 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.312 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.0 -53.19 52.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.052 0.453 . . . . 0.0 110.039 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mp -67.14 -28.06 67.83 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.981 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.25 76.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.649 0.261 . . . . 0.0 110.453 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -31.1 72.16 Favored 'General case' 0 C--O 1.261 1.687 0 CA-C-O 121.233 0.539 . . . . 0.0 111.025 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -71.4 -43.46 66.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.061 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -65.52 -36.18 83.06 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.728 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.23 -39.04 91.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.105 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.29 -32.84 71.57 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.977 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -66.18 -22.15 66.35 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.156 0.503 . . . . 0.0 110.92 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.92 -12.93 56.95 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.823 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.77 22.52 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.582 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.2 105.14 13.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 122.031 0.919 . . . . 0.0 112.291 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.5 p -87.74 -31.41 19.69 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.174 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' B' ' 94' ' ' ILE . 43.9 mt-10 -101.93 109.42 21.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.412 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -131.95 155.81 41.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.971 -179.482 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 111.509 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.02 126.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -123.11 116.77 24.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.247 0.546 . . . . 0.0 110.63 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.48 157.11 24.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.65 ' HG2' HG22 ' B' ' 89' ' ' THR . 50.3 mtp180 -135.7 144.97 46.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.195 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.48 -130.14 10.49 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.241 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -89.88 3.92 51.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.157 0.503 . . . . 0.0 110.333 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.24 -6.4 54.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.307 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.24 -35.12 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.759 0.824 . . . . 0.0 110.288 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.0 p -61.23 -43.69 98.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.178 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.425 ' HB2' HG21 ' B' ' 14' ' ' ILE . 99.7 mttt -66.13 -38.79 89.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.328 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.99 87.86 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -71.7 -35.33 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.889 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.563 ' O ' HG13 ' B' ' 55' ' ' ILE . 25.2 t70 -64.63 -45.09 88.36 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -54.21 -53.65 50.55 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.87 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.9 -33.15 59.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.639 ' OE1' ' HD3' ' B' ' 57' ' ' ARG . 5.8 tp10 -67.41 -40.08 85.56 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.563 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.4 mt -60.66 -42.49 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.142 0.496 . . . . 0.0 110.804 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.09 -42.98 91.81 Favored 'Isoleucine or valine' 0 C--O 1.256 1.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.777 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.639 ' HD3' ' OE1' ' B' ' 54' ' ' GLU . 2.7 ptm180 -81.34 -2.92 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.209 -175.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.94 19.05 12.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.764 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -139.5 -58.06 0.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.647 -0.421 . . . . 0.0 112.116 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.87 -53.04 4.16 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.279 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 91.4 mt -120.82 106.43 11.66 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -97.15 -39.27 9.37 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.54 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -114.58 6.22 15.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.35 31.37 4.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.169 0.509 . . . . 0.0 111.746 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -134.32 136.99 52.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.505 ' CD ' HH21 ' B' ' 95' ' ' ARG . 41.6 mt-10 -119.49 159.29 24.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 110.44 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.99 123.92 55.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -83.57 -60.58 2.08 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.23 0.331 . . . . 0.0 110.364 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -158.03 140.62 14.6 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.85 124.19 60.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -137.45 143.22 41.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.51 142.18 18.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 O-C-N 123.133 0.271 . . . . 0.0 110.336 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.17 172.4 32.58 Favored Glycine 0 C--O 1.238 0.363 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 121.82 25.27 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.515 0.674 . . . . 0.0 110.451 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -98.38 118.68 35.6 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.431 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' B' ' 86' ' ' ARG . 43.5 t -78.67 120.28 29.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.475 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.61 148.86 30.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 27.7 p -94.41 126.7 39.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.119 0.485 . . . . 0.0 110.887 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -78.37 -29.41 47.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.77 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -139.71 -89.17 0.19 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.796 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -106.12 -76.01 0.62 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.87 18.98 10.43 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.72 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -82.72 96.8 8.27 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -85.37 112.26 20.67 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 123.83 0.707 . . . . 0.0 111.513 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 63.7 m -99.67 124.48 44.94 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.422 ' HG3' HG22 ' B' ' 76' ' ' VAL . 0.0 OUTLIER -107.07 112.43 25.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.73 136.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 21.0 p -63.86 122.29 16.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.014 0.526 . . . . 0.0 110.24 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.65 HG22 ' HG2' ' B' ' 42' ' ' ARG . 77.4 p -127.68 157.5 40.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.112 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.4 tt -139.41 131.87 36.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.6 112.91 24.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.43 116.8 53.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.886 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.19 128.62 56.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.387 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.501 HD13 ' H ' ' B' ' 94' ' ' ILE . 0.2 OUTLIER -128.84 155.26 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.072 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.505 HH21 ' CD ' ' B' ' 66' ' ' GLU . 60.6 ttp180 -119.54 120.91 38.14 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.686 0.616 . . . . 0.0 110.412 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -82.39 -175.14 5.55 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt . . . . . 0 CA--C 1.548 0.885 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.259 174.433 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.645 -0.132 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t -77.43 -35.1 54.35 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.8 p -151.64 -171.26 3.88 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . 103.12 -169.68 19.02 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.845 178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.0 m -91.33 107.19 19.78 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 98.7 Cg_endo -93.93 7.16 2.55 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.54 2.16 . . . . 0.0 112.655 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.272 20.4 p 47.57 88.11 0.11 Allowed Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -88.13 -173.45 0.95 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.669 2.246 . . . . 0.0 112.074 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.0 m -147.32 -81.46 0.14 Allowed 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.542 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -127.87 15.66 6.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.712 0.292 . . . . 0.0 111.306 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.7 133.97 63.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.457 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.79 135.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.0 tp -97.26 115.31 27.4 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.8 99.19 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.334 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.71 72.08 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.073 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 17' ' ' LYS . 5.7 ptpp? 172.69 -48.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.48 1.112 . . . . 0.0 112.475 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 32.5 mmmt -100.29 164.77 15.69 Favored Pre-proline 0 C--O 1.256 1.403 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.2 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.5 164.14 34.01 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.595 2.196 . . . . 0.0 110.914 172.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.484 HG21 ' OD1' ' A' ' 51' ' ' ASP . 7.8 p -58.26 -42.81 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.414 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.9 ptp -58.89 -25.93 63.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.12 -38.02 81.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -77.59 -33.28 53.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.46 -47.14 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.359 0.6 . . . . 0.0 109.84 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 20' ' ' MET . 87.0 mt -66.17 -29.66 69.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.782 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -67.99 -43.67 78.39 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.8 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.24 -30.52 70.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.132 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.31 -36.08 66.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.998 0.428 . . . . 0.0 110.182 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 m -70.18 -35.05 73.69 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.3 mt -63.88 -27.07 68.91 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.616 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.618 HD21 ' HG3' ' A' ' 96' ' ' LYS . 14.3 mt -57.69 -41.32 81.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 111.6 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -78.28 -5.26 51.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -102.78 -4.45 24.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 109.714 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.28 13.61 58.44 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.193 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 20.7 t -101.01 89.55 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.628 0.727 . . . . 0.0 109.27 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 50.9 m -81.17 -24.71 37.35 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.571 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 35.2 mt-10 -110.65 111.21 22.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -129.23 154.07 39.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.042 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.026 -177.451 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.97 117.91 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 123.794 0.684 . . . . 0.0 110.497 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.89 120.81 40.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -113.37 115.03 27.46 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 122.742 0.417 . . . . 0.0 110.195 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.25 39.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HG2' HG22 ' A' ' 89' ' ' THR . 44.1 mtm180 -133.77 148.52 51.39 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 120.817 0.342 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.96 -130.44 10.97 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.782 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.56 -0.45 57.52 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 122.232 -0.569 . . . . 0.0 112.06 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.77 6.41 24.57 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -57.77 -37.1 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 110.0 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.8 p -67.66 -29.7 69.06 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.989 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.97 -29.2 58.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.296 0.57 . . . . 0.0 109.66 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.24 -45.35 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.397 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.06 -38.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 55' ' ' ILE . 13.6 t70 -57.91 -42.39 84.64 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.3 m -55.3 -52.69 62.64 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.015 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.68 -34.13 51.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . 0.257 11.6 pt-20 -69.96 -31.7 69.55 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.561 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.5 mt -62.4 -47.81 91.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.955 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.9 t -57.91 -48.82 83.03 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 16.6 ptm180 -72.75 -14.56 61.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -109.39 0.72 19.55 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.499 -0.88 . . . . 0.0 113.213 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -108.69 -19.28 13.48 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.04 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -146.25 -70.13 0.26 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.451 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.0 86.06 7.07 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -75.54 -73.6 0.25 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.931 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.6 2.25 55.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -113.88 24.42 12.09 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.187 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.38 133.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.148 0.499 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -101.53 143.62 31.29 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.2 mt -124.65 140.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.99 -73.39 0.52 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.115 0.483 . . . . 0.0 111.242 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -170.49 157.52 5.97 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.32 115.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -113.28 128.61 56.52 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.97 132.79 47.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.78 169.46 41.89 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.905 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 m -81.44 138.45 35.54 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 122.969 0.508 . . . . 0.0 109.67 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -115.87 130.49 56.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.686 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -96.56 112.33 28.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.01 148.38 20.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 120.859 0.361 . . . . 0.0 111.129 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.8 p -94.24 120.62 34.74 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.349 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.4 t -74.12 -47.97 32.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.565 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -119.0 -86.09 0.65 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.416 0.627 . . . . 0.0 110.547 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -116.0 -61.49 1.73 Allowed 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.327 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.59 8.27 7.81 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.063 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -76.67 92.62 3.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -87.46 134.12 33.64 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.285 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.0 t -128.67 160.28 32.97 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -113.25 125.08 53.92 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.33 122.24 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 p -65.24 130.47 43.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.465 HG22 ' HG2' ' A' ' 42' ' ' ARG . 41.7 p -128.54 145.42 51.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.68 138.17 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.0 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -121.9 111.0 16.55 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.393 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -107.07 110.5 31.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.16 124.91 53.24 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.4 pt -134.66 168.73 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.526 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 30.5 ttt180 -135.04 155.57 50.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.618 ' HG3' HD21 ' A' ' 30' ' ' LEU . 47.7 mmtm -109.27 145.2 36.33 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm . . . . . 0 C--O 1.254 1.301 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.01 175.503 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.421 0.153 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.8 p -73.28 150.14 42.19 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 123.47 0.708 . . . . 0.0 112.29 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.0 p -100.82 -70.94 0.72 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.561 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.98 -37.3 2.24 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 41.3 p -99.71 127.45 33.94 Favored Pre-proline 0 C--N 1.318 -0.773 0 C-N-CA 122.588 0.355 . . . . 0.0 110.058 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.12 18.41 1.31 Allowed 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 123.17 2.58 . . . . 0.0 113.34 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -97.2 130.95 28.46 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.049 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -48.76 115.16 1.51 Allowed 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 123.412 2.741 . . . . 0.0 113.543 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -100.83 22.46 12.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.182 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -95.98 18.23 13.78 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.425 0.631 . . . . 0.0 110.425 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.59 132.73 69.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.322 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.895 0.379 . . . . 0.0 111.386 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -96.29 114.76 26.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.561 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.82 98.27 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.253 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 72.83 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.435 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.498 ' HG3' ' HG2' ' B' ' 17' ' ' LYS . 5.2 ptpp? 172.25 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.789 1.236 . . . . 0.0 112.244 174.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' B' ' 16' ' ' LYS . 32.3 mmmt -100.19 164.19 16.84 Favored Pre-proline 0 C--O 1.255 1.366 0 O-C-N 122.227 -0.296 . . . . 0.0 111.309 -174.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.02 164.48 29.82 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.997 2.465 . . . . 0.0 110.869 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.9 -42.25 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptp -58.09 -26.12 62.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -68.38 -39.48 81.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.411 0.624 . . . . 0.0 110.104 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.62 -33.34 58.39 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.478 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.31 -48.46 88.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.706 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.32 -29.39 70.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.037 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.06 -46.79 73.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.01 85.82 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.123 0.487 . . . . 0.0 111.134 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.222 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 43.2 m -72.16 -36.55 69.35 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.208 0.527 . . . . 0.0 110.26 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.458 ' HB3' ' HB ' ' B' ' 34' ' ' VAL . 94.4 mt -62.99 -30.01 71.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.695 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.604 HD21 ' HG3' ' B' ' 96' ' ' LYS . 17.5 mt -54.0 -42.82 69.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.855 171.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.59 -9.57 58.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.418 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -99.38 -3.78 33.07 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.952 0.406 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.08 12.27 57.79 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.459 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' B' ' 29' ' ' LEU . 20.9 t -100.65 90.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.537 0.684 . . . . 0.0 109.695 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 44.3 m -82.05 -25.29 34.72 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.583 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 37.2 mt-10 -109.58 110.8 21.99 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.444 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.76 152.56 37.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 -177.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.58 119.03 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.492 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.9 121.02 40.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.62 113.89 25.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.045 0.45 . . . . 0.0 110.289 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 152.0 38.07 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.438 ' HG2' HG22 ' B' ' 89' ' ' THR . 46.7 mtm180 -134.8 151.41 50.93 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.764 0.316 . . . . 0.0 110.689 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 -128.01 10.9 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.748 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -91.17 -1.04 57.8 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 122.359 -0.495 . . . . 0.0 112.099 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 8.06 21.04 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.408 HG23 HG21 ' B' ' 90' ' ' ILE . 67.6 mt -58.12 -37.86 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.774 0.797 . . . . 0.0 109.924 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 29.2 p -66.39 -30.63 71.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.239 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.67 -31.26 61.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.03 75.98 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.421 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.17 -37.43 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.643 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.499 ' O ' HG13 ' B' ' 55' ' ' ILE . 14.7 t70 -59.11 -40.24 84.75 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.6 m -57.47 -52.99 63.12 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.851 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 m -70.93 -34.65 56.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.97 -33.14 73.21 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.293 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.499 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.9 mt -61.87 -48.78 87.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.126 175.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.09 -49.42 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -72.25 -18.26 61.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -104.0 -3.45 24.61 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.882 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -106.54 -15.2 14.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.39 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -149.65 -69.67 0.2 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 mp -88.76 86.94 7.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.146 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.86 -73.17 0.3 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.839 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.9 4.84 51.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -115.2 26.51 10.04 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.042 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.2 tp -107.25 130.26 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 120.871 0.367 . . . . 0.0 110.98 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -96.99 147.0 24.44 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.1 mt -126.6 138.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -88.08 -73.49 0.49 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -172.02 160.94 5.5 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 65.7 mt -125.83 115.49 43.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -111.79 124.19 51.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.22 136.43 56.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.7 170.17 41.02 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.796 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.4 m -80.61 140.8 35.55 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -118.67 130.99 56.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t -97.4 114.47 34.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.75 148.88 22.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.055 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 31.7 p -94.43 117.49 30.2 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.969 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 43.8 t -69.57 -53.78 17.28 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 122.97 0.508 . . . . 0.0 111.409 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -112.74 -84.83 0.58 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.35 0.595 . . . . 0.0 110.444 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -117.03 -62.07 1.63 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.293 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.79 7.19 8.9 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.066 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -76.47 95.13 3.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -91.73 134.43 34.73 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.836 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 34.0 t -127.42 162.7 25.73 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -115.16 125.83 53.88 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 119.32 54.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -63.66 129.05 38.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.438 HG22 ' HG2' ' B' ' 42' ' ' ARG . 47.0 p -127.37 147.3 50.27 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.827 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.408 HG21 HG23 ' B' ' 46' ' ' ILE . 15.2 tt -139.36 137.35 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.528 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.05 112.48 19.19 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.046 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.4 mt -107.31 111.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.16 127.15 56.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.975 0.416 . . . . 0.0 110.667 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -136.35 167.48 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.263 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' OE2' ' B' ' 36' ' ' GLU . 36.8 ttt180 -134.07 153.47 51.78 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.904 0.383 . . . . 0.0 110.138 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.604 ' HG3' HD21 ' B' ' 30' ' ' LEU . 46.7 mmtm -108.35 140.56 41.46 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm . . . . . 0 C--N 1.311 -1.085 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.11 173.137 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.218 -0.601 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 t -60.83 -45.52 94.13 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 121.331 0.586 . . . . 0.0 110.555 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 p -100.18 20.75 14.03 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.386 0.612 . . . . 0.0 110.505 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.34 92.78 0.17 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -61.73 117.25 26.45 Favored Pre-proline 0 C--O 1.244 0.813 0 O-C-N 124.318 0.658 . . . . 0.0 112.591 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -100.52 6.87 0.69 Allowed 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.66 2.24 . . . . 0.0 111.699 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.2 m 66.45 103.23 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.55 0.74 . . . . 0.0 110.985 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -74.33 -175.14 2.07 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.162 1.908 . . . . 0.0 113.222 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -130.8 -176.85 4.12 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.178 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -84.96 12.8 6.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.05 0.54 . . . . 0.0 112.196 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 19.3 m -98.96 129.98 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.106 0.479 . . . . 0.0 110.458 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' HG12 ' A' ' 39' ' ' ILE . 35.6 m -118.47 139.36 46.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.836 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.0 127.29 43.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.761 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.52 110.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.37 53.55 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.234 -1.46 . . . . 0.0 113.894 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -157.51 -58.97 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -100.79 162.28 21.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.997 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.72 156.75 55.64 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.236 1.957 . . . . 0.0 112.014 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -50.87 -32.4 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.725 1.21 . . . . 0.0 113.776 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.3 ptp -56.81 -31.6 64.88 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -75.93 -37.15 59.01 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.842 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.7 -37.34 73.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.36 -47.5 90.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.254 0.55 . . . . 0.0 110.05 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.18 -32.22 71.38 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.944 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -67.51 -44.46 78.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.671 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.75 90.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.273 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.44 -35.54 81.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.979 0.419 . . . . 0.0 111.047 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.3 m -69.9 -39.13 76.42 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 95.1 mt -69.73 -35.86 75.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.39 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.8 tm? -59.39 -45.58 91.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.933 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.422 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -79.75 -21.64 44.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.56 -19.84 3.75 Favored Glycine 0 CA--C 1.5 -0.904 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.2 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 22.0 t -71.81 94.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.471 0.653 . . . . 0.0 109.349 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -79.26 -17.47 54.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.216 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.57 130.91 23.62 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -130.15 156.15 42.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.185 -178.396 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 43.4 t -121.46 113.55 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.304 0.574 . . . . 0.0 110.425 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.419 HG12 ' CG2' ' A' ' 12' ' ' VAL . 65.2 mt -95.14 122.01 46.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 80.4 mttt -120.92 120.64 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.95 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.64 167.24 12.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.769 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -139.29 141.94 37.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.21 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 59.93 -106.72 1.06 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -83.31 -21.18 33.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.19 0.519 . . . . 0.0 109.95 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.32 -8.7 56.97 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.14 -39.2 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.606 0.717 . . . . 0.0 110.386 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -64.55 -29.51 70.54 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.664 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -78.34 -37.35 44.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.559 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.306 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -73.14 -35.7 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.766 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.48 ' OD2' HG21 ' A' ' 19' ' ' VAL . 18.1 t70 -58.83 -47.92 83.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.3 m -53.07 -54.14 39.87 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.205 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.35 -29.17 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.35 -36.77 79.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.6 mt -65.44 -50.14 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.962 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.27 -44.57 84.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -75.55 -1.95 26.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -130.42 6.6 4.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.612 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -114.13 -61.9 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -76.41 -50.08 15.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.591 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.4 tp -159.46 105.91 1.69 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.31 -27.67 15.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.506 1.129 . . . . 0.0 111.869 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.76 -42.49 89.03 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.607 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -122.34 108.38 13.17 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.985 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -161.35 145.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.77 156.13 43.89 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.0 mt -104.35 141.21 20.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -95.93 -38.25 10.33 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.332 -0.23 . . . . 0.0 110.902 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -167.78 146.38 4.69 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.486 0.491 . . . . 0.0 109.835 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.52 97.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 124.356 1.062 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.8 142.08 50.38 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.405 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.76 134.95 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.18 151.28 22.6 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.15 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -79.57 124.72 28.77 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -107.69 135.29 49.36 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.953 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -103.8 115.28 45.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.35 0.595 . . . . 0.0 111.092 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.22 135.05 59.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.11 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.4 p -80.15 121.67 25.86 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.45 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.9 t -59.61 -41.17 89.78 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.651 0.594 . . . . 0.0 111.397 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -178.56 -40.06 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -120.17 -155.41 0.62 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.19 17.39 1.02 Allowed Glycine 0 CA--C 1.537 1.464 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -78.5 100.44 6.88 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -85.77 103.52 14.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.0 m -84.46 114.82 22.2 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.261 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -89.35 110.06 20.9 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.87 132.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.219 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -71.41 126.77 30.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.937 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 46.5 p -127.99 154.61 45.42 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.964 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -135.28 135.08 52.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.555 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -112.5 111.1 21.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.642 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 90' ' ' ILE . 43.5 mm -108.28 110.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.62 122.01 39.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.17 149.4 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -126.6 127.55 45.41 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -77.61 151.92 34.14 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.689 0.757 . . . . 0.0 112.866 -174.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 N--CA 1.437 -1.117 0 C-N-CA 126.154 1.782 . . . . 0.0 106.459 179.138 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 111.165 0.061 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m 62.82 13.39 6.47 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m 60.42 93.01 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.64 78.99 0.87 Allowed Glycine 0 CA--C 1.501 -0.819 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.463 ' HB ' ' HD3' ' B' ' 6' ' ' PRO . 23.3 m -61.19 -53.39 63.56 Favored Pre-proline 0 CA--C 1.568 1.662 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' B' ' 5' ' ' THR . 85.2 Cg_endo -85.64 -39.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 121.164 1.243 . . . . 0.0 112.695 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -136.02 100.0 10.96 Favored Pre-proline 0 C--O 1.249 1.034 0 C-N-CA 122.659 0.384 . . . . 0.0 110.419 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -89.57 108.33 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.86 2.374 . . . . 0.0 111.516 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -92.56 17.86 9.5 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.313 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -106.81 7.29 30.17 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 18.9 m -96.66 129.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.118 0.485 . . . . 0.0 111.487 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.407 ' CG2' HG12 ' B' ' 39' ' ' ILE . 34.4 m -119.97 139.41 47.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.893 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.11 124.47 44.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mm -95.22 112.4 27.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.805 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.33 47.31 0.01 OUTLIER Glycine 0 C--N 1.313 -0.727 0 C-N-CA 119.136 -1.507 . . . . 0.0 114.338 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -151.73 -58.05 0.15 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.874 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' B' ' 18' ' ' PRO . 56.0 mtpt -101.52 162.62 19.89 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' B' ' 17' ' ' LYS . 28.7 Cg_endo -62.56 155.43 58.5 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.518 2.145 . . . . 0.0 112.162 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.82 -31.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.5 1.12 . . . . 0.0 113.992 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -57.52 -34.35 69.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -71.76 -40.78 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.751 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -69.16 -38.48 78.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.638 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.26 -46.85 88.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.338 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.5 -37.03 79.72 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.235 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.68 95.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.75 88.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.562 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.11 -35.71 81.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.7 m -67.39 -41.94 84.17 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.49 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.93 -34.77 75.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 2.0 tm? -59.89 -44.17 94.39 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.42 -25.25 66.66 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.306 0.574 . . . . 0.0 111.779 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -79.13 -14.75 58.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.672 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.83 -16.32 6.5 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.964 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' B' ' 30' ' ' LEU . 21.5 t -74.68 94.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -83.25 -15.03 51.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.1 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.425 ' OE2' ' HE3' ' B' ' 68' ' ' LYS . 10.0 pt-20 -140.01 130.03 24.88 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.424 ' H ' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -131.32 155.61 41.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.21 -178.175 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 43.0 t -121.77 113.52 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.663 0.744 . . . . 0.0 110.872 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.407 HG12 ' CG2' ' B' ' 12' ' ' VAL . 61.7 mt -94.64 123.08 46.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.037 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 82.5 mttt -121.36 123.11 41.35 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.172 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.78 166.77 14.41 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.316 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -139.68 140.72 36.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.203 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.91 -105.41 0.92 Allowed Glycine 0 N--CA 1.466 0.649 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -84.32 -23.29 30.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.867 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.08 -7.22 47.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.1 mt -57.22 -39.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.727 0.775 . . . . 0.0 109.723 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.2 t -64.03 -32.42 73.96 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.54 -37.66 59.86 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.184 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.92 83.67 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.088 0.471 . . . . 0.0 111.525 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.86 -35.22 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.802 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.439 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.5 t70 -59.93 -45.04 93.9 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.7 m -54.88 -56.85 14.99 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.322 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.89 -29.84 44.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.46 -35.27 77.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.779 0.323 . . . . 0.0 110.158 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 51' ' ' ASP . 80.2 mt -67.16 -50.85 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 88.2 t -55.59 -44.87 78.17 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.92 -2.55 27.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' B' ' 62' ' ' ALA . 12.8 t30 -132.48 9.01 4.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.318 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -113.27 -60.1 1.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.296 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.51 -51.44 9.97 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.08 0.467 . . . . 0.0 111.1 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 67.8 tp -158.25 104.67 1.87 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' B' ' 58' ' ' ASN . . . -92.76 -22.03 19.6 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.329 -176.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.38 -43.87 80.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -117.96 105.67 12.14 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -161.18 141.02 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.56 156.32 45.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.098 0.475 . . . . 0.0 109.739 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.39 140.42 20.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.425 ' HE3' ' OE2' ' B' ' 36' ' ' GLU . 64.9 tttm -93.83 -40.58 10.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.292 -0.255 . . . . 0.0 110.944 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.74 147.05 4.89 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.438 0.462 . . . . 0.0 109.759 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 pt -145.62 100.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 124.521 1.128 . . . . 0.0 109.698 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.104 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.75 135.86 56.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.0 150.94 22.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.353 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -79.48 124.0 28.07 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -106.98 134.87 49.49 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.933 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -103.63 115.86 46.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.247 0.546 . . . . 0.0 110.847 176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.14 134.18 64.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.09 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 35.2 p -80.23 120.79 24.79 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.096 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 35.8 t -60.34 -40.5 90.9 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.47 0.481 . . . . 0.0 111.71 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -178.06 -39.2 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -121.46 -156.7 0.7 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.98 25.77 0.66 Allowed Glycine 0 CA--C 1.534 1.243 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -84.89 96.23 9.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -81.46 105.48 12.66 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.733 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.6 m -83.67 112.97 20.53 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -87.07 109.39 19.38 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.74 132.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 128.76 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 58.0 p -130.13 154.27 47.66 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 14.9 tt -134.84 136.34 52.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.504 0.192 . . . . 0.0 110.524 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -115.21 112.32 22.31 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.417 HD11 HD11 ' B' ' 90' ' ' ILE . 43.6 mm -108.91 110.61 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.85 120.77 37.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -121.94 149.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -127.43 126.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -77.51 151.43 34.58 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.935 -174.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.435 -1.177 0 C-N-CA 125.234 1.414 . . . . 0.0 107.778 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.509 -0.623 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p -68.89 137.88 54.22 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.358 0.412 . . . . 0.0 111.389 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -114.29 -1.49 13.57 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.963 0.411 . . . . 0.0 110.695 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.7 -42.7 5.35 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.896 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 37.8 m -130.98 126.07 21.51 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 4.1 Cg_exo -77.17 162.95 31.06 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.865 2.376 . . . . 0.0 112.505 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 p -87.73 125.51 64.72 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.267 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.16 164.96 11.29 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.833 2.355 . . . . 0.0 112.575 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -138.3 105.22 5.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -135.92 16.09 3.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.668 0.747 . . . . 0.0 109.713 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 ' HB ' ' A' ' 38' ' ' VAL . 31.0 m -120.08 133.45 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.052 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.53 144.45 30.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.255 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -105.83 121.63 44.45 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.09 103.35 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.19 51.11 0.03 OUTLIER Glycine 0 C--O 1.24 0.49 0 C-N-CA 119.515 -1.326 . . . . 0.0 114.086 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -166.33 -55.32 0.03 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.125 0.462 . . . . 0.0 110.831 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.86 154.71 37.1 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.22 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -62.7 160.23 33.64 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.327 2.018 . . . . 0.0 111.638 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -49.93 -34.17 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.53 1.132 . . . . 0.0 113.267 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.458 ' O ' HD13 ' A' ' 24' ' ' LEU . 26.8 ptm -60.1 -27.35 66.95 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.609 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -80.83 -25.81 37.5 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.118 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -83.88 -37.62 22.17 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.553 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.426 ' O ' HD13 ' A' ' 27' ' ' LEU . 73.2 t -59.29 -55.59 22.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.045 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 20' ' ' MET . 8.3 mp -62.31 -31.32 71.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.081 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.24 -42.84 99.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 123.117 0.26 . . . . 0.0 111.241 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.495 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -64.92 -40.37 94.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.782 0.325 . . . . 0.0 110.403 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 23' ' ' VAL . 8.6 mp -63.13 -39.34 94.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.449 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.6 m -66.0 -34.42 78.05 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.5 mt -70.87 -36.42 72.78 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.664 0.269 . . . . 0.0 111.325 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.5 mt -59.61 -42.6 93.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.05 0.453 . . . . 0.0 110.067 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -65.75 -25.17 67.15 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -89.24 -2.42 58.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.746 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.1 12.2 40.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.171 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.6 t -99.34 115.23 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -101.31 -30.64 11.38 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.93 105.79 14.32 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.036 0.922 . . . . 0.0 112.784 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -117.38 154.53 19.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.512 -177.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HB ' HG12 ' A' ' 11' ' ' VAL . 50.3 t -121.69 120.63 62.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.103 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -96.78 120.52 46.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.275 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 91' ' ' GLU . 48.1 mttp -108.26 121.29 44.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.72 138.12 53.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -137.1 120.13 16.55 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.53 76.44 1.27 Allowed Glycine 0 C--O 1.219 -0.804 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.92 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 68.0 -15.66 0.2 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.3 6.05 3.97 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.813 0.445 . . . . 0.0 111.869 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.426 HG23 HG21 ' A' ' 90' ' ' ILE . 68.2 mt -56.73 -37.91 55.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.448 1.099 . . . . 0.0 109.406 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.1 p -67.56 -24.87 65.57 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.137 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -86.96 -29.96 21.65 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.534 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.24 -42.61 96.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.7 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.63 -40.75 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.214 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 55' ' ' ILE . 17.2 t70 -57.65 -44.18 85.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.445 0.641 . . . . 0.0 109.281 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 91.0 m -57.94 -51.08 71.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.678 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.448 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 33.8 m -69.85 -32.36 51.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.122 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.35 -36.48 83.84 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.8 mt -67.64 -46.77 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.141 0.496 . . . . 0.0 110.385 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' THR . 67.2 t -59.71 -38.27 75.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.166 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 53' ' ' VAL . 15.9 ptm180 -91.87 17.68 8.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.609 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -133.07 -41.73 0.9 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -86.91 -60.45 1.98 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.629 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.56 -58.28 3.42 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.045 0.45 . . . . 0.0 111.588 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.5 tp -148.0 102.49 3.39 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.3 -26.88 17.11 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.871 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.03 -50.28 66.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.15 0.5 . . . . 0.0 111.775 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -103.81 105.8 16.12 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.106 0.479 . . . . 0.0 110.882 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 tp -159.79 127.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.431 0.692 . . . . 0.0 110.652 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.81 149.57 51.4 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 173.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.77 134.67 46.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -90.95 -60.37 1.93 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.118 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -155.55 147.91 23.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.41 111.02 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -113.73 135.28 54.11 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.546 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -136.65 133.59 48.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.3 179.31 48.14 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.596 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 m -80.71 124.07 28.72 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.636 0.774 . . . . 0.0 110.971 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 25.7 tt0 -88.99 117.54 28.08 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t -103.88 108.87 25.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.39 145.77 34.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.326 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.9 p -83.78 127.12 33.57 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m -53.92 -54.09 43.6 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.545 0.528 . . . . 0.0 111.322 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -167.25 -57.84 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.28 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -86.53 -79.61 0.26 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.906 0.384 . . . . 0.0 110.605 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.85 29.77 1.01 Allowed Glycine 0 C--O 1.223 -0.532 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.139 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -93.63 105.62 17.65 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -70.53 109.16 4.67 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.591 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -100.35 109.27 21.45 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 89.7 mtt180 -101.63 117.87 35.79 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -124.44 135.1 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.312 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 m -62.94 120.57 11.62 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 123.697 0.799 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 p -127.19 152.02 47.92 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 122.641 0.377 . . . . 0.0 110.364 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.426 HG21 HG23 ' A' ' 46' ' ' ILE . 15.9 tt -143.71 142.2 24.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.163 0 CA-C-O 120.782 0.325 . . . . 0.0 110.607 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' A' ' 40' ' ' LYS . 44.3 mt-10 -123.5 121.14 34.92 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.778 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -113.06 111.61 36.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.84 117.15 31.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.51 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 pt -119.16 168.17 11.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.935 0.398 . . . . 0.0 110.659 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -125.23 118.62 26.43 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.742 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -105.1 78.74 1.42 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.136 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? . . . . . 0 C--O 1.274 2.354 0 C-N-CA 124.082 0.953 . . . . 0.0 110.004 176.25 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 16.8 m -84.31 -7.33 59.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.511 0.324 . . . . 0.0 111.826 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t 69.53 18.9 7.65 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.858 0.863 . . . . 0.0 111.015 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.65 145.28 17.64 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 10.2 t -137.97 143.18 38.7 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 5' ' ' THR . 2.9 Cg_exo -77.19 -2.95 13.19 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.414 2.076 . . . . 0.0 113.276 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -112.81 129.13 24.76 Favored Pre-proline 0 N--CA 1.436 -1.173 0 CA-C-O 120.99 0.424 . . . . 0.0 110.26 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.21 98.08 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.198 1.932 . . . . 0.0 111.873 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 30.1 t -104.71 -40.57 5.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.928 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -136.84 16.05 3.08 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 20.9 m -115.68 131.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.174 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.78 145.78 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 60.5 tp -108.62 118.79 37.7 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.001 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -83.89 113.43 22.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.75 45.16 0.02 OUTLIER Glycine 0 C--O 1.237 0.305 0 C-N-CA 119.48 -1.343 . . . . 0.0 114.057 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -163.34 -59.69 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.241 0.52 . . . . 0.0 110.291 177.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.17 155.52 38.83 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.21 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.26 158.99 41.61 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.569 2.179 . . . . 0.0 111.385 174.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.478 HG21 ' OD2' ' B' ' 51' ' ' ASP . 7.6 p -48.75 -35.1 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.599 1.16 . . . . 0.0 113.113 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.418 ' O ' HD13 ' B' ' 24' ' ' LEU . 26.3 ptm -57.66 -29.77 64.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.969 0.414 . . . . 0.0 111.743 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.27 -30.58 54.38 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.63 -38.22 40.25 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.434 ' O ' HD13 ' B' ' 27' ' ' LEU . 66.7 t -60.35 -55.83 21.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.418 HD13 ' O ' ' B' ' 20' ' ' MET . 8.3 mp -63.79 -25.27 68.1 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.43 -44.9 85.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.666 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.459 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -63.54 -42.91 98.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.967 0.413 . . . . 0.0 110.65 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.434 HD13 ' O ' ' B' ' 23' ' ' VAL . 8.8 mp -61.23 -35.72 77.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.486 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 61.9 m -69.89 -35.74 74.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.294 0.569 . . . . 0.0 109.794 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -68.9 -35.3 76.68 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 122.159 -0.338 . . . . 0.0 111.368 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 91.1 mt -59.5 -41.12 89.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.084 0.469 . . . . 0.0 110.585 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -67.25 -25.04 65.89 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.077 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -87.94 -0.92 57.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.967 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.34 0.02 53.83 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.739 -0.744 . . . . 0.0 114.424 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.48 113.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -100.93 -27.74 13.14 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.901 0.381 . . . . 0.0 111.436 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.06 110.44 20.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.826 0.822 . . . . 0.0 112.198 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.492 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -123.16 152.75 28.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.963 -175.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.62 119.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 CA-C-O 121.156 0.503 . . . . 0.0 110.29 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -96.3 120.98 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.24 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.42 ' HG2' ' HG2' ' B' ' 91' ' ' GLU . 49.4 mttp -107.79 120.99 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.156 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -119.3 137.14 53.88 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -135.79 117.81 15.34 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.82 76.47 1.31 Allowed Glycine 0 C--O 1.217 -0.931 0 N-CA-C 114.742 0.657 . . . . 0.0 114.742 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 67.18 -15.04 0.17 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.89 6.87 4.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.0 0.429 . . . . 0.0 111.607 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.4 HG23 HG21 ' B' ' 90' ' ' ILE . 67.8 mt -55.99 -39.42 57.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 124.57 1.148 . . . . 0.0 109.778 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.0 p -64.66 -29.0 69.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.8 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.21 -28.59 27.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.571 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -65.62 -40.52 92.66 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.288 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.63 -40.97 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.171 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.478 ' OD2' HG21 ' B' ' 19' ' ' VAL . 15.6 t70 -54.68 -48.12 72.77 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.613 0.721 . . . . 0.0 109.518 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.46 ' O ' HG23 ' B' ' 56' ' ' VAL . 64.3 m -54.52 -52.0 63.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.941 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.26 -33.47 58.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.313 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.48 -35.91 82.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.098 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.7 mt -67.66 -47.38 80.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 120.946 0.403 . . . . 0.0 110.259 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 52' ' ' THR . 81.0 t -59.36 -38.49 75.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.936 -177.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -90.88 18.46 6.58 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.286 -0.259 . . . . 0.0 111.529 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.73 -48.74 0.88 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.235 0.54 . . . . 0.0 110.603 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -81.23 -52.2 7.59 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -80.81 -60.32 2.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.191 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -146.13 104.12 3.79 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.81 -24.73 16.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.925 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.71 -46.89 64.95 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.36 0.6 . . . . 0.0 111.361 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -104.13 105.83 16.13 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.987 0.423 . . . . 0.0 110.693 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -160.82 131.31 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.387 0.675 . . . . 0.0 109.905 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.81 147.46 42.56 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.5 mt -104.65 133.62 48.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -89.5 -60.43 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.092 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.04 149.28 27.01 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -138.2 109.61 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -112.01 134.85 53.31 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.515 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.29 130.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.59 177.89 46.57 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.063 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.5 m -79.46 125.27 29.34 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.087 0.955 . . . . 0.0 111.254 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 27.5 tt0 -90.1 116.5 28.16 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.448 HG22 ' HG2' ' B' ' 86' ' ' ARG . 40.5 t -101.55 107.4 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.48 146.58 33.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 120.707 0.289 . . . . 0.0 110.249 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 25.3 p -85.51 128.26 34.68 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -57.23 -51.52 69.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.017 0.437 . . . . 0.0 111.341 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -168.98 -60.19 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.541 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -85.79 -78.16 0.28 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.191 0.52 . . . . 0.0 110.765 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.36 35.21 0.76 Allowed Glycine 0 CA--C 1.501 -0.782 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.108 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -98.72 108.18 20.81 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -74.66 110.14 8.71 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.375 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 36.7 m -99.06 112.8 24.83 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 96.6 mtt180 -105.31 111.17 23.8 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.98 133.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.66 120.25 10.83 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 123.651 0.78 . . . . 0.0 110.609 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.0 p -125.92 151.18 47.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.4 HG21 HG23 ' B' ' 46' ' ' ILE . 15.6 tt -141.74 143.58 26.92 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 120.626 0.251 . . . . 0.0 110.813 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.42 ' HG2' ' HG2' ' B' ' 40' ' ' LYS . 42.5 mt-10 -124.36 121.75 35.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.886 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.06 113.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.53 115.42 27.95 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 pt -118.83 161.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.728 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -120.23 118.53 30.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -102.97 78.85 1.7 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? . . . . . 0 C--O 1.279 2.61 0 C-N-CA 124.395 1.078 . . . . 0.0 109.775 177.315 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 p30 . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.23 138.36 52.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.959 0.409 . . . . 0.0 110.824 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.51 151.03 33.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.0 tp -116.63 131.77 56.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 48' ' ' LYS . 51.2 mm -84.41 121.98 37.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.18 -115.74 3.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.453 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.64 12.25 16.0 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.55 147.0 58.37 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.365 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.11 147.93 80.53 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.396 2.064 . . . . 0.0 110.781 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 23' ' ' VAL . 13.8 p -58.64 -28.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 112.072 -175.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 24' ' ' LEU . 27.1 ptt? -64.03 -24.0 67.55 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.19 0.519 . . . . 0.0 111.331 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.81 -30.49 51.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.021 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -82.82 -37.57 24.28 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.077 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 19' ' ' VAL . 67.4 t -58.25 -51.06 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.021 0.439 . . . . 0.0 110.687 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 20' ' ' MET . 9.2 mp -67.37 -30.05 69.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.124 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.65 -44.96 80.53 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.826 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.28 -35.28 80.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.187 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.4 -36.8 79.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -67.74 -35.68 79.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.514 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.4 mt -63.97 -36.45 84.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' A' ' 96' ' ' LYS . 3.4 tm? -63.21 -46.87 85.01 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.7 -4.01 44.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.573 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.95 -22.94 17.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.7 -8.3 4.91 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.979 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.97 107.28 20.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.156 0.503 . . . . 0.0 110.624 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.6 p -85.6 -25.65 26.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -118.84 113.97 21.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -122.55 146.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 123.274 0.358 . . . . 0.0 110.701 -178.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.44 118.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.2 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.8 mt -93.66 122.32 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.45 129.28 56.65 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.089 0.471 . . . . 0.0 109.785 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.12 169.59 17.37 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.496 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HB3' HG22 ' A' ' 89' ' ' THR 0.309 0.0 OUTLIER -158.64 149.92 20.69 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.498 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.35 -120.02 8.98 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.223 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 ptm180 -87.0 -3.33 59.08 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.235 0.54 . . . . 0.0 110.96 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.63 -6.9 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.303 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.86 -36.13 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.991 0.516 . . . . 0.0 110.382 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -62.27 -35.88 80.34 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.179 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.445 ' HB2' HG21 ' A' ' 14' ' ' ILE . 65.3 mttm -75.08 -32.84 61.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.173 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.54 96.3 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 110.724 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.52 -39.87 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.51 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.2 t70 -57.9 -39.02 76.89 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.242 0.617 . . . . 0.0 110.006 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -66.68 -55.53 14.75 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.46 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.9 -31.15 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.647 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 31.0 tt0 -64.94 -44.48 89.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.3 mt -61.3 -49.01 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.95 0.405 . . . . 0.0 110.065 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.22 -36.59 58.34 Favored 'Isoleucine or valine' 0 C--O 1.259 1.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -87.4 -7.43 57.72 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.81 24.74 7.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.284 0.564 . . . . 0.0 111.583 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -137.1 -65.89 0.53 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -86.6 -51.25 6.27 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.687 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mp -132.16 112.84 12.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -101.19 -57.81 2.01 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.177 0.923 . . . . 0.0 112.096 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.14 -36.02 66.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.212 0.53 . . . . 0.0 111.631 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.04 -15.95 45.66 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 62' ' ' ALA . 16.6 tt -80.22 148.31 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.077 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -139.06 145.04 39.09 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -173.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -90.93 145.81 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -105.25 -52.59 2.81 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.114 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -169.39 152.2 4.78 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt -138.47 119.96 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.554 0.742 . . . . 0.0 110.32 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -133.5 133.99 42.91 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.715 -0.615 . . . . 0.0 110.874 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.24 136.79 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.42 162.85 29.87 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.622 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 12.0 p -82.13 125.54 30.99 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.687 ' HA ' HE21 ' A' ' 75' ' ' GLN . 0.0 OUTLIER -104.62 146.3 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.767 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.31 -1.142 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.61 134.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -66.18 108.21 2.2 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.822 0.701 . . . . 0.0 111.362 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.514 HG22 ' HB3' ' A' ' 42' ' ' ARG . 35.1 p -105.83 150.15 25.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.092 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.53 131.34 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.08 115.99 27.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.9 mt -110.71 114.0 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.47 122.33 47.46 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 120.675 0.274 . . . . 0.0 110.577 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.9 pt -120.99 157.08 24.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.969 0.414 . . . . 0.0 110.421 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -119.56 118.54 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.336 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HB2' HD23 ' A' ' 30' ' ' LEU . 32.3 mmmt . . . . . 0 C--N 1.286 -2.18 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p30 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.4 132.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.224 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.43 152.58 25.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.891 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -117.91 126.39 52.27 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' B' ' 48' ' ' LYS . 49.3 mm -80.91 119.02 29.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.463 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.72 -116.75 3.72 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.018 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -114.63 15.47 17.67 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.769 0.319 . . . . 0.0 111.078 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -84.07 146.4 48.47 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.683 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.52 143.03 79.92 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.8 2.334 . . . . 0.0 110.858 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.6 -30.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.446 ' O ' HD13 ' B' ' 24' ' ' LEU . 27.0 ptt? -60.95 -28.48 69.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 111.135 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.61 -35.6 67.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.016 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -78.81 -37.37 40.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.19 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.37 -51.93 65.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.694 0.283 . . . . 0.0 110.649 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 20' ' ' MET . 8.1 mp -67.49 -28.63 68.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.908 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -66.23 -46.02 78.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.01 86.24 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 121.35 0.595 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 92.6 mt -65.48 -39.46 91.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.358 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.4 m -65.7 -37.05 85.36 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.394 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.5 mt -62.91 -37.17 85.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.709 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' B' ' 96' ' ' LYS . 3.4 tm? -61.86 -45.93 91.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -80.4 -2.3 45.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.825 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -93.48 -27.8 16.47 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.9 2.74 3.4 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.62 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.17 111.44 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 117.881 0.84 . . . . 0.0 110.087 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 p -87.79 -32.43 19.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -112.39 117.95 33.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.444 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -125.19 147.61 29.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.452 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.62 119.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.425 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 55.2 mt -95.05 123.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -115.73 130.49 56.87 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 121.481 0.658 . . . . 0.0 110.11 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.31 169.12 18.35 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.493 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.533 ' HB3' HG22 ' B' ' 89' ' ' THR 0.288 0.0 OUTLIER -158.45 149.79 20.92 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.685 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.92 -117.48 7.51 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.404 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -88.96 -4.6 58.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.032 0.444 . . . . 0.0 110.757 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.79 -9.05 59.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.03 -36.23 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.567 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 33.5 t -62.36 -35.53 79.41 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.248 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.445 ' HB2' HG21 ' B' ' 14' ' ' ILE . 64.9 mttm -76.3 -34.51 59.06 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.684 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.69 88.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.12 0.486 . . . . 0.0 111.039 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -73.23 -40.38 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.828 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.417 ' O ' HG13 ' B' ' 55' ' ' ILE . 32.4 t70 -58.55 -41.53 85.8 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.064 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 73.0 m -63.44 -54.96 28.31 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.001 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.44 -30.36 49.54 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.622 ' OE1' ' HB3' ' A' ' 74' ' ' SER . 27.7 tt0 -66.3 -43.49 86.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.417 HG13 ' O ' ' B' ' 51' ' ' ASP . 76.2 mt -61.71 -47.79 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.184 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.1 -34.36 56.48 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -89.16 -6.49 56.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -123.61 18.56 9.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.961 0.41 . . . . 0.0 111.697 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -131.97 -68.01 0.65 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.426 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -85.56 -49.05 8.35 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.733 -171.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 mp -133.54 112.0 11.14 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.507 ' O ' HG22 ' B' ' 65' ' ' ILE . . . -100.21 -63.36 1.14 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 124.013 0.821 . . . . 0.0 111.472 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.49 -37.03 86.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.112 0.565 . . . . 0.0 112.503 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.06 -15.36 41.55 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.507 HG22 ' O ' ' B' ' 62' ' ' ALA . 16.2 tt -80.41 148.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.608 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.545 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 40.4 tt0 -138.75 147.3 42.49 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -93.71 143.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -102.57 -52.46 3.09 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.294 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -169.87 150.97 4.01 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.98 118.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 123.575 0.547 . . . . 0.0 110.746 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.04 134.88 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.685 -0.634 . . . . 0.0 110.752 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.99 137.37 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.8 163.42 31.16 Favored Glycine 0 C--N 1.315 -0.619 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.647 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 17.5 p -83.38 124.27 30.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.361 0.601 . . . . 0.0 112.226 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . 0.659 HE21 ' HA ' ' B' ' 75' ' ' GLN . 0.0 OUTLIER -103.05 145.93 29.15 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 C--N 1.305 -1.35 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.813 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' ' 86' ' ' ARG . 22.7 mtp180 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.17 134.95 50.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.2 p -66.29 108.66 2.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.472 0.653 . . . . 0.0 111.84 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.533 HG22 ' HB3' ' B' ' 42' ' ' ARG . 33.8 p -106.49 148.98 27.55 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.568 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.05 130.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.813 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -113.64 113.74 25.46 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.93 116.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.4 121.24 44.3 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.606 0.241 . . . . 0.0 110.59 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 pt -119.54 154.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.545 ' HD3' ' OE1' ' B' ' 66' ' ' GLU . 60.3 ttt180 -117.47 121.3 40.65 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.508 ' HB2' HD23 ' B' ' 30' ' ' LEU . 32.2 mmmt -102.35 132.77 48.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.891 176.877 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 120.92 0.39 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.16 133.91 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.315 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.88 145.29 32.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.335 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 tp -107.18 124.32 49.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 48' ' ' LYS . 46.3 mm -89.36 117.23 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 118.685 -1.722 . . . . 0.0 115.171 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -155.07 -41.08 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.976 0.888 . . . . 0.0 110.695 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -101.43 158.06 32.49 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.967 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.3 157.11 55.98 Favored 'Trans proline' 0 C--O 1.248 0.995 0 C-N-CA 121.845 1.696 . . . . 0.0 110.129 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG21 ' OD1' ' A' ' 51' ' ' ASP . 14.7 p -56.9 -26.91 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.463 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.6 ptp -62.91 -28.57 70.14 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.77 -35.73 32.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.251 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.34 -34.63 72.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.278 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 19' ' ' VAL . 96.4 t -60.57 -48.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.653 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 20' ' ' MET . 88.4 mt -66.29 -31.56 72.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.468 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.99 -50.76 61.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.43 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.33 -38.89 92.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.65 -45.06 73.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.146 0.978 . . . . 0.0 109.604 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 m -71.57 -41.4 69.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.072 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.1 mt -60.66 -37.67 82.35 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.489 0.316 . . . . 0.0 111.786 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 93.6 mt -61.76 -36.74 81.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.746 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -95.37 0.77 53.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.99 0.424 . . . . 0.0 111.333 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -90.72 -31.35 16.6 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.86 -19.95 2.9 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.673 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -80.03 99.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 m -78.16 -37.34 46.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.388 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.514 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 9.9 pt-20 -120.26 118.66 31.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.8 pt -119.5 160.31 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.71 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.39 112.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.199 0.524 . . . . 0.0 110.745 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.54 126.63 44.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -114.29 112.82 23.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.51 133.87 54.34 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.557 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.593 ' HG2' HG22 ' A' ' 89' ' ' THR . 87.4 mtt180 -129.76 143.61 50.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.21 81.35 0.1 OUTLIER Glycine 0 C--O 1.211 -1.333 0 O-C-N 123.784 0.677 . . . . 0.0 114.49 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 58.66 -7.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 126.192 1.797 . . . . 0.0 115.083 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.58 -3.12 29.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.411 HG23 HG21 ' A' ' 90' ' ' ILE . 69.7 mt -51.7 -39.33 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.188 1.395 . . . . 0.0 110.663 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -68.27 -24.46 64.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.562 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.4 ' HB2' HG21 ' A' ' 14' ' ' ILE . 69.0 mttm -84.86 -27.72 26.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.059 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.58 -44.61 81.79 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.812 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.01 -35.23 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.054 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.52 ' OD1' HG21 ' A' ' 19' ' ' VAL . 15.0 t70 -59.52 -47.87 83.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -54.75 -56.47 18.94 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.338 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 m -67.13 -30.76 50.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.29 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.562 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 27.1 tt0 -65.99 -38.69 89.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.42 0.45 . . . . 0.0 111.014 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.7 mt -66.26 -49.68 74.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.466 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.05 -50.47 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.562 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 35.0 ptt180 -68.56 -7.78 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -115.33 -12.07 11.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.716 0.769 . . . . 0.0 110.369 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -105.77 -53.5 2.63 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -82.22 -60.39 2.23 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.201 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.481 HD12 ' H ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -146.85 105.62 3.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -176.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 6.21 46.12 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.441 ' H ' HD13 ' A' ' 61' ' ' LEU . 31.4 t70 -95.05 -65.0 1.01 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.484 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' H ' HD12 ' A' ' 61' ' ' LEU . 45.9 mttm -98.94 94.24 6.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tp -148.91 141.13 17.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -132.58 152.99 51.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.6 132.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -75.03 -53.75 8.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -173.71 156.84 2.98 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -129.96 115.69 34.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 91' ' ' GLU . 12.5 ptm180 -139.46 147.55 41.51 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.414 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.414 HG12 HG21 ' B' ' 70' ' ' ILE . 11.6 p -144.23 146.76 20.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.29 -171.01 36.07 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.181 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.518 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 36.8 p -108.46 123.83 49.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -99.85 117.57 34.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 C--N 1.319 -0.729 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.102 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 . . . . . 0 CA--C 1.501 -0.913 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.3 t -127.77 125.94 65.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.162 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 p -67.03 121.57 15.85 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.593 HG22 ' HG2' ' A' ' 42' ' ' ARG . 64.6 p -117.47 153.91 32.32 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.411 HG21 HG23 ' A' ' 46' ' ' ILE . 17.6 tt -142.78 129.79 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.454 ' HB2' ' HG3' ' A' ' 71' ' ' ARG . 3.4 mp0 -107.08 105.83 16.04 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.3 mm -102.26 110.77 29.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.31 128.91 54.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.612 0.244 . . . . 0.0 110.382 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.1 155.07 40.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.514 ' HD3' ' OE1' ' A' ' 36' ' ' GLU . 53.1 ttp180 -133.04 126.2 31.34 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.504 0.669 . . . . 0.0 111.592 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.41 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--O 1.239 0.513 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 20.9 m -120.37 138.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.428 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.36 145.48 35.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.032 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.17 126.45 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.413 HG21 ' HB2' ' B' ' 48' ' ' LYS . 46.4 mm -90.47 115.89 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.84 44.84 0.02 OUTLIER Glycine 0 CA--C 1.523 0.564 0 C-N-CA 118.849 -1.643 . . . . 0.0 114.855 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.89 -43.08 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 117.655 0.728 . . . . 0.0 110.875 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.472 ' HE2' ' HD2' ' B' ' 18' ' ' PRO . 13.5 mmmm -101.32 156.87 34.65 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.449 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.472 ' HD2' ' HE2' ' B' ' 17' ' ' LYS . 29.1 Cg_endo -64.64 157.77 53.78 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.293 1.996 . . . . 0.0 110.727 172.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.444 ' O ' HG23 ' B' ' 23' ' ' VAL . 13.9 p -56.12 -27.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.1 ptp -63.05 -29.24 70.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.065 0.459 . . . . 0.0 111.007 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.32 -37.88 36.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.201 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.62 -36.32 78.49 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.531 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.444 HG23 ' O ' ' B' ' 19' ' ' VAL . 66.2 t -61.2 -47.46 93.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 20' ' ' MET . 89.9 mt -67.66 -30.43 69.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.161 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.3 -51.38 53.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.85 -37.99 89.03 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.353 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 27.7 tp -55.02 -45.61 75.18 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.213 1.005 . . . . 0.0 109.194 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 48.7 m -70.47 -40.72 73.48 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.883 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.5 mt -61.32 -38.1 85.64 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.477 0.311 . . . . 0.0 111.499 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 98.3 mt -61.76 -38.48 88.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.101 0.56 . . . . 0.0 111.882 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.89 -5.37 51.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.424 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -84.13 -31.83 25.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.212 0.53 . . . . 0.0 109.788 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.06 -15.01 3.05 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.063 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.15 97.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -73.95 -39.14 63.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.32 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.552 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 10.2 pt-20 -121.14 118.56 30.0 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.41 0.624 . . . . 0.0 111.576 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.6 162.49 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.859 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 57.4 t -129.18 115.66 36.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.23 0.538 . . . . 0.0 110.369 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.8 mt -94.24 122.4 45.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.01 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -110.43 111.75 23.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.145 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.58 132.52 55.09 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.642 ' HG2' HG22 ' B' ' 89' ' ' THR . 87.8 mtt180 -129.06 144.06 51.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.44 80.98 0.12 Allowed Glycine 0 C--O 1.214 -1.11 0 O-C-N 123.879 0.737 . . . . 0.0 114.338 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 56.35 -3.81 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.998 1.719 . . . . 0.0 115.138 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.16 -3.07 34.24 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.271 0.557 . . . . 0.0 110.851 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.404 HG23 HG21 ' B' ' 90' ' ' ILE . 69.2 mt -51.67 -40.46 26.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.857 1.263 . . . . 0.0 110.365 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.6 t -66.12 -28.66 68.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.651 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.413 ' HB2' HG21 ' B' ' 14' ' ' ILE . 68.7 mttm -82.98 -28.39 29.76 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.508 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.8 86.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 120.945 0.402 . . . . 0.0 110.748 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.72 -36.69 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.545 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.468 ' O ' HG13 ' B' ' 55' ' ' ILE . 15.0 t70 -58.86 -46.85 86.79 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -54.45 -57.8 9.93 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.672 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.34 -29.3 45.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.871 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.525 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 24.0 tt0 -67.68 -36.93 81.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.968 0.413 . . . . 0.0 111.089 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.468 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.0 mt -66.56 -50.17 68.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.241 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.04 -50.45 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.525 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 34.5 ptt180 -67.83 -8.21 34.27 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -116.63 -12.51 10.91 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.759 0.79 . . . . 0.0 110.46 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -104.8 -53.51 2.67 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -82.64 -59.93 2.35 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.943 -172.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.558 HD12 ' H ' ' B' ' 64' ' ' LYS . 0.3 OUTLIER -146.72 106.31 3.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.39 6.32 44.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.407 ' H ' HD13 ' B' ' 61' ' ' LEU . 33.0 t70 -94.81 -57.8 2.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.402 0.62 . . . . 0.0 110.924 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.558 ' H ' HD12 ' B' ' 61' ' ' LEU . 48.8 mttm -107.74 95.42 5.67 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.127 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tp -149.22 139.29 16.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.457 ' HB2' ' HE2' ' B' ' 97' ' ' LYS . 45.2 tt0 -130.33 148.39 52.15 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.91 123.94 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -67.45 -59.76 3.12 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.646 0.591 . . . . 0.0 109.847 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.38 154.69 8.72 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.414 HG21 HG12 ' A' ' 72' ' ' VAL . 71.1 mt -129.7 114.14 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 123.617 0.573 . . . . 0.0 109.66 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' B' ' 91' ' ' GLU . 12.4 ptm180 -138.07 146.68 43.24 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.308 -0.245 . . . . 0.0 111.177 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.6 144.69 23.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.82 -171.42 36.11 Favored Glycine 0 CA--C 1.5 -0.874 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.807 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.525 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 26.3 p -107.35 124.77 50.3 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 122.563 0.345 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -100.71 117.08 34.09 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.313 -1.01 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.8 179.636 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 . . . . . 0 CA--C 1.502 -0.901 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.37 126.07 68.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.084 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 73.8 p -67.32 122.99 19.1 Favored 'General case' 0 C--O 1.266 1.956 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.642 HG22 ' HG2' ' B' ' 42' ' ' ARG . 60.7 p -119.4 153.49 35.13 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.404 HG21 HG23 ' B' ' 46' ' ' ILE . 18.3 tt -142.46 131.28 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.456 ' HB2' ' HG3' ' B' ' 71' ' ' ARG . 3.4 mp0 -109.02 105.5 15.04 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.588 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mm -102.6 110.72 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.87 129.85 55.89 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.874 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' B' ' 36' ' ' GLU . 35.4 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.597 0.236 . . . . 0.0 110.66 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.552 ' HD3' ' OE2' ' B' ' 36' ' ' GLU . 51.2 ttp180 -126.62 125.3 41.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.978 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.402 ' HB2' HD22 ' B' ' 30' ' ' LEU . 0.0 OUTLIER -89.34 120.67 30.89 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' B' ' 66' ' ' GLU . 67.3 mttm . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.7 p30 . . . . . 0 CA--C 1.51 -0.568 0 CA-C-O 120.698 0.285 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.36 112.49 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -110.55 134.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.264 0.555 . . . . 0.0 110.74 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.59 129.5 43.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.8 mm -91.28 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.99 50.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.103 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -157.6 -65.05 0.09 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 117.22 0.51 . . . . 0.0 110.682 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -101.82 168.45 9.02 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.36 167.13 19.35 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.058 1.839 . . . . 0.0 112.253 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.48 HG11 ' OD2' ' A' ' 51' ' ' ASP . 93.1 t -50.32 -38.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.373 1.069 . . . . 0.0 112.602 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.3 ptp -52.02 -31.45 29.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.03 -32.87 63.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 121.507 0.67 . . . . 0.0 110.404 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -80.52 -34.64 35.47 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.285 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.01 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.291 0.567 . . . . 0.0 109.693 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.56 -35.95 81.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.032 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.47 96.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.288 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -9.19 57.69 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.11 0.481 . . . . 0.0 111.76 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.97 -43.99 7.56 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -60.3 -40.33 90.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.55 -36.07 81.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.396 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.529 HD23 ' HG3' ' A' ' 96' ' ' LYS . 3.4 tm? -64.86 -39.23 93.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -67.29 -17.82 64.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.17 0.51 . . . . 0.0 111.188 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -91.96 -4.56 54.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.4 -7.56 32.34 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.098 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.44 99.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -89.45 -29.64 18.87 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.095 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.32 115.99 30.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.782 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -127.81 156.14 39.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.555 -178.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.0 t -124.95 124.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.807 0.692 . . . . 0.0 110.549 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.7 mt -105.65 130.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.419 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.39 122.99 41.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.189 0.519 . . . . 0.0 110.897 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.73 155.05 33.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -133.01 141.07 48.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.449 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.47 -118.58 7.91 Favored Glycine 0 CA--C 1.505 -0.574 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.304 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -94.65 8.08 43.58 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.84 -0.38 57.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.888 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.25 -38.3 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 p -62.72 -32.01 73.04 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.305 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -70.19 -37.27 75.06 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.1 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.93 91.22 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.546 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.89 -33.95 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.551 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.529 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 t70 -62.63 -45.24 93.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.7 m -57.0 -53.35 59.04 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.552 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.9 m -66.05 -36.05 76.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.27 -45.18 94.19 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 123.132 0.27 . . . . 0.0 111.563 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.4 mt -60.59 -43.03 93.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.49 -43.95 98.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.503 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -83.45 13.64 4.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.273 0.558 . . . . 0.0 111.41 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -119.99 -45.68 2.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.845 0.355 . . . . 0.0 110.277 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.4 ptp180 -81.8 -21.65 37.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.544 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 60.9 t80 -117.56 -70.12 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.391 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.544 ' HG ' ' CD2' ' A' ' 60' ' ' PHE . 90.0 mt -132.61 114.82 14.67 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.08 -33.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.245 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.33 -52.61 9.6 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.451 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -97.21 88.46 4.47 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.607 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -160.73 120.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.899 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.541 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 10.2 pt-20 -121.7 134.95 54.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 111.056 177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.8 mt -88.81 139.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -84.62 -54.92 4.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.074 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -170.69 152.62 3.83 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.1 mt -134.08 116.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 77.1 mtp180 -116.83 137.47 52.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.866 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.91 124.44 50.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 -168.37 24.71 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.537 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.6 p -118.04 124.34 47.87 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.128 0.489 . . . . 0.0 110.783 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -100.01 128.19 46.13 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--N 1.312 -1.038 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 CA--C 1.506 -0.733 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.25 126.43 73.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -67.64 128.45 36.5 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.473 0.483 . . . . 0.0 110.96 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.4 p -123.0 160.41 26.34 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 71' ' ' ARG . 13.0 tt -146.06 124.35 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -105.0 110.46 22.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.286 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -109.93 116.77 53.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.25 125.18 51.86 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.02 159.0 32.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.541 ' HD2' ' OE2' ' A' ' 66' ' ' GLU . 41.6 ttm180 -126.22 132.32 51.77 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 123.46 0.704 . . . . 0.0 111.18 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HG3' HD23 ' A' ' 30' ' ' LEU . 34.2 mmtp . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.642 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p30 . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.88 0.371 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.1 115.17 47.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.14 134.57 53.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.086 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 tp -97.58 127.63 43.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.342 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mm -88.52 110.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.3 52.23 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.016 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -159.72 -65.4 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.219 0.509 . . . . 0.0 110.405 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -101.54 168.04 9.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.423 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.59 164.62 30.37 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.978 1.785 . . . . 0.0 112.393 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 95.2 t -46.77 -38.39 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.128 1.371 . . . . 0.0 113.22 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptp -52.31 -35.08 49.65 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -69.9 -35.39 74.57 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.19 0.519 . . . . 0.0 110.685 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -78.75 -35.49 44.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.16 -50.82 78.72 Favored 'Isoleucine or valine' 0 C--O 1.252 1.231 0 CA-C-O 121.601 0.715 . . . . 0.0 109.124 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.89 -32.53 74.28 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.158 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.85 94.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.021 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.16 68.38 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.168 0.509 . . . . 0.0 110.754 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.83 -44.19 42.22 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.468 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -63.21 -38.55 91.6 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.832 0.349 . . . . 0.0 111.152 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.24 -39.04 89.25 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 122.315 -0.241 . . . . 0.0 110.92 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.475 HD23 ' HG3' ' B' ' 96' ' ' LYS . 3.4 tm? -60.19 -40.13 88.96 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.709 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.87 -20.92 66.01 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.045 0.45 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -87.17 -9.28 55.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.11 -4.55 23.82 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.844 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.24 96.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 0.0 109.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -84.03 -28.24 27.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -114.84 120.42 39.93 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.436 ' H ' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.98 154.56 40.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 O-C-N 123.16 0.288 . . . . 0.0 111.348 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.68 124.36 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.216 0.532 . . . . 0.0 110.56 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.64 130.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.343 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.26 123.95 44.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.173 0.511 . . . . 0.0 110.904 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 153.94 35.18 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -129.1 143.39 50.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.47 -122.76 15.35 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 116.312 -0.404 . . . . 0.0 113.533 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.17 11.64 24.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.905 0.383 . . . . 0.0 110.944 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.33 -1.04 57.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.509 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.49 -37.25 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.126 0.571 . . . . 0.0 110.36 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.5 p -66.12 -31.36 72.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.233 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -69.15 -39.96 78.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.31 91.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.606 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -72.4 -34.28 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.589 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.556 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.0 t70 -62.73 -45.18 93.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 90.4 m -56.23 -53.74 53.55 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.622 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.24 -34.23 67.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.959 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -60.99 -47.97 84.0 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.556 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.8 mt -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.883 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.01 -41.03 91.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -85.76 14.7 5.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.24 0.543 . . . . 0.0 111.043 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -121.33 -45.44 2.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.277 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.8 ptp180 -83.28 -19.28 36.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.462 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.55 ' CD2' ' HG ' ' B' ' 61' ' ' LEU . 57.8 t80 -118.66 -71.56 0.73 Allowed 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.64 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.55 ' HG ' ' CD2' ' B' ' 60' ' ' PHE . 94.0 mt -131.15 114.91 15.69 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.158 0.504 . . . . 0.0 111.71 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.26 -32.16 11.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.551 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.83 -49.48 11.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.0 87.35 3.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.413 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -160.71 119.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 11.0 pt-20 -122.04 136.16 54.89 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.131 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.42 143.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.76 -58.14 2.68 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.925 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -167.67 152.0 6.61 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 67.0 mt -133.35 115.56 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' B' ' 90' ' ' ILE . 73.9 mtp180 -115.06 136.41 53.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.822 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.72 126.08 56.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.12 -168.45 26.19 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.156 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.2 p -116.27 121.14 41.12 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.359 0.6 . . . . 0.0 111.235 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -96.22 127.2 42.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.643 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.228 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.437 -1.111 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 72.7 t -115.7 125.24 72.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -67.26 127.08 31.31 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.969 0.414 . . . . 0.0 111.232 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 67.8 p -121.42 159.37 26.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.095 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' B' ' 71' ' ' ARG . 12.3 tt -146.21 124.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.933 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -103.59 113.16 26.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.31 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.9 mt -112.02 114.64 47.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.32 125.45 53.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 pt -126.07 158.54 35.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' B' ' 66' ' ' GLU . 41.5 ttm180 -124.53 134.95 52.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.475 ' HG3' HD23 ' B' ' 30' ' ' LEU . 34.1 mmtp -97.66 148.52 23.24 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 123.849 0.86 . . . . 0.0 109.517 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.517 175.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.508 0.671 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 58.3 t -116.06 119.59 62.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.11 147.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.098 0.475 . . . . 0.0 111.284 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 tp -110.76 134.82 52.16 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.52 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.412 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.69 -138.06 4.59 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -101.68 18.3 20.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.86 154.67 38.23 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.152 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.44 148.15 53.81 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.187 2.591 . . . . 0.0 112.499 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.532 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -54.68 -36.15 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.762 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.417 ' O ' HD13 ' A' ' 24' ' ' LEU . 26.9 ptt? -59.31 -24.76 63.58 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -64.86 -38.59 91.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -85.33 -33.42 22.07 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.987 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.5 t -62.29 -55.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.169 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 20' ' ' MET . 9.3 mp -62.05 -26.45 68.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.692 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.481 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.68 -45.75 70.86 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.118 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -61.58 -42.45 98.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp -61.84 -38.26 87.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.1 m -68.2 -37.94 81.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.924 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 96.7 mt -63.18 -34.99 78.83 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.368 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.9 mt -57.52 -41.8 81.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.28 -16.89 62.49 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -91.63 2.05 56.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.51 0.672 . . . . 0.0 110.338 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.68 -3.81 59.31 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.56 91.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 t -90.24 -12.13 38.87 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.96 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 43.3 tt0 -124.56 111.98 16.3 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.444 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -125.89 156.82 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.823 0.345 . . . . 0.0 111.698 -177.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -126.35 125.49 67.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.009 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.81 129.45 61.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.125 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -118.73 123.54 45.1 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -121.01 153.07 37.82 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -129.59 140.95 51.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.089 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.7 -135.04 18.6 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.292 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -83.05 2.63 34.1 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.5 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.5 30.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.579 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.35 -36.95 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.361 0.601 . . . . 0.0 109.705 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.1 p -61.55 -37.42 83.73 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.543 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -67.64 -42.84 81.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.153 -178.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -64.02 -45.27 89.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.466 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.8 -36.77 65.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.805 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.532 ' OD2' HG21 ' A' ' 19' ' ' VAL . 17.9 t70 -59.59 -47.63 84.83 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 56' ' ' VAL . 87.2 m -53.36 -53.56 49.28 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.444 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -69.98 -31.18 46.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 25.3 tt0 -68.61 -32.17 71.87 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.947 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.3 mt -68.69 -42.83 83.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.119 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 52' ' ' THR . 59.8 t -69.19 -30.93 47.98 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 CA-C-O 121.25 0.548 . . . . 0.0 111.292 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 40.4 ptt180 -88.88 14.98 9.16 Favored 'General case' 0 C--O 1.211 -0.94 0 O-C-N 122.023 -0.423 . . . . 0.0 110.299 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -128.67 -56.02 1.22 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -73.27 -29.15 62.54 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -97.96 -63.21 1.15 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.023 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.48 110.55 5.69 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.798 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.41 -46.69 8.2 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.555 1.159 . . . . 0.0 110.777 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.91 -29.52 58.45 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.77 97.23 7.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -160.95 143.69 4.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.957 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.72 141.72 51.48 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.35 125.6 68.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HD2' ' HG3' ' A' ' 36' ' ' GLU . 29.6 mtpp -86.05 -62.48 1.51 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.28 149.29 5.91 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.014 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.2 mt -139.15 99.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.22 136.79 54.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.8 t -102.16 132.7 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.82 167.29 28.24 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.881 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 p -93.88 135.89 34.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.829 0.347 . . . . 0.0 110.825 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 36.0 tt0 -100.48 114.18 27.56 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.479 HG22 ' HG2' ' A' ' 86' ' ' ARG . 45.1 t . . . . . 0 C--N 1.321 -0.652 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.479 ' HG2' HG22 ' A' ' 76' ' ' VAL . 99.5 mtt180 . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.58 136.44 58.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.7 p -70.24 127.26 32.19 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.518 0.675 . . . . 0.0 111.956 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.0 p -133.11 160.15 38.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.774 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.67 139.53 48.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -118.13 110.76 18.0 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -111.5 119.74 60.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.41 120.26 30.56 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.723 0.297 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.34 168.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 ttt180 -136.85 133.7 36.12 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.22 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 70.7 mmtt . . . . . 0 C--N 1.289 -2.052 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.241 0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.03 114.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -111.29 143.46 21.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.01 138.28 43.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -86.18 125.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.792 0.329 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.56 -140.0 7.46 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.777 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -99.81 14.87 28.82 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -91.31 154.38 44.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.328 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.96 146.68 56.14 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.203 2.602 . . . . 0.0 112.391 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.435 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.1 p -51.66 -35.52 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.307 1.043 . . . . 0.0 113.516 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.09 -25.34 66.89 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.27 -36.96 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.495 0.664 . . . . 0.0 110.117 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -87.04 -33.66 19.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.205 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 19' ' ' VAL . 65.6 t -61.31 -55.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.583 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.66 -26.16 68.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.761 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -68.34 -44.18 75.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.173 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -41.72 96.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.14 -36.81 80.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.958 0.408 . . . . 0.0 110.671 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 37.9 m -68.66 -38.36 80.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 95.6 mt -63.58 -35.18 79.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.254 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.2 mt -55.84 -42.81 76.32 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -71.61 -15.14 62.24 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -93.38 1.7 56.8 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.37 0.605 . . . . 0.0 110.382 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.42 -8.27 58.55 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.657 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.92 91.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.249 0.547 . . . . 0.0 109.605 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -90.16 -13.17 36.19 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.773 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -123.91 116.62 23.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.906 -0.496 . . . . 0.0 109.669 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 157.9 42.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-O 120.806 0.336 . . . . 0.0 111.633 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.0 124.7 65.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.218 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.9 mt -106.97 127.43 62.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.03 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -117.22 122.32 43.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.689 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.59 40.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -128.17 139.82 52.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.332 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.83 -136.14 20.25 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.239 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -80.52 0.53 33.36 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 122.439 -0.447 . . . . 0.0 111.53 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.43 -0.81 27.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.627 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 75.2 mt -55.91 -38.87 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.15 0.5 . . . . 0.0 110.021 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -61.71 -38.03 86.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.733 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.401 ' NZ ' ' HB2' ' B' ' 48' ' ' LYS . 0.0 OUTLIER -66.14 -41.56 90.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.28 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.89 81.23 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.209 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.11 -34.09 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.462 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.525 ' O ' HG13 ' B' ' 55' ' ' ILE . 12.3 t70 -60.9 -47.18 87.56 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -54.84 -55.08 34.21 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 18.0 m -68.14 -31.88 53.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.131 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.521 ' HG3' ' HE ' ' B' ' 57' ' ' ARG . 27.3 tt0 -68.6 -31.01 69.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.099 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.525 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.0 mt -69.54 -43.59 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.191 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.41 -31.36 52.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 CA-C-O 121.297 0.57 . . . . 0.0 111.335 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.521 ' HE ' ' HG3' ' B' ' 54' ' ' GLU . 40.0 ptt180 -88.66 17.27 5.64 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -131.56 -57.08 1.0 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.138 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -72.55 -26.68 61.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -101.65 -64.03 1.09 Allowed 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.975 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -141.93 112.33 7.07 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.7 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.9 -50.23 5.82 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 124.293 0.995 . . . . 0.0 110.875 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.49 -28.76 62.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -105.54 98.02 7.77 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.442 0.639 . . . . 0.0 110.755 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tp -161.15 145.12 4.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.869 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -126.17 138.48 53.66 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.24 126.72 63.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -86.63 -64.47 1.15 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -166.33 146.98 6.31 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.393 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.3 mt -139.43 100.82 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.19 143.46 50.49 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.59 123.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.56 168.64 24.1 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.761 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.51 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 35.1 p -92.96 133.34 36.22 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.659 0.384 . . . . 0.0 110.907 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 36.1 tt0 -99.61 114.49 27.57 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' B' ' 86' ' ' ARG . 46.7 t . . . . . 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.474 ' HG2' HG22 ' B' ' 76' ' ' VAL . 99.6 mtt180 . . . . . 0 N--CA 1.435 -1.199 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.62 137.4 56.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 7.2 p -72.31 127.47 32.67 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.464 0.649 . . . . 0.0 112.223 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.75 158.38 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.114 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.04 139.54 50.06 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -119.16 112.38 19.44 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -112.39 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.01 35.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 pt -125.14 163.26 26.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 120.983 0.421 . . . . 0.0 110.482 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' B' ' 96' ' ' LYS . 76.4 ttt180 -132.44 134.21 44.81 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' B' ' 95' ' ' ARG . 69.4 mmtt -97.6 -170.36 1.99 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.318 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt . . . . . 0 C--O 1.256 1.4 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.195 176.773 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 121.547 0.689 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.65 120.37 60.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.156 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.53 139.69 42.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.991 0.424 . . . . 0.0 110.693 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.3 tp -104.21 136.73 43.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.313 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -84.09 123.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.4 -159.49 11.77 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.03 13.41 1.79 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -86.07 152.48 56.03 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 121.95 -0.469 . . . . 0.0 112.162 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.65 150.79 59.16 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.859 2.373 . . . . 0.0 112.213 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.545 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.4 p -56.23 -35.31 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.503 0.721 . . . . 0.0 112.388 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.1 ptp -57.89 -30.81 66.17 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.93 -34.08 74.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -79.09 -33.34 44.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.196 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 66.1 t -61.62 -48.52 88.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.84 -38.54 91.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.645 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.81 -44.64 96.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.2 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.38 96.61 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.19 0.519 . . . . 0.0 111.012 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 95.3 mt -64.92 -38.97 92.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.806 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.9 m -67.74 -31.79 71.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.2 mt -70.6 -40.37 73.25 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 122.088 -0.383 . . . . 0.0 110.245 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.56 -40.97 89.07 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.372 0.606 . . . . 0.0 109.406 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -59.13 -30.21 67.96 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.44 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -91.26 3.19 55.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.52 11.99 57.58 Favored Glycine 0 C--O 1.244 0.759 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.921 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.31 98.04 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 13.1 p -87.46 -13.87 42.01 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.404 ' OE1' ' HG3' ' A' ' 68' ' ' LYS . 36.6 tt0 -128.66 111.79 13.56 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -126.35 159.66 35.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.02 127.29 51.46 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-O 121.573 0.701 . . . . 0.0 110.86 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -101.88 124.29 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.52 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 81.8 mttt -115.46 114.27 24.81 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.32 0.581 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.07 158.49 17.7 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.848 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.546 ' HG2' HG22 ' A' ' 89' ' ' THR . 54.8 mtm180 -133.54 148.68 51.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.91 -121.58 19.57 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 123.559 0.537 . . . . 0.0 113.016 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -92.0 -0.28 57.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.63 -4.03 46.92 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -54.9 -36.07 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.7 0.8 . . . . 0.0 110.529 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -63.39 -35.49 80.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.616 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.23 -30.04 60.42 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.3 82.35 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.31 -37.19 64.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.184 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.545 ' OD2' HG21 ' A' ' 19' ' ' VAL . 34.9 t70 -60.66 -43.39 97.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.875 0.369 . . . . 0.0 110.086 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -58.71 -51.25 70.77 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.279 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.96 -32.37 51.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.59 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 7.6 tp10 -63.66 -40.3 96.51 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.1 mt -64.21 -44.33 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.81 -39.59 82.34 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.831 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.522 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 2.6 ptm180 -80.66 1.33 30.43 Favored 'General case' 0 C--O 1.206 -1.199 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -128.17 11.35 6.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.081 0.467 . . . . 0.0 111.789 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -118.1 -66.71 1.05 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.709 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -75.9 -67.17 0.7 Allowed 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.827 0.346 . . . . 0.0 110.386 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.484 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -138.23 109.25 6.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -87.04 -44.9 11.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.429 1.08 . . . . 0.0 110.343 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.96 -28.71 67.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.619 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -121.02 106.84 11.96 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -159.26 120.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.291 0.567 . . . . 0.0 110.506 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -98.45 134.39 41.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.264 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.5 mt -101.2 122.64 53.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 1.9 tmtp? -83.58 -55.59 4.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.398 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -173.55 154.25 2.49 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -133.4 116.18 24.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -119.31 134.79 55.02 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.725 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 90' ' ' ILE . 46.4 t -125.84 131.57 71.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.88 28.92 Favored Glycine 0 CA--C 1.493 -1.335 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -115.18 145.11 42.71 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 117.228 0.514 . . . . 0.0 111.238 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -114.48 134.81 54.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 C--N 1.311 -1.072 0 CA-C-O 121.408 0.623 . . . . 0.0 110.93 178.075 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.836 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.85 139.62 42.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.8 p -67.41 126.29 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 O-C-N 123.757 0.661 . . . . 0.0 110.828 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.546 HG22 ' HG2' ' A' ' 42' ' ' ARG . 46.6 p -132.03 151.19 51.89 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.2 tt -136.11 140.0 44.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.92 109.42 15.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.68 111.8 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.12 122.58 47.98 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.978 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.32 157.65 24.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.783 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.5 ttp180 -126.02 133.44 51.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.484 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 3.1 tmtm? . . . . . 0 N--CA 1.413 -2.288 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.235 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 C--O 1.246 0.87 0 CA-C-O 121.614 0.721 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.38 126.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.067 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.51 139.8 46.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.104 0.478 . . . . 0.0 110.495 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 tp -104.32 138.23 41.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.299 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -85.34 123.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.253 0.549 . . . . 0.0 111.295 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.9 -160.49 11.91 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.48 12.46 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -84.64 153.42 61.29 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.805 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.28 154.32 29.58 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.755 2.304 . . . . 0.0 111.772 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.443 HG21 ' OD2' ' B' ' 51' ' ' ASP . 7.1 p -61.58 -35.88 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.028 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.408 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.3 ptp -56.93 -28.74 62.44 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.179 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.18 -36.83 77.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -76.42 -32.92 58.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.434 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 70.2 t -60.94 -50.48 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 20' ' ' MET . 91.9 mt -64.1 -34.36 77.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.35 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.72 81.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.73 97.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.963 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 97.6 mt -63.8 -37.93 89.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.618 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -34.54 77.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.191 0.519 . . . . 0.0 110.251 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.38 -40.55 81.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.201 -0.312 . . . . 0.0 110.421 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.67 -39.35 80.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.096 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.25 -28.78 69.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.354 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -92.5 6.67 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.873 0.368 . . . . 0.0 111.909 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.73 60.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.433 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.82 97.57 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 31.7 p -83.8 -21.71 32.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -122.2 115.27 22.09 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.454 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.65 154.34 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.04 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.06 128.48 67.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 CA-C-O 121.775 0.798 . . . . 0.0 111.22 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -101.91 124.67 55.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.728 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.6 mttt -114.82 115.68 27.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.398 0.618 . . . . 0.0 110.744 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.41 158.54 18.36 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.488 ' HG2' HG22 ' B' ' 89' ' ' THR . 50.9 mtm180 -132.33 149.94 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.61 -117.08 9.84 Favored Glycine 0 N--CA 1.446 -0.643 0 O-C-N 123.604 0.565 . . . . 0.0 113.02 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -97.43 0.5 47.85 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.16 -2.96 43.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.686 0.279 . . . . 0.0 111.699 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.79 -36.21 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.887 0.875 . . . . 0.0 110.268 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.2 p -63.64 -35.4 80.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.37 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -76.29 -29.42 57.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.44 77.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -71.04 -34.91 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.515 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.0 t70 -60.87 -42.97 98.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.003 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.1 m -60.63 -53.17 60.7 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.512 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.35 -31.78 52.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 8.3 tp10 -64.92 -39.72 93.95 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.515 HG13 ' O ' ' B' ' 51' ' ' ASP . 81.7 mt -63.08 -45.65 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.6 t -60.52 -39.23 80.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.507 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 2.9 ptm180 -79.64 -2.87 44.68 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -127.21 20.75 6.81 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.041 0.448 . . . . 0.0 111.383 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -125.8 -66.58 0.93 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.547 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -77.61 -67.47 0.72 Allowed 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.479 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 0.6 OUTLIER -137.21 110.0 7.6 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -86.59 -47.34 9.3 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 124.264 0.977 . . . . 0.0 110.71 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.56 -30.89 65.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.796 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -117.8 102.54 9.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.546 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -156.16 121.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.102 0.477 . . . . 0.0 110.647 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' B' ' 95' ' ' ARG . 23.5 mm-40 -99.98 133.79 43.85 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.061 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.45 123.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.21 -52.85 5.92 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.79 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -176.88 152.95 0.99 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.83 115.5 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -118.2 134.59 54.88 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.822 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.52 134.51 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.58 -167.44 37.9 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.9 p -109.66 149.28 29.94 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 117.59 0.695 . . . . 0.0 111.076 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.45 132.8 56.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.316 -0.849 0 CA-C-O 121.387 0.613 . . . . 0.0 111.318 177.312 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.41 138.99 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 13.1 p -66.24 128.02 34.47 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.216 0.532 . . . . 0.0 110.859 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.488 HG22 ' HG2' ' B' ' 42' ' ' ARG . 47.9 p -132.87 148.64 52.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.118 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 15.4 tt -133.62 139.37 48.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -118.09 108.9 15.78 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.72 111.8 37.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.0 123.24 49.88 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.815 0.341 . . . . 0.0 110.216 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -121.97 155.85 26.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' B' ' 35' ' ' SER . 60.7 ttp180 -126.06 128.5 47.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.484 ' HD3' ' H ' ' B' ' 97' ' ' LYS . 2.7 tmtm? -104.94 143.34 33.3 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 -174.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.484 ' H ' ' HD3' ' B' ' 96' ' ' LYS . 74.4 mmtt . . . . . 0 C--O 1.263 1.8 0 CA-C-O 117.253 -1.356 . . . . 0.0 107.697 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.184 0.516 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -95.19 117.58 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 m -107.95 136.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.441 0.638 . . . . 0.0 111.57 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.26 104.74 14.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.819 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.89 107.7 12.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.375 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.53 36.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.921 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -160.21 -50.95 0.05 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.85 0.86 . . . . 0.0 110.611 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -97.97 154.88 37.6 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.777 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.78 156.37 62.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.914 2.409 . . . . 0.0 113.077 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.34 -41.73 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.811 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -62.85 -25.19 68.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.954 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.14 -21.83 56.13 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.294 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.0 -35.53 17.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.57 -50.65 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.143 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.09 -29.07 69.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.06 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -70.22 -48.15 58.31 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.621 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.86 91.03 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.516 0.51 . . . . 0.0 110.681 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.1 -30.6 71.56 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.305 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 93.7 m -78.89 -42.57 26.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 99.0 mt -62.78 -31.73 72.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.821 0.344 . . . . 0.0 110.732 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.96 -45.12 96.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.84 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.05 -25.64 64.57 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.421 0.629 . . . . 0.0 110.006 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' THR . 15.1 mm100 -80.01 -3.64 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.386 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 -7.93 36.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.447 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -85.44 97.18 5.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 42.5 m -98.38 0.01 44.58 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.796 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -135.38 115.15 12.89 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 155.35 41.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 O-C-N 123.306 0.379 . . . . 0.0 110.684 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.22 122.93 62.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.55 132.6 47.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.285 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.454 ' HG2' ' HG2' ' A' ' 91' ' ' GLU . 53.5 mttp -121.53 122.13 39.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.34 0.591 . . . . 0.0 111.359 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.68 147.73 50.77 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.158 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HG3' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.0 152.04 50.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 -124.25 9.12 Favored Glycine 0 C--N 1.309 -0.964 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.274 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -92.69 2.66 56.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.209 0.528 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.56 -7.68 55.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.967 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -55.83 -40.78 63.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.7 t -63.11 -33.38 75.33 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.959 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.79 -35.82 62.51 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.157 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.26 93.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.743 0.306 . . . . 0.0 111.508 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.88 -33.23 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 110.768 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.1 t70 -66.23 -40.82 90.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -57.46 -46.51 83.56 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.566 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -71.38 -36.74 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.07 -45.81 79.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.413 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 74.1 mt -59.16 -50.35 80.1 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.788 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.83 -46.4 96.6 Favored 'Isoleucine or valine' 0 C--O 1.256 1.407 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -80.18 -5.48 56.15 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.119 0.485 . . . . 0.0 112.265 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -125.69 12.02 7.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -123.09 -41.49 2.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.772 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -123.71 -57.58 1.63 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.338 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.27 76.68 7.58 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.459 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 18.26 19.05 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.321 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -149.65 -59.7 0.21 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.515 0.674 . . . . 0.0 110.414 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -94.07 80.75 4.08 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.098 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.5 tp -159.2 145.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.291 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.41 167.93 21.0 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.036 0.446 . . . . 0.0 110.78 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.71 128.26 55.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.86 -57.45 3.75 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -177.03 146.9 0.53 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.4 pt -130.55 129.64 64.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.27 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -135.97 143.73 45.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.409 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 p -137.44 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.98 -145.42 5.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 m -138.38 134.47 34.21 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 65.2 tt0 -96.83 140.29 31.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.804 0.335 . . . . 0.0 110.276 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.705 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 94.3 mtt180 . . . . . 0 CA--C 1.491 -1.293 0 CA-C-O 120.893 0.378 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.55 136.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 m -62.81 123.99 19.89 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 123.566 0.541 . . . . 0.0 109.855 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 42' ' ' ARG . 33.7 p -130.57 146.53 52.11 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.365 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -135.6 140.11 45.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.729 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.454 ' HG2' ' HG2' ' A' ' 40' ' ' LYS . 43.8 mt-10 -120.13 115.49 23.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.868 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.06 115.49 49.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.66 128.13 55.08 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -132.77 159.72 43.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 35' ' ' SER . 59.4 ttp180 -140.93 145.56 36.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' C ' ' HD3' ' A' ' 96' ' ' LYS . 12.7 tmtt? . . . . . 0 C--N 1.302 -1.473 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.976 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.5 p30 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.094 0.474 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 48.4 t -102.36 109.27 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.8 m -103.16 137.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.763 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.45 108.38 19.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.917 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.38 116.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.097 0.475 . . . . 0.0 109.927 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.38 35.46 0.02 OUTLIER Glycine 0 C--N 1.311 -0.823 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.829 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -161.92 -48.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.967 0.907 . . . . 0.0 111.212 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -99.88 155.48 36.41 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.391 -174.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.77 153.1 79.61 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.736 2.291 . . . . 0.0 112.374 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.446 ' O ' HG23 ' B' ' 23' ' ' VAL . 7.1 p -52.51 -39.47 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.616 0.767 . . . . 0.0 112.858 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -63.38 -26.78 68.91 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.76 -25.86 60.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.317 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.04 -37.85 21.61 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 19' ' ' VAL . 61.4 t -58.55 -49.56 81.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.426 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.3 -28.4 68.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.748 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -69.66 -47.9 61.71 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.447 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -45.62 87.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.606 0.566 . . . . 0.0 110.977 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.04 -31.49 72.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.157 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 90.6 m -77.12 -44.47 30.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.595 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 96.6 mt -61.57 -31.64 71.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.92 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.5 -45.29 94.32 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.128 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -69.57 -24.78 63.75 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.428 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -79.91 -8.56 59.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.153 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.48 2.83 33.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.231 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.86 96.19 5.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 41.4 m -100.08 2.81 43.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -137.48 111.35 8.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.437 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.23 157.2 40.62 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.063 -176.147 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 60.4 t -127.13 122.23 59.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.268 0.556 . . . . 0.0 111.073 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.07 130.43 50.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' B' ' 91' ' ' GLU . 52.4 mttp -120.5 122.77 41.36 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.46 0.648 . . . . 0.0 111.291 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.45 ' HG3' HG22 ' B' ' 89' ' ' THR . 0.1 OUTLIER -130.98 151.85 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.97 -126.19 11.8 Favored Glycine 0 C--N 1.303 -1.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.177 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -89.79 1.21 56.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.07 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.82 -8.16 55.6 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.235 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.45 -39.96 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.407 0.683 . . . . 0.0 110.799 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 40.6 t -63.25 -33.48 75.58 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.065 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -75.31 -35.18 61.29 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.321 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.14 88.86 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.263 0.554 . . . . 0.0 111.381 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.72 -30.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.503 ' O ' HG13 ' B' ' 55' ' ' ILE . 22.9 t70 -66.4 -42.98 87.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 70.4 m -56.5 -47.5 79.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.786 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.6 m -70.1 -38.1 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.83 -46.45 78.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.15 0.281 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.1 mt -58.56 -51.1 75.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.017 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.18 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--O 1.254 1.341 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -79.98 -5.04 54.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -127.28 14.86 7.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -125.86 -38.69 2.18 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.818 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -126.69 -57.96 1.33 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.16 74.85 8.73 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.983 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.88 24.96 8.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.293 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -153.52 -59.77 0.13 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.772 0.796 . . . . 0.0 109.754 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.488 ' HB3' ' OXT' ' B' ' 97' ' ' LYS . 46.7 mttm -98.25 81.71 2.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.106 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.415 ' O ' ' HE3' ' B' ' 97' ' ' LYS . 8.9 tp -157.53 146.13 10.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.84 169.49 17.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.148 0.499 . . . . 0.0 110.854 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.47 128.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -79.9 -58.59 3.1 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 43.5 tt0 -175.82 145.04 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.03 0.932 . . . . 0.0 108.913 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.91 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.45 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 53.5 mtt180 -135.79 139.67 43.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.09 144.07 36.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.41 -145.69 6.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -136.37 137.68 40.81 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -99.1 139.69 34.38 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.728 0.299 . . . . 0.0 110.197 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.315 -0.916 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.999 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.6 133.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 20.3 m -60.0 124.6 20.72 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.546 0.529 . . . . 0.0 109.904 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.45 HG22 ' HG3' ' B' ' 42' ' ' ARG . 33.5 p -132.22 144.69 50.81 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.249 -176.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.8 tt -134.04 140.44 46.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.548 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' B' ' 40' ' ' LYS . 45.0 mt-10 -120.28 115.18 23.07 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.273 0.629 . . . . 0.0 109.611 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.37 115.98 51.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.15 128.26 54.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -132.75 159.98 42.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' B' ' 35' ' ' SER . 59.2 ttp180 -141.22 146.29 36.7 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.977 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 12.7 tmtt? -91.34 141.81 28.37 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.488 ' OXT' ' HB3' ' B' ' 64' ' ' LYS . 98.1 mttt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 121.304 0.573 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.25 122.24 68.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.6 156.55 14.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.073 0.463 . . . . 0.0 111.441 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.45 133.5 55.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.4 112.52 21.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.74 -155.71 13.24 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.68 26.27 0.18 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.92 150.56 36.96 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.75 150.58 81.97 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.939 2.426 . . . . 0.0 112.852 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.49 HG21 ' OD1' ' A' ' 51' ' ' ASP . 10.5 p -57.92 -38.31 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.55 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.401 ' O ' HD13 ' A' ' 24' ' ' LEU . 23.2 ptp -59.98 -27.34 66.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.936 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.85 -32.44 72.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 110.123 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -80.07 -35.85 36.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.658 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 60.3 t -59.11 -52.69 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.811 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 20' ' ' MET . 8.7 mp -65.85 -31.74 72.87 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.031 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.16 -44.79 87.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.19 -41.93 99.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 88.8 mt -61.15 -35.6 77.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.144 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.6 m -69.81 -36.71 75.86 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.526 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.2 mt -68.2 -33.36 74.29 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.3 mt -59.4 -39.88 84.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.602 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.91 -27.88 66.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.95 -6.15 56.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.59 14.71 34.11 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 121.049 -0.595 . . . . 0.0 112.866 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.47 96.13 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 122.153 -0.616 . . . . 0.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 p -88.43 -8.15 55.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -131.35 112.86 13.1 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.476 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -123.42 144.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.293 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.5 123.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.544 0.528 . . . . 0.0 110.62 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.04 121.81 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -116.57 127.48 54.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.368 0.604 . . . . 0.0 110.917 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -118.7 157.74 26.87 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.565 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -127.07 146.75 50.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.762 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.7 -116.81 9.69 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.287 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -99.45 4.21 46.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 110.789 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.36 50.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.92 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.8 mt -54.28 -40.05 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.725 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.3 t -64.75 -21.72 66.82 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.596 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -87.88 -29.97 20.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.51 84.83 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.093 0.473 . . . . 0.0 110.402 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -72.94 -33.23 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.0 t70 -64.21 -48.73 74.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -55.95 -50.34 71.04 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.924 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -68.15 -31.01 49.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.903 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 31.5 tt0 -68.19 -37.81 81.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.924 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 51' ' ' ASP . 79.5 mt -58.59 -43.4 87.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.429 0.456 . . . . 0.0 111.047 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.35 -43.75 80.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -79.36 8.79 5.53 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -135.21 7.06 3.36 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -117.53 -68.6 0.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.258 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HB3' HD22 ' A' ' 61' ' ' LEU . 87.4 m-85 -79.46 -69.34 0.59 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 2.5 mm? -122.62 102.61 8.16 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.34 -24.49 27.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.985 0.803 . . . . 0.0 111.214 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -96.97 -45.97 6.39 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.461 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.65 81.17 8.74 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.722 0.773 . . . . 0.0 111.636 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.5 134.52 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.095 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -114.01 141.82 46.94 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.74 126.58 48.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -82.21 -68.78 0.67 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.722 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -159.39 140.41 12.67 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -128.14 115.82 40.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -119.34 134.25 55.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.12 128.25 25.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.45 . . . . 0.0 110.099 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.32 -147.14 5.65 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.932 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -109.34 133.56 52.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -116.58 125.46 51.87 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.813 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 . . . . . 0 CA--C 1.5 -0.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.7 t -119.35 134.04 64.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 p -67.28 123.37 20.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 123.703 0.627 . . . . 0.0 109.46 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 p -127.67 152.6 47.48 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.861 0.363 . . . . 0.0 111.366 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.7 tt -139.17 135.19 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.644 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.44 114.34 22.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.97 115.75 50.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.95 55.18 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.48 158.27 34.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.334 0.587 . . . . 0.0 111.629 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -112.77 114.88 27.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.647 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.583 ' NZ ' ' HB2' ' A' ' 61' ' ' LEU . 13.6 mmmt . . . . . 0 C--N 1.286 -2.154 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.576 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 . . . . . 0 CA--C 1.517 -0.323 0 CA-C-O 121.393 0.616 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.47 122.72 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.33 163.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 120.818 0.342 . . . . 0.0 111.012 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 tp -124.19 134.34 53.31 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.93 113.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.074 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.65 -157.62 12.48 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.543 ' H ' ' HD3' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -76.63 26.29 0.13 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.42 148.56 35.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.71 152.3 64.07 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.811 2.341 . . . . 0.0 113.193 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.606 HG21 ' OD2' ' B' ' 51' ' ' ASP . 8.9 p -58.33 -39.86 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.414 ' O ' HD13 ' B' ' 24' ' ' LEU . 22.9 ptp -58.18 -25.64 61.78 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.221 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.9 -32.33 70.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 109.932 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -81.17 -37.04 29.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.485 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 51.9 t -58.81 -52.41 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 123.763 0.664 . . . . 0.0 110.374 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.414 HD13 ' O ' ' B' ' 20' ' ' MET . 8.4 mp -66.47 -30.15 70.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.738 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.449 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.34 -45.96 82.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.165 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.78 -41.23 99.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.558 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.9 mt -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.714 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -72.87 -32.98 65.8 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.295 0.569 . . . . 0.0 110.221 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 94.0 mt -70.72 -32.42 69.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 90.3 mt -60.08 -39.82 87.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.584 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -69.01 -24.39 64.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.616 0.722 . . . . 0.0 110.779 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -83.62 -3.3 57.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.43 12.45 51.21 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.145 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -91.05 95.88 5.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.5 p -89.09 -5.83 57.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.711 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.88 116.15 16.13 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.438 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -127.06 144.32 37.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.689 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.33 121.64 68.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.14 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -107.14 121.89 60.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.3 132.29 56.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.075 0.465 . . . . 0.0 110.174 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.85 159.16 28.74 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.761 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -129.89 143.55 50.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.737 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.13 -117.64 8.71 Favored Glycine 0 CA--C 1.497 -1.065 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.166 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -99.02 0.95 44.87 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.266 0.555 . . . . 0.0 110.176 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.75 -7.09 52.28 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.985 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.34 -40.38 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 110.802 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.39 -28.08 69.74 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.388 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -82.17 -29.7 31.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.73 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.14 -45.28 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.35 -33.59 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.086 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.606 ' OD2' HG21 ' B' ' 19' ' ' VAL . 35.4 t70 -62.4 -46.61 87.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.894 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -58.85 -51.03 71.76 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.907 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.75 -30.63 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.925 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 33.4 tt0 -68.91 -35.49 76.9 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.742 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.455 HG13 ' O ' ' B' ' 51' ' ' ASP . 79.6 mt -61.23 -43.18 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.741 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 67.4 t -68.46 -43.67 83.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.998 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 28.7 ptt180 -79.02 8.72 5.21 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.576 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -131.84 -3.51 3.64 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.395 0.617 . . . . 0.0 111.17 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.74 -64.75 1.2 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.745 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' B' ' 61' ' ' LEU . 90.1 m-85 -80.56 -74.63 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.595 ' HB2' ' NZ ' ' B' ' 96' ' ' LYS . 2.4 mm? -119.57 103.2 9.21 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -84.7 -31.93 23.81 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 124.186 0.929 . . . . 0.0 110.809 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.91 -41.17 12.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.266 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -91.62 80.38 5.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.389 0.614 . . . . 0.0 111.814 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -161.24 136.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.693 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.48 ' OE1' ' HD2' ' B' ' 97' ' ' LYS . 47.1 mt-10 -116.75 143.29 45.84 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 125.16 50.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -81.69 -66.93 0.83 Allowed 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 123.274 0.359 . . . . 0.0 110.839 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -161.32 139.67 9.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.43 117.03 45.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -120.01 132.0 55.33 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.96 129.34 44.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.65 -148.39 6.61 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.076 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -106.72 133.54 51.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -118.82 125.75 50.27 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.865 179.063 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.44 135.83 57.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.8 p -69.88 124.72 24.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 50.8 p -128.59 152.86 47.84 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.893 0.377 . . . . 0.0 111.162 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 tt -139.6 136.74 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.04 112.13 18.76 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.775 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.84 117.61 55.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.49 128.1 54.65 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.4 pt -126.23 151.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 111.999 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -105.9 115.33 30.04 Favored 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.924 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.595 ' NZ ' ' HB2' ' B' ' 61' ' ' LEU . 13.8 mmmt -90.43 131.53 36.14 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.999 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HD2' ' OE1' ' B' ' 66' ' ' GLU . 28.4 mtpp . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 60.8 t -105.38 114.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.4 147.46 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 120.911 0.386 . . . . 0.0 111.074 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.11 122.72 45.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -88.25 105.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.573 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.17 58.91 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.128 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -163.06 -56.26 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.252 0.549 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -101.05 166.04 13.12 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.601 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -71.31 163.0 40.6 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.993 1.796 . . . . 0.0 111.303 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.29 -41.4 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -62.86 -24.88 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -73.32 -38.17 65.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -72.33 -33.24 67.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.143 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.07 -47.53 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.129 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.64 -31.75 71.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.942 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -71.72 -41.93 67.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.202 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -70.63 -34.29 71.92 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.68 -51.63 68.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.049 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.534 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 10.0 t -67.77 -35.56 78.92 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.7 mt -62.23 -34.15 75.94 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.8 mt -64.65 -23.9 67.41 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.851 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -100.31 -14.0 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 28' ' ' THR . 78.6 mt-30 -79.44 -20.22 48.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.838 0.351 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.48 -4.72 7.15 Favored Glycine 0 CA--C 1.492 -1.345 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.092 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -86.29 96.0 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.0 m -67.75 -30.43 69.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.501 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.62 126.34 20.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.737 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -121.77 161.14 22.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.933 -176.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -124.21 121.66 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.1 mt -104.84 125.26 59.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 66.0 mttm -119.83 120.08 35.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.294 0.568 . . . . 0.0 110.524 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -116.28 155.51 28.25 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.027 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -131.63 141.47 49.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.232 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.46 -126.91 9.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.548 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -81.98 -10.96 59.09 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.57 35.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.182 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -55.6 -38.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 121.26 0.552 . . . . 0.0 109.61 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.7 p -71.48 -13.77 61.92 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.251 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -95.06 -26.52 16.01 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.6 0.36 . . . . 0.0 110.09 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -69.8 -46.07 66.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 110.766 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.67 -36.26 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 55' ' ' ILE . 45.5 t0 -59.92 -52.2 66.44 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.711 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.9 m -54.19 -52.01 62.56 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.56 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.405 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 23.7 m -69.3 -33.72 59.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 24.9 tt0 -72.05 -26.17 62.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.408 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.2 mt -70.09 -46.62 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.733 174.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.22 -48.97 85.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.77 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 38.9 ptt180 -78.29 37.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.518 0.675 . . . . 0.0 110.034 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.54 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 9.6 t30 -153.14 -51.04 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.8 ptm180 -76.69 -11.48 59.85 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -142.94 -60.74 0.43 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.494 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD13 ' HB ' ' A' ' 65' ' ' ILE 0.297 0.6 OUTLIER -110.91 88.97 2.91 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.984 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.99 23.79 10.23 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.884 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -143.01 -69.42 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.795 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -86.52 75.16 9.78 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.619 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.5 tp -161.79 137.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.92 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 9.6 pt-20 -130.37 167.52 18.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.099 0.476 . . . . 0.0 111.235 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.6 mt -104.87 139.54 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 50.9 tptt -80.92 -59.81 2.53 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -177.49 159.93 1.57 Allowed 'General case' 0 C--O 1.25 1.13 0 C-N-CA 124.869 1.267 . . . . 0.0 107.604 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.62 119.16 45.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -125.11 133.81 52.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.29 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.69 132.63 67.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.97 163.38 33.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.088 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.417 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 52.5 p -90.49 126.32 35.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.564 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -81.7 113.91 20.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 86' ' ' ARG . 24.3 t . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG2' HG22 ' A' ' 76' ' ' VAL . 50.1 mtm180 . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.4 t -133.42 123.78 47.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -59.51 127.98 34.76 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 120.935 0.398 . . . . 0.0 111.058 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.9 p -133.48 162.17 32.6 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 17.7 tt -137.7 142.76 35.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.773 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -120.25 108.54 14.32 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.046 0.939 . . . . 0.0 108.711 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -118.77 129.48 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . . . -131.24 130.35 42.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.8 pt -121.62 153.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.427 ' HD3' ' OE2' ' A' ' 66' ' ' GLU . 35.3 ttt180 -129.99 140.1 50.95 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.247 0.546 . . . . 0.0 112.07 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm . . . . . 0 C--N 1.321 -0.656 0 C-N-CA 124.566 1.146 . . . . 0.0 110.324 175.02 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 61.1 t -109.22 112.56 41.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.0 147.63 12.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.111 0.481 . . . . 0.0 111.272 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 tp -105.73 122.37 45.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.6 mm -88.85 104.59 15.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.01 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.58 59.19 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.793 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -165.02 -57.07 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.331 0.586 . . . . 0.0 110.429 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -100.75 165.59 14.02 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.132 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.08 162.4 42.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.24 1.96 . . . . 0.0 111.313 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.07 -42.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -61.21 -25.08 66.8 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.68 -37.25 65.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.66 -32.88 64.22 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.167 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.76 -48.67 86.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.923 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.94 -30.34 70.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.204 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.577 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -72.65 -43.46 63.16 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -68.68 -32.72 72.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.42 -52.51 65.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.139 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' B' ' 32' ' ' GLN . 10.1 t -65.69 -38.22 88.63 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.656 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -60.29 -36.56 78.16 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 92.5 mt -63.74 -23.82 67.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.031 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -100.14 -15.45 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' B' ' 28' ' ' THR . 79.7 mt-30 -78.14 -27.48 48.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.819 0.342 . . . . 0.0 110.766 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.35 -6.88 3.98 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.466 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.47 97.18 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -67.16 -31.98 72.77 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.456 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -140.37 125.85 18.99 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.072 0.463 . . . . 0.0 111.489 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.538 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -121.83 158.68 25.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.309 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.94 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 48.9 t -121.5 122.38 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.507 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -104.83 125.32 59.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.738 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 67.6 mttm -119.57 120.33 36.41 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -116.39 155.28 28.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.594 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -130.42 140.38 50.57 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.913 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.86 -129.44 10.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.703 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -82.34 -9.33 59.51 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.105 0.479 . . . . 0.0 110.156 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.1 -5.55 36.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.013 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.4 mt -54.26 -40.73 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.48 0.657 . . . . 0.0 109.997 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 75.4 p -67.08 -23.4 65.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.169 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -85.39 -28.45 25.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.281 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -67.74 -45.32 75.33 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.77 -37.23 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.005 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.57 ' O ' HG13 ' B' ' 55' ' ' ILE . 44.0 t0 -56.94 -52.89 63.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.576 0.75 . . . . 0.0 109.202 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.2 m -54.7 -52.16 63.29 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.854 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.445 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.2 m -70.29 -32.97 52.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.104 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 24.3 tt0 -71.37 -26.38 62.77 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.973 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.6 mt -70.13 -46.39 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.879 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.14 -49.81 82.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.827 0.346 . . . . 0.0 110.898 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 39.3 ptt180 -77.48 36.73 0.2 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-O 121.449 0.642 . . . . 0.0 110.032 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . 0.414 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 7.9 t30 -152.1 -52.18 0.12 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 123.092 0.557 . . . . 0.0 110.496 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.2 ptm180 -74.4 -14.84 60.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -139.74 -64.78 0.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.321 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.425 HD13 ' HB ' ' B' ' 65' ' ' ILE 0.278 0.5 OUTLIER -107.88 93.98 4.83 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -177.565 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.69 13.36 35.12 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.693 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.94 -69.25 0.54 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.803 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -83.23 75.73 9.93 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.655 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.425 ' HB ' HD13 ' B' ' 61' ' ' LEU . 8.0 tp -161.71 143.32 3.53 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 C-N-CA 124.198 0.999 . . . . 0.0 108.768 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' B' ' 95' ' ' ARG . 10.2 pt-20 -137.93 164.16 29.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.907 0.384 . . . . 0.0 111.6 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.38 138.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' B' ' 93' ' ' ALA . 52.3 tptt -81.55 -60.54 2.22 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -175.82 160.39 2.38 Favored 'General case' 0 C--O 1.262 1.744 0 C-N-CA 124.795 1.238 . . . . 0.0 107.903 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.7 mt -131.48 119.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -125.88 135.02 51.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.677 0.275 . . . . 0.0 110.354 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.55 131.54 73.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.4 165.83 35.65 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.75 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.503 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 37.0 p -89.75 127.27 35.93 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.798 0.332 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -81.35 114.08 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' B' ' 86' ' ' ARG . 25.8 t . . . . . 0 C--N 1.3 -1.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.54 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 34.6 mtm180 . . . . . 0 CA--C 1.502 -0.896 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.39 123.13 46.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 m -58.41 127.51 32.5 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.33 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 36.4 p -134.18 159.33 41.21 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 123.595 0.758 . . . . 0.0 109.764 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 16.3 tt -134.42 142.09 41.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -120.61 106.61 11.92 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 123.915 0.886 . . . . 0.0 108.668 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.37 130.2 71.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 68' ' ' LYS . . . -129.87 132.02 46.28 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -123.49 149.04 27.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.248 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.416 ' HB3' ' HG3' ' B' ' 66' ' ' GLU . 41.7 ttt180 -125.39 144.24 50.6 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.575 -174.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -84.1 -170.11 2.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.063 1.345 . . . . 0.0 110.24 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 97' ' ' LYS . 21.3 pttp . . . . . 0 C--O 1.261 1.679 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.233 0.54 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 59.7 t -105.08 123.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.085 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -120.25 142.83 34.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.683 0.278 . . . . 0.0 110.825 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 131.8 47.3 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.786 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.426 HG21 ' HB2' ' A' ' 48' ' ' LYS . 44.7 mm -93.75 111.68 25.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.878 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.66 28.97 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.03 -1.557 . . . . 0.0 114.622 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.56 -50.01 0.41 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.791 0.795 . . . . 0.0 112.155 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -100.93 160.64 26.14 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.59 159.68 35.58 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 121.741 1.627 . . . . 0.0 110.893 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.507 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.5 p -55.66 -38.54 50.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.0 ptm -61.05 -26.08 67.38 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.999 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.41 -43.34 77.41 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -70.95 -35.07 72.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.595 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 19' ' ' VAL . 59.2 t -60.34 -51.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.647 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.8 mt -65.91 -33.81 76.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.844 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -64.94 -45.52 85.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.227 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.99 95.53 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.427 0.454 . . . . 0.0 110.481 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.67 -35.11 78.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.427 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 m -73.89 -43.6 57.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.735 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 94.1 mt -64.47 -34.39 78.09 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.147 0.499 . . . . 0.0 110.587 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -58.73 -44.73 90.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.348 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.26 -22.38 63.84 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.94 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -82.0 -2.29 51.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.076 0.465 . . . . 0.0 110.9 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.58 -8.89 32.48 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 t -92.07 92.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.568 ' HA ' HD22 ' A' ' 30' ' ' LEU . 57.4 p -95.78 -9.92 30.43 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.199 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.24 104.99 10.52 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -127.15 157.67 38.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.151 -175.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.3 t -124.21 116.98 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.194 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.85 121.6 48.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 85.7 mttt -118.14 120.99 39.4 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.269 0.556 . . . . 0.0 110.378 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -115.65 156.45 25.85 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.951 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HG2' HG22 ' A' ' 89' ' ' THR . 88.3 mtt180 -130.91 143.15 50.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.19 -119.6 11.99 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.515 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -85.73 -8.7 58.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.439 0.638 . . . . 0.0 110.433 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.42 -4.53 42.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.166 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -56.01 -36.71 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.564 0.697 . . . . 0.0 109.912 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.3 p -64.64 -31.51 72.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.576 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HB2' HG21 ' A' ' 14' ' ' ILE . 28.5 mtpp -78.85 -31.44 45.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.502 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -65.77 -46.82 77.33 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.414 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -72.08 -33.87 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.873 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' OD2' HG21 ' A' ' 19' ' ' VAL . 31.3 t70 -60.24 -47.47 85.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.9 m -53.3 -53.7 47.12 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.414 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.18 -30.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.61 -39.8 88.54 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 51' ' ' ASP . 89.0 mt -59.97 -45.55 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.25 -40.44 86.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.093 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -83.55 15.77 2.95 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.31 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -136.72 12.66 3.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.847 0.832 . . . . 0.0 109.255 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.07 -49.04 0.28 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.147 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.46 ' CD2' HD23 ' A' ' 61' ' ' LEU . 56.2 t80 -90.24 -70.36 0.67 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.955 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.46 HD23 ' CD2' ' A' ' 60' ' ' PHE . 4.1 mm? -129.43 110.38 11.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.128 0.489 . . . . 0.0 111.316 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.7 12.57 36.25 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.943 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -126.04 -64.09 1.07 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.415 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 98.2 mttt -78.76 102.08 7.93 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.686 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tp -160.66 126.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.83 0.452 . . . . 0.0 110.329 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.517 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 41.0 tt0 -119.19 130.64 55.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.3 mt -95.21 128.06 46.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.65 -62.07 1.57 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.258 0.349 . . . . 0.0 111.239 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 10.0 tp10 -162.59 141.71 9.05 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.95 107.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.208 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.495 ' HE ' ' CD ' ' A' ' 69' ' ' GLU . 91.0 mtt180 -131.18 144.91 51.7 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.519 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.02 132.51 66.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.24 -174.42 22.81 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.122 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -124.78 128.46 48.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -106.84 138.84 42.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.313 -0.99 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.7 120.91 60.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.4 t -63.5 128.19 34.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.602 HG22 ' HG2' ' A' ' 42' ' ' ARG . 61.5 p -120.76 134.35 55.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.424 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -123.12 128.39 75.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -107.65 110.77 22.72 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -103.98 106.78 20.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.76 40.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.901 0.381 . . . . 0.0 110.432 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.11 151.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.364 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HD3' ' OE1' ' A' ' 66' ' ' GLU . 75.3 ttt180 -121.85 119.29 31.19 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.493 0.663 . . . . 0.0 110.255 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HE3' ' O ' ' A' ' 64' ' ' LYS . 8.3 mmmm . . . . . 0 C--N 1.284 -2.265 0 CA-C-O 121.392 0.615 . . . . 0.0 112.403 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.898 0.38 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.16 124.56 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.813 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.83 141.08 42.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.019 0.438 . . . . 0.0 111.581 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.24 129.62 46.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.874 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.09 111.36 24.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.469 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.76 28.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 119.105 -1.521 . . . . 0.0 114.911 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.97 -48.72 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.265 0.533 . . . . 0.0 111.661 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -101.55 160.9 25.2 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.61 162.3 21.7 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.981 1.787 . . . . 0.0 111.728 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.426 ' O ' HG23 ' B' ' 23' ' ' VAL . 7.2 p -58.71 -38.46 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.576 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 25.7 ptm -62.61 -26.24 68.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.639 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -66.69 -46.76 74.56 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -67.21 -34.29 77.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.835 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 19' ' ' VAL . 58.3 t -61.21 -50.51 80.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.618 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 20' ' ' MET . 86.3 mt -67.32 -36.03 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.641 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.428 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.01 -44.56 95.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.336 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.49 98.77 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.371 0.419 . . . . 0.0 110.499 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.8 -36.17 82.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.571 . . . . 0.0 111.049 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 59.7 m -72.51 -45.06 61.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.659 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 93.6 mt -64.06 -33.67 76.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.298 0.571 . . . . 0.0 110.262 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' B' ' 35' ' ' SER . 0.2 OUTLIER -58.41 -46.66 86.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.375 -177.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -68.28 -21.85 64.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.352 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.68 -4.25 55.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.34 -3.92 29.72 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.906 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -95.93 91.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.395 0.616 . . . . 0.0 109.516 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . 0.508 ' HA ' HD22 ' B' ' 30' ' ' LEU . 58.3 p -94.78 -8.61 37.04 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.346 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.82 104.98 9.63 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.515 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -125.29 159.11 32.95 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.981 -173.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.7 117.12 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.198 0.523 . . . . 0.0 110.147 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -97.83 121.08 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.4 mttt -118.12 119.97 36.32 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.391 0.615 . . . . 0.0 110.178 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -115.2 156.56 25.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.667 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.563 ' HG2' HG22 ' B' ' 89' ' ' THR . 92.3 mtt180 -130.73 144.51 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.593 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.28 -123.44 23.3 Favored Glycine 0 C--O 1.215 -1.09 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.232 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -81.18 -12.77 59.11 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.224 0.535 . . . . 0.0 110.915 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.83 -3.47 28.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -55.15 -37.92 44.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.46 0.648 . . . . 0.0 109.793 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.4 p -64.69 -31.68 73.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.836 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -79.12 -29.73 43.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -65.33 -48.32 73.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 120.78 0.324 . . . . 0.0 110.957 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.98 -34.6 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.514 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.3 t70 -58.49 -48.65 80.09 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -52.46 -53.43 45.69 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.378 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -31.17 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.98 -39.43 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 51' ' ' ASP . 89.8 mt -59.33 -47.69 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.722 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -59.31 -39.4 78.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 CA-C-O 121.123 0.487 . . . . 0.0 110.863 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -84.86 17.12 2.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -141.65 18.47 2.18 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -150.26 -46.44 0.13 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.078 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.48 ' O ' HD22 ' B' ' 61' ' ' LEU . 62.7 t80 -92.37 -68.13 0.82 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.852 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.48 HD22 ' O ' ' B' ' 60' ' ' PHE . 3.9 mm? -132.49 111.84 11.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.805 0.336 . . . . 0.0 111.014 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.79 13.96 31.93 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.534 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -127.53 -64.7 0.97 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.088 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.536 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 98.4 mttt -74.91 99.67 3.88 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.903 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.8 tp -160.34 128.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.506 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 38.2 tt0 -122.64 129.65 52.09 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -94.44 127.21 46.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . 0.422 ' HD3' ' HB1' ' B' ' 93' ' ' ALA . 49.2 tttp -87.73 -63.07 1.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.556 0.535 . . . . 0.0 111.188 -175.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 10.5 tp10 -161.63 140.41 9.65 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 pt -143.31 110.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.284 0.564 . . . . 0.0 110.73 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 92.9 mtt180 -133.57 145.62 50.24 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.726 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.29 128.81 75.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.27 -173.52 19.24 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.557 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 126.07 43.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -105.46 139.01 40.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.311 -1.094 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 66.6 t -129.3 117.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -64.02 131.23 46.98 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.563 HG22 ' HG2' ' B' ' 42' ' ' ARG . 59.9 p -123.22 133.73 54.19 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.559 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 16.1 tt -121.44 128.83 75.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.68 107.37 16.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.401 HD11 HD11 ' B' ' 90' ' ' ILE . 44.9 mm -102.79 107.02 21.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . 0.422 ' HB1' ' HD3' ' B' ' 68' ' ' LYS . . . -115.29 120.97 41.43 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.531 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -127.94 149.46 32.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.298 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.506 ' HD3' ' OE2' ' B' ' 66' ' ' GLU . 71.5 ttt180 -119.37 118.27 30.74 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.5 0.666 . . . . 0.0 110.349 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' B' ' 64' ' ' LYS . 7.6 mmmm -84.16 129.58 34.89 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.407 ' OXT' ' HB3' ' B' ' 64' ' ' LYS . 55.8 mtpt . . . . . 0 C--O 1.257 1.492 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.938 0.399 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.9 t -120.4 124.67 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.82 149.38 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.825 0.345 . . . . 0.0 111.189 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.81 123.57 48.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.774 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -89.54 99.36 9.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.43 52.35 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.452 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -166.68 -56.34 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.04 167.76 10.25 Favored Pre-proline 0 CA--C 1.555 1.166 0 O-C-N 122.393 -0.192 . . . . 0.0 111.027 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.33 153.66 61.38 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.162 1.908 . . . . 0.0 112.514 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.91 -40.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.497 1.119 . . . . 0.0 113.469 -177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.42 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.3 ptm -62.5 -25.83 68.22 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.709 0.804 . . . . 0.0 111.823 -175.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -84.05 -27.77 28.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.022 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -73.14 -37.64 66.55 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 89.2 t -57.57 -47.78 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.567 0.698 . . . . 0.0 109.547 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.6 mt -65.26 -36.31 83.71 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.076 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.791 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.87 87.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.605 0.241 . . . . 0.0 111.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 86.8 mt -66.49 -31.55 72.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.6 0.714 . . . . 0.0 110.296 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 91.2 m -74.18 -40.35 62.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.176 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 97.5 mt -62.27 -38.68 90.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.192 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.9 tp -57.17 -46.12 83.08 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.9 -23.63 66.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.762 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 28' ' ' THR . 83.3 mm-40 -81.35 -11.91 59.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.185 0.516 . . . . 0.0 110.355 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.7 24.36 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.539 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.97 93.96 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 121.397 0.617 . . . . 0.0 109.599 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 p -89.04 -21.31 23.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.61 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -108.04 105.52 15.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -121.08 149.65 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.691 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.9 120.78 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.272 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -103.17 122.82 56.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.463 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -115.42 124.55 51.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 111.331 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.69 143.26 47.85 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.351 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -129.81 127.15 39.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.631 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.89 -138.35 14.1 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.934 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -82.97 4.31 26.41 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.487 0.661 . . . . 0.0 110.869 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.99 -4.01 53.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.553 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.71 -43.49 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.119 0.568 . . . . 0.0 110.575 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -19.14 64.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -90.45 -32.8 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.63 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.71 -43.59 88.69 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.912 0.387 . . . . 0.0 111.719 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.08 -32.67 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.434 ' O ' HG13 ' A' ' 55' ' ' ILE . 23.9 t70 -65.82 -38.95 90.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.4 m -60.42 -51.33 69.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.078 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 35.9 m -66.17 -38.15 81.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.675 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mm-40 -59.72 -36.56 76.8 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.1 mt -66.88 -44.19 89.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 0.0 110.292 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.76 -38.75 82.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.725 0.298 . . . . 0.0 111.725 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.675 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 4.1 ptm180 -89.84 11.24 20.81 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.86 -30.71 3.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.268 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -93.78 -59.07 2.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.33 -55.24 12.74 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.964 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -160.0 108.35 1.71 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.57 -35.12 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 123.972 0.795 . . . . 0.0 112.745 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.05 -26.64 68.34 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' H ' HD12 ' A' ' 61' ' ' LEU . 35.0 mmtp -122.36 101.51 7.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.718 0.295 . . . . 0.0 110.765 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tp -156.94 146.7 11.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG2' HH21 ' A' ' 95' ' ' ARG . 7.8 tp10 -135.19 141.26 45.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.27 132.57 40.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -91.45 -48.11 7.06 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.937 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -173.83 145.87 1.18 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.45 97.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.678 0.751 . . . . 0.0 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -127.69 141.89 51.48 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.782 -0.574 . . . . 0.0 110.978 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.85 143.75 29.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.3 -165.69 21.95 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.674 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m -115.46 144.83 43.25 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 59.4 tt0 -101.67 131.17 48.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 86' ' ' ARG . 49.4 t . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.449 ' HG2' HG22 ' A' ' 76' ' ' VAL . 79.0 mtt180 . . . . . 0 CA--C 1.504 -0.791 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.19 138.78 52.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.9 t -75.24 136.41 40.95 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.7 p -136.14 145.22 45.59 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.4 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.45 138.91 53.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.364 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -115.42 111.69 21.19 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.74 110.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.88 124.13 50.93 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 pt -124.49 162.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 120.848 0.356 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.4 HH21 ' HG2' ' A' ' 66' ' ' GLU . 49.1 ttp180 -129.98 108.68 10.29 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? . . . . . 0 C--N 1.289 -2.022 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 -173.053 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 120.95 0.405 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.68 119.71 61.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.53 148.05 15.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.454 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.47 120.24 41.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.707 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.96 100.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.73 51.19 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.509 -1.329 . . . . 0.0 113.916 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -167.08 -55.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -100.14 168.47 9.38 Favored Pre-proline 0 CA--C 1.556 1.176 0 O-C-N 122.129 -0.357 . . . . 0.0 111.106 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.81 156.15 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.236 1.957 . . . . 0.0 112.302 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.81 -43.89 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.0 ptp -54.89 -32.85 61.4 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -77.73 -28.39 50.77 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.929 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.73 -37.95 64.94 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 79.7 t -57.68 -47.86 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.484 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.072 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.57 -43.54 89.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.2 -38.08 89.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.5 mt -65.89 -31.21 72.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.33 0.586 . . . . 0.0 110.358 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' B' ' 32' ' ' GLN . 64.4 m -74.88 -42.09 58.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.796 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.3 mt -60.86 -38.53 85.87 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.616 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 tp -57.18 -44.24 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.157 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.2 -16.22 62.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.827 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' B' ' 28' ' ' THR . 82.5 mm-40 -87.27 -7.82 57.44 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.306 0.574 . . . . 0.0 109.889 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.61 34.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.757 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.6 t -99.05 95.76 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.274 0.559 . . . . 0.0 109.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 12.8 p -90.49 -25.49 20.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.425 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -103.37 107.6 18.5 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.466 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -123.88 148.0 28.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 120.91 0.386 . . . . 0.0 110.743 -179.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.43 122.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.678 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.3 mt -105.39 120.22 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.997 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -113.55 123.33 49.73 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.362 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.31 147.39 42.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.426 ' NE ' HG11 ' B' ' 87' ' ' VAL . 3.0 tmt_? -133.09 129.48 38.03 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.116 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.77 -142.13 16.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.0 5.67 11.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.35 0.595 . . . . 0.0 110.81 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.25 -5.21 55.83 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.5 -44.38 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.407 0.683 . . . . 0.0 110.81 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.0 t -59.82 -32.64 70.84 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.049 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -76.8 -34.24 57.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.753 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -45.61 83.22 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 120.803 0.335 . . . . 0.0 111.768 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.51 -35.88 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.424 ' O ' HG13 ' B' ' 55' ' ' ILE . 29.8 t70 -62.59 -41.57 99.04 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 91.5 m -57.03 -50.04 73.94 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.903 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 35.4 m -67.09 -38.42 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.659 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 17.0 mm-40 -59.72 -38.91 82.97 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.5 mt -64.36 -45.02 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.25 -37.02 77.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 120.96 0.409 . . . . 0.0 111.792 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.659 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 4.5 ptm180 -91.48 11.63 23.4 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -126.13 -29.52 3.03 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.096 0.474 . . . . 0.0 110.968 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -93.86 -58.28 2.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -68.69 -58.39 4.3 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.47 HD12 ' H ' ' B' ' 64' ' ' LYS . 0.2 OUTLIER -157.95 109.58 2.27 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.34 -42.13 12.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 124.423 1.077 . . . . 0.0 112.63 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.1 -34.25 68.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 0.0 112.585 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.47 ' H ' HD12 ' B' ' 61' ' ' LEU . 35.1 mmtp -118.05 101.11 7.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.168 0.509 . . . . 0.0 110.966 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.04 146.31 13.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.467 ' HG2' HH21 ' B' ' 95' ' ' ARG . 9.0 tp10 -132.17 143.8 50.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.86 129.74 50.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -90.57 -47.9 7.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -172.55 147.03 1.8 Allowed 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.751 0.657 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.01 94.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.443 0.697 . . . . 0.0 110.54 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -127.56 141.17 51.71 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.311 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.87 144.48 24.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.27 -175.32 35.81 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.618 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 45.8 m -107.08 143.91 34.52 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.391 0.615 . . . . 0.0 112.266 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 61.1 tt0 -99.71 132.56 44.97 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' B' ' 86' ' ' ARG . 47.0 t . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.446 ' HG2' HG22 ' B' ' 76' ' ' VAL . 83.2 mtt180 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.426 HG11 ' NE ' ' B' ' 42' ' ' ARG . 96.0 t -126.99 137.42 57.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -74.48 135.49 42.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.571 . . . . 0.0 110.701 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 35.3 p -136.96 146.11 45.0 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.51 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.83 137.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.235 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -113.53 111.33 21.71 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 57.5 mt -110.55 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.93 123.75 50.52 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.802 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.0 pt -124.59 162.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.237 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.467 HH21 ' HG2' ' B' ' 66' ' ' GLU . 47.5 ttp180 -128.84 107.33 9.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 7.0 tmtm? -84.57 131.75 34.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.936 -174.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.57 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 34.7 mmtp . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.17 0.509 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.5 t -122.53 111.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.38 146.62 10.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.941 0.4 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 tp -112.2 124.17 51.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 51.0 mt -88.3 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 O-C-N 123.186 0.303 . . . . 0.0 110.865 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.27 -94.42 0.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.661 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -103.42 6.97 38.02 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -98.25 145.43 29.82 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.636 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.93 151.35 82.34 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.52 2.147 . . . . 0.0 112.503 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.43 HG23 ' OG1' ' A' ' 52' ' ' THR . 7.0 p -52.83 -41.4 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -58.85 -28.81 66.44 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.27 -39.0 86.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 93.2 m-85 -75.03 -37.6 61.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 69.4 t -60.85 -54.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.329 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.84 -32.54 73.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.97 -47.24 72.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.502 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.78 99.54 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 123.485 0.491 . . . . 0.0 111.064 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 88.0 mt -62.41 -34.74 77.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.021 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.7 m -73.96 -34.19 64.16 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.394 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 84.6 mt -67.26 -32.25 73.13 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-O 120.838 0.351 . . . . 0.0 110.909 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.49 -30.01 71.05 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.328 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -84.28 -4.89 59.14 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.985 0.898 . . . . 0.0 109.805 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -101.72 -19.83 15.22 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.593 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.08 11.29 10.07 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.693 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.61 94.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.626 0.713 . . . . 0.0 109.358 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -71.1 -41.09 71.04 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.464 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.42 124.06 50.21 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.54 0.686 . . . . 0.0 111.857 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -128.69 156.84 41.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.523 -177.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -120.29 128.41 75.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.3 mt -108.72 120.16 59.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.66 133.93 54.44 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.323 0.582 . . . . 0.0 110.122 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.6 162.63 31.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.435 ' HE ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -150.86 149.97 30.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.14 -130.29 11.27 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -88.9 1.06 55.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.678 0.751 . . . . 0.0 109.776 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.61 -6.25 58.82 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.432 HG23 HG21 ' A' ' 90' ' ' ILE . 75.6 mt -53.97 -37.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.232 0.539 . . . . 0.0 110.442 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.3 t -61.99 -30.46 70.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -83.01 -21.95 33.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.122 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.46 -47.02 65.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.832 0.348 . . . . 0.0 110.263 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.511 ' HA ' HG22 ' A' ' 53' ' ' VAL . 9.9 p -69.83 -32.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.164 0.506 . . . . 0.0 109.796 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.416 ' OD2' HG21 ' A' ' 19' ' ' VAL . 36.4 t70 -61.72 -44.06 97.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.083 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 19' ' ' VAL . 85.6 m -63.85 -48.06 78.25 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.268 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 50' ' ' VAL . 33.5 m -69.39 -33.81 59.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.72 -43.62 96.01 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.181 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.9 mt -56.68 -46.78 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.65 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.0 -43.87 98.19 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.895 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -83.95 10.22 10.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.133 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -125.1 -16.93 5.89 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.48 0.657 . . . . 0.0 111.142 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -105.82 -47.48 3.87 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.19 -67.5 0.83 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.901 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 3.4 mm? -130.98 104.5 7.16 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 120.979 0.419 . . . . 0.0 110.43 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.98 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.091 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.98 -36.68 59.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.176 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -123.15 89.05 3.04 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.633 0.73 . . . . 0.0 110.54 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.14 131.32 10.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.995 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.21 146.15 51.18 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.29 135.6 35.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -85.45 -57.92 2.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.067 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -168.93 151.4 4.87 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.43 116.9 26.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -126.68 146.24 50.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -147.43 137.53 16.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.1 -157.42 13.92 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.655 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.6 m -113.46 128.51 56.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.03 141.52 45.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.308 -1.234 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.18 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.435 HG11 ' HE ' ' A' ' 42' ' ' ARG . 45.8 t -132.42 140.5 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 p -71.02 119.9 15.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 123.62 0.575 . . . . 0.0 110.54 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.5 p -116.53 154.11 30.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.948 0.499 . . . . 0.0 109.881 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.432 HG21 HG23 ' A' ' 46' ' ' ILE . 16.9 tt -143.07 132.18 20.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 108.0 16.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.96 116.05 48.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.58 125.12 49.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.413 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.7 pt -122.46 152.22 26.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -122.42 109.29 14.2 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.362 0.601 . . . . 0.0 111.272 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HE2' ' HB2' ' A' ' 61' ' ' LEU . 4.3 mmmp? . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.235 0.54 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 53.3 t -118.1 111.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.75 148.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.827 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp -115.13 122.39 45.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.463 ' HA ' ' CZ ' ' B' ' 22' ' ' TYR . 55.3 mt -86.99 131.71 34.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.945 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.21 -97.41 0.25 Allowed Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.72 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -99.15 -0.11 42.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.119 0.485 . . . . 0.0 110.338 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.01 145.91 32.63 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.655 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.98 154.65 73.13 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.906 2.404 . . . . 0.0 112.21 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.413 HG23 ' OG1' ' B' ' 52' ' ' THR . 7.2 p -56.16 -40.91 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.546 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.12 -30.1 67.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -63.87 -39.19 93.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.709 0.766 . . . . 0.0 109.706 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . 0.463 ' CZ ' ' HA ' ' B' ' 14' ' ' ILE . 92.8 m-85 -76.89 -37.85 54.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.676 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 65.4 t -60.65 -52.89 56.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.71 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.52 -33.62 75.99 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.219 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -64.91 -47.42 77.83 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.576 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.34 96.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.35 -34.48 76.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 111.313 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 73.4 m -73.53 -34.38 65.19 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.523 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.1 mt -67.19 -31.0 71.1 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.921 0.391 . . . . 0.0 111.268 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.21 -26.26 67.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -86.89 -2.64 58.75 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.749 0.785 . . . . 0.0 109.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -105.29 -16.31 14.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.655 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.65 13.27 14.75 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.64 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.74 95.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 22.4 m -73.2 -38.95 65.92 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.136 0.575 . . . . 0.0 112.475 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.25 122.74 44.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.491 0.662 . . . . 0.0 111.623 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.494 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.27 156.88 40.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.85 -176.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 62.1 t -121.36 126.54 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.285 0.564 . . . . 0.0 110.247 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -108.26 121.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.04 135.09 54.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.208 0.528 . . . . 0.0 110.494 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.96 160.67 37.57 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.437 ' HE ' HG11 ' B' ' 87' ' ' VAL . 0.0 OUTLIER -149.53 147.65 28.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -126.04 7.21 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -93.98 1.95 56.17 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.735 0.779 . . . . 0.0 109.464 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.67 -6.33 59.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.521 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.404 HG23 HG21 ' B' ' 90' ' ' ILE . 71.4 mt -53.97 -36.86 32.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 CA-C-O 121.891 0.853 . . . . 0.0 109.732 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -63.95 -30.54 71.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.047 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -82.36 -25.27 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.715 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.53 80.59 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.924 0.392 . . . . 0.0 110.419 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' B' ' 53' ' ' VAL . 12.7 p -71.09 -33.29 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.567 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.429 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.8 t70 -59.51 -47.18 86.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.454 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.413 ' OG1' HG23 ' B' ' 19' ' ' VAL . 63.7 m -60.25 -48.42 81.83 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.4 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.441 HG22 ' HA ' ' B' ' 50' ' ' VAL . 33.4 m -70.26 -32.44 50.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.07 -41.79 94.75 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.982 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.429 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.4 mt -57.8 -48.59 83.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.816 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.02 -43.28 95.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.948 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' B' ' 53' ' ' VAL . 12.8 ptm180 -84.29 11.73 7.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.72 -15.29 4.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.17 0.509 . . . . 0.0 110.753 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -103.69 -52.38 2.99 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -85.8 -65.61 0.99 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.476 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.462 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 3.4 mm? -131.25 106.86 8.58 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 123.027 0.531 . . . . 0.0 110.692 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.92 -19.39 17.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.022 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.76 -33.32 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.763 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -124.38 89.74 3.13 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.01 137.65 19.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.008 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.52 143.2 41.53 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -100.85 138.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -87.21 -55.64 3.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.12 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -171.66 150.73 2.77 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.41 117.7 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -126.62 148.23 49.82 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.709 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -147.73 138.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.43 -155.27 10.17 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.8 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.6 m -118.86 124.93 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -107.45 144.88 33.75 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.282 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.437 HG11 ' HE ' ' B' ' 42' ' ' ARG . 48.0 t -135.77 136.84 49.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 19.1 p -68.4 120.89 15.22 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.734 0.646 . . . . 0.0 110.934 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 51.6 p -117.28 155.44 29.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.821 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.404 HG21 HG23 ' B' ' 46' ' ' ILE . 16.6 tt -143.87 132.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -116.21 105.76 12.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.9 mt -103.66 119.04 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.66 124.27 44.82 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.1 pt -121.25 151.99 24.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.62 108.89 14.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.979 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.462 ' HE2' ' HB2' ' B' ' 61' ' ' LEU . 4.1 mmmp? -80.38 133.99 35.97 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? . . . . . 0 C--N 1.283 -2.321 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 169.051 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.667 0.27 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.9 t -113.82 124.78 70.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.07 145.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.985 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.82 131.12 48.33 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.6 mm -95.97 120.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.047 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.64 50.48 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.911 -1.614 . . . . 0.0 114.185 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -155.57 -57.54 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.437 0.618 . . . . 0.0 110.748 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -101.99 163.9 16.85 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -59.49 158.7 26.32 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.242 1.962 . . . . 0.0 111.699 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.446 HG21 ' OD2' ' A' ' 51' ' ' ASP . 10.0 p -52.92 -31.33 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 124.301 1.041 . . . . 0.0 113.437 -175.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.429 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.5 ptm -57.11 -32.58 66.46 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.62 0.368 . . . . 0.0 111.788 -174.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -71.82 -38.24 70.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.098 0.475 . . . . 0.0 110.537 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -76.57 -36.26 57.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.246 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 19' ' ' VAL . 93.2 t -58.03 -53.51 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.089 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.7 mt -58.64 -36.27 73.83 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.398 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.29 96.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.396 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.03 -56.44 20.96 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.56 0.537 . . . . 0.0 111.949 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 27' ' ' LEU 0.342 0.0 OUTLIER -69.53 -19.07 63.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.496 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -72.01 -46.09 58.49 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.8 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.07 -41.18 86.85 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.227 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 96' ' ' LYS . 95.7 mt -55.31 -41.92 73.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.653 0.596 . . . . 0.0 111.509 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.02 5.33 52.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.983 0.42 . . . . 0.0 111.715 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -99.37 -30.14 12.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.82 0.343 . . . . 0.0 110.178 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.49 -15.03 1.09 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.57 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.7 100.53 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 23.2 p -79.49 -22.51 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.1 111.74 14.37 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.263 0.554 . . . . 0.0 110.274 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.55 161.16 19.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.035 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 45.3 t -128.86 125.77 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.469 . . . . 0.0 110.861 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.71 120.89 57.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -118.84 118.37 31.38 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.111 0.481 . . . . 0.0 110.683 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -109.96 148.12 32.2 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HG2' HG22 ' A' ' 89' ' ' THR . 70.9 mtp180 -122.51 143.78 49.5 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.343 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.74 -130.05 12.63 Favored Glycine 0 N--CA 1.44 -1.088 0 O-C-N 123.5 0.5 . . . . 0.0 112.948 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -90.46 5.7 46.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.629 0.728 . . . . 0.0 110.475 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.23 -3.15 54.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.243 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.451 HG23 HG21 ' A' ' 90' ' ' ILE . 69.7 mt -54.47 -37.21 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.786 0.834 . . . . 0.0 110.404 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.1 t -64.26 -26.95 68.73 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.056 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -83.24 -27.91 29.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.372 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -68.12 -43.98 77.17 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -71.33 -35.2 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.17 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.6 t70 -60.64 -47.21 87.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.934 0.772 . . . . 0.0 109.069 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -54.12 -56.25 19.92 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.9 -22.85 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.4 ' HG2' HH21 ' B' ' 86' ' ' ARG . 28.8 tt0 -74.84 -37.35 62.29 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.529 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.7 mt -61.86 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.709 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -55.14 -43.58 70.9 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.377 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 54.8 mtm180 -71.45 3.09 4.11 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.426 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 2.8 t-20 -137.47 16.4 2.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.956 0.884 . . . . 0.0 109.689 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -128.75 -63.77 0.96 Allowed 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.413 -176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -106.77 -36.87 6.56 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.296 -176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 95.7 mt -131.49 103.74 6.58 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.215 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.51 -73.87 0.61 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.34 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.26 6.91 40.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.075 0.465 . . . . 0.0 110.681 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.93 24.02 12.81 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.478 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.22 153.52 12.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -125.22 169.16 12.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.153 0.501 . . . . 0.0 111.085 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -109.1 135.97 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -86.79 -66.42 0.91 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.116 0.26 . . . . 0.0 110.782 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 71' ' ' ARG . 42.8 tt0 -162.71 145.54 10.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.4 mt -127.75 116.15 42.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.425 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 79.9 mtp180 -121.27 135.98 55.04 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.526 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.97 131.3 73.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.2 -163.81 11.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.115 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.2 p -131.41 111.42 11.81 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -87.61 131.35 34.45 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.132 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 C--N 1.313 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.455 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.514 HH21 ' HG2' ' B' ' 54' ' ' GLU . 39.0 mtm180 . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.72 117.26 50.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.1 m -61.19 127.45 31.59 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.771 0.67 . . . . 0.0 109.226 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 42' ' ' ARG . 24.5 p -127.97 151.8 48.68 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.002 0.43 . . . . 0.0 111.836 -176.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.451 HG21 HG23 ' A' ' 46' ' ' ILE . 15.5 tt -129.8 128.6 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.289 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.33 106.27 15.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -103.98 117.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.66 133.69 55.67 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.8 pt -138.87 151.33 23.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 35' ' ' SER . 12.9 ptp180 -130.66 158.4 40.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 123.496 0.498 . . . . 0.0 110.838 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.516 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 121.484 0.659 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 80.7 t -117.28 124.55 73.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -116.39 143.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 120.897 0.379 . . . . 0.0 110.862 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -100.37 128.99 46.3 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -94.56 119.78 43.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.224 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.89 45.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.391 -1.385 . . . . 0.0 114.213 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -150.56 -58.87 0.18 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.469 0.635 . . . . 0.0 110.432 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -101.45 164.35 16.12 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.511 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -59.99 156.35 39.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.27 1.98 . . . . 0.0 111.751 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.484 ' O ' HG23 ' B' ' 23' ' ' VAL . 8.3 p -50.6 -30.42 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.541 1.136 . . . . 0.0 113.827 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.457 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 24.9 ptm -58.65 -30.38 67.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.028 0.442 . . . . 0.0 111.958 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.78 -38.36 64.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.648 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -76.73 -34.8 58.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 19' ' ' VAL . 78.9 t -58.89 -54.24 36.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 CA-C-O 121.273 0.559 . . . . 0.0 110.122 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 20' ' ' MET . 94.8 mt -57.86 -38.7 76.18 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.02 98.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.276 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -56.7 18.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.049 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.566 HD13 ' H ' ' B' ' 27' ' ' LEU 0.361 0.0 OUTLIER -69.45 -19.46 63.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 118.454 -1.298 . . . . 0.0 114.087 -178.714 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.5 m -72.04 -45.92 58.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.127 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.87 -40.12 91.35 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.215 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' B' ' 96' ' ' LYS . 95.3 mt -57.16 -42.05 80.34 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.638 0.586 . . . . 0.0 111.888 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -92.64 1.83 57.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.898 0.38 . . . . 0.0 111.685 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -95.79 -37.04 10.93 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.002 0.429 . . . . 0.0 110.074 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.66 -18.58 0.29 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 119.803 -1.189 . . . . 0.0 112.802 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.22 99.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.453 0.644 . . . . 0.0 109.362 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 20.3 p -79.75 -17.26 53.91 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.49 -176.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.96 112.36 10.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.766 0.317 . . . . 0.0 110.454 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.567 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -120.01 161.12 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.272 -177.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 41.5 t -128.81 123.21 58.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.066 0.46 . . . . 0.0 110.484 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.57 122.06 55.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.152 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.4 119.31 33.56 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -111.53 146.57 37.08 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.553 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' B' ' 89' ' ' THR . 74.0 mtp180 -120.64 142.72 49.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.5 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 -129.12 12.33 Favored Glycine 0 C--N 1.303 -1.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.851 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -89.47 8.24 31.96 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.017 0.437 . . . . 0.0 111.005 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.67 -1.64 57.38 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.228 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.416 HG23 HG21 ' B' ' 90' ' ' ILE . 68.5 mt -54.65 -37.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.337 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.19 -32.17 73.5 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.588 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -78.84 -31.16 45.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.831 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -64.27 -45.76 86.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.242 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.45 -35.65 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.484 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.7 t70 -59.59 -50.19 74.86 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -52.02 -54.87 24.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.305 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.67 -21.35 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.514 ' HG2' HH21 ' A' ' 86' ' ' ARG . 30.2 tt0 -75.97 -37.12 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.421 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.484 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.1 mt -61.86 -49.73 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.846 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.95 -42.39 71.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' B' ' 61' ' ' LEU . 56.4 mtm180 -73.53 6.32 3.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.861 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . 0.433 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 2.6 t-20 -139.21 16.09 2.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.85 0.833 . . . . 0.0 109.589 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.39 -64.46 0.94 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.13 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -105.23 -37.14 6.99 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.303 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 94.8 mt -132.26 103.49 6.26 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.127 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 -74.1 0.61 Allowed 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.125 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.22 5.14 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.141 0.496 . . . . 0.0 110.09 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -111.96 24.91 12.13 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.026 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -148.91 154.43 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.78 164.16 24.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.362 0.601 . . . . 0.0 111.143 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.67 138.69 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -89.96 -60.85 1.82 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.91 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -166.54 144.9 5.39 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.759 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.2 mt -128.67 119.76 50.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -127.06 138.6 53.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.382 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.25 129.58 74.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.93 -164.95 11.86 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.063 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 29.3 p -131.55 109.55 10.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -86.35 130.86 34.36 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.317 -0.839 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.567 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.426 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 53.2 mtm180 . . . . . 0 N--CA 1.422 -1.825 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.35 117.51 51.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -60.96 125.75 24.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 123.833 0.708 . . . . 0.0 109.232 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.527 HG22 ' HG2' ' B' ' 42' ' ' ARG . 25.6 p -128.26 148.85 50.66 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.201 0.524 . . . . 0.0 112.074 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.416 HG21 HG23 ' B' ' 46' ' ' ILE . 14.4 tt -127.73 132.1 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.53 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.29 107.13 15.17 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.1 mt -105.68 113.45 42.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.536 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.37 132.7 56.53 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -136.9 152.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' B' ' 35' ' ' SER . 12.6 ptp180 -131.53 156.62 45.39 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 120.915 0.388 . . . . 0.0 110.983 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' B' ' 30' ' ' LEU . 0.0 OUTLIER -125.79 118.15 24.93 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -176.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 mttm . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.251 174.053 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.883 0.373 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 71.6 t -102.11 113.21 37.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -102.92 135.45 40.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.023 0.439 . . . . 0.0 110.811 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.71 119.3 37.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.458 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 52.0 mt -90.58 116.48 31.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.145 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.76 41.59 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.896 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -161.04 -55.35 0.05 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.335 0.567 . . . . 0.0 111.715 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -99.98 159.33 30.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.887 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.43 156.0 33.2 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.902 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.4 -35.87 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.144 0.978 . . . . 0.0 112.611 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.415 ' HG3' HD22 ' A' ' 21' ' ' ASN . 26.9 ptt? -64.13 -24.71 67.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.415 HD22 ' HG3' ' A' ' 20' ' ' MET . 0.9 OUTLIER -73.44 -28.1 61.79 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 99.7 m-85 -83.82 -33.01 25.01 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.833 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 61.2 t -59.72 -52.74 57.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-O 121.314 0.578 . . . . 0.0 109.857 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.92 -30.02 70.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.011 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -47.91 75.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.64 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.07 98.2 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.356 0.41 . . . . 0.0 110.577 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 96.0 mt -62.5 -42.4 99.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.022 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.1 m -66.61 -36.46 82.67 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.499 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -71.92 -27.49 62.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.678 0.275 . . . . 0.0 111.091 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -65.75 -36.85 84.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.77 -19.44 65.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.315 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -85.58 -5.64 59.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.45 -7.68 40.02 Favored Glycine 0 C--O 1.242 0.651 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.156 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.15 100.8 11.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.406 0.622 . . . . 0.0 109.701 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.451 ' HA ' HD22 ' A' ' 30' ' ' LEU . 33.8 p -87.22 -25.25 24.11 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.631 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.85 105.25 14.01 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.08 0.552 . . . . 0.0 109.626 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -123.1 163.36 22.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.616 0.246 . . . . 0.0 111.183 -176.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -126.85 122.37 60.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.29 0.567 . . . . 0.0 110.927 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.18 128.69 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.4 123.4 36.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.53 0.681 . . . . 0.0 110.472 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.68 148.21 41.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HG2' HG22 ' A' ' 89' ' ' THR . 67.9 mtm180 -128.29 147.59 50.61 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.212 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.88 -135.83 17.65 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -89.57 9.63 26.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.092 0.472 . . . . 0.0 110.995 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 14' ' ' ILE . . . -84.23 -2.61 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -53.22 -36.26 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -61.57 -28.93 69.69 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.602 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB2' HG21 ' A' ' 14' ' ' ILE . 60.8 mttm -84.53 -27.78 27.13 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.918 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.77 93.18 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.7 p -73.47 -29.29 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.116 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.448 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.1 t70 -71.28 -43.99 66.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 m -58.68 -50.22 74.68 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.85 -28.64 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.734 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -50.31 70.54 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 51' ' ' ASP . 72.2 mt -58.99 -44.25 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.28 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.34 -36.11 70.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -93.83 -2.43 53.53 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.771 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -123.84 12.18 9.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.891 0.853 . . . . 0.0 110.267 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.78 -50.16 0.83 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -85.83 -66.4 0.9 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.1 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.1 mt -144.91 115.09 7.5 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.99 -34.32 11.82 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 124.165 0.916 . . . . 0.0 110.5 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -76.4 -19.22 58.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.69 71.76 1.18 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.966 0.412 . . . . 0.0 110.775 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -161.86 152.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.88 154.33 46.11 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.65 136.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -90.0 -58.67 2.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.193 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.49 151.33 7.83 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.8 122.79 14.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -132.19 145.38 51.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.64 143.12 23.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.76 -157.25 19.65 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.554 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -110.11 135.67 50.55 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.703 0.287 . . . . 0.0 110.301 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -119.42 130.26 55.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 C--N 1.312 -1.033 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.914 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 . . . . . 0 N--CA 1.438 -1.041 0 CA-C-O 120.8 0.333 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.52 140.96 43.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.4 m -73.01 131.06 41.67 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.437 HG22 ' HG2' ' A' ' 42' ' ' ARG . 40.5 p -132.13 147.09 52.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -129.76 138.04 55.17 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.46 109.46 14.87 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.62 124.27 69.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.871 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.39 37.13 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 120.599 0.238 . . . . 0.0 110.81 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 pt -125.26 151.17 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 35' ' ' SER . 25.4 ptt180 -138.63 147.43 42.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 122.035 0.921 . . . . 0.0 113.451 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 21.6 mmtm . . . . . 0 C--N 1.303 -1.423 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.663 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 . . . . . 0 CA--C 1.512 -0.507 0 CA-C-O 121.267 0.556 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 67.8 t -100.09 112.99 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -103.13 133.6 46.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.69 116.65 30.31 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.66 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.492 ' HA ' ' CZ ' ' B' ' 22' ' ' TYR . 50.4 mt -88.23 116.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.462 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.69 35.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.791 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -156.12 -54.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.235 0.517 . . . . 0.0 112.197 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.402 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 54.1 mtmt -99.64 157.32 34.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.28 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 156.25 22.94 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.844 2.363 . . . . 0.0 112.696 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.413 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.2 p -52.94 -33.87 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.162 0.985 . . . . 0.0 112.881 -176.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -63.76 -25.58 68.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.663 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -72.76 -33.83 66.6 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . 0.492 ' CZ ' ' HA ' ' B' ' 14' ' ' ILE . 99.7 m-85 -77.92 -33.28 51.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.62 -54.37 36.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.086 0.469 . . . . 0.0 109.964 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.88 -29.82 70.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.429 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.29 -46.3 80.99 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.518 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.16 97.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.456 0.473 . . . . 0.0 110.719 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.45 -41.88 97.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.3 m -64.76 -37.63 88.26 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.928 0.394 . . . . 0.0 110.403 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.98 -27.78 62.99 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.404 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' B' ' 35' ' ' SER . 0.5 OUTLIER -64.68 -38.9 92.56 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.87 -22.7 67.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.618 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.76 -10.77 59.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.118 0.485 . . . . 0.0 110.605 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.5 -13.01 20.96 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.139 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.49 100.99 8.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.076 0.465 . . . . 0.0 110.344 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . 0.423 ' HA ' HD22 ' B' ' 30' ' ' LEU . 33.7 p -84.05 -29.35 26.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.845 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.49 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 39.3 tt0 -107.68 111.53 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.491 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -127.3 162.51 32.35 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 43.4 t -124.95 123.09 64.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.644 0.735 . . . . 0.0 111.254 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.18 128.54 54.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -127.96 125.15 38.95 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.275 0.56 . . . . 0.0 110.208 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.24 147.75 43.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' B' ' 89' ' ' THR . 53.9 mtm180 -127.5 146.24 50.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.96 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.9 -135.19 15.07 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.794 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -91.47 9.57 31.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.411 0.624 . . . . 0.0 111.036 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.44 ' HB1' HG22 ' B' ' 14' ' ' ILE . . . -83.77 -2.12 55.64 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.354 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.8 mt -53.55 -36.43 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-O 121.624 0.726 . . . . 0.0 109.901 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -60.73 -34.93 75.15 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.039 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -79.33 -30.58 42.81 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.346 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.85 92.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.369 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.21 -33.37 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.088 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.445 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.2 t70 -65.51 -45.4 83.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.116 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.0 m -57.45 -50.7 72.18 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.95 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.45 -30.36 48.67 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.575 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -50.08 73.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.4 mt -58.04 -45.71 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.219 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.03 -34.53 60.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.134 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -94.03 0.01 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -126.8 11.32 7.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.791 0.805 . . . . 0.0 110.23 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -134.85 -49.06 0.75 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.91 -67.07 0.83 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.57 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.481 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 96.0 mt -144.77 115.97 7.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.83 -39.03 10.03 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.903 0.752 . . . . 0.0 110.198 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.69 -13.65 61.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.094 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.92 71.44 1.47 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.767 0.318 . . . . 0.0 111.201 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.402 HD12 ' NZ ' ' B' ' 96' ' ' LYS . 17.7 tt -162.24 156.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -145.6 154.35 42.05 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.15 137.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -90.13 -56.41 3.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.337 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -170.17 153.16 4.44 Favored 'General case' 0 C--O 1.251 1.172 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.98 127.0 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -134.8 144.37 47.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.53 143.09 23.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.8 -158.85 22.88 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.759 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -111.86 131.58 55.27 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -114.69 131.96 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.693 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t . . . . . 0 C--N 1.308 -1.237 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.669 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 . . . . . 0 N--CA 1.438 -1.03 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -122.01 139.22 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -72.85 128.06 34.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.422 HG22 ' HG2' ' B' ' 42' ' ' ARG . 40.8 p -129.39 147.48 51.22 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -175.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.69 138.21 54.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.66 109.3 14.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.95 123.89 69.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.65 122.79 44.51 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -126.99 150.03 32.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.49 ' HD3' ' OE1' ' B' ' 36' ' ' GLU . 23.8 ptt180 -137.09 150.51 48.06 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 20.9 mmtm -93.49 -170.91 2.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.18 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.416 ' HB2' ' NZ ' ' B' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.16 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--O 1.239 0.503 0 CA-C-O 121.596 0.712 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.19 120.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -110.82 145.76 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.264 0.554 . . . . 0.0 111.112 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.79 132.63 51.68 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.075 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -89.66 102.31 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 16' ' ' LYS . . . 178.86 55.55 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 118.229 -1.938 . . . . 0.0 115.551 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 53.8 tttm 178.07 -42.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.472 0.636 . . . . 0.0 110.69 171.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -92.39 159.82 36.19 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.243 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.82 162.15 40.02 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.152 1.901 . . . . 0.0 111.308 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.408 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.4 p -54.77 -41.39 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -59.95 -30.19 68.91 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.738 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -72.29 -34.4 68.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.067 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -73.01 -33.18 65.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.65 -55.83 21.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.101 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.52 -27.3 69.06 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.684 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.01 77.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.907 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.31 98.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.294 0.371 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.04 -33.18 75.21 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.47 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.8 m -64.4 -36.73 85.11 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.441 0.639 . . . . 0.0 109.738 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.82 -35.51 72.51 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.7 mt -58.43 -42.58 87.63 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.167 0.508 . . . . 0.0 110.239 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -66.79 -23.76 66.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.892 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -87.65 -2.68 58.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.7 8.93 47.75 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.07 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.38 94.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 m -85.69 -22.6 27.78 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.633 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -109.7 107.45 17.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.47 142.05 36.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -116.1 123.91 71.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.013 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.03 123.92 62.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 85.7 mttt -120.18 124.02 44.71 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.491 0.662 . . . . 0.0 109.834 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.34 160.04 21.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.457 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -131.37 145.09 51.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.278 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' O ' HG13 ' A' ' 46' ' ' ILE . . . 69.57 -127.8 20.36 Favored Glycine 0 N--CA 1.433 -1.552 0 O-C-N 123.533 0.52 . . . . 0.0 112.445 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.23 0.02 56.58 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.38 . . . . 0.0 111.35 -176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.74 2.06 27.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.134 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 43' ' ' GLY . 75.1 mt -57.25 -40.89 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.463 0.649 . . . . 0.0 109.698 175.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.3 t -70.66 -16.44 62.81 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.954 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -89.83 -33.97 16.3 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.56 89.45 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.128 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 13.7 p -67.76 -43.32 86.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.556 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.9 t70 -54.83 -44.51 73.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.6 m -57.96 -53.55 57.0 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.983 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.54 -30.14 46.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 50' ' ' VAL . 46.4 mt-10 -60.19 -47.93 83.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 123.401 0.438 . . . . 0.0 110.286 174.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.2 mt -60.6 -40.62 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 121.232 0.539 . . . . 0.0 110.62 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.93 -27.51 42.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 CA-C-O 121.14 0.495 . . . . 0.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -100.96 2.63 40.89 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -116.45 9.78 14.42 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.198 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -139.1 -71.24 0.4 Allowed 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.419 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 74.4 t80 -60.5 -64.49 0.93 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.131 0.491 . . . . 0.0 110.842 -174.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.473 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.0 mt -141.28 113.62 8.1 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.27 -35.69 10.66 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 124.161 0.913 . . . . 0.0 110.175 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.1 -45.85 59.01 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.073 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.66 97.65 8.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.591 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.466 HD13 ' HZ2' ' A' ' 96' ' ' LYS . 7.2 tp -158.63 138.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.266 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.617 ' HG2' HH21 ' A' ' 95' ' ' ARG . 7.9 tp10 -124.74 149.98 46.71 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tp -107.52 137.19 39.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -100.54 -53.64 3.04 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.542 -1.263 . . . . 0.0 111.511 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 71' ' ' ARG . 35.6 tt0 -170.53 144.81 2.47 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.1 mt -135.49 119.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.498 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 21.9 mtm180 -128.92 136.61 50.62 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.39 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.58 119.0 58.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.98 167.62 34.87 Favored Glycine 0 C--N 1.303 -1.287 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.631 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 m -85.87 118.65 25.49 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 5.9 tp60 -95.64 131.87 41.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.437 -1.078 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.901 -179.728 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 . . . . . 0 N--CA 1.439 -1.013 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.57 130.23 72.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.696 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.54 118.43 7.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.5 p -125.86 155.16 41.63 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.427 -0.171 . . . . 0.0 111.069 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 14.4 tt -136.99 131.27 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.12 110.99 21.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.32 118.32 57.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.0 117.93 30.56 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 123.298 0.374 . . . . 0.0 110.332 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.6 pt -114.87 158.37 15.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.617 HH21 ' HG2' ' A' ' 66' ' ' GLU . 34.4 ttp180 -130.39 111.79 12.66 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.207 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 26.8 mmtm . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.559 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.821 0.343 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.46 119.96 63.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.46 142.05 24.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.192 0.52 . . . . 0.0 111.585 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.33 131.83 51.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.879 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -89.57 99.95 10.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.16 43.63 0.16 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 117.935 -2.079 . . . . 0.0 116.112 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -173.83 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.456 1.128 . . . . 0.0 110.444 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -91.59 160.87 35.67 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.395 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.66 164.09 34.47 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.133 1.888 . . . . 0.0 110.929 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.464 HG23 ' OG1' ' B' ' 52' ' ' THR . 8.4 p -57.24 -37.37 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.118 0.567 . . . . 0.0 111.738 -176.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -64.07 -29.36 70.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.662 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -73.97 -34.94 64.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -70.7 -34.03 71.53 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.799 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.46 -55.16 26.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.429 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.7 -28.69 70.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.53 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.413 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.43 -43.07 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.184 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.17 99.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.124 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.6 -34.73 78.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.806 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.0 m -64.88 -36.3 83.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.137 0.494 . . . . 0.0 110.11 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -69.91 -36.94 75.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.558 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.42 HD23 ' O ' ' B' ' 34' ' ' VAL . 95.2 mt -57.31 -43.42 83.26 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.056 0.455 . . . . 0.0 110.346 177.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.802 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -87.65 -0.87 57.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.158 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.74 13.85 36.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.041 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.42 ' O ' HD23 ' B' ' 30' ' ' LEU . 32.5 t -101.08 92.97 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -82.9 -24.34 33.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.151 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -109.06 109.32 20.31 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.448 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -122.44 142.76 37.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.27 179.229 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.02 125.08 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.36 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -107.51 123.87 63.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -120.51 123.2 42.36 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.56 161.73 18.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -132.76 145.72 51.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.941 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.4 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 68.35 -127.88 24.2 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 123.451 0.47 . . . . 0.0 112.654 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.35 -0.77 57.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.022 0.439 . . . . 0.0 111.778 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.88 1.98 25.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.4 HG13 ' O ' ' B' ' 43' ' ' GLY . 73.3 mt -58.14 -41.17 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.69 0.757 . . . . 0.0 109.805 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 44.2 t -67.77 -22.14 65.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.405 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -84.84 -33.57 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.37 86.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.601 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' B' ' 54' ' ' GLU . 14.5 p -66.47 -44.07 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.4 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.486 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.1 t70 -56.55 -39.38 73.34 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.464 ' OG1' HG23 ' B' ' 19' ' ' VAL . 57.3 m -61.68 -52.62 63.55 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.98 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.48 -31.14 49.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.203 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' B' ' 50' ' ' VAL . 44.9 mt-10 -59.38 -45.9 90.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.626 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.486 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.9 mt -61.95 -40.64 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.894 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.84 -26.02 37.65 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.157 0.503 . . . . 0.0 111.59 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -100.75 0.52 39.01 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.864 -0.523 . . . . 0.0 111.914 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -116.41 12.75 15.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.182 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -137.89 -68.96 0.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.01 -62.7 1.47 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.868 0.366 . . . . 0.0 111.148 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.446 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.1 mt -142.8 115.12 8.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.01 -34.17 10.19 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 124.241 0.963 . . . . 0.0 109.968 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.5 -41.47 60.64 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.907 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -103.91 99.11 8.87 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.425 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.415 HD13 ' HZ2' ' B' ' 96' ' ' LYS . 7.0 tp -157.99 140.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.041 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.621 ' HG2' HH21 ' B' ' 95' ' ' ARG . 7.1 tp10 -125.83 146.82 49.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -105.44 134.53 46.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -98.85 -54.01 3.12 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.503 -1.279 . . . . 0.0 111.291 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . 0.401 ' OE2' ' HD3' ' B' ' 71' ' ' ARG . 29.3 tt0 -169.87 143.32 2.57 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.7 mt -131.89 118.81 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.401 ' HD3' ' OE2' ' B' ' 69' ' ' GLU . 25.6 mtm180 -127.55 137.25 52.56 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.582 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.55 117.23 51.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.16 165.77 33.89 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.515 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -84.44 115.98 22.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.45 0.7 . . . . 0.0 109.375 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -94.04 132.44 38.52 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.307 -1.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.644 -179.424 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 CA--C 1.498 -1.043 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -114.46 129.48 70.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -61.86 120.38 10.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.9 p -127.64 155.12 44.4 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.308 -0.245 . . . . 0.0 111.221 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -136.83 131.42 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.838 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.35 109.94 19.12 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 56.1 mt -110.88 117.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.95 118.83 34.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.193 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 pt -116.67 152.03 18.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.836 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.621 HH21 ' HG2' ' B' ' 66' ' ' GLU . 35.0 ttp180 -124.21 114.04 19.1 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 28.0 mmtm -80.24 146.8 31.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.861 174.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.385 0.428 . . . . 0.0 111.643 -177.347 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 120.898 0.38 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.46 112.27 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.26 133.9 44.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.642 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -120.83 130.42 53.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.29 133.81 44.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.41 48.5 0.02 OUTLIER Glycine 0 C--N 1.348 1.196 0 C-N-CA 119.439 -1.363 . . . . 0.0 115.628 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -174.71 -51.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 118.04 0.92 . . . . 0.0 112.031 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.13 158.1 33.85 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.732 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 165.74 17.89 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.373 2.048 . . . . 0.0 111.417 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG21 ' OD2' ' A' ' 51' ' ' ASP . 11.6 p -53.06 -28.72 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 C-N-CA 124.353 1.061 . . . . 0.0 113.296 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.6 mtp -62.83 -29.74 70.96 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -71.07 -28.82 64.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.18 0.515 . . . . 0.0 109.64 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -89.62 -42.66 11.26 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.183 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 82.3 t -60.79 -49.82 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.787 0.327 . . . . 0.0 110.68 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.24 -19.79 64.76 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.984 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.406 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -77.37 -48.79 16.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.44 85.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 97.4 mt -60.3 -34.48 73.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.7 m -76.09 -40.95 51.91 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.0 mt -61.35 -38.56 87.37 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.1 -42.78 95.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.395 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.73 -16.38 45.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.918 0.39 . . . . 0.0 110.411 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -78.61 -34.12 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.29 -4.0 1.27 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.87 100.36 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -79.34 -21.11 46.3 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.151 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.38 121.48 22.38 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.261 0.553 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -126.36 158.63 36.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.503 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.86 122.02 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.4 mt -105.45 121.1 57.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 99.6 mttt -108.34 141.25 40.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -133.38 157.4 45.62 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -133.98 135.09 43.23 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 46' ' ' ILE . . . 67.59 -135.01 30.72 Favored Glycine 0 C--O 1.212 -1.237 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.683 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -74.12 -2.45 24.6 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.35 -9.97 59.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.488 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 43' ' ' GLY . 78.7 mt -53.35 -33.87 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.272 0.629 . . . . 0.0 110.797 178.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 p -63.07 -30.6 71.72 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.095 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -86.98 -25.85 24.09 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.374 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -63.29 -48.38 78.34 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.41 0.624 . . . . 0.0 109.984 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.1 -38.18 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.406 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.4 t70 -59.8 -47.99 83.49 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.518 0.511 . . . . 0.0 109.732 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 56' ' ' VAL . 95.2 m -55.82 -54.26 46.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.193 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.31 -31.0 49.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.278 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 26.6 tt0 -67.87 -37.6 82.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.275 0.359 . . . . 0.0 110.531 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 68.9 mt -64.89 -47.97 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 52' ' ' THR . 61.4 t -58.17 -52.71 55.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.449 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -66.63 -13.51 61.24 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -116.64 2.32 12.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 15.8 ptm180 -117.78 -34.44 4.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.127 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -90.1 -58.85 2.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.697 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' A' ' 64' ' ' LYS . 47.2 tp -155.84 109.49 2.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 -6.04 28.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.443 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -87.95 -41.92 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.006 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 67.2 mttm -124.43 99.01 6.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -155.2 145.34 13.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.5 148.24 50.5 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.166 0.508 . . . . 0.0 110.131 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.2 mt -102.91 133.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -92.85 -51.42 5.09 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.967 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -160.55 141.36 11.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.2 99.89 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 123.132 0.573 . . . . 0.0 110.388 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.22 153.95 51.76 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.775 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.08 135.95 42.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.27 -165.69 15.5 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.189 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -100.27 128.73 46.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.076 0.55 . . . . 0.0 109.874 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -108.15 112.41 24.92 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 86' ' ' ARG . 21.9 t . . . . . 0 C--N 1.313 -0.984 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.403 ' HG2' HG22 ' A' ' 76' ' ' VAL . 46.1 mtm180 . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.19 133.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.7 t -66.02 134.88 53.82 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.352 0.596 . . . . 0.0 110.915 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.2 p -132.14 160.34 36.31 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.161 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 18.5 tt -140.78 135.58 34.14 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -111.38 115.79 29.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.64 112.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 123.96 50.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.496 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.6 pt -125.85 152.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.166 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -130.05 124.51 33.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.894 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 . . . . . 0 C--O 1.243 0.735 0 CA-C-O 120.781 0.324 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.92 111.51 30.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.69 131.63 47.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.983 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -118.27 127.18 53.48 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.8 mt -99.76 133.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 48.31 0.02 OUTLIER Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.496 -1.335 . . . . 0.0 115.446 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -172.95 -50.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.868 0.834 . . . . 0.0 112.598 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.416 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 32.0 mmmt -99.64 158.52 32.0 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 122.241 -0.287 . . . . 0.0 110.806 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.91 164.26 22.46 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.557 2.171 . . . . 0.0 111.173 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.476 HG21 ' OD1' ' B' ' 51' ' ' ASP . 13.4 p -52.43 -27.23 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 123.994 0.918 . . . . 0.0 113.326 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 92.9 mtp -65.14 -27.17 68.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -72.9 -26.23 61.35 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.409 0.623 . . . . 0.0 109.625 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . 0.416 ' HE2' ' O ' ' B' ' 17' ' ' LYS . 90.1 m-85 -93.42 -42.84 9.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.101 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.453 HG23 HG22 ' B' ' 19' ' ' VAL . 99.0 t -60.8 -49.56 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 121.345 0.593 . . . . 0.0 110.432 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mp -67.46 -24.18 65.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.79 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.11 -45.92 46.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.19 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.75 97.69 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.932 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 98.8 mt -60.33 -38.09 82.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.153 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.1 m -70.19 -43.62 70.38 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -60.18 -39.05 85.13 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -41.34 89.53 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.522 0.514 . . . . 0.0 111.168 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -85.37 -15.05 44.45 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.312 0.577 . . . . 0.0 110.164 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -79.21 -36.42 40.13 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.528 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.26 -3.9 0.92 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.638 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -97.99 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 117.511 0.656 . . . . 0.0 109.389 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -78.29 -21.78 49.21 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.963 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.23 118.32 19.36 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.174 0.511 . . . . 0.0 111.092 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.533 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -124.95 159.25 31.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.923 -176.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.67 121.49 60.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.029 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -104.94 122.66 58.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 99.3 mttt -110.47 139.24 45.88 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 123.65 0.594 . . . . 0.0 109.979 177.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -132.61 154.92 49.58 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -132.22 134.0 44.81 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.42 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 70.28 -135.53 25.78 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.691 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.6 -2.83 27.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.47 57.98 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.539 0.209 . . . . 0.0 111.275 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.42 HG13 ' O ' ' B' ' 43' ' ' GLY . 77.7 mt -52.96 -35.63 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.479 0.657 . . . . 0.0 110.43 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 53.4 p -62.35 -35.71 79.95 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.92 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -81.61 -26.81 34.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -62.47 -47.77 82.54 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.25 0.548 . . . . 0.0 110.613 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.66 -38.06 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.661 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.476 ' OD1' HG21 ' B' ' 19' ' ' VAL . 13.3 t70 -57.58 -49.92 74.82 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.418 ' O ' HG23 ' B' ' 56' ' ' VAL . 90.1 m -54.2 -54.3 41.79 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.473 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.0 m -69.3 -30.63 46.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.551 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.447 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 25.8 tt0 -68.11 -37.42 81.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 123.302 0.376 . . . . 0.0 110.71 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' B' ' 59' ' ' ARG . 73.7 mt -64.56 -48.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 52' ' ' THR . 58.8 t -57.7 -53.69 41.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 32.2 ptt180 -65.77 -9.69 30.55 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -120.04 -1.24 10.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 15.5 ptm180 -115.18 -33.79 5.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.166 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -89.41 -59.69 2.15 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.704 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' B' ' 64' ' ' LYS . 46.1 tp -153.94 107.74 2.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.87 -1.61 39.73 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.064 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -92.63 -50.75 5.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.918 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.413 ' HB2' HD21 ' B' ' 61' ' ' LEU . 66.3 mttm -115.22 96.65 5.78 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.817 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -152.14 146.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -132.25 149.53 52.35 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -105.69 132.33 52.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -91.72 -50.28 5.83 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.866 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -163.55 143.24 8.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.566 0.541 . . . . 0.0 109.602 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -143.96 98.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.742 0.817 . . . . 0.0 110.269 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -132.91 153.28 51.53 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.397 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.45 137.42 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.65 -169.88 25.57 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.667 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -93.73 137.17 33.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -115.42 116.33 28.05 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' B' ' 86' ' ' ARG . 26.3 t . . . . . 0 C--N 1.308 -1.225 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' B' ' 76' ' ' VAL . 52.3 mtm180 . . . . . 0 CA--C 1.505 -0.777 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.65 135.97 58.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.5 t -69.59 135.98 50.67 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.875 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.03 159.55 38.47 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.491 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 19.2 tt -139.08 135.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.84 113.33 25.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.0 113.49 44.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.15 122.14 44.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 32.7 pt -124.11 149.17 28.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.204 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -127.33 127.57 44.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.988 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 0.7 OUTLIER -78.59 136.74 37.59 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.459 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 27.5 mtpp . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.4 p30 . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 22.9 m -102.38 130.83 51.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.583 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.89 142.45 40.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.526 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.39 129.19 52.34 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.34 113.06 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.935 0.397 . . . . 0.0 111.269 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.08 -161.3 25.51 Favored Glycine 0 C--O 1.253 1.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.322 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.23 5.18 8.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -82.16 158.47 66.91 Favored Pre-proline 0 CA--C 1.547 0.854 0 O-C-N 122.154 -0.341 . . . . 0.0 111.093 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.18 153.81 67.11 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.101 2.534 . . . . 0.0 113.475 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.507 HG21 ' OD1' ' A' ' 51' ' ' ASP . 7.1 p -54.76 -39.91 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.06 0.944 . . . . 0.0 113.356 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -55.55 -30.58 61.01 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.33 -39.49 92.49 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.007 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -80.97 -34.31 33.2 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.14 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 19' ' ' VAL . 57.4 t -59.2 -49.97 81.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.065 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.14 -34.66 78.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.58 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -50.6 65.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.07 86.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.237 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.25 -41.17 97.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.7 m -62.6 -38.55 90.62 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 88.6 mt -64.25 -38.58 91.54 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.65 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.99 -48.85 78.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.812 0.695 . . . . 0.0 110.536 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -79.38 -12.83 59.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.198 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -79.98 -25.85 40.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.99 -12.47 3.88 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.799 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.98 93.06 3.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.292 0.568 . . . . 0.0 109.479 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -87.65 18.4 4.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -155.73 110.34 2.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.473 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -130.33 160.64 41.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.342 -175.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.3 t -124.59 122.76 64.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.332 0.587 . . . . 0.0 110.662 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -100.93 129.32 52.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.0 119.68 36.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.096 0.474 . . . . 0.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -113.74 153.21 29.4 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -142.86 137.56 29.66 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.535 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.48 -130.83 10.26 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -95.18 10.06 37.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.077 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.56 2.02 49.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.934 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.405 HG23 HG21 ' A' ' 90' ' ' ILE . 73.9 mt -57.31 -43.28 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.149 0.579 . . . . 0.0 111.282 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.3 p -66.6 -24.81 66.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.689 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.62 -30.71 52.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.5 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -70.67 -43.77 68.43 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.325 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.85 -33.29 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.075 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' OD1' HG21 ' A' ' 19' ' ' VAL . 18.0 t70 -58.97 -50.36 74.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.4 m -53.61 -52.76 58.8 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.105 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.8 m -70.31 -36.27 66.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.73 -29.08 68.96 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 121.493 0.663 . . . . 0.0 109.43 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.5 mt -69.57 -48.75 64.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 122.003 -0.435 . . . . 0.0 110.626 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -59.84 -36.31 65.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 120.946 0.403 . . . . 0.0 111.348 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 6.1 ptm180 -82.08 0.81 38.87 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -115.29 -45.77 2.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.884 0.373 . . . . 0.0 111.544 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 16.2 ptm180 -72.85 -28.36 62.48 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -105.62 -72.53 0.71 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.231 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.507 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 96.0 mt -142.2 116.52 9.55 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -93.15 -37.57 12.04 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 124.497 1.123 . . . . 0.0 110.42 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.7 -40.33 92.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.79 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -108.12 99.44 8.88 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 121.191 0.519 . . . . 0.0 111.364 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.42 132.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.454 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.49 136.96 53.9 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -99.48 130.05 49.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -80.04 -55.82 4.68 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -171.32 147.3 2.44 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.71 123.92 55.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -122.43 139.93 53.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.039 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -132.57 125.45 53.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.28 25.78 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.494 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 88' ' ' SER . 50.1 m -115.38 129.05 56.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 117.278 0.539 . . . . 0.0 111.082 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 53.5 tt0 -93.18 141.63 28.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.122 0.969 . . . . 0.0 108.543 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.481 HG22 ' HG2' ' A' ' 86' ' ' ARG . 22.4 t . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 98.1 mtt180 . . . . . 0 CA--C 1.513 -0.451 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -134.75 139.22 47.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 19.2 m -72.35 136.65 46.21 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.556 0.743 . . . . 0.0 112.436 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.448 HG21 ' OE1' ' A' ' 75' ' ' GLN . 80.9 p -129.15 170.73 13.18 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.909 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.405 HG21 HG23 ' A' ' 46' ' ' ILE . 13.7 tt -146.93 123.78 3.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.477 176.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.14 113.49 26.8 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.03 115.51 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.19 121.14 42.06 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.574 0.225 . . . . 0.0 110.836 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.81 148.32 25.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.636 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.43 147.63 40.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.137 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 4.4 mmtm . . . . . 0 C--N 1.294 -1.818 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.505 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 p30 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.87 133.12 48.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.078 0.466 . . . . 0.0 111.493 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.67 143.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.553 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 56.8 tp -106.52 125.65 51.26 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.87 116.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 120.996 0.426 . . . . 0.0 111.099 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.98 -158.8 22.38 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.201 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -79.28 4.17 15.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.02 158.53 67.2 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 122.346 -0.222 . . . . 0.0 110.661 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.69 153.93 68.84 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.214 2.61 . . . . 0.0 113.214 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.502 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.3 p -54.53 -39.8 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.346 1.058 . . . . 0.0 113.394 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -57.56 -27.26 62.5 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.95 -36.74 80.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -83.19 -35.46 25.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.415 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 19' ' ' VAL . 82.1 t -58.38 -50.95 76.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.876 178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.22 -36.51 84.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.6 -48.09 78.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.832 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.08 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.925 0.393 . . . . 0.0 111.088 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.54 -41.76 98.43 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.9 m -61.16 -39.62 90.8 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.521 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.3 mt -63.51 -38.69 92.1 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.59 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.3 -46.02 86.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.138 0.494 . . . . 0.0 110.696 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.83 -7.51 59.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -84.87 -25.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.81 -15.71 3.31 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.612 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.65 94.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.169 0.509 . . . . 0.0 109.93 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -90.48 19.04 5.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.962 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -155.25 107.84 2.72 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.505 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.15 158.74 41.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -174.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.19 121.72 62.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.508 0.67 . . . . 0.0 111.015 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.77 129.03 50.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.92 122.74 44.09 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.26 0.552 . . . . 0.0 110.777 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -116.77 154.34 30.85 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -142.94 136.03 28.14 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.542 0.526 . . . . 0.0 110.35 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.33 -132.92 11.46 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -93.48 13.56 21.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 110.267 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.95 1.41 56.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.27 -43.78 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.305 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -65.92 -24.25 66.79 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.955 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -79.6 -32.2 41.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.035 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -68.29 -44.18 76.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.08 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.51 -33.91 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.113 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.502 ' OD1' HG21 ' B' ' 19' ' ' VAL . 13.7 t70 -58.51 -49.28 77.95 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -54.58 -51.78 64.19 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.908 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.45 -37.11 69.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -66.97 -30.52 70.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.304 0.573 . . . . 0.0 109.58 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.7 mt -67.33 -49.18 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.106 -0.371 . . . . 0.0 110.649 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.28 -39.42 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.794 0.331 . . . . 0.0 111.542 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' B' ' 62' ' ' ALA . 7.6 ptm180 -79.82 -1.98 41.37 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -110.79 -43.8 3.75 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.769 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -75.16 -34.27 61.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -99.96 -69.15 0.78 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.851 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.529 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.9 mt -144.97 116.6 8.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -93.21 -38.06 11.75 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 124.501 1.125 . . . . 0.0 110.789 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.365 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -108.53 100.14 9.44 Favored 'General case' 0 C--O 1.253 1.254 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.0 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tp -160.18 130.01 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.638 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.15 135.05 53.22 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.73 131.61 45.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' B' ' 68' ' ' LYS . 9.5 tmtt? -83.26 -56.41 3.78 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -170.89 146.22 2.5 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -130.45 123.61 55.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -121.23 140.41 52.07 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.607 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.22 125.67 51.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' B' ' 88' ' ' SER . . . -165.11 -171.46 31.37 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.001 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 88' ' ' SER . 49.0 m -111.0 125.77 54.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.101 0.451 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 53.3 tt0 -89.81 141.9 28.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.899 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.494 HG22 ' HG2' ' B' ' 86' ' ' ARG . 20.7 t . . . . . 0 C--N 1.313 -0.982 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 99.7 mtt180 . . . . . 0 CA--C 1.502 -0.903 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 135.63 56.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 74' ' ' SER . 20.1 m -68.08 137.17 54.77 Favored 'General case' 0 C--O 1.261 1.693 0 C-N-CA 123.708 0.803 . . . . 0.0 112.193 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.444 HG21 ' OE1' ' B' ' 75' ' ' GLN . 68.4 p -129.42 171.01 12.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.472 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.57 123.03 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.952 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.81 113.36 26.71 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -110.96 116.39 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.36 120.38 40.16 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.059 0.457 . . . . 0.0 110.922 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -120.69 143.8 31.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -110.78 147.61 34.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.284 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.529 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 3.3 mmtm -128.81 136.06 49.98 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 122.733 0.413 . . . . 0.0 111.802 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? . . . . . 0 C--O 1.258 1.504 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -178.992 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 N--CA 1.465 0.304 0 CA-C-O 121.437 0.637 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.75 148.43 8.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.14 135.03 58.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 120.915 0.388 . . . . 0.0 110.606 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.34 132.35 40.47 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.439 HG21 ' HB2' ' A' ' 48' ' ' LYS . 49.4 mm -94.54 111.16 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.712 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.27 0.02 OUTLIER Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.374 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -135.86 -76.37 0.44 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.052 0.426 . . . . 0.0 110.529 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -99.39 169.38 8.22 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.198 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.36 161.74 16.22 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.355 2.037 . . . . 0.0 112.239 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -51.37 -30.87 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.076 1.35 . . . . 0.0 113.591 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptp -62.85 -26.91 68.99 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.33 -31.35 58.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.148 0.499 . . . . 0.0 109.952 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.81 -36.36 50.33 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.9 t -61.13 -50.85 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.011 0.434 . . . . 0.0 109.903 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.71 -26.49 64.37 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.89 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.9 -44.81 72.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.693 0.282 . . . . 0.0 110.287 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.45 -24.4 67.16 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 90.1 mt -77.89 -45.73 23.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.145 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -63.64 -34.95 78.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.177 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 87.6 mt -61.63 -35.06 76.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 111.385 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.62 -31.07 71.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.493 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.75 -23.2 65.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -79.81 -15.82 56.69 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.984 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.66 -12.01 18.38 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.912 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.42 106.95 15.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.956 0.884 . . . . 0.0 112.049 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.1 p -87.82 -31.18 19.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.007 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 44.5 mt-10 -103.67 107.81 18.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.016 0.436 . . . . 0.0 109.837 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -129.83 157.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.291 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.2 t -126.92 124.1 63.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.119 0.485 . . . . 0.0 111.002 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.26 126.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -123.32 119.08 29.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.168 0.509 . . . . 0.0 110.141 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.5 156.59 27.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.632 ' HG2' HG22 ' A' ' 89' ' ' THR . 44.1 mtp180 -134.77 147.17 49.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.024 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.28 -134.81 20.19 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -85.1 5.84 28.07 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.392 -0.475 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.38 -3.5 52.95 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -57.37 -32.63 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.446 0.698 . . . . 0.0 110.009 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -61.39 -43.56 98.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.017 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 14' ' ' ILE . 99.7 mttt -67.6 -36.44 80.87 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.506 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.86 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.61 -36.3 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.953 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.571 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.3 t70 -62.43 -45.89 91.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.8 m -56.53 -53.66 54.95 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.48 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.03 -34.54 70.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.207 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.583 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 6.0 tp10 -65.75 -40.7 92.34 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 51' ' ' ASP . 75.8 mt -60.11 -42.99 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.016 0.436 . . . . 0.0 110.48 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.04 -44.68 95.36 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.229 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 2.5 ptm180 -80.03 -2.56 44.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.54 20.69 11.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.09 0.471 . . . . 0.0 111.728 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -139.43 -61.41 0.55 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.15 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -92.03 -54.72 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.527 -174.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 90.2 mt -119.03 107.26 13.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -98.25 -46.55 5.78 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.167 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.45 9.87 31.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -132.39 29.05 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.895 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.66 134.59 58.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' CD ' HH21 ' A' ' 95' ' ' ARG . 40.2 mt-10 -115.95 157.87 23.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.212 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -100.42 123.39 53.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -82.78 -61.82 1.77 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.992 0.425 . . . . 0.0 110.841 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.93 141.27 17.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.3 pt -130.12 121.56 51.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -132.98 144.74 50.32 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.63 144.83 18.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.77 171.72 28.21 Favored Glycine 0 C--N 1.318 -0.431 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 t -79.21 122.8 26.75 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.709 0.766 . . . . 0.0 110.477 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -99.23 122.2 42.09 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.325 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.459 HG22 ' HG3' ' A' ' 86' ' ' ARG . 44.2 t . . . . . 0 C--N 1.311 -1.081 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HG3' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.946 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.413 ' HB ' HH21 ' A' ' 42' ' ' ARG . 62.7 t -126.46 137.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 p -65.2 121.15 14.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 123.445 0.466 . . . . 0.0 110.065 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.632 HG22 ' HG2' ' A' ' 42' ' ' ARG . 73.4 p -127.46 158.59 36.94 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.458 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -139.47 133.97 38.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.78 112.97 23.62 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.98 117.74 55.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.49 130.01 56.74 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -131.1 157.57 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.499 HH21 ' CD ' ' A' ' 66' ' ' GLU . 59.2 ttp180 -122.37 122.95 40.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.66 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp . . . . . 0 C--N 1.306 -1.307 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.773 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 121.098 0.475 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 32.7 m -101.62 151.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.87 135.74 56.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.883 0.373 . . . . 0.0 110.102 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.9 132.77 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' B' ' 48' ' ' LYS . 48.2 mm -94.48 112.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.054 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.56 38.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.278 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.21 -76.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.262 0.553 . . . . 0.0 110.747 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -99.5 169.25 8.36 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -60.71 161.45 21.32 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.387 2.058 . . . . 0.0 112.486 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -50.03 -32.4 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.882 1.273 . . . . 0.0 113.544 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 24.2 ptp -60.97 -32.04 71.59 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -71.07 -33.99 70.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.941 0.401 . . . . 0.0 109.958 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -75.53 -36.2 60.55 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.312 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.0 -53.19 52.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.052 0.453 . . . . 0.0 110.039 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mp -67.14 -28.06 67.83 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.981 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.25 76.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.649 0.261 . . . . 0.0 110.453 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -31.1 72.16 Favored 'General case' 0 C--O 1.261 1.687 0 CA-C-O 121.233 0.539 . . . . 0.0 111.025 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -71.4 -43.46 66.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.061 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -65.52 -36.18 83.06 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.728 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.23 -39.04 91.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.105 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.29 -32.84 71.57 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.977 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -66.18 -22.15 66.35 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.156 0.503 . . . . 0.0 110.92 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.92 -12.93 56.95 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.823 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.77 22.52 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.582 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.2 105.14 13.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 122.031 0.919 . . . . 0.0 112.291 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.5 p -87.74 -31.41 19.69 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.174 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' B' ' 94' ' ' ILE . 43.9 mt-10 -101.93 109.42 21.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.412 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -131.95 155.81 41.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.971 -179.482 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 111.509 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.02 126.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -123.11 116.77 24.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.247 0.546 . . . . 0.0 110.63 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.48 157.11 24.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.65 ' HG2' HG22 ' B' ' 89' ' ' THR . 50.3 mtp180 -135.7 144.97 46.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.195 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.48 -130.14 10.49 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.241 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -89.88 3.92 51.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.157 0.503 . . . . 0.0 110.333 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.24 -6.4 54.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.307 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.24 -35.12 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.759 0.824 . . . . 0.0 110.288 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.0 p -61.23 -43.69 98.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.178 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.425 ' HB2' HG21 ' B' ' 14' ' ' ILE . 99.7 mttt -66.13 -38.79 89.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.328 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.99 87.86 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -71.7 -35.33 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.889 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.563 ' O ' HG13 ' B' ' 55' ' ' ILE . 25.2 t70 -64.63 -45.09 88.36 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -54.21 -53.65 50.55 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.87 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.9 -33.15 59.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.639 ' OE1' ' HD3' ' B' ' 57' ' ' ARG . 5.8 tp10 -67.41 -40.08 85.56 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.563 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.4 mt -60.66 -42.49 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.142 0.496 . . . . 0.0 110.804 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.09 -42.98 91.81 Favored 'Isoleucine or valine' 0 C--O 1.256 1.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.777 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.639 ' HD3' ' OE1' ' B' ' 54' ' ' GLU . 2.7 ptm180 -81.34 -2.92 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.209 -175.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.94 19.05 12.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.764 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -139.5 -58.06 0.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.647 -0.421 . . . . 0.0 112.116 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.87 -53.04 4.16 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.279 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 91.4 mt -120.82 106.43 11.66 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -97.15 -39.27 9.37 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.54 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -114.58 6.22 15.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.35 31.37 4.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.169 0.509 . . . . 0.0 111.746 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -134.32 136.99 52.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.505 ' CD ' HH21 ' B' ' 95' ' ' ARG . 41.6 mt-10 -119.49 159.29 24.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 110.44 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.99 123.92 55.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -83.57 -60.58 2.08 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.23 0.331 . . . . 0.0 110.364 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -158.03 140.62 14.6 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.85 124.19 60.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -137.45 143.22 41.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.51 142.18 18.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 O-C-N 123.133 0.271 . . . . 0.0 110.336 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.17 172.4 32.58 Favored Glycine 0 C--O 1.238 0.363 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 121.82 25.27 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.515 0.674 . . . . 0.0 110.451 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -98.38 118.68 35.6 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.431 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' B' ' 86' ' ' ARG . 43.5 t . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.475 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.422 ' HG3' HG22 ' B' ' 76' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.73 136.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 21.0 p -63.86 122.29 16.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.014 0.526 . . . . 0.0 110.24 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.65 HG22 ' HG2' ' B' ' 42' ' ' ARG . 77.4 p -127.68 157.5 40.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.112 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.4 tt -139.41 131.87 36.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.6 112.91 24.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.43 116.8 53.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.886 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.19 128.62 56.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.387 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.501 HD13 ' H ' ' B' ' 94' ' ' ILE . 0.2 OUTLIER -128.84 155.26 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.072 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.505 HH21 ' CD ' ' B' ' 66' ' ' GLU . 60.6 ttp180 -119.54 120.91 38.14 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.686 0.616 . . . . 0.0 110.412 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -82.39 -175.14 5.55 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt . . . . . 0 CA--C 1.548 0.885 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.259 174.433 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.712 0.292 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.7 133.97 63.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.457 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.79 135.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.0 tp -97.26 115.31 27.4 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.8 99.19 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.334 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.71 72.08 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.073 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 17' ' ' LYS . 5.7 ptpp? 172.69 -48.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.48 1.112 . . . . 0.0 112.475 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 32.5 mmmt -100.29 164.77 15.69 Favored Pre-proline 0 C--O 1.256 1.403 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.2 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.5 164.14 34.01 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.595 2.196 . . . . 0.0 110.914 172.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.484 HG21 ' OD1' ' A' ' 51' ' ' ASP . 7.8 p -58.26 -42.81 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.414 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.9 ptp -58.89 -25.93 63.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.12 -38.02 81.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -77.59 -33.28 53.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.46 -47.14 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.359 0.6 . . . . 0.0 109.84 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 20' ' ' MET . 87.0 mt -66.17 -29.66 69.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.782 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -67.99 -43.67 78.39 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.8 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.24 -30.52 70.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.132 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.31 -36.08 66.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.998 0.428 . . . . 0.0 110.182 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 m -70.18 -35.05 73.69 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.3 mt -63.88 -27.07 68.91 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.616 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.618 HD21 ' HG3' ' A' ' 96' ' ' LYS . 14.3 mt -57.69 -41.32 81.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 111.6 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -78.28 -5.26 51.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -102.78 -4.45 24.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 109.714 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.28 13.61 58.44 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.193 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 20.7 t -101.01 89.55 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.628 0.727 . . . . 0.0 109.27 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 50.9 m -81.17 -24.71 37.35 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.571 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 35.2 mt-10 -110.65 111.21 22.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -129.23 154.07 39.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.042 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.026 -177.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.97 117.91 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 123.794 0.684 . . . . 0.0 110.497 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.89 120.81 40.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -113.37 115.03 27.46 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 122.742 0.417 . . . . 0.0 110.195 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.25 39.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HG2' HG22 ' A' ' 89' ' ' THR . 44.1 mtm180 -133.77 148.52 51.39 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 120.817 0.342 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.96 -130.44 10.97 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.782 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.56 -0.45 57.52 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 122.232 -0.569 . . . . 0.0 112.06 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.77 6.41 24.57 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -57.77 -37.1 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 110.0 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.8 p -67.66 -29.7 69.06 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.989 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.97 -29.2 58.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.296 0.57 . . . . 0.0 109.66 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.24 -45.35 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.397 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.06 -38.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 55' ' ' ILE . 13.6 t70 -57.91 -42.39 84.64 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.3 m -55.3 -52.69 62.64 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.015 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.68 -34.13 51.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . 0.257 11.6 pt-20 -69.96 -31.7 69.55 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.561 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.5 mt -62.4 -47.81 91.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.955 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.9 t -57.91 -48.82 83.03 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 16.6 ptm180 -72.75 -14.56 61.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -109.39 0.72 19.55 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.499 -0.88 . . . . 0.0 113.213 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -108.69 -19.28 13.48 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.04 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -146.25 -70.13 0.26 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.451 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.0 86.06 7.07 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -75.54 -73.6 0.25 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.931 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.6 2.25 55.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -113.88 24.42 12.09 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.187 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.38 133.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.148 0.499 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -101.53 143.62 31.29 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.2 mt -124.65 140.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.99 -73.39 0.52 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.115 0.483 . . . . 0.0 111.242 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -170.49 157.52 5.97 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.32 115.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -113.28 128.61 56.52 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.97 132.79 47.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.78 169.46 41.89 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.905 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 m -81.44 138.45 35.54 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 122.969 0.508 . . . . 0.0 109.67 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -115.87 130.49 56.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.686 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 C--N 1.316 -0.856 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.33 122.24 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 p -65.24 130.47 43.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.465 HG22 ' HG2' ' A' ' 42' ' ' ARG . 41.7 p -128.54 145.42 51.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.68 138.17 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.0 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -121.9 111.0 16.55 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.393 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -107.07 110.5 31.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.16 124.91 53.24 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.4 pt -134.66 168.73 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.526 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 30.5 ttt180 -135.04 155.57 50.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.618 ' HG3' HD21 ' A' ' 30' ' ' LEU . 47.7 mmtm . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.425 0.631 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.59 132.73 69.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.322 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.895 0.379 . . . . 0.0 111.386 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -96.29 114.76 26.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.561 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.82 98.27 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.253 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 72.83 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.435 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.498 ' HG3' ' HG2' ' B' ' 17' ' ' LYS . 5.2 ptpp? 172.25 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.789 1.236 . . . . 0.0 112.244 174.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' B' ' 16' ' ' LYS . 32.3 mmmt -100.19 164.19 16.84 Favored Pre-proline 0 C--O 1.255 1.366 0 O-C-N 122.227 -0.296 . . . . 0.0 111.309 -174.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.02 164.48 29.82 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.997 2.465 . . . . 0.0 110.869 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.9 -42.25 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptp -58.09 -26.12 62.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -68.38 -39.48 81.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.411 0.624 . . . . 0.0 110.104 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.62 -33.34 58.39 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.478 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.31 -48.46 88.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.706 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.32 -29.39 70.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.037 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.06 -46.79 73.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.01 85.82 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.123 0.487 . . . . 0.0 111.134 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.222 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 43.2 m -72.16 -36.55 69.35 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.208 0.527 . . . . 0.0 110.26 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.458 ' HB3' ' HB ' ' B' ' 34' ' ' VAL . 94.4 mt -62.99 -30.01 71.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.695 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.604 HD21 ' HG3' ' B' ' 96' ' ' LYS . 17.5 mt -54.0 -42.82 69.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.855 171.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.59 -9.57 58.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.418 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -99.38 -3.78 33.07 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.952 0.406 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.08 12.27 57.79 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.459 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' B' ' 29' ' ' LEU . 20.9 t -100.65 90.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.537 0.684 . . . . 0.0 109.695 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 44.3 m -82.05 -25.29 34.72 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.583 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 37.2 mt-10 -109.58 110.8 21.99 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.444 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.76 152.56 37.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 -177.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.58 119.03 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.492 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.9 121.02 40.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.62 113.89 25.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.045 0.45 . . . . 0.0 110.289 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 152.0 38.07 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.438 ' HG2' HG22 ' B' ' 89' ' ' THR . 46.7 mtm180 -134.8 151.41 50.93 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.764 0.316 . . . . 0.0 110.689 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 -128.01 10.9 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.748 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -91.17 -1.04 57.8 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 122.359 -0.495 . . . . 0.0 112.099 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 8.06 21.04 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.408 HG23 HG21 ' B' ' 90' ' ' ILE . 67.6 mt -58.12 -37.86 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.774 0.797 . . . . 0.0 109.924 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 29.2 p -66.39 -30.63 71.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.239 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.67 -31.26 61.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.03 75.98 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.421 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.17 -37.43 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.643 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.499 ' O ' HG13 ' B' ' 55' ' ' ILE . 14.7 t70 -59.11 -40.24 84.75 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.6 m -57.47 -52.99 63.12 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.851 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 m -70.93 -34.65 56.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.97 -33.14 73.21 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.293 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.499 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.9 mt -61.87 -48.78 87.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.126 175.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.09 -49.42 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -72.25 -18.26 61.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -104.0 -3.45 24.61 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.882 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -106.54 -15.2 14.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.39 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -149.65 -69.67 0.2 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 mp -88.76 86.94 7.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.146 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.86 -73.17 0.3 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.839 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.9 4.84 51.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -115.2 26.51 10.04 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.042 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.2 tp -107.25 130.26 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 120.871 0.367 . . . . 0.0 110.98 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -96.99 147.0 24.44 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.1 mt -126.6 138.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -88.08 -73.49 0.49 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -172.02 160.94 5.5 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 65.7 mt -125.83 115.49 43.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -111.79 124.19 51.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.22 136.43 56.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.7 170.17 41.02 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.796 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.4 m -80.61 140.8 35.55 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -118.67 130.99 56.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 C--N 1.314 -0.935 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.475 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 119.32 54.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -63.66 129.05 38.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.438 HG22 ' HG2' ' B' ' 42' ' ' ARG . 47.0 p -127.37 147.3 50.27 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.827 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.408 HG21 HG23 ' B' ' 46' ' ' ILE . 15.2 tt -139.36 137.35 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.528 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.05 112.48 19.19 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.046 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.4 mt -107.31 111.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.16 127.15 56.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.975 0.416 . . . . 0.0 110.667 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -136.35 167.48 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.263 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' OE2' ' B' ' 36' ' ' GLU . 36.8 ttt180 -134.07 153.47 51.78 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.904 0.383 . . . . 0.0 110.138 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.604 ' HG3' HD21 ' B' ' 30' ' ' LEU . 46.7 mmtm -108.35 140.56 41.46 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm . . . . . 0 C--N 1.311 -1.085 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.11 173.137 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 p30 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 19.3 m -98.96 129.98 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.106 0.479 . . . . 0.0 110.458 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' HG12 ' A' ' 39' ' ' ILE . 35.6 m -118.47 139.36 46.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.836 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.0 127.29 43.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.761 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.52 110.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.37 53.55 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.234 -1.46 . . . . 0.0 113.894 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -157.51 -58.97 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -100.79 162.28 21.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.997 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.72 156.75 55.64 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.236 1.957 . . . . 0.0 112.014 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.48 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -50.87 -32.4 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.725 1.21 . . . . 0.0 113.776 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.3 ptp -56.81 -31.6 64.88 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -75.93 -37.15 59.01 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.842 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.7 -37.34 73.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.36 -47.5 90.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.254 0.55 . . . . 0.0 110.05 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.18 -32.22 71.38 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.944 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -67.51 -44.46 78.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.671 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.75 90.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.273 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.44 -35.54 81.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.979 0.419 . . . . 0.0 111.047 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.3 m -69.9 -39.13 76.42 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 95.1 mt -69.73 -35.86 75.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.39 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.8 tm? -59.39 -45.58 91.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.933 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.422 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -79.75 -21.64 44.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.56 -19.84 3.75 Favored Glycine 0 CA--C 1.5 -0.904 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.2 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 22.0 t -71.81 94.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.471 0.653 . . . . 0.0 109.349 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -79.26 -17.47 54.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.216 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.57 130.91 23.62 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -130.15 156.15 42.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.185 -178.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 43.4 t -121.46 113.55 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.304 0.574 . . . . 0.0 110.425 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.419 HG12 ' CG2' ' A' ' 12' ' ' VAL . 65.2 mt -95.14 122.01 46.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 80.4 mttt -120.92 120.64 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.95 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.64 167.24 12.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.769 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -139.29 141.94 37.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.21 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 59.93 -106.72 1.06 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -83.31 -21.18 33.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.19 0.519 . . . . 0.0 109.95 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.32 -8.7 56.97 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.14 -39.2 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.606 0.717 . . . . 0.0 110.386 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -64.55 -29.51 70.54 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.664 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -78.34 -37.35 44.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.559 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.306 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -73.14 -35.7 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.766 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.48 ' OD2' HG21 ' A' ' 19' ' ' VAL . 18.1 t70 -58.83 -47.92 83.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.3 m -53.07 -54.14 39.87 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.205 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.35 -29.17 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.35 -36.77 79.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.6 mt -65.44 -50.14 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.962 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.27 -44.57 84.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -75.55 -1.95 26.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -130.42 6.6 4.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.612 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -114.13 -61.9 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -76.41 -50.08 15.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.591 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.4 tp -159.46 105.91 1.69 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.31 -27.67 15.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.506 1.129 . . . . 0.0 111.869 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.76 -42.49 89.03 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.607 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -122.34 108.38 13.17 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.985 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -161.35 145.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.77 156.13 43.89 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.0 mt -104.35 141.21 20.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -95.93 -38.25 10.33 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.332 -0.23 . . . . 0.0 110.902 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -167.78 146.38 4.69 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.486 0.491 . . . . 0.0 109.835 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.52 97.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 124.356 1.062 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.8 142.08 50.38 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.405 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.76 134.95 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.18 151.28 22.6 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.15 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -79.57 124.72 28.77 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -107.69 135.29 49.36 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.953 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.319 -0.757 0 CA-C-O 121.35 0.595 . . . . 0.0 111.092 176.557 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.87 132.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.219 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -71.41 126.77 30.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.937 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 46.5 p -127.99 154.61 45.42 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.964 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -135.28 135.08 52.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.555 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -112.5 111.1 21.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.642 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 90' ' ' ILE . 43.5 mm -108.28 110.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.62 122.01 39.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.17 149.4 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -126.6 127.55 45.41 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.8 tptt . . . . . 0 C--N 1.299 -1.599 0 CA-C-O 121.689 0.757 . . . . 0.0 112.866 -174.462 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 C--O 1.243 0.739 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 18.9 m -96.66 129.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.118 0.485 . . . . 0.0 111.487 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.407 ' CG2' HG12 ' B' ' 39' ' ' ILE . 34.4 m -119.97 139.41 47.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.893 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.11 124.47 44.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mm -95.22 112.4 27.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.805 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.33 47.31 0.01 OUTLIER Glycine 0 C--N 1.313 -0.727 0 C-N-CA 119.136 -1.507 . . . . 0.0 114.338 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -151.73 -58.05 0.15 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.874 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' B' ' 18' ' ' PRO . 56.0 mtpt -101.52 162.62 19.89 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' B' ' 17' ' ' LYS . 28.7 Cg_endo -62.56 155.43 58.5 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.518 2.145 . . . . 0.0 112.162 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.82 -31.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.5 1.12 . . . . 0.0 113.992 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -57.52 -34.35 69.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -71.76 -40.78 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.751 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -69.16 -38.48 78.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.638 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.26 -46.85 88.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.338 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.5 -37.03 79.72 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.235 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.68 95.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.75 88.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.562 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.11 -35.71 81.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.7 m -67.39 -41.94 84.17 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.49 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.93 -34.77 75.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 2.0 tm? -59.89 -44.17 94.39 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.42 -25.25 66.66 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.306 0.574 . . . . 0.0 111.779 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -79.13 -14.75 58.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.672 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.83 -16.32 6.5 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.964 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' B' ' 30' ' ' LEU . 21.5 t -74.68 94.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -83.25 -15.03 51.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.1 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.425 ' OE2' ' HE3' ' B' ' 68' ' ' LYS . 10.0 pt-20 -140.01 130.03 24.88 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.424 ' H ' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -131.32 155.61 41.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.21 -178.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 43.0 t -121.77 113.52 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.663 0.744 . . . . 0.0 110.872 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.407 HG12 ' CG2' ' B' ' 12' ' ' VAL . 61.7 mt -94.64 123.08 46.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.037 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 82.5 mttt -121.36 123.11 41.35 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.172 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.78 166.77 14.41 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.316 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -139.68 140.72 36.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.203 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.91 -105.41 0.92 Allowed Glycine 0 N--CA 1.466 0.649 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -84.32 -23.29 30.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.867 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.08 -7.22 47.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.1 mt -57.22 -39.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.727 0.775 . . . . 0.0 109.723 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.2 t -64.03 -32.42 73.96 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.54 -37.66 59.86 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.184 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.92 83.67 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.088 0.471 . . . . 0.0 111.525 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.86 -35.22 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.802 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.439 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.5 t70 -59.93 -45.04 93.9 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.7 m -54.88 -56.85 14.99 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.322 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.89 -29.84 44.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.46 -35.27 77.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.779 0.323 . . . . 0.0 110.158 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 51' ' ' ASP . 80.2 mt -67.16 -50.85 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 88.2 t -55.59 -44.87 78.17 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.92 -2.55 27.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' B' ' 62' ' ' ALA . 18.9 t-20 -132.48 9.01 4.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.318 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -113.27 -60.1 1.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.296 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.51 -51.44 9.97 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.08 0.467 . . . . 0.0 111.1 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 67.8 tp -158.25 104.67 1.87 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' B' ' 58' ' ' ASN . . . -92.76 -22.03 19.6 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.329 -176.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.38 -43.87 80.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -117.96 105.67 12.14 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -161.18 141.02 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.56 156.32 45.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.098 0.475 . . . . 0.0 109.739 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.39 140.42 20.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . 0.425 ' HE3' ' OE2' ' B' ' 36' ' ' GLU . 64.9 tttm -93.83 -40.58 10.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.292 -0.255 . . . . 0.0 110.944 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.74 147.05 4.89 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.438 0.462 . . . . 0.0 109.759 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 pt -145.62 100.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 124.521 1.128 . . . . 0.0 109.698 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.104 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.75 135.86 56.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.0 150.94 22.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.353 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -79.48 124.0 28.07 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -106.98 134.87 49.49 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.933 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.24 0.56 0 CA-C-O 121.247 0.546 . . . . 0.0 110.847 176.526 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 . . . . . 0 N--CA 1.441 -0.922 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.74 132.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 128.76 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 58.0 p -130.13 154.27 47.66 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 14.9 tt -134.84 136.34 52.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.504 0.192 . . . . 0.0 110.524 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -115.21 112.32 22.31 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.417 HD11 HD11 ' B' ' 90' ' ' ILE . 43.6 mm -108.91 110.61 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.85 120.77 37.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -121.94 149.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -127.43 126.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -77.51 151.43 34.58 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.935 -174.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.435 -1.177 0 C-N-CA 125.234 1.414 . . . . 0.0 107.778 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--O 1.223 -0.312 0 CA-C-O 121.668 0.747 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 ' HB ' ' A' ' 38' ' ' VAL . 31.0 m -120.08 133.45 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.052 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.53 144.45 30.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.255 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -105.83 121.63 44.45 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.09 103.35 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.19 51.11 0.03 OUTLIER Glycine 0 C--O 1.24 0.49 0 C-N-CA 119.515 -1.326 . . . . 0.0 114.086 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -166.33 -55.32 0.03 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.125 0.462 . . . . 0.0 110.831 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.86 154.71 37.1 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.22 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD2' ' ND2' ' A' ' 21' ' ' ASN . 38.6 Cg_exo -62.7 160.23 33.64 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.327 2.018 . . . . 0.0 111.638 174.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -49.93 -34.17 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.53 1.132 . . . . 0.0 113.267 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.458 ' O ' HD13 ' A' ' 24' ' ' LEU . 26.8 ptm -60.1 -27.35 66.95 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.609 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.475 ' ND2' ' HD2' ' A' ' 18' ' ' PRO . 43.9 m-80 -80.83 -25.81 37.5 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.118 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -83.88 -37.62 22.17 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.553 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.426 ' O ' HD13 ' A' ' 27' ' ' LEU . 73.2 t -59.29 -55.59 22.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.045 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 20' ' ' MET . 8.3 mp -62.31 -31.32 71.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.081 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.24 -42.84 99.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 123.117 0.26 . . . . 0.0 111.241 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.495 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -64.92 -40.37 94.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.782 0.325 . . . . 0.0 110.403 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 23' ' ' VAL . 8.6 mp -63.13 -39.34 94.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.449 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.6 m -66.0 -34.42 78.05 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.5 mt -70.87 -36.42 72.78 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.664 0.269 . . . . 0.0 111.325 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.5 mt -59.61 -42.6 93.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.05 0.453 . . . . 0.0 110.067 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -65.75 -25.17 67.15 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -89.24 -2.42 58.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.746 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.1 12.2 40.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.171 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.6 t -99.34 115.23 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -101.31 -30.64 11.38 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.93 105.79 14.32 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.036 0.922 . . . . 0.0 112.784 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -117.38 154.53 19.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.512 -177.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HB ' HG12 ' A' ' 11' ' ' VAL . 50.3 t -121.69 120.63 62.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.103 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -96.78 120.52 46.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.275 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 91' ' ' GLU . 48.1 mttp -108.26 121.29 44.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.72 138.12 53.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -137.1 120.13 16.55 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.53 76.44 1.27 Allowed Glycine 0 C--O 1.219 -0.804 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.92 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 68.0 -15.66 0.2 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.3 6.05 3.97 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.813 0.445 . . . . 0.0 111.869 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.426 HG23 HG21 ' A' ' 90' ' ' ILE . 68.2 mt -56.73 -37.91 55.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.448 1.099 . . . . 0.0 109.406 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.1 p -67.56 -24.87 65.57 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.137 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -86.96 -29.96 21.65 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.534 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.24 -42.61 96.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.7 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.63 -40.75 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.214 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 55' ' ' ILE . 17.2 t70 -57.65 -44.18 85.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.445 0.641 . . . . 0.0 109.281 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 91.0 m -57.94 -51.08 71.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.678 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.448 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 33.8 m -69.85 -32.36 51.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.122 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.35 -36.48 83.84 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.8 mt -67.64 -46.77 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.141 0.496 . . . . 0.0 110.385 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' THR . 67.2 t -59.71 -38.27 75.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.166 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 53' ' ' VAL . 15.9 ptm180 -91.87 17.68 8.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.609 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -133.07 -41.73 0.9 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -86.91 -60.45 1.98 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.629 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.56 -58.28 3.42 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.045 0.45 . . . . 0.0 111.588 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.5 tp -148.0 102.49 3.39 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.3 -26.88 17.11 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.871 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.03 -50.28 66.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.15 0.5 . . . . 0.0 111.775 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -103.81 105.8 16.12 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.106 0.479 . . . . 0.0 110.882 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 tp -159.79 127.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.431 0.692 . . . . 0.0 110.652 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.81 149.57 51.4 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 173.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.77 134.67 46.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -90.95 -60.37 1.93 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.118 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -155.55 147.91 23.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.41 111.02 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -113.73 135.28 54.11 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.546 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -136.65 133.59 48.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.3 179.31 48.14 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.596 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 m -80.71 124.07 28.72 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.636 0.774 . . . . 0.0 110.971 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 25.7 tt0 -88.99 117.54 28.08 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.055 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 89.7 mtt180 . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -124.44 135.1 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.312 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 m -62.94 120.57 11.62 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 123.697 0.799 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 p -127.19 152.02 47.92 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 122.641 0.377 . . . . 0.0 110.364 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.426 HG21 HG23 ' A' ' 46' ' ' ILE . 15.9 tt -143.71 142.2 24.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.163 0 CA-C-O 120.782 0.325 . . . . 0.0 110.607 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' A' ' 40' ' ' LYS . 44.3 mt-10 -123.5 121.14 34.92 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.778 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -113.06 111.61 36.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.84 117.15 31.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.51 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 pt -119.16 168.17 11.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.935 0.398 . . . . 0.0 110.659 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -125.23 118.62 26.43 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.742 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt . . . . . 0 C--N 1.307 -1.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.136 179.309 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 . . . . . 0 C--O 1.238 0.453 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 20.9 m -115.68 131.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.174 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.78 145.78 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 60.5 tp -108.62 118.79 37.7 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.001 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -83.89 113.43 22.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.75 45.16 0.02 OUTLIER Glycine 0 C--O 1.237 0.305 0 C-N-CA 119.48 -1.343 . . . . 0.0 114.057 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -163.34 -59.69 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.241 0.52 . . . . 0.0 110.291 177.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.17 155.52 38.83 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.21 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.45 ' HD2' ' ND2' ' B' ' 21' ' ' ASN . 35.5 Cg_exo -63.26 158.99 41.61 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.569 2.179 . . . . 0.0 111.385 174.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.478 HG21 ' OD2' ' B' ' 51' ' ' ASP . 7.6 p -48.75 -35.1 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.599 1.16 . . . . 0.0 113.113 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.418 ' O ' HD13 ' B' ' 24' ' ' LEU . 26.3 ptm -57.66 -29.77 64.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.969 0.414 . . . . 0.0 111.743 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.45 ' ND2' ' HD2' ' B' ' 18' ' ' PRO . 40.7 m-80 -77.27 -30.58 54.38 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.63 -38.22 40.25 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.434 ' O ' HD13 ' B' ' 27' ' ' LEU . 66.7 t -60.35 -55.83 21.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.418 HD13 ' O ' ' B' ' 20' ' ' MET . 8.3 mp -63.79 -25.27 68.1 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.43 -44.9 85.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.666 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.459 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -63.54 -42.91 98.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.967 0.413 . . . . 0.0 110.65 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.434 HD13 ' O ' ' B' ' 23' ' ' VAL . 8.8 mp -61.23 -35.72 77.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.486 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 61.9 m -69.89 -35.74 74.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.294 0.569 . . . . 0.0 109.794 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -68.9 -35.3 76.68 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 122.159 -0.338 . . . . 0.0 111.368 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 91.1 mt -59.5 -41.12 89.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.084 0.469 . . . . 0.0 110.585 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -67.25 -25.04 65.89 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.077 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -87.94 -0.92 57.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.967 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.34 0.02 53.83 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.739 -0.744 . . . . 0.0 114.424 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.48 113.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -100.93 -27.74 13.14 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.901 0.381 . . . . 0.0 111.436 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.06 110.44 20.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.826 0.822 . . . . 0.0 112.198 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.492 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -123.16 152.75 28.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.963 -175.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.62 119.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 CA-C-O 121.156 0.503 . . . . 0.0 110.29 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -96.3 120.98 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.24 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.42 ' HG2' ' HG2' ' B' ' 91' ' ' GLU . 49.4 mttp -107.79 120.99 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.156 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -119.3 137.14 53.88 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -135.79 117.81 15.34 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.82 76.47 1.31 Allowed Glycine 0 C--O 1.217 -0.931 0 N-CA-C 114.742 0.657 . . . . 0.0 114.742 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 67.18 -15.04 0.17 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.89 6.87 4.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.0 0.429 . . . . 0.0 111.607 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.4 HG23 HG21 ' B' ' 90' ' ' ILE . 67.8 mt -55.99 -39.42 57.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 124.57 1.148 . . . . 0.0 109.778 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.0 p -64.66 -29.0 69.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.8 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.21 -28.59 27.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.571 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -65.62 -40.52 92.66 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.288 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.63 -40.97 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.171 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.478 ' OD2' HG21 ' B' ' 19' ' ' VAL . 15.6 t70 -54.68 -48.12 72.77 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.613 0.721 . . . . 0.0 109.518 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.46 ' O ' HG23 ' B' ' 56' ' ' VAL . 64.3 m -54.52 -52.0 63.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.941 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.26 -33.47 58.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.313 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.48 -35.91 82.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.098 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.7 mt -67.66 -47.38 80.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 120.946 0.403 . . . . 0.0 110.259 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 52' ' ' THR . 81.0 t -59.36 -38.49 75.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.936 -177.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -90.88 18.46 6.58 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.286 -0.259 . . . . 0.0 111.529 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.73 -48.74 0.88 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.235 0.54 . . . . 0.0 110.603 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -81.23 -52.2 7.59 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -80.81 -60.32 2.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.191 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -146.13 104.12 3.79 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.81 -24.73 16.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.925 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.71 -46.89 64.95 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.36 0.6 . . . . 0.0 111.361 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -104.13 105.83 16.13 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.987 0.423 . . . . 0.0 110.693 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -160.82 131.31 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.387 0.675 . . . . 0.0 109.905 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.81 147.46 42.56 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.5 mt -104.65 133.62 48.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -89.5 -60.43 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.092 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.04 149.28 27.01 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -138.2 109.61 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -112.01 134.85 53.31 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.515 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.29 130.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.59 177.89 46.57 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.063 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.5 m -79.46 125.27 29.34 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.087 0.955 . . . . 0.0 111.254 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 27.5 tt0 -90.1 116.5 28.16 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.448 HG22 ' HG2' ' B' ' 86' ' ' ARG . 40.5 t . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 96.6 mtt180 . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.98 133.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.66 120.25 10.83 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 123.651 0.78 . . . . 0.0 110.609 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.0 p -125.92 151.18 47.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.4 HG21 HG23 ' B' ' 46' ' ' ILE . 15.6 tt -141.74 143.58 26.92 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 120.626 0.251 . . . . 0.0 110.813 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.42 ' HG2' ' HG2' ' B' ' 40' ' ' LYS . 42.5 mt-10 -124.36 121.75 35.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.886 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.06 113.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.53 115.42 27.95 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 pt -118.83 161.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.728 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -120.23 118.53 30.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -102.97 78.85 1.7 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? . . . . . 0 C--O 1.279 2.61 0 C-N-CA 124.395 1.078 . . . . 0.0 109.775 177.315 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 t -142.3 160.64 39.85 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.5 t -105.71 13.62 29.49 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.47 123.22 7.65 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.347 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -90.91 141.08 26.35 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.83 156.46 48.47 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.527 2.151 . . . . 0.0 111.627 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 9.0 t -133.8 140.85 37.83 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 3.0 Cg_exo -79.4 125.41 6.3 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.439 2.093 . . . . 0.0 113.282 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.5 t -133.18 102.1 5.45 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -133.0 1.23 3.54 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.23 138.36 52.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.959 0.409 . . . . 0.0 110.824 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.51 151.03 33.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.0 tp -116.63 131.77 56.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 48' ' ' LYS . 51.2 mm -84.41 121.98 37.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.18 -115.74 3.44 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.453 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.64 12.25 16.0 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.55 147.0 58.37 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.365 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.11 147.93 80.53 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.396 2.064 . . . . 0.0 110.781 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 23' ' ' VAL . 13.8 p -58.64 -28.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.598 0.759 . . . . 0.0 112.072 -175.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 24' ' ' LEU . 27.1 ptt? -64.03 -24.0 67.55 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.19 0.519 . . . . 0.0 111.331 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.81 -30.49 51.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.021 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -82.82 -37.57 24.28 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.077 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 19' ' ' VAL . 67.4 t -58.25 -51.06 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.021 0.439 . . . . 0.0 110.687 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 20' ' ' MET . 9.2 mp -67.37 -30.05 69.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.124 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.65 -44.96 80.53 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.826 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.28 -35.28 80.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.187 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.4 -36.8 79.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -67.74 -35.68 79.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.514 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.4 mt -63.97 -36.45 84.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' A' ' 96' ' ' LYS . 3.4 tm? -63.21 -46.87 85.01 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -77.7 -4.01 44.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.573 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.95 -22.94 17.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.7 -8.3 4.91 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.979 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.97 107.28 20.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.156 0.503 . . . . 0.0 110.624 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.6 p -85.6 -25.65 26.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -118.84 113.97 21.9 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -122.55 146.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 123.274 0.358 . . . . 0.0 110.701 -178.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.44 118.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.2 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.8 mt -93.66 122.32 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.45 129.28 56.65 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.089 0.471 . . . . 0.0 109.785 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.12 169.59 17.37 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.496 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HB3' HG22 ' A' ' 89' ' ' THR 0.309 0.0 OUTLIER -158.64 149.92 20.69 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.498 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.35 -120.02 8.98 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.223 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 ptm180 -87.0 -3.33 59.08 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.235 0.54 . . . . 0.0 110.96 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.63 -6.9 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.303 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.86 -36.13 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.991 0.516 . . . . 0.0 110.382 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -62.27 -35.88 80.34 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.179 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.445 ' HB2' HG21 ' A' ' 14' ' ' ILE . 65.3 mttm -75.08 -32.84 61.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.173 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.54 96.3 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 110.724 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.52 -39.87 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.51 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.2 t70 -57.9 -39.02 76.89 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.242 0.617 . . . . 0.0 110.006 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -66.68 -55.53 14.75 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.46 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.9 -31.15 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.647 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 31.0 tt0 -64.94 -44.48 89.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.3 mt -61.3 -49.01 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.95 0.405 . . . . 0.0 110.065 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.22 -36.59 58.34 Favored 'Isoleucine or valine' 0 C--O 1.259 1.555 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -87.4 -7.43 57.72 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.81 24.74 7.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.284 0.564 . . . . 0.0 111.583 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -137.1 -65.89 0.53 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -86.6 -51.25 6.27 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.687 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mp -132.16 112.84 12.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -101.19 -57.81 2.01 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 124.177 0.923 . . . . 0.0 112.096 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.14 -36.02 66.6 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.212 0.53 . . . . 0.0 111.631 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.04 -15.95 45.66 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 62' ' ' ALA . 16.6 tt -80.22 148.31 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.077 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -139.06 145.04 39.09 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -173.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -90.93 145.81 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -105.25 -52.59 2.81 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.114 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -169.39 152.2 4.78 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt -138.47 119.96 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.554 0.742 . . . . 0.0 110.32 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -133.5 133.99 42.91 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.715 -0.615 . . . . 0.0 110.874 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.24 136.79 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.42 162.85 29.87 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.622 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 12.0 p -82.13 125.54 30.99 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.687 ' HA ' HE21 ' A' ' 75' ' ' GLN . 0.0 OUTLIER -104.62 146.3 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.767 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.3 t -94.57 106.02 17.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.23 161.54 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.31 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.0 p -97.15 139.17 33.53 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 121.233 0.54 . . . . 0.0 112.016 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -77.51 178.45 7.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.555 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -56.01 -34.55 65.93 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.41 -44.37 21.55 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.4 48.74 0.17 Allowed Glycine 0 C--N 1.296 -1.655 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -112.49 135.52 53.1 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -74.93 110.01 8.87 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.703 0.627 . . . . 0.0 111.077 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -117.11 129.28 55.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -89.79 132.08 35.42 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.61 134.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -66.18 108.21 2.2 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.822 0.701 . . . . 0.0 111.362 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.514 HG22 ' HB3' ' A' ' 42' ' ' ARG . 35.1 p -105.83 150.15 25.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.092 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.53 131.34 43.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.08 115.99 27.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.9 mt -110.71 114.0 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.47 122.33 47.46 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 120.675 0.274 . . . . 0.0 110.577 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.9 pt -120.99 157.08 24.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.969 0.414 . . . . 0.0 110.421 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -119.56 118.54 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.336 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HB2' HD23 ' A' ' 30' ' ' LEU . 32.3 mmmt -98.6 131.48 44.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 C--N 1.303 -1.418 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 175.304 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 C--O 1.223 -0.31 0 CA-C-O 120.379 0.133 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p -135.27 13.75 3.53 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.229 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 34.8 t -78.84 -73.14 0.35 Allowed 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.417 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.32 92.32 1.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.128 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 37.2 p -105.62 132.7 20.66 Favored Pre-proline 0 N--CA 1.432 -1.329 0 O-C-N 122.691 -0.299 . . . . 0.0 111.26 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 5' ' ' THR . 14.3 Cg_exo -71.57 -21.81 25.24 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.168 1.912 . . . . 0.0 109.916 173.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 56.5 m -84.51 124.68 73.13 Favored Pre-proline 0 N--CA 1.426 -1.649 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.912 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.03 140.33 89.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.355 2.703 . . . . 0.0 111.985 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -98.88 -44.09 6.49 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -107.12 -0.41 22.85 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.4 132.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.224 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.43 152.58 25.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.891 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -117.91 126.39 52.27 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' B' ' 48' ' ' LYS . 49.3 mm -80.91 119.02 29.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.463 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.72 -116.75 3.72 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.018 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -114.63 15.47 17.67 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.769 0.319 . . . . 0.0 111.078 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -84.07 146.4 48.47 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.683 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.52 143.03 79.92 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.8 2.334 . . . . 0.0 110.858 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.6 -30.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.446 ' O ' HD13 ' B' ' 24' ' ' LEU . 27.0 ptt? -60.95 -28.48 69.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 111.135 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.61 -35.6 67.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.016 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -78.81 -37.37 40.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.19 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -58.37 -51.93 65.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.694 0.283 . . . . 0.0 110.649 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 20' ' ' MET . 8.1 mp -67.49 -28.63 68.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.908 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -66.23 -46.02 78.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.01 86.24 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 121.35 0.595 . . . . 0.0 110.959 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 92.6 mt -65.48 -39.46 91.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.358 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.4 m -65.7 -37.05 85.36 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.394 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.5 mt -62.91 -37.17 85.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.709 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' B' ' 96' ' ' LYS . 3.4 tm? -61.86 -45.93 91.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -80.4 -2.3 45.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.825 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -93.48 -27.8 16.47 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.9 2.74 3.4 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.62 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.17 111.44 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 117.881 0.84 . . . . 0.0 110.087 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 p -87.79 -32.43 19.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -112.39 117.95 33.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.444 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -125.19 147.61 29.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.452 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.62 119.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.425 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 55.2 mt -95.05 123.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -115.73 130.49 56.87 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 121.481 0.658 . . . . 0.0 110.11 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.31 169.12 18.35 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.493 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.533 ' HB3' HG22 ' B' ' 89' ' ' THR 0.288 0.0 OUTLIER -158.45 149.79 20.92 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.685 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.92 -117.48 7.51 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.404 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -88.96 -4.6 58.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.032 0.444 . . . . 0.0 110.757 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.79 -9.05 59.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.03 -36.23 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.567 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 33.5 t -62.36 -35.53 79.41 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.248 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.445 ' HB2' HG21 ' B' ' 14' ' ' ILE . 64.9 mttm -76.3 -34.51 59.06 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.684 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.69 88.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.12 0.486 . . . . 0.0 111.039 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -73.23 -40.38 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.828 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.417 ' O ' HG13 ' B' ' 55' ' ' ILE . 32.4 t70 -58.55 -41.53 85.8 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.064 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 73.0 m -63.44 -54.96 28.31 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.001 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.44 -30.36 49.54 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.622 ' OE1' ' HB3' ' A' ' 74' ' ' SER . 27.7 tt0 -66.3 -43.49 86.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.417 HG13 ' O ' ' B' ' 51' ' ' ASP . 76.2 mt -61.71 -47.79 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.184 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.1 -34.36 56.48 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -89.16 -6.49 56.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -123.61 18.56 9.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.961 0.41 . . . . 0.0 111.697 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -131.97 -68.01 0.65 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.426 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -85.56 -49.05 8.35 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.733 -171.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 mp -133.54 112.0 11.14 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.507 ' O ' HG22 ' B' ' 65' ' ' ILE . . . -100.21 -63.36 1.14 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 124.013 0.821 . . . . 0.0 111.472 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.49 -37.03 86.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.112 0.565 . . . . 0.0 112.503 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.06 -15.36 41.55 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.507 HG22 ' O ' ' B' ' 62' ' ' ALA . 16.2 tt -80.41 148.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.608 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.545 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 40.4 tt0 -138.75 147.3 42.49 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -93.71 143.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -102.57 -52.46 3.09 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.294 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -169.87 150.97 4.01 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.98 118.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 123.575 0.547 . . . . 0.0 110.746 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.04 134.88 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.685 -0.634 . . . . 0.0 110.752 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.99 137.37 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.8 163.42 31.16 Favored Glycine 0 C--N 1.315 -0.619 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.647 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 17.5 p -83.38 124.27 30.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.361 0.601 . . . . 0.0 112.226 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . 0.659 HE21 ' HA ' ' B' ' 75' ' ' GLN . 0.0 OUTLIER -103.05 145.93 29.15 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.56 107.84 19.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -117.91 163.91 14.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 22.5 p -99.55 139.33 35.36 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.564 0.697 . . . . 0.0 112.099 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 20.4 m -74.85 178.34 5.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.485 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -60.16 -31.71 70.36 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.73 -52.49 8.32 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.182 0.991 . . . . 0.0 108.64 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.88 48.56 0.07 OUTLIER Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -114.39 133.08 55.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -72.43 115.45 11.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 123.621 0.575 . . . . 0.0 110.979 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 24.3 t -122.89 130.5 52.94 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' ' 86' ' ' ARG . 22.7 mtp180 -90.24 132.19 35.65 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.17 134.95 50.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.2 p -66.29 108.66 2.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.472 0.653 . . . . 0.0 111.84 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.533 HG22 ' HB3' ' B' ' 42' ' ' ARG . 33.8 p -106.49 148.98 27.55 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.568 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.05 130.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.813 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -113.64 113.74 25.46 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -108.93 116.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.4 121.24 44.3 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.606 0.241 . . . . 0.0 110.59 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 pt -119.54 154.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.545 ' HD3' ' OE1' ' B' ' 66' ' ' GLU . 60.3 ttt180 -117.47 121.3 40.65 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.508 ' HB2' HD23 ' B' ' 30' ' ' LEU . 32.2 mmmt -102.35 132.77 48.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.891 176.877 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.5 m -109.21 -35.66 6.24 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 m -101.54 136.69 40.97 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.31 56.7 4.96 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.0 m 66.36 96.88 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 124.301 1.04 . . . . 0.0 112.448 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -73.71 137.21 24.51 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.846 2.364 . . . . 0.0 112.453 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 9.8 t -99.55 135.93 20.48 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 3.4 Cg_exo -80.49 116.66 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.117 1.878 . . . . 0.0 112.393 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 m -108.19 7.84 27.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.776 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -92.85 13.1 21.41 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.286 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.16 133.91 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.315 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.88 145.29 32.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.335 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.7 tp -107.18 124.32 49.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 48' ' ' LYS . 46.3 mm -89.36 117.23 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 118.685 -1.722 . . . . 0.0 115.171 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -155.07 -41.08 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.976 0.888 . . . . 0.0 110.695 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -101.43 158.06 32.49 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.967 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.3 157.11 55.98 Favored 'Trans proline' 0 C--O 1.248 0.995 0 C-N-CA 121.845 1.696 . . . . 0.0 110.129 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG21 ' OD1' ' A' ' 51' ' ' ASP . 14.7 p -56.9 -26.91 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.463 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.6 ptp -62.91 -28.57 70.14 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.77 -35.73 32.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.251 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.34 -34.63 72.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.278 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 19' ' ' VAL . 96.4 t -60.57 -48.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.653 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 20' ' ' MET . 88.4 mt -66.29 -31.56 72.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.468 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.99 -50.76 61.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.43 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.33 -38.89 92.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.65 -45.06 73.76 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.146 0.978 . . . . 0.0 109.604 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 m -71.57 -41.4 69.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.072 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.1 mt -60.66 -37.67 82.35 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.489 0.316 . . . . 0.0 111.786 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 93.6 mt -61.76 -36.74 81.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.746 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -95.37 0.77 53.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.99 0.424 . . . . 0.0 111.333 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -90.72 -31.35 16.6 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.86 -19.95 2.9 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.673 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -80.03 99.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 m -78.16 -37.34 46.1 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.388 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 9.9 pt-20 -120.26 118.66 31.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.8 pt -119.5 160.31 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.71 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.39 112.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.199 0.524 . . . . 0.0 110.745 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.54 126.63 44.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -114.29 112.82 23.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.51 133.87 54.34 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.557 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.593 ' HG2' HG22 ' A' ' 89' ' ' THR . 87.4 mtt180 -129.76 143.61 50.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.21 81.35 0.1 OUTLIER Glycine 0 C--O 1.211 -1.333 0 O-C-N 123.784 0.677 . . . . 0.0 114.49 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 58.66 -7.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 126.192 1.797 . . . . 0.0 115.083 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.58 -3.12 29.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.411 HG23 HG21 ' A' ' 90' ' ' ILE . 69.7 mt -51.7 -39.33 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.188 1.395 . . . . 0.0 110.663 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -68.27 -24.46 64.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.562 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.4 ' HB2' HG21 ' A' ' 14' ' ' ILE . 69.0 mttm -84.86 -27.72 26.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.059 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.58 -44.61 81.79 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.812 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.01 -35.23 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.054 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.52 ' OD1' HG21 ' A' ' 19' ' ' VAL . 15.0 t70 -59.52 -47.87 83.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -54.75 -56.47 18.94 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.338 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 m -67.13 -30.76 50.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.29 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.562 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 27.1 tt0 -65.99 -38.69 89.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.42 0.45 . . . . 0.0 111.014 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.7 mt -66.26 -49.68 74.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.466 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.05 -50.47 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.562 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 35.0 ptt180 -68.56 -7.78 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -115.33 -12.07 11.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.716 0.769 . . . . 0.0 110.369 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -105.77 -53.5 2.63 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -82.22 -60.39 2.23 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.201 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.481 HD12 ' H ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -146.85 105.62 3.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -176.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 6.21 46.12 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.441 ' H ' HD13 ' A' ' 61' ' ' LEU . 31.4 t70 -95.05 -65.0 1.01 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.484 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' H ' HD12 ' A' ' 61' ' ' LEU . 45.9 mttm -98.94 94.24 6.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tp -148.91 141.13 17.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 45.0 tt0 -132.58 152.99 51.44 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.6 132.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -75.03 -53.75 8.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -173.71 156.84 2.98 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -129.96 115.69 34.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 91' ' ' GLU . 12.5 ptm180 -139.46 147.55 41.51 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.414 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.414 HG12 HG21 ' B' ' 70' ' ' ILE . 11.6 p -144.23 146.76 20.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.29 -171.01 36.07 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.181 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.518 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 36.8 p -108.46 123.83 49.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -99.85 117.57 34.46 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.65 115.39 42.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.12 163.86 36.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.255 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.8 p -97.66 143.66 28.1 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.3 t -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 175.9 -38.96 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 124.272 1.029 . . . . 0.0 108.324 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -123.47 -156.51 0.71 Allowed 'General case' 0 C--O 1.251 1.144 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.8 75.02 1.1 Allowed Glycine 0 C--N 1.31 -0.901 0 CA-C-O 121.557 0.532 . . . . 0.0 113.767 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -147.38 104.01 3.61 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.2 120.15 24.99 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.341 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.3 m -103.15 123.81 47.4 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.23 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -104.86 117.31 33.72 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.3 t -127.77 125.94 65.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.162 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 p -67.03 121.57 15.85 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.593 HG22 ' HG2' ' A' ' 42' ' ' ARG . 64.6 p -117.47 153.91 32.32 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.411 HG21 HG23 ' A' ' 46' ' ' ILE . 17.6 tt -142.78 129.79 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.454 ' HB2' ' HG3' ' A' ' 71' ' ' ARG . 3.4 mp0 -107.08 105.83 16.04 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.3 mm -102.26 110.77 29.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.31 128.91 54.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.612 0.244 . . . . 0.0 110.382 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.1 155.07 40.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.514 ' HD3' ' OE1' ' A' ' 36' ' ' GLU . 53.1 ttp180 -133.04 126.2 31.34 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.504 0.669 . . . . 0.0 111.592 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.41 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -88.8 124.3 34.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 66' ' ' GLU . 68.0 mttm . . . . . 0 C--N 1.317 -0.827 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.62 0.248 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -115.92 -168.8 1.48 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 32.9 t -143.88 146.19 32.84 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.08 147.37 4.53 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 8.1 t -159.18 141.71 10.21 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.75 168.07 25.69 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.072 1.848 . . . . 0.0 109.911 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 39.6 m -101.78 109.74 60.29 Favored Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.664 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.57 166.99 10.31 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.284 1.99 . . . . 0.0 111.295 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -114.61 -78.49 0.58 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.383 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -106.03 14.94 27.17 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 20.9 m -120.37 138.82 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.428 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.36 145.48 35.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.032 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.17 126.45 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.413 HG21 ' HB2' ' B' ' 48' ' ' LYS . 46.4 mm -90.47 115.89 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.84 44.84 0.02 OUTLIER Glycine 0 CA--C 1.523 0.564 0 C-N-CA 118.849 -1.643 . . . . 0.0 114.855 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.89 -43.08 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 117.655 0.728 . . . . 0.0 110.875 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.472 ' HE2' ' HD2' ' B' ' 18' ' ' PRO . 13.5 mmmm -101.32 156.87 34.65 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.449 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.472 ' HD2' ' HE2' ' B' ' 17' ' ' LYS . 29.1 Cg_endo -64.64 157.77 53.78 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.293 1.996 . . . . 0.0 110.727 172.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.444 ' O ' HG23 ' B' ' 23' ' ' VAL . 13.9 p -56.12 -27.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.1 ptp -63.05 -29.24 70.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.065 0.459 . . . . 0.0 111.007 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.32 -37.88 36.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.201 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.62 -36.32 78.49 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.531 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.444 HG23 ' O ' ' B' ' 19' ' ' VAL . 66.2 t -61.2 -47.46 93.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 20' ' ' MET . 89.9 mt -67.66 -30.43 69.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.161 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.3 -51.38 53.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.85 -37.99 89.03 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.353 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 27.7 tp -55.02 -45.61 75.18 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.213 1.005 . . . . 0.0 109.194 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 48.7 m -70.47 -40.72 73.48 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.883 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.5 mt -61.32 -38.1 85.64 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.477 0.311 . . . . 0.0 111.499 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 98.3 mt -61.76 -38.48 88.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.101 0.56 . . . . 0.0 111.882 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.89 -5.37 51.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.424 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -84.13 -31.83 25.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.212 0.53 . . . . 0.0 109.788 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.06 -15.01 3.05 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.063 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.15 97.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -73.95 -39.14 63.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.32 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.552 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 10.2 pt-20 -121.14 118.56 30.0 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.41 0.624 . . . . 0.0 111.576 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.6 162.49 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.859 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 57.4 t -129.18 115.66 36.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.23 0.538 . . . . 0.0 110.369 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.8 mt -94.24 122.4 45.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.01 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -110.43 111.75 23.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.145 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.58 132.52 55.09 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.642 ' HG2' HG22 ' B' ' 89' ' ' THR . 87.8 mtt180 -129.06 144.06 51.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.44 80.98 0.12 Allowed Glycine 0 C--O 1.214 -1.11 0 O-C-N 123.879 0.737 . . . . 0.0 114.338 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 56.35 -3.81 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.998 1.719 . . . . 0.0 115.138 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.16 -3.07 34.24 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.271 0.557 . . . . 0.0 110.851 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.404 HG23 HG21 ' B' ' 90' ' ' ILE . 69.2 mt -51.67 -40.46 26.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.857 1.263 . . . . 0.0 110.365 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.6 t -66.12 -28.66 68.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.651 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.413 ' HB2' HG21 ' B' ' 14' ' ' ILE . 68.7 mttm -82.98 -28.39 29.76 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.508 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.8 86.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 120.945 0.402 . . . . 0.0 110.748 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.72 -36.69 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.545 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.468 ' O ' HG13 ' B' ' 55' ' ' ILE . 15.0 t70 -58.86 -46.85 86.79 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -54.45 -57.8 9.93 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.672 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.34 -29.3 45.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.871 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.525 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 24.0 tt0 -67.68 -36.93 81.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.968 0.413 . . . . 0.0 111.089 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.468 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.0 mt -66.56 -50.17 68.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.241 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.04 -50.45 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.525 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 34.5 ptt180 -67.83 -8.21 34.27 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -116.63 -12.51 10.91 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.759 0.79 . . . . 0.0 110.46 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -104.8 -53.51 2.67 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -82.64 -59.93 2.35 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.943 -172.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.558 HD12 ' H ' ' B' ' 64' ' ' LYS . 0.3 OUTLIER -146.72 106.31 3.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.39 6.32 44.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.407 ' H ' HD13 ' B' ' 61' ' ' LEU . 33.0 t70 -94.81 -57.8 2.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.402 0.62 . . . . 0.0 110.924 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.558 ' H ' HD12 ' B' ' 61' ' ' LEU . 48.8 mttm -107.74 95.42 5.67 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.127 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tp -149.22 139.29 16.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.457 ' HB2' ' HE2' ' B' ' 97' ' ' LYS . 45.2 tt0 -130.33 148.39 52.15 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.91 123.94 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -67.45 -59.76 3.12 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.646 0.591 . . . . 0.0 109.847 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.38 154.69 8.72 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.414 HG21 HG12 ' A' ' 72' ' ' VAL . 71.1 mt -129.7 114.14 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 123.617 0.573 . . . . 0.0 109.66 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' B' ' 91' ' ' GLU . 12.4 ptm180 -138.07 146.68 43.24 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.308 -0.245 . . . . 0.0 111.177 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 13.3 p -143.6 144.69 23.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.82 -171.42 36.11 Favored Glycine 0 CA--C 1.5 -0.874 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.807 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.525 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 26.3 p -107.35 124.77 50.3 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 122.563 0.345 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -100.71 117.08 34.09 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.0 110.5 28.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.8 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.28 160.73 35.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 120.711 0.291 . . . . 0.0 110.409 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 13.1 p -92.62 145.64 24.28 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.004 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 41.2 t -69.69 -42.31 74.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 174.04 -38.38 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -122.44 -158.84 0.8 Allowed 'General case' 0 C--O 1.253 1.267 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.04 76.99 1.18 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-O 121.331 0.406 . . . . 0.0 112.724 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -149.66 105.66 3.46 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.05 122.16 28.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.688 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.2 m -104.48 125.92 51.1 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.686 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -107.52 114.78 29.01 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.37 126.07 68.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.084 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 73.8 p -67.32 122.99 19.1 Favored 'General case' 0 C--O 1.266 1.956 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.642 HG22 ' HG2' ' B' ' 42' ' ' ARG . 60.7 p -119.4 153.49 35.13 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.404 HG21 HG23 ' B' ' 46' ' ' ILE . 18.3 tt -142.46 131.28 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.456 ' HB2' ' HG3' ' B' ' 71' ' ' ARG . 3.4 mp0 -109.02 105.5 15.04 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.588 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mm -102.6 110.72 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.87 129.85 55.89 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.874 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' B' ' 36' ' ' GLU . 35.4 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.597 0.236 . . . . 0.0 110.66 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.552 ' HD3' ' OE2' ' B' ' 36' ' ' GLU . 51.2 ttp180 -126.62 125.3 41.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.978 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.402 ' HB2' HD22 ' B' ' 30' ' ' LEU . 0.0 OUTLIER -89.34 120.67 30.89 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' B' ' 66' ' ' GLU . 67.3 mttm . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m -92.44 98.05 11.23 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.709 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.3 t -102.59 136.3 42.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.882 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.15 -27.36 18.77 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.913 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.7 p -95.51 153.22 39.56 Favored Pre-proline 0 N--CA 1.428 -1.526 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.311 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -73.61 -57.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p 51.51 76.41 0.55 Allowed Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.206 1.002 . . . . 0.0 113.277 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.71 -75.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.392 2.061 . . . . 0.0 113.51 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.2 p -150.14 14.9 0.81 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 120.927 0.394 . . . . 0.0 111.486 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -95.09 3.37 54.86 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.761 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.36 112.49 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -110.55 134.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.264 0.555 . . . . 0.0 110.74 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.59 129.5 43.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.223 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.8 mm -91.28 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.99 50.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.103 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -157.6 -65.05 0.09 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 117.22 0.51 . . . . 0.0 110.682 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -101.82 168.45 9.02 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.36 167.13 19.35 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.058 1.839 . . . . 0.0 112.253 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG11 ' OD2' ' A' ' 51' ' ' ASP . 93.1 t -50.32 -38.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.373 1.069 . . . . 0.0 112.602 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.3 ptp -52.02 -31.45 29.81 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.03 -32.87 63.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 121.507 0.67 . . . . 0.0 110.404 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -80.52 -34.64 35.47 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.285 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.01 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.291 0.567 . . . . 0.0 109.693 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.56 -35.95 81.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.032 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.47 96.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.288 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -9.19 57.69 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.11 0.481 . . . . 0.0 111.76 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -95.97 -43.99 7.56 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -60.3 -40.33 90.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.55 -36.07 81.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.396 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.529 HD23 ' HG3' ' A' ' 96' ' ' LYS . 3.4 tm? -64.86 -39.23 93.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -67.29 -17.82 64.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.17 0.51 . . . . 0.0 111.188 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -91.96 -4.56 54.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.4 -7.56 32.34 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.098 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.44 99.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.243 0.544 . . . . 0.0 109.949 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -89.45 -29.64 18.87 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.095 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.32 115.99 30.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.782 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -127.81 156.14 39.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.555 -178.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.0 t -124.95 124.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.807 0.692 . . . . 0.0 110.549 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.7 mt -105.65 130.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.419 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.39 122.99 41.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.189 0.519 . . . . 0.0 110.897 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.73 155.05 33.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -133.01 141.07 48.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.449 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.47 -118.58 7.91 Favored Glycine 0 CA--C 1.505 -0.574 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.304 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -94.65 8.08 43.58 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.84 -0.38 57.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.888 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.25 -38.3 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 p -62.72 -32.01 73.04 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.305 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -70.19 -37.27 75.06 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.1 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.93 91.22 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.546 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.89 -33.95 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.551 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.529 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 t70 -62.63 -45.24 93.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.7 m -57.0 -53.35 59.04 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.552 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.9 m -66.05 -36.05 76.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.27 -45.18 94.19 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 123.132 0.27 . . . . 0.0 111.563 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.4 mt -60.59 -43.03 93.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.49 -43.95 98.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.503 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -83.45 13.64 4.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.273 0.558 . . . . 0.0 111.41 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -119.99 -45.68 2.46 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.845 0.355 . . . . 0.0 110.277 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.4 ptp180 -81.8 -21.65 37.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.544 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 60.9 t80 -117.56 -70.12 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.391 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.544 ' HG ' ' CD2' ' A' ' 60' ' ' PHE . 90.0 mt -132.61 114.82 14.67 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.08 -33.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.245 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.33 -52.61 9.6 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.451 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -97.21 88.46 4.47 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.607 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -160.73 120.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.899 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.541 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 10.2 pt-20 -121.7 134.95 54.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 111.056 177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.8 mt -88.81 139.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -84.62 -54.92 4.4 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.074 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -170.69 152.62 3.83 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.1 mt -134.08 116.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 77.1 mtp180 -116.83 137.47 52.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.866 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.91 124.44 50.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 -168.37 24.71 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.537 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.6 p -118.04 124.34 47.87 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.128 0.489 . . . . 0.0 110.783 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -100.01 128.19 46.13 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.96 115.58 28.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.68 160.59 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.426 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.6 p -91.72 126.92 36.98 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 120.794 0.33 . . . . 0.0 110.35 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -79.94 -20.43 45.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.403 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -163.38 -82.37 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.19 -80.03 0.58 Allowed 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.35 31.35 6.24 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.12 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -106.56 106.57 17.16 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.02 136.39 34.52 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.24 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 t -130.83 136.81 49.02 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -101.07 120.4 40.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.25 126.43 73.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -67.64 128.45 36.5 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.473 0.483 . . . . 0.0 110.96 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.4 p -123.0 160.41 26.34 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 71' ' ' ARG . 13.0 tt -146.06 124.35 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -105.0 110.46 22.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.286 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -109.93 116.77 53.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.25 125.18 51.86 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.02 159.0 32.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.541 ' HD2' ' OE2' ' A' ' 66' ' ' GLU . 41.6 ttm180 -126.22 132.32 51.77 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 123.46 0.704 . . . . 0.0 111.18 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HG3' HD23 ' A' ' 30' ' ' LEU . 34.2 mmtp -92.87 149.9 20.96 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.642 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.254 1.333 0 C-N-CA 124.074 0.95 . . . . 0.0 109.489 175.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttm . . . . . 0 CA--C 1.51 -0.561 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -107.23 149.67 27.48 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.1 t -83.63 173.4 11.41 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.61 67.49 1.11 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.103 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 9.4 t -140.51 139.15 19.77 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 5' ' ' THR . 1.3 Cg_endo -82.69 -7.13 11.57 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.203 1.935 . . . . 0.0 112.486 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 31.2 p -119.89 123.58 28.37 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.17 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.05 114.41 2.43 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 C-N-CA 122.808 2.338 . . . . 0.0 112.491 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 36.8 t -89.66 118.64 29.43 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -128.26 9.44 6.16 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.64 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.1 115.17 47.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.14 134.57 53.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.086 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 tp -97.58 127.63 43.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.342 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mm -88.52 110.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.3 52.23 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.016 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -159.72 -65.4 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.219 0.509 . . . . 0.0 110.405 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -101.54 168.04 9.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.423 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.59 164.62 30.37 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.978 1.785 . . . . 0.0 112.393 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 95.2 t -46.77 -38.39 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.128 1.371 . . . . 0.0 113.22 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptp -52.31 -35.08 49.65 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -69.9 -35.39 74.57 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.19 0.519 . . . . 0.0 110.685 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -78.75 -35.49 44.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.16 -50.82 78.72 Favored 'Isoleucine or valine' 0 C--O 1.252 1.231 0 CA-C-O 121.601 0.715 . . . . 0.0 109.124 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.89 -32.53 74.28 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.158 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.85 94.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.021 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.16 68.38 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.168 0.509 . . . . 0.0 110.754 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.83 -44.19 42.22 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.468 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -63.21 -38.55 91.6 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.832 0.349 . . . . 0.0 111.152 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.24 -39.04 89.25 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 122.315 -0.241 . . . . 0.0 110.92 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.475 HD23 ' HG3' ' B' ' 96' ' ' LYS . 3.4 tm? -60.19 -40.13 88.96 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.709 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.87 -20.92 66.01 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.045 0.45 . . . . 0.0 111.714 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -87.17 -9.28 55.62 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.11 -4.55 23.82 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.844 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.24 96.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 0.0 109.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -84.03 -28.24 27.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -114.84 120.42 39.93 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.436 ' H ' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.98 154.56 40.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 O-C-N 123.16 0.288 . . . . 0.0 111.348 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.68 124.36 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.216 0.532 . . . . 0.0 110.56 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.64 130.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.343 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.26 123.95 44.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.173 0.511 . . . . 0.0 110.904 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 153.94 35.18 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -129.1 143.39 50.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.47 -122.76 15.35 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 116.312 -0.404 . . . . 0.0 113.533 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -92.17 11.64 24.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.905 0.383 . . . . 0.0 110.944 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.33 -1.04 57.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.509 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.49 -37.25 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.126 0.571 . . . . 0.0 110.36 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.5 p -66.12 -31.36 72.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.233 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -69.15 -39.96 78.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.481 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.31 91.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.606 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -72.4 -34.28 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.589 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.556 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.0 t70 -62.73 -45.18 93.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 90.4 m -56.23 -53.74 53.55 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.622 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.24 -34.23 67.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.959 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -60.99 -47.97 84.0 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.556 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.8 mt -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.883 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.01 -41.03 91.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -85.76 14.7 5.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.24 0.543 . . . . 0.0 111.043 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -121.33 -45.44 2.33 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.277 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.8 ptp180 -83.28 -19.28 36.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.462 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.55 ' CD2' ' HG ' ' B' ' 61' ' ' LEU . 57.8 t80 -118.66 -71.56 0.73 Allowed 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.64 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.55 ' HG ' ' CD2' ' B' ' 60' ' ' PHE . 94.0 mt -131.15 114.91 15.69 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.158 0.504 . . . . 0.0 111.71 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.26 -32.16 11.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.551 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.83 -49.48 11.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.0 87.35 3.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.413 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -160.71 119.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 11.0 pt-20 -122.04 136.16 54.89 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.131 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.42 143.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.76 -58.14 2.68 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.925 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -167.67 152.0 6.61 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 67.0 mt -133.35 115.56 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' B' ' 90' ' ' ILE . 73.9 mtp180 -115.06 136.41 53.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.822 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.72 126.08 56.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.12 -168.45 26.19 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.156 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.2 p -116.27 121.14 41.12 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.359 0.6 . . . . 0.0 111.235 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -96.22 127.2 42.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.643 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.3 114.99 26.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -121.38 157.44 24.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.009 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 16.9 p -87.94 127.44 35.37 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 120.894 0.378 . . . . 0.0 110.476 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 47.1 t -76.76 -31.93 57.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.468 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -153.42 -77.67 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -120.17 -76.37 0.58 Allowed 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 121.086 0.47 . . . . 0.0 110.058 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.84 35.96 4.16 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.782 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -114.66 111.83 21.93 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.28 136.85 32.79 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.536 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 35.4 t -129.69 137.73 50.78 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -100.77 118.89 37.76 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 72.7 t -115.7 125.24 72.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -67.26 127.08 31.31 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.969 0.414 . . . . 0.0 111.232 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 67.8 p -121.42 159.37 26.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.095 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' B' ' 71' ' ' ARG . 12.3 tt -146.21 124.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.933 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -103.59 113.16 26.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.31 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.9 mt -112.02 114.64 47.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.32 125.45 53.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 pt -126.07 158.54 35.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' B' ' 66' ' ' GLU . 41.5 ttm180 -124.53 134.95 52.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.677 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.475 ' HG3' HD23 ' B' ' 30' ' ' LEU . 34.1 mmtp -97.66 148.52 23.24 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 123.849 0.86 . . . . 0.0 109.517 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.517 175.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 C--O 1.216 -0.698 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 p -127.0 -52.09 1.43 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.064 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 m -145.43 167.97 21.67 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 122.122 -0.361 . . . . 0.0 110.424 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.24 58.16 0.02 OUTLIER Glycine 0 CA--C 1.499 -0.929 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 22.0 p -106.35 133.98 19.99 Favored Pre-proline 0 N--CA 1.433 -1.307 0 C-N-CA 122.22 0.208 . . . . 0.0 110.983 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 2.0 Cg_endo -82.79 23.34 0.82 Allowed 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.597 2.198 . . . . 0.0 111.031 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.6 p -110.25 152.2 43.06 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.621 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.13 169.38 18.25 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.054 1.836 . . . . 0.0 110.365 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 p -81.63 81.89 7.55 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.264 0.554 . . . . 0.0 110.846 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -121.33 11.53 10.77 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.394 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 58.3 t -116.06 119.59 62.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.11 147.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.098 0.475 . . . . 0.0 111.284 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 tp -110.76 134.82 52.16 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.52 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.412 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.69 -138.06 4.59 Favored Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -101.68 18.3 20.71 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -96.86 154.67 38.23 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.152 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.44 148.15 53.81 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.187 2.591 . . . . 0.0 112.499 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.532 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -54.68 -36.15 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.762 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.417 ' O ' HD13 ' A' ' 24' ' ' LEU . 26.9 ptt? -59.31 -24.76 63.58 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -64.86 -38.59 91.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -85.33 -33.42 22.07 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.987 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.5 t -62.29 -55.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.169 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 20' ' ' MET . 9.3 mp -62.05 -26.45 68.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.692 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.481 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.68 -45.75 70.86 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.118 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -61.58 -42.45 98.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp -61.84 -38.26 87.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.1 m -68.2 -37.94 81.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.924 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 96.7 mt -63.18 -34.99 78.83 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.368 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.9 mt -57.52 -41.8 81.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.28 -16.89 62.49 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -91.63 2.05 56.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.51 0.672 . . . . 0.0 110.338 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.68 -3.81 59.31 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.56 91.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 t -90.24 -12.13 38.87 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.96 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 43.3 tt0 -124.56 111.98 16.3 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.444 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -125.89 156.82 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.823 0.345 . . . . 0.0 111.698 -177.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -126.35 125.49 67.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.009 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.81 129.45 61.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.125 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -118.73 123.54 45.1 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -121.01 153.07 37.82 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -129.59 140.95 51.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.089 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.7 -135.04 18.6 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.292 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -83.05 2.63 34.1 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.5 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.5 30.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.579 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.35 -36.95 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.361 0.601 . . . . 0.0 109.705 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.1 p -61.55 -37.42 83.73 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.543 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -67.64 -42.84 81.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.153 -178.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -64.02 -45.27 89.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.466 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.8 -36.77 65.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.805 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.532 ' OD2' HG21 ' A' ' 19' ' ' VAL . 17.9 t70 -59.59 -47.63 84.83 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 56' ' ' VAL . 87.2 m -53.36 -53.56 49.28 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.444 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -69.98 -31.18 46.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 25.3 tt0 -68.61 -32.17 71.87 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.947 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.3 mt -68.69 -42.83 83.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.119 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 52' ' ' THR . 59.8 t -69.19 -30.93 47.98 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 CA-C-O 121.25 0.548 . . . . 0.0 111.292 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 40.4 ptt180 -88.88 14.98 9.16 Favored 'General case' 0 C--O 1.211 -0.94 0 O-C-N 122.023 -0.423 . . . . 0.0 110.299 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -128.67 -56.02 1.22 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -73.27 -29.15 62.54 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -97.96 -63.21 1.15 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.023 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.48 110.55 5.69 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.798 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.41 -46.69 8.2 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.555 1.159 . . . . 0.0 110.777 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.91 -29.52 58.45 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.77 97.23 7.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -160.95 143.69 4.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.957 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.72 141.72 51.48 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.35 125.6 68.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HD2' ' HG3' ' A' ' 36' ' ' GLU . 29.6 mtpp -86.05 -62.48 1.51 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -167.28 149.29 5.91 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.014 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.2 mt -139.15 99.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.22 136.79 54.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.8 t -102.16 132.7 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.82 167.29 28.24 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.881 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 p -93.88 135.89 34.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.829 0.347 . . . . 0.0 110.825 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.486 ' HG2' HG13 ' A' ' 77' ' ' VAL . 36.0 tt0 -100.48 114.18 27.56 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG22 ' HG2' ' A' ' 86' ' ' ARG . 45.1 t -95.86 108.19 20.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.486 HG13 ' HG2' ' A' ' 75' ' ' GLN . 26.1 m -124.52 165.79 20.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.269 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.7 p -88.36 131.74 34.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 120.902 0.382 . . . . 0.0 110.461 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.4 t -86.21 -30.55 22.31 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.762 0.315 . . . . 0.0 111.032 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -144.87 -76.5 0.22 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.322 0.582 . . . . 0.0 110.711 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -123.24 -79.42 0.61 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.406 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.34 7.43 26.67 Favored Glycine 0 CA--C 1.506 -0.493 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.017 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -84.3 107.47 16.61 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -79.0 137.11 37.42 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.703 0.627 . . . . 0.0 110.582 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.9 t -125.07 129.28 49.93 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.479 ' HG2' HG22 ' A' ' 76' ' ' VAL . 99.5 mtt180 -102.83 125.53 49.61 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.58 136.44 58.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.7 p -70.24 127.26 32.19 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.518 0.675 . . . . 0.0 111.956 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.0 p -133.11 160.15 38.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.774 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.67 139.53 48.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -118.13 110.76 18.0 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -111.5 119.74 60.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.41 120.26 30.56 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.723 0.297 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.34 168.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 ttt180 -136.85 133.7 36.12 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.22 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 70.7 mmtt -95.72 -170.46 2.15 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt . . . . . 0 C--O 1.255 1.351 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.998 176.172 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.5 tpp . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m 71.06 176.46 0.28 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.073 0.949 . . . . 0.0 111.301 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 45.8 t -107.0 -52.2 2.8 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.715 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.49 -7.82 53.42 Favored Glycine 0 CA--C 1.503 -0.683 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.597 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 40.5 p 52.9 82.28 0.25 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.458 1.103 . . . . 0.0 113.417 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -90.97 173.21 2.93 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 122.501 2.134 . . . . 0.0 111.447 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p 55.98 91.53 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.65 1.18 . . . . 0.0 113.264 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.99 112.99 1.46 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.051 2.5 . . . . 0.0 112.614 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -95.5 11.32 33.38 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.508 0.67 . . . . 0.0 109.976 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -94.57 9.26 39.31 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.734 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.03 114.96 48.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -111.29 143.46 21.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.01 138.28 43.48 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -86.18 125.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.792 0.329 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.56 -140.0 7.46 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.777 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -99.81 14.87 28.82 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -91.31 154.38 44.62 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.328 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.96 146.68 56.14 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.203 2.602 . . . . 0.0 112.391 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.435 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.1 p -51.66 -35.52 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.307 1.043 . . . . 0.0 113.516 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.09 -25.34 66.89 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.27 -36.96 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.495 0.664 . . . . 0.0 110.117 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -87.04 -33.66 19.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.205 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 19' ' ' VAL . 65.6 t -61.31 -55.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.583 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.66 -26.16 68.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.761 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -68.34 -44.18 75.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.173 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -41.72 96.19 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.14 -36.81 80.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.958 0.408 . . . . 0.0 110.671 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 37.9 m -68.66 -38.36 80.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 95.6 mt -63.58 -35.18 79.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.254 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 91.2 mt -55.84 -42.81 76.32 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -71.61 -15.14 62.24 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -93.38 1.7 56.8 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.37 0.605 . . . . 0.0 110.382 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.42 -8.27 58.55 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.657 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.92 91.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.249 0.547 . . . . 0.0 109.605 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -90.16 -13.17 36.19 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.773 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -123.91 116.62 23.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.906 -0.496 . . . . 0.0 109.669 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 157.9 42.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-O 120.806 0.336 . . . . 0.0 111.633 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.0 124.7 65.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.218 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.9 mt -106.97 127.43 62.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.03 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -117.22 122.32 43.68 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.689 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.51 151.59 40.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -128.17 139.82 52.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.332 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.83 -136.14 20.25 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.239 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -80.52 0.53 33.36 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 122.439 -0.447 . . . . 0.0 111.53 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.43 -0.81 27.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.627 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 75.2 mt -55.91 -38.87 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.15 0.5 . . . . 0.0 110.021 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -61.71 -38.03 86.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.733 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.401 ' NZ ' ' HB2' ' B' ' 48' ' ' LYS . 0.0 OUTLIER -66.14 -41.56 90.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.28 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 -45.89 81.23 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.209 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.11 -34.09 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.462 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.525 ' O ' HG13 ' B' ' 55' ' ' ILE . 12.3 t70 -60.9 -47.18 87.56 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -54.84 -55.08 34.21 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 18.0 m -68.14 -31.88 53.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.131 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.521 ' HG3' ' HE ' ' B' ' 57' ' ' ARG . 27.3 tt0 -68.6 -31.01 69.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.099 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.525 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.0 mt -69.54 -43.59 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.191 176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.41 -31.36 52.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 CA-C-O 121.297 0.57 . . . . 0.0 111.335 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.521 ' HE ' ' HG3' ' B' ' 54' ' ' GLU . 40.0 ptt180 -88.66 17.27 5.64 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.896 0.379 . . . . 0.0 110.358 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -131.56 -57.08 1.0 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.138 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -72.55 -26.68 61.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -101.65 -64.03 1.09 Allowed 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.975 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -141.93 112.33 7.07 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.7 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.9 -50.23 5.82 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 124.293 0.995 . . . . 0.0 110.875 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.49 -28.76 62.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.918 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -105.54 98.02 7.77 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.442 0.639 . . . . 0.0 110.755 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tp -161.15 145.12 4.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.869 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -126.17 138.48 53.66 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.24 126.72 63.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -86.63 -64.47 1.15 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -166.33 146.98 6.31 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.393 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.3 mt -139.43 100.82 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -124.19 143.46 50.49 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.59 123.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.56 168.64 24.1 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.761 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.51 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 35.1 p -92.96 133.34 36.22 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.659 0.384 . . . . 0.0 110.907 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . 0.454 ' HG2' HG13 ' B' ' 77' ' ' VAL . 36.1 tt0 -99.61 114.49 27.57 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' B' ' 86' ' ' ARG . 46.7 t -96.19 107.81 20.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.454 HG13 ' HG2' ' B' ' 75' ' ' GLN . 19.9 m -124.21 168.11 17.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.158 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 17.4 p -91.02 132.83 35.76 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.843 0.354 . . . . 0.0 110.102 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 36.7 t -88.35 -26.36 22.26 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.329 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -148.57 -84.36 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.093 0.557 . . . . 0.0 110.596 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -113.03 -80.27 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.671 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.84 3.79 25.87 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.11 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -78.47 103.84 8.68 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -77.68 137.2 38.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.505 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.2 t -124.39 130.01 51.71 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.474 ' HG2' HG22 ' B' ' 76' ' ' VAL . 99.6 mtt180 -101.5 128.17 47.85 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.62 137.4 56.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 7.2 p -72.31 127.47 32.67 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.464 0.649 . . . . 0.0 112.223 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.75 158.38 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.114 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.04 139.54 50.06 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -119.16 112.38 19.44 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -112.39 116.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.01 35.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 pt -125.14 163.26 26.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 120.983 0.421 . . . . 0.0 110.482 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' B' ' 96' ' ' LYS . 76.4 ttt180 -132.44 134.21 44.81 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' B' ' 95' ' ' ARG . 69.4 mmtt -97.6 -170.36 1.99 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.318 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt . . . . . 0 C--O 1.256 1.4 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.195 176.773 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.496 -1.107 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 p -170.94 135.49 1.05 Allowed 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 123.828 0.705 . . . . 0.0 109.155 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m -133.39 4.22 3.67 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.983 0.421 . . . . 0.0 110.762 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.09 -10.17 75.72 Favored Glycine 0 N--CA 1.463 0.449 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 34.7 p -85.39 147.02 45.96 Favored Pre-proline 0 N--CA 1.418 -2.07 0 CA-C-N 115.084 -0.558 . . . . 0.0 109.75 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 3.7 Cg_exo -81.83 23.41 0.77 Allowed 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.695 2.264 . . . . 0.0 111.419 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.8 p -91.41 116.74 67.04 Favored Pre-proline 0 N--CA 1.434 -1.237 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.351 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.51 138.65 27.3 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.912 1.741 . . . . 0.0 111.251 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.3 p -83.32 87.23 6.96 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.161 0.505 . . . . 0.0 110.32 176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -118.3 12.46 13.42 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.547 0.689 . . . . 0.0 110.385 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.65 120.37 60.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.156 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.53 139.69 42.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.991 0.424 . . . . 0.0 110.693 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.3 tp -104.21 136.73 43.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.313 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.3 mm -84.09 123.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.4 -159.49 11.77 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.03 13.41 1.79 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -86.07 152.48 56.03 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 121.95 -0.469 . . . . 0.0 112.162 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.65 150.79 59.16 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.859 2.373 . . . . 0.0 112.213 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.545 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.4 p -56.23 -35.31 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.503 0.721 . . . . 0.0 112.388 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.1 ptp -57.89 -30.81 66.17 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.93 -34.08 74.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -79.09 -33.34 44.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.196 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 66.1 t -61.62 -48.52 88.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.84 -38.54 91.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.645 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.81 -44.64 96.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.2 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.38 96.61 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.19 0.519 . . . . 0.0 111.012 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 95.3 mt -64.92 -38.97 92.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.806 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.9 m -67.74 -31.79 71.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.2 mt -70.6 -40.37 73.25 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 122.088 -0.383 . . . . 0.0 110.245 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.56 -40.97 89.07 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.372 0.606 . . . . 0.0 109.406 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -59.13 -30.21 67.96 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.44 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -91.26 3.19 55.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.52 11.99 57.58 Favored Glycine 0 C--O 1.244 0.759 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.921 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.31 98.04 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 13.1 p -87.46 -13.87 42.01 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.404 ' OE1' ' HG3' ' A' ' 68' ' ' LYS . 36.6 tt0 -128.66 111.79 13.56 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -126.35 159.66 35.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.02 127.29 51.46 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-O 121.573 0.701 . . . . 0.0 110.86 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -101.88 124.29 55.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.52 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 81.8 mttt -115.46 114.27 24.81 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.32 0.581 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.07 158.49 17.7 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.848 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.546 ' HG2' HG22 ' A' ' 89' ' ' THR . 54.8 mtm180 -133.54 148.68 51.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.91 -121.58 19.57 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 123.559 0.537 . . . . 0.0 113.016 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -92.0 -0.28 57.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.63 -4.03 46.92 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -54.9 -36.07 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.7 0.8 . . . . 0.0 110.529 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -63.39 -35.49 80.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.616 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.23 -30.04 60.42 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.3 82.35 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.31 -37.19 64.61 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.184 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.545 ' OD2' HG21 ' A' ' 19' ' ' VAL . 34.9 t70 -60.66 -43.39 97.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.875 0.369 . . . . 0.0 110.086 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -58.71 -51.25 70.77 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.279 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.96 -32.37 51.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.59 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 7.6 tp10 -63.66 -40.3 96.51 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.1 mt -64.21 -44.33 97.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.81 -39.59 82.34 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.831 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.522 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 2.6 ptm180 -80.66 1.33 30.43 Favored 'General case' 0 C--O 1.206 -1.199 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -128.17 11.35 6.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.081 0.467 . . . . 0.0 111.789 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -118.1 -66.71 1.05 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.709 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -75.9 -67.17 0.7 Allowed 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.827 0.346 . . . . 0.0 110.386 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.484 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -138.23 109.25 6.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -87.04 -44.9 11.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.429 1.08 . . . . 0.0 110.343 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.96 -28.71 67.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.619 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -121.02 106.84 11.96 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -159.26 120.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.291 0.567 . . . . 0.0 110.506 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -98.45 134.39 41.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.264 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.5 mt -101.2 122.64 53.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 1.9 tmtp? -83.58 -55.59 4.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.398 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -173.55 154.25 2.49 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -133.4 116.18 24.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -119.31 134.79 55.02 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.725 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 90' ' ' ILE . 46.4 t -125.84 131.57 71.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.88 28.92 Favored Glycine 0 CA--C 1.493 -1.335 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -115.18 145.11 42.71 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 117.228 0.514 . . . . 0.0 111.238 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -114.48 134.81 54.73 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.2 m -88.98 123.34 41.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.408 0.623 . . . . 0.0 110.93 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.26 136.5 59.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.65 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.0 p -83.93 115.3 22.23 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.165 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.8 t -63.29 -41.45 98.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.163 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -140.31 -73.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -122.56 -82.14 0.65 Allowed 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.784 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.67 46.7 1.13 Allowed Glycine 0 CA--C 1.498 -0.981 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.96 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -128.56 95.3 4.09 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -84.76 120.64 26.66 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.595 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 t -105.33 134.6 48.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.72 114.79 29.16 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.85 139.62 42.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.8 p -67.41 126.29 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 O-C-N 123.757 0.661 . . . . 0.0 110.828 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.546 HG22 ' HG2' ' A' ' 42' ' ' ARG . 46.6 p -132.03 151.19 51.89 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.363 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.2 tt -136.11 140.0 44.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.92 109.42 15.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.68 111.8 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.12 122.58 47.98 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.978 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.32 157.65 24.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.783 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.5 ttp180 -126.02 133.44 51.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.484 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 3.1 tmtm? -108.1 139.46 42.73 Favored 'General case' 0 N--CA 1.413 -2.288 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.235 -174.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 73.9 mmtt . . . . . 0 C--O 1.256 1.395 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.5 p -89.72 -35.99 15.45 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m 71.73 -38.83 0.43 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.947 1.299 . . . . 0.0 112.212 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.6 -153.87 7.61 Favored Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 38.3 p -79.89 130.56 66.54 Favored Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 122.253 0.221 . . . . 0.0 111.024 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.73 178.63 6.91 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 123.107 2.538 . . . . 0.0 112.096 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 60.0 m -88.71 127.22 57.09 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.191 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.24 122.08 11.06 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 123.428 2.752 . . . . 0.0 112.55 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -103.08 85.83 2.58 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.215 0.531 . . . . 0.0 110.016 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -129.04 15.09 6.29 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.614 0.721 . . . . 0.0 110.886 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.38 126.92 66.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.067 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.51 139.8 46.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.104 0.478 . . . . 0.0 110.495 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 tp -104.32 138.23 41.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.299 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -85.34 123.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.253 0.549 . . . . 0.0 111.295 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.9 -160.49 11.91 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.48 12.46 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -84.64 153.42 61.29 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.805 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.28 154.32 29.58 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.755 2.304 . . . . 0.0 111.772 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.443 HG21 ' OD2' ' B' ' 51' ' ' ASP . 7.1 p -61.58 -35.88 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.028 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.408 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 23.3 ptp -56.93 -28.74 62.44 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.179 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.18 -36.83 77.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -76.42 -32.92 58.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.434 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 70.2 t -60.94 -50.48 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 20' ' ' MET . 91.9 mt -64.1 -34.36 77.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.35 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.72 81.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.73 97.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.963 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 97.6 mt -63.8 -37.93 89.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.618 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -34.54 77.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.191 0.519 . . . . 0.0 110.251 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.38 -40.55 81.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.201 -0.312 . . . . 0.0 110.421 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.67 -39.35 80.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.096 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.25 -28.78 69.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.354 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -92.5 6.67 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.873 0.368 . . . . 0.0 111.909 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.73 60.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.433 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.82 97.57 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 31.7 p -83.8 -21.71 32.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -122.2 115.27 22.09 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.454 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.65 154.34 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.04 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.06 128.48 67.16 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 CA-C-O 121.775 0.798 . . . . 0.0 111.22 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 62.5 mt -101.91 124.67 55.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.728 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.6 mttt -114.82 115.68 27.39 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.398 0.618 . . . . 0.0 110.744 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.41 158.54 18.36 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.064 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.488 ' HG2' HG22 ' B' ' 89' ' ' THR . 50.9 mtm180 -132.33 149.94 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.61 -117.08 9.84 Favored Glycine 0 N--CA 1.446 -0.643 0 O-C-N 123.604 0.565 . . . . 0.0 113.02 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -97.43 0.5 47.85 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.16 -2.96 43.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.686 0.279 . . . . 0.0 111.699 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.79 -36.21 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.887 0.875 . . . . 0.0 110.268 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 32.2 p -63.64 -35.4 80.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.37 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -76.29 -29.42 57.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.44 77.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -71.04 -34.91 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.515 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.0 t70 -60.87 -42.97 98.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.003 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.1 m -60.63 -53.17 60.7 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.512 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.35 -31.78 52.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 8.3 tp10 -64.92 -39.72 93.95 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.515 HG13 ' O ' ' B' ' 51' ' ' ASP . 81.7 mt -63.08 -45.65 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.6 t -60.52 -39.23 80.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.507 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 2.9 ptm180 -79.64 -2.87 44.68 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -127.21 20.75 6.81 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.041 0.448 . . . . 0.0 111.383 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -125.8 -66.58 0.93 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.547 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -77.61 -67.47 0.72 Allowed 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.479 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 0.6 OUTLIER -137.21 110.0 7.6 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -86.59 -47.34 9.3 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 124.264 0.977 . . . . 0.0 110.71 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.56 -30.89 65.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.796 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -117.8 102.54 9.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.546 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -156.16 121.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.102 0.477 . . . . 0.0 110.647 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' B' ' 95' ' ' ARG . 23.5 mm-40 -99.98 133.79 43.85 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.061 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.45 123.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.21 -52.85 5.92 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.79 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -176.88 152.95 0.99 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.83 115.5 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -118.2 134.59 54.88 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.822 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.52 134.51 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.58 -167.44 37.9 Favored Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.9 p -109.66 149.28 29.94 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 117.59 0.695 . . . . 0.0 111.076 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.45 132.8 56.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 m -88.47 120.74 37.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.387 0.613 . . . . 0.0 111.318 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.3 138.41 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.34 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 12.6 p -82.74 118.1 23.13 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.765 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 48.4 t -63.82 -42.02 97.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.133 0.492 . . . . 0.0 110.977 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -139.5 -75.38 0.36 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -126.53 -79.23 0.6 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.409 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.63 58.78 0.44 Allowed Glycine 0 C--N 1.306 -1.116 0 C-N-CA 119.866 -1.159 . . . . 0.0 112.989 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -144.28 103.6 4.0 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -93.1 118.16 30.89 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.732 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -100.39 136.18 40.68 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.5 112.61 25.74 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.41 138.99 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 13.1 p -66.24 128.02 34.47 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.216 0.532 . . . . 0.0 110.859 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.488 HG22 ' HG2' ' B' ' 42' ' ' ARG . 47.9 p -132.87 148.64 52.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.118 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 15.4 tt -133.62 139.37 48.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -118.09 108.9 15.78 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.72 111.8 37.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.0 123.24 49.88 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.815 0.341 . . . . 0.0 110.216 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -121.97 155.85 26.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' B' ' 35' ' ' SER . 60.7 ttp180 -126.06 128.5 47.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.484 ' HD3' ' H ' ' B' ' 97' ' ' LYS . 2.7 tmtm? -104.94 143.34 33.3 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 -174.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.484 ' H ' ' HD3' ' B' ' 96' ' ' LYS . 74.4 mmtt . . . . . 0 C--O 1.263 1.8 0 CA-C-O 117.253 -1.356 . . . . 0.0 107.697 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mmm . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -68.25 -27.02 65.98 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.792 0.33 . . . . 0.0 111.239 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 m -123.95 165.84 16.72 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.09 -53.82 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 p -87.74 161.73 43.82 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -84.94 9.81 4.0 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.649 2.233 . . . . 0.0 113.005 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 m -91.5 112.34 53.75 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.08 120.34 6.76 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.328 2.019 . . . . 0.0 111.972 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 m -98.64 137.31 37.45 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.658 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -112.45 9.01 19.6 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.701 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -95.19 117.58 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 m -107.95 136.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.441 0.638 . . . . 0.0 111.57 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.26 104.74 14.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.819 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.89 107.7 12.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.375 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.53 36.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.921 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -160.21 -50.95 0.05 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.85 0.86 . . . . 0.0 110.611 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -97.97 154.88 37.6 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.777 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.78 156.37 62.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.914 2.409 . . . . 0.0 113.077 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.34 -41.73 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.811 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -62.85 -25.19 68.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.954 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.14 -21.83 56.13 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.294 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.0 -35.53 17.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.57 -50.65 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.143 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.09 -29.07 69.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.06 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -70.22 -48.15 58.31 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.621 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.86 91.03 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.516 0.51 . . . . 0.0 110.681 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.1 -30.6 71.56 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.305 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 93.7 m -78.89 -42.57 26.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 99.0 mt -62.78 -31.73 72.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.821 0.344 . . . . 0.0 110.732 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.96 -45.12 96.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.84 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.05 -25.64 64.57 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.421 0.629 . . . . 0.0 110.006 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' THR . 15.1 mm100 -80.01 -3.64 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.386 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 -7.93 36.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.447 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -85.44 97.18 5.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 42.5 m -98.38 0.01 44.58 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.796 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -135.38 115.15 12.89 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 155.35 41.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 O-C-N 123.306 0.379 . . . . 0.0 110.684 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.22 122.93 62.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.55 132.6 47.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.285 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' HG2' ' HG2' ' A' ' 91' ' ' GLU . 53.5 mttp -121.53 122.13 39.0 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.34 0.591 . . . . 0.0 111.359 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.68 147.73 50.77 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.158 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HG3' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.0 152.04 50.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 -124.25 9.12 Favored Glycine 0 C--N 1.309 -0.964 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.274 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -92.69 2.66 56.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.209 0.528 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.56 -7.68 55.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.967 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -55.83 -40.78 63.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.7 t -63.11 -33.38 75.33 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.959 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.79 -35.82 62.51 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.157 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.26 93.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.743 0.306 . . . . 0.0 111.508 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.88 -33.23 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 110.768 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.1 t70 -66.23 -40.82 90.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -57.46 -46.51 83.56 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.566 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -71.38 -36.74 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.07 -45.81 79.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.413 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 74.1 mt -59.16 -50.35 80.1 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.788 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.83 -46.4 96.6 Favored 'Isoleucine or valine' 0 C--O 1.256 1.407 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -80.18 -5.48 56.15 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.119 0.485 . . . . 0.0 112.265 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -125.69 12.02 7.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -123.09 -41.49 2.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.772 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -123.71 -57.58 1.63 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.338 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.27 76.68 7.58 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.459 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.09 18.26 19.05 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.321 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -149.65 -59.7 0.21 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.515 0.674 . . . . 0.0 110.414 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HB3' ' OXT' ' A' ' 97' ' ' LYS . 48.3 mttm -94.07 80.75 4.08 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.098 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' O ' ' HE3' ' A' ' 97' ' ' LYS . 8.5 tp -159.2 145.6 7.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.291 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.41 167.93 21.0 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.036 0.446 . . . . 0.0 110.78 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.71 128.26 55.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.86 -57.45 3.75 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -177.03 146.9 0.53 Allowed 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.4 pt -130.55 129.64 64.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.27 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -135.97 143.73 45.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.409 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 p -137.44 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.98 -145.42 5.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 m -138.38 134.47 34.21 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 65.2 tt0 -96.83 140.29 31.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.804 0.335 . . . . 0.0 110.276 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -100.91 109.96 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.28 150.71 18.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 120.812 0.339 . . . . 0.0 110.604 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 p -85.69 124.26 32.02 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.286 0.565 . . . . 0.0 109.897 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.2 m -92.17 -19.67 22.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.299 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -141.15 -82.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 110.589 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -135.18 -72.25 0.47 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.64 -16.19 29.69 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.614 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -65.75 110.49 2.83 Favored 'General case' 0 C--O 1.253 1.284 0 O-C-N 122.621 -0.341 . . . . 0.0 110.944 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -90.99 152.36 20.72 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.15 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.1 t -141.57 152.67 44.27 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 94.3 mtt180 -121.36 131.69 54.33 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 120.893 0.378 . . . . 0.0 110.743 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.55 136.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 m -62.81 123.99 19.89 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 123.566 0.541 . . . . 0.0 109.855 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 42' ' ' ARG . 33.7 p -130.57 146.53 52.11 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.365 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -135.6 140.11 45.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.729 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.454 ' HG2' ' HG2' ' A' ' 40' ' ' LYS . 43.8 mt-10 -120.13 115.49 23.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.868 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.06 115.49 49.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.66 128.13 55.08 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -132.77 159.72 43.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 35' ' ' SER . 59.4 ttp180 -140.93 145.56 36.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' C ' ' HD3' ' A' ' 96' ' ' LYS . 12.7 tmtt? -89.72 141.48 28.57 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.976 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' OXT' ' HB3' ' A' ' 64' ' ' LYS . 98.2 mttt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 CA--C 1.494 -1.203 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -125.5 -52.54 1.6 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.951 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 40.1 t 66.84 96.6 0.06 Allowed 'General case' 0 C--N 1.35 0.625 0 O-C-N 124.094 0.871 . . . . 0.0 111.482 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.33 -121.74 2.62 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 66.8 p -84.94 145.97 44.8 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.57 -162.43 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.29 1.993 . . . . 0.0 110.909 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -55.49 131.22 70.75 Favored Pre-proline 0 C--O 1.253 1.276 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.06 107.77 0.19 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.571 2.847 . . . . 0.0 113.219 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.7 p -163.92 -47.02 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.701 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -89.58 8.42 31.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.185 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 48.4 t -102.36 109.27 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.8 m -103.16 137.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.763 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.45 108.38 19.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.917 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.38 116.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.097 0.475 . . . . 0.0 109.927 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.38 35.46 0.02 OUTLIER Glycine 0 C--N 1.311 -0.823 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.829 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -161.92 -48.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.967 0.907 . . . . 0.0 111.212 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -99.88 155.48 36.41 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.391 -174.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.77 153.1 79.61 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.736 2.291 . . . . 0.0 112.374 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.446 ' O ' HG23 ' B' ' 23' ' ' VAL . 7.1 p -52.51 -39.47 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.616 0.767 . . . . 0.0 112.858 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -63.38 -26.78 68.91 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.76 -25.86 60.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.317 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.04 -37.85 21.61 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 19' ' ' VAL . 61.4 t -58.55 -49.56 81.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.426 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.3 -28.4 68.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.748 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -69.66 -47.9 61.71 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.447 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -45.62 87.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.606 0.566 . . . . 0.0 110.977 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.3 mt -63.04 -31.49 72.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.157 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 90.6 m -77.12 -44.47 30.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.595 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 96.6 mt -61.57 -31.64 71.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.92 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.5 -45.29 94.32 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.128 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -69.57 -24.78 63.75 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.428 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -79.91 -8.56 59.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.153 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.48 2.83 33.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.231 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.86 96.19 5.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 41.4 m -100.08 2.81 43.56 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -137.48 111.35 8.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.437 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.23 157.2 40.62 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.063 -176.147 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 60.4 t -127.13 122.23 59.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.268 0.556 . . . . 0.0 111.073 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.07 130.43 50.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' B' ' 91' ' ' GLU . 52.4 mttp -120.5 122.77 41.36 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.46 0.648 . . . . 0.0 111.291 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.51 148.85 50.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.989 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.45 ' HG3' HG22 ' B' ' 89' ' ' THR . 0.1 OUTLIER -130.98 151.85 50.94 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.97 -126.19 11.8 Favored Glycine 0 C--N 1.303 -1.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.177 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -89.79 1.21 56.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.07 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.82 -8.16 55.6 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.235 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.45 -39.96 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.407 0.683 . . . . 0.0 110.799 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 40.6 t -63.25 -33.48 75.58 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.065 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -75.31 -35.18 61.29 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.321 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.14 88.86 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.263 0.554 . . . . 0.0 111.381 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.72 -30.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.503 ' O ' HG13 ' B' ' 55' ' ' ILE . 22.9 t70 -66.4 -42.98 87.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 70.4 m -56.5 -47.5 79.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.786 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.6 m -70.1 -38.1 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.83 -46.45 78.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.15 0.281 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.1 mt -58.56 -51.1 75.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.017 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.18 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--O 1.254 1.341 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -79.98 -5.04 54.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -127.28 14.86 7.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -125.86 -38.69 2.18 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.818 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -126.69 -57.96 1.33 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.16 74.85 8.73 Favored 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.983 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.88 24.96 8.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.293 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -153.52 -59.77 0.13 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.772 0.796 . . . . 0.0 109.754 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.488 ' HB3' ' OXT' ' B' ' 97' ' ' LYS . 46.7 mttm -98.25 81.71 2.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.106 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.415 ' O ' ' HE3' ' B' ' 97' ' ' LYS . 8.9 tp -157.53 146.13 10.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.84 169.49 17.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.148 0.499 . . . . 0.0 110.854 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.47 128.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -79.9 -58.59 3.1 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 43.5 tt0 -175.82 145.04 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.03 0.932 . . . . 0.0 108.913 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -127.91 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.45 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 53.5 mtt180 -135.79 139.67 43.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.09 144.07 36.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.41 -145.69 6.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -136.37 137.68 40.81 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -99.1 139.69 34.38 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.728 0.299 . . . . 0.0 110.197 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -100.71 112.1 32.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.99 153.04 18.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.301 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 9.7 p -88.16 124.89 34.27 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.095 0.474 . . . . 0.0 109.779 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 22.4 m -92.2 -19.06 22.62 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.787 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -144.48 -79.56 0.19 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.162 0.505 . . . . 0.0 110.269 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -136.15 -75.88 0.43 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.441 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.17 -8.78 46.63 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.5 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -72.7 109.64 6.47 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -89.65 153.87 20.4 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 124.046 0.841 . . . . 0.0 109.154 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -141.12 144.72 35.03 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -114.91 130.57 56.93 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 123.334 0.396 . . . . 0.0 110.836 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.6 133.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 20.3 m -60.0 124.6 20.72 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.546 0.529 . . . . 0.0 109.904 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.45 HG22 ' HG3' ' B' ' 42' ' ' ARG . 33.5 p -132.22 144.69 50.81 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.249 -176.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.8 tt -134.04 140.44 46.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.548 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' B' ' 40' ' ' LYS . 45.0 mt-10 -120.28 115.18 23.07 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.273 0.629 . . . . 0.0 109.611 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.37 115.98 51.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.15 128.26 54.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -132.75 159.98 42.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' B' ' 35' ' ' SER . 59.2 ttp180 -141.22 146.29 36.7 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.977 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 12.7 tmtt? -91.34 141.81 28.37 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.488 ' OXT' ' HB3' ' B' ' 64' ' ' LYS . 98.1 mttt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m 56.69 20.76 5.29 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 173.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.3 t -133.42 176.95 8.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.93 -104.28 0.17 Allowed Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.0 m 66.45 97.38 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 123.823 0.849 . . . . 0.0 112.322 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -67.58 127.23 16.03 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.74 2.293 . . . . 0.0 112.336 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -84.07 133.58 45.28 Favored Pre-proline 0 N--CA 1.429 -1.481 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.116 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.9 104.01 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.85 2.366 . . . . 0.0 111.772 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -97.31 -27.57 14.44 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.0 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -132.83 10.52 4.28 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.304 0.573 . . . . 0.0 110.812 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.25 122.24 68.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.6 156.55 14.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.073 0.463 . . . . 0.0 111.441 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.45 133.5 55.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.4 112.52 21.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.74 -155.71 13.24 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.68 26.27 0.18 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.92 150.56 36.96 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.75 150.58 81.97 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.939 2.426 . . . . 0.0 112.852 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG21 ' OD1' ' A' ' 51' ' ' ASP . 10.5 p -57.92 -38.31 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.55 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.401 ' O ' HD13 ' A' ' 24' ' ' LEU . 23.2 ptp -59.98 -27.34 66.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.936 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -68.85 -32.44 72.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 110.123 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -80.07 -35.85 36.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.658 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 60.3 t -59.11 -52.69 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.811 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 20' ' ' MET . 8.7 mp -65.85 -31.74 72.87 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.031 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.16 -44.79 87.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -63.19 -41.93 99.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 88.8 mt -61.15 -35.6 77.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.144 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.6 m -69.81 -36.71 75.86 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.526 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.2 mt -68.2 -33.36 74.29 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 89.3 mt -59.4 -39.88 84.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.602 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.91 -27.88 66.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.95 -6.15 56.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.59 14.71 34.11 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 121.049 -0.595 . . . . 0.0 112.866 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.47 96.13 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 122.153 -0.616 . . . . 0.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 p -88.43 -8.15 55.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -131.35 112.86 13.1 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.476 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -123.42 144.85 31.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.293 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.5 123.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.544 0.528 . . . . 0.0 110.62 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.04 121.81 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -116.57 127.48 54.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.368 0.604 . . . . 0.0 110.917 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -118.7 157.74 26.87 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.565 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -127.07 146.75 50.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.762 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.7 -116.81 9.69 Favored Glycine 0 CA--C 1.494 -1.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.287 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -99.45 4.21 46.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 110.789 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.36 50.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.92 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.8 mt -54.28 -40.05 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.725 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.3 t -64.75 -21.72 66.82 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.596 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -87.88 -29.97 20.49 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.51 84.83 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.093 0.473 . . . . 0.0 110.402 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -72.94 -33.23 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.0 t70 -64.21 -48.73 74.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -55.95 -50.34 71.04 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.924 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -68.15 -31.01 49.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.903 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 31.5 tt0 -68.19 -37.81 81.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.924 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 51' ' ' ASP . 79.5 mt -58.59 -43.4 87.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.429 0.456 . . . . 0.0 111.047 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.35 -43.75 80.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -79.36 8.79 5.53 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -135.21 7.06 3.36 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -117.53 -68.6 0.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.258 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HB3' HD22 ' A' ' 61' ' ' LEU . 87.4 m-85 -79.46 -69.34 0.59 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 2.5 mm? -122.62 102.61 8.16 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.34 -24.49 27.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.985 0.803 . . . . 0.0 111.214 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -96.97 -45.97 6.39 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.461 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.65 81.17 8.74 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.722 0.773 . . . . 0.0 111.636 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.5 134.52 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.095 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.544 ' OE1' ' HD2' ' A' ' 97' ' ' LYS . 47.2 mt-10 -114.01 141.82 46.94 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.74 126.58 48.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -82.21 -68.78 0.67 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.722 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -159.39 140.41 12.67 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -128.14 115.82 40.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -119.34 134.25 55.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.12 128.25 25.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.45 . . . . 0.0 110.099 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.32 -147.14 5.65 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.932 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -109.34 133.56 52.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -116.58 125.46 51.87 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.61 108.64 18.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.16 160.77 9.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.153 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.5 p -93.91 119.84 33.37 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.496 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.3 t -57.74 -62.6 1.68 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.892 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -144.81 -78.54 0.19 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.69 -69.86 0.55 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.817 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.64 29.99 0.45 Allowed Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.913 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -92.85 125.76 37.61 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -82.1 143.67 31.33 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 123.511 0.507 . . . . 0.0 110.508 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.6 t -139.9 136.03 33.48 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -93.99 112.42 24.25 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.7 t -119.35 134.04 64.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 p -67.28 123.37 20.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 123.703 0.627 . . . . 0.0 109.46 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.8 p -127.67 152.6 47.48 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.861 0.363 . . . . 0.0 111.366 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.7 tt -139.17 135.19 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.644 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.44 114.34 22.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.97 115.75 50.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.95 55.18 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.48 158.27 34.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.334 0.587 . . . . 0.0 111.629 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -112.77 114.88 27.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.647 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.583 ' NZ ' ' HB2' ' A' ' 61' ' ' LEU . 13.6 mmmt -88.93 131.98 34.9 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.576 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.544 ' HD2' ' OE1' ' A' ' 66' ' ' GLU . 28.5 mtpp . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 120.726 0.298 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -75.82 -61.54 1.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m 63.51 26.3 14.73 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.094 0.558 . . . . 0.0 111.767 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.63 118.97 15.42 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.368 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 24.6 m -88.87 -45.98 0.44 Allowed Pre-proline 0 CA--C 1.586 2.341 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.09 138.81 44.78 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 121.644 1.562 . . . . 0.0 113.027 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 33.1 m -81.95 121.38 79.08 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.967 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.9 98.69 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.898 2.399 . . . . 0.0 112.017 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 17.1 m -116.91 8.03 13.41 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-O 121.397 0.618 . . . . 0.0 109.852 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -144.98 12.63 1.43 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.108 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.47 122.72 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.33 163.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 120.818 0.342 . . . . 0.0 111.012 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 tp -124.19 134.34 53.31 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.93 113.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.074 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.65 -157.62 12.48 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.543 ' H ' ' HD3' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -76.63 26.29 0.13 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.42 148.56 35.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.71 152.3 64.07 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.811 2.341 . . . . 0.0 113.193 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.606 HG21 ' OD2' ' B' ' 51' ' ' ASP . 8.9 p -58.33 -39.86 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.414 ' O ' HD13 ' B' ' 24' ' ' LEU . 22.9 ptp -58.18 -25.64 61.78 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.221 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -69.9 -32.33 70.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 109.932 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -81.17 -37.04 29.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.485 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 51.9 t -58.81 -52.41 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 123.763 0.664 . . . . 0.0 110.374 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.414 HD13 ' O ' ' B' ' 20' ' ' MET . 8.4 mp -66.47 -30.15 70.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.738 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.449 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.34 -45.96 82.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.165 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -62.78 -41.23 99.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.558 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.9 mt -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.714 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -72.87 -32.98 65.8 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.295 0.569 . . . . 0.0 110.221 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 94.0 mt -70.72 -32.42 69.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 90.3 mt -60.08 -39.82 87.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.584 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -69.01 -24.39 64.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.616 0.722 . . . . 0.0 110.779 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -83.62 -3.3 57.6 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.43 12.45 51.21 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.145 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -91.05 95.88 5.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 30.5 p -89.09 -5.83 57.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.711 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.88 116.15 16.13 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.438 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -127.06 144.32 37.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.689 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.33 121.64 68.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.14 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -107.14 121.89 60.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.3 132.29 56.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.075 0.465 . . . . 0.0 110.174 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.85 159.16 28.74 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.761 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -129.89 143.55 50.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.737 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.13 -117.64 8.71 Favored Glycine 0 CA--C 1.497 -1.065 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.166 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -99.02 0.95 44.87 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.266 0.555 . . . . 0.0 110.176 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.75 -7.09 52.28 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.985 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.34 -40.38 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.832 0.853 . . . . 0.0 110.802 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.39 -28.08 69.74 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.388 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -82.17 -29.7 31.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.73 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.14 -45.28 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.35 -33.59 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.086 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.606 ' OD2' HG21 ' B' ' 19' ' ' VAL . 35.4 t70 -62.4 -46.61 87.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.894 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 84.9 m -58.85 -51.03 71.76 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.907 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.75 -30.63 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.925 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 33.4 tt0 -68.91 -35.49 76.9 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.742 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.455 HG13 ' O ' ' B' ' 51' ' ' ASP . 79.6 mt -61.23 -43.18 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.741 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 67.4 t -68.46 -43.67 83.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.998 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 28.7 ptt180 -79.02 8.72 5.21 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.576 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -131.84 -3.51 3.64 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.395 0.617 . . . . 0.0 111.17 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.74 -64.75 1.2 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.745 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' B' ' 61' ' ' LEU . 90.1 m-85 -80.56 -74.63 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.595 ' HB2' ' NZ ' ' B' ' 96' ' ' LYS . 2.4 mm? -119.57 103.2 9.21 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -84.7 -31.93 23.81 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 124.186 0.929 . . . . 0.0 110.809 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.91 -41.17 12.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.266 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -91.62 80.38 5.37 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.389 0.614 . . . . 0.0 111.814 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -161.24 136.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.693 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.48 ' OE1' ' HD2' ' B' ' 97' ' ' LYS . 47.1 mt-10 -116.75 143.29 45.84 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.7 125.16 50.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -81.69 -66.93 0.83 Allowed 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 123.274 0.359 . . . . 0.0 110.839 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -161.32 139.67 9.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.43 117.03 45.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -120.01 132.0 55.33 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.96 129.34 44.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.65 -148.39 6.61 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.076 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -106.72 133.54 51.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -118.82 125.75 50.27 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.58 111.12 21.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.865 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.28 160.44 11.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.293 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 31.2 p -95.84 117.79 31.24 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.676 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 41.2 t -56.46 -60.86 2.91 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.923 0.764 . . . . 0.0 112.247 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -145.43 -77.2 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.498 0.666 . . . . 0.0 109.216 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.95 -70.45 0.51 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.967 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.54 36.05 0.43 Allowed Glycine 0 C--O 1.22 -0.75 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.09 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -97.62 122.76 41.07 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -80.06 143.61 33.86 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.74 0.65 . . . . 0.0 111.006 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 41.4 t -138.38 137.98 37.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.78 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -96.69 110.56 22.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.44 135.83 57.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.8 p -69.88 124.72 24.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 50.8 p -128.59 152.86 47.84 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.893 0.377 . . . . 0.0 111.162 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 tt -139.6 136.74 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.04 112.13 18.76 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.775 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.84 117.61 55.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.49 128.1 54.65 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.4 pt -126.23 151.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 111.999 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -105.9 115.33 30.04 Favored 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.924 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.595 ' NZ ' ' HB2' ' B' ' 61' ' ' LEU . 13.8 mmmt -90.43 131.53 36.14 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.999 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HD2' ' OE1' ' B' ' 66' ' ' GLU . 28.4 mtpp . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 CA--C 1.514 -0.436 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 m -130.74 -47.2 1.04 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.614 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -85.27 6.58 25.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.193 0.521 . . . . 0.0 112.17 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.23 79.27 0.3 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.7 p -93.25 107.22 24.07 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 122.286 0.235 . . . . 0.0 110.794 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.97 -36.47 10.19 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.525 2.15 . . . . 0.0 111.741 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.3 m 71.93 90.23 0.07 OUTLIER Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 124.458 1.103 . . . . 0.0 111.437 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -98.55 15.68 0.57 Allowed 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.199 2.6 . . . . 0.0 111.116 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 t -101.99 140.53 36.14 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.353 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -88.03 0.63 55.71 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 60.8 t -105.38 114.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.4 147.46 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 120.911 0.386 . . . . 0.0 111.074 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.11 122.72 45.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -88.25 105.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.573 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.17 58.91 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.128 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -163.06 -56.26 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.252 0.549 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -101.05 166.04 13.12 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.601 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -71.31 163.0 40.6 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.993 1.796 . . . . 0.0 111.303 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.29 -41.4 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -62.86 -24.88 68.02 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -73.32 -38.17 65.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -72.33 -33.24 67.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.143 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.07 -47.53 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.129 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.64 -31.75 71.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.942 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -71.72 -41.93 67.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.202 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -70.63 -34.29 71.92 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.68 -51.63 68.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.049 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.534 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 10.0 t -67.77 -35.56 78.92 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.7 mt -62.23 -34.15 75.94 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 120.992 0.425 . . . . 0.0 111.126 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.8 mt -64.65 -23.9 67.41 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.851 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -100.31 -14.0 18.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 28' ' ' THR . 78.6 mt-30 -79.44 -20.22 48.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.838 0.351 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.48 -4.72 7.15 Favored Glycine 0 CA--C 1.492 -1.345 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.092 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -86.29 96.0 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.0 m -67.75 -30.43 69.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.501 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -139.62 126.34 20.63 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.737 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -121.77 161.14 22.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.933 -176.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -124.21 121.66 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.1 mt -104.84 125.26 59.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 66.0 mttm -119.83 120.08 35.45 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.294 0.568 . . . . 0.0 110.524 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -116.28 155.51 28.25 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.027 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -131.63 141.47 49.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.232 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.46 -126.91 9.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.548 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -81.98 -10.96 59.09 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.57 35.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.182 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.0 mt -55.6 -38.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 121.26 0.552 . . . . 0.0 109.61 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.7 p -71.48 -13.77 61.92 Favored 'General case' 0 C--O 1.208 -1.087 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.251 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -95.06 -26.52 16.01 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.6 0.36 . . . . 0.0 110.09 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -69.8 -46.07 66.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 110.766 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.67 -36.26 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.517 ' O ' HG13 ' A' ' 55' ' ' ILE . 45.5 t0 -59.92 -52.2 66.44 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.711 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.9 m -54.19 -52.01 62.56 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.56 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.405 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 23.7 m -69.3 -33.72 59.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' B' ' 74' ' ' SER . 24.9 tt0 -72.05 -26.17 62.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.408 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 51' ' ' ASP . 81.2 mt -70.09 -46.62 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.733 174.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.22 -48.97 85.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.77 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 54' ' ' GLU . 38.9 ptt180 -78.29 37.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.518 0.675 . . . . 0.0 110.034 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.54 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 9.6 t30 -153.14 -51.04 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 14.8 ptm180 -76.69 -11.48 59.85 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -142.94 -60.74 0.43 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.494 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD13 ' HB ' ' A' ' 65' ' ' ILE 0.297 0.6 OUTLIER -110.91 88.97 2.91 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.984 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.99 23.79 10.23 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.884 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -143.01 -69.42 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.795 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -86.52 75.16 9.78 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.619 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.5 tp -161.79 137.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.92 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 9.6 pt-20 -130.37 167.52 18.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.099 0.476 . . . . 0.0 111.235 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.6 mt -104.87 139.54 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 50.9 tptt -80.92 -59.81 2.53 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -177.49 159.93 1.57 Allowed 'General case' 0 C--O 1.25 1.13 0 C-N-CA 124.869 1.267 . . . . 0.0 107.604 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.62 119.16 45.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -125.11 133.81 52.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.29 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.69 132.63 67.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.97 163.38 33.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.088 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.417 ' HB3' ' OE1' ' B' ' 54' ' ' GLU . 52.5 p -90.49 126.32 35.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.564 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.419 ' HG2' HG13 ' A' ' 77' ' ' VAL . 22.1 tt0 -81.7 113.91 20.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 86' ' ' ARG . 24.3 t -100.6 106.9 20.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' A' ' 75' ' ' GLN . 28.5 m -128.57 163.91 31.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.035 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.5 p -98.23 130.38 44.95 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.796 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.5 m -62.3 -59.67 4.68 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.442 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -165.14 -49.6 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.475 ' HB2' ' HG3' ' A' ' 83' ' ' ARG . 6.9 m-20 -82.7 5.26 21.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.875 0.47 . . . . 0.0 111.002 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.5 11.83 56.6 Favored Glycine 0 C--O 1.21 -1.357 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 81' ' ' ASP . 78.3 mtp180 -71.25 109.7 5.44 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -73.71 131.47 41.65 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.224 0.328 . . . . 0.0 110.623 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.1 t -129.39 133.88 47.59 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG2' HG22 ' A' ' 76' ' ' VAL . 50.1 mtm180 -98.54 135.37 40.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.4 t -133.42 123.78 47.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -59.51 127.98 34.76 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 120.935 0.398 . . . . 0.0 111.058 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.9 p -133.48 162.17 32.6 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 17.7 tt -137.7 142.76 35.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.773 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -120.25 108.54 14.32 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.046 0.939 . . . . 0.0 108.711 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.5 mt -118.77 129.48 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . . . -131.24 130.35 42.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.081 0.467 . . . . 0.0 110.306 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.8 pt -121.62 153.59 25.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.427 ' HD3' ' OE2' ' A' ' 66' ' ' GLU . 35.3 ttt180 -129.99 140.1 50.95 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.247 0.546 . . . . 0.0 112.07 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -79.29 -174.31 4.1 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.566 1.146 . . . . 0.0 110.324 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 C--O 1.261 1.682 0 CA-C-O 117.964 -1.017 . . . . 0.0 108.533 174.256 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.462 ' HG3' ' H ' ' B' ' 2' ' ' SER . 20.5 ptp . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.462 ' H ' ' HG3' ' B' ' 1' ' ' MET . 15.6 m -69.2 134.66 49.52 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m -104.15 106.23 16.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.229 0.538 . . . . 0.0 110.955 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.66 60.45 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' B' ' 6' ' ' PRO . 41.4 m -69.84 -59.47 4.49 Favored Pre-proline 0 CA--C 1.561 1.382 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' B' ' 5' ' ' THR . 83.6 Cg_endo -80.35 -18.07 9.9 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 121.171 1.247 . . . . 0.0 113.002 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -167.56 144.27 3.6 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.7 150.89 27.94 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.102 1.868 . . . . 0.0 110.882 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.7 p -105.63 -20.51 13.44 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -114.83 4.74 14.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 61.1 t -109.22 112.56 41.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.0 147.63 12.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.111 0.481 . . . . 0.0 111.272 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 tp -105.73 122.37 45.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.6 mm -88.85 104.59 15.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.01 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.58 59.19 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.793 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -165.02 -57.07 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.331 0.586 . . . . 0.0 110.429 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -100.75 165.59 14.02 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.132 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.08 162.4 42.39 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.24 1.96 . . . . 0.0 111.313 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.07 -42.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -61.21 -25.08 66.8 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.68 -37.25 65.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.66 -32.88 64.22 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.167 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.76 -48.67 86.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.923 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.94 -30.34 70.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.204 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.577 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -72.65 -43.46 63.16 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -68.68 -32.72 72.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.42 -52.51 65.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.139 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' B' ' 32' ' ' GLN . 10.1 t -65.69 -38.22 88.63 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.656 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 88.9 mt -60.29 -36.56 78.16 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 92.5 mt -63.74 -23.82 67.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.031 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -100.14 -15.45 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' B' ' 28' ' ' THR . 79.7 mt-30 -78.14 -27.48 48.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.819 0.342 . . . . 0.0 110.766 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.35 -6.88 3.98 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.466 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.47 97.18 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -67.16 -31.98 72.77 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.456 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -140.37 125.85 18.99 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.072 0.463 . . . . 0.0 111.489 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.538 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -121.83 158.68 25.15 Favored 'Isoleucine or valine' 0 C--O 1.254 1.309 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.94 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 48.9 t -121.5 122.38 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.507 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 54.7 mt -104.83 125.32 59.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.738 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 67.6 mttm -119.57 120.33 36.41 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -116.39 155.28 28.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.594 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -130.42 140.38 50.57 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.913 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.86 -129.44 10.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.703 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -82.34 -9.33 59.51 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.105 0.479 . . . . 0.0 110.156 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.1 -5.55 36.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.013 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.4 mt -54.26 -40.73 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.48 0.657 . . . . 0.0 109.997 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 75.4 p -67.08 -23.4 65.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.169 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -85.39 -28.45 25.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.281 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -67.74 -45.32 75.33 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.77 -37.23 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.005 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.57 ' O ' HG13 ' B' ' 55' ' ' ILE . 44.0 t0 -56.94 -52.89 63.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.576 0.75 . . . . 0.0 109.202 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 89.2 m -54.7 -52.16 63.29 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.854 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.445 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.2 m -70.29 -32.97 52.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.104 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 24.3 tt0 -71.37 -26.38 62.77 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.973 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.6 mt -70.13 -46.39 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.879 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.14 -49.81 82.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 120.827 0.346 . . . . 0.0 110.898 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' B' ' 54' ' ' GLU . 39.3 ptt180 -77.48 36.73 0.2 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-O 121.449 0.642 . . . . 0.0 110.032 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . 0.414 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 7.9 t30 -152.1 -52.18 0.12 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 123.092 0.557 . . . . 0.0 110.496 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 14.2 ptm180 -74.4 -14.84 60.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -139.74 -64.78 0.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.321 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.425 HD13 ' HB ' ' B' ' 65' ' ' ILE 0.278 0.5 OUTLIER -107.88 93.98 4.83 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -177.565 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.69 13.36 35.12 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.693 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -133.94 -69.25 0.54 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.803 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -83.23 75.73 9.93 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.655 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.425 ' HB ' HD13 ' B' ' 61' ' ' LEU . 8.0 tp -161.71 143.32 3.53 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 C-N-CA 124.198 0.999 . . . . 0.0 108.768 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' B' ' 95' ' ' ARG . 10.2 pt-20 -137.93 164.16 29.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.907 0.384 . . . . 0.0 111.6 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.38 138.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' B' ' 93' ' ' ALA . 52.3 tptt -81.55 -60.54 2.22 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -175.82 160.39 2.38 Favored 'General case' 0 C--O 1.262 1.744 0 C-N-CA 124.795 1.238 . . . . 0.0 107.903 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.7 mt -131.48 119.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -125.88 135.02 51.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.677 0.275 . . . . 0.0 110.354 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.55 131.54 73.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.4 165.83 35.65 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.75 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.503 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 37.0 p -89.75 127.27 35.93 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 120.798 0.332 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . 0.419 ' HG2' HG13 ' B' ' 77' ' ' VAL . 24.2 tt0 -81.35 114.08 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' B' ' 86' ' ' ARG . 25.8 t -101.32 106.63 19.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' B' ' 75' ' ' GLN . 28.6 m -129.01 162.05 37.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.596 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 14.9 p -96.39 130.07 43.6 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 24.1 m -63.05 -58.93 5.63 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.541 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -164.89 -53.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.426 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.4 ' HB2' ' HG3' ' B' ' 83' ' ' ARG . 9.3 m-20 -79.76 7.62 8.27 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.679 0.392 . . . . 0.0 111.369 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.13 9.65 59.2 Favored Glycine 0 C--O 1.206 -1.647 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.619 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . 0.4 ' HG3' ' HB2' ' B' ' 81' ' ' ASP . 81.1 mtp180 -71.64 108.95 5.25 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -73.71 137.18 43.88 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.094 0.473 . . . . 0.0 110.571 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 32.9 t -133.5 138.14 45.97 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.54 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 34.6 mtm180 -102.48 135.23 44.48 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 177.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.39 123.13 46.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 m -58.41 127.51 32.5 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.33 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 36.4 p -134.18 159.33 41.21 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 123.595 0.758 . . . . 0.0 109.764 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 16.3 tt -134.42 142.09 41.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -120.61 106.61 11.92 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 123.915 0.886 . . . . 0.0 108.668 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.37 130.2 71.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 68' ' ' LYS . . . -129.87 132.02 46.28 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -123.49 149.04 27.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.248 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.416 ' HB3' ' HG3' ' B' ' 66' ' ' GLU . 41.7 ttt180 -125.39 144.24 50.6 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.575 -174.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -84.1 -170.11 2.92 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.063 1.345 . . . . 0.0 110.24 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 97' ' ' LYS . 21.3 pttp . . . . . 0 C--O 1.261 1.679 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.3 t -69.33 -55.57 10.03 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 123.6 0.562 . . . . 0.0 112.441 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.3 t -95.18 -56.65 2.66 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.733 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.36 28.31 27.93 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.898 -1.144 . . . . 0.0 111.637 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 p -120.86 148.1 47.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.35 115.47 2.89 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.58 2.186 . . . . 0.0 113.097 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 9.8 t -83.07 142.47 44.4 Favored Pre-proline 0 C--N 1.311 -1.075 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.205 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 15.9 Cg_exo -68.64 178.89 3.47 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 122.871 2.381 . . . . 0.0 112.44 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -85.18 35.33 0.58 Allowed 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.537 0.735 . . . . 0.0 110.551 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -102.83 8.85 39.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.233 0.54 . . . . 0.0 109.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 59.7 t -105.08 123.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.085 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -120.25 142.83 34.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.683 0.278 . . . . 0.0 110.825 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.39 131.8 47.3 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.786 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.426 HG21 ' HB2' ' A' ' 48' ' ' LYS . 44.7 mm -93.75 111.68 25.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.878 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.66 28.97 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.03 -1.557 . . . . 0.0 114.622 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.56 -50.01 0.41 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.791 0.795 . . . . 0.0 112.155 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -100.93 160.64 26.14 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.59 159.68 35.58 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 121.741 1.627 . . . . 0.0 110.893 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.507 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.5 p -55.66 -38.54 50.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.0 ptm -61.05 -26.08 67.38 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.999 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.41 -43.34 77.41 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -70.95 -35.07 72.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.595 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 19' ' ' VAL . 59.2 t -60.34 -51.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.647 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.8 mt -65.91 -33.81 76.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.844 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -64.94 -45.52 85.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.227 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.99 95.53 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.427 0.454 . . . . 0.0 110.481 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.67 -35.11 78.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.427 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 m -73.89 -43.6 57.96 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.735 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 94.1 mt -64.47 -34.39 78.09 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.147 0.499 . . . . 0.0 110.587 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -58.73 -44.73 90.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.348 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.26 -22.38 63.84 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.94 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -82.0 -2.29 51.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.076 0.465 . . . . 0.0 110.9 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.58 -8.89 32.48 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 t -92.07 92.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.568 ' HA ' HD22 ' A' ' 30' ' ' LEU . 57.4 p -95.78 -9.92 30.43 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.199 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.24 104.99 10.52 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -127.15 157.67 38.57 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.151 -175.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 39.3 t -124.21 116.98 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.194 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.85 121.6 48.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 85.7 mttt -118.14 120.99 39.4 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.269 0.556 . . . . 0.0 110.378 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -115.65 156.45 25.85 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.951 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HG2' HG22 ' A' ' 89' ' ' THR . 88.3 mtt180 -130.91 143.15 50.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.19 -119.6 11.99 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.515 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -85.73 -8.7 58.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.439 0.638 . . . . 0.0 110.433 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.42 -4.53 42.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.166 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.3 mt -56.01 -36.71 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.564 0.697 . . . . 0.0 109.912 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.3 p -64.64 -31.51 72.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.576 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HB2' HG21 ' A' ' 14' ' ' ILE . 28.5 mtpp -78.85 -31.44 45.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.502 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -65.77 -46.82 77.33 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.414 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -72.08 -33.87 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.873 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' OD2' HG21 ' A' ' 19' ' ' VAL . 31.3 t70 -60.24 -47.47 85.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.9 m -53.3 -53.7 47.12 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.414 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.18 -30.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.61 -39.8 88.54 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 51' ' ' ASP . 89.0 mt -59.97 -45.55 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.25 -40.44 86.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.093 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -83.55 15.77 2.95 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.31 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -136.72 12.66 3.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.847 0.832 . . . . 0.0 109.255 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.07 -49.04 0.28 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.147 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.46 ' CD2' HD23 ' A' ' 61' ' ' LEU . 56.2 t80 -90.24 -70.36 0.67 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.955 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.46 HD23 ' CD2' ' A' ' 60' ' ' PHE . 4.1 mm? -129.43 110.38 11.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.128 0.489 . . . . 0.0 111.316 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.7 12.57 36.25 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.943 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -126.04 -64.09 1.07 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.415 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 98.2 mttt -78.76 102.08 7.93 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.686 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tp -160.66 126.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.83 0.452 . . . . 0.0 110.329 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.517 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 41.0 tt0 -119.19 130.64 55.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.3 mt -95.21 128.06 46.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.65 -62.07 1.57 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.258 0.349 . . . . 0.0 111.239 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 10.0 tp10 -162.59 141.71 9.05 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.95 107.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.208 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.495 ' HE ' ' CD ' ' A' ' 69' ' ' GLU . 91.0 mtt180 -131.18 144.91 51.7 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.519 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.02 132.51 66.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.24 -174.42 22.81 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.122 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -124.78 128.46 48.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -106.84 138.84 42.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.98 107.89 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.36 151.19 18.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.619 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.0 p -93.2 115.8 28.41 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.0 t -75.43 -38.93 59.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -128.93 -96.84 0.39 Allowed 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.84 0.353 . . . . 0.0 111.13 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 5.6 m-20 -93.42 -76.1 0.48 Allowed 'General case' 0 C--O 1.216 -0.695 0 CA-C-O 121.788 0.804 . . . . 0.0 109.268 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 81' ' ' ASP . . . -125.67 21.39 6.31 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -79.54 101.8 8.47 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -85.07 132.65 34.29 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.434 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 t -133.66 130.95 38.95 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -88.69 124.75 34.41 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.7 120.91 60.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.4 t -63.5 128.19 34.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.602 HG22 ' HG2' ' A' ' 42' ' ' ARG . 61.5 p -120.76 134.35 55.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.424 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -123.12 128.39 75.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -107.65 110.77 22.72 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -103.98 106.78 20.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.76 40.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.901 0.381 . . . . 0.0 110.432 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.11 151.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.364 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HD3' ' OE1' ' A' ' 66' ' ' GLU . 75.3 ttt180 -121.85 119.29 31.19 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.493 0.663 . . . . 0.0 110.255 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HE3' ' O ' ' A' ' 64' ' ' LYS . 8.3 mmmm -85.29 131.02 34.48 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.392 0.615 . . . . 0.0 112.403 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' OXT' ' HB3' ' A' ' 64' ' ' LYS . 55.9 mtpt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 CA--C 1.502 -0.877 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.9 m -147.04 136.28 22.59 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 24.5 t 65.98 -165.61 0.23 Allowed 'General case' 0 CA--C 1.551 0.99 0 O-C-N 123.922 0.764 . . . . 0.0 110.203 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.49 65.22 0.6 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.476 ' HB ' ' HD3' ' B' ' 6' ' ' PRO . 27.5 m -54.19 -50.88 82.11 Favored Pre-proline 0 CA--C 1.579 2.088 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' B' ' 5' ' ' THR . 18.6 Cg_exo -69.88 -50.53 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 121.553 1.502 . . . . 0.0 112.23 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' B' ' 8' ' ' PRO . 10.0 t -169.56 138.51 1.61 Allowed Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 7' ' ' THR . 1.1 Cg_endo -82.07 115.53 2.67 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.442 2.095 . . . . 0.0 111.843 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 50.6 m -99.13 16.11 23.78 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.869 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -114.48 9.8 16.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.994 -0.441 . . . . 0.0 110.7 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.16 124.56 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.813 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.83 141.08 42.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.019 0.438 . . . . 0.0 111.581 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.24 129.62 46.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.874 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.09 111.36 24.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.469 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.76 28.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 119.105 -1.521 . . . . 0.0 114.911 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.97 -48.72 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.265 0.533 . . . . 0.0 111.661 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -101.55 160.9 25.2 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.61 162.3 21.7 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.981 1.787 . . . . 0.0 111.728 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.426 ' O ' HG23 ' B' ' 23' ' ' VAL . 7.2 p -58.71 -38.46 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.576 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 25.7 ptm -62.61 -26.24 68.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.639 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -66.69 -46.76 74.56 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -67.21 -34.29 77.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.835 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 19' ' ' VAL . 58.3 t -61.21 -50.51 80.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.618 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 20' ' ' MET . 86.3 mt -67.32 -36.03 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.641 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.428 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.01 -44.56 95.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.336 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.49 98.77 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.371 0.419 . . . . 0.0 110.499 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.8 -36.17 82.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.571 . . . . 0.0 111.049 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 59.7 m -72.51 -45.06 61.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.659 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 93.6 mt -64.06 -33.67 76.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.298 0.571 . . . . 0.0 110.262 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' B' ' 35' ' ' SER . 0.2 OUTLIER -58.41 -46.66 86.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.375 -177.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -68.28 -21.85 64.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.352 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.68 -4.25 55.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.34 -3.92 29.72 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.906 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -95.93 91.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.395 0.616 . . . . 0.0 109.516 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . 0.508 ' HA ' HD22 ' B' ' 30' ' ' LEU . 58.3 p -94.78 -8.61 37.04 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.346 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.82 104.98 9.63 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.515 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -125.29 159.11 32.95 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.981 -173.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.7 117.12 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.198 0.523 . . . . 0.0 110.147 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -97.83 121.08 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 83.4 mttt -118.12 119.97 36.32 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.391 0.615 . . . . 0.0 110.178 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -115.2 156.56 25.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.667 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.563 ' HG2' HG22 ' B' ' 89' ' ' THR . 92.3 mtt180 -130.73 144.51 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.593 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.28 -123.44 23.3 Favored Glycine 0 C--O 1.215 -1.09 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.232 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -81.18 -12.77 59.11 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.224 0.535 . . . . 0.0 110.915 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.83 -3.47 28.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -55.15 -37.92 44.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.46 0.648 . . . . 0.0 109.793 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.4 p -64.69 -31.68 73.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.836 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -79.12 -29.73 43.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -65.33 -48.32 73.43 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 120.78 0.324 . . . . 0.0 110.957 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.98 -34.6 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.514 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.3 t70 -58.49 -48.65 80.09 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -52.46 -53.43 45.69 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.378 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.82 -31.17 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.98 -39.43 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 51' ' ' ASP . 89.8 mt -59.33 -47.69 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.722 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -59.31 -39.4 78.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 CA-C-O 121.123 0.487 . . . . 0.0 110.863 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -84.86 17.12 2.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -141.65 18.47 2.18 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -150.26 -46.44 0.13 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.078 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.48 ' O ' HD22 ' B' ' 61' ' ' LEU . 62.7 t80 -92.37 -68.13 0.82 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.852 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.48 HD22 ' O ' ' B' ' 60' ' ' PHE . 3.9 mm? -132.49 111.84 11.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.805 0.336 . . . . 0.0 111.014 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.79 13.96 31.93 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.534 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -127.53 -64.7 0.97 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.088 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.536 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 98.4 mttt -74.91 99.67 3.88 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.903 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.8 tp -160.34 128.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.506 ' OE2' ' HD3' ' B' ' 95' ' ' ARG . 38.2 tt0 -122.64 129.65 52.09 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -94.44 127.21 46.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.422 ' HD3' ' HB1' ' B' ' 93' ' ' ALA . 49.2 tttp -87.73 -63.07 1.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.556 0.535 . . . . 0.0 111.188 -175.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' B' ' 71' ' ' ARG . 10.5 tp10 -161.63 140.41 9.65 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 pt -143.31 110.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.284 0.564 . . . . 0.0 110.73 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' B' ' 69' ' ' GLU . 92.9 mtt180 -133.57 145.62 50.24 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.726 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 54.0 t -118.29 128.81 75.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.27 -173.52 19.24 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.557 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 126.07 43.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -105.46 139.01 40.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.56 109.63 24.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.39 154.34 17.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.319 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 30.3 p -95.56 116.43 28.82 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 46.2 t -76.46 -34.09 58.7 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -132.27 -99.71 0.29 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.102 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.51 -73.42 0.54 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.31 20.18 5.91 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -77.04 99.93 5.49 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -82.46 136.36 34.93 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 123.761 0.663 . . . . 0.0 110.105 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 18.9 t -139.74 133.19 30.14 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -87.27 130.71 34.49 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 66.6 t -129.3 117.98 44.7 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -64.02 131.23 46.98 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.563 HG22 ' HG2' ' B' ' 42' ' ' ARG . 59.9 p -123.22 133.73 54.19 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.559 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 16.1 tt -121.44 128.83 75.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.68 107.37 16.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.401 HD11 HD11 ' B' ' 90' ' ' ILE . 44.9 mm -102.79 107.02 21.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . 0.422 ' HB1' ' HD3' ' B' ' 68' ' ' LYS . . . -115.29 120.97 41.43 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.531 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -127.94 149.46 32.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.298 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.506 ' HD3' ' OE2' ' B' ' 66' ' ' GLU . 71.5 ttt180 -119.37 118.27 30.74 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.5 0.666 . . . . 0.0 110.349 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' B' ' 64' ' ' LYS . 7.6 mmmm -84.16 129.58 34.89 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.407 ' OXT' ' HB3' ' B' ' 64' ' ' LYS . 55.8 mtpt . . . . . 0 C--O 1.257 1.492 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.7 t -76.83 111.08 11.97 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 m -145.03 152.28 39.88 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.87 178.11 20.72 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.2 p 56.1 96.47 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 124.426 1.09 . . . . 0.0 113.032 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.04 130.27 33.81 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 122.888 2.392 . . . . 0.0 113.017 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 10.2 t -88.28 141.18 30.65 Favored Pre-proline 0 N--CA 1.436 -1.163 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 15.9 Cg_exo -69.37 178.21 4.55 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.448 2.099 . . . . 0.0 111.199 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.5 m -78.44 78.75 4.9 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.367 0.603 . . . . 0.0 110.293 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -140.21 11.34 2.37 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.164 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.9 t -120.4 124.67 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.82 149.38 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.825 0.345 . . . . 0.0 111.189 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.81 123.57 48.17 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.774 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -89.54 99.36 9.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.43 52.35 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.452 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -166.68 -56.34 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.04 167.76 10.25 Favored Pre-proline 0 CA--C 1.555 1.166 0 O-C-N 122.393 -0.192 . . . . 0.0 111.027 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.33 153.66 61.38 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.162 1.908 . . . . 0.0 112.514 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.91 -40.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.497 1.119 . . . . 0.0 113.469 -177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.42 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.3 ptm -62.5 -25.83 68.22 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.709 0.804 . . . . 0.0 111.823 -175.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -84.05 -27.77 28.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.022 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -73.14 -37.64 66.55 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 89.2 t -57.57 -47.78 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.567 0.698 . . . . 0.0 109.547 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.6 mt -65.26 -36.31 83.71 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.076 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.791 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.87 87.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.605 0.241 . . . . 0.0 111.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 86.8 mt -66.49 -31.55 72.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.6 0.714 . . . . 0.0 110.296 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 91.2 m -74.18 -40.35 62.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.176 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 97.5 mt -62.27 -38.68 90.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.192 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.9 tp -57.17 -46.12 83.08 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.9 -23.63 66.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.762 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 28' ' ' THR . 83.3 mm-40 -81.35 -11.91 59.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.185 0.516 . . . . 0.0 110.355 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.7 24.36 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.539 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.97 93.96 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 121.397 0.617 . . . . 0.0 109.599 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 p -89.04 -21.31 23.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.61 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -108.04 105.52 15.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -121.08 149.65 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.691 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.9 120.78 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.272 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -103.17 122.82 56.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.463 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -115.42 124.55 51.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 111.331 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.69 143.26 47.85 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.351 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -129.81 127.15 39.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.631 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.89 -138.35 14.1 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.934 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -82.97 4.31 26.41 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.487 0.661 . . . . 0.0 110.869 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.99 -4.01 53.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.553 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.71 -43.49 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.119 0.568 . . . . 0.0 110.575 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -19.14 64.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -90.45 -32.8 16.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.63 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.71 -43.59 88.69 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.912 0.387 . . . . 0.0 111.719 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.08 -32.67 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.434 ' O ' HG13 ' A' ' 55' ' ' ILE . 23.9 t70 -65.82 -38.95 90.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.4 m -60.42 -51.33 69.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.078 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 35.9 m -66.17 -38.15 81.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.675 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mm-40 -59.72 -36.56 76.8 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 51' ' ' ASP . 71.1 mt -66.88 -44.19 89.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 0.0 110.292 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.76 -38.75 82.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 120.725 0.298 . . . . 0.0 111.725 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.675 ' HD3' ' OE2' ' A' ' 54' ' ' GLU . 4.1 ptm180 -89.84 11.24 20.81 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.86 -30.71 3.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.268 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -93.78 -59.07 2.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.33 -55.24 12.74 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.964 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -160.0 108.35 1.71 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.57 -35.12 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 123.972 0.795 . . . . 0.0 112.745 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.05 -26.64 68.34 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' H ' HD12 ' A' ' 61' ' ' LEU . 35.0 mmtp -122.36 101.51 7.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.718 0.295 . . . . 0.0 110.765 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tp -156.94 146.7 11.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG2' HH21 ' A' ' 95' ' ' ARG . 7.8 tp10 -135.19 141.26 45.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.27 132.57 40.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -91.45 -48.11 7.06 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.937 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -173.83 145.87 1.18 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.45 97.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.678 0.751 . . . . 0.0 110.899 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -127.69 141.89 51.48 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.782 -0.574 . . . . 0.0 110.978 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.85 143.75 29.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.3 -165.69 21.95 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.674 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m -115.46 144.83 43.25 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 59.4 tt0 -101.67 131.17 48.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 86' ' ' ARG . 49.4 t -112.81 111.31 35.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -123.98 157.43 30.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.921 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.3 p -97.52 123.36 41.36 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.845 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.4 t -71.92 -41.35 67.97 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.209 0.528 . . . . 0.0 110.887 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -128.73 -70.2 0.68 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -138.36 -80.11 0.34 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.546 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.99 -7.1 61.39 Favored Glycine 0 C--N 1.31 -0.885 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -72.97 97.58 2.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -91.12 148.65 22.22 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.863 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.6 m -139.5 135.56 33.62 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.484 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.449 ' HG2' HG22 ' A' ' 76' ' ' VAL . 79.0 mtt180 -102.02 124.78 48.23 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.19 138.78 52.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.9 t -75.24 136.41 40.95 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.7 p -136.14 145.22 45.59 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.4 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.45 138.91 53.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.364 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -115.42 111.69 21.19 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.74 110.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.88 124.13 50.93 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 pt -124.49 162.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 120.848 0.356 . . . . 0.0 110.209 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.4 HH21 ' HG2' ' A' ' 66' ' ' GLU . 49.1 ttp180 -129.98 108.68 10.29 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 7.1 tmtm? -84.15 130.87 34.82 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 -173.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 35.3 mmtp . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -85.73 -75.2 0.38 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 24.3 p -93.8 138.97 31.41 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.472 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.79 49.6 0.85 Allowed Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -82.05 122.7 79.91 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 123.384 0.674 . . . . 0.0 110.557 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.47 -32.23 80.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.502 2.135 . . . . 0.0 112.907 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -99.62 133.09 22.09 Favored Pre-proline 0 C--N 1.31 -1.136 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.27 114.6 3.93 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.538 2.158 . . . . 0.0 112.235 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -87.81 -4.43 58.87 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.661 0.743 . . . . 0.0 109.812 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -94.27 8.81 40.5 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.946 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.68 119.71 61.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.53 148.05 15.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.454 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.47 120.24 41.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.707 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.96 100.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.73 51.19 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 119.509 -1.329 . . . . 0.0 113.916 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -167.08 -55.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -100.14 168.47 9.38 Favored Pre-proline 0 CA--C 1.556 1.176 0 O-C-N 122.129 -0.357 . . . . 0.0 111.106 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.81 156.15 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.236 1.957 . . . . 0.0 112.302 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.81 -43.89 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.0 ptp -54.89 -32.85 61.4 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -77.73 -28.39 50.77 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.929 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.73 -37.95 64.94 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 79.7 t -57.68 -47.86 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.484 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.072 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.57 -43.54 89.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.2 -38.08 89.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 87.5 mt -65.89 -31.21 72.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.33 0.586 . . . . 0.0 110.358 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' B' ' 32' ' ' GLN . 64.4 m -74.88 -42.09 58.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.796 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 92.3 mt -60.86 -38.53 85.87 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.616 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 tp -57.18 -44.24 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.157 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.2 -16.22 62.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.827 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' B' ' 28' ' ' THR . 82.5 mm-40 -87.27 -7.82 57.44 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.306 0.574 . . . . 0.0 109.889 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.61 34.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.757 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.6 t -99.05 95.76 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.274 0.559 . . . . 0.0 109.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 12.8 p -90.49 -25.49 20.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.425 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -103.37 107.6 18.5 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.466 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -123.88 148.0 28.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 120.91 0.386 . . . . 0.0 110.743 -179.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.43 122.62 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.678 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 67.3 mt -105.39 120.22 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.997 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -113.55 123.33 49.73 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.362 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.31 147.39 42.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.426 ' NE ' HG11 ' B' ' 87' ' ' VAL . 3.0 tmt_? -133.09 129.48 38.03 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.116 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.77 -142.13 16.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.0 5.67 11.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.35 0.595 . . . . 0.0 110.81 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.25 -5.21 55.83 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.5 -44.38 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.407 0.683 . . . . 0.0 110.81 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.0 t -59.82 -32.64 70.84 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.049 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -76.8 -34.24 57.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.753 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -45.61 83.22 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 120.803 0.335 . . . . 0.0 111.768 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.51 -35.88 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.424 ' O ' HG13 ' B' ' 55' ' ' ILE . 29.8 t70 -62.59 -41.57 99.04 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 91.5 m -57.03 -50.04 73.94 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.903 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 35.4 m -67.09 -38.42 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.659 ' OE2' ' HD3' ' B' ' 57' ' ' ARG . 17.0 mm-40 -59.72 -38.91 82.97 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.5 mt -64.36 -45.02 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.25 -37.02 77.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 120.96 0.409 . . . . 0.0 111.792 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.659 ' HD3' ' OE2' ' B' ' 54' ' ' GLU . 4.5 ptm180 -91.48 11.63 23.4 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -126.13 -29.52 3.03 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.096 0.474 . . . . 0.0 110.968 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -93.86 -58.28 2.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -68.69 -58.39 4.3 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.47 HD12 ' H ' ' B' ' 64' ' ' LYS . 0.2 OUTLIER -157.95 109.58 2.27 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.34 -42.13 12.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 124.423 1.077 . . . . 0.0 112.63 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.1 -34.25 68.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 0.0 112.585 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.47 ' H ' HD12 ' B' ' 61' ' ' LEU . 35.1 mmtp -118.05 101.11 7.99 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.168 0.509 . . . . 0.0 110.966 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.04 146.31 13.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.467 ' HG2' HH21 ' B' ' 95' ' ' ARG . 9.0 tp10 -132.17 143.8 50.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.86 129.74 50.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -90.57 -47.9 7.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -172.55 147.03 1.8 Allowed 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.751 0.657 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.01 94.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.443 0.697 . . . . 0.0 110.54 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -127.56 141.17 51.71 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.311 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.87 144.48 24.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.27 -175.32 35.81 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.618 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 45.8 m -107.08 143.91 34.52 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.391 0.615 . . . . 0.0 112.266 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 61.1 tt0 -99.71 132.56 44.97 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' B' ' 86' ' ' ARG . 47.0 t -115.01 108.31 25.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.45 157.53 23.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.28 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 32.0 p -96.94 124.41 40.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.941 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 48.2 t -74.55 -36.29 63.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.965 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -133.84 -74.44 0.48 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -133.66 -80.7 0.47 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.755 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.76 -3.88 62.18 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.151 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -74.07 97.98 3.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -87.87 154.26 20.67 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.239 -177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.7 m -143.85 134.88 25.49 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.599 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.446 ' HG2' HG22 ' B' ' 76' ' ' VAL . 83.2 mtt180 -103.95 125.58 50.44 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 173.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.426 HG11 ' NE ' ' B' ' 42' ' ' ARG . 96.0 t -126.99 137.42 57.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -74.48 135.49 42.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.571 . . . . 0.0 110.701 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 35.3 p -136.96 146.11 45.0 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.51 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.83 137.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.235 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -113.53 111.33 21.71 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 57.5 mt -110.55 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.93 123.75 50.52 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.802 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.0 pt -124.59 162.35 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.237 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.467 HH21 ' HG2' ' B' ' 66' ' ' GLU . 47.5 ttp180 -128.84 107.33 9.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 7.0 tmtm? -84.57 131.75 34.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.936 -174.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.57 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 34.7 mmtp . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 tpp . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.623 0.249 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 t -110.84 -75.18 0.62 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.815 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -119.56 170.16 9.42 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.56 159.29 16.17 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.1 m -70.4 -46.3 19.61 Favored Pre-proline 0 CA--C 1.577 1.987 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.2 123.11 13.05 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 121.737 1.624 . . . . 0.0 111.914 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.3 m -72.73 118.56 69.1 Favored Pre-proline 0 N--CA 1.435 -1.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.503 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.31 121.23 7.58 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.886 2.391 . . . . 0.0 112.205 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.7 m -89.01 16.01 7.72 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.235 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -98.7 15.55 24.88 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.17 0.509 . . . . 0.0 110.481 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.5 t -122.53 111.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.38 146.62 10.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.941 0.4 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 tp -112.2 124.17 51.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 51.0 mt -88.3 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 O-C-N 123.186 0.303 . . . . 0.0 110.865 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.27 -94.42 0.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.661 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -103.42 6.97 38.02 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -98.25 145.43 29.82 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.636 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.93 151.35 82.34 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.52 2.147 . . . . 0.0 112.503 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.43 HG23 ' OG1' ' A' ' 52' ' ' THR . 7.0 p -52.83 -41.4 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -58.85 -28.81 66.44 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.27 -39.0 86.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 93.2 m-85 -75.03 -37.6 61.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 69.4 t -60.85 -54.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.329 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.84 -32.54 73.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -66.97 -47.24 72.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.502 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.78 99.54 Favored 'General case' 0 C--O 1.223 -0.322 0 O-C-N 123.485 0.491 . . . . 0.0 111.064 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 88.0 mt -62.41 -34.74 77.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.021 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.7 m -73.96 -34.19 64.16 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.394 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 84.6 mt -67.26 -32.25 73.13 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-O 120.838 0.351 . . . . 0.0 110.909 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.49 -30.01 71.05 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.328 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -84.28 -4.89 59.14 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.985 0.898 . . . . 0.0 109.805 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -101.72 -19.83 15.22 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.593 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.08 11.29 10.07 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.693 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.61 94.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.626 0.713 . . . . 0.0 109.358 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -71.1 -41.09 71.04 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.464 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.42 124.06 50.21 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.54 0.686 . . . . 0.0 111.857 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -128.69 156.84 41.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.523 -177.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.2 t -120.29 128.41 75.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.3 mt -108.72 120.16 59.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.66 133.93 54.44 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.323 0.582 . . . . 0.0 110.122 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.6 162.63 31.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.435 ' HE ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -150.86 149.97 30.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.14 -130.29 11.27 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -88.9 1.06 55.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.678 0.751 . . . . 0.0 109.776 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.61 -6.25 58.82 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.432 HG23 HG21 ' A' ' 90' ' ' ILE . 75.6 mt -53.97 -37.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.232 0.539 . . . . 0.0 110.442 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.3 t -61.99 -30.46 70.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -83.01 -21.95 33.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.122 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.46 -47.02 65.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.832 0.348 . . . . 0.0 110.263 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.511 ' HA ' HG22 ' A' ' 53' ' ' VAL . 9.9 p -69.83 -32.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.164 0.506 . . . . 0.0 109.796 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.416 ' OD2' HG21 ' A' ' 19' ' ' VAL . 36.4 t70 -61.72 -44.06 97.65 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.083 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 19' ' ' VAL . 85.6 m -63.85 -48.06 78.25 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.268 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 50' ' ' VAL . 33.5 m -69.39 -33.81 59.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.72 -43.62 96.01 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.181 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.9 mt -56.68 -46.78 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.65 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.0 -43.87 98.19 Favored 'Isoleucine or valine' 0 C--O 1.253 1.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.895 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -83.95 10.22 10.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.133 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -125.1 -16.93 5.89 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.48 0.657 . . . . 0.0 111.142 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -105.82 -47.48 3.87 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.19 -67.5 0.83 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.901 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 3.4 mm? -130.98 104.5 7.16 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 120.979 0.419 . . . . 0.0 110.43 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.98 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.091 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.98 -36.68 59.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.176 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -123.15 89.05 3.04 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.633 0.73 . . . . 0.0 110.54 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.14 131.32 10.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.995 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.21 146.15 51.18 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt -100.29 135.6 35.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -85.45 -57.92 2.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.067 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -168.93 151.4 4.87 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.43 116.9 26.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -126.68 146.24 50.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -147.43 137.53 16.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.1 -157.42 13.92 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.655 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.6 m -113.46 128.51 56.47 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.03 141.52 45.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.8 t -95.39 113.84 30.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.15 158.84 35.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.207 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.1 p -85.98 146.57 26.61 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -72.98 -48.24 38.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.324 0.583 . . . . 0.0 110.146 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 179.08 -41.18 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.86 -167.09 1.38 Allowed 'General case' 0 C--O 1.251 1.163 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.18 56.48 4.86 Favored Glycine 0 C--N 1.316 -0.579 0 CA-C-N 118.341 0.519 . . . . 0.0 112.081 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -124.33 114.71 19.91 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -83.73 130.09 34.95 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 123.887 0.742 . . . . 0.0 110.706 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.3 t -127.19 138.61 53.16 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -98.07 129.22 44.91 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.435 HG11 ' HE ' ' A' ' 42' ' ' ARG . 45.8 t -132.42 140.5 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 p -71.02 119.9 15.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 123.62 0.575 . . . . 0.0 110.54 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.5 p -116.53 154.11 30.99 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 122.948 0.499 . . . . 0.0 109.881 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.432 HG21 HG23 ' A' ' 46' ' ' ILE . 16.9 tt -143.07 132.18 20.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.328 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 108.0 16.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.96 116.05 48.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.58 125.12 49.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.413 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.7 pt -122.46 152.22 26.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -122.42 109.29 14.2 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.362 0.601 . . . . 0.0 111.272 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HE2' ' HB2' ' A' ' 61' ' ' LEU . 4.3 mmmp? -79.31 135.07 36.63 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? . . . . . 0 C--N 1.285 -2.198 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.039 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 C--O 1.211 -0.955 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 35.5 t -71.76 -36.88 70.52 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.1 t -130.47 162.42 29.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.07 -167.71 24.82 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -106.26 106.28 56.74 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -84.59 -179.43 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.584 2.189 . . . . 0.0 112.109 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -83.47 145.48 48.19 Favored Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.222 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.26 140.36 53.13 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.829 2.352 . . . . 0.0 112.032 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 35.0 p -115.88 2.98 13.67 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.907 0.384 . . . . 0.0 111.777 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -97.92 13.34 31.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.235 0.54 . . . . 0.0 110.405 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 53.3 t -118.1 111.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.75 148.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.827 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp -115.13 122.39 45.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.463 ' HA ' ' CZ ' ' B' ' 22' ' ' TYR . 55.3 mt -86.99 131.71 34.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.945 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.21 -97.41 0.25 Allowed Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.72 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -99.15 -0.11 42.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.119 0.485 . . . . 0.0 110.338 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.01 145.91 32.63 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.655 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.98 154.65 73.13 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.906 2.404 . . . . 0.0 112.21 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.413 HG23 ' OG1' ' B' ' 52' ' ' THR . 7.2 p -56.16 -40.91 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.546 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.12 -30.1 67.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -63.87 -39.19 93.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.709 0.766 . . . . 0.0 109.706 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . 0.463 ' CZ ' ' HA ' ' B' ' 14' ' ' ILE . 92.8 m-85 -76.89 -37.85 54.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.676 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 65.4 t -60.65 -52.89 56.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.71 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.52 -33.62 75.99 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.219 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -64.91 -47.42 77.83 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.576 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.34 96.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.35 -34.48 76.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 111.313 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 73.4 m -73.53 -34.38 65.19 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.523 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.1 mt -67.19 -31.0 71.1 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.921 0.391 . . . . 0.0 111.268 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.21 -26.26 67.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -86.89 -2.64 58.75 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.749 0.785 . . . . 0.0 109.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -105.29 -16.31 14.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.655 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.65 13.27 14.75 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.64 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.74 95.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 22.4 m -73.2 -38.95 65.92 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.136 0.575 . . . . 0.0 112.475 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.25 122.74 44.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.491 0.662 . . . . 0.0 111.623 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.494 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.27 156.88 40.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.85 -176.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 62.1 t -121.36 126.54 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.285 0.564 . . . . 0.0 110.247 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -108.26 121.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.04 135.09 54.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.208 0.528 . . . . 0.0 110.494 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.96 160.67 37.57 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.437 ' HE ' HG11 ' B' ' 87' ' ' VAL . 0.0 OUTLIER -149.53 147.65 28.44 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -126.04 7.21 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -93.98 1.95 56.17 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.735 0.779 . . . . 0.0 109.464 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.67 -6.33 59.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.521 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.404 HG23 HG21 ' B' ' 90' ' ' ILE . 71.4 mt -53.97 -36.86 32.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 CA-C-O 121.891 0.853 . . . . 0.0 109.732 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -63.95 -30.54 71.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.047 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -82.36 -25.27 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.715 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.53 80.59 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.924 0.392 . . . . 0.0 110.419 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' B' ' 53' ' ' VAL . 12.7 p -71.09 -33.29 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.567 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.429 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.8 t70 -59.51 -47.18 86.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.454 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.413 ' OG1' HG23 ' B' ' 19' ' ' VAL . 63.7 m -60.25 -48.42 81.83 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.4 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.441 HG22 ' HA ' ' B' ' 50' ' ' VAL . 33.4 m -70.26 -32.44 50.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -65.07 -41.79 94.75 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.982 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.429 HG13 ' O ' ' B' ' 51' ' ' ASP . 71.4 mt -57.8 -48.59 83.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.816 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.02 -43.28 95.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.948 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' B' ' 53' ' ' VAL . 12.8 ptm180 -84.29 11.73 7.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.72 -15.29 4.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.17 0.509 . . . . 0.0 110.753 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -103.69 -52.38 2.99 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -85.8 -65.61 0.99 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.476 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.462 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 3.4 mm? -131.25 106.86 8.58 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 123.027 0.531 . . . . 0.0 110.692 176.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.92 -19.39 17.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.022 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.76 -33.32 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.763 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -124.38 89.74 3.13 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.01 137.65 19.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.008 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.52 143.2 41.53 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -100.85 138.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -87.21 -55.64 3.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.12 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -171.66 150.73 2.77 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.41 117.7 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -126.62 148.23 49.82 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.709 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -147.73 138.42 17.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.43 -155.27 10.17 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.8 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.6 m -118.86 124.93 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -107.45 144.88 33.75 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.92 113.35 33.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.91 157.37 35.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.466 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 15.8 p -84.27 143.14 29.74 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.796 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 22.7 m -71.29 -43.43 67.14 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.003 0.43 . . . . 0.0 110.865 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 172.93 -39.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.689 1.596 . . . . 0.0 107.304 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -103.52 -164.72 1.09 Allowed 'General case' 0 C--O 1.252 1.216 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.13 56.79 4.86 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 118.632 0.651 . . . . 0.0 112.317 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -124.31 115.35 20.86 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -84.66 128.6 34.68 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.757 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -126.11 140.65 52.41 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -97.08 132.62 42.69 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.437 HG11 ' HE ' ' B' ' 42' ' ' ARG . 48.0 t -135.77 136.84 49.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 19.1 p -68.4 120.89 15.22 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.734 0.646 . . . . 0.0 110.934 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 51.6 p -117.28 155.44 29.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.821 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.404 HG21 HG23 ' B' ' 46' ' ' ILE . 16.6 tt -143.87 132.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -116.21 105.76 12.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.9 mt -103.66 119.04 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.66 124.27 44.82 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.544 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 49.1 pt -121.25 151.99 24.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -121.62 108.89 14.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.979 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.462 ' HE2' ' HB2' ' B' ' 61' ' ' LEU . 4.1 mmmp? -80.38 133.99 35.97 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? . . . . . 0 C--N 1.283 -2.321 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 169.051 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.433 -1.278 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 m 64.61 12.45 7.53 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 174.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t 70.62 10.48 7.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.134 0.974 . . . . 0.0 111.141 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.21 136.66 3.19 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.6 p -128.96 104.21 18.51 Favored Pre-proline 0 C--N 1.309 -1.163 0 CA-C-O 120.998 0.428 . . . . 0.0 111.745 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.35 162.59 8.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.391 2.06 . . . . 0.0 112.239 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 m -134.34 118.61 13.9 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -84.09 -172.85 1.39 Allowed 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.615 2.21 . . . . 0.0 113.854 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 p -145.43 165.45 28.5 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -103.61 14.17 31.74 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.667 0.27 . . . . 0.0 111.235 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.9 t -113.82 124.78 70.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.07 145.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.985 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.82 131.12 48.33 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.6 mm -95.97 120.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.047 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.64 50.48 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.911 -1.614 . . . . 0.0 114.185 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -155.57 -57.54 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.437 0.618 . . . . 0.0 110.748 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -101.99 163.9 16.85 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -59.49 158.7 26.32 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.242 1.962 . . . . 0.0 111.699 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.446 HG21 ' OD2' ' A' ' 51' ' ' ASP . 10.0 p -52.92 -31.33 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 124.301 1.041 . . . . 0.0 113.437 -175.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.429 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.5 ptm -57.11 -32.58 66.46 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.62 0.368 . . . . 0.0 111.788 -174.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -71.82 -38.24 70.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.098 0.475 . . . . 0.0 110.537 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -76.57 -36.26 57.71 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.246 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 19' ' ' VAL . 93.2 t -58.03 -53.51 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.089 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 20' ' ' MET . 95.7 mt -58.64 -36.27 73.83 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.398 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.29 96.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.396 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.03 -56.44 20.96 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.56 0.537 . . . . 0.0 111.949 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 27' ' ' LEU 0.342 0.0 OUTLIER -69.53 -19.07 63.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.496 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -72.01 -46.09 58.49 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.8 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.07 -41.18 86.85 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.227 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 96' ' ' LYS . 95.7 mt -55.31 -41.92 73.01 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.653 0.596 . . . . 0.0 111.509 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.02 5.33 52.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.983 0.42 . . . . 0.0 111.715 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -99.37 -30.14 12.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.82 0.343 . . . . 0.0 110.178 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.49 -15.03 1.09 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.57 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.7 100.53 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 23.2 p -79.49 -22.51 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -127.1 111.74 14.37 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.263 0.554 . . . . 0.0 110.274 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.55 161.16 19.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.035 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 45.3 t -128.86 125.77 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.469 . . . . 0.0 110.861 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.71 120.89 57.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -118.84 118.37 31.38 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.111 0.481 . . . . 0.0 110.683 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -109.96 148.12 32.2 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HG2' HG22 ' A' ' 89' ' ' THR . 70.9 mtp180 -122.51 143.78 49.5 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.343 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.74 -130.05 12.63 Favored Glycine 0 N--CA 1.44 -1.088 0 O-C-N 123.5 0.5 . . . . 0.0 112.948 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -90.46 5.7 46.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.629 0.728 . . . . 0.0 110.475 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.23 -3.15 54.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.243 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.451 HG23 HG21 ' A' ' 90' ' ' ILE . 69.7 mt -54.47 -37.21 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.786 0.834 . . . . 0.0 110.404 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.1 t -64.26 -26.95 68.73 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.056 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -83.24 -27.91 29.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.372 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -68.12 -43.98 77.17 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -71.33 -35.2 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.17 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 55' ' ' ILE . 37.6 t70 -60.64 -47.21 87.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.934 0.772 . . . . 0.0 109.069 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -54.12 -56.25 19.92 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.9 -22.85 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.4 ' HG2' HH21 ' B' ' 86' ' ' ARG . 28.8 tt0 -74.84 -37.35 62.29 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.529 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 51' ' ' ASP . 77.7 mt -61.86 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.709 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -55.14 -43.58 70.9 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.377 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 54.8 mtm180 -71.45 3.09 4.11 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.426 ' HB2' ' NH2' ' B' ' 86' ' ' ARG . 2.8 t-20 -137.47 16.4 2.94 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.956 0.884 . . . . 0.0 109.689 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -128.75 -63.77 0.96 Allowed 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.413 -176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -106.77 -36.87 6.56 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.296 -176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 95.7 mt -131.49 103.74 6.58 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.215 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.51 -73.87 0.61 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.34 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.26 6.91 40.9 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.075 0.465 . . . . 0.0 110.681 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -112.93 24.02 12.81 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.478 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.22 153.52 12.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -125.22 169.16 12.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.153 0.501 . . . . 0.0 111.085 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -109.1 135.97 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -86.79 -66.42 0.91 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.116 0.26 . . . . 0.0 110.782 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 71' ' ' ARG . 42.8 tt0 -162.71 145.54 10.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.4 mt -127.75 116.15 42.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.425 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 79.9 mtp180 -121.27 135.98 55.04 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.526 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.97 131.3 73.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.2 -163.81 11.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.115 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.2 p -131.41 111.42 11.81 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -87.61 131.35 34.45 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.132 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -90.87 118.31 35.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.12 156.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.946 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 29.3 p -96.97 119.16 34.92 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.557 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.2 m -65.69 -31.22 72.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.081 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -153.17 -80.35 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.12 -82.99 0.46 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.497 0.665 . . . . 0.0 110.418 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.22 18.34 9.6 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.806 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 78' ' ' THR . 76.6 mtp180 -82.14 101.68 10.58 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -87.86 124.14 33.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.846 0.716 . . . . 0.0 110.241 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.8 t -126.11 147.36 49.62 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.514 HH21 ' HG2' ' B' ' 54' ' ' GLU . 39.0 mtm180 -97.09 139.11 33.57 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 119.104 -1.038 . . . . 0.0 108.43 173.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.72 117.26 50.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.1 m -61.19 127.45 31.59 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.771 0.67 . . . . 0.0 109.226 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 42' ' ' ARG . 24.5 p -127.97 151.8 48.68 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.002 0.43 . . . . 0.0 111.836 -176.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.451 HG21 HG23 ' A' ' 46' ' ' ILE . 15.5 tt -129.8 128.6 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.289 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.33 106.27 15.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.8 mt -103.98 117.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.66 133.69 55.67 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.8 pt -138.87 151.33 23.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 35' ' ' SER . 12.9 ptp180 -130.66 158.4 40.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 O-C-N 123.496 0.498 . . . . 0.0 110.838 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.516 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -127.01 117.44 22.48 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.8 mttm . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.102 174.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.6 p -110.58 116.54 31.53 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 120.926 0.394 . . . . 0.0 110.68 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 11.0 p -85.28 159.87 19.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.91 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.18 141.56 17.64 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.479 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 30.3 m -131.19 108.87 15.07 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.43 -44.3 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.074 1.85 . . . . 0.0 112.782 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -123.69 148.37 56.05 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.038 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.63 121.51 8.76 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.883 2.389 . . . . 0.0 111.465 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 35.9 t -122.48 16.62 10.46 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -93.96 16.78 13.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.888 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 80.7 t -117.28 124.55 73.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -116.39 143.8 25.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 120.897 0.379 . . . . 0.0 110.862 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -100.37 128.99 46.3 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 49.8 mm -94.56 119.78 43.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.224 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.89 45.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.391 -1.385 . . . . 0.0 114.213 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -150.56 -58.87 0.18 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.469 0.635 . . . . 0.0 110.432 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -101.45 164.35 16.12 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.511 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -59.99 156.35 39.51 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.27 1.98 . . . . 0.0 111.751 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.484 ' O ' HG23 ' B' ' 23' ' ' VAL . 8.3 p -50.6 -30.42 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.541 1.136 . . . . 0.0 113.827 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.457 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 24.9 ptm -58.65 -30.38 67.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.028 0.442 . . . . 0.0 111.958 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.78 -38.36 64.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.648 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -76.73 -34.8 58.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 19' ' ' VAL . 78.9 t -58.89 -54.24 36.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 CA-C-O 121.273 0.559 . . . . 0.0 110.122 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 20' ' ' MET . 94.8 mt -57.86 -38.7 76.18 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.02 98.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.276 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.51 -56.7 18.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.049 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.566 HD13 ' H ' ' B' ' 27' ' ' LEU 0.361 0.0 OUTLIER -69.45 -19.46 63.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 118.454 -1.298 . . . . 0.0 114.087 -178.714 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.5 m -72.04 -45.92 58.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.127 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.87 -40.12 91.35 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.215 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' B' ' 96' ' ' LYS . 95.3 mt -57.16 -42.05 80.34 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.638 0.586 . . . . 0.0 111.888 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -92.64 1.83 57.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.898 0.38 . . . . 0.0 111.685 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -95.79 -37.04 10.93 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.002 0.429 . . . . 0.0 110.074 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.66 -18.58 0.29 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 119.803 -1.189 . . . . 0.0 112.802 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.22 99.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.453 0.644 . . . . 0.0 109.362 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' B' ' 95' ' ' ARG . 20.3 p -79.75 -17.26 53.91 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.49 -176.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -134.96 112.36 10.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.766 0.317 . . . . 0.0 110.454 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.567 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -120.01 161.12 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.272 -177.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 41.5 t -128.81 123.21 58.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-O 121.066 0.46 . . . . 0.0 110.484 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.57 122.06 55.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.152 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.4 119.31 33.56 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -111.53 146.57 37.08 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.553 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' B' ' 89' ' ' THR . 74.0 mtp180 -120.64 142.72 49.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.5 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 -129.12 12.33 Favored Glycine 0 C--N 1.303 -1.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.851 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -89.47 8.24 31.96 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.017 0.437 . . . . 0.0 111.005 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.67 -1.64 57.38 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.228 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.416 HG23 HG21 ' B' ' 90' ' ' ILE . 68.5 mt -54.65 -37.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.337 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.19 -32.17 73.5 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.588 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -78.84 -31.16 45.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.831 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -64.27 -45.76 86.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.242 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.45 -35.65 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.484 ' O ' HG13 ' B' ' 55' ' ' ILE . 18.7 t70 -59.59 -50.19 74.86 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -52.02 -54.87 24.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.305 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.67 -21.35 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.514 ' HG2' HH21 ' A' ' 86' ' ' ARG . 30.2 tt0 -75.97 -37.12 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.421 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.484 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.1 mt -61.86 -49.73 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.846 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.95 -42.39 71.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' B' ' 61' ' ' LEU . 56.4 mtm180 -73.53 6.32 3.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.861 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . 0.433 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 2.6 t-20 -139.21 16.09 2.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.85 0.833 . . . . 0.0 109.589 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.39 -64.46 0.94 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.13 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -105.23 -37.14 6.99 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.303 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 94.8 mt -132.26 103.49 6.26 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.127 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.77 -74.1 0.61 Allowed 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.125 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.22 5.14 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.141 0.496 . . . . 0.0 110.09 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -111.96 24.91 12.13 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.026 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -148.91 154.43 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.78 164.16 24.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.362 0.601 . . . . 0.0 111.143 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.67 138.69 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -89.96 -60.85 1.82 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.91 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -166.54 144.9 5.39 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.759 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 69.2 mt -128.67 119.76 50.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -127.06 138.6 53.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.382 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.25 129.58 74.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.93 -164.95 11.86 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.063 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 29.3 p -131.55 109.55 10.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -86.35 130.86 34.36 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -90.38 114.19 27.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.3 155.7 36.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.57 0.224 . . . . 0.0 110.818 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' B' ' 83' ' ' ARG . 15.8 p -96.48 118.27 32.64 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.025 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 16.3 m -64.79 -35.55 81.45 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.358 0.663 . . . . 0.0 112.039 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -149.28 -81.74 0.12 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.954 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -101.65 -77.86 0.54 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.289 0.566 . . . . 0.0 110.938 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.77 19.36 8.43 Favored Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.326 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' B' ' 78' ' ' THR . 79.8 mtp180 -84.59 105.92 15.76 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.458 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -90.95 128.95 36.99 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.965 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -130.78 144.97 51.82 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.426 ' NH2' ' HB2' ' A' ' 58' ' ' ASN . 53.2 mtm180 -93.46 137.76 32.43 Favored 'General case' 0 N--CA 1.422 -1.825 0 C-N-CA 119.537 -0.865 . . . . 0.0 108.712 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.35 117.51 51.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -60.96 125.75 24.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 123.833 0.708 . . . . 0.0 109.232 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.527 HG22 ' HG2' ' B' ' 42' ' ' ARG . 25.6 p -128.26 148.85 50.66 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.201 0.524 . . . . 0.0 112.074 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.416 HG21 HG23 ' B' ' 46' ' ' ILE . 14.4 tt -127.73 132.1 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.53 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.29 107.13 15.17 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 60.1 mt -105.68 113.45 42.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.536 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.37 132.7 56.53 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -136.9 152.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' B' ' 35' ' ' SER . 12.6 ptp180 -131.53 156.62 45.39 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 120.915 0.388 . . . . 0.0 110.983 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' B' ' 30' ' ' LEU . 0.0 OUTLIER -125.79 118.15 24.93 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -176.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 mttm . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.251 174.053 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 C--O 1.213 -0.842 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m -96.61 -21.82 17.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.57 0.7 . . . . 0.0 109.449 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -139.98 154.64 47.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.79 118.33 2.53 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.336 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 6' ' ' PRO . 20.6 p -94.26 -46.78 0.28 Allowed Pre-proline 0 CA--C 1.565 1.548 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HD3' ' OG1' ' A' ' 5' ' ' THR . 2.3 Cg_endo -84.91 23.25 0.85 Allowed 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 122.282 1.988 . . . . 0.0 112.102 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -74.37 131.17 80.82 Favored Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.62 122.5 11.13 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.033 2.489 . . . . 0.0 111.776 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.8 t -150.16 -82.89 0.1 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -146.77 3.47 0.84 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.284 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 71.6 t -102.11 113.21 37.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -102.92 135.45 40.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.023 0.439 . . . . 0.0 110.811 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.71 119.3 37.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.458 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 22' ' ' TYR . 52.0 mt -90.58 116.48 31.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.145 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.76 41.59 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.896 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -161.04 -55.35 0.05 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.335 0.567 . . . . 0.0 111.715 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -99.98 159.33 30.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.887 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.43 156.0 33.2 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.902 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.4 -35.87 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.144 0.978 . . . . 0.0 112.611 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.415 ' HG3' HD22 ' A' ' 21' ' ' ASN . 26.9 ptt? -64.13 -24.71 67.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.415 HD22 ' HG3' ' A' ' 20' ' ' MET . 0.9 OUTLIER -73.44 -28.1 61.79 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 14' ' ' ILE . 99.7 m-85 -83.82 -33.01 25.01 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.833 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 61.2 t -59.72 -52.74 57.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-O 121.314 0.578 . . . . 0.0 109.857 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.92 -30.02 70.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.011 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -47.91 75.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.64 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.07 98.2 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.356 0.41 . . . . 0.0 110.577 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 96.0 mt -62.5 -42.4 99.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.022 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.1 m -66.61 -36.46 82.67 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.499 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.7 mt -71.92 -27.49 62.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.678 0.275 . . . . 0.0 111.091 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -65.75 -36.85 84.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.77 -19.44 65.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.315 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -85.58 -5.64 59.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.45 -7.68 40.02 Favored Glycine 0 C--O 1.242 0.651 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.156 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.15 100.8 11.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.406 0.622 . . . . 0.0 109.701 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.451 ' HA ' HD22 ' A' ' 30' ' ' LEU . 33.8 p -87.22 -25.25 24.11 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.631 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.85 105.25 14.01 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.08 0.552 . . . . 0.0 109.626 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -123.1 163.36 22.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 120.616 0.246 . . . . 0.0 111.183 -176.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.4 t -126.85 122.37 60.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.29 0.567 . . . . 0.0 110.927 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.18 128.69 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.4 123.4 36.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.53 0.681 . . . . 0.0 110.472 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.68 148.21 41.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HG2' HG22 ' A' ' 89' ' ' THR . 67.9 mtm180 -128.29 147.59 50.61 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.212 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.88 -135.83 17.65 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -89.57 9.63 26.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.092 0.472 . . . . 0.0 110.995 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 14' ' ' ILE . . . -84.23 -2.61 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.3 mt -53.22 -36.26 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.6 t -61.57 -28.93 69.69 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.602 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB2' HG21 ' A' ' 14' ' ' ILE . 60.8 mttm -84.53 -27.78 27.13 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.918 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.77 93.18 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.7 p -73.47 -29.29 26.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.116 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.448 ' O ' HG13 ' A' ' 55' ' ' ILE . 16.1 t70 -71.28 -43.99 66.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 m -58.68 -50.22 74.68 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.85 -28.64 42.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.734 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -50.31 70.54 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 51' ' ' ASP . 72.2 mt -58.99 -44.25 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.28 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.34 -36.11 70.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -93.83 -2.43 53.53 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.771 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -123.84 12.18 9.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.891 0.853 . . . . 0.0 110.267 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.78 -50.16 0.83 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -85.83 -66.4 0.9 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.1 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.1 mt -144.91 115.09 7.5 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.99 -34.32 11.82 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 124.165 0.916 . . . . 0.0 110.5 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -76.4 -19.22 58.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.69 71.76 1.18 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.966 0.412 . . . . 0.0 110.775 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -161.86 152.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.88 154.33 46.11 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.65 136.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -90.0 -58.67 2.43 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.193 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.49 151.33 7.83 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.8 122.79 14.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -132.19 145.38 51.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.64 143.12 23.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.76 -157.25 19.65 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.554 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -110.11 135.67 50.55 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.703 0.287 . . . . 0.0 110.301 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -119.42 130.26 55.19 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.41 110.01 24.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.8 153.44 7.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.054 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.6 m -106.57 123.51 48.21 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 m -89.82 -31.85 17.19 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.899 0.381 . . . . 0.0 111.874 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -137.3 -150.59 0.36 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.29 -33.07 55.82 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -173.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.29 42.02 1.02 Allowed Glycine 0 C--O 1.211 -1.296 0 C-N-CA 119.67 -1.253 . . . . 0.0 112.426 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -125.35 105.34 9.02 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 122.272 -0.546 . . . . 0.0 110.257 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -93.29 151.88 19.52 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -148.62 138.2 22.01 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -109.97 116.96 32.56 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.8 0.333 . . . . 0.0 110.177 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.52 140.96 43.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.4 m -73.01 131.06 41.67 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.437 HG22 ' HG2' ' A' ' 42' ' ' ARG . 40.5 p -132.13 147.09 52.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -129.76 138.04 55.17 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -121.46 109.46 14.87 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.62 124.27 69.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.871 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.39 37.13 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 120.599 0.238 . . . . 0.0 110.81 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 pt -125.26 151.17 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 35' ' ' SER . 25.4 ptt180 -138.63 147.43 42.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 122.035 0.921 . . . . 0.0 113.451 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 21.6 mmtm -91.47 -171.23 2.86 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.663 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.544 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.578 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 120.009 -0.043 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.0 p -69.54 -42.76 74.18 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.501 0.667 . . . . 0.0 110.04 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 22.4 t -131.18 118.16 20.06 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.02 140.48 7.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.928 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 27.1 m -132.37 93.24 25.97 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -90.51 4.92 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.306 2.004 . . . . 0.0 113.096 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.7 m -121.14 97.26 47.93 Favored Pre-proline 0 N--CA 1.433 -1.314 0 CA-C-O 121.036 0.446 . . . . 0.0 110.019 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.36 137.61 7.13 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.126 1.884 . . . . 0.0 111.396 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -78.11 91.77 4.34 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.277 0.561 . . . . 0.0 109.919 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -121.53 2.35 10.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.334 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 67.8 t -100.09 112.99 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -103.13 133.6 46.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.813 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.69 116.65 30.31 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.66 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.492 ' HA ' ' CZ ' ' B' ' 22' ' ' TYR . 50.4 mt -88.23 116.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.462 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.69 35.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.791 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -156.12 -54.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.235 0.517 . . . . 0.0 112.197 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.402 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 54.1 mtmt -99.64 157.32 34.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.28 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 156.25 22.94 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 122.844 2.363 . . . . 0.0 112.696 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.413 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.2 p -52.94 -33.87 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.162 0.985 . . . . 0.0 112.881 -176.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -63.76 -25.58 68.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.663 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -72.76 -33.83 66.6 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . 0.492 ' CZ ' ' HA ' ' B' ' 14' ' ' ILE . 99.7 m-85 -77.92 -33.28 51.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.62 -54.37 36.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.086 0.469 . . . . 0.0 109.964 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.88 -29.82 70.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.429 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.29 -46.3 80.99 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.518 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.16 97.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.456 0.473 . . . . 0.0 110.719 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.45 -41.88 97.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.3 m -64.76 -37.63 88.26 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.928 0.394 . . . . 0.0 110.403 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.98 -27.78 62.99 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.404 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' B' ' 35' ' ' SER . 0.5 OUTLIER -64.68 -38.9 92.56 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.87 -22.7 67.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.618 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.76 -10.77 59.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.118 0.485 . . . . 0.0 110.605 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.5 -13.01 20.96 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.139 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.49 100.99 8.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.076 0.465 . . . . 0.0 110.344 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . 0.423 ' HA ' HD22 ' B' ' 30' ' ' LEU . 33.7 p -84.05 -29.35 26.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.845 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.49 ' OE1' ' HD3' ' B' ' 95' ' ' ARG . 39.3 tt0 -107.68 111.53 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.491 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -127.3 162.51 32.35 Favored 'Isoleucine or valine' 0 C--O 1.249 1.077 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 43.4 t -124.95 123.09 64.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.644 0.735 . . . . 0.0 111.254 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.18 128.54 54.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -127.96 125.15 38.95 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.275 0.56 . . . . 0.0 110.208 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.24 147.75 43.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' B' ' 89' ' ' THR . 53.9 mtm180 -127.5 146.24 50.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.96 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.9 -135.19 15.07 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.794 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -91.47 9.57 31.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.411 0.624 . . . . 0.0 111.036 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.44 ' HB1' HG22 ' B' ' 14' ' ' ILE . . . -83.77 -2.12 55.64 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.354 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.8 mt -53.55 -36.43 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-O 121.624 0.726 . . . . 0.0 109.901 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -60.73 -34.93 75.15 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.039 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -79.33 -30.58 42.81 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.346 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.85 92.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.369 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.21 -33.37 50.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.088 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.445 ' O ' HG13 ' B' ' 55' ' ' ILE . 17.2 t70 -65.51 -45.4 83.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.116 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.0 m -57.45 -50.7 72.18 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.95 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.45 -30.36 48.67 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.575 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -50.08 73.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.4 mt -58.04 -45.71 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.219 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.03 -34.53 60.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.134 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -94.03 0.01 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -126.8 11.32 7.19 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.791 0.805 . . . . 0.0 110.23 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -134.85 -49.06 0.75 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.91 -67.07 0.83 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.57 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.481 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 96.0 mt -144.77 115.97 7.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.83 -39.03 10.03 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.903 0.752 . . . . 0.0 110.198 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.69 -13.65 61.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.094 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -130.92 71.44 1.47 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.767 0.318 . . . . 0.0 111.201 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.402 HD12 ' NZ ' ' B' ' 96' ' ' LYS . 17.7 tt -162.24 156.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -145.6 154.35 42.05 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.15 137.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -90.13 -56.41 3.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.337 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -170.17 153.16 4.44 Favored 'General case' 0 C--O 1.251 1.172 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.98 127.0 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -134.8 144.37 47.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.53 143.09 23.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.8 -158.85 22.88 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.759 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.8 p -111.86 131.58 55.27 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -114.69 131.96 56.57 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.693 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -98.69 107.97 21.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 m -101.99 153.76 5.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.541 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 22.1 m -106.25 121.59 44.51 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 22.5 m -89.86 -29.51 18.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -137.89 -150.89 0.37 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.21 -31.79 58.6 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 120.746 0.307 . . . . 0.0 110.64 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.6 39.97 0.88 Allowed Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.912 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -121.16 109.58 15.16 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -97.22 152.85 18.44 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.772 0.67 . . . . 0.0 109.653 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -149.83 136.42 19.21 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -106.13 117.97 35.41 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.387 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -122.01 139.22 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -72.85 128.06 34.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.422 HG22 ' HG2' ' B' ' 42' ' ' ARG . 40.8 p -129.39 147.48 51.22 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -175.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.69 138.21 54.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.66 109.3 14.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.95 123.89 69.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.65 122.79 44.51 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 pt -126.99 150.03 32.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.49 ' HD3' ' OE1' ' B' ' 36' ' ' GLU . 23.8 ptt180 -137.09 150.51 48.06 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 20.9 mmtm -93.49 -170.91 2.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.18 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.416 ' HB2' ' NZ ' ' B' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.333 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.16 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 CA--C 1.514 -0.439 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 p -91.6 161.22 15.02 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.602 0.239 . . . . 0.0 110.464 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.1 m -125.9 12.48 7.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.136 0.493 . . . . 0.0 111.473 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.57 -55.89 0.27 Allowed Glycine 0 CA--C 1.502 -0.739 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.2 p -81.19 144.4 54.18 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -63.38 -40.34 32.2 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.966 1.777 . . . . 0.0 110.677 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.5 t -71.28 127.77 90.98 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.662 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 21.3 Cg_exo -66.77 -49.64 1.49 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.996 1.797 . . . . 0.0 111.344 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.3 m -159.6 -83.49 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.014 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -134.86 17.51 3.53 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.596 0.712 . . . . 0.0 110.029 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.19 120.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -110.82 145.76 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.264 0.554 . . . . 0.0 111.112 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.79 132.63 51.68 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.075 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -89.66 102.31 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 16' ' ' LYS . . . 178.86 55.55 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 118.229 -1.938 . . . . 0.0 115.551 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 53.8 tttm 178.07 -42.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.472 0.636 . . . . 0.0 110.69 171.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -92.39 159.82 36.19 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.243 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.82 162.15 40.02 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.152 1.901 . . . . 0.0 111.308 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.408 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.4 p -54.77 -41.39 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -59.95 -30.19 68.91 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.738 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -72.29 -34.4 68.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.067 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -73.01 -33.18 65.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.65 -55.83 21.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.101 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.52 -27.3 69.06 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.684 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.01 77.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.907 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.31 98.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.294 0.371 . . . . 0.0 110.856 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.04 -33.18 75.21 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.47 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.8 m -64.4 -36.73 85.11 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.441 0.639 . . . . 0.0 109.738 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.82 -35.51 72.51 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.7 mt -58.43 -42.58 87.63 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.167 0.508 . . . . 0.0 110.239 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -66.79 -23.76 66.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.892 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -87.65 -2.68 58.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.7 8.93 47.75 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.07 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -97.38 94.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 m -85.69 -22.6 27.78 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.633 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -109.7 107.45 17.49 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -119.47 142.05 36.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -116.1 123.91 71.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.013 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -107.03 123.92 62.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 85.7 mttt -120.18 124.02 44.71 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.491 0.662 . . . . 0.0 109.834 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.34 160.04 21.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.457 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -131.37 145.09 51.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.278 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' O ' HG13 ' A' ' 46' ' ' ILE . . . 69.57 -127.8 20.36 Favored Glycine 0 N--CA 1.433 -1.552 0 O-C-N 123.533 0.52 . . . . 0.0 112.445 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -88.23 0.02 56.58 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.38 . . . . 0.0 111.35 -176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.74 2.06 27.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.134 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 43' ' ' GLY . 75.1 mt -57.25 -40.89 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.463 0.649 . . . . 0.0 109.698 175.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.3 t -70.66 -16.44 62.81 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.954 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -89.83 -33.97 16.3 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.56 89.45 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.128 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 13.7 p -67.76 -43.32 86.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.556 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.9 t70 -54.83 -44.51 73.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.6 m -57.96 -53.55 57.0 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.983 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.54 -30.14 46.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 50' ' ' VAL . 46.4 mt-10 -60.19 -47.93 83.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 123.401 0.438 . . . . 0.0 110.286 174.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.2 mt -60.6 -40.62 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 121.232 0.539 . . . . 0.0 110.62 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.93 -27.51 42.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 CA-C-O 121.14 0.495 . . . . 0.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -100.96 2.63 40.89 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -116.45 9.78 14.42 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.198 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -139.1 -71.24 0.4 Allowed 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.419 ' CD2' ' HG ' ' A' ' 61' ' ' LEU . 74.4 t80 -60.5 -64.49 0.93 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.131 0.491 . . . . 0.0 110.842 -174.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.473 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 95.0 mt -141.28 113.62 8.1 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.27 -35.69 10.66 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 124.161 0.913 . . . . 0.0 110.175 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.1 -45.85 59.01 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.073 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.66 97.65 8.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.591 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.466 HD13 ' HZ2' ' A' ' 96' ' ' LYS . 7.2 tp -158.63 138.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.266 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.617 ' HG2' HH21 ' A' ' 95' ' ' ARG . 7.9 tp10 -124.74 149.98 46.71 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tp -107.52 137.19 39.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -100.54 -53.64 3.04 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.542 -1.263 . . . . 0.0 111.511 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 71' ' ' ARG . 35.6 tt0 -170.53 144.81 2.47 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.1 mt -135.49 119.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.498 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 21.9 mtm180 -128.92 136.61 50.62 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.39 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.58 119.0 58.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.98 167.62 34.87 Favored Glycine 0 C--N 1.303 -1.287 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.631 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 m -85.87 118.65 25.49 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 5.9 tp60 -95.64 131.87 41.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.94 107.45 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.901 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.38 161.24 16.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.644 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.4 p -100.21 152.44 20.28 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.0 t -82.7 -72.56 0.44 Allowed 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.744 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -155.24 11.71 0.34 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.473 0.654 . . . . 0.0 109.838 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 82' ' ' GLY . 24.5 t70 -160.68 -159.38 0.68 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.433 ' H ' ' CG ' ' A' ' 81' ' ' ASP . . . -76.42 11.06 14.09 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.213 0.915 . . . . 0.0 112.709 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -73.45 107.31 5.66 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -88.54 137.65 32.13 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.2 m -129.0 130.49 46.71 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -95.53 120.08 35.15 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.57 130.23 72.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.696 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.54 118.43 7.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.5 p -125.86 155.16 41.63 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.427 -0.171 . . . . 0.0 111.069 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 14.4 tt -136.99 131.27 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -113.12 110.99 21.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.32 118.32 57.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.0 117.93 30.56 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 123.298 0.374 . . . . 0.0 110.332 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.6 pt -114.87 158.37 15.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.617 HH21 ' HG2' ' A' ' 66' ' ' GLU . 34.4 ttp180 -130.39 111.79 12.66 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.207 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 26.8 mmtm -79.03 143.45 35.63 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.559 174.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt . . . . . 0 C--N 1.307 -1.263 0 O-C-N 123.127 0.267 . . . . 0.0 110.832 -178.57 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 C--O 1.213 -0.83 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.4 p -102.4 -63.36 1.16 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 120.882 0.373 . . . . 0.0 111.148 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 17.1 p -68.06 -60.66 2.32 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 123.787 0.835 . . . . 0.0 111.248 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.82 -148.62 19.28 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 11.6 p -148.58 138.12 12.49 Favored Pre-proline 0 C--N 1.317 -0.84 0 C-N-CA 123.234 0.613 . . . . 0.0 109.835 177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 5' ' ' THR . 10.1 Cg_endo -82.24 160.47 17.68 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.704 2.269 . . . . 0.0 112.8 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -91.17 132.44 34.09 Favored Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.605 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -89.13 141.34 4.18 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.884 2.39 . . . . 0.0 113.108 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -115.95 -18.24 10.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.246 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -112.66 17.7 18.92 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.821 0.343 . . . . 0.0 111.402 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.46 119.96 63.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.46 142.05 24.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.192 0.52 . . . . 0.0 111.585 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.33 131.83 51.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.879 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mm -89.57 99.95 10.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.16 43.63 0.16 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 117.935 -2.079 . . . . 0.0 116.112 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -173.83 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.456 1.128 . . . . 0.0 110.444 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -91.59 160.87 35.67 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.395 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.66 164.09 34.47 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.133 1.888 . . . . 0.0 110.929 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.464 HG23 ' OG1' ' B' ' 52' ' ' THR . 8.4 p -57.24 -37.37 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.118 0.567 . . . . 0.0 111.738 -176.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -64.07 -29.36 70.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.662 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -73.97 -34.94 64.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -70.7 -34.03 71.53 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.799 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.46 -55.16 26.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.429 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.7 -28.69 70.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.53 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.413 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.43 -43.07 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.184 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.17 99.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.124 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.6 -34.73 78.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.806 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 86.0 m -64.88 -36.3 83.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.137 0.494 . . . . 0.0 110.11 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -69.91 -36.94 75.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.558 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.42 HD23 ' O ' ' B' ' 34' ' ' VAL . 95.2 mt -57.31 -43.42 83.26 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.056 0.455 . . . . 0.0 110.346 177.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.802 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -87.65 -0.87 57.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.158 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.74 13.85 36.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.041 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.42 ' O ' HD23 ' B' ' 30' ' ' LEU . 32.5 t -101.08 92.97 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -82.9 -24.34 33.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.151 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -109.06 109.32 20.31 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.448 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -122.44 142.76 37.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.27 179.229 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.02 125.08 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.36 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -107.51 123.87 63.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -120.51 123.2 42.36 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.56 161.73 18.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -132.76 145.72 51.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.941 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.4 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 68.35 -127.88 24.2 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 123.451 0.47 . . . . 0.0 112.654 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.35 -0.77 57.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.022 0.439 . . . . 0.0 111.778 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.88 1.98 25.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.4 HG13 ' O ' ' B' ' 43' ' ' GLY . 73.3 mt -58.14 -41.17 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.69 0.757 . . . . 0.0 109.805 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 44.2 t -67.77 -22.14 65.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.405 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -84.84 -33.57 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.37 86.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.601 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' B' ' 54' ' ' GLU . 14.5 p -66.47 -44.07 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.4 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.486 ' O ' HG13 ' B' ' 55' ' ' ILE . 37.1 t70 -56.55 -39.38 73.34 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.464 ' OG1' HG23 ' B' ' 19' ' ' VAL . 57.3 m -61.68 -52.62 63.55 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.98 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.48 -31.14 49.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.203 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' B' ' 50' ' ' VAL . 44.9 mt-10 -59.38 -45.9 90.16 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.626 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.486 HG13 ' O ' ' B' ' 51' ' ' ASP . 68.9 mt -61.95 -40.64 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.894 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.84 -26.02 37.65 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.157 0.503 . . . . 0.0 111.59 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -100.75 0.52 39.01 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.864 -0.523 . . . . 0.0 111.914 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -116.41 12.75 15.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.182 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -137.89 -68.96 0.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.01 -62.7 1.47 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.868 0.366 . . . . 0.0 111.148 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.446 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.1 mt -142.8 115.12 8.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.01 -34.17 10.19 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 124.241 0.963 . . . . 0.0 109.968 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.5 -41.47 60.64 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.907 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -103.91 99.11 8.87 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.425 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.415 HD13 ' HZ2' ' B' ' 96' ' ' LYS . 7.0 tp -157.99 140.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.041 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.621 ' HG2' HH21 ' B' ' 95' ' ' ARG . 7.1 tp10 -125.83 146.82 49.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -105.44 134.53 46.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -98.85 -54.01 3.12 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.503 -1.279 . . . . 0.0 111.291 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . 0.401 ' OE2' ' HD3' ' B' ' 71' ' ' ARG . 29.3 tt0 -169.87 143.32 2.57 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 72.7 mt -131.89 118.81 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.401 ' HD3' ' OE2' ' B' ' 69' ' ' GLU . 25.6 mtm180 -127.55 137.25 52.56 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.582 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.55 117.23 51.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.16 165.77 33.89 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.515 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -84.44 115.98 22.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.45 0.7 . . . . 0.0 109.375 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -94.04 132.44 38.52 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.48 108.96 21.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.644 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -118.56 164.82 14.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.71 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 25.5 p -103.94 145.87 29.51 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 47.8 t -78.13 -62.34 1.71 Allowed 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.762 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.15 6.69 0.07 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.935 0.398 . . . . 0.0 110.756 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' B' ' 82' ' ' GLY . 24.6 t70 -161.09 -156.29 0.45 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' B' ' 81' ' ' ASP . . . -73.25 6.48 14.87 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 118.787 0.721 . . . . 0.0 113.657 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.36 108.8 5.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -88.59 144.42 26.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 123.52 0.512 . . . . 0.0 109.983 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.1 m -132.92 125.56 30.15 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.755 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -91.97 114.42 26.95 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 87.4 t -114.46 129.48 70.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -61.86 120.38 10.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.9 p -127.64 155.12 44.4 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.308 -0.245 . . . . 0.0 111.221 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 tt -136.83 131.42 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.838 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.35 109.94 19.12 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 56.1 mt -110.88 117.38 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.95 118.83 34.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.193 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 pt -116.67 152.03 18.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.836 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.621 HH21 ' HG2' ' B' ' 66' ' ' GLU . 35.0 ttp180 -124.21 114.04 19.1 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 28.0 mmtm -80.24 146.8 31.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.861 174.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.385 0.428 . . . . 0.0 111.643 -177.347 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.5 p 56.39 94.49 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 t -146.28 -41.58 0.2 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.832 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.72 175.61 14.15 Favored Glycine 0 N--CA 1.422 -2.291 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 p -100.57 151.06 37.47 Favored Pre-proline 0 C--N 1.286 -2.184 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.29 -17.1 55.39 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.844 2.362 . . . . 0.0 112.66 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -142.61 140.27 18.41 Favored Pre-proline 0 N--CA 1.422 -1.846 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.61 124.1 10.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.271 1.981 . . . . 0.0 111.973 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 t -137.57 -50.4 0.61 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.78 0.324 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -100.14 13.57 33.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.898 0.38 . . . . 0.0 111.08 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.46 112.27 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.26 133.9 44.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.642 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -120.83 130.42 53.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.29 133.81 44.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.41 48.5 0.02 OUTLIER Glycine 0 C--N 1.348 1.196 0 C-N-CA 119.439 -1.363 . . . . 0.0 115.628 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -174.71 -51.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 118.04 0.92 . . . . 0.0 112.031 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -97.13 158.1 33.85 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.732 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 165.74 17.89 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.373 2.048 . . . . 0.0 111.417 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG21 ' OD2' ' A' ' 51' ' ' ASP . 11.6 p -53.06 -28.72 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 C-N-CA 124.353 1.061 . . . . 0.0 113.296 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.6 mtp -62.83 -29.74 70.96 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -71.07 -28.82 64.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.18 0.515 . . . . 0.0 109.64 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -89.62 -42.66 11.26 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.183 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 82.3 t -60.79 -49.82 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.787 0.327 . . . . 0.0 110.68 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.24 -19.79 64.76 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.984 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.406 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -77.37 -48.79 16.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.44 85.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 97.4 mt -60.3 -34.48 73.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.7 m -76.09 -40.95 51.91 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 93.0 mt -61.35 -38.56 87.37 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.1 -42.78 95.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.395 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.73 -16.38 45.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.918 0.39 . . . . 0.0 110.411 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -78.61 -34.12 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.29 -4.0 1.27 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.87 100.36 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -79.34 -21.11 46.3 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.151 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.38 121.48 22.38 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.261 0.553 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -126.36 158.63 36.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.503 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.86 122.02 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.4 mt -105.45 121.1 57.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 99.6 mttt -108.34 141.25 40.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -133.38 157.4 45.62 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -133.98 135.09 43.23 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 46' ' ' ILE . . . 67.59 -135.01 30.72 Favored Glycine 0 C--O 1.212 -1.237 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.683 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -74.12 -2.45 24.6 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.35 -9.97 59.16 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.488 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 43' ' ' GLY . 78.7 mt -53.35 -33.87 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.272 0.629 . . . . 0.0 110.797 178.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 p -63.07 -30.6 71.72 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.095 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -86.98 -25.85 24.09 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.374 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -63.29 -48.38 78.34 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.41 0.624 . . . . 0.0 109.984 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.1 -38.18 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.406 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 55' ' ' ILE . 18.4 t70 -59.8 -47.99 83.49 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.518 0.511 . . . . 0.0 109.732 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 56' ' ' VAL . 95.2 m -55.82 -54.26 46.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.193 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.31 -31.0 49.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.278 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 26.6 tt0 -67.87 -37.6 82.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.275 0.359 . . . . 0.0 110.531 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 68.9 mt -64.89 -47.97 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 52' ' ' THR . 61.4 t -58.17 -52.71 55.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.179 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.449 ' NE ' ' HA ' ' A' ' 54' ' ' GLU . 32.1 ptt180 -66.63 -13.51 61.24 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -116.64 2.32 12.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 15.8 ptm180 -117.78 -34.44 4.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.127 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -90.1 -58.85 2.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.697 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' A' ' 64' ' ' LYS . 47.2 tp -155.84 109.49 2.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.39 -6.04 28.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.443 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -87.95 -41.92 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.006 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 67.2 mttm -124.43 99.01 6.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tp -155.2 145.34 13.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.5 148.24 50.5 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.166 0.508 . . . . 0.0 110.131 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.2 mt -102.91 133.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -92.85 -51.42 5.09 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.967 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -160.55 141.36 11.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 pt -143.2 99.89 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 123.132 0.573 . . . . 0.0 110.388 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.22 153.95 51.76 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.775 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.08 135.95 42.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.27 -165.69 15.5 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.189 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -100.27 128.73 46.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.076 0.55 . . . . 0.0 109.874 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -108.15 112.41 24.92 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 85' ' ' SER . 21.9 t -102.03 111.94 33.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.52 163.96 32.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.035 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.6 p -85.87 130.47 34.54 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.3 m -79.53 -27.17 41.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.067 0.461 . . . . 0.0 110.043 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -143.28 -80.84 0.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -133.8 -83.9 0.45 Allowed 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.845 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.1 45.75 2.07 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.091 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -133.13 104.12 6.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -91.38 126.65 36.53 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.818 0.699 . . . . 0.0 110.242 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 32.3 t -114.94 137.74 51.64 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.403 ' HG2' HG22 ' A' ' 76' ' ' VAL . 46.1 mtm180 -113.4 109.01 18.0 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.19 133.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.7 t -66.02 134.88 53.82 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.352 0.596 . . . . 0.0 110.915 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.2 p -132.14 160.34 36.31 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.161 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 18.5 tt -140.78 135.58 34.14 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -111.38 115.79 29.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.64 112.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 123.96 50.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.496 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.6 pt -125.85 152.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.166 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -130.05 124.51 33.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.894 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -74.6 140.01 44.06 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 28.1 mtpp . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 52.3 p -142.89 -44.67 0.3 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.834 0.35 . . . . 0.0 111.714 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.3 t -85.28 -9.81 57.24 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.843 0.354 . . . . 0.0 111.414 -177.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.32 98.78 2.31 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.874 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -133.32 143.89 50.1 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.35 -5.55 11.86 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.416 2.077 . . . . 0.0 113.521 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -159.75 142.39 10.06 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.7 101.11 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.982 2.455 . . . . 0.0 112.127 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -112.4 -0.14 15.44 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.412 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -113.99 14.61 18.45 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 120.781 0.324 . . . . 0.0 110.841 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.92 111.51 30.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.69 131.63 47.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.983 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -118.27 127.18 53.48 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.8 mt -99.76 133.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 48.31 0.02 OUTLIER Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.496 -1.335 . . . . 0.0 115.446 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -172.95 -50.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.868 0.834 . . . . 0.0 112.598 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.416 ' O ' ' HE2' ' B' ' 22' ' ' TYR . 32.0 mmmt -99.64 158.52 32.0 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 122.241 -0.287 . . . . 0.0 110.806 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.91 164.26 22.46 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.557 2.171 . . . . 0.0 111.173 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.476 HG21 ' OD1' ' B' ' 51' ' ' ASP . 13.4 p -52.43 -27.23 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 123.994 0.918 . . . . 0.0 113.326 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 92.9 mtp -65.14 -27.17 68.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -72.9 -26.23 61.35 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.409 0.623 . . . . 0.0 109.625 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . 0.416 ' HE2' ' O ' ' B' ' 17' ' ' LYS . 90.1 m-85 -93.42 -42.84 9.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.101 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.453 HG23 HG22 ' B' ' 19' ' ' VAL . 99.0 t -60.8 -49.56 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 121.345 0.593 . . . . 0.0 110.432 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mp -67.46 -24.18 65.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.79 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.11 -45.92 46.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.19 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.75 97.69 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.932 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 23' ' ' VAL . 98.8 mt -60.33 -38.09 82.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.153 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.1 m -70.19 -43.62 70.38 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -60.18 -39.05 85.13 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -41.34 89.53 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.522 0.514 . . . . 0.0 111.168 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -85.37 -15.05 44.45 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.312 0.577 . . . . 0.0 110.164 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -79.21 -36.42 40.13 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.528 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.26 -3.9 0.92 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.638 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -97.99 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 117.511 0.656 . . . . 0.0 109.389 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.2 m -78.29 -21.78 49.21 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.963 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.23 118.32 19.36 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.174 0.511 . . . . 0.0 111.092 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.533 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -124.95 159.25 31.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.923 -176.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.67 121.49 60.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.029 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -104.94 122.66 58.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 99.3 mttt -110.47 139.24 45.88 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 123.65 0.594 . . . . 0.0 109.979 177.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -132.61 154.92 49.58 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -132.22 134.0 44.81 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.42 ' O ' HG13 ' B' ' 46' ' ' ILE . . . 70.28 -135.53 25.78 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.691 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.6 -2.83 27.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.47 57.98 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.539 0.209 . . . . 0.0 111.275 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.42 HG13 ' O ' ' B' ' 43' ' ' GLY . 77.7 mt -52.96 -35.63 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.479 0.657 . . . . 0.0 110.43 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 53.4 p -62.35 -35.71 79.95 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.92 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -81.61 -26.81 34.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -62.47 -47.77 82.54 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.25 0.548 . . . . 0.0 110.613 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.66 -38.06 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.661 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.476 ' OD1' HG21 ' B' ' 19' ' ' VAL . 13.3 t70 -57.58 -49.92 74.82 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.418 ' O ' HG23 ' B' ' 56' ' ' VAL . 90.1 m -54.2 -54.3 41.79 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.473 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 21.0 m -69.3 -30.63 46.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.551 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.447 ' HA ' ' NE ' ' B' ' 57' ' ' ARG . 25.8 tt0 -68.11 -37.42 81.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 123.302 0.376 . . . . 0.0 110.71 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' B' ' 59' ' ' ARG . 73.7 mt -64.56 -48.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 52' ' ' THR . 58.8 t -57.7 -53.69 41.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.318 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' B' ' 54' ' ' GLU . 32.2 ptt180 -65.77 -9.69 30.55 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -120.04 -1.24 10.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' B' ' 55' ' ' ILE . 15.5 ptm180 -115.18 -33.79 5.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.166 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -89.41 -59.69 2.15 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.704 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' B' ' 64' ' ' LYS . 46.1 tp -153.94 107.74 2.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.87 -1.61 39.73 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.064 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -92.63 -50.75 5.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.918 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.413 ' HB2' HD21 ' B' ' 61' ' ' LEU . 66.3 mttm -115.22 96.65 5.78 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.817 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -152.14 146.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -132.25 149.53 52.35 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -105.69 132.33 52.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -91.72 -50.28 5.83 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.866 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -163.55 143.24 8.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.566 0.541 . . . . 0.0 109.602 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 21.7 pt -143.96 98.2 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.742 0.817 . . . . 0.0 110.269 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -132.91 153.28 51.53 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.397 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.45 137.42 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.65 -169.88 25.57 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.667 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -93.73 137.17 33.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -115.42 116.33 28.05 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' B' ' 85' ' ' SER . 26.3 t -106.09 108.32 24.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.12 166.81 28.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.783 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' B' ' 83' ' ' ARG . 17.6 p -89.89 127.76 36.07 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.337 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 18.0 m -77.33 -25.22 50.95 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.371 0.605 . . . . 0.0 110.958 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -145.22 -81.99 0.15 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -132.26 -74.24 0.51 Allowed 'General case' 0 C--O 1.209 -1.074 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.869 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.02 30.0 11.31 Favored Glycine 0 C--O 1.22 -0.762 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.667 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' B' ' 78' ' ' THR . 77.4 ttt180 -116.62 105.11 12.07 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -88.07 128.86 35.42 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.492 0.495 . . . . 0.0 110.135 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' B' ' 76' ' ' VAL . 32.6 t -117.53 138.83 51.64 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' B' ' 76' ' ' VAL . 52.3 mtm180 -114.12 108.97 17.7 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.65 135.97 58.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.5 t -69.59 135.98 50.67 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.875 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 40.8 p -132.03 159.55 38.47 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.491 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 19.2 tt -139.08 135.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.84 113.33 25.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.0 113.49 44.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.15 122.14 44.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 32.7 pt -124.11 149.17 28.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.204 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -127.33 127.57 44.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.988 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' B' ' 97' ' ' LYS . 0.7 OUTLIER -78.59 136.74 37.59 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.459 ' N ' ' HD3' ' B' ' 96' ' ' LYS . 27.5 mtpp . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 ttp . . . . . 0 CA--C 1.487 -1.452 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 t 56.99 87.67 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.493 1.121 . . . . 0.0 110.174 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 m -119.25 18.61 12.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.841 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.84 178.7 26.83 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -86.73 115.51 62.64 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -56.34 -33.18 90.88 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.557 2.838 . . . . 0.0 113.649 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 m -145.77 101.59 4.25 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -88.9 118.45 0.93 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.574 2.183 . . . . 0.0 112.909 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.3 m -97.4 104.58 16.62 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.128 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -123.61 10.25 9.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.089 0.471 . . . . 0.0 110.66 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 22.9 m -102.38 130.83 51.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.583 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.89 142.45 40.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.526 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.39 129.19 52.34 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.34 113.06 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.935 0.397 . . . . 0.0 111.269 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.08 -161.3 25.51 Favored Glycine 0 C--O 1.253 1.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.322 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.23 5.18 8.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -82.16 158.47 66.91 Favored Pre-proline 0 CA--C 1.547 0.854 0 O-C-N 122.154 -0.341 . . . . 0.0 111.093 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.18 153.81 67.11 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.101 2.534 . . . . 0.0 113.475 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.507 HG21 ' OD1' ' A' ' 51' ' ' ASP . 7.1 p -54.76 -39.91 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.06 0.944 . . . . 0.0 113.356 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -55.55 -30.58 61.01 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.33 -39.49 92.49 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.007 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -80.97 -34.31 33.2 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.14 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 19' ' ' VAL . 57.4 t -59.2 -49.97 81.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.065 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.1 mt -67.14 -34.66 78.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.58 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -65.01 -50.6 65.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.07 86.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.237 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.25 -41.17 97.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.7 m -62.6 -38.55 90.62 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.789 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 88.6 mt -64.25 -38.58 91.54 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.65 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.99 -48.85 78.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.812 0.695 . . . . 0.0 110.536 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -79.38 -12.83 59.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.198 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -79.98 -25.85 40.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.99 -12.47 3.88 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.799 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.98 93.06 3.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.292 0.568 . . . . 0.0 109.479 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -87.65 18.4 4.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -155.73 110.34 2.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.473 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -130.33 160.64 41.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.342 -175.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 48.3 t -124.59 122.76 64.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.332 0.587 . . . . 0.0 110.662 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -100.93 129.32 52.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.0 119.68 36.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.096 0.474 . . . . 0.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . . . -113.74 153.21 29.4 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -142.86 137.56 29.66 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.535 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.48 -130.83 10.26 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -95.18 10.06 37.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.077 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.56 2.02 49.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.934 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.405 HG23 HG21 ' A' ' 90' ' ' ILE . 73.9 mt -57.31 -43.28 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.149 0.579 . . . . 0.0 111.282 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.3 p -66.6 -24.81 66.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.689 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.62 -30.71 52.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.5 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . . . -70.67 -43.77 68.43 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.325 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.85 -33.29 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.075 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' OD1' HG21 ' A' ' 19' ' ' VAL . 18.0 t70 -58.97 -50.36 74.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.4 m -53.61 -52.76 58.8 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.105 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.8 m -70.31 -36.27 66.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.73 -29.08 68.96 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 121.493 0.663 . . . . 0.0 109.43 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 51' ' ' ASP . 73.5 mt -69.57 -48.75 64.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 122.003 -0.435 . . . . 0.0 110.626 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -59.84 -36.31 65.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 120.946 0.403 . . . . 0.0 111.348 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 6.1 ptm180 -82.08 0.81 38.87 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -115.29 -45.77 2.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.884 0.373 . . . . 0.0 111.544 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 16.2 ptm180 -72.85 -28.36 62.48 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -105.62 -72.53 0.71 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.231 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.507 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 96.0 mt -142.2 116.52 9.55 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -93.15 -37.57 12.04 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 124.497 1.123 . . . . 0.0 110.42 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.7 -40.33 92.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.79 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -108.12 99.44 8.88 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 121.191 0.519 . . . . 0.0 111.364 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.42 132.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.454 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.49 136.96 53.9 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -99.48 130.05 49.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -80.04 -55.82 4.68 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -171.32 147.3 2.44 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.71 123.92 55.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -122.43 139.93 53.3 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.039 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -132.57 125.45 53.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.28 25.78 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.494 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 88' ' ' SER . 50.1 m -115.38 129.05 56.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 117.278 0.539 . . . . 0.0 111.082 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 53.5 tt0 -93.18 141.63 28.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.122 0.969 . . . . 0.0 108.543 -178.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.481 HG22 ' HG2' ' A' ' 86' ' ' ARG . 22.4 t -116.1 113.25 42.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.18 170.59 18.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 120.673 0.273 . . . . 0.0 110.599 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 81' ' ' ASP . 26.2 p -95.92 142.52 28.06 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.4 t -78.06 -22.15 49.51 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.589 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 178.57 -45.95 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.902 0.881 . . . . 0.0 109.037 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.493 ' O ' ' HB ' ' A' ' 78' ' ' THR . 17.6 t70 -123.56 -154.22 0.6 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.62 -2.43 7.63 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.092 0.797 . . . . 0.0 115.092 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.39 103.06 0.76 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -77.7 140.6 39.56 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.392 0.677 . . . . 0.0 111.719 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.9 m -131.59 123.04 27.09 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.285 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 98.1 mtt180 -102.77 120.06 39.92 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -134.75 139.22 47.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 19.2 m -72.35 136.65 46.21 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 123.556 0.743 . . . . 0.0 112.436 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.448 HG21 ' OE1' ' A' ' 75' ' ' GLN . 80.9 p -129.15 170.73 13.18 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.909 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.405 HG21 HG23 ' A' ' 46' ' ' ILE . 13.7 tt -146.93 123.78 3.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.477 176.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.14 113.49 26.8 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.03 115.51 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.19 121.14 42.06 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.574 0.225 . . . . 0.0 110.836 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.81 148.32 25.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.636 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.43 147.63 40.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.137 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HE3' ' HB2' ' A' ' 61' ' ' LEU . 4.4 mmtm -128.05 137.4 52.16 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.505 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? . . . . . 0 C--O 1.265 1.886 0 O-C-N 123.337 0.398 . . . . 0.0 110.585 -178.915 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtp . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.7 p -69.81 3.69 2.43 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -78.77 -19.12 52.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.758 0.79 . . . . 0.0 108.902 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.43 -101.77 0.44 Allowed Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.828 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -84.05 157.13 63.32 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -88.97 1.97 5.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.046 2.498 . . . . 0.0 111.44 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -85.05 125.4 70.53 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.838 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.68 98.67 0.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.584 2.19 . . . . 0.0 112.395 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 30.1 m -123.99 9.64 8.76 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.354 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -141.2 17.21 2.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.639 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.87 133.12 48.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.078 0.466 . . . . 0.0 111.493 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.67 143.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.553 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 56.8 tp -106.52 125.65 51.26 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.87 116.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 120.996 0.426 . . . . 0.0 111.099 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.98 -158.8 22.38 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.201 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -79.28 4.17 15.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.02 158.53 67.2 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 122.346 -0.222 . . . . 0.0 110.661 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.69 153.93 68.84 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.214 2.61 . . . . 0.0 113.214 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.502 HG21 ' OD1' ' B' ' 51' ' ' ASP . 7.3 p -54.53 -39.8 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.346 1.058 . . . . 0.0 113.394 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -57.56 -27.26 62.5 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.95 -36.74 80.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -83.19 -35.46 25.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.415 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 19' ' ' VAL . 82.1 t -58.38 -50.95 76.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.876 178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.22 -36.51 84.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -63.6 -48.09 78.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.832 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.08 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.925 0.393 . . . . 0.0 111.088 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.54 -41.76 98.43 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 89.9 m -61.16 -39.62 90.8 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.521 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 89.3 mt -63.51 -38.69 92.1 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.59 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.3 -46.02 86.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.138 0.494 . . . . 0.0 110.696 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.83 -7.51 59.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -84.87 -25.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.81 -15.71 3.31 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.612 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.65 94.39 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.169 0.509 . . . . 0.0 109.93 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -90.48 19.04 5.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.962 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -155.25 107.84 2.72 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.505 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -129.15 158.74 41.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -174.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.19 121.72 62.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.508 0.67 . . . . 0.0 111.015 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.77 129.03 50.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.477 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.92 122.74 44.09 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.26 0.552 . . . . 0.0 110.777 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -116.77 154.34 30.85 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -142.94 136.03 28.14 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.542 0.526 . . . . 0.0 110.35 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.33 -132.92 11.46 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -93.48 13.56 21.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 110.267 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.95 1.41 56.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.27 -43.78 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.305 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -65.92 -24.25 66.79 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.955 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -79.6 -32.2 41.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.035 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -68.29 -44.18 76.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.08 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.51 -33.91 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.113 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.502 ' OD1' HG21 ' B' ' 19' ' ' VAL . 13.7 t70 -58.51 -49.28 77.95 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -54.58 -51.78 64.19 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.908 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.45 -37.11 69.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -66.97 -30.52 70.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.304 0.573 . . . . 0.0 109.58 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 51' ' ' ASP . 73.7 mt -67.33 -49.18 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 122.106 -0.371 . . . . 0.0 110.649 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.28 -39.42 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.794 0.331 . . . . 0.0 111.542 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' B' ' 62' ' ' ALA . 7.6 ptm180 -79.82 -1.98 41.37 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -110.79 -43.8 3.75 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.769 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -75.16 -34.27 61.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -99.96 -69.15 0.78 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.851 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.529 ' HB2' ' HE3' ' B' ' 96' ' ' LYS . 95.9 mt -144.97 116.6 8.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -93.21 -38.06 11.75 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 124.501 1.125 . . . . 0.0 110.789 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.365 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -108.53 100.14 9.44 Favored 'General case' 0 C--O 1.253 1.254 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.0 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tp -160.18 130.01 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.638 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.15 135.05 53.22 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.73 131.61 45.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' B' ' 68' ' ' LYS . 9.5 tmtt? -83.26 -56.41 3.78 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -170.89 146.22 2.5 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 73.3 mt -130.45 123.61 55.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -121.23 140.41 52.07 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.607 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.22 125.67 51.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' B' ' 88' ' ' SER . . . -165.11 -171.46 31.37 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.001 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 88' ' ' SER . 49.0 m -111.0 125.77 54.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.101 0.451 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 53.3 tt0 -89.81 141.9 28.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.899 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.494 HG22 ' HG2' ' B' ' 86' ' ' ARG . 20.7 t -116.39 115.79 50.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.36 172.38 16.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' B' ' 81' ' ' ASP . 25.6 p -97.51 143.28 28.38 Favored 'General case' 0 N--CA 1.413 -2.292 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 46.6 t -77.21 -23.01 51.47 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 178.9 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.525 ' O ' ' HB ' ' B' ' 78' ' ' THR . 15.6 t70 -123.56 -154.7 0.62 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 177.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.51 -1.17 7.47 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 114.974 0.75 . . . . 0.0 114.974 -175.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.59 105.6 1.26 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 117.472 0.636 . . . . 0.0 109.437 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -78.85 144.35 35.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.484 0.659 . . . . 0.0 111.895 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -132.43 127.93 36.41 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.539 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 99.7 mtt180 -108.89 116.76 32.6 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 135.63 56.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 74' ' ' SER . 20.1 m -68.08 137.17 54.77 Favored 'General case' 0 C--O 1.261 1.693 0 C-N-CA 123.708 0.803 . . . . 0.0 112.193 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.444 HG21 ' OE1' ' B' ' 75' ' ' GLN . 68.4 p -129.42 171.01 12.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.472 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.57 123.03 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.952 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.81 113.36 26.71 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -110.96 116.39 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.36 120.38 40.16 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.059 0.457 . . . . 0.0 110.922 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -120.69 143.8 31.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -110.78 147.61 34.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.284 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.529 ' HE3' ' HB2' ' B' ' 61' ' ' LEU . 3.3 mmtm -128.81 136.06 49.98 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 122.733 0.413 . . . . 0.0 111.802 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? . . . . . 0 C--O 1.258 1.504 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -178.992 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 119.911 -0.09 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 p 55.56 -173.61 0.06 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.772 0.829 . . . . 0.0 112.737 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.6 m -89.93 -56.59 3.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.263 0.554 . . . . 0.0 109.882 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.616 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -122.24 161.65 16.32 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 p -102.62 98.28 10.72 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 34.3 Cg_endo -98.07 -172.77 0.16 Allowed 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 123.015 2.477 . . . . 0.0 110.356 175.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -114.88 87.78 15.62 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-O 121.141 0.496 . . . . 0.0 112.201 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 6' ' ' PRO . 22.4 Cg_endo -96.03 101.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.908 0 C-N-CA 122.863 2.375 . . . . 0.0 110.753 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -138.76 -66.58 0.47 Allowed 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.683 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -111.84 18.97 18.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.437 0.637 . . . . 0.0 111.518 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.75 148.43 8.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.14 135.03 58.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 120.915 0.388 . . . . 0.0 110.606 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.34 132.35 40.47 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.439 HG21 ' HB2' ' A' ' 48' ' ' LYS . 49.4 mm -94.54 111.16 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.712 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.27 0.02 OUTLIER Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.374 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -135.86 -76.37 0.44 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.052 0.426 . . . . 0.0 110.529 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -99.39 169.38 8.22 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.198 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.36 161.74 16.22 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.355 2.037 . . . . 0.0 112.239 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -51.37 -30.87 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.076 1.35 . . . . 0.0 113.591 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptp -62.85 -26.91 68.99 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.33 -31.35 58.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.148 0.499 . . . . 0.0 109.952 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -77.81 -36.36 50.33 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.9 t -61.13 -50.85 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.011 0.434 . . . . 0.0 109.903 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.71 -26.49 64.37 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.89 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -68.9 -44.81 72.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.693 0.282 . . . . 0.0 110.287 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.45 -24.4 67.16 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 23' ' ' VAL . 90.1 mt -77.89 -45.73 23.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.145 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -63.64 -34.95 78.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.177 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 87.6 mt -61.63 -35.06 76.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.892 0.377 . . . . 0.0 111.385 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.62 -31.07 71.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.493 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.75 -23.2 65.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.228 0.537 . . . . 0.0 109.783 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -79.81 -15.82 56.69 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.984 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.66 -12.01 18.38 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.912 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.42 106.95 15.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.956 0.884 . . . . 0.0 112.049 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.1 p -87.82 -31.18 19.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.007 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 44.5 mt-10 -103.67 107.81 18.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.016 0.436 . . . . 0.0 109.837 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -129.83 157.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.291 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.2 t -126.92 124.1 63.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.119 0.485 . . . . 0.0 111.002 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.26 126.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -123.32 119.08 29.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.168 0.509 . . . . 0.0 110.141 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.5 156.59 27.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.632 ' HG2' HG22 ' A' ' 89' ' ' THR . 44.1 mtp180 -134.77 147.17 49.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.024 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.28 -134.81 20.19 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -85.1 5.84 28.07 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.392 -0.475 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.38 -3.5 52.95 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -57.37 -32.63 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.446 0.698 . . . . 0.0 110.009 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 p -61.39 -43.56 98.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.017 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 14' ' ' ILE . 99.7 mttt -67.6 -36.44 80.87 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.506 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.86 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.61 -36.3 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.953 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.571 ' O ' HG13 ' A' ' 55' ' ' ILE . 26.3 t70 -62.43 -45.89 91.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.8 m -56.53 -53.66 54.95 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.48 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.03 -34.54 70.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.207 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.583 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 6.0 tp10 -65.75 -40.7 92.34 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 51' ' ' ASP . 75.8 mt -60.11 -42.99 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.016 0.436 . . . . 0.0 110.48 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.04 -44.68 95.36 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.229 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 2.5 ptm180 -80.03 -2.56 44.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.54 20.69 11.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.09 0.471 . . . . 0.0 111.728 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -139.43 -61.41 0.55 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.15 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -92.03 -54.72 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.527 -174.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 90.2 mt -119.03 107.26 13.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -98.25 -46.55 5.78 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.167 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.45 9.87 31.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -132.39 29.05 4.31 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.895 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.66 134.59 58.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' CD ' HH21 ' A' ' 95' ' ' ARG . 40.2 mt-10 -115.95 157.87 23.91 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.212 -178.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -100.42 123.39 53.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -82.78 -61.82 1.77 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.992 0.425 . . . . 0.0 110.841 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.93 141.27 17.6 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.3 pt -130.12 121.56 51.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -132.98 144.74 50.32 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.63 144.83 18.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.77 171.72 28.21 Favored Glycine 0 C--N 1.318 -0.431 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 t -79.21 122.8 26.75 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.709 0.766 . . . . 0.0 110.477 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -99.23 122.2 42.09 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.325 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.459 HG22 ' HG3' ' A' ' 86' ' ' ARG . 44.2 t -81.98 120.69 33.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.57 145.75 33.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.699 0.285 . . . . 0.0 110.287 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.7 p -90.9 125.67 35.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.042 0.449 . . . . 0.0 110.688 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 m -79.66 -23.56 42.42 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.574 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.0 -91.04 0.11 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 122.656 0.382 . . . . 0.0 111.079 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.07 -67.32 0.94 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.0 14.28 6.64 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.292 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -76.85 96.26 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.37 107.95 18.24 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.845 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.9 m -98.32 121.08 39.81 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HG3' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -103.13 113.14 26.38 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.413 ' HB ' HH21 ' A' ' 42' ' ' ARG . 62.7 t -126.46 137.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 p -65.2 121.15 14.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 123.445 0.466 . . . . 0.0 110.065 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.632 HG22 ' HG2' ' A' ' 42' ' ' ARG . 73.4 p -127.46 158.59 36.94 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.458 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -139.47 133.97 38.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.78 112.97 23.62 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.98 117.74 55.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.49 130.01 56.74 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -131.1 157.57 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.499 HH21 ' CD ' ' A' ' 66' ' ' GLU . 59.2 ttp180 -122.37 122.95 40.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.66 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -84.08 -173.98 5.02 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 97' ' ' LYS . 18.3 ptmt . . . . . 0 C--O 1.251 1.152 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.499 -0.985 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 84.0 p 49.51 -160.4 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 O-C-N 124.683 1.239 . . . . 0.0 112.422 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 35.4 t -86.48 6.68 29.33 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.283 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.5 143.64 15.24 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.944 -0.645 . . . . 0.0 112.184 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 29.9 m 70.04 93.6 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.18 0 CA-C-O 121.559 0.695 . . . . 0.0 112.135 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -96.6 24.27 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.188 2.592 . . . . 0.0 112.375 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' B' ' 8' ' ' PRO . 7.1 t -115.74 138.43 23.92 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 7' ' ' THR . 24.2 Cg_exo -67.25 157.89 59.56 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.644 2.229 . . . . 0.0 111.918 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.408 ' OG ' HG22 ' B' ' 11' ' ' VAL . 33.6 p -106.73 -169.49 1.56 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.198 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -97.46 24.21 6.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.098 0.475 . . . . 0.0 111.235 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.408 HG22 ' OG ' ' B' ' 9' ' ' SER . 32.7 m -101.62 151.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.87 135.74 56.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.883 0.373 . . . . 0.0 110.102 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.9 132.77 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.93 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' B' ' 48' ' ' LYS . 48.2 mm -94.48 112.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.054 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.56 38.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.278 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.21 -76.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.262 0.553 . . . . 0.0 110.747 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -99.5 169.25 8.36 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -60.71 161.45 21.32 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.387 2.058 . . . . 0.0 112.486 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -50.03 -32.4 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.882 1.273 . . . . 0.0 113.544 -174.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 24.2 ptp -60.97 -32.04 71.59 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -71.07 -33.99 70.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.941 0.401 . . . . 0.0 109.958 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -75.53 -36.2 60.55 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.312 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.0 -53.19 52.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.052 0.453 . . . . 0.0 110.039 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mp -67.14 -28.06 67.83 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.981 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.25 76.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.649 0.261 . . . . 0.0 110.453 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -31.1 72.16 Favored 'General case' 0 C--O 1.261 1.687 0 CA-C-O 121.233 0.539 . . . . 0.0 111.025 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -71.4 -43.46 66.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.061 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 53.3 m -65.52 -36.18 83.06 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.728 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.23 -39.04 91.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.105 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.29 -32.84 71.57 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.977 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -66.18 -22.15 66.35 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.156 0.503 . . . . 0.0 110.92 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.92 -12.93 56.95 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.823 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.77 22.52 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.582 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.2 105.14 13.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 122.031 0.919 . . . . 0.0 112.291 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 51.5 p -87.74 -31.41 19.69 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.174 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' B' ' 94' ' ' ILE . 43.9 mt-10 -101.93 109.42 21.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.412 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -131.95 155.81 41.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.971 -179.482 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -123.96 125.42 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 111.509 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.02 126.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -123.11 116.77 24.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.247 0.546 . . . . 0.0 110.63 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.48 157.11 24.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.65 ' HG2' HG22 ' B' ' 89' ' ' THR . 50.3 mtp180 -135.7 144.97 46.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.195 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.48 -130.14 10.49 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.241 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -89.88 3.92 51.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.157 0.503 . . . . 0.0 110.333 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.24 -6.4 54.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.307 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.24 -35.12 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.759 0.824 . . . . 0.0 110.288 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.0 p -61.23 -43.69 98.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.178 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.425 ' HB2' HG21 ' B' ' 14' ' ' ILE . 99.7 mttt -66.13 -38.79 89.02 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.328 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.99 87.86 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -71.7 -35.33 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.889 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.563 ' O ' HG13 ' B' ' 55' ' ' ILE . 25.2 t70 -64.63 -45.09 88.36 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -54.21 -53.65 50.55 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.87 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.9 -33.15 59.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.639 ' OE1' ' HD3' ' B' ' 57' ' ' ARG . 5.8 tp10 -67.41 -40.08 85.56 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.563 HG13 ' O ' ' B' ' 51' ' ' ASP . 75.4 mt -60.66 -42.49 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.142 0.496 . . . . 0.0 110.804 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.09 -42.98 91.81 Favored 'Isoleucine or valine' 0 C--O 1.256 1.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.777 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.639 ' HD3' ' OE1' ' B' ' 54' ' ' GLU . 2.7 ptm180 -81.34 -2.92 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.209 -175.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -119.94 19.05 12.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.764 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -139.5 -58.06 0.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.647 -0.421 . . . . 0.0 112.116 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.87 -53.04 4.16 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.279 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 57' ' ' ARG . 91.4 mt -120.82 106.43 11.66 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' B' ' 57' ' ' ARG . . . -97.15 -39.27 9.37 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.54 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -114.58 6.22 15.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.35 31.37 4.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.169 0.509 . . . . 0.0 111.746 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -134.32 136.99 52.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.505 ' CD ' HH21 ' B' ' 95' ' ' ARG . 41.6 mt-10 -119.49 159.29 24.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 110.44 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.99 123.92 55.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -83.57 -60.58 2.08 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.23 0.331 . . . . 0.0 110.364 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -158.03 140.62 14.6 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.85 124.19 60.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.915 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -137.45 143.22 41.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.51 142.18 18.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 O-C-N 123.133 0.271 . . . . 0.0 110.336 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.17 172.4 32.58 Favored Glycine 0 C--O 1.238 0.363 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 121.82 25.27 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.515 0.674 . . . . 0.0 110.451 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -98.38 118.68 35.6 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.431 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' B' ' 86' ' ' ARG . 43.5 t -78.67 120.28 29.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.475 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.61 148.86 30.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 27.7 p -94.41 126.7 39.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.119 0.485 . . . . 0.0 110.887 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -78.37 -29.41 47.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.77 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -139.71 -89.17 0.19 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.796 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -106.12 -76.01 0.62 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.87 18.98 10.43 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.72 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -82.72 96.8 8.27 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -85.37 112.26 20.67 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 123.83 0.707 . . . . 0.0 111.513 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 63.7 m -99.67 124.48 44.94 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.422 ' HG3' HG22 ' B' ' 76' ' ' VAL . 0.0 OUTLIER -107.07 112.43 25.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.73 136.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 21.0 p -63.86 122.29 16.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.014 0.526 . . . . 0.0 110.24 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.65 HG22 ' HG2' ' B' ' 42' ' ' ARG . 77.4 p -127.68 157.5 40.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.112 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 17.4 tt -139.41 131.87 36.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.6 112.91 24.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.43 116.8 53.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.886 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.19 128.62 56.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.387 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.501 HD13 ' H ' ' B' ' 94' ' ' ILE . 0.2 OUTLIER -128.84 155.26 40.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.072 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.505 HH21 ' CD ' ' B' ' 66' ' ' GLU . 60.6 ttp180 -119.54 120.91 38.14 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.686 0.616 . . . . 0.0 110.412 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -82.39 -175.14 5.55 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt . . . . . 0 CA--C 1.548 0.885 0 CA-C-O 119.42 -0.324 . . . . 0.0 111.259 174.433 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.645 -0.132 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t -77.43 -35.1 54.35 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.8 p -151.64 -171.26 3.88 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . 103.12 -169.68 19.02 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.845 178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.0 m -91.33 107.19 19.78 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 98.7 Cg_endo -93.93 7.16 2.55 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.54 2.16 . . . . 0.0 112.655 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.272 20.4 p 47.57 88.11 0.11 Allowed Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -88.13 -173.45 0.95 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.669 2.246 . . . . 0.0 112.074 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.0 m -147.32 -81.46 0.14 Allowed 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.542 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -127.87 15.66 6.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.712 0.292 . . . . 0.0 111.306 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.7 133.97 63.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.457 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.79 135.66 62.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.0 tp -97.26 115.31 27.4 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.8 99.19 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.334 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.71 72.08 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.073 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 17' ' ' LYS . 5.7 ptpp? 172.69 -48.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.48 1.112 . . . . 0.0 112.475 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 32.5 mmmt -100.29 164.77 15.69 Favored Pre-proline 0 C--O 1.256 1.403 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.2 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.5 164.14 34.01 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.595 2.196 . . . . 0.0 110.914 172.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.484 HG21 ' OD1' ' A' ' 51' ' ' ASP . 7.8 p -58.26 -42.81 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.414 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.9 ptp -58.89 -25.93 63.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.12 -38.02 81.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -77.59 -33.28 53.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.46 -47.14 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.359 0.6 . . . . 0.0 109.84 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 20' ' ' MET . 87.0 mt -66.17 -29.66 69.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.782 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -67.99 -43.67 78.39 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.8 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.24 -30.52 70.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.132 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.31 -36.08 66.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.998 0.428 . . . . 0.0 110.182 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 m -70.18 -35.05 73.69 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 91.3 mt -63.88 -27.07 68.91 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.616 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.618 HD21 ' HG3' ' A' ' 96' ' ' LYS . 14.3 mt -57.69 -41.32 81.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 111.6 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -78.28 -5.26 51.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -102.78 -4.45 24.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 109.714 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.28 13.61 58.44 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.193 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 20.7 t -101.01 89.55 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.628 0.727 . . . . 0.0 109.27 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 50.9 m -81.17 -24.71 37.35 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.571 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' OE2' ' HD2' ' A' ' 95' ' ' ARG . 35.2 mt-10 -110.65 111.21 22.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -129.23 154.07 39.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.042 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.026 -177.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.97 117.91 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 123.794 0.684 . . . . 0.0 110.497 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.89 120.81 40.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -113.37 115.03 27.46 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 122.742 0.417 . . . . 0.0 110.195 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.25 39.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HG2' HG22 ' A' ' 89' ' ' THR . 44.1 mtm180 -133.77 148.52 51.39 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 120.817 0.342 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.96 -130.44 10.97 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.782 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.56 -0.45 57.52 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 122.232 -0.569 . . . . 0.0 112.06 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.77 6.41 24.57 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.6 mt -57.77 -37.1 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.514 0.673 . . . . 0.0 110.0 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.8 p -67.66 -29.7 69.06 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.989 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.97 -29.2 58.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.296 0.57 . . . . 0.0 109.66 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.24 -45.35 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.397 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.06 -38.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 55' ' ' ILE . 13.6 t70 -57.91 -42.39 84.64 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.3 m -55.3 -52.69 62.64 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.015 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.68 -34.13 51.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . 0.257 11.6 pt-20 -69.96 -31.7 69.55 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.561 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 51' ' ' ASP . 70.5 mt -62.4 -47.81 91.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.955 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.9 t -57.91 -48.82 83.03 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 16.6 ptm180 -72.75 -14.56 61.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -109.39 0.72 19.55 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.499 -0.88 . . . . 0.0 113.213 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -108.69 -19.28 13.48 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.04 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -146.25 -70.13 0.26 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.451 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.0 86.06 7.07 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' ARG . . . -75.54 -73.6 0.25 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.931 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.6 2.25 55.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -113.88 24.42 12.09 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.187 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.38 133.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.148 0.499 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -101.53 143.62 31.29 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.2 mt -124.65 140.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -89.99 -73.39 0.52 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.115 0.483 . . . . 0.0 111.242 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -170.49 157.52 5.97 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.32 115.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -113.28 128.61 56.52 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.97 132.79 47.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.78 169.46 41.89 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.905 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 m -81.44 138.45 35.54 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 122.969 0.508 . . . . 0.0 109.67 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -115.87 130.49 56.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.686 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -96.56 112.33 28.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.01 148.38 20.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 120.859 0.361 . . . . 0.0 111.129 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.8 p -94.24 120.62 34.74 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.349 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.4 t -74.12 -47.97 32.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.565 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -119.0 -86.09 0.65 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.416 0.627 . . . . 0.0 110.547 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -116.0 -61.49 1.73 Allowed 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.327 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.59 8.27 7.81 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.063 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -76.67 92.62 3.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -87.46 134.12 33.64 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.285 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.0 t -128.67 160.28 32.97 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -113.25 125.08 53.92 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.33 122.24 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 p -65.24 130.47 43.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.465 HG22 ' HG2' ' A' ' 42' ' ' ARG . 41.7 p -128.54 145.42 51.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 -176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.68 138.17 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.0 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -121.9 111.0 16.55 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.393 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.4 mt -107.07 110.5 31.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.16 124.91 53.24 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.4 pt -134.66 168.73 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.526 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 30.5 ttt180 -135.04 155.57 50.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.618 ' HG3' HD21 ' A' ' 30' ' ' LEU . 47.7 mmtm -109.27 145.2 36.33 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm . . . . . 0 C--O 1.254 1.301 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.01 175.503 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.421 0.153 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.8 p -73.28 150.14 42.19 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 123.47 0.708 . . . . 0.0 112.29 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.0 p -100.82 -70.94 0.72 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.561 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.98 -37.3 2.24 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 41.3 p -99.71 127.45 33.94 Favored Pre-proline 0 C--N 1.318 -0.773 0 C-N-CA 122.588 0.355 . . . . 0.0 110.058 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.12 18.41 1.31 Allowed 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 123.17 2.58 . . . . 0.0 113.34 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -97.2 130.95 28.46 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.049 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -48.76 115.16 1.51 Allowed 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 123.412 2.741 . . . . 0.0 113.543 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -100.83 22.46 12.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.182 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -95.98 18.23 13.78 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.425 0.631 . . . . 0.0 110.425 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.59 132.73 69.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.322 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.895 0.379 . . . . 0.0 111.386 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -96.29 114.76 26.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.561 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.82 98.27 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.253 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 72.83 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.435 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.498 ' HG3' ' HG2' ' B' ' 17' ' ' LYS . 5.2 ptpp? 172.25 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.789 1.236 . . . . 0.0 112.244 174.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' B' ' 16' ' ' LYS . 32.3 mmmt -100.19 164.19 16.84 Favored Pre-proline 0 C--O 1.255 1.366 0 O-C-N 122.227 -0.296 . . . . 0.0 111.309 -174.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.02 164.48 29.82 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.997 2.465 . . . . 0.0 110.869 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.9 -42.25 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptp -58.09 -26.12 62.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -68.38 -39.48 81.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.411 0.624 . . . . 0.0 110.104 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.62 -33.34 58.39 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.478 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.31 -48.46 88.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.706 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.32 -29.39 70.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.037 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -67.06 -46.79 73.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.01 85.82 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.123 0.487 . . . . 0.0 111.134 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.222 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 43.2 m -72.16 -36.55 69.35 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.208 0.527 . . . . 0.0 110.26 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.458 ' HB3' ' HB ' ' B' ' 34' ' ' VAL . 94.4 mt -62.99 -30.01 71.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.695 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.604 HD21 ' HG3' ' B' ' 96' ' ' LYS . 17.5 mt -54.0 -42.82 69.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.855 171.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.59 -9.57 58.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.418 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -99.38 -3.78 33.07 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.952 0.406 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.08 12.27 57.79 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.459 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' B' ' 29' ' ' LEU . 20.9 t -100.65 90.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.537 0.684 . . . . 0.0 109.695 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 44.3 m -82.05 -25.29 34.72 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.583 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' B' ' 95' ' ' ARG . 37.2 mt-10 -109.58 110.8 21.99 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.444 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -128.76 152.56 37.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 -177.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.58 119.03 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.492 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.9 121.02 40.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.62 113.89 25.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.045 0.45 . . . . 0.0 110.289 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.94 152.0 38.07 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.438 ' HG2' HG22 ' B' ' 89' ' ' THR . 46.7 mtm180 -134.8 151.41 50.93 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.764 0.316 . . . . 0.0 110.689 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 -128.01 10.9 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.748 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -91.17 -1.04 57.8 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 122.359 -0.495 . . . . 0.0 112.099 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 8.06 21.04 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.408 HG23 HG21 ' B' ' 90' ' ' ILE . 67.6 mt -58.12 -37.86 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.774 0.797 . . . . 0.0 109.924 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 29.2 p -66.39 -30.63 71.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.239 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.67 -31.26 61.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.03 75.98 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.421 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.17 -37.43 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.643 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.499 ' O ' HG13 ' B' ' 55' ' ' ILE . 14.7 t70 -59.11 -40.24 84.75 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 85.6 m -57.47 -52.99 63.12 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.851 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 m -70.93 -34.65 56.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.97 -33.14 73.21 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.293 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.499 HG13 ' O ' ' B' ' 51' ' ' ASP . 74.9 mt -61.87 -48.78 87.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.126 175.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.09 -49.42 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -72.25 -18.26 61.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -104.0 -3.45 24.61 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.882 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -106.54 -15.2 14.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.39 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -149.65 -69.67 0.2 Allowed 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 mp -88.76 86.94 7.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.146 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.86 -73.17 0.3 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.839 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.9 4.84 51.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -115.2 26.51 10.04 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.042 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 8.2 tp -107.25 130.26 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 120.871 0.367 . . . . 0.0 110.98 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -96.99 147.0 24.44 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 72.1 mt -126.6 138.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -88.08 -73.49 0.49 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -172.02 160.94 5.5 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 65.7 mt -125.83 115.49 43.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -111.79 124.19 51.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.22 136.43 56.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.7 170.17 41.02 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.796 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.4 m -80.61 140.8 35.55 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -118.67 130.99 56.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t -97.4 114.47 34.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.75 148.88 22.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.055 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 31.7 p -94.43 117.49 30.2 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.969 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 43.8 t -69.57 -53.78 17.28 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 122.97 0.508 . . . . 0.0 111.409 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -112.74 -84.83 0.58 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.35 0.595 . . . . 0.0 110.444 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -117.03 -62.07 1.63 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.293 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.79 7.19 8.9 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.066 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -76.47 95.13 3.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -91.73 134.43 34.73 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.836 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 34.0 t -127.42 162.7 25.73 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -115.16 125.83 53.88 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.0 119.32 54.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 14.7 p -63.66 129.05 38.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.438 HG22 ' HG2' ' B' ' 42' ' ' ARG . 47.0 p -127.37 147.3 50.27 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.827 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.408 HG21 HG23 ' B' ' 46' ' ' ILE . 15.2 tt -139.36 137.35 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.528 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.05 112.48 19.19 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.046 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 63.4 mt -107.31 111.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.16 127.15 56.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.975 0.416 . . . . 0.0 110.667 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -136.35 167.48 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.263 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' OE2' ' B' ' 36' ' ' GLU . 36.8 ttt180 -134.07 153.47 51.78 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.904 0.383 . . . . 0.0 110.138 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.604 ' HG3' HD21 ' B' ' 30' ' ' LEU . 46.7 mmtm -108.35 140.56 41.46 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm . . . . . 0 C--N 1.311 -1.085 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.11 173.137 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.218 -0.601 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 t -60.83 -45.52 94.13 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 121.331 0.586 . . . . 0.0 110.555 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 p -100.18 20.75 14.03 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.386 0.612 . . . . 0.0 110.505 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.34 92.78 0.17 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -61.73 117.25 26.45 Favored Pre-proline 0 C--O 1.244 0.813 0 O-C-N 124.318 0.658 . . . . 0.0 112.591 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -100.52 6.87 0.69 Allowed 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.66 2.24 . . . . 0.0 111.699 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.2 m 66.45 103.23 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.55 0.74 . . . . 0.0 110.985 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -74.33 -175.14 2.07 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.162 1.908 . . . . 0.0 113.222 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -130.8 -176.85 4.12 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.178 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -84.96 12.8 6.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.05 0.54 . . . . 0.0 112.196 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 19.3 m -98.96 129.98 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.106 0.479 . . . . 0.0 110.458 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' HG12 ' A' ' 39' ' ' ILE . 35.6 m -118.47 139.36 46.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.836 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.0 127.29 43.85 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.761 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.52 110.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.37 53.55 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.234 -1.46 . . . . 0.0 113.894 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -157.51 -58.97 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -100.79 162.28 21.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.997 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.72 156.75 55.64 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.236 1.957 . . . . 0.0 112.014 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG21 ' OD2' ' A' ' 51' ' ' ASP . 7.1 p -50.87 -32.4 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.725 1.21 . . . . 0.0 113.776 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.3 ptp -56.81 -31.6 64.88 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -75.93 -37.15 59.01 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.842 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.7 -37.34 73.55 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.688 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.36 -47.5 90.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.254 0.55 . . . . 0.0 110.05 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.18 -32.22 71.38 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.944 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -67.51 -44.46 78.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.671 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.75 90.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.273 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.44 -35.54 81.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.979 0.419 . . . . 0.0 111.047 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.3 m -69.9 -39.13 76.42 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 95.1 mt -69.73 -35.86 75.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.39 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.8 tm? -59.39 -45.58 91.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.933 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.422 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -79.75 -21.64 44.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.56 -19.84 3.75 Favored Glycine 0 CA--C 1.5 -0.904 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.2 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 22.0 t -71.81 94.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.471 0.653 . . . . 0.0 109.349 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -79.26 -17.47 54.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.216 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.57 130.91 23.62 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -130.15 156.15 42.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.185 -178.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 43.4 t -121.46 113.55 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.304 0.574 . . . . 0.0 110.425 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.419 HG12 ' CG2' ' A' ' 12' ' ' VAL . 65.2 mt -95.14 122.01 46.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 80.4 mttt -120.92 120.64 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.95 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.64 167.24 12.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.769 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -139.29 141.94 37.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.21 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 59.93 -106.72 1.06 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -83.31 -21.18 33.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.19 0.519 . . . . 0.0 109.95 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.32 -8.7 56.97 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.14 -39.2 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.606 0.717 . . . . 0.0 110.386 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.5 t -64.55 -29.51 70.54 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.664 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -78.34 -37.35 44.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.559 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.306 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -73.14 -35.7 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.766 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.48 ' OD2' HG21 ' A' ' 19' ' ' VAL . 18.1 t70 -58.83 -47.92 83.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.3 m -53.07 -54.14 39.87 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.205 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.35 -29.17 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.35 -36.77 79.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.6 mt -65.44 -50.14 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.962 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.27 -44.57 84.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -75.55 -1.95 26.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -130.42 6.6 4.86 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.612 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -114.13 -61.9 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -76.41 -50.08 15.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.591 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.4 tp -159.46 105.91 1.69 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.31 -27.67 15.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.506 1.129 . . . . 0.0 111.869 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.76 -42.49 89.03 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.607 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -122.34 108.38 13.17 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.985 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tp -161.35 145.8 4.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.77 156.13 43.89 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.0 mt -104.35 141.21 20.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -95.93 -38.25 10.33 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.332 -0.23 . . . . 0.0 110.902 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -167.78 146.38 4.69 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.486 0.491 . . . . 0.0 109.835 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.52 97.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 124.356 1.062 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.8 142.08 50.38 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.976 -0.689 . . . . 0.0 112.405 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.76 134.95 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.18 151.28 22.6 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.15 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -79.57 124.72 28.77 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -107.69 135.29 49.36 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.953 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -103.8 115.28 45.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.35 0.595 . . . . 0.0 111.092 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.22 135.05 59.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.11 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.4 p -80.15 121.67 25.86 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.45 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.9 t -59.61 -41.17 89.78 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.651 0.594 . . . . 0.0 111.397 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -178.56 -40.06 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -120.17 -155.41 0.62 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.19 17.39 1.02 Allowed Glycine 0 CA--C 1.537 1.464 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -78.5 100.44 6.88 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -85.77 103.52 14.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.0 m -84.46 114.82 22.2 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.261 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -89.35 110.06 20.9 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.87 132.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.219 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -71.41 126.77 30.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.937 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 46.5 p -127.99 154.61 45.42 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.964 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 15.3 tt -135.28 135.08 52.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.555 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -112.5 111.1 21.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.642 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 90' ' ' ILE . 43.5 mm -108.28 110.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.62 122.01 39.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.17 149.4 25.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -126.6 127.55 45.41 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -77.61 151.92 34.14 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.689 0.757 . . . . 0.0 112.866 -174.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 N--CA 1.437 -1.117 0 C-N-CA 126.154 1.782 . . . . 0.0 106.459 179.138 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 111.165 0.061 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m 62.82 13.39 6.47 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m 60.42 93.01 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.64 78.99 0.87 Allowed Glycine 0 CA--C 1.501 -0.819 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.463 ' HB ' ' HD3' ' B' ' 6' ' ' PRO . 23.3 m -61.19 -53.39 63.56 Favored Pre-proline 0 CA--C 1.568 1.662 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' B' ' 5' ' ' THR . 85.2 Cg_endo -85.64 -39.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 121.164 1.243 . . . . 0.0 112.695 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -136.02 100.0 10.96 Favored Pre-proline 0 C--O 1.249 1.034 0 C-N-CA 122.659 0.384 . . . . 0.0 110.419 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -89.57 108.33 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.86 2.374 . . . . 0.0 111.516 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -92.56 17.86 9.5 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.313 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -106.81 7.29 30.17 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' B' ' 38' ' ' VAL . 18.9 m -96.66 129.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.118 0.485 . . . . 0.0 111.487 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.407 ' CG2' HG12 ' B' ' 39' ' ' ILE . 34.4 m -119.97 139.41 47.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.893 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.11 124.47 44.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mm -95.22 112.4 27.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.805 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.33 47.31 0.01 OUTLIER Glycine 0 C--N 1.313 -0.727 0 C-N-CA 119.136 -1.507 . . . . 0.0 114.338 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -151.73 -58.05 0.15 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.874 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' B' ' 18' ' ' PRO . 56.0 mtpt -101.52 162.62 19.89 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' B' ' 17' ' ' LYS . 28.7 Cg_endo -62.56 155.43 58.5 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 122.518 2.145 . . . . 0.0 112.162 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.82 -31.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.5 1.12 . . . . 0.0 113.992 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -57.52 -34.35 69.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -71.76 -40.78 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.751 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -69.16 -38.48 78.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.638 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -58.26 -46.85 88.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.338 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.5 -37.03 79.72 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.235 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.68 95.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.75 88.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.562 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.11 -35.71 81.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.7 m -67.39 -41.94 84.17 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.49 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 94.2 mt -68.93 -34.77 75.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 2.0 tm? -59.89 -44.17 94.39 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.42 -25.25 66.66 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.306 0.574 . . . . 0.0 111.779 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -79.13 -14.75 58.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.672 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.83 -16.32 6.5 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.964 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' B' ' 30' ' ' LEU . 21.5 t -74.68 94.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -83.25 -15.03 51.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.1 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.425 ' OE2' ' HE3' ' B' ' 68' ' ' LYS . 10.0 pt-20 -140.01 130.03 24.88 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.424 ' H ' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -131.32 155.61 41.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.21 -178.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' B' ' 11' ' ' VAL . 43.0 t -121.77 113.52 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.663 0.744 . . . . 0.0 110.872 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.407 HG12 ' CG2' ' B' ' 12' ' ' VAL . 61.7 mt -94.64 123.08 46.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.037 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' B' ' 90' ' ' ILE . 82.5 mttt -121.36 123.11 41.35 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.172 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.78 166.77 14.41 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.316 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -139.68 140.72 36.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.203 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.91 -105.41 0.92 Allowed Glycine 0 N--CA 1.466 0.649 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -84.32 -23.29 30.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.867 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.08 -7.22 47.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 72.1 mt -57.22 -39.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.727 0.775 . . . . 0.0 109.723 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 38.2 t -64.03 -32.42 73.96 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.54 -37.66 59.86 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.184 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.54 -47.92 83.67 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-O 121.088 0.471 . . . . 0.0 111.525 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.86 -35.22 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.802 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.439 ' O ' HG13 ' B' ' 55' ' ' ILE . 21.5 t70 -59.93 -45.04 93.9 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 63.7 m -54.88 -56.85 14.99 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.322 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.89 -29.84 44.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.46 -35.27 77.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.779 0.323 . . . . 0.0 110.158 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 51' ' ' ASP . 80.2 mt -67.16 -50.85 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 88.2 t -55.59 -44.87 78.17 Favored 'Isoleucine or valine' 0 C--O 1.254 1.315 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.92 -2.55 27.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' B' ' 62' ' ' ALA . 18.9 t-20 -132.48 9.01 4.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.318 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -113.27 -60.1 1.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.296 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.51 -51.44 9.97 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.08 0.467 . . . . 0.0 111.1 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 67.8 tp -158.25 104.67 1.87 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' B' ' 58' ' ' ASN . . . -92.76 -22.03 19.6 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.329 -176.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.38 -43.87 80.31 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -117.96 105.67 12.14 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tp -161.18 141.02 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.56 156.32 45.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.098 0.475 . . . . 0.0 109.739 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.39 140.42 20.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.425 ' HE3' ' OE2' ' B' ' 36' ' ' GLU . 64.9 tttm -93.83 -40.58 10.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.292 -0.255 . . . . 0.0 110.944 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -167.74 147.05 4.89 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.438 0.462 . . . . 0.0 109.759 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 pt -145.62 100.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 124.521 1.128 . . . . 0.0 109.698 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.104 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.75 135.86 56.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.0 150.94 22.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.353 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 15.0 m -79.48 124.0 28.07 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -106.98 134.87 49.49 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.933 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -103.63 115.86 46.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.247 0.546 . . . . 0.0 110.847 176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.14 134.18 64.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.09 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 35.2 p -80.23 120.79 24.79 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.096 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 35.8 t -60.34 -40.5 90.9 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.47 0.481 . . . . 0.0 111.71 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -178.06 -39.2 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -121.46 -156.7 0.7 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.98 25.77 0.66 Allowed Glycine 0 CA--C 1.534 1.243 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -84.89 96.23 9.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -81.46 105.48 12.66 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.733 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.6 m -83.67 112.97 20.53 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -87.07 109.39 19.38 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.74 132.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 128.76 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 58.0 p -130.13 154.27 47.66 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' B' ' 40' ' ' LYS . 14.9 tt -134.84 136.34 52.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.504 0.192 . . . . 0.0 110.524 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -115.21 112.32 22.31 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.417 HD11 HD11 ' B' ' 90' ' ' ILE . 43.6 mm -108.91 110.61 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.85 120.77 37.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -121.94 149.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -127.43 126.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -77.51 151.43 34.58 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.935 -174.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.435 -1.177 0 C-N-CA 125.234 1.414 . . . . 0.0 107.778 179.885 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.509 -0.623 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p -68.89 137.88 54.22 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.358 0.412 . . . . 0.0 111.389 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -114.29 -1.49 13.57 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.963 0.411 . . . . 0.0 110.695 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.7 -42.7 5.35 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.896 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 37.8 m -130.98 126.07 21.51 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 4.1 Cg_exo -77.17 162.95 31.06 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.865 2.376 . . . . 0.0 112.505 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 p -87.73 125.51 64.72 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.267 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.16 164.96 11.29 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.833 2.355 . . . . 0.0 112.575 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -138.3 105.22 5.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -135.92 16.09 3.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.668 0.747 . . . . 0.0 109.713 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 ' HB ' ' A' ' 38' ' ' VAL . 31.0 m -120.08 133.45 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.052 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.53 144.45 30.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.255 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -105.83 121.63 44.45 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.09 103.35 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.19 51.11 0.03 OUTLIER Glycine 0 C--O 1.24 0.49 0 C-N-CA 119.515 -1.326 . . . . 0.0 114.086 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -166.33 -55.32 0.03 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.125 0.462 . . . . 0.0 110.831 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.86 154.71 37.1 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.22 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD2' ' ND2' ' A' ' 21' ' ' ASN . 38.6 Cg_exo -62.7 160.23 33.64 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.327 2.018 . . . . 0.0 111.638 174.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -49.93 -34.17 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.53 1.132 . . . . 0.0 113.267 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.458 ' O ' HD13 ' A' ' 24' ' ' LEU . 26.8 ptm -60.1 -27.35 66.95 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.609 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.475 ' ND2' ' HD2' ' A' ' 18' ' ' PRO . 43.9 m-80 -80.83 -25.81 37.5 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.118 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -83.88 -37.62 22.17 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.553 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.426 ' O ' HD13 ' A' ' 27' ' ' LEU . 73.2 t -59.29 -55.59 22.62 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.045 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 20' ' ' MET . 8.3 mp -62.31 -31.32 71.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.081 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -61.24 -42.84 99.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 123.117 0.26 . . . . 0.0 111.241 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.495 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -64.92 -40.37 94.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.782 0.325 . . . . 0.0 110.403 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 23' ' ' VAL . 8.6 mp -63.13 -39.34 94.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.449 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.6 m -66.0 -34.42 78.05 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 25' ' ' ALA . 89.5 mt -70.87 -36.42 72.78 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.664 0.269 . . . . 0.0 111.325 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 26' ' ' ALA . 92.5 mt -59.61 -42.6 93.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.05 0.453 . . . . 0.0 110.067 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -65.75 -25.17 67.15 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -89.24 -2.42 58.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.746 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.1 12.2 40.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.171 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.6 t -99.34 115.23 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -101.31 -30.64 11.38 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.93 105.79 14.32 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.036 0.922 . . . . 0.0 112.784 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -117.38 154.53 19.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.512 -177.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HB ' HG12 ' A' ' 11' ' ' VAL . 50.3 t -121.69 120.63 62.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.103 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -96.78 120.52 46.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.275 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 91' ' ' GLU . 48.1 mttp -108.26 121.29 44.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.72 138.12 53.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -137.1 120.13 16.55 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.53 76.44 1.27 Allowed Glycine 0 C--O 1.219 -0.804 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.92 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 68.0 -15.66 0.2 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.3 6.05 3.97 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.813 0.445 . . . . 0.0 111.869 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.426 HG23 HG21 ' A' ' 90' ' ' ILE . 68.2 mt -56.73 -37.91 55.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.448 1.099 . . . . 0.0 109.406 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.1 p -67.56 -24.87 65.57 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.137 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -86.96 -29.96 21.65 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.534 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.24 -42.61 96.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.7 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.63 -40.75 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.214 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 55' ' ' ILE . 17.2 t70 -57.65 -44.18 85.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.445 0.641 . . . . 0.0 109.281 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 91.0 m -57.94 -51.08 71.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.678 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.448 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 33.8 m -69.85 -32.36 51.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.122 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.35 -36.48 83.84 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 51' ' ' ASP . 76.8 mt -67.64 -46.77 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.141 0.496 . . . . 0.0 110.385 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' THR . 67.2 t -59.71 -38.27 75.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.166 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 53' ' ' VAL . 15.9 ptm180 -91.87 17.68 8.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.609 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -133.07 -41.73 0.9 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -86.91 -60.45 1.98 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.629 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.56 -58.28 3.42 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.045 0.45 . . . . 0.0 111.588 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.5 tp -148.0 102.49 3.39 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.3 -26.88 17.11 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.871 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.03 -50.28 66.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.15 0.5 . . . . 0.0 111.775 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -103.81 105.8 16.12 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 121.106 0.479 . . . . 0.0 110.882 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 tp -159.79 127.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.431 0.692 . . . . 0.0 110.652 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.81 149.57 51.4 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 173.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.77 134.67 46.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -90.95 -60.37 1.93 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.118 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -155.55 147.91 23.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.41 111.02 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -113.73 135.28 54.11 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.546 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -136.65 133.59 48.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.3 179.31 48.14 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.596 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 m -80.71 124.07 28.72 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.636 0.774 . . . . 0.0 110.971 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 86' ' ' ARG . 25.7 tt0 -88.99 117.54 28.08 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t -103.88 108.87 25.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.39 145.77 34.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.326 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.9 p -83.78 127.12 33.57 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m -53.92 -54.09 43.6 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.545 0.528 . . . . 0.0 111.322 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -167.25 -57.84 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.28 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -86.53 -79.61 0.26 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.906 0.384 . . . . 0.0 110.605 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.85 29.77 1.01 Allowed Glycine 0 C--O 1.223 -0.532 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.139 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -93.63 105.62 17.65 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -70.53 109.16 4.67 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.591 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -100.35 109.27 21.45 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 75' ' ' GLN . 89.7 mtt180 -101.63 117.87 35.79 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -124.44 135.1 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.312 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 m -62.94 120.57 11.62 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 123.697 0.799 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 p -127.19 152.02 47.92 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 122.641 0.377 . . . . 0.0 110.364 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.426 HG21 HG23 ' A' ' 46' ' ' ILE . 15.9 tt -143.71 142.2 24.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.163 0 CA-C-O 120.782 0.325 . . . . 0.0 110.607 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' A' ' 40' ' ' LYS . 44.3 mt-10 -123.5 121.14 34.92 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.778 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -113.06 111.61 36.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.84 117.15 31.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.51 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 pt -119.16 168.17 11.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.935 0.398 . . . . 0.0 110.659 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -125.23 118.62 26.43 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.742 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -105.1 78.74 1.42 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.136 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? . . . . . 0 C--O 1.274 2.354 0 C-N-CA 124.082 0.953 . . . . 0.0 110.004 176.25 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 16.8 m -84.31 -7.33 59.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.511 0.324 . . . . 0.0 111.826 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t 69.53 18.9 7.65 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.858 0.863 . . . . 0.0 111.015 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.65 145.28 17.64 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 10.2 t -137.97 143.18 38.7 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 5' ' ' THR . 2.9 Cg_exo -77.19 -2.95 13.19 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.414 2.076 . . . . 0.0 113.276 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -112.81 129.13 24.76 Favored Pre-proline 0 N--CA 1.436 -1.173 0 CA-C-O 120.99 0.424 . . . . 0.0 110.26 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.21 98.08 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.198 1.932 . . . . 0.0 111.873 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 30.1 t -104.71 -40.57 5.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.928 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -136.84 16.05 3.08 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 20.9 m -115.68 131.98 66.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.174 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.78 145.78 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 60.5 tp -108.62 118.79 37.7 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.001 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -83.89 113.43 22.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.75 45.16 0.02 OUTLIER Glycine 0 C--O 1.237 0.305 0 C-N-CA 119.48 -1.343 . . . . 0.0 114.057 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -163.34 -59.69 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.241 0.52 . . . . 0.0 110.291 177.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.17 155.52 38.83 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.21 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.45 ' HD2' ' ND2' ' B' ' 21' ' ' ASN . 35.5 Cg_exo -63.26 158.99 41.61 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.569 2.179 . . . . 0.0 111.385 174.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.478 HG21 ' OD2' ' B' ' 51' ' ' ASP . 7.6 p -48.75 -35.1 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.599 1.16 . . . . 0.0 113.113 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.418 ' O ' HD13 ' B' ' 24' ' ' LEU . 26.3 ptm -57.66 -29.77 64.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.969 0.414 . . . . 0.0 111.743 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.45 ' ND2' ' HD2' ' B' ' 18' ' ' PRO . 40.7 m-80 -77.27 -30.58 54.38 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.63 -38.22 40.25 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.924 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.434 ' O ' HD13 ' B' ' 27' ' ' LEU . 66.7 t -60.35 -55.83 21.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.027 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.418 HD13 ' O ' ' B' ' 20' ' ' MET . 8.3 mp -63.79 -25.27 68.1 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -65.43 -44.9 85.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.666 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.459 ' O ' ' HG ' ' B' ' 30' ' ' LEU . . . -63.54 -42.91 98.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.967 0.413 . . . . 0.0 110.65 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.434 HD13 ' O ' ' B' ' 23' ' ' VAL . 8.8 mp -61.23 -35.72 77.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.486 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 61.9 m -69.89 -35.74 74.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.294 0.569 . . . . 0.0 109.794 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' B' ' 25' ' ' ALA . 90.5 mt -68.9 -35.3 76.68 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 122.159 -0.338 . . . . 0.0 111.368 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 26' ' ' ALA . 91.1 mt -59.5 -41.12 89.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.084 0.469 . . . . 0.0 110.585 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -67.25 -25.04 65.89 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.077 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -87.94 -0.92 57.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.967 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.34 0.02 53.83 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.739 -0.744 . . . . 0.0 114.424 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.48 113.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -100.93 -27.74 13.14 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.901 0.381 . . . . 0.0 111.436 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.06 110.44 20.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.826 0.822 . . . . 0.0 112.198 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.492 HD13 ' H ' ' B' ' 37' ' ' ILE . 0.2 OUTLIER -123.16 152.75 28.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.963 -175.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.62 119.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 CA-C-O 121.156 0.503 . . . . 0.0 110.29 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -96.3 120.98 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.24 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.42 ' HG2' ' HG2' ' B' ' 91' ' ' GLU . 49.4 mttp -107.79 120.99 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.156 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 49' ' ' ALA . . . -119.3 137.14 53.88 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -135.79 117.81 15.34 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.82 76.47 1.31 Allowed Glycine 0 C--O 1.217 -0.931 0 N-CA-C 114.742 0.657 . . . . 0.0 114.742 175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 67.18 -15.04 0.17 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.89 6.87 4.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.0 0.429 . . . . 0.0 111.607 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.4 HG23 HG21 ' B' ' 90' ' ' ILE . 67.8 mt -55.99 -39.42 57.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 124.57 1.148 . . . . 0.0 109.778 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.0 p -64.66 -29.0 69.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.8 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.21 -28.59 27.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.571 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 41' ' ' ALA . . . -65.62 -40.52 92.66 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.288 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.63 -40.97 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.171 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.478 ' OD2' HG21 ' B' ' 19' ' ' VAL . 15.6 t70 -54.68 -48.12 72.77 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.613 0.721 . . . . 0.0 109.518 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.46 ' O ' HG23 ' B' ' 56' ' ' VAL . 64.3 m -54.52 -52.0 63.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.941 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.26 -33.47 58.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.313 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.48 -35.91 82.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.098 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 51' ' ' ASP . 77.7 mt -67.66 -47.38 80.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 120.946 0.403 . . . . 0.0 110.259 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 52' ' ' THR . 81.0 t -59.36 -38.49 75.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.936 -177.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -90.88 18.46 6.58 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.286 -0.259 . . . . 0.0 111.529 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.73 -48.74 0.88 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.235 0.54 . . . . 0.0 110.603 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -81.23 -52.2 7.59 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -80.81 -60.32 2.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.191 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -146.13 104.12 3.79 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.81 -24.73 16.34 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.925 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.71 -46.89 64.95 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.36 0.6 . . . . 0.0 111.361 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -104.13 105.83 16.13 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.987 0.423 . . . . 0.0 110.693 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 tp -160.82 131.31 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 123.387 0.675 . . . . 0.0 109.905 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.81 147.46 42.56 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 67.5 mt -104.65 133.62 48.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -89.5 -60.43 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.092 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.04 149.28 27.01 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -138.2 109.61 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -112.01 134.85 53.31 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.515 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.29 130.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.59 177.89 46.57 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.063 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 10.5 m -79.46 125.27 29.34 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.087 0.955 . . . . 0.0 111.254 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' B' ' 86' ' ' ARG . 27.5 tt0 -90.1 116.5 28.16 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.448 HG22 ' HG2' ' B' ' 86' ' ' ARG . 40.5 t -101.55 107.4 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.48 146.58 33.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 120.707 0.289 . . . . 0.0 110.249 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' THR . . . . . . . . . . . . . 25.3 p -85.51 128.26 34.68 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -57.23 -51.52 69.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.017 0.437 . . . . 0.0 111.341 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -168.98 -60.19 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.541 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -85.79 -78.16 0.28 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.191 0.52 . . . . 0.0 110.765 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.36 35.21 0.76 Allowed Glycine 0 CA--C 1.501 -0.782 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.108 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -98.72 108.18 20.81 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -74.66 110.14 8.71 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.375 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 36.7 m -99.06 112.8 24.83 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' B' ' 75' ' ' GLN . 96.6 mtt180 -105.31 111.17 23.8 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.98 133.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.66 120.25 10.83 Favored 'General case' 0 C--O 1.256 1.42 0 C-N-CA 123.651 0.78 . . . . 0.0 110.609 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 39.0 p -125.92 151.18 47.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.4 HG21 HG23 ' B' ' 46' ' ' ILE . 15.6 tt -141.74 143.58 26.92 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 120.626 0.251 . . . . 0.0 110.813 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.42 ' HG2' ' HG2' ' B' ' 40' ' ' LYS . 42.5 mt-10 -124.36 121.75 35.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.886 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.06 113.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.53 115.42 27.95 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 120.885 0.374 . . . . 0.0 110.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 pt -118.83 161.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.728 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -120.23 118.53 30.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.41 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -102.97 78.85 1.7 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? . . . . . 0 C--O 1.279 2.61 0 C-N-CA 124.395 1.078 . . . . 0.0 109.775 177.315 . . . . . . . . 0 0 . 1 stop_ save_